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NO FATE BUT WHAT WE MAKE: A CASE OF FULL RECOVERY FROM SUDDEN
CARDIAC ARREST
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INTRODUCTION. Cardiac Arrest (CA) is an important cause of death, 50 percent occurring
outside hospitals. One-half of these patients are found in Ventricular Fibrillation (VF) or
pulseless ventricular taquicardia. Within this group, better survival is achieved with early
deﬁbrillation (less than four to eight minutes). Early BLS is also associated with better
survival, by delaying the deterioration of the cardiac rhythm to asystole.
METHODS. Case report.
RESULTS. We describe the case of a 80 years old man, who suffered CA shortly after arrival
to his local health department, for an appointment with his GP. Several weeks before he began
to suffer from typical effort angina and that day he was feeling unwell. Basic Life Support
(BLS) was started promptly and an Advance Life Support (ALS) team was requested through
the national emergency number. Nine minutes after, ALS team arrived and conﬁrmed CA,
with VF. The victim was deﬁbrillated with a 200 J shock and BLS resumed. When oro-
tracheal intubation was attempted, masseter muscle contraction was noticed, so BLS was
discontinued for reevaluation. The rhythm had become a wide QRS tachycardia with pulse
and the victim recovered spontaneous breathing. Partial consciousness was recovered
(Glasgow Coma Score: 11). On physical examination blood pressure was 133/62 mmHg,
heart rate 130 bpm and pulse oximetry 97%. The patient was transferred to an emergency
department. Half an hour later, as he recovered consciousness fully, he complained of chest
pain. The ECG showed a sinus rhythm with a heart rate of 75, right bundle branch block and
ST segment depression in in leads V4 to V6. Laboratorial tests showed cardiac troponine I
0.78 ng/ml. A coronary angiography performed urgently, disclosed signiﬁcant left main plus
three vessel – coronary artery disease. Left anterior descending artery (LAD) was occluded,
with late retrograde ﬂow. Eighteen hours after the CA, a quadruple coronary artery bypass
grafting operation was undertaken. During surgery, a fresh thrombus was removed from the
proximal LAD.
Post-operative course was uneventful and the patient was discharged on day 7 after the
procedure. Sixteen months later, he remains asymptomatic.
CONCLUSION. This case illustrates the possibility of a happy end after an episode of
sudden CA, in an old patient with undiagnosed severe coronary artery disease and presumable
acute coronary syndrome.
Although ALS was started nine minutes after the witnessed collapse, return of spontaneous
circulation after the ﬁrst deﬁbrillation and prompt breathing recovery contributed to the
success of the resuscitation maneuvers. The fact that CA occurred in a health care facility
allowed prompt BLS, which contributed to the recovery. Furthermore, the speed in the
detection and treatment of the acute reversible cause (myocardial ischemia in this case) was
crucial for long-term prognosis.
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INTRODUCTION. Hyperglycemia has suppressive effects on immune function and an
associated increased risk of infection, endothelial damage and development of tissue ischemia
due to acidosis or inﬂammation. (1) We aimed to study the possible association between
hyperglycemia and outcome in a population of critically ill trauma patients.
METHODS. Analysis of a cohort of trauma admitted in the emergency room in a 6 years
period, using the prospective registry that uses TRISS methodology for severity analysis.
Percentage, mean, standard deviation, 25th – 75th, Chi-square and Fisher’s exact test were
used for the statistical analysis (p\0.05 was consider signiﬁcant). Hyperglycemia was
considered when glycemia at admittance was C 106 mg/d. Patients with hypoglycemia
(\80 mg/dL) were excluded from the analysis.
RESULTS. 883 patients (85.3 % of 1035 patients) had hyperglycemia. In this group 703 were
men (79.6%) with a mean age of 44.49 ± 20.71 (p\0.01). Road trafﬁc accidents (56.3%),
falls (29.7%), and penetrating injuries (5.8 %) account for most of the injury mechanisms.
Patients with hyperglycemia were more severely injured resulting in signiﬁcant differences
concerning Revised Trauma Score (RTS) (5.95 ± 1.42), Injury Severity Score (ISS)
(25.15 ± 11.41, p\0.001) and probability of survival (69.8 ± 28.59, p\0.001).
Mortality was 30.1% for the hyperglycemia group and 16.4% for the normoglycemic group
(p = 0.001). The logistic regression model showed glycemia at admittance as an independent
prognostic factor (OR: 1.003; 95%CI: 1.001–1.004) after controlling for age, gender type of
trauma and severity of trauma.
CONCLUSION. Increases in 10 points in the glycemia implies an increase of more than 10
times in mortality showing that the simple glycemia admittance determination is of farthest
value.
REFERENCE(S). Yendamuri S e col. Admission Hyperglicemia as a prognostic Indicator in
Trauma. J Trauma. 2003;55:33–38.
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‘‘COLONIZATION PRESSURE’’ AND AIRBORNE TRANSMISSION: TWO IMPOR-
TANT PARAMETERS OF A UNIQUE EPIDEMIOLOGICAL BEHAVIOUR OF
A. BAUMANNII IN ICU
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INTRODUCTION. Despite contact-isolation precautions routinely applied against carriers
of multi-drug resistant bacteria in our ICU, A. baumannii remains highly endemic. This study
aimed to record the incidence of A. baumannii-carriage and to explore the presence of an
endemic or an epidemic situation.
METHODS. For 13 months (screening-period) we performed a prospective cohort study by
screening for A. baumannii-carriage with pharyngeal, cutaneous and rectal swabs, at
admission and then once-weekly. We also performed environmental sampling of inanimate
surfaces. Despite the initial schedule, we continued our study for the next 12 months (post-
screening period) because of an outbreak of A. baumannii revealed by the molecular analysis
of the ﬁrst period. Clinical samples and additional specimens from the environment were
taken during the post-screening period (surfaces, air, ﬁlters of the acclimatization system).
Molecular analysis (rep-PCR) of the strains of the two periods was performed to identify
possible horizontal transmission and exogenous A. baumannii-reservoirs. Correlation was
calculated between weekly ‘‘colonisation pressure’’ of A. baumannii-carriers and acquisition
of A. baumannii-carriage in the screening-period.
RESULTS. 301 patients were admitted in the ICU, 284 were eligible for analysis. In the
screening-period, 6% admitted- and 16% acquired-carriage was recorded. One clone (among
six) of A. baumannii ‘‘circulated’’ in the unit in both periods of the study (one epidemic
clone). A sustained survival of A. baumannii on the surfaces and in the air was detected.
Correlation was found between the weekly ‘‘colonization pressure’’ of A. baumannii and the
acquisition of A. baumannii-carriage (p = 0.004). For a weekly ‘‘colonization pressure’’
above 20%, the possibility for acquisition of A. baumannii-carriage increased 23 times
(RR = 23.42, 95% CI: 3.127–175, P = 0.0001).
CONCLUSION. Admitted-carriers were the sources for both endemic and epidemic situa-
tions in the unit. Secondary inanimate reservoirs and airborne transmission of A. baumannii
played an important role in the evolution and duration of the outbreak. Screening for
admitted-carriage and contact-isolation precautions for A. baumannii carriers are not always
effective measures for the control of an outbreak. High levels of a weekly ‘‘colonisation
pressure’’ could be considered a preliminary sign of an A. baumannii-outbreak and help
clinicians apply adequate control measures.
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INTRODUCTION. Sepsis is an important cause of admission in intensive care units (ICUs)
and is associated with high morbidity and mortality. The goal of our study was to better deﬁne
the epidemiology of community-acquired sepsis (CAS) in Portuguese ICUs.
METHODS. Prospective observational study of all patients admitted to 17 Portuguese ICU
(41% of all Portuguese ICU beds) from 1st December 2004 to 30th November 2005.
Washington consensus conference sepsis deﬁnitions were used. Co-morbidities considered
were: chemotherapy, radiotherapy, malignancy, corticotherapy, HIV infection, AIDS and
chronic diseases such as: cardiovascular, respiratory, liver, renal and haematological. Chi-
square test and logistic regression were used in statistical analysis.
RESULTS. 22% of the 4202 patients admitted to the ICUs during the study period had CAS
(Severe sepsis 40%; Septic shock 50%). CAS patients were mostly male (64%) and a median
age of 63 (18–100). Although a shorter hospital length of stay (LOS) was observed in CAS
patients (18 vs. 19 d; p = 0,001), they had a higher SAPS II score on admission (47 vs. 41)
and stayed longer in the ICU LOS (9 vs. 5 days; p\0,001). Median time between hospital
and ICU admission was 2 days (1–16) and SOFA score on ICU admission was 7.14 ± 3.75.
The most common site of infection was respiratory (61%) followed by intra-abdominal 18%
and urinary 7%. Septic shock patients were older, had higher SAPS II and SOFA scores on
ICU admission and the abdomen was more often the source of sepsis. Health care associated
infections represented 23% of all cases. Infections were microbiologically documented (MD)
in 39% of the cases and blood cultures were positive in 20%. There was a small predominance
of Gram + organism (41%). The most common pathogens were St. pneumoniae (21%), E.
coli (18%) and Staph. aureus (17%, including 3,4% methicilin-resistant). Half of the patients
had at least 1 co-morbidity and 23% C 2 co-morbidities, mainly cardiovascular (19%) and
respiratory disease (19%). Number of co-morbidities (p = 0,031), malignancy (p = 0.001),
chronic liver disease (p\0.001) and chronic renal failure (p = 0.028) were associated with
ICU mortality. Globally, ICU (30% vs. 23%) and hospital (38% vs. 32%) mortality of CAS
patients were signiﬁcantly higher than non-CAS patients. Variables associated with mortality
were: age (OR 1.014), male (OR 1.608), SAPS II (OR 1.050), SOFA on hospital admission
(OR 1.174), C 1 co-morbidity (OR 1.430), MD (OR 1.402), bacteremia (OR 1.807) and
septic shock (OR 4.272).
CONCLUSION. CAS is a frequent cause of ICU admission. CAS patients usually have co-
morbidities, a higher SAPS II score, a signiﬁcantly longer ICU LOS and a signiﬁcantly higher
ICU and hospital mortality. Most of episodes were not MD. The presence of septic shock,
MD, namely bacteremia, and at least 1 co-morbidity were the variables more strongly
associated with mortality.
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POLYCLONAL P. AERUGINOSA IN ICU: NO NEED FOR ISOLATION PRECAU-
TIONS IN ENDEMIC SITUATIONS
K. Arvaniti*, E. Synnefaki, D. Lathyris, E. Blougoura, M. Nastou, V. Metaxa, D. Matamis
Intensive Care Medicine, Papageorgiou Hospital, Thessaloniki, Greece
INTRODUCTION. In our ICU, P. aeruginosa is the third cause of nosocomial infections.
This study aimed to identify the epidemiology of this pathogen in order to assess the pos-
sibility of an unrecognized outbreak and the usefulleness of screening cultures and contact
isolation precautions.
METHODS. We performed a prospective cohort study for 13 months. P. aeruginosa-carriage
was recorded by pharyngeal, cutaneous and rectal swabs at admission and then once-weekly.
A patient was considered as admitted-carrier if he had the ﬁrst screening sample positive for
P. aeruginosa and as acquired-carrier if he had the ﬁrst sample negative and at least one
positive sample during his ICU stay. Environmental sampling was performed before and after
routine daily disinfection. Demographical data, severity scores, duration of invasive proce-
dures and antibiotics administered in the ICU were recorded. Preventive contact-isolation and
contact-isolation precautions were applied only for carriers of other multi-drug resistant
microorganisms. All ﬁrst P. aeruginosa-isolates as well as environmental strains were typed
by repetitive extragenic palindromic sequence-based PCR (rep-PCR). Multivariate analysis
identiﬁed risk factors for admitted and acquired P. aeruginosa-carriage.
RESULTS. 284 among 301 admitted patients were eligible for analysis. 6% admitted and
13% acquired P. aeruginosa-carriage was revealed, pharynx was the principal site of carriage
(50%). P. aeruginosa was found in tap water and sinks. The molecular typing identiﬁed 43
different rep-PCR proﬁles, no similarity was found between carriage- and water-isolates. The
conditional probability for acquisition of P. aeruginosa-carriage was: 4% for days 0–9, 13%
for days 10–19, 20% for days 20–29, 23% for days 30–39 and 29% for days 40–50. In
multivariate analysis, risk factors for admitted-carriage were: transfer from another ICU (OR:
7.22; CI: 1.75–29.82, P = 0.006) and administration of antibiotics before the ICU admission
(OR: 4.71, CI: 1.12–19.78, P = 0.034). For acquisition of P. aeruginosa-carriage, age
(OR = 1.038; CI: 1.013–1.06, P = 0.002) and the transfer from another ICU were inde-
pendent risk factors in the multivariate analysis.
CONCLUSION. P. aeruginosa in our ICU showed a polyclonal endemicity and a low
capacity for horizontal transmission despite the non application of contact-isolation precau-
tions for carriers. Transfer from another ICU and exposure to antibiotics identiﬁed admitted-
carriers of P.aeruginosa. Screening and isolation of P. aeruginosa-carriers are not necessary
for endemic situations with non-multiresistant strains of P. aeruginosa.
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INTRODUCTION. To present the evolution of multiresistance markers (MMR) in ICU-
acquired infections according to the site of infection.
METHODS. Prospective, multicenter, cohort study. Patients admitted to the participating
ICUs during the year 2007 were included. Patients were followed until ICU discharge or up to
a maximum of 30 days. The following infections were assessed: mechanical ventilation-
related pneumonia (VAP), urinary tract infection related to the urinary catheter (C-UTI), and
catheter-related bacteremias/primary bacteremias (PB(VCB). MMR identiﬁed were deﬁned
according to the CDC (1). Data were collected using a program developed with Acces 97
database. Resistance rates are expressed as % of isolations resistant to the antibiotics selected
in respect to each pathogen evaluated. Multiresistance rates for each infection analyzed are
presented. Rates of previous years are compared.
RESULTS. A total of 12,453 patients admitted to the participating ICUs were included, 1367
of which (11.0%) developed 1577 infections (12.7%) during their ICU stay. A total of 1625
microorganisms were recovered, 926 (57%) of which were Gram-negative pathogens, 506
(31.4%) Gram-positive, 179 (11%) fungi, and 14 (0.9%) of other bacteriologic families.
MMR according to the infection focus are shown in table.
TABLE 1
GLOBAL VAP C-UTI CV-B/PB
Staphylococcus aureus methicillin-resistant 24.2 24.6 ND 25.0
Staphylococcus epider methicillin-resistant 80.9 ND ND 82.5
Escherichia coli ciproﬂoxacin-resista 34.4 32.1 35.4 ND
Escherichia coli cefotaxime-resistant 16.9 17.0 12.4 ND
Acinetobacter spp imipenem-resistant 76.4 72.2 93.3 93.3
P. aeruginosa amikacin-resistant 12.9 14.0 13.5 5.0
P. aeruginosa ceftazidime-resistant 27.2 27.8 28.0 20.8
P. aeruginosa ciproﬂoxacin-resista 37.1 35.3 43.6 20.8
P. aeruginosa imipenem-resistant 32.0 36.8 25.8 14.3
P. aeruginosa pipe/tazo-resistant 18.9 18.7 23.7 12.5
CONCLUSION. Differences in the resistance markers in P. aeruginosa according to the
infection focus.
REFERENCE(S). (1) Center for Infectious Diseases Control. Am J Infect Control 1999;
27:279.
GRANT ACKNOWLEDGEMENT. (*) ENVIN-UCI sudy supported by Sanoﬁ-Aventis.
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INTRODUCTION. Panresistant Pseudomonas aeruginosa(Pa)has emerged in Rio de Janeiro
in 1999;Panresistant Acinetobacter sp.(Acn) has emerged in 2003,both has become a public
health problem.Pu blic Hospital of Macae(MPH)is localized 190 km far from Rio de Janeiro
city;it is a 127-bed trauma hospital.
METHODS. 35 patients(pts) colonized or infected by panresistant Pa or Acn were ana-
lyzed(JUL-DEC/2007).Panresistant strains were deﬁned as those susceptible only to amikacin
or polymyxin and resistant to all antimicrobials tested.Nosocomial infections were deﬁned by
the CDC.The cumulative incidence of infections was calculated.Antimicrobial susceptibility
was performed using Vitek-1.Genotyping of was performed by RAPD-PCR.APACHE II
score (24 h)and Charlson score was calculated(2,3).
RESULTS. The cumulative incidences of panresistant Pa and Acn were 0.9/1,000 pts-day
(0.24–1.63)and 0.96 pts-day (0- 1.77),respectively.The majority of pts were admitted at
intensive care units(77%).Ventilator-associated pneumonia(12 pts)and primary bloodstream
infection (10 pts)were the most commom infections diagnosed.The days between hospital-
ization and isolation,for Acn is median 13,and for the Pa is 30,with p = 0,02.Infections were
caused by Acn sp.in 14 pts and by Pa in 9 pts.The mortality rate by Pa or Acn was 47%.9
pts(26%)had their isolates typed.The Acn strains had unique DNA pattern,but analysis of Pa
strains showed a polyclonal pattern.
CONCLUSION. The emergence of panresistant Pa may have occurred by the acquisition of
mechanismsofresistanceofthepreviouslysusceptiblestrains.Cross-transmissionwasprobably
responsible for the emergence of panresistant Acn.These two mechanisms of acquisition of
resistance may explain the difference in time from hospitalization to the ﬁrst isolation of the
resistantstrainobservedinourstudy.Measuresinvolvingantimicrobialuseandtocontaincross-
transmission of strains are important in the control of resistance in the hospital.
REFERENCE(S). 1-Pellegrino FL,Teixeira LM,Carvalho Md Mda G,Aranha Noue ´r S,Pinto
De Oliveira M,Mello Sampaio JL,D’Avila Freitas A, Ferreira AL,Amorim Ed Ede L,Riley
LW, Moreira BM. Occurrence of a multidrug-resistant Pseudomonas aeruginosa clone in
different hospitals in Rio de Janeiro,Brazil.J Clin Microbiol. 2002 Jul;40(7):2420–4.
2-Charlson ME,Pompei P,Ales KL,MacKenzie CR.A new method of classifying prognostic
comorbidity in longitudinal studies: development and validation. J Chronic Dis.
1987;40(5):373–83.
3-Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease
classiﬁcation system. Crit Care Med. 1985 Oct;13(10):818–29.
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INTRODUCTION. Acinetobacter Baumanni is an important cause of nosocomial infection
in critically ill patients. Many isolates exhibit multi-drug resistance, raising concerns over our
ability to treat serious infections with these organisms. The risk factors and clinical outcome
for resistance are poorly deﬁned.
METHODS. A descriptive retrospective observational study was undertaken of all episodes
of Acinetobacter baumanni bacteremia occurring in 40-beded tertiary level multidisciplinary
intensive care unit (ICU) of a teaching hospital. Over a period of one year, patients with
Acinetobacter baumanni infection in their ﬁrst blood stream sample were considered. The
proﬁle of patients with multi-drug resistant (MDR) A. baumanni blood stream infection (BSI)
was compared to the patients with susceptible Acinetobacter baumanni BSI.
RESULTS. Of the 104(72 males,32 females) patients with Acinetobacter baumanni
BSI,43(41.3%)had MDR A. baumanni infection while 61(58.7%) had susceptible A. bau-
manni infection. Mean age of patients with MDR A. baumanni BSI was 43 ± 34 years while
the mean age of susceptible group was 47 ± 39 years. MDR A. baumanni infection occurred
signiﬁcantly higher in males as compared to females (30/43 vs. 13/43,P = 0.03).Patients with
MDR A. baumanni BSI had signiﬁcantly higher number of patients with history of previous
hospitalization(38/43 vs. 25/61,P = 0.01)and had signiﬁcantly received Carbepenem(29/
43vs17/61,P = 0.01) as compared to the patients with susceptible A. baumanni BSI. There
was no signiﬁcant difference in the mean duration of the hospital stay before being shifted to
ICU (15 ± 12.4 vs. 12 ± 10.9,P = 0.2) however, patients with MDR A. baumanni had
prolonged ICU stay (33.5 ± 25 vs. 20.4 ± 16.2,P = 0.04) as compared to the patients with
susceptible A. baumanni BSI. The odds of having a MDR A baumanni BSI was signiﬁcantly
higher in post-operative patients (19/43 vs. 12/61, OR = 2.2,95% CI = 0.98–5.1, P = 0.05,
patients with grade IV pancreatitis (24/43 vs. 16/61, OR = 2.1, 95%CI = 1–4.4,P = 0.04,
with solid malignancy(18/43 vs. 9/43,OR = 2.8,95%CI = 1.1–6.9,P = 0.01) and in diabetics
(28/43 vs. 18/61, OR = 2.2,95% CI = 1–4.4, P = 0.02. However, susceptible A. baumanni
BSI occurred signiﬁcantly in patients with lower respiratory tract infections as compared to
MDR A. baumanni BSI(38/61 vs. 12/43,P = 0.03). BSI with MDR A. baumanni was an
independent risk factor for mechanical ventilation (32/43 vs. 23/61,P = 0.04) and mortality
(28/43 vs. 19/61,P = 0.03) as compared to the susceptible A.baumanni BSI. The mean SAPS
II(simpliﬁed acute physiology score) predicted death rate was signiﬁcantly higher in patients
with MDR A. baumanni BSI as compared with those having susceptible A. baumanni (63%
vs. 41%,P = 0.04).
CONCLUSION. MDR Acinetobacter is more likely to be found in patients with solid
malignancy, diabetics and grade IV pancreatitis. It was an independent risk factor for
mechanical ventilation, mortality and SAPS predicted death rate in patients.
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INTRODUCTION. Among critically ill patients, Acinetobacter spp. cause serious infections,
the management of which is complicated by antimicrobial resistance, including carbapenem
resistance. The data from various studies regarding the impact of these infections on mortality
are conﬂicting.
METHODS. Prospective, epidemiological study of infections due to A. baumanii in an ICU
of a tertiary care hospital. The data collected included demographic and clinical character-
istics of all patients admitted to the ICU from August 2004 to January 2007. A patient was
considered to have an infection due to A. baumanii when the bacterium was isolated from a
blood culture and he also had clinical signs of infection. Positive bronchial cultures were
considered to represent colonization. Only the ﬁrst episode of infection for each patient was
included. Statistical analysis was done with SPSS v.16.
RESULTS. During the study period 447 patients were admitted to the ICU, of whom 63%
were surgical. Their mean age was 66 years and 61% of them were male. Their mean
APACHE II score was 18. Thirty-ﬁve cases of bloodstream infections due to A.baumanii
(BSI) were identiﬁed (8% of patients). Of these, 13 were due to ventilator-associated pneu-
monia, 2 to abdominal infections, 11 were catheter-related and 9 were primary. Prior
bronchial colonization with A.baumanii was found to be a signiﬁcant risk factor for BSI
(p = 0.000). The isolated strains of A.baumanii were highly resistant: 79% to carbapenems,
73% to ampicillin/sulbactam, 97% to quinolones and 97% to maxipime. 66% were susceptible
only to colistin (tigecycline excluded), while in the last year of the study, when tigecycline
was included in the testing, resistance to tigecycline was found to be 15%.
Patients with BSI due to A.baumanii had a 28 days mortality of 47% and an in-hospital
mortality of 70%. BSI was signiﬁcantly related to increased in-hospital mortality (p = 0.000).
CONCLUSION. Multi-drug resistant A.baumanii is an important cause of infection in our
ICU leading to increased in-hospital mortality. Bronchial colonization seems to be a pre-
disposing factor and hygiene measures must be implemented, in order to minimize the risk.
REFERENCE(S). 1. Playford EG, Craig JC, Iredell JR. Carbapenem-resistant Acinetobacter
baumanii in intensive care unit patients: risk factors for acquisition, infection and theire
consequences. J Hosp Inf 2007;65:204–211.
2. Blot S, Vandewoude K, Colardyn F. Nosocomial bacteremia involving Acinetobacter
baumanii in critically ill patients: a matched cohort study. Intensive Care Med 2003
Mar;29(3):471–5.
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INTRODUCTION. Surveillance of device related infection is one of the mean objectives in
Spain. Infection rates (IR) are inﬂuenced by both the intrinsic and extrinsic risk factors (RF);
the latest vary according to the hospital. Objective: To compare IR in ICU according to the
hospital size
METHODS. Prospective study performed through out 3 months per year during 2 consec-
utive years (2006 and 2007), using the methodology and database of the ENVIN-HELICS.
Characteristics of the patients, use of devices and IR per 100 patients and per 1,000 days of
ICU’ stay/ device were analysed. Hospitals were classiﬁed as small (SH)\200 beds, medium
(MH) 200–500 beds and big (BH)[500 beds. udy.
RESULTS. 112 ICU were evaluated. Their location was: 14 (12,5%) belonged to SH, 45
(40,1%) to MH, and 53 (47,3%) to BH. 24137 patients were studied, distributed as follow:
1191 (4,9%)/10686 (44,2%)/12260 (50,7%). Mean age: 62,9/62,8/60,3 years. APACHE II
score: 13,5 (8,1)/ 13 (8,5)/15 (8,2). Immune system alterations: 6,3/7,3/10,5%. Mechanical
ventilation (MV): 32,2/35,5/47,4%. Central venous catheter (CVC): 61,3/ 1,9???? /89,9%.
Urinary tract infection (UTI): 66/66,4/78%. Extra renal depuration: 0,2/ 1,1/2,4%. Length of
stay: 6,4/ 7,1/ 8,4 days. Mortality: 8,2/9,2/12,8%. Colonization-infection by MRSA: 0,67/
1,31/1,8%; Acinetobacter: 0,1/1,1/2,7%; multiresistant P aeruginosa: 0,4/0,6/1,3%, and by
BLEE: 0,4/0,6/1%.
TABLE 1
SH MH BH
INF x100 pts 7,8 11,6 16,7
INF x 1000 days 12,2 16,2 19,7
VAP x 100 pts 3,4 5,7 6,8
VAP x 100 pts with MV 10,6 16,2 14,4
VAP x 1000 days MV 0,84 12,6 17,1
UTI x 100 pts 1,5 2,5 4,1
UTI x 100 pts with UC 2,2 3,9 5,6
UTI x 1000 days UC 0,2 3,6 6,2
PB + CRB x 100 pts 2,3 2,3 4,1
PB + CRB x 100 pts with CVC 3,8 3,7 5,1
PB + CRB x 1000 days CVC 0,3 3,1 6,5
CONCLUSION. Major participation of MH and BH. The severity, length of stay and
exposition to risk factors are directly proportional to the hospital size, as well as the multi-
resistant bacterial infection and IR due to more prolonged stay and devices. Stratiﬁcation is
mandatory in the evaluation of IR according to the ICU size.
GRANT ACKNOWLEDGEMENT. Aventis.
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SPECTRUM OF ACINETOBACTER INFECTIONS IN PATIENTS ADMITTED TO
THE ICU OF A TERTIARY CARE CENTER
R. Chawla
1, T. Jhamb*
1, R. Sardana
2
1Respiratory and Critical Care Medicine,
2Microbiology, Indraprastha Apollo Hospitals,
New Delhi, India
INTRODUCTION. Acinetobacter has emerged as the major pathogen responsible for
infections in ICU patients. It is commonly ESBL positive and resistant to vast majority of
drugs. However, there is lack of data from Indian patients
METHODS. To elucidate the characteristics of patients, co-morbidities, site of isolation,
sensitivity patterns and outcome of ICU patients with Acinetobacter infections
RESULTS. Forty nine critically ill patients (56.4 ± 15.5 years, 20–79 years; M:F 33:16;
Apache II score 20.6 ± 7.9, 4–35) with Acinetobacter infection from different sites were
included over a six month period. Majority had hospital acquired infections (n = 29, 59.2%)
with the commonest site of isolation being the respiratory secretions (n = 28, 57.1%).
Pneumonia (n = 10, 20.4) was the commonest diagnostic group followed by sepsis (n = 7,
14.3%). Co-morbidities were commonly present (n = 23, 46.9%) with diabetes being the
commonest (n = 9, 18.4%). Majority of the patients were on mechanical ventilation (n = 28,
57.1%). History of prior broad spectrum antibiotic use was present in 19 patients (38.8%).
Third generation cephalosporins alone were largely ineffective (sensitivity rates\5% of all
the isolates). Isolates demonstrated high rates of resistance to Meropenem (n = 31, 63.1%),
Imipenem (n = 30, 61.2%) and Piperacillin-Tazobactam combination (n = 28, 57%). Only
two antibiotics, namely, Polymyxin B (only one isolate found to be resistant) and Cefope-
razone-Sulbactam (only 5 isolates were resistant) demonstrated good efﬁcacy against the
isolates (see ﬁgure). Hospital mortality was 20.4% (n = 10).
CONCLUSION. Acinetobacter is frequently isolated from ICU patients with lung being the
commonest focus. History of broad spectrum antibiotic use is common. A vast majority of the
antibiotics including the carbapenems seem to be largely ineffective. Polymyxin B and
Cefoperazone-Sulbactam are useful antimicrobial agents against Acinetobacter infections.
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REDUCTION OF BLOODSTREAM S. AUREUS/METHICILLIN RESISTANT
S. AUREUS INFECTION WITH REGULAR ANTISEPTIC BODY WASH-RETRO-
SPECTIVE ANALYSIS
V. Ramar*, G. Rajendiran, A. K. Mani
Intensive Care Unit, Apollo First Med Hospital, Chennai, India
INTRODUCTION. The aim of this study was to analyze the efﬁcacy of the antiseptic
Stellisept  body lotion, containing Undecylenamide Propyl Trimonium Methosulphate
(2.5 g/100 g) and Phenoxyethanol (2.5 g/100 g), for the eradication of bloodstream Staphy-
lococcus aureus (S. aureus) especially methicillin resistant S. aureus (MRSA) infection in
patients admitted to mixed medical-surgical ICU.
METHODS. Between October 2006 and June 2007, all patients admitted to ICU were given
regular body wash with antiseptic Stellisept
  body lotion irrespective of their infection/
colonization status. The number of central venous catheters placed and all blood cultures
positive for S. aureus including MRSA were retrospectively collected and compared with the
patients admitted to the ICU in the preceding nine months between January 2006 and Sep-
tember 2006 where Stellisept
  body wash was not used. For the purpose of this study only
central venous catheters placed in the ICU and blood cultures that were positive after 48 h of
ICU admission were used.
RESULTS. Between January 2006 and September 2006, 694 patients were admitted to the
ICU, 113 central venous catheters were placed and 55 patients developed S. aureus bacter-
emia out of which 21 were MRSA. Between October 2006 and June 2007, 648 patients were
admitted to the ICU, 105 central venous catheters were placed and 14 patients developed S.
aureus bacteremia out of which 9 were MRSA. After the regular body wash with antiseptic
Stellisept  body lotion of all ICU patients there was a signiﬁcant reduction in the incidence
of bloodstream S. aureus (p\0.05) and MRSA (p = 0.019) infection.
REFERENCE(S). 1. Gu ¨nter Kampf and Axel Kramer. Eradication of methicillin-resistant
Staphylococcus aureus with an antiseptic soap and nasal mupirocin among colonized patients
– an open uncontrolled clinical trial. Annals of Clinical Microbiology and Antimicrobials
2004, 3:9. 03 June 2004.
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EPIDEMIC BLOODSTREAM INFECTION CAUSED BY CARBAPENEM-RESIS-
TANT KLEBSIELLA PNEUMONIAE IN A GREEK ICU. ONE YEAR
PROSPECTIVE STUDY
E. Mouloudi*
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1, K. Katsanoulas
1, T. Giasnetsova
1, E. Protonotariou
2,
D. Soﬁanou
2, N. Gritsi-Gerogianni
1
INTRODUCTION. Carbapenem resistance of Klebsiella pneumoniae has increased in our
hospital from 1,75% in 2005 to 22% in 2006.The aim of our study was the evaluation of
treatment, infection outcome and mortality rate of patients with Bloodstream Infections (BSI)
caused by Carbapenem-Resistant Klebsiella Pneumoniae (CRKP) in the ICU of a 1200-bed
tertiary greek hospital.
METHODS. We prospectively studied all patients with BSI due to CRKP in our ICU, during
1-year period (from 1/1/2007 to 1/1/2008). 40 blood isolates from 25 patients carried metallo-
beta-lactamases and were resistant to carbapenems. The isolates were susceptible to amino-
glycosides (100%) and colimycine (100%). Treatment, infection outcome and patient
mortality were assessed.
RESULTS. 25 patients (15 male, 10 female, age 54 ± 21,8 years) had BSI due to CRKP.
Admission APACHE II score was 15,1 ± 6 and SOFA score on the ﬁrst day of infection was
7,1 ± 2,6. BSI occurred 15,2 ± 8,7 days after admission. The patients’ length of stay in the
ICU was 27,3 ± 15 days. All patients received aminoglycosides (100%) and among them 17
patients with septic shock received combination therapy with colimycine. 80% of patients
recovered from BSI while 36% of included patients died; in 55% of them BSI due to CRKP
was considered responsible for their death.
CONCLUSION. The emergence of CRKP has important implications to the future ability to
treat these infections. In our study, the most consistently in vitro active agents were am-
inoglycosides and colimycine. Combination therapy may affect outcome in septic shock
patients with BSI due to CRKP.
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GOALS TO DECREASE THE INCIDENCE OF MULTI-RESISTANT ACINETOBAC-
TER SP. IN A CRITICAL CARE UNIT
M. Lugarinho*, L. J. P. Peixoto, R. Beranger, P. C. P. Souza
1Intensive Care Unit, Hospital de Clı ´nicas Mario Lioni, Rio de Janeiro, Brazil
INTRODUCTION. The presence of multi-resistant Acinetobacter sp. is a current challenge
in critical care units all over the world. This gram negative bacteria is characterized by
survival in the environment for long periods of time, requiring few conditions for its growth.
In this study we are monitoring the impact of the incidence of Acinetobacter sp. MDR
(resistance to ampicillin/sulbactam and carbapenems) in an ICU, after intensiﬁcation of
measures for prevention and control of hospital infection, with involvement of the multi-
disciplinary team.
METHODS. Prospective study, with pre and post-intervention, in a general private ICU, with
23 beds. We classiﬁed a multidrug resistant when the bacteria were resistant to carbapenems
and ampicilina/sulbactam. We calculated the incidence rate monthly (absolute number of new
cases after 48 h of the admission in the hospital, over the number of patients/day). The
intervention measures to be implemented were discussed at meetings with the ‘‘brainstorm’’
technique with the whole ICU team. Measures selected were: intensiﬁcation of hand washing,
use of alcohol gel, adherence to the contact measurements advices and withdrawal of rings
and bracelets; review the process of cleaning the environment and care of ventilation material.
It was established as our goal to maintain the rates under the maximum limit expected of the
previous year.
RESULTS. The measures were implemented in December 2006. There was a good partici-
pation and adherence of all staff. The goal established was the incidence below of the
maximum limit expected of 2006 (13,6 new cases per 1000 patients/day). It has been observed
already in the ﬁrst half of the following year a reduction of the rates, to even better than to the
lasts two years (5,6 new cases per 1000 patients/day). In July 2007 there was another outbreak
of the multiresistant bacteria (18,9 new cases per 1000 patient/day). After that, we reintro-
duced all the training measurements and for the next months our rates showed reduction to the
previous level (4,9 new cases per 1000 patients/day).
CONCLUSION. The implementation of an appropriate program involving all staff members
can reduce the presence of multi-resistant Acinetobacter sp in an ICU. But the vigilance and
adherence to the recommendations must be maintained and monitored continuously so that
such results can be sustainable.
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INCIDENCE AND ANTIBIOTIC RESISTANCE PATTERN OF EXTENDED SPEC-
TRUM BETA LACTAMASE PRODUCING ORGANISMS FROM INPATIENT
SAMPLES FROM A TERTIARY CARE HOSPITAL IN INDIA
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INTRODUCTION. Infections due to extended spectrum beta lactamase (ESBL) producing
multi drug resistant Enterobacteriaceae is increasingly seen world wide. The threat of ESBL’s
is higher in India than in the western world.
METHODS. This retrospective review of the Microbiology database was done to ﬁnd out the
prevalence of ESBL’s at Manipal Hospital, Bangalore, India (a 650 bed tertiary care centre) in
2007. The laboratory received 16392 requests for culture from January to December 2007.
1228 E.coli and 514 Klebsiella pneumonia isolates were analysed. Antibiotic susceptibility
testing was done by the CLSI guidelines. Cefotaxime and cefotaxime plus clavulanic acid
discs and ceftazidime and ceftazidime plus clavulanic acid discs were used for the conﬁr-
mation of ESBL’s.
RESULTS. The prevalence of ESBL’s was 40.8% (710/1742)-ESBL E. coli was 39.3% (483/
1228) and ESBL Klebsiella pneumonia was 43.6% (224/514). Resistance to antibiotics among
ESBL’s was as follows: Amikacin 9.3% (66/710), Netilmycin 7.0%, oﬂoxacin 78%. Among
the beta lactam/beta lactam inhibitor combinations—increased resistance to piperacillin- ta-
zobactum was seen (67.9%) as compared to Cefaperazone/sulbactum (36.8%). Resitance to
carbapenem–Imipenem 0.8% and Meropenem 0.5% was low. Four isolates were resistant to
both carbapenems and two to all the above antibiotics.
CONCLUSION. The ESBL prevalence from inpatient samples at our hospital was 40.8%.
Most of the ESBL’s were multidrug resistant. Cefaperazone/sulbactum showed a higher
sensitivity compared to Piperacillin/tazobactum. Low level of resistance to Carbapenems was
prevalent.
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REDUCTION OF ICU ACQUIRED MRSA, ACINETOBACTER AND VRE WITH
INTRODUCTION OF SDD
D. T. Doberenz*, M. Templeton, R. Meacher
Intensive Care Unit, Charing Cross Hospital, London, United Kingdom
INTRODUCTION. Selective digestive decontamination (SDD) may reduce colonization
with multiresistant bacteria, e.g. acinetobacter, in intubated critically ill patients. With
addition of vancomycin to SDD a reduction of methicillin resistant staphyloccocus aureus
(MRSA) has been demonstrated. SDD with topical tobramycin, colistin, vancomycin and
nystatin has been administered to patients intubated[48 h at our ICU since January 2007,
together with expanded microbiological screening for resistant bacteria (MRSA screeing only
before).
METHODS. Retrospective observational study of patients intubated[48 h in the same ICU
in the ﬁrst six months of 2006 (no SDD)and 2007(with SDD). Data were obtained from ICU
and microbiology databases. ICU acquired colonization was deﬁned as C1 positive sample
for MRSA, multiresistant acinetobacter (MRA), other cephalosporin resistant gram-negative
bacteria (RGNB) and VRE[48 after ICU admission and up to 48 h after ICU discharge.
RESULTS. A total of 304 and 253 patients were admitted to our ICU in the ﬁrst six months
of 2006 and 2007, respectively. The table shows results for patients intubated[48 h only.
RGNB includes cephalosporin resistant E.coli, Enterobacter and Klebsiella.
TABLE 1
1 January–30
June 2006
1 January–30
June 2007
Patients intubated[48 h 114 125
Mean APACHE II 21 21
ICU deaths (%) 27 (24%) 30 (24%
Total ventilator days 1076 1210
Mean ventilator days/patient 9.4 9.7
Patients with acq. MRSA (%) 6 (5.3%) 1 (0.8%)
Patients with acq MRA (%) 25 (21.9%) 5 (4%)
Patients with acq. RGNB 9 (7.9%) 9 (7.2%)
Patients with acq. VRE 10 (8.8%) 5 (4.0%)
CONCLUSION. In the ﬁrst six months after intoduction of SDD acquisition of MRSA, MRA
and VRE decreased compared to the same time period the year before, RGNB acquisition
remained the same. 3 of 9 acquired RGNB in 2007 were only detected on new expanded
screening. This seems to conﬁrm that SDD with vancomycin can decrease MRSA and aci-
netobacter without a rise in other resistance. Longer term observation of ICU ecology with
on-going SDD remains necessary.
REFERENCE(S). Agusti C, Pujol M, Argerich J et al, J Antimicrob Chemotherapy
2002;49:205–8. De la Cal M, Cerda E, van Saene H et al, J Hosp Inf 2004;56:175–83.
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BUFFERED HYPERCAPNIA ATTENUATES THE DEVELOPMENT OF SEPTIC
SHOCK IN SYSTEMIC POLYMICROBIAL SEPSIS
M. Contreras*, B. Higgins, J. Costello, M. Ni Chonghaile, J. G. Laffey
Department of Anaesthesia and Intensive Care Medicine, University College Hospital Gal-
way, Lung Biology Group, National Centre for Biomedical Engineering S, Galway, Ireland
INTRODUCTION. Lung protective mechanical ventilation is integral component of the
management of acute lung injury (ALI), however such strategies are often associated with
elevated PaCO2. Whereas current concepts presuppose that improved outcome is due to
limitation of lung stretch, increasing evidence exists to support an independent protective
effect of elevated CO2 tension. Hypercapnic acidosis protects against lung injury in several
contexts, including pulmonary and mesenteric ischaemia-reperfusion (1) and sepsis induced
lung injury (2). In contrast, buffered hypercapnia, i.e. hypercapnia with normal pH, worsens
ischaemia-reperfusion induced lung injury (3). However, the effect of buffered hypercapnia
on the evolution of shock due to systemic sepsis has not been investigated.
METHODS. Adult male Sprague-Dawley rats (330–450 g) were randomised to be exposed
to environmental hypercapnia (8% CO2) or normocapnia for 72 h, at which stage the animals
had a buffered hypercapnia. On day four, following induction of anaesthesia, mechanical
ventilaiton and placement of lines, animals were subjected to caecal ligation and puncture
(CLP) and received normocapnia (FiCO2 0.0, n = 12) or hypercapnia (FiCO2 0.05, n = 12).
Animals were ventilated for 6 h and haemodynamic parameters, indices of anaerobic
metabolism (blood lactate, base deﬁcit), lung mechanics were assessed. Broncho-alveolar
lavage specimens, blood and peritoneal ﬂuid were analysed post-mortem.
RESULTS. Buffered hypercapnia attenuated the development of septic shock. The time to
reduction of arterial blood pressure to 50% of baseline level was signiﬁcantly longer in the
hypercapnia group (p = 0.0023). This was associated with better survival at 6 h and sig-
niﬁcantly lower blood lactate levels in the buffered hypercapnia group (p\0.05). Total urine
output was signiﬁcantly higher in the buffered hypercapnia group (p = 0.0022). Static lung
compliance, arterial oxygenation did not differ between the two group, however there was a
trend of reduced broncho-alveolar IL-6 levels in the hypercapnia group.
CONCLUSION. Buffered hypercapnia proved to be protective in evolving septic shock, with
better presevation of arterial blood pressure and lesser increases in blood lactate levels,
compared to controls. These protective effects were persistent during the experiment.
REFERENCE(S). 1. Laffey JG et al. Effects of therapeutic hypercapnia on mesenteric
ischaemia-reperfusion injury. Am J Respir Crit Care Med 2003;168:1383–1390.
2. Laffey JG et al. Hypercapnic acidosis attenuates endotoxin-induced acute lung injury. Am J
Respir Crit Care Med 2004;169:46–56.
3. Laffey JG et al. Buffering hypercapnic acidosis worsens acute lung injury. Am J Respir Crit
Care Med 2000; 161:141–146.
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CHANGES IN EEG, BRAIN SPECIFIC PROTEINS AND COGNITIVE FUNC-
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INTRODUCTION. Septic encephalopathy as example of organ dysfunction in septic patients
is associated with EEG changes and increased levels of brain speciﬁc proteins (BSP). The
pathophysiological mechanism is unclear, but possibly mediated by a direct neurocytotoxic
effect of circulating cytokines. We determined the correlation between EEG changes, BSP,
and cognitive functions (CF) in volunteers exposed to endotoxin (LPS).
METHODS. Healthy male volunteers (n = 15) received 2 ng/kg E. coli LPS. Cytokines,
temperature, heart rate and BSP were determined at 0–1–2–4–8 hrs after LPS infusion. CF-
tests were performed at 0–2–8 hrs, and EEG changes were monitored continuously.
RESULTS. Volunteers experienced the expected ﬂu-like symptoms, illustrated by an increase
in temperature of 1.4 ± 0.5oC and an increase in heart rate of 27 ± 9 bpm. Circulating
cytokines increased to 814 ± 516, 1111 ± 548 and 108 ± 106 pg/ml) for respectively TNF-
a, IL-6, and IL-10. Endotoxemia induced no clinical relevant EEG changes by both visual and
quantitative analysis. NSE and S100-b (BSP’s) decreased from 11.5 ± 2.0 to 7.7 ± 1.4 lg/l
(p\0.0001) and 51 ± 8 to40 ± 9 ng/l (p = 0.076) respectively, whereas GFAP did not
change. All domains of the CF showed a signiﬁcant improvement after the administration of
LPS. Peak concentrations of circulating TNF-a and IL-6 were negatively correlated with
S100b (r =- 0.63 and r =- 0.65, p = 0.012 and p = 0.009, respectively). No correlations
were found between cytokines, EEG parameters and CF.
CONCLUSION. Experimental human endotoxemia results in high levels of circulating
cytokines, no signiﬁcant changes in EEG background activity and is associated with lower
BSP, and improved CF. We found no indications of direct neurocytotoxic effects of cytokines
on the brain.
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HUMAN NEUTROPHIL PEPTIDES INDUCE INFLAMMATION IN HEMOR-
RHAGIC SHOCK HEMODILUTION RESUSCITATION
K. Quinn*, M. Henriques, S. Voglis, H. Zhang
Critical Care and Anesthesia, St. Michael’s Hospital, Toronto, Canada
INTRODUCTION. Fluid resuscitation in the perioperative care of hypotensive trauma
patients can exacerbate the injury sustained during hemorrhagic shock. Polymorphonuclear
leukocytes (PMN) release human neutrophil peptides (HNP) upon activation and are known to
play a pivotal role in reperfusion associated organ injury. We hypothesize that HNP play an
important role in mediating proinﬂammatory and prothrombotic responses during ischemia
and reperfusion following hemorrhagic shock.
METHODS. Male Sprague-Dawley rats were subjected to hemorrhagic shock initiated by
blood withdrawal to reduce MAP to 40 mm Hg within 15 min. After a 60 min hypotensive
period, rats underwent isovolumetric resuscitation using either whole blood (B) or an equal
mix of whole blood and lactated Ringer’s solution (B/R) to restore values of MAP to 80 –
90 mm Hg for 1 hr. Blood was drawn for cytokine analysis. PMN-induced inﬂammation was
assessed in a co-culture of human primary pulmonary artery endothelial cells (HPAEC) with
primary human PMN stimulated with HNP. Platelet aggregation and expression of CD62P
was examined following stimulation with HNP.
RESULTS. MIP-2 and TNF-\alpha levels at baseline were similar between B and B/R rats but
following HSR were signiﬁcantly increased in the B/R group (Table 1). Direct stimulation of
HPAEC with HNP increased PMN adhesion, which was associated with IL-6 and IL-8
production from HPAEC and an increased surface expression of CD11b in PMN (Table 2).
HNP increased P-selectin expression, induced aggregation, and prolonged the transient
aggregation mediated by ADP in both human and murine platelets.
TABLE 1 HEMODILUTION-INDUCED INFLAMMATION IN RATS
Whole
blood pre
(B)
Post
Whole blood/
lactated Ringer’s
(B/R)
TNF-\alpha 20.12 ± 2.18 35.14 ± 4.51 18.07 ± 2.87 667.50 ± 84.86*
MIP-2 134.00 ± 8.32 198.70 ± 19.43 165.90 ± 17.80 324.20 ± 61.57*
Cytokine concentrations are pg/mL. *P\0.001
TABLE 2 PMN-INDUCED INFLAMMATION IN HPAEC AND PMN
Control HNP (1 ug/mL) HNP (10 ug/mL)
Adhesion (PMN) 1.00 ± 0.00 0.73 ± 0.16 8.00 ± 3.10*
CD11b (PMN) 1.00 ± 0.00 1.17 ± 0.14 2.03 ± 0.03*
IL-6 (HPAEC) 0.49 ± 0.14 0.68 ± 0.09 11.80 ± 0.69*
IL-8 (HPAEC) 13.98 ± 3.45 12.65 ± 1.75 114.2 ± 7.29*
Fold-increase in Adhesion and CD11b. Cytokine concentrations are pg/mL. *P\0.05
CONCLUSION. Resuscitation using the hemodilution method caused signiﬁcant inﬂam-
mation associated with PMN inﬁltration. HNP released from neutrophils play a crucial role in
mediating inﬂammation through activation of the endothelium, leukocytes and platelets.
GRANT ACKNOWLEDGEMENT. Supported by the Canadian Institutes for Health
Research (CIHR).
0722
HIGH VS. MODERATE FLUID MANAGEMENT INCREASES MORTALITY IN
TWO DIFFERENT EXPERIMENTAL SEPSIS MODELS
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INTRODUCTION. Aggressive ﬂuid resuscitation may improve outcome in septic patients
[1]. For selected patient groups, however, this approach can be detrimental by increasing the
risk of lung edema and abdominal compartment syndrome [2,3]. The aim of this study was to
test the effects of a high vs. moderate volume ﬂuid administration strategy on hemodynamics,
organ function and survival in two relevant experimental sepsis models.
METHODS. 48 anesthetized pigs were invasively monitored (systemic and regional ﬂows and
pressures). They were randomized (full factorial design) to 3 groups (controls, endotoxin
infusion and fecal peritonitis) and 2 treatments (high and moderate volume resuscitation),
respectively,for24hrs oruntildeathoccurred.Highvolumeadministrationconsistedof20 ml/
kg/h, including 5 ml/kg/h HES 6%; moderate volume administration consisted of 10 ml/kg/h).
Ventilationwas adjustedtokeep theanimalsnormoxicandnormocapnic,andplateaupressures
were kept at\35 mmHg. Differences between groups were assessed by MANOVA using two
between-subject factors (model and volume approach) and time as within-subject factor. Pre-
liminary data on control and peritonitis pigs have been presented previously.
RESULTS. Mortality was highest in peritonitis high volume (87%) and endotoxin high
volume (75%) groups (peritonitis moderate volume: 50%; endotoxin moderate volume: 13%;
p\0.01). One animal in the control high volume group died, while all control moderate
volume pigs survived 24 hrs. Filling pressures (CVP, PAOP) increased in all groups, with
highest pressures in peritonitis high volume (p\0.01), while mixed venous saturation was
lowest in both peritonitis groups (p\0.02). The arterial lactate concentration increased in
both peritonitis groups (p\0.05), while the oxygenation index decreased in all groups, with
lowest values in the peritonitis high volume group (p\0.05).
CONCLUSION. High volume resuscitation reduced oxygenation and survival, with the most
detrimental effects in animals with peritonitis. This study suggests that a prolonged aggressive
ﬂuid strategy may not generally be beneﬁcial in sepsis.
REFERENCE(S). 1. Rivers, E. et al. (2001) Early goal-directed therapy in the treatment of
severe sepsis and septic shock. N. Engl. J. Med. 345, 1368–1377.
2. Arlati, S. et al. (2007) Decreased ﬂuid volume to reduce organ damage: a new approach to
burn shock resuscitation? A preliminary study. Resuscitation 72, 371.
3. Balogh, Z. et al. (2003) Supranormal trauma resuscitation causes more cases of abdominal
compartment syndrome. Arch Surg 138, 637–42; discussion 642–3.
GRANT ACKNOWLEDGEMENT. Supported by grant 3200BO/102268 made available by
the Swiss National Fund, Bern, Switzerland.
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IMMUNE AND BIOENERGETIC FUNCTION IN NEUTROPHILS IN AN IN VITRO
MODEL OF SEPSIS
A. Gutierrez del Arroyo*, F. Franco, M. Singer, G. Bellingan
Medicine, Wolfson Institute for Biomedical Research, University College, London, United
Kingdom
INTRODUCTION. Mitochondrial bioenergetic dysfunction is described in many cell types
during prolonged sepsis, including monocytes [1, 2]. The resulting lack of energy supply may
be responsible for the decreased functioning of these cells. Neutrophils, on the other hand,
rely predominantly on glycolysis for their ATP supply. We therefore studied neutrophil
phagocytic function and cell surface receptor expression plus glycolytic respiration (measured
by ATP levels and lactate production) in an in vitro model of sepsis.
METHODS. Neutrophils were isolated from 20 ml blood samples taken from 10 healthy
volunteers. These were incubated for 24 h in plasma pooled from either 6 separate healthy
controls or 6 patients on Day 1 of septic shock. At 24 h, cell viability (apoptosis/necrosis) was
assessed by Annexin-V-FLUOS; surface CD16 expression (marker of activation) by FACS;
oxidative burst following PMA stimulation by Phagoburst
TM; ATP levels by ATP-Lite and
lactate production by lactate-Trinity. Data were analysed by paired Student’s t test and Mann
Whitney U, as appropriate.
RESULTS. Compared to their healthy plasma counterparts, neutrophils incubated in septic
plasma for 24 h showed deceased cell death, a higher state of activation (higher CD16
expression) and increased oxidative burst activity (Table 1). ATP content and supernatant
lactate levels were also signiﬁcantly higher in these cells.
TABLE 1
Necrosis* Apoptosis* CD16* Oxidative
burst*
ATP
content
*
Lactate *
control 0.07(0–0.4) 24% (14–28) 47% (12–60) 1 1 1
septic 0.03(0–0.07) 11% (8–16) 90% (73–94) 2.5(1.5–6.8) 2 (1.1–3) 1.8(1.3–4.2)
*p\0.05 compared to controls; ratio to control;data shown as median(range)
CONCLUSION. Neutrophils incubated in septic plasma showed a higher level of functional
capacity and glycolytic activity, and greater longevity. Whether this is related to increased
activation by septic mediators or, potentially, loss of inhibitory factors present in healthy
plasma requires further elucidation. This in vitro model offers a useful means of assessing
leukocyte function and bioenergetic status, and for comparing different cell populations.
REFERENCE(S). 1. Belikova I, Lukaszewicz AC, Faivre V, Damoisel C, Singer M, Payen
D: Oxygen consumption of human peripheral blood mononuclear cells in severe human
sepsis. Crit Care Med 2007,35:2702–2708.
2. Brealey D, Brand M, Hargreaves I, Heales S, Land J, Smolenski R, Davies NA, Cooper CE,
Singer M: Association between mitochondrial dysfunction and severity and outcome of septic
shock. Lancet 2002,360:219–223.
GRANT ACKNOWLEDGEMENT. UK Intensive Care Society.
0724
HAEMODYNAMIC AND METABOLIC EFFECTS OF VASOPRESSIN AND TER-
LIPRESSIN IN OVINE SEPTIC SHOCK
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INTRODUCTION. Arginine vasopressin (AVP) and terlipressin (TP) are regularly used in
the support of patients with septic shock. Recently, AVP has been shown to improve survival
in less-severe septic shock patients
1. Nevertheless, there is still concern regarding negative
effects on cardiac output and global oxygen transport
2. The present study was conducted as a
prospective, randomized, controlled laboratory experiment to compare the haemodynamic
and metabolic effects of a continuous infusion of AVP and TP using an established ovine
model of septic shock.
METHODS. Twenty-four ewes were anaesthetized and instrumented for chronic haemody-
namic monitoring. A laparotomy was performed and faeces were taken from the caecum
under sterile conditions. After baseline measurements (BL1) had been performed, the faeces
were injected into the peritoneal cavity. A second set of measurements (BL2) was taken after
the onset of septic shock (deﬁned as mean arterial pressure (MAP) inferior to 60 mmHg). The
animals were then randomly assigned to receive either AVP (0.5 mU/kg/min; n = 8) or TP
(1 \mug/kg/h; n = 8). The control group (n = 8) received only the vehicle (normal saline). If
necessary, norepinephrine was titrated to maintain MAP at 70 ± 5 mmHg in all groups.
RESULTS. Baseline characteristics did not differ between groups. Compared to BL2, both
AVP and TP signiﬁcantly increased MAP (p inferior to 0.05). Ten hours after the onset of
septic shock, heart rate (HR) was signiﬁcantly decreased in the treatment groups as compared
to the control group (p inferior to 0.05). Cardiac index (CI), cardiac troponin and arterial
lactate levels were similar between groups. In addition, there were no between group dif-
ferences in serum creatinine and urinary output. Following 12 h of septic shock, mixed venous
oxygen saturation (SvO2) and base excess tended to be higher in animals treated with AVP or
TP as compared to the control group.
CONCLUSION. Our data suggest that early low-dose infusion of AVP or TP is a safe and
efﬁcacious treatment option in ovine septic shock. Both agents increased MAP without
impairing CI and without inducing myocardial ischaemia or renal dysfunction. Whether or not
the decrease in heart rate seen in the treatment groups represents a therapeutic advantage
remains to be elucidated in future trials.
REFERENCE(S). 1. Russell JA, et al. N Engl J Med. 2008; 358: 877–887.
2. Russell JA. Crit Care Med 2007; 35: 609–615.
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USEFULLNESS OF STROKE VOLUME VARIATION (SVV) AND PULSE PRES-
SURE VARIATION (PPV) IN AN INTERNAL ICU: A PROSPECTIVE STUDY ON
THE PREVALENCE OF CONTROLLED VENTILATION AND SINUS RHYTHM
DURING 632 HEMODYNAMIC MEASUREMENTS
W. Huber*
1, C. Bopp
1, A. Umgelter
1, M. Franzen
1, W. Reindl
1, R. Schmid
1
12nd Medical Department, Klinikum Rechts der Isar, Technical University of Munich,
Munich, Germany
INTRODUCTION. Appropriate assessment of preload and volume responsiveness are cor-
nerstones of ICU therapy. In several recent trials comparing pressure-based (CVP, PAWP),
volume-based (ITBI, GEDI) and variability-based (SVV, PPV) preload parameters, CVP and
PAWP had the lowest predictive values, and the variability parameters were slightly more
predictive than the volume-based. However, the use of variability parameters is restricted to
patients with sinus rhythm (SR) and controlled (CV) mechanical ventilation. Little is known
about the prevalence of SR and CV in long term treatment of ICU patients.
METHODS. From February 1 to July 31 2007, the prevalence of SR and CV was docu-
mented immediately before 632 thermodilution measurements in 42 consecutive patients with
newly inserted PiCCO catheters (Pulsion, Munich, Germany). The average frequency of
haemodynamic measurements was three per day.
RESULTS. PiCCO device in 42 patients out of 214 admissions (19.6%). Mean age 61.1 ±
17.4 years, 16 female, 26 male, APACHE-II 21.7 ± 7.8. Underlying diseases 21/42 sepsis/
SIRS, 9/42 liver cirrhosis, 5/42 pancreatitis, 5/42 pneumonia/ARDS; 2 cardiogenic shock;
mortality 15/42 (36%). Patients were under catecholamines in 259/632 measurements (41%).
TheprevalenceofbothSRandCVwas60/632(9.5%).In422/632(66.8%)ofthemeasurements,
thepatientshadSR,butwerenotonCV.In19/632(3%),thepatientswereonCV,buttheywere
arrhythmic. In 131/632 (20.7%), the patients were neither on CV nor they had SR.
TABLE 1 PEVALENCE OF SR AND CV
SR + CV+ SR + CV- SR- CV+ SR- CV-
All measurements 60/632 (9.5%) 422/632 (66.8%) 19/632 (3%) 131/632 (20.7%)
Measurements within ﬁrst day 16/122 (13%) 73/122 (60%) 7/122 (6%) 26/122 (21%)
Evaluating only the ﬁrst three measurements within the ﬁrst 24 h after the insertion of the
PiCCO catheter, the prevalence of SR and CV was 16/122 (13%; in two patients only one
measurement was performed). In 73/122 (60%) measurements, the patients had SR, but they
were not under CV. In 7/122 (6%) measurements, the patients were under CV, but they
suffered from arrhythmia. In 26/122 (21%), the patients were neither on CV nor they had SR.
CONCLUSION. Despite several studies demonstrating superior prediction of volume
responsiveness as compared to volumetric and pressure parameters, the variability parameters
SVV and PPV cannot be used in a signiﬁcant percentage of patients in an internal ICU.
Therefore, in high risk patients, monitoring of volumetric parameters such as GEDI, ITBI and
ELWI and echocardiography should be available.
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FLUID RESPONSIVENESS PREDICTION BY PASSIVE LEG RAISING AND
BREATH RELATED INDICES IN THE NON ARRHYTHMIC SHOCKED PATIENT
WITHOUT SPONTANEOUS BREATHING ACTIVITY
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INTRODUCTION. The aim of the study was to compare the performance of respiratory
changes in pulse pressure \Delta
RESP PP, and passive leg raising (PLR) induced changes in
cardiac output \Delta
PLR CO and pulse pressure \Delta
PLR PP in a wide population of medical
ICU patients to predict an increase in CO[15% after 500 ml ﬂuid loading (FL).
METHODS. Prospective, multicentre study with ethical approval. Deeply sedated patients
under mechanical ventilation with shock were enrolled. Study phases: patient supine, PLR
(patient supine, legs at 45 ), after FL . Measurements: invasive and noninvasive arterial
pressure and cardiac output (thermodilution) at each phase. Discriminative power was
assessed by the area under the ROC curve (AUC) and likelihood ratios (LHR).
RESULTS. Among the 97 patients included (age 57 ± 16 yrs, SAPSII 57 ± 18, 7% with
acute cor pulmonale on ultrasonography), 78 were receiving norepinephrine (0.7 ± 0.8 lg/
kg/min) and 21 epinephrine (0.4 ± 0.4 lg/kg/min). Respiratory rate was 24 ± 6/min, heart/
respiratory rate ratio 4.5 ± 1.6, mean plateau and end expiratory pressure difference 13 ± 4
cmH2O, tidal volume (Vt) 6.9 ± 1 ml/kg ([8 ml/kg in only 15 patients). 31 (33%) patients
were responders (CO increase[15%). The mean \DeltaResp PP was 5.4 ± 4.6%.
The AUC of \DeltaResp PP to predict ﬂuid responsiveness was 0.76 [0.65–0.87]. With a 5%
cut-off, positive and negative LHR were 3.2 [2.0–5.2] and 0.3 [0.2–0.6], respectively. For
\DeltaPRL PP, the AUC was 0.78 [0.68–0.88]. Positive and negative LHR were 2.6 [1.7–4.1]
and 0.4 [0.2–0.7] with a 9% cut-off. For both \DeltaResp PP and \DeltaPLR PP, these LHR
led to similar changes in post-test probabilities of ﬂuid responsiveness (about only 20–25%)
in the whole population. For \DeltaPLR CO, the AUC was 0.89 [0.81–0.97] with positive and
negative LHR of 6.2 [3.3–11.5] and 0.1 [0.1–0.4] with a 7% cut-off (changes in ﬂuid
responsiveness probability of 35–45%). PLR induced changes in non-invasive blood pressure
measurements were associated with poor AUC, below 0.69. Among the 48 patients who
increased central venous pressure (CVP) of at least 2 mmHg during PLR, \DeltaPLR PP was
associated with an AUC of 0.88 [0.77–1], positive and negative LHR of 5.8 [1.7–4.1] and 0.2
[0.2–0.7] with a 9% cut-off (changes in probability of 30–35%). In this subpopulation, the
AUC of \DeltaPLR CO was 0.92 [0.80–1] and a 7% cut-off was associated with positive and
negative LHR of 11 [3.7–32.9] and 0.1[0.0–0.6], respectively (45% change in probability).
CONCLUSION. In our study, the respiratory changes in arterial waveform were small and
did not alow \DeltaResp PP to predict ﬂuid responsiveness, probably because of the current
ventilator settings in the participating ICUs. On the other hand, DPLRCO was performing
well. DPLRPP may be a simple and readily surrogate in the subgroup of patients increasing
CVP of at least 2 mmHg.
REFERENCE(S). 1 Antonelli M et al. (2007) Hemodynamic monitoring in shock and
implications for management. International Consensus Conference, Paris, France, 27–28
April 2006. Intensive Care Med 33: 575–590.
S186 21st ESICM Annual Congress – Lisbon, Portugal – 21–24 September 20080727
PASSIVE LEG RAISING FOR PREDICTING FLUID RESPONSIVENESS: IMPOR-
TANCE OF THE POSTURAL CHANGE
J. Jabot, J. L. Teboul, C. Richard, X. Monnet*
Service de re ´animation me ´dicale, EA 4046, AP-HP, ho ˆpital de Bice ˆtre, Univ Paris-Sud,
faculte ´ de me ´decine Paris-Sud, Le Kremlin-Bice ˆtre, France
INTRODUCTION. For predicting ﬂuid responsiveness by passive leg raising (PLR), the
lower limbs can be elevated at 45  either from the 45  semi-recumbent position (PLR-
SEMIREC) or from the supine position (PLRSUPINE). PLRSUPINE could have a lower
hemodynamic impact than PLRSEMIREC since it should not recruit the splanchnic venous
reservoir.
METHODS. Thirty-ﬁve patients with circulatory failure who responded to an initial PLR-
SEMIREC by an increase in cardiac index C 10%. In these patients, PLRSEMIREC, a
transfer from the semi-recumbent to the supine position and PLRSUPINE were performed in
all patients in a random order before ﬂuid expansion (500 mL saline).
RESULTS. PLRSEMIREC, supine transfer and PLRSUPINE signiﬁcantly increased the
pulse-contour derived cardiac index (PiCCOplus) by 22[17–28]%, 9[5–15]% and 10[7–14]%
(p\0.05 vs. PLRSEMIREC for the latter two), respectively. These maneuvers signiﬁcantly
increased the right ventricular end-diastolic area (echocardiography) by 20[14–29]%, 9[5–
16]% and 10[5–16]% (p\0.05 vs. PLRSEMIREC for the latter two) and the central venous
pressure by 33[22–50]%, 15[10–20]% and 20[15–29]% (p\0.05 vs. PLRSEMIREC for the
latter two), respectively. Volume expansion signiﬁcantly increased cardiac index by 27[14–
38]% and all patients were responders to volume expansion. If an increase in cardiac index
310% had considered as a positive response to PLRSUPINE, 15(43%) patients would have
been unduly predicted as non-responders to ﬂuid administration by PLRSUPINE.
CONCLUSION. PLRSEMIREC indices larger increase in cardiac preload than PLRSUPINE
and may be preferred for predicting ﬂuid responsiveness.
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SUBLINGUAL FUNCTIONAL CAPILLARY DENSITY IS ASSOCIATED WITH
LACTATE LEVEL IN PATIENTS WITH ACUTE HEART FAILURE
C. den Uil*
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1Cardiology, Erasmus MC, Rotterdam,
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INTRODUCTION. We tested whether functional capillary density (FCD) is impaired in
patients with acute heart failure (AHF) who have an elevated lactate level.
METHODS. We investigated 33 AHF patients\24 h after admission. SDF imaging was
used to image the sublingual microcirculation. MAS software was used to measure FCD.
Values are shown as medians [IQR].
RESULTS. Patients with an elevated lactate level ([1.7 mmol/L, n = 14) were compared to
those with a normal lactate level (\=1.7 mmol/L, n = 19). FCD was lower in patients who
had an elevated lactate level compared to patients with a normal lactate level (11.2 [10.3–
11.6] mm
-1 vs. 12.2 [10.4–13.1 mm
-1, respectively). Between both groups, there were no
differences in HR, MAP, CVP, mean PAP, PCWP, CI, and SVR.
CONCLUSION. Elevated lactate levels are related to alterations in microcirculatory perfu-
sion in patients with AHF.
0729
ENDOTHELIN RECEPTOR ANTAGONISTS IN SECONDARY PULMONARY
HYPERTENSION
H. Michalopoulou*, P. Stamatis, A. Bakhal, J. Vaitsis, D. Stamatis
Cardiology Department, Metaxa Hospital, Athens, Greece
INTRODUCTION. The effect of endothelin receptor antagonist Bosentan with its selective
activity upon the pulmonary capillaries favors the hemodynamic and clinical proﬁle of
patients with idiopathic pulmonary hypertension, whereas its use in cases of secondary pul-
monary hypertension has not been established yet.
METHODS. 44 patients (53.4 ± 9.7 years old, 20 male) with secondary pulmonary hyper-
tension in functional stage III-IV according to WHO classiﬁcation were studied for a time
period of 40 ± 7 months. The patients were divided in two groups: group A (n = 24) who
received conventional treatment with anticoagulants, calcium-channel blockers and diuretics,
and group B (n = 20) who received Bosentan. Between the groups there was no signiﬁcant
difference concerning their WHO functional class, the etiology of pulmonary hypertension
and test of vasoreactivity.
RESULTS. The pulmonary artery systolic pressure (PASP) was reduced to 48 ± 27.6 from
94.8 ± 26.6 mmHg in group B, versus 92.8 ± 21.5 from 95.2 ± 22.7 mmHg in group A
(p\0.05). The mean pulmonary artery pressure decreased to 42.7 ± 12.8 from
55.8 ± 13.7 mmHg in group B, versus 52.6 ± 13.1 from 54.4 ± 12.6 mmHg in group A
(p = 0.05). The pulmonary vascular resistance (PVR) decreased to 8.2 ± 3.5 from
10.7 ± 3.8 IU Wood in group B, versus 9.9 ± 3.5 from 10.6 ± 3.2 IU Wood in group A
(p\0.05). Concerning the increase in the cardiac index, there were no signiﬁcant differences
between the groups. Mortality was 41.2% (10/24) in group A and 15% (3/20) in group B
(p = 0.001).
CONCLUSION. Bosentan demonstrates a beneﬁcial hemodynamic and clinical effect and
represents a most promising factor with an extension in its use to treat secondary pulmonary
hypertension.
0730
MECHANISMS OF UNSUCCESSFUL SPONTANEOUS BREATHING TRIAL IN
HIGH-RISK PATIENTS: AN ECHOCARDIOGRAPHY DOPPLER STUDY
J. Amiel*, A. Dugard, B. Franc ¸ois, N. Pichon, M. Clavel, H. Gastinne, P. Vignon
Medical-surgical Intensive Care Unit, Dupuytren Teaching Hospital, Limoges, France
INTRODUCTION. Congestive heart failure has been reported as a common source of
unsuccessful extubation, especially in patients with cardiac disease or chronic obstructive
pulmonary disease (COPD). Spontaneous breathing trial (SBT) is recommended prior to a
planned extubation. We sought to evaluate the ability of transthoracic echocardiography
(TTE) to identify a cardiac source of unsuccessful SBT in high-risk patients.
METHODS. During a 2-month period, all patients with a congestive heart failure (ejection
fraction [EF] B 40%) and/or a COPD who were mechanically ventilated[24 h were pro-
spectively studied. TTE was performed prior to (T0) and at the end of (T1) the SBT (30 min,
unless unsuccessful). The following measurements were performed in triplicate at end-
expiration and averaged: left ventricular end-diastolic (LVEDV) and end-systolic (LVESV)
volumes with EF using the modiﬁed Simpson’s rule, maximal Doppler velocity of mitral E
and A waves, E/A and E/E’ ratios (tissue Doppler at the lateral mitral ring), stroke volume
(SV) using the Doppler method at the level of the aortic ring, and the surface of the color
Doppler jet normalized by the left atrial surface in the presence of a mitral regurgitation
(MR). In each patients, parameters were compared between T0 and T1 using the matched-
pairs Wilcoxon test. Results are expressed in median and 95% conﬁdence intervals. Our local
Ethics Committee agreed with the protocol.
RESULTS. 16 patients (heart failure, 14; COPD, 3) were studied (SAPS 2: 43 [34–51];
duration of mechanical ventilation: 75 h [70–234]). SBT was unsuccessful in 4 patients and
another patient who passed the SBT was reintubated within 24 h for progressive accumulation
of tracheal secretion due to inefﬁcient cough. The remaining 11 patients underwent both a
successful SBT and extubation. Overall, LVEF remained stable between T0 and T1 whereas
LV ﬁlling pressures signiﬁcantly increased, as reﬂected by the higher E, E/A and E/E’ values
(table; *p\0.05). In patients with unsuccessful SBT, E, E/A and E/E’ values increased of
19.6 cm/s, 0.67 and 1.97 when compared to 7.9 cm/s, 0.08 and 0.32 in patients who passed
the SBT, respectively. When MR was present at T0 (n = 8), its normalized surface increased
of 2.1 cm
2 in patient with unsuccessful SBT, and was comparable (+0.14 cm
2) in the
remaining patients.
TABLE 1
LVEDV
mL
LVESV
mL
EF % SV mL E cm/s E/A E/E’
T0 120/104–170 83/64–124 35/28–40 43/37–47 73/58–88 1.2/0.7–1.7 6.7/5.8–11.7
T1 126/110–174* 89/67–127 34/27–41 49/42–59 92/70–114* 1.6/0.9–2.2* 9.5/7.0–13.5
CONCLUSION. In this study, SBT signiﬁcantly increased LV ﬁlling pressures and the
surface of MR, when present. These variations were more pronounced in the subset of patients
with unsuccessful SBT. Even in patients with severe congestive heart failure, the absence of
documented variation of LV ﬁlling pressure and MR during the SBT appeared as a good
predictor of successful extubation.
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COMPLICATIONS OF HYPOTHERMIA APPLIED FOR PREVENTING CERE-
BRAL EDEMA AFTER LARGE HEMISPHERIC INFARCTION
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1, C. M. Reichelt
1, I. Dzialowski
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3
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2Neurology, Carl Gustav Carus University Hospital Dresden, Dresden,
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3Critical Care&Stroke, Columbia University, New York, United States
INTRODUCTION. Large hemispheric infarction carries a mortality rate of 40–80%. Man-
agement of brain swelling includes mild to moderate hypothermia, osmotherapy, and
decompressive hemicraniectomy.
METHODS. We treated 34 patients with large hemispheric infarctions between August 2006
and December 2007 with the combination of insulin infusion (target glucose 4.6–6.1 mmol/
L), mild hypothermia (33–35 C) using a surface cooling or intravascular heat exchange
device, and hypertonic saline (3% sodium chloride acetate) at a rate 1 ml/kg (goal sodium
150–155 mmol/L) within 72 h of symptom onset. We predeﬁned and collected all compli-
cations and procedures that could potentially occur during the hospital course in the Columbia
University Large Hemispheric Infarctions Outcomes Project database, evaluated their fre-
quency and the patient’s neurological outcome at 3 months.
RESULTS. Of the 34 patients 15 had right-sided infarctions and median age was 65.5 (range
38–83) years. Baseline NIHSS was 18.6 ± 5.3. At 3 months, 17 patients had died; support
had been actively withdrawn in 13 cases. The mRS was 1 in 1 patient, 3 in 3 patients, 4 in 2
patients and 5 in 11 patients.
The most frequent complications included pulmonary edema (n = 25), tracheobronchitis
(n = 17), hypotension (n = 17), thrombocytopenia (n = 16), atrial ﬁbrillation with rapid
ventricular response (n = 11), sepsis and septic shock (n = 9), acute renal failure (n = 9),
anemia requiring transfusion (n = 9), aspiration and ventilator-acquired pneumonia (n = 8),
urinary tract infection (n = 6), coagulopathy (n = 6), leucopenia (n = 4), rhabdomyolysis
(n = 5), myocardial ischemia (n = 2), and paralytic ileus (n = 2).
CONCLUSION. Mild hypothermia (33–35 C) offers a feasible alternative strategy to
decrease massive cerebral edema after large hemispheric infarction as part of intensive care
treatment protocol. Several complications may counteract the therapeutic effect of hypo-
thermia, therefore detailed attention should be given to their prevention and management.
0732
COLD-INDUCED CHANGES IN PLASMA VOLUME (PV) AND MICROVASCULAR
PERMEABILITY: THE EFFECT OF INSULIN ADMINISTRATION
H. K. Brekke*, S. M. Hammersborg, T. Nedrebø, O. Haugen, P. Husby, M. Farstad
Anesthesia and Intensive Care, Haukeland University Hospital, Bergen, Norway
INTRODUCTION. Induced hypothermia by surface- or endovascular-cooling increases
microvascular permeability for water and macromolecules. An inﬂammatory reaction may be
responsible. We hypothesized that an increase in capillary permeability can be counteracted
by an anti-inﬂammatory effect of insulin (1,2).
METHODS. 21 anesthetized piglets were randomized to normothermia (NT-group), hypo-
thermia (HT-group) and hypothermia with insulin (HTI-group). (n = 7, in all groups). All
animals had an endovascular cooling catheter (Alsius, USA). The HT- and HTI-groups were
cooled to 28 C for 4 h. The NT-group was kept normothermic. All animals received 4 ml/kg/
h of Ringer’s solution. The NT-and HT-groups were given 1 ml/kg/h of 5%- Glucose solu-
tion. The HTI-group received Insulin 1 IE/h and an infusion of 20%-Glucose, 1 ml/kg/h, with
Potassium 0,08 mmol/ml. The glucose-infusion-rate was adjusted to keep blood glucose level
in the range of 4–7 mmol/l. Hematocrit (Hct), plasma-cytokines (TNF-a, IL-1b, IL-10) and
PV were measured and net ﬂuid balance (NFB) and ﬂuid- and protein extravasation calcu-
lated. Statistics: by SPSS v.15.Normalized Values as mean (SEM). Signiﬁcance level:
p\0.05.
RESULTS. NFB was similar in all groups. PV remained unchanged in the NT-group and
decreased 16.6 (2.3)% and 8.4 (3.5)% in the HT-and HTI-groups. The reduction was higher in
the HT-group compared with the NT-group (P = 0.016) while the reduction found in the
HTI-group was in between and did not differ signiﬁcantly from the other groups. Hct
increased in the HT-group, the change tending to be higher as compared with the change of
the NT-group (P = 0.07). The results of the HTI-group were found in between the others.
Fluid extravasation rate tended to increase slightly in the HT-group, while the values
remained stable in the two other groups. The albumin mass was reduced by 22.4 (3.3) % in the
HT-group, 15.4 (2.7) % in the HTI-group and 6.5 (2.7) % in the NT-group. Compared with
the NT-group, the decrease of the HP-group was signiﬁcantly higher (P = 0.006) while the
decrease of the HTI-group tended to be higher (P = 0.076). TNF-a tended to increase in the
HT-group, whereas the values of the HTI-group remained stable. We did not ﬁnd any dif-
ferences for IL-1b, IL-10.
CONCLUSION. The results conﬁrmed our previous studies regarding the effect of hypo-
thermia on capillary permeability (3). Even though the results of the HTI-group did not differ
signiﬁcantly from the others, the pattern of trends found, suggest a modulating effect of
insulin on the cold-induced increase in capillary permeability
REFERENCE(S). 1: Das. Nutrition 2001;17: 409–13. 2: Nedrebø et al., J Physiol, 2004; 559:
581–89. 3: Hammersborg et al, Resuscitation, 2005; 65: 211–19.
GRANT ACKNOWLEDGEMENT. The Frank Mohn Foundation, Bergen, Norway.
0733
FAVORABLE NEUROLOGICAL OUTCOME AT INTENSIVE CARE UNIT DIS-
CHARGE AND 6 MONTHS AFTER CARDIOPULMONARY RESUSCITATION OF
ASYSTOLE PATIENTS TREATED WITH INDUCED MILD HYPOTHERMIA
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INTRODUCTION. Induced mild hypothermia therapy (MHyT) improves neurological
outcome in post resuscitation cardiac arrest (CA) patients with ventricular ﬁbrillation/
tachykardia (VF/VT). Patients with asystole as initial rhythm were excluded from earlier
studies due to poor neurological outcome. The present study enrolled both patients with
asystole or VF/VT; one of the objectives was to assess neurological function at ICU discharge
and six months after CPR.
METHODS. Prospective multi-center single arm registry in 49 patients with witnessed
cardiac arrest and succesful CPR who were selected for MHyT. Patients had to be[18 years
old and unconscious at ICU/ER admission (GCS\8), with a time interval between cardiac
arrest and initiation of MHyT treatment of\6 hrs. Treatment was performed for 24 hrs with
a target temperature of 32,5 C. Neurological status was documented upon ICU/ER arrival,
during MHyT treatment, at ICU discharge and 6 months after the event as measured by the
Glasgow Outcome Scale (GOS). Temperature measurements were continuously taken
throughout the cooling period via bladder catheter. For MHyT treatment the Deltatherm
device (KCI, USA) was used.
RESULTS. Of the 49 patients included in the registry 31 (63%) had VF/VT and 18 (36,7%)
had asystole/PEA as ﬁrst rhythm. Good neurological recovery at ICU discharge (GOS 5/4)
was seen in 22 (45%) of the patients, 9 (18,4%) were neurologically impaired (GOS 3/2) and
16 (33%) died. In the follow up investigation after 6 months 19 patients (38,7%) showed
favorable neurological outcome (GOS 5/4), 2 (4%) were severly neurological impaired (GOS
3/2), 26 (53%) died. 2 patients with GOS 5 at ICU discharge were lost to the follow up, one
(GOS 5) died due to another event. Good neurological recovery was seen in 45,16 %(n = 14)
of patients with VF/VT and in 27,7 % (n = 5) patients with asystole 6 months after CPR
CONCLUSION. MHyT improves neurological outcome in patients with witnessed CA
regardless of the initial rhythm. Favorable results in VF/VT patients were similar to preceding
studies. Hypothermia also appears to provide neurological protection in patients presenting
with asystole at ICU discharge as well as 6 months after the event.
REFERENCE(S). 1. Hypothermia after Cardiac Arrest Study Group. N Engl J Med 2002;
346:549–556 2) Bernard SA et al. N Engl J Med 2002; 346: 557–563.
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SURFACE COOLING VERSUS CORE COOLING: COMPARATIVE STUDIES OF
MICROVASCULAR FLUID - AND PROTEINSHIFTS IN A PORCINE MODEL
S. M. Hammersborg*, H. K. Brekke, O. Haugen, M. Farstad, P. Husby
Anesthesia and Intensive Care, Haukeland University Hospital, Bergen, Norway
INTRODUCTION. Cooling to 28 C by immersion in ice sludge, results in increased
microvascular permeability for water and macromolecules (1,2). This is in contrast to core-
cooling during cardiopulmonary bypass. Here the permeability is increased for water only,
whereas the intravascular protein masses remains stable (3). In the present study we
hypothesized that core cooling by an endovascular catheter would represent a gentler cooling
method than surface cooling with respect to water- and macromolecule permeability.
METHODS. 14 anesthetized piglets were, following 60 min normothermia, randomly cooled
by surface cooling (SC-group, n = 7) or core cooling (CC-group, n = 7) to about 28  C.
Fluid balance, hemodynamic variables, colloid osmotic pressures (plasma/ interstitial ﬂuid),
hematocrit, serum concentrations of albumin and protein, intracranial pressure (ICP) and
cerebral metabolic markers of ischemia, were measured. Fluid shifts and changes in albumin
and protein masses were calculated. At the end of the experiments total tissue water content
was assessed in different tissues and compared with a normothermic control-group.
RESULTS. Hypothermia induced an increase in the ﬂuid extravasation rate from 33.9 (31.9)
to 109.0 (16.5) and 27.8 (28.0) to 95.6 (29.1) ml/ kg/ min 9 10–3, in the SC-group and CC-
group, respectively. Albumin extravasation was reﬂected by a signiﬁcant drop in the albumin
mass from 148.8 (11.7) to 111.4 (10.3) (P\0.001) in the SC-group and from 163.4 (27.8) to
136.8 (19.0) g/kg 9 10-2 (p\0.01) in the CC-group during the experiments. Similar
decreases were obtained in the protein masses as well.
The total tissue water content increased in most organs including brain in both study-groups
compared with a control. ICP and cerebral metabolic markers remained normal in both groups
CONCLUSION. Rapid lowering of body core temperature to 28  C results in extravasation
of water and proteins to the same extent either hypothermia is a result of surface- or core
cooling. Cold-induced ﬂuid extravasation is associated with edema in most tissue including
brain.
REFERENCE(S). 1. Hammersborg et al.,Resuscitation 2005; 65: 211–19.
2. Endrich et al., Res Exp Med 1990; 190: 365–79.
3. Farstad et al., Acta Anaesthesiol Scand 2003; 47: 397–406.
GRANT ACKNOWLEDGEMENT. This study was ﬁnancially supported by RAKOS(Re-
gionalt akuttmedisinsk kompetansesenter) Stavanger, Norway.
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PULSE PRESSURE VARIATION IN HEMORRHAGIC SHOCK: THE EFFECTIVE-
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INTRODUCTION. Hemorrhage remains a primary cause of death in civilian and military
trauma. Volume replacement and surgical bleeding control are the most important issues in
the treatment of hemorrhagic shock. Bedside indicators of ventricular preload have been
proposed as predictors of ﬂuid responsiveness. This goal could be achieved reducing arterial
pulse pressure (DPP) variation induced by mechanical ventilation. The systolic pressure
variation (SPV) has been shown to be a predictor of ﬂuid responsiveness. This prospective
study was undertaken to determine the DPP, SPV and cardiac output (CO) in a swine model of
controlled hemorrhagic shock and volume replacement with lactated Ringers’ solution and
hypertonic saline + 6% with hydroxyethyl starch.
METHODS. Fifteen pigs were anesthetized, instrumented and randomized into three groups:
Sham (S), lactated Ringer solution (LR) and hypertonic saline in 6% with hydroxyethyl starch
130/0,4 (HHES). Hemorrhage was induced by blood withdrawal by a catheter placed through
the femoral artery until a mean arterial pressure (MAP) of 40 mmHg was achieved. This
pressure was maintained for 30 minutes. At this point, the animals received 32 ml/Kg/ for 20
minutes (LR) or a bolus dose of HHES,4 ml/Kg for 5 minutes. Thirty minutes after the
resuscitation, total shed blood was reinfused to the animals. Sham animals were not bled.
DPP, SPV and CO were monitored at the following time points: before hemorrhage (Base-
line), when a pressure of 40 mmHg was achieved (Tshock), 30 minutes of MAP of 40 mmHg
(T0), 30 min, 60 min,120 min and 240 min after treatment (T30, T60, T120,T240). Statistical
analyses were performed using one-way analysis of variance followed by Tukey-Kramer test.
A p value of 0.05 was considered statistically signiﬁcant.
RESULTS. During shock, DPP was signiﬁcant higher in groups LR (51.00 ± 17.59;
p\0.05) and HHES (53.00 ± 17.32; p\0.05) when compared to Sham (16.20 ± 10.96),
but no signiﬁcant differences between them. At time T0, only HHES (49.67 ± 20.21;
p\0.05) was signiﬁcantly different from Sham (22.58 ± 11.84). At time T30, HHES
(29.67 ± 17.16; p\0.05) differed when compared to Sham (19.18 ± 9.01), but after T60 no
signiﬁcant differences were detected in the three groups. When SPV and CO were analyzed,
there were no signiﬁcant differences at time points.
CONCLUSION. Small volume hypertonic saline + 6% with hydroxyethyl starch promotes
similar volume expansion as large volume LR, reducing the large dPP induced by
hemorrhage.
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PLATELET DYSFUNCTION IN OUT-PATIENTS WITH LEFT VENTRICULAR
ASSIST DEVICES (LVAD)
B. M. Steinlechner*
1, P. Zeidler
1, B. Birkenberg
1, M. Duris
1, L. Milosevic
1, G. Wieselthaler
2,
E. Wolner
2, B. Jilma
3, M. Dworschak
1
1Division of Cardiothoracic and Vascular Anaesthesia and Intensive Care,
2Division of
Cardiothoracic Surgery,
3Institute of Medical and Chemical Laboratory Diagnostics, Medical
University of Vienna, Vienna, Austria
INTRODUCTION. Nowadays, left ventricular assist devices (LVAD) are increasingly used
as a bridge to transplant in heart failure patients. These patients are generally anticoagulated
with phenprocoumon and aspirin. During heart transplant severe bleeding frequently poses a
serious problem. Despite lack of evidence, desmopressin is often administered successfully
when other means fail. We hypothesised that apart from aspirin-induced cyclooxygenase
inhibition an additional platelet dysfunction is present in these patients. In order to evaluate
this aspect we employed multiple monitoring devices for platelet function.
METHODS. Blood from 12 out-patients after elective LVAD implantation and 12 healthy
matched volunteers was screened with the help of thrombelastography (TEG
 ), platelet
function analyzer (PFA-100
 ) and a new whole blood aggregometer (Multiplate
 ) [1].
Additionally, we measured von Willebrand Factor (vWF) antigen levels and vWF:RCo
activity (vWF ristocetin co-factor). The anticoagulation regimen for LVAD patients consisted
of 100 mg of aspirin PO daily combined with phenprocoumon (INR: 2.5–3.5) [2].
RESULTS. Oral anticoagulation produced an average INR of 3.5. Aspirin reduced MA-AA
(Maximum Amplitude Arachidonic Acid; TEG
 )b y[60% in patients (p = 0.001 vs. con-
trols). The effectiveness of aspirin to suppress arachidonic acid-induced aggregation was also
reﬂected by an almost 75% decrease in the ASPItest (Aspirin Test; Multiplate
 )( p\0.001
vs. controls) while ADP-induced aggregation was not altered in patients (p = 0.805). Platelet
function under high shear was invariably and severely compromised: CADP-CT (collagen
adenosine diphosphate closure times; PFA-100
 ) were 2.5-fold longer in patients than in
controls (p\0.001), and 50% of patients had maximal CADP-CT values of 300 s. While
vWF antigen levels were 80% higher in patients (p\0.001), vWF:RiCO was subnormal
(\60%) in 5/12 patients. Ristocetin-induced aggregation was also 3-fold higher in controls
than in patients (p\0.001).
CONCLUSION. This indicates that LVAD out-patients have an additional functional platelet
defect, which affects the glycoprotein Ib/vWF axis. Therefore, desmopressin use in the
management of bleeding in these patients seems justiﬁed.
REFERENCE(S). 1. Toth O, Calatzis A, Penz S, Losonczy H, Siess W. Multiple electrode
aggregometry: a new device to measure platelet aggregation in whole blood. Thromb Hae-
most 2006; 96:781–788.
2. Cooper JR, Jr., Abrams J, Frazier OH, Radovancevic R, Radovancevic B, Bracey AW,
Kindo MJ, Gregoric ID. Fatal pulmonary microthrombi during surgical therapy for end-stage
heart failure: possible association with antiﬁbrinolytic therapy. J Thorac Cardiovasc Surg
2006; 131:963–968.
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INTRODUCTION. Near Infra-Red Spectroscopy is a novel method for rapid and non-
invasive assessment of tissue oxygen saturation (StO2). An association between StO2 (%) and
oxygen delivery has been demonstrated during shock, trauma and resuscitation. We sought to
explore StO2 during cardiac surgery and its association with post-operative outcome.
METHODS. 74 adult patients undergoing ﬁrst-time, elective, single procedure cardiac sur-
gery requiring cardiopulmonary bypass (CPB) were studied. StO2 was measured from the
thenar eminence (Inspectra Tissue Spectrometer Model 325, Hutchinson Technology Inc,
USA) through anaesthesia and surgery, and arrival on the Intensive Care Unit (ICU). Outcome
was deﬁned as length of ventilation and ICU stay, post-operative length of stay and morbidity
outcome (POMS) on post-operative days 1, 3, 5, 8 and 15 (the presence or absence of a
infectious, pulmonary, cardiovascular, wound, haematological, pain, renal or gastrointestinal
complication). All clinical information was prospectively collected.
RESULTS. StO2 rose from baseline during induction of anaesthesia (81.7 to 88.5, p\0.001)
then fell during surgery (mean 78.9) with a signiﬁcant change in minimum StO2 during CPB
(75.9 to 68.2 p\0.0001). The mean StO2 during the 1st 5 minutes of anaesthesia was lower
in those patients with than without POMS on D15 (81.1 ± 7.0 v 87.6 ± 7.7, p = 0.04) with
the mean StO2 during those ﬁrst 5 minutes being predictive of the presence of D15 POMS
(ROC 0.762, p = 0.01). Lower mean StO2 during the ﬁrst 20 minutes of ICU monitoring was
observed in those with than without POMS on D3 (72.9 ± 12.9 v 85.5 ± 8.4, p = 0.009) and
was predictive of the presence of D3 POMS (ROC 0.793, p\0.0001).
CONCLUSION. StO2 during anaesthesia and ICU is predictive of post-operative compli-
cations on D15 and D3 respectively, with lower StO2 being associated with poorer outcome.
Such data suggest that reduced tissue oxygen delivery, as measured by StO2, may be asso-
ciated with poorer outcome - an association which may in theory be causal. Were this the
case, interventions targeted at maintaining StO2 may beneﬁcially impact on such outcome.
This hypothesis seems worthy of further exploration.
GRANT ACKNOWLEDGEMENT. This work was supported by an unrestricted educa-
tional grant from Hutchison Technology (Inc). We are indebited to the patients and staff at the
Heart Hospital, London for their support and cooperation.
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NARY BYPASS OPERATION– RISK FACTORS FOR POSTOPERATIVE
INCREASE
T. Gu ¨nther
1, A. Liebold
2, G. Noeldge-Schomburg
1, D. A. Vagts*
1
1Dep. of Anaesthesiology and Intensive Care Medicine,
2Dep. of Cardiac Surgery, University
of Rostock, Rostock, Germany
INTRODUCTION. Increased arterial blood lactate levels have been identiﬁed as a good
predictor of postoperative morbidity and mortality. However, little is known about factors that
might inﬂuence this increase. Therefore we examined the changes in blood lactate levels
during and after cardiopulmonary bypass (CPB) as well as blood gas levels, pressure and ﬂow
parameters, metabolic values, body temperatures and substitution of catecholamines.
METHODS. We conducted a retrospective clinical study with consecutive patients
(n = 403) undergoing cardiopulmonary bypass for cardiac surgery at a university hospital.
The difference between pre- and postoperative lactate levels was obtained and its relationship
to the perioperative factors was analysed. Patients were assigned to three groups: slight
increase in lactate levels (SIL, n = 154, increase\0.8 mmol/L), medium increase in lactate
levels (MIL, n = 105, 0.8 mmol/L B increase\1.4 mmol/L) and high increase in lactate
levels (HIL, n = 144, 1.4 mmol/L B increase). Differences between the three groups in the
potential risk factors were identiﬁed by one-way ANOVA and Bonferroni correction. Cor-
relations were assessed with either Spearmans rank correlation test or Pearsons correlation
test, as appropriate.
RESULTS. Analysis of variance indicated that the three groups differed signiﬁcantly in
maximum glucose concentration during CPB (p\0.001) and during ICU stay (p\0.001),
application of insulin during CPB (p = 0.001) and during ICU stay (p\0.001), total per-
fusion duration (p\0.001) and aortic clamp duration (p = 0.002). Correlation analysis
identiﬁed all of these potential risk factors to be positively correlated to the increase of arterial
blood lactate levels (p\0.001). Correlation of increase in lactate to the administration of
catecholamines was not veriﬁed.
CONCLUSION. Hyperglycemia and long CPB duration are associated with increased lactate
levels. Attempts to reduce glucose concentration and CPB duration may result in lower lactate
concentrations after cardiac surgery.
REFERENCE(S). 1. Munoz R, Laussen PC, Palacio G, Zienko L, Piercey G, Wessel DL.
Changes in whole blood lactate levels during cardiopulmonary bypass for surgery for con-
genital cardiac disease: an early indicator of morbidity and mortality. J Thorac Cardiovasc
Surg 119: 155–62, 2000.
2. Mustafa I, Roth H, Hanaﬁah A, Hakim T, Anwar M, Siregar E, Leverve XM. Effect of
cardiopulmonary bypass on lactate metabolism. Intensive Care Med 29: 1279–85, 2003.3.
Maillet JM, Le BP, Cantoni M, Nataf P, Ruffenach A, Lessana A, Brodaty D. Frequency, risk
factors, and outcome of hyperlactatemia after cardiac surgery. Chest 123: 1361–6, 2003.
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ELECTROCARDIOGRAPHIC ST-T ABNORMALITIES FOLLOWING CARDIAC
VALVE SURGERY WITH NORMAL CORONARY VESSELS. PERIOPERATIVE
MYOCARDIAL INFARCTION?
R. Jara-Rubio*, M. Fernandez, C. Llamas, D. Bixquert, M. Royo-Villanova, A. Padilla
Intensive Care, Hospital Virgen de la Arrixaca, Murcia, Spain
INTRODUCTION. ECG abnormalities after cardiac valve surgery may be similar to those
seen during spontaneous myocardial infarction, and few reports describe them. In patients
who have undergone valve surgery, new ST-T abnormalities are common but not necessarily
diagnostic of myocardial ischemia. However, when new Q waves appear in territories other
than those identiﬁed before surgery, myocardial infarction should be considered, particularly
if associated with elevated biomarkers, new wall motion abnormalities or haemodynamic
instability (1–2). The purpose of this study is to asses the incidence of ST-T abnormalities and
perioperative myocardial infarction, clinical manifestations (electrocardiographic, echocar-
diographic, biomarkers elevation) and prognosis, in patients with cardiac valve surgery
without coronary artery disease.
METHODS. Retrospective analysis of patients who underwent cardiac valve replacement in
a Tertiary University Hospital over a ten year period. After surgery, the patients were rou-
tinely admitted to the Intensive Care Unit (ICU). We excluded patients with angiographically
signiﬁcant coronary lesions before surgery and those with aortic dissection. Statistical anal-
ysis was performed with SPSS 12.0.
RESULTS. Between 1997 and 2007, 3700 patients underwent cardiac surgery in our hospital.
Of them, 1600 (43.24%) were operated for valve replacement. 30 (1.8%) patients had, in the
ﬁrst 24 h of ICU stay ST-T abnormalities. 18 (60%) showed new Q waves and at least one of
the following: echocardiographic ﬁndings consistent with Myocardial infarction (MI), ele-
vated biomarkers (Troponin T) ﬁve fold the upper reference limit (0.1 ng/ml) or
haemodynamic instability. Baseline characteristics were as follows: Age(yr) 57.6 ± 14.6;
LVEF %:57.8 ± 6; Sex(%female) 47; ExtracCirc.(min.): 134 ± 60; Aortic clamp (min.):
68.4 ± 29.4; Hypertension 37%; Diabetes 13.6%; Euroscore 4.6 ± 2.3. Clinical outcome and
complications: ICU stay (days) 5.8 ± 3.8 (1–20); Mechanical ventilation (hours) 40 ± 13 (0–
360); Intraaortic balloon pump 23.3% (n = 7); Low cardiac output 37%;(n = 11); ST
changes Inferior leads:46% (n = 14); Inferior + right:20 % (n = 6); Anterior:16.7 %
(n = 5); New onset Q waves 60 %;n = 18; Cardiogenic shock 13.3%;n = 4; Emergency
coronary artery bypass 10 %;n = 3; Mortality causes: Cardiogenic shock n = 4; Multiple
organ failure n = 2; Mortality: 20%; n = 6.
CONCLUSION. perioperative myocardial infarction following valve surgery is a fairly
uncommon complication, that must be suspected in patients with ST abnormalities; in our
patients, it is associated with increased mortality. Inferior leads were the most frequently
affected, with high proportion of right ventricular dysfunction. Strategies must be directed
towards early diagnosis, including angiography in patients hemodynamically unstable.
REFERENCE(S). 1. K. Thygesen et al. Universal deﬁnition of myocardial infarction.
European Heart Journal 2007; 28: 2525–38.
2. Nesher N, Alghamdi AA, Singh SK, Sever JY, Christakis GT, Goldman BS, Cohen GN,
Moussa F, Fremes SE.Troponin after cardiac surgery: a predictor or a phenomenon?Ann
Thorac Surg. 2008 Apr;85(4):1348–54.
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INTRODUCTION. The monitoring of mixed venous saturation(SVO2) necessitates the use
of a Pulmonary Artery Catheter. SVO2 measurement is now frequently replaced by the
measure of venous saturation in the superior vena cava (ScVO2). The aim of our study is to
analyze the correlation between ScVO2 and SVO2 and their predictive value of low output
state following cardiac surgery.
METHODS. SVO2, ScVO2 and cardiac output were monitored in 15 patients during 24 h
following cardiac surgery. SVO2 and continuous cardiac output were monitored using optical
pulmonary Swan Ganz catheter and Vigileo monitoring from Edwards LifeScience. ScVO2
was monitored using optical central venous catheter and monitoring from Pulsion. Data were
collected every two seconds. Paired data for ScVo2 and SVO2 were analyzed with T test and
linear regression. Logistic regression was used to predict low output state from ScvO2 and
SVO2. The statistical analysis was performed using Stata 8 for UNIX.
RESULTS. ScVO2 underestimates SVO2 (SVO2 = 62.88 +- 6.20, ScVO2 = 57.35 +- 9.20,
p\0.0001 at paired T test) and poorly correlates with SVO2 at linear regression (R
2 = 0.57,
ScVO2 coefﬁcient = 0.446, const = 37.45). Predictive value of ScVO2 for low output state
as deﬁned by a CI\2.4 l/min was poor (*LROC = 0.6) at logistic regression as compared
with SVO2 (LROC = 0.69).
CONCLUSION. ScVO2, on the average, underestimates SVO2 and is only of low value to
detect low output state following cardiac surgery.
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ADAPTIVE SUPPORT VENTILATION (ASV) DOES NOT AFFECT SEDATION
REQUIREMENTS IN PATIENTS AFTER CORONARY ARTERY BYPASS GRAFT-
ING (CABG)
A. Kudoga, D. A. Dongelmans*, J. M. Binnekade, M. J. Schultz
Intensive Care Medicine, Academical medical Center, Amsterdam, Netherlands
INTRODUCTION. ASV maintains an operator preset alveolar minute ventilation by pro-
viding automatic selection of ventilatory settings and continuous breath by breath adaptation
(1). We studied the inﬂuence of ASV on need for sedatives (propofol) and tes (morphine) in
patients after CABG.
METHODS. Randomized controlled trial comparing ASV with pressure control/pressure
support (PC/PS)–mechanical ventilation (MV) in 128 patients after Coronary Artery Bypass
Grafting (CABG). Data on prescribed propofol and morphine were retrieved from the patient
data management system (in the ICU) and from the patient’s charts (in the OR). Data are
means ± SD, or medians [IQR] where appropriate. Statistics: T-tests were used to analyze
differences between groups; non parametric tests were used when applicable
RESULTS. There were no differences between ASV– and PC/PS–MV patients regarding
demographics, length of stay in ICU/hospital, and creatinine levels. Sedation use in the OR
was similar. Duration of intubation and mechanical ventilation was 16.7 ± 6.1 h versus
17.9 ± 1.0 h with ASV and PC/PS–MV, respectively (P = 0.35). There were no differences
in prescribed propofol and morphine (Table 1).
TABLE 1 SEDATIVES AND ANALGESICS CHARACTERISTICS
ASV N = 64 PC/PS–MV N = 64 P–value
Propofol – total dose (mg/kg) 9.44 [4.12 – 15.66] 8.38 [4.90 – 12.44] 0.83
Propofol – duration (minutes) 308 [168 – 455] 318 [200 – 780] 0.93
Propofol – duration after
reaching core temp 368
144 [67 – 217] 135 [60 – 238] 0.41
Morphine – total dose (mg/kg) 0.05 [0.03 – 0.12] 0.05 [0.03 – 0.07] 0.41
CONCLUSION. ASV does not affect the use of propofol and morphine in patients after
CABG.
REFERENCE(S). 1)Brunner JX, Iotti GA: Adaptive Support Ventilation (ASV). Minerva
Anestesiol 2002, 68(5):365–368.
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INTRODUCTION. Severe sepsis usually leads to a life-threatening acute critical illness and
short-term mortality has been used to measure the outcome. Severe sepsis often causes several
organ dysfunctions, from which surviving patients may recover slowly. An important long-
term outcome is the assessment of quality of life (QOL) after critical illness.The aim of the
study was to assess the long-term mortality, quality of life (QOL), quality-adjusted life years
(QALY) and costs per one QALY in an unselected ICU patient population with severe sepsis.
METHODS. A total of 470 adult patients with severe sepsis were treated in 24 mixed ICUs
between November 1, 2004 and February 28, 2005. The QOL before critical illness was
assessed in 252 patients and QOL after severe sepsis in 156 patients (58% of the patients
surviving in April 30, 2006). Ninety-eight patients responded to both questionnaires. QOL
was assessed by a generic EuroQol (EQ-5D) measurement with summary index (EQsum) and
visual analogue scale (VAS).
RESULTS. The two-year mortality after severe sepsis was 44.9% (211/470). The median
response time for QOL assessment after severe sepsis was 17 months (IQR 16–18). The
median EQsum index (63, IQR 48–79) and EQ VAS (66, IQR 50–80) were lower after severe
sepsis than age- and gender-adjusted reference values (p\0.001 and p\0.001). The
decrease between the mean EQsum reference value and that of severe sepsis patients was 23
(95% CI, 20–26). The difference between the mean EQ VAS reference values and the mean
EQ VAS was 8 (95% CI, 5–11). The mean calculated QALYs after severe sepsis were 9.2
(95% CI, 8.2–10.2) and the calculated cost for one QALY was only 2533 € for all survivors
and non-survivors.
CONCLUSION. Two-year mortality after severe sepsis was high (44.9%) and the QOL was
lower after severe sepsis than before critical illness as assessed by EQ-5D. However, the mean
QALYs for the surviving patients were reasonable and the cost for one QALY was reasonably
low, which makes intensive care in patients with severe sepsis cost-effective.
GRANT ACKNOWLEDGEMENT. EVO grant from Tampere University Hospital.
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INTRODUCTION. Measures that integrate mortality and morbidity, such as quality-adjusted
life years (QALYs), have been proposed as outcomes for critical care clinical trials. We
sought to describe the statistical distribution of QALYs in a cohort of ARDS patients, and to
estimate sample size requirements for a hypothetical interventional trial using QALYs as the
primary outcome.
METHODS. We used SF-36 data collected during a multicentre prospective observational
study of ARDS patients(1) to generate utility values for patients at 3, 6, and 12 months using
the SF-6D. While patients remained in the ICU we assigned a utility of 0, and patients who
died were assigned a utility of 0 from that point forward. QALY values for each patient were
calculated from the area under the utility-time curve. We used the distribution of these
QALYs to estimate the sample size needed to detect a combined mortality reduction and
increase in QALYs among survivors, and considered additional permutations where these
outcomes were affected differentially. We estimated sample size requirements using multiple
simulations and compared results to what a standard chi-squared comparison of mortality
proportions would require.
RESULTS. From 195 enrolled patients we could generate QALY outcomes for 168 (86.2%)
at 6 months and 159 (81.5%) at 1-year follow-up. The median (IQR) patient age was 48 (37–
61) years, and APACHE II score 25 (20–30). The median ICU length of stay was 21 (11–37)
days, the ICU mortality rate was 78/195 (40.0%), and the 6-month mortality was 87/177
(49.2%). The required sample size (80% power; 2-sided alpha = 0.05)for an intervention that
reduced mortality from 48% to 44% and improved QALY by 0.025 in survivors at 6 months
was 580 per group, compared with 2436 patients per group for a hi-squared comparison of
these same mortality proportions. When only mortality or only QALY in survivors improved
by these amounts, 3364 and 1856 patients per group would be needed, respectively. When
QALY in survivors and mortality moved in opposite directions meaningful estimates could
not be generated.
CONCLUSION. QALYs may be a more patient-centred, feasible outcome in ICU trials
yielding a major gain in statistical power under certain conditions. However, like all com-
posite endpoints, the individual components of this outcome must be examined separately to
ensure they are not differentially affected by the trial intervention.
REFERENCE(S). 1. MS Herridge et al. One-Year Outcomes in Survivors of the Acute
Respiratory Distress Syndrome. N Engl J Med 2003, 348:683–693.
GRANT ACKNOWLEDGEMENT. OTS Block-Term Grant; for the Canadian Critical Care
Trials Group.
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SHORT AND LONG TERM OUTCOME OF PATIENTS RECIEVING HAEMOFIL-
TRATION DURING CRITICAL ILLNESS
L. Srinivasa*, G. Scholey, A. J. D. Parry-Jones
Department of Intensive Care Medicine, University Hospital of Wales, Cardiff, United
Kingdom
INTRODUCTION. Acute renal failure requiring renal replacement therapy (RRT) is com-
mon in critically ill patients. Mortality in this group of patients is high, ranging from 28 to
90%. The purpose of the study was to deﬁne the outcome of patients requiring haemoﬁltration
(HF) during critical illness and outcome following discharge from our adult general ICU, over
a 3 year period, of patients still requiring RRT at time of hospital discharge.
METHODS. Between January 2004 and December 2006, 436 patients (total admission were
3890) received RRT in our ICU as noted by our database. We looked into the ICU and
hospital mortality and their relation to renal plus respiratory or renal plus cardiovascular or
both. All patients requiring long term renal support were available from our computer based
registry.
RESULTS. Of the 436 patients, 47% of patients were admitted with a respiratory cause and
35% with cardiovascular cause. The average number of ventilator days was 9.3 and average
haemoﬁltration 5.49 days. Our ICU mortality was 37%. 11.9% subsequently died in hospital.
17% were transferred to other hospitals in the region following critical care discharge. 54
patients were identiﬁed as having pre-existing renal impairment and hospital mortality in this
group was 46.29%. Of the 382 patients admitted to ICU with normal renal function pre critical
illness, 10 still required RRT at time of hospital discharge. At the end of 1 year of follow up, 4
had died, 3 were still on haemodialysis (Abdominal aortic aneurysm repair, perforated duo-
denal ulcer and diabetic ketoacidosis) and 2 patients were being monitored. By 2 years post
follow up no patients required RRT. The monitored patient’s diagnoses were TTP and SLE.
The mortality of patients admitted with speciﬁc organ failures were
TABLE 1
Organ Failure Hospital Mortality (%) Average Age
Renal + Respiratory 33.6 56.2
Renal + Cardiovascular 35.2 59.9
Renal + Respiratory + Cardiovascular 28.6 60.92
CONCLUSION. Of the survivors of critical illness requiring RRT, 2.61% required RRT for
up to one year following ICU discharge. 2 years after discharge no patients with normal renal
function preadmission required RRT. The mortality of patients discharged from hospital still
requiring RRT was 40%. These results have implications for what patients, or the patient’s
relatives, are told when RRT is deemed necessary during critical illness. It also has impli-
cations for those commissioning RRT services in survivors of critical illness. Our mortality
for patients requiring RRT is low. The lower mortality for 3 organ failure versus 2 probably
represents non escalation treatment limitations and needs further investigation.
REFERENCE(S). 1. Noble, J.S.; MacKirdy, F.N.; Donaldson, S.I.; Howie, J.C. Renal and
respiratory failure in Scottish ICU. Anaesthesia,Vol56, Nn  2, Feb. 2001,pp.124–129(6).
0745
PREVALENCE AND RISK FACTORS FOR POST-TRAUMATIC STRESS DISOR-
DER SYMPTOMS ONE YEAR AFTER MECHANICAL VENTILATION
G. Bugedo*, E. Tobar, D. Arbulo, D. Bugedo, J. Varas, F. Riquelme, M. T. Lira, M. Aguirre
Medicina Intensiva, Universidad Catolica de Chile,
2Paciente Critico, Universidad de Chile,
Santiago, Chile
INTRODUCTION. Patients suffering critical illnes are at risk of developing post-traumatic
stress disorder (PTSD). We assessed prevalence and risk factors for PTSD symptoms in
patients who required mechanical ventilation one year after ICU stay.
METHODS. Two-hundred and eighty-seven patients who required mechanical ventila-
tion[48 h were enrolled in a prospective, nonrandomized, multicenter study in Chile
(ClinicalTrials.gov NCT00403208). Main exclusion criteria were neurologic impairment and
end-stage organ disease. One-year mortality was 48%, and survivors were screened tele-
phonically for memories of traumatic experiences during ICU stay (nightmares, panic, pain,
and suffocation) and PTSD symptoms by means of the post-traumatic stress syndrome-10
(PTSS-10) scale. PTSS-10 score[35 was deﬁned as PTSD. Statistical analysis included
MannWhitney and Fisher’s exact tests for univariate analysis, and multiple logistic regression
to test risk factors for PTSD.
RESULTS. Fifty percent (75/149) of patients answered the questionnaire (52 could not be
reached, 14 refused consent, and 8 were not able to respond). Average PTSS-10 score was
29 ± 14, and 20 (37%) patients had a score[35. Gender (M:24 ± 11 vs. F:35 ± 14,
p\0.001), medical condition (p\0.015) and oxygenation index at 24 h (p\0.009) were
correlated to PTSS-10 score. No relationship was found between hypnotics, analgesic and
neuromuscular blockade use and doses, or level of sedation during mechanical ventilation and
PTSD symptoms. Patients with traumatic memories had a greater prevalence of PTSS-
10[35 (p\0.005). Multivariate analysis showed only gender to be predictive of PTSD
symptoms.
CONCLUSION. Prevalence of PTSD symptoms in patients surviving critical illnes and
mechanical ventilation was more frequent in women, and similar to other studies. None of
sedation variables studied was related to PTSD symptoms.
REFERENCE(S). Stoll C, et al. Intensive Care Med 1999; 25: 697–704.
GRANT ACKNOWLEDGEMENT. Conicyt Chile, FONIS SA05I20091.
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ESTABLISHING AN ICU FOLLOW-UP CLINIC: FEASIBLE AND OF VALUE
A. Schandl, E. Hellgren, A. Svensson-Raskh, O. C. Brattstro ¨m, M. K. Karlsson, P. V. Sackey*
Anesthesiology and Intensive Care Medicine, Physiology and Pharmacology, Karolinska
Institutet, Stockholm, Sweden
INTRODUCTION. Intensive Care Unit (ICU) survivors are at risk for physical or psycho-
logical sequelae after critical illness. Medical practioners outside the ICU may not recognize
or understand these sequelae. While there are no consensus recommendations of how to
organize ICU follow-up, experiences of others suggest that repeated follow-up may be
valuable for evaluation after intensive care.
METHODS. In 2007 a multidisciplinary follow-up team was formed, consisting of three
physicians, two nurses and a physiotherapist from the General ICU. Hospital psychiatrists
were involved to dsicuss consensus for patient referrals, as well as the Pain Clinic.
Patients treated for 4 days or longer in the General ICU are seen in the ward by a nurse from
the follow-up team 2–5 days after ICU discharge. Patients are briefed about their ICU stay,
and the ICU follow-up is described shortly. Visits to the ICU Follow-up Clinic are 3, 6 and
12 months after ICU discharge. Prior to each visit patients ﬁll in ICU Memory Tool, Short
Form-36, Hospital Anxiety and Depression Scale (HAD) and Impact of Event Scale (IES). At
each visit the patient meets a nurse, a physician and a physiotherapist from the ICU. Mem-
ories from the ICU are ventilated and the course of illness and treatments during the ICU stay
are described. Patients with[25 points in IES or[10 in any of the two subscales of HAD are
referred to a collaborating psychiatrist. Patients with mean daily pain score above 3 on the
Visual Analog Scale or with untreated neuropathic pain are referred to the Pain Clinic.
Questionnaire results and potential further referral are discussed with the patient. Muscle
strength, mobility and restrictions in physical functioning are evaluated and the patient per-
forms a 6 minute walking test. If necessary patients are referred to their local out-clinic
physiotherapist.
RESULTS. During the ﬁrst year of follow-up, 95 patients who spent[96 h in the ICU and
survived to follow-up were invited and 57 came for follow-up. Eight patients were referred for
more extensive psychiatric evaluation, of which four were found to be in need for speciﬁc
treatment (cognitive behavioural therapy, antidepressive treatment) or repeated assessment.
Two patients were referred to the Pain Clinic. Thirty-eight patients were found to be in need
of physiotherapy recommendations or referral. Evaluation of the follow-up indicates a high
degree of patient satisfaction.
CONCLUSION. Follow-up of ICU survivors by an ICU-based multidisciplinary team is
feasible and can help identify unmet physical and psychological needs of ICU survivors
during the ﬁrst year after intensive care. A liaison between ICU clinicians and other spe-
cialists for referral of patients with psychological, somatic or pain sequelae is essential.
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TWO YEARS ROUTINE BASED FOLLOW-UP AFTER INTENSIVE CARE
H. Flaatten, A. K. Muri, R. Kva ˚le*
ICU, Haukeland University Hopsital, Bergen, Norway
INTRODUCTION. Morbidity after intensive care spans from impaired physical function to
mental problems. However, few ICUs have regular follow-up routines. In rural areas it is
inconvenient for patients to visit an out-patient clinic. From January 2006 we implemented a
two-step follow-up in our ICU, and the experiences from the ﬁrst two years are presented
METHODS. The study was conducted in a 10 bed general ICU. All survivors ([16 years)
with a LOS[48 h were eligible. 3 months after ICU discharge they were contacted by
telephone, two questionnaires (EQ 5D and Karnofsky score) were applied, and a semi-
structured interview performed. This part was performed by one of six trained ICU nurses. If
the patient expressed a wish for a follow-up, or the interviewer deemed this necessary,
patients were invited to the out-patient clinic at the hospital.
RESULTS. During the ﬁrst two years, 738 adult patients were treated in the ICU, mean SAPS
II score was 41.9, hospital mortality 24%. 214 (75%) of 285 eligible patients were followed
up, and 57 patients wanted a second follow-up at the hospital. The ﬁgure shows results from
EQ-5D (mean sum before 0.78 and after 3.25). The mean Karnofsky score was 66. An
unpleasant memory was reported by 57%, most often hallucinations (24%) or anxiety (11%).
In 6% pain was remembered as a problem.
CONCLUSION. Three months after the ICU stay the daily life of a large part of our patients
were still reduced, with perceived QOL worse than pre-ICU. However, most patients seem to
cope with such problems without the need for a second consultation in our ICU, making this
model cost-effective.
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EFFICACY OF TIGECYCLIN VERSUS HIGH DOSE OF AMPICILLIN-SULBAC-
TAM IN VENTILATOR ASSOCIATED PNEUMONIA CAUSED BY
ACINETOBACTER BAUMANII
F. G. Frantzeskaki*
1, A. Xanthaki
2, A. Betrosian
1
1Intensive Care Unit,
2Microbiology department, Ippokration Hospital, Athens, Greece
INTRODUCTION. Acinetobacter baumanii is an important cause of infections in patients in
intensive care units. Sulbactam combinations are bactericidal against A.baumanii in in vivo
models. Tigecycline, the ﬁrst clinically available semisynthetic glycylcycline approved for
clinical use, has been shown to have potent activity against a wide variety of gram–positive
and gram-negative pathogens, including multidrug resistant (MDR) strains. We prospectively
studied the efﬁcacy of tigecyclin versus a high dose regimen of ampicillin-sulbactam (A/S) in
patients with Ventilator Associated Pneumonia (VAP) caused by A.baumanii.
METHODS. Twenty-three mechanical ventilated patients[72 h (mean age: 70 ± 7) that
developed VAP and had positive A. baumannii tracheal aspirates were enrolled in the study.
The case was considered to be aetiologically conﬁrmed if A. baumannii was isolated and
quantitative culture of broncho-alveolar lavage ([104 cfu/mL) was achieved. The antimi-
crobial susceptibility of the isolates was determined using the disk-diffusion (Kirby-Bauer)
method, the VITEK II system and the E-test method (AB Biodisk, Solna-Sweden). All iso-
lates exhibited resistance to almost all antibiotics routinely tested, excluding colistin.
Susceptibility to tigecyclin was intermediate. Ten of the patients received tigecyclin intra-
venously (Group A), as monotherapy (50 mg twice daily) while thirteen of them received 9 g
A/S (Group B) three times daily (cumulative dose of 9 g sulbactam daily, adjusted for
creatinine clearance). Follow up cultures and clinical evaluation of all patients was performed
ﬁve days after the initiation of therapy. Clinical success was deﬁned by a lessening of the
signs and symptoms of VAP, while microbiologic success was deﬁned as eradication of the
pathogen in BAL cultures.
RESULTS. Follow up BAL revealed microbiologic success in 8 patients of Group A (80%)
and 10 patients of Group B (77%) (p = 0.86). Clinical success was observed in 7 patients of
Group A (70%) and 10 patients of Group B (77%) (p = 0.7). There was no signiﬁcant
difference in 14 days and 30 days mortality between the two groups. Adverse reactions
occurred in 2 patients (15.3%) of Group B (reversible nephrotoxicity and diarrhea), which did
not lead to discontinuation of treatment. Toxicity was not observed with tigecyclin use.
CONCLUSION. In this study tigecyclin and high-dose ampicillin/sulbactam were compa-
rably effective treatment options for MDR A.baumanii VAP, while tigecycline therapy seems
safer. The administration of these regimens could prevent the excessive use of polymixins in
intensive care units and the subsequent development of pandrug resistant strains.
REFERENCE(S). 1. Bantar C., Schell C, Posse G, Limansky A, Ballerini V. Comparative
time-kill study of doxycycline, tigecycline, sulbactam, and imipenem against several clones
of Acinetobacter baumannii. : Diagn Microbiol Infect Dis. 2008 Mar 27.
2. Betrosian A, Frantzeskaki F, Xanthaki A, et al. High-dose ampicillin-sulbactam as an
alternative treatment of late onset VAP from multidrug-resistant acinetobacter baumannii.
Scand J Infect Dis 2007; 39: 38–43.
3. MullangiPK,PankeyGA.Tigecyclineincriticalcare.Crit Care Clin.2008Apr;24(2):365–75.
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VENTILATOR ASSOCIATED PNEUMONIA FROM MULTI-RESISTANT, COLIS-
TIN SENSITIVE, ACINETOBACTER BAUMANNII
E. Zakynthinos*
1, E. Petinaki
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1, E. Theodorou
1, O. Apostolopoulou
1,
C. Diakaki
1, A. Kessaris
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3
1Critical Care Department,
2Department of Microbiology, University Hospital of Larissa,
Larissa,
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INTRODUCTION. Retrospective studies have reported good clinical and microbiological
success rates using intravenous colistin as monotherapy to treat multiresistant A. baumannii
ventilator associated pneumonia (VAP), comparable to that obtained with imipenem at the
time to treat VAP due to imipenem-susceptible strains. However, colistin as monotherapy led
to poor results in mouse pneumonia by multiresistant A baumannii, due to inadequate pen-
etration into the pulmonary parenchyma.
METHODS. Between November 2003 to December 2006, 74 consecutive patients developed
microbiologically documented VAP due to A. baumannii susceptible only to colistin. Twenty
four from these patients were excluded from the study as they were requiring antibiotics
against Gram negative bacteria for infections other than VAP, or they were considered to
suffer from multimicrobial VAP. The rest were prospectively, randomized to administer
colistin only (3 MU three times daily, adjusted for creatinine clearance) (Group A) or
combination therapy with colistin (dose as group A) and ampicillin/sulbactam 24 (16 + 8) gr
IV (Group B). Eleven more patients were also excluded in the course of the study due to
development of conﬁrmed infections from microorganisms other than A. baumannii. Finally,
Group A consisted from 19 patients (age 56.6 ± 14.3) Group B consisted from 20 patients
(age 56.9 ± 18.7). The clinical response of VAP (improvement of symptoms, clear decrease
of purulent bronchial secretions, constant decrease of vasopressors) was assessed on day 5th
of treatment.
RESULTS. Group A did not differ to Group B in APACHE II on admission to ICU
(14.5 ± 3.1 vs. 16.5 ± 4.7), SOFA score on diagnosis of VAP (7.6 ± 2 vs. 7.9 ± 3.1), the
clinical presentation with septic shock (52.9 vs. 47.1%), or the existence of bacteremia. In
univariate logistic regression analysis only the combination treatment (70% vs. 15.8,
p = 0.001, OR = 12.44(2.6–59.3)) and SOFA B 8 (58.3 vs. 20%, p = 0.024, OR = 0.179
(0.04–0.8)) were associated with clinical response of VAP.
CONCLUSION. Combination therapy with colistin and high dose of ampicillin/sulbactam
seem to be more effective in VAP due to multiresistant—only colistin sensitive—A. bau-
mannii VAP.
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COLISTIN VERSUS TIGECYCLINE IN VENTILATOR ASSOCIATED PNEUMO-
NIA CAUSED BY ACINETOBACTER BAUMANII
F. G. Frantzeskaki*, M. Theodorakopoulou, A. Armaganidis
Second Department of Intensive Care, University General Hospital ‘‘Attikon ’’, Athens,
Greece
INTRODUCTION. The emergence of multidrug resistant (MDR) gram-negative bacteria
necessitated the revival of older antibiotic drug classes such as polymyxins (colistin) and
tetracyclines. Tigecycline, the ﬁrst clinically available semisynthetic glycylcycline approved
for clinical use, has been shown to have potent activity against a wide variety of gram–
positive and gram-negative pathogens, including MDR strains. We retrospectively evaluated
the efﬁcacy of tigecyclin versus colistin in patients with Ventilator Associated Pneumonia
(VAP) caused by A.baumanii.
METHODS. Twenty-ﬁve mechanical ventilated patients[72 h (mean age: 70 ± 7) that
developed VAP and had positive A. baumannii tracheal aspirates were enrolled in the study.
The case was considered to be aetiologically conﬁrmed if A. baumannii was isolated and
quantitative culture of broncho-alveolar lavage ([104 cfu/mL) was achieved. The antimi-
crobial susceptibility of the isolates was determined using the disk-diffusion (Kirby–Bauer)
method, the VITEK II system and the E-test method (AB Biodisk, Solna-Sweden).Interpre-
tation of the susceptibility results was in accordance to the Clinical and Laboratory Standards
Institute (CLSI). All isolates exhibited resistance to almost all antibiotics routinely tested,
excluding colistin. Susceptibility to tigecyclin was intermediate. Ten of the patients received
tigecyclin intravenously (Group A), as monotherapy (50 mg twice daily) while ﬁfteen of them
received colistin intravenously, as monotherapy or in combination with cefepime (3*106 IU
three times daily, adjusted for creatinine clearance) (Group B). Follow up cultures and clinical
evaluation of all patients was performed ﬁve days after the initiation of therapy. Clinical
success was deﬁned by a lessening of the signs and symptoms of VAP, while microbiologic
success was deﬁned as eradication of the pathogen in BAL cultures.
RESULTS. Follow up BAL revealed microbiologic success in 8 patients of Group A (80%)
and 10 patients of Group B (66,6%) (p = 0.86). Clinical success was observed in 7 patients of
Group A (70%) and 9 patients of Group B (60%) (p = 0.7). There was no signiﬁcant dif-
ference in 14 days and 30 days mortality between the two groups. Adverse reactions occurred
in 5 patients (33%) of Group B (reversible nephrotoxicity), which did not lead to discon-
tinuation of treatment. Toxicity was not observed with tigecyclin use.
CONCLUSION. Colistin and tigecycline seem equally effective in eradication of multidrug
resistant A. baumanii in BAL cultures of patients with VAP. However, tigecycline admin-
istration seems to be safer than colistin in the clinical treatment of these patients. More data
are needed, in order to clarify the role of these regiments in the treatment of A.baumanii
infections.
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NEBULIZED COLISTINE IN THE TREATMENT OF MULTIRESISTANT PSEU-
DOMONAS AERUGINOSA NOSOCOMIAL PNEUMONIA
S. Motaouakkil*, B. Charra, A. Hachimi, A. Benslama
Medical Intensive Care Unit, Ibn Rochd University Hospital, Casablanca, Morocco
INTRODUCTION. The multi resistant Pseudomonas aeruginosa (MRPA) nosocomial
pneumonias are responsible for an important mortality and morbidity in ICU. We report our
experience in the use of the nebulized colistine in the treatment of the MRPA nosocomial
pneumonias (NP).
METHODS. It is a prospective observational study performed during 2 years (2006–2007)
concerning all patients having developed MRPA nosocomial pneumonias, treated by nebu-
lized colistine. The criterions of success treatment were extubation and ICU mortality.
RESULTS. We count 32 patients (12 women and 20 men) which the mean age was
48 ± 19 years. All patient have been mechanical ventilation which the mean length was
29 ± 5,5 days. The bronchial sampling technique was broncho-alveolar lavage (BAL). The
mean delay of infection was 7 ± 2 days. The isolated MRPA was sensitive only to the
colistine. The treatment was nebulized colistine for all patient (4 MUI/day) and intravenous
way (4 MUI/day) if the bloodculture was positive (n = 5) for the same germ. No one has been
developed sign of toxicity to the colistine. The mean delay of extubation after starting
treatment was 10 days. The sterilization of the sampling has been gotten on average on the
eighth day. No case of mortality has been noted.
CONCLUSION. It seems that nebulized colistine is an important alternative to treat MRPA
nosocomial pneumonia in ICU. Our result needs conﬁrmation by others multicentric studies.
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LIMITING THE DURATION OF ANTIBIOTIC THERAPY IMPROVES OUTCOMES
IN PATIENTS ADMITTED TO THE INTENSIVE CARE UNIT WITH PNEUMONIA
S. Soni, M. Hussain, P. G. Hayden*
Intensive Care Unit, Medway Maritime Hospital, Gillingham, United Kingdom
INTRODUCTION. Whilst antibiotics have reduced mortality from sepsis, their use is
associated with increased healthcare associated infections, emergence of drug-resistant
organisms, increased hospital length of stay, morbidity and mortality and increased cost.
There is now evidence that strict control over antibiotic prescription, with appropriately
shortened durations of regimes reduces cost, does not compromise outcome, and may be
beneﬁcial in critically ill patients [1, 2].
METHODS. We performed a retrospective analysis of 56 patients admitted consecutively to
our ICU with severe pneumonia over the past 12 months and evaluated the suitability of
antibiotic chemotherapy based on choice of agent, duration of therapy, modiﬁcation following
assessment of the clinical state of the patient and microbiological data. We excluded patients
with chronic immunodeﬁciency states or those who died within 24 h of admission to the ICU.
Data analysis was performed using the InStat v.3 statistical package (GraphPad Software Inc,
USA).
RESULTS. Of the 56 patients, 31 (55.4%) received appropriate antibiotic chemotherapy, 8
(14.2%) received an incorrect antibiotic, and 17 (30.4%) received an inappropriately long
duration of therapy based on microbiological data, clinical response and current hospital
guidelines. Sputum cultures/tracehal aspirates taken on admission were positive in 13 (23.6%)
patients despite clinical evidence of pneumonia. The incidence of hospital acquired infection
(HAI) was signiﬁcantly higher in those patients receiving incorrect antibiotic choice or
prolonged duration of therapy (12 vs. 6 infections, p = 0.023). When stratiﬁed by duration of
therapy, those patients receiving B 5 days of antibiotics had signiﬁcantly reduced ventilator
days (5.8 vs. 10.2 days; p = 0.027), duration of ICU stay (6.9 vs. 12.4 days; p = 0.02), and
reduced HAI (3 vs. 14 episodes; p = 0.0093) despite being comparable for age, relevant
comorbidities, and severity of illness (APACHE II score 19.6 vs. 19.4; p = 0.9).
CONCLUSION. 1. Shortened antibiotic regimes based on clinical assessment, response to
empiric therapy and microbiological data are associated with reduced incidence of hospital
acquired infections, ventilator days, and duration of intensive care length of stay.
2. Accurate diagnosis of infection may be improved using biochemical markers such as
procalcitonin assay or clinical infection scores such as CPIS (Clinical Pulmonary Infection
Score) given the low yield from sputum culture/tracheal aspirate.
REFERENCE(S). 1. Singh N, Rogers P, Atwood C, Wagener M, Yu V. Short-course empiric
antibiotic therapy for patients with pulmonary inﬁltrates in the intensive care unit. Am J
Respir Crit Care Med 2000; 162:505–511.
2. Corona A, Wilson PR, Grassi M, Singer M. Prospective audit of bacteraemia management
in a university hospital ICU using a general strategy of short-course monotherapy. J Anti-
microb Chemother 2004; 54:809–816.
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REGIONAL COOLING OF EXTRACORPOREAL BLOOD CIRCUIT: A NOVEL
ANTICOAGULATION APPROACH FOR CONTINUOUS RENAL REPLACEMENT
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INTRODUCTION. An optimal anticoagulation strategy during CRRT in critically ill still
remains unresolved issue. It is well known that cooling of blood decreases its ability to clot.
Therefore, we developed and experimentally tested a device designed for regional blood
cooling in CRRT extracorporeal circuit as a non-anticoagulant measure to prevent circuit
clotting.
METHODS. We developed the device for selective cooling of extracorporeal circuit (20
centigrade) allowing blood rewarming (38 centigrade) just before returning into the body. 12
anesthetized and ventilated pigs were randomized to receive either 6 hrs of continuous
hemoﬁltration with application of this device (COOL; N = 6) or without it (CONTR; N = 6).
In neither of these groups any anticoagulant was used. In 15, 60, 180, 360 min after starting
hemoﬁltration variables related to circuit patency (time to clotting [TC], number of alarm-
triggered pump stopping, venous circuit pressure [VP]) were assessed. In addition, thrombin-
antithrombin complexes [TAT circ], a marker of coagulation activation in circuit were
measured.
RESULTS. Data are median and interquartile range. While the patency of all circuits treated
with selective cooling was well maintained within the observation period, 5 of 6 sessions were
prematurely clotted in untreated group (TC 197 min (180;240)). Similarly, the number of
alarm-triggered pump stopping was signiﬁcantly higher in nonintervened group (COOL 1.5
(0;2) vs. CONTR 6 (5;7)).
TABLE 1
Variable Group 15 Time 60 180 360
VP (mmHg) COOL 110 (88;122) 100 (78;158) 80 (80;125) 80 (80;205)
CONTR 140 (110;180) 265
ab(200;360) 360
ab(315;418) —
TAT circ
(lg/L)
COOL 13.7 (9.4;23) 44.4
b (37;48.6) 70.2
b (46.8;141) 103.6
b (47.4;110)
CONTR 30.2
a (20.7;36.6) 78
b (56.6;91,9) 173.5
b (121;192) —
a = p\0,05 vs. COOL; b = p\0,05 vs. 15
CONCLUSION. In this experimental setting, our novel device for regional extracorporeal
blood cooling completely prevented circuit clotting. The efﬁcacy and safety of this emerging
strategy will further be validated.
GRANT ACKNOWLEDGEMENT. MSM 0021620819 Replacement of and support to
some vital organs.
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COMPLIANCE WITH LOW VT VENTILATION STRATEGY AND USE OF A NEW
SCALES ON THE ICU
A. G. Foulkes*, J. Murphy, C. Nesbitt, J. A. Walker
Intensive Care Unit, Royal Liverpool University Hospital, Liverpool, United Kingdom
INTRODUCTION. It has been shown
1 that patients with Acute Lung Injury (ALI), and
Acute Respiratory Distress Syndrome (ARDS) gain morbidity and mortality beneﬁt from use
of low tidal volumes (Vt) and low (\30 cm H2O) peak inspiratory pressure (Pinsp) with
invasive ventilation.
Vt’s of 6–8 ml.kg
-1 of ideal weight have been recommended; this weight is calculated using
a formula based on patients’ height. Our unit advocates use of this guidance in determining
ventilator settings for patients with ARDS and ALI (based on oxygenation criteria), but our
compliance with this guidance was not known. The Soehnle Professional 3020 system is an
industrial use electronic scale which allows patients to be weighed without being moved; its
use has not previously been described in a critical care setting.
METHODS. Prospective audit of tidal volumes achieved per kg of actual and ideal weight in
fully ventilated patients with ARDS or ALI.
During October and November 2007, 20 patients were assessed. Vt’s were recorded for each
of the ﬁrst 24 h of ventilation. Values were excluded if an assisted breathing mode was in use.
Notes and x-rays were reviewed to conﬁrm diagnoses of ARDS/ALI. Patients without X-ray
changes were included in the analysis. Patients were measured to calculate ideal weight, and
weighed using a Soehnle Professional 3020 system. This uses chocks placed under bed wheels
to weigh bed and patient together, allowing deduction of the weight of the bed and equipment
to derive patient weight. The weight of all equipment on our ICU was measured prior to
introduction of the scales.
PaO2 at the time of highest FiO2 requirement was recorded, and highest Pinsp used during the
ﬁrst 24 h.
RESULTS. 17 patients met oxygenation criteria for ALI, 12 of these met criteria for ARDS.
Actual weight was greater than ideal weight in 12 patients. Average actual weight was
149.9% of ideal weight. Only 5 patients received low Vt ventilation (6–8 ml kg
-1 ideal
weight). A further 5 had median Vt between 8.0 and 8.5 ml kg
-1 ideal weight. 1 patient
required peak inspiratory pressure over 30 cm H2O. Median Vt was 9.2 ml kg
-1 of ideal
weight and 6.7 ml kg
-1 of actual weight. There were no adverse incidents related to use of
the Soehnle scales, and staff required only 10 minutes training in their use.
CONCLUSION. Compliance with low Vt was good in terms of actual weight but relatively
poor in terms of ideal weight. Patients were being ventilated with excessive Vt. Compliance
with low Pinsp was very good. Ideal weight was lower than actual weight and this seems
likely to be a factor in the tendency to excessive Vt. The Soehnle 3020 system is a safe way of
weighing unstable critically ill patients.
REFERENCE(S). 1. Ventilation with lower tidal volumes compared with traditional tidal
volumes for ALI and ARDS. NEJM 2000;342:1301–07.
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ARE TIDAL VOLUMES DELIVERED BY THE VENTILATOR AND RECEIVED BY
THE PATIENT SIMILAR?
A. Lyazidi*
1, J. Richard
2, A. W. Thille
1, O. Besson
3, L. Brochard
1
1Medical intensive care unit, Universite ´ Paris XII, CHU Henri Mondor, Cre ´teil,
2Medical
intensive care unit, CHU Charles Nicolle, Rouen,
3AGEPS, APHP, Paris, France
INTRODUCTION. During volume controlled ventilation (VCV), several factors can modify
the volume (VT) really delivered to the patient’s lung, such as ambient pressure and tem-
perature, water content, and the amount of compressed gas in the tubings. Consequently, the
preset VT can differ from the VT delivered to patient’s lungs. This bench study aimed at
assessing the ability of ICU ventilators to accurately deliver a pre-set VT, by compensating
compressed gas and accurately predicting ﬁnal VT in body temperature and pressure, satu-
rated with water vapour (BTPS) conditions, from initial ambient temperature and pressure dry
gas conditions (ATPD).
METHODS. Ten ICU ventilators with compensation of compressed gas (Avea, Elise ´e350,
Engstro ¨m, Esprit, Evita XL, Extend, PB7200, PB840, Servo I) and three ventilators without
compensation (Bird 8400, Avea compensation off, Servo I compensation off) were evaluated
using a Michigan lung test model. We compared three pre-set VT (300, 500 and 800 ml), with
three simulations of the respiratory system (obstructive, restrictive, normal), with and without
an inspiratory pause. With two pneumotachographs, we measured the VT delivered by the
ventilator in ATPD conditions and the VT received by the test lung, and used appropriate
corrections for simulating BTPS conditions.
RESULTS. Overall, the compensation algorithms for compressed gas allowed to reduce
errors on delivered VT in ATPD condition (P\0.05). Errors persisted, however, from at
ATPD to BTPS condition with frequent overestimations (the ﬁgure averages values for all
ventilators without versus with compensation). Large errors persisted frequently for all
respiratory system conditions, from -10% to +24 % of the preset VT.
CONCLUSION. Errors in delivered volumes were signiﬁcantly different between both
groups of ventilators. Despite technological improvements, performances of ventilators
remain heterogeneous regarding the accurate delivery of VT.
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REGIONAL DEPENDENCY OF RESPIRATORY TIME CONSTANTS ON DIFFER-
ENT LEVELS OF PEEP IN PATIENTS WITH ACUTE LUNG INJURY
S. Pulletz*, M. Kott, G. Elke, D. Scha ¨dler, G. Zick, J. Scholz, N. Weiler, I. Frerichs
Department of Anaesthesiology and Intensive Care Medicine, University Medical Centre
Schleswig-Holstein, Campus Kiel, Kiel, Germany
INTRODUCTION. Injured lungs consist of fast and slow compartments characterized by
fast and slow inhomogeneously respiratory time constants (au). So far, regional au has only
been determined in animal models of acute lung injury (ALI) by dynamic computed
tomography. The aim of our study was to determine regional au and the dependency of au on
different positive end-expiratory pressure (PEEP) levels in patients with acute ALI using
electrical impedance tomography (EIT).
METHODS. Five adult patients with ALI caused by pneumonia were included. To determine
the inspiratory au, sustained step increase in airway pressure was performed from 0, 8 and 15
cm H2O of PEEP to 35 cm H2O. EIT scans were obtained at a rate of 25 cycles/s using the
Goe-MF II device (Cardinal Health, Hoechberg, Germany). Regional au and the percentage of
the corresponding lung tissue were calculated by a bi-exponential ﬁt of the data from the
global, ventral and dorsal lung regions in the chest cross-section.
RESULTS. The results of the global regions are shown in Table 1. Higher au values and
percentages of lung tissue with slow au were found in dorsal than in ventral regions. Higher
PEEP levels decreased the fast and slow au in global and dorsal regions without signiﬁcant
changes in compartment size.
TABLE 1
PEEP global
au1
global au
2
global
A1
(%)
global
A2
(%)
vent.
au 1
vent.
au 2
vent.
A1
(%)
vent.
A2
(%)
dorsal
au1
dorsal
au2
dorsal
A1
(%)
dorsal
A2
(%)
0 1.4 62.8 71.4 28.6 1.3 68.6 73.7 26.3 1.6 96.3 59.2 40.8
8 1.1 43.8 73 27 1 48.8 73.3 26.7 1.4 91.3 63 37
15 0.8 24.8 67.5 32.5 0.9 51.4 73.4 26.6 1 72.2 50.9 49.1
Mean fast and slow time constants and the percentages of corresponding lung tissue
CONCLUSION. EIT is a sensitive method for monitoring regional au. The results indicate
overdistension in ventral and lack of recruitment in dorsal lung regions in our patient group.
GRANT ACKNOWLEDGEMENT. This work is funded by the DFG (German Research
Foundation)
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SPATIAL DISTRIBUTION OF VENTILATION DURING LUNG PROTECTIVE
MECHANICAL VENTILATION IN EXPERIMENTAL LUNG INJURY
G. Elke*, G. Zick, D. Scha ¨dler, S. Pulletz, F. Reifferscheid, J. Scholz, N. Weiler, I. Frerichs
Department of Anaesthesiology and Intensive Care Medicine, University Medical Center
Schleswig-Holstein, Campus Kiel, Kiel, Germany
INTRODUCTION. Lung protective ventilation strategies for acute respiratory distress
syndrome (ARDS) consider the use of a reduced tidal volume (VT = 6 ml/kg) (1). Extra-
corporeal CO2 removal with the aim of further reducing VT may additionally limit injurious
effects of ventilation in severe ARDS. However, ventilation with VT\6 ml/kg may cause
pulmonary de-recruitment. The aim of this prospective experimental animal study was to
evaluate the distribution of regional lung ventilation during ventilation with 5 ml/kg VT
combined with extracorporeal CO2 removal compared to 10 ml/kg VT without extracorporeal
CO2 removal by using electrical impedance tomography (EIT).
METHODS. 10 anesthetized supine pigs (50 ± 5 kg, mean ± sd) were ventilated in a
pressure-regulated volume-controlled mode. A pumpless arteriovenous extracorporeal
membrane oxygenator (interventional lung assist (ILA), Novalung, Hechingen, Germany) was
connected to one femoral artery and vein before acute lung injury was induced by repeated
saline lavage. Inspiratory oxygen concentration was increased to 100% and positive end-
expiratory pressure (PEEP) was set 2 cmH2O above the lower inﬂection point determined by a
constant low ﬂow inﬂation maneuver. Subsequently, 5 animals were ventilated with 10 ml/kg
VT and clamped ILA for 30 min followed by a 30 min period of ventilation with 5 ml/kg VT
and open ILA. The other 5 animals were ventilated in reversed order. Regional lung venti-
lation was determined from EIT measurements (EIT system Goe MF II, Cardinal Health,
Ho ¨chberg, Germany) during baseline conditions at ventilation with 5 and 10 ml/kg VT in the
normal lung, after induction of lung injury as well as 5 and 30 min after ventilation with low
VT and open ILA or high VT and clamped ILA, respectively. Changes in ventilation distri-
bution were calculated as anterior-to-posterior shifts in ventilation evaluated from ventilation
proﬁles and so-called centers of ventilation (2).
RESULTS. A signiﬁcant shift in ventilation towards the dependent lung regions was
observed in injured lungs after having set PEEP using pressure-volume curve. This shift in
ventilation was not inﬂuenced by the lower VT ventilation combined with ILA and maintained
over the whole time period independent of the chronological order. The center of ventilation
was located at 50.5 ± 2.5 % of the anterior-to-posterior chest diameter during low VT and
open ILA and 50.1 ± 2.2 % during high VT and clamped ILA, respectively.
CONCLUSION. Spatial distribution of ventilation in the lavaged lung is not impaired by the
use of lower VT ventilation strategy in combination with ILA under the prerequisite that
PEEP is adequately set.
REFERENCE(S). 1. The ARDS Network. N Engl J Med 2000;342:1301–8, 2. Frerichs et al
Am J Respir Crit Care Med 2006;174:772–9.
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PRONE POSITION DECREASES REGIONAL LUNG INFLAMMATION DURING
EXPERIMENTAL ALI. A PET STUDY
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INTRODUCTION. Ventilation with high tidal volumes may harm the lung in acute lung
injury (ALI) by increasing both lung inﬂammation and permeability of the alveolar-capillary
membrane, resulting in increased mortality. Whether high or low PEEP or prone positioning
(PP) improves patient outcome remains controversial. Mathematical analysis of the expiratory
pressure-volume (P-V) curve allows determination of speciﬁc points (inﬂection point (c) and
point of maximal compliance decrease (Pmcd)) which might help tailoring PEEP level from
individual characteristics of respiratory mechanics. The aim of this study is to evaluate
regional lung inﬂammation, perfusion, ventilation and aerated volume assessed with Positron
Emission Tomography (PET) in supine position (SP) at 2 PEEP levels, and in PP during
experimental ALI.
METHODS. ALI was performed in 21 piglets by tracheal instillation of hydrochloric acid.
Animals were then randomly assigned to 3 experimental groups, based on the characteristics of
their expiratory P-V curve. 14 animals were studied in SP with PEEP = c + 2 cm H2O (c + 2
group, n = 7), or = Pmcd + 2 cm H2O (Pmcd + 2 group, n = 7). The 7 remaining animals
werestudied inPP withPEEP = c + 2 cmH2O (PP group).Tidal volume was thenadjusted in
all groups to keep plateau pressure below 30 cm H2O. 2 hours after randomization, ventilation
and aerated volume, tissue fraction (FT) and perfusion were assessed with PET using inhaled
13 N, density analysis and
15O labelled water, respectively. Lung inﬂammation was assessed
with PET as lung uptake of
18F-FDG (Ki) normalized by tissue fraction (Ki/FT).
RESULTS. PEEP was signiﬁcantly higher in the Pmcd + 2 group (13 ± 3) than in c + 2
(5 ± 3) and PP (4 ± 2 cm H2O) groups. Tidal volumes were signiﬁcantly reduced in the
Pmcd + 2 group (6.2 ± 1.6 ml/kg) as compared to c + 2 (9.4 ± 0.7 ml/kg) and PP
(9.4 ± 1.4 ml/kg) groups.
In SP, increasing PEEP level did not signiﬁcantly modify anterior-to-posterior distribution of
both ventilation and perfusion. PP signiﬁcantly redistributed perfusion and ventilation
towards ventral regions. The values of Ki/FT were signiﬁcantly lower in the PP group, as
compared to both SP groups.
CONCLUSION. In this model of ALI, high or low PEEP level did not reduce lung
inﬂammation. PP decreases lung inﬂammation, as compared to SP. This effect might be
related to a protective effect of PP on ventilator-induced lung injury.
GRANT ACKNOWLEDGEMENT. Hospices Civils de Lyon and IBA radio-isotopes
France.
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PROPHYLAXIS OF CONTRAST INDUCED NEPHROPATHY – IS THERE AN
ADDITIONAL EFFECT OF SODIUM BICARBONATE TO THEOPHYLLINE?
W. Huber*, S. Schmid, M. Franzen, A. Umgelter, R. Fritsch, V. Becker, S. Schwendy,
B. Saugel, R. M. Schmid
2nd Medical Department, Klinikum Rechts der Isar, Technical University of Munich, Munich,
Germany
INTRODUCTION. Contrast-induced nephropathy (CIN; increase in serum creatinine of
[=0.5-mg/dl and/or[=25% within 48 h after contrast-medium) is the third leading cause of
hospital-acquired acute renal failure. CIN is frequently found in ICU-patients, and it is
associated with increased mortality and prolonged hospitalisation. Hydration as well as
theophylline are among the most promising prophylactic approaches. Several studies suggest,
that hydration with sodium bicarbonate might be superior to hydration by saline. Therefore, it
was the aim of our double-blind study to compare the effects of a hydration with sodium
bicarbonate (B) to hydration with saline (S) in addition to prophylaxis with theophylline.
METHODS. 87 patients with serum creatinine[=1.1 mg/dl and/or an otherwise increased
risk of CIN (diabetes, nephrotoxic medication) were randomised to receive hydration with B
(0.154 molar sodium bicarbonate) or S (0.9% saline) in adddition to 200 mg theophylline i.v.
30 min before contrast-medium (CM). The hydration solution was administered at 3 mL/kg
for 1 h prior to CM and 1 mL/Kg for 6 h after CM. Primary end point: Incidence of CIN
(increase in serum creatinine[=0.5mg/dl and/or[=25% within 48 h after CM). Secondary
end points: time courses of serum-creatinine, glomerular ﬁltration rate (GFR), and BUN.
Multiple regression with regard to maximum increase in serum creatinine after CM. Statistics:
Chi-square-test; Wilcoxon-test; multiple regression analysis; SPSS software version 16.0.
RESULTS. Patients of group S and group B were comparable with regard to baseline creatinine
(1.27 ± 0.62 vs. 1.03 ± 0.47; p = 0.072), baseline BUN (33.7 ± 19.5 vs. 29.3 ± 19.5;
p = 0.242),amountofCM(115 ± 63.5vs.103 ± 48.3;p = 0.290),baselineMehranscore(8.1 ±
3.5 vs. 8.2 ± 4.7; p = 0.633) and prevalence of other risk factors (RF) such as ICU, diabetes,
hypertension and nephrotoxic medication. In patients with sodium bicarbonate prophylaxis in
additiontotheophylline,asigniﬁcantlowerincidenceofCIN0/43(0%)wasfoundascomparedto
patients of group S 4/44 (9.1%; p = 0.043). Compared to baseline, serum creatinine levels sig-
niﬁcantlydecreasedafter24 h(0.97 ± 0.43;p = 0.05)and48 h(0.93 ± 0.42;p = 0.009)ingroup
B. GFR increased (24 h: 97.2 ± 59.7; p = 0.054, 48 h: 103.3 ± 68.4; p = 0.046).
Bycontrast,ingroupS,serumcreatinineandGFRdidnotchangesigniﬁcantlyafter24 hand48 h.
Acomparisonofthechangesvs.baselinedemonstratedsigniﬁcantdifferencesbetweengroupSand
group B 24 h (p = 0.014) and 48 h (p = 0.028) after CM. The mean maximum increase of serum
creatininewithin48 hwas0.073ingroupS,whereasitdecreasedby0.028ingroupB(p = 0.018).
Multiple regressionanalysis revealed prophylaxis withS (p = 0.014), old age (p = 0.017), female
gender (p = 0.001), decreased heart rate (p = 0.016) and nephrotoxic medication (p = 0.003) as
independent risk factors for CIN.
CONCLUSION. 1. Hydration with 0.154 molar sodium bicarbonate provides signiﬁcant
reduction of the risk of CIN in addition to theophylline as compared to hydration with saline.
2. Old age, female gender, decreased heart rate and nephrotoxic medication are independent
risk factors for CIN.
0761
RENAL PROTECTION AFTER TRAUMATIC RHABDOMYOLYSIS: IS ADDI-
TIONAL ALKALINIZATION OF THE URINE BETTER THAN FORCED
DIURESIS ALONE?
C. Sitzwohl*, B. Auer, T. Gamsja ¨ger, J. Weber, M. Hu ¨pﬂ, C. Gonano, C. Weinstabl,
S. Kettner- Anesthesia and Intensive Care, Medical University of Vienna, Vienna, Austria
INTRODUCTION. After major trauma to the muscles, myoglobin is released into the sys-
temic circulation. Myoglobin can precipitate thereby impeding renal function. This can lead
to myoglobinuric renal failure, with an incidence of 4–33%. A recommended therapeutic
approach to prevent myoglobinuric renal failure is the alkalinization of the urine by admin-
istering sodium bicarbonate. Retrospective clinical studies and small trials advocate this
therapy. However, two recent larger retrospective trials suggested that alkalinization of the
urine does not offer any beneﬁt over hydration and maintaining forced diuresis in these
patients. We therefore tested the hypothesis, that forced diuresis with large-volume crystalloid
infusion is equally effective in protecting renal function in patients with severe rhabdomy-
olysis than additional alkalinization of the urine.
METHODS. After institutional approval 30 consecutive trauma patients were enrolled in this
study.Tobeeligiblethepatientshadtohaveaserummyoglobinabove2000 mmol/l.Patientswere
excludedfromthestudyiftheyhadanypreexistingrenaldisease.Afterenrollmentthepatientswere
randomly assigned to two treatments. In the Control Group patients received 5 ml/kg/h Ringer
Lactatetoachieveadiuresisof3–4 ml/kg/h.Ifdiuresiswasnotsufﬁcient100 mlofMannitol20%
was administered three times daily. If diuresis still did not achieve targeted volumes a continuous
infusionof0,05 mg/kg/hfurosemidewasstarted,andtitratedtoachievethetargeteddiuresis.Inthe
second, the Alkaline Group, patients received the same volume and diuretics management as the
ControlGroup.Additionallyactivealkalinizationoftheurinewasperformedbytheadministration
ofsodiumbicarbonate.Aninitialbolusof100 mmolSodiumBicarbonatewasgivenfollowedbya
continuous infusion of 0,1 mmol/kg/h. The continuous infusion of Sodium Bicarbonate was then
adjusted to keep the urinary pH[7.Renal Injury was deﬁned accordingtotheRIFLE Criteriafor
Acute Kidney Injury. If diuresis decreased\0,5 ml/kg/hr despite the above mentioned efforts to
increase diuresis, or the patients blood urea nitrogen increased[100 mg/ml, or serum creatinine
increased C 4 mg/dl, continuous veno-venous hemoﬁltration was started. The study was stopped
after 72 h or when serum myoglobin decreased\250 mg/dl.
RESULTS. 30 patients were included in the study, 15 in each group. The APACHE scores
were similar in both groups. The incidence of Risk, Injury and Failure were comparable in the
two groups (table). One patient in the Alkaline Group and no patient in the Control Group had
to undergo hemoﬁltration. Urinary ph in the Alkaline/Control Group after 24 h was 7,3 ± 0,4/
6,8 ± 0,5 and after 48 h 7,5 ± 0,3/7,2 ± 0,3.
TABLE 1
Kidney injury group -RIFLE classiﬁcation Alkaline
group
Control
group
Normal 10 9
Risk/Creatinine x 1,5 1 2
Injury/Creatinine x 2 3 4
Failure/Creatinine x 3 1
CONCLUSION. In this prospective randomized trial, large-volume crystalloid infusion is
equally effective in protecting renal function in patients with severe rhabdomyolysis than
additional active alkalinization of the urine. Interestingly the urinary pH was the same in both
groups after 48 h of forced diuresis with lactated Ringers Solution.
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SELECTIVE INOS INHIBITOR PREVENTS RENAL MICROVASCULAR HYPOXIA
IN EARLY STAGE OF ISCHEMIA-REPERFUSION
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INTRODUCTION. Growing interest surrounds the role of microvascular dysfunction and
renal hypoxia in the initiation and development of acute renal failure. Regarding ischemia-
reperfusion(I/R)-induced ARF, this role is poorly understood. In the kidney nitric oxide(NO)
is important for adequate endothelial function and regulation of oxygen metabolism. There-
fore the aim of this study was to investigate if early I/R-induced renal microvascular hypoxia
can be prevented by nitric oxide synthase(NOS) inhibitors.
METHODS. Prospective animal study, where 28 rats were divided in 4 groups: (1) I/R group
underwent a 30 minutes supra-renal aortic clamping (n = 7), (2) I/R treated with a non
selective NOS inhibitor L-NAME (n = 7), (3) I/R treated with a selective iNOS inhibitor L-
NIL(n = 7) and (4) time-control group(n = 7). Cortical (C\muPO2), and medul-
lary(M\muPO2) microvascular oxygen pressure, renal oxygen delivery(DO2ren), renal oxygen
consumption(VO2ren) and renal oxygen extraction(O2ER) were measured using oxygen-
quenched phosphorescent method throughout 2 h of reperfusion (1). Renal function was
assessed with creatinine clearance and excretion fraction of Na
+.
RESULTS. While renal arterial resistance increased (+192% vs. baseline, p\0.05), renal
blood ﬂow, C\muPO2 and M\muPO2 dropped 2 h after the reperfusion (-70, - 42 and -42%
respectively, p\0.05), as well as DO2ren and VO2ren (-70%, p\0.0001, and -28%,
p\0.05). Whereas L-NAME further decreased DO2ren,V O 2ren, C\muPO2 and M\muPO2,
and deteriorated renal function, L-NIL partially prevented the drop of DO2ren, C\muPO2 and
M\muPO2(53 ± 4 vs. 39 ± 3.5 and 41 ± 1.8 vs. 30 ± 2.8 mmHg respectively, p\0.05)and
increased VO2ren (0.37 ± 0.04 vs. 0.13 ± 0.01 ml min g
-1,p \0.05) in comparison with
baseline value. L-NIL also prevented deterioration of renal function. Both L-NIL and L-
NAME increased O2ER.
CONCLUSION. This study showed that microvascular hypoxia occurs in early stage of renal
I/R and demonstrates that microcirculation-targeted therapeutic strategies based on iNOS
inhibition have beneﬁcial effects on renal oxygenation and function. In contrast, inhibition of
eNOS further decreased microvascular PO2 highlighting its role in post-ischemic microva-
cular oxygenation regulation. Furthermore, inhibition function of NO on renal oxygen
consumption during ischemia-reperfusion is described.
REFERENCE(S). 1. Johannes T, Mik EG, Ince C: Dual-wavelength phosphorimetry for
determination of cortical and subcortical microvascular oxygenation in rat kidney. J Appl
Physiol 2006; 100: 1301–10.
GRANT ACKNOWLEDGEMENT. This Study was suppored in part by a grant from the
French Ministry of Foreign Affairs (EGIDE).
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NGAL IN URINE AND PLASMA AS A PREDICTIVE BIOMARKER OF ACUTE
KIDNEY INJURY (AKI) IN ADULT ICU PATIENTS
H. R. H. de Geus*
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1Intensive Care,
2Anesthesiology, Erasmus Medical Center, rotterdam, Netherlands
INTRODUCTION. Previous studies have shown that neutrophil gelatinase-associated li-
pocalin (NGAL) is an early predictive biomarker of ischemic and nephrotoxic AKI(1,2).The
ability to use NGAL as a biomarker for early AKI has never been studied in critically ill adult
patients with mixed etiologies. Therefore, we assessed the ability of urine (uNGAL) and
plasma NGAL (pNGAL) to predict AKI development and characterize the degree of AKI in a
heterogeneous adult ICU population.
METHODS. We conducted a prospective cohort study of critically ill adult patients from
September 2007 until April 2008. Clinical data and serum creatinine were collected for up to
72 h from admission. Urine and plasma samples were collected at admission and at 4, 8, 24,
36, 48, 60 and 72 h. AKI was classiﬁed using the RIFLE criteria (Risk, Injury, Failure or AKI
I, II and III). Healthy volunteers served as a control group. Non parametric tests were used to
compare continuous variables between groups.
RESULTS. A total of 93 patients and 31 controls were included and analyzed. Mean age of
patients and controls were 58 and 28 years respectively. The severity of illness score
(APACHE II) was for patients without AKI 20.1 (8–33), for AKI-Risk 20.7 (10–34), for AKI-
Injury 27.5 (17–44) and for AKI-Failure 25.4 (15–40). Overall mortality was 30%. Mean peak
pNGAL and uNGAL levels were 98 ng/ml (42–98) and 108 ng/ml (1–108) in the healthy
volunteers, 260 ng/ml (108–758) and 223 ng/ml (8–1080) in patients without AKI, 538 ng/ml
(144–1475) and 1129 ng/ml (61–5000) in AKI-R, 759 ng/ml (288 – 1425) and 1433 ng/ml
(127–5000) in AKI-I, and 1708 ng/ml (357- 3598) and 3062 ng/ml (565–5000) in AKI-F. A
total number of 15 (16%) patients required renal replacement therapy (RRT), 2 of the AKI-I
and 13 of the AKI-F.
CONCLUSION.1.BothuNGALandpNGALlevelsarealreadyelevatedonadmissioninpatients
without AKI according to Riﬂe creatinine criteria compared to the levels of healthy volunteers
2.uNGALandpNGALlevelspredicttheseverityofAKI,uNGALseemstobemoresensitivethan
pNGAL 3.NGAL is a useful marker of AKI in a heterogeneous adult ICU population.
REFERENCE(S). 1. Mishra et al. Lancet 2005;365:1231–38.
2. Wagener et al. Anesthesiology 2006;105:485–91.
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INCIDENCE OF RENAL REPLACEMENT THERAPY IN INTENSIVE CARE
PATIENTSTREATEDWITHDIFFERENTHYDROXYETHYLSTARCHSOLUTIONS
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INTRODUCTION. The results of the currently published VISEP study [1] suggest that
treatment with HES 200/0.5 preparations may impair renal function as compared to sole
crystalloid infusion in critically ill patients. However, experimental and small scale clinical
data demonstrate the safety of modern HES 130/0.4 solutions [2, 3]. Therefore, the purpose of
the current retrospective study was to compare the impact of 6% HES 130/0.4 and 10% HES
200/0.5 on requirements of renal replacement therapy in critically ill patients.
METHODS. We analyzed 8408 surgical intensive patients treated with HES solutions in the
University Hospital of Muenster, Germany, between 2000 and 2006. Among these patients,
7813 were treated with 6% HES 130/0.4 and 595 patients with 10% HES 200/0.5.
RESULTS. A total of 812 patients (10.4%) required continuous veno-venous hemodiaﬁl-
tration (CVVHDF). However, the need for CVVHDF was more common in patients treated
with 10% HES 200/0.5 as compared to 6% HES 130/0.4 (35.5% vs. 6.1%; OR 11.5; 95% CI
9.5–14.1; Fig. 1). In addition, mean creatinine plasma concentrations were higher in the 10%
HES 200/0.5 group as compared to patients treated with 6% HES 130/0.4 (1.42 ± 0.84 vs.
1.19 ± 0.75 mg/dL; p\0.001).
CONCLUSION. The results of the present study are in accordance with the VISEP study [1]
and suggest that HES 200/0.5 may impair renal function in critically ill patients. However, the
current data demonstrate that renal function was better maintained in patients treated with 6%
HES 130/0.4 as compared to 10% HES 200/0.5. Clinical studies evaluating the safety of 6%
HES 130/0.4 as compared to sole crystalloids in critically ill patients are now needed.
REFERENCE(S). 1. Brunkhorst FM. N Engl J Med 2008, 358:125–139.
2. Marx G. Crit Care Med 2006, 34:3005–3010.
3. Palumbo D. Minerva Anestesiol 2006, 72:655–664.
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THE ‘‘CYTOSCORE’’ PREDICTS SURVIVAL IN SEVERE SEPSIS
M. J. O Dwyer*, T. Ryan
Department of Anaesthesia and Intensive Care Medicine, St James s Hospital, Dublin, Ireland
INTRODUCTION. We have previously demonstrated that a distinct anti-inﬂammatory pattern
of cytokine gene expression is associated with increased mortality in severe sepsis (1,2). Based
onanintegral biologicalmeasure ofapatients’immunological responsetoaninfective insult,we
suggest that a novel scoring system, termed a ‘‘cytoscore’’, is predictive of ICU mortality.
METHODS. Sixty two patients admitted to the ICU with a diagnosis of severe sepsis were
recruited. IFNgamma, IL-10, IL-23 and IL-27 were assayed on ICU admission using QRT-
PCR. IL-6 protein was assayed using ELISA. Recursive partitioning dichotomised each
patients’ ratio of IL-10:IFNgamma and IL-27:IL-23 into either a high and low category, with
a score of 1 for high and 0 for low. A composite ﬁgure, termed a cytoscore and ranging from 0
to 2, is then calculated for each patient.
RESULTS. There is a direct relationship between the absolute ratio of both IL-10:IFNgamma
and IL-27:IL-23 mRNA and increased mortality (p\0.05). The robustness of the cytoscore
is described in Table 1. The cytoscore accurately describes the temporal pattern of survival in
patients with sepsis (p log rank\0.0001,ﬁgure A). Addition of IL-6 protein data can add an
extra layer of complexity to the score by describing a very high risk group (cytoscore 3)
characterised by early ICU mortality (ﬁgure B).
TABLE 1 CONTINGENCY TABLE OF CYTOSCORE AND OUTCOME
Death (%) Discharge (%)
high risk (cytoscore 2) 5 (83) 1 (17)
intermediate risk (cytoscore 1) 7 (27) 22 (73)
low risk (cytoscore 0) 0 (0) 11 (100)
Chi squared statistic 15.2, p = 0.0005
CONCLUSION. The cytoscore predicts events remote from the time of assay. Consequently,
this pattern of gene expression may represent a causal as opposed to a reactive phenomenon.
The cytoscore may be of use both in risk stratiﬁcation and in patient selection in the setting of
novel inﬂammatory interventional therapies.
REFERENCE(S). 1. O’Dwyer MJ et al (2006) The Occurrence of Severe Sepsis and Septic
Shock Are Related to Distinct Patterns of Cytokine Gene Expression. Shock 26:544–50.
2. O’Dwyer MJ et al (2008) The human response to infection is associated with distinct
patterns of interleukin 23 and interleukin 27 expression. Intensive Care Med 34(4):683–91.
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INTRODUCTION. We measure procalcitonin (PCT) levels using the BRAHMS immuno-
chromatographic technique. As small changes in the PCT value may be used to guide duration
of antibiotic prescription and to inform prognosis (1) it is important to obtain accurate results.
We have performed a study to investigate the reliability and interpretation of the PCT requests
within Clinical Biochemistry at our institution.
METHODS. During a 10 month period (April 2007 to January 2008) 30 PCT results were
reported by State Registered Biomedical Scientists (BMS). Each test band wes then inter-
preted by a further 10 BMS who were unaware of the original reported value.
RESULTS. The results are shown in the following table.
TABLE 1 PCT VALUES FOR 30 PCT ASSAYS
PCT value
(ng/ml)
Number
reported
Number of BMS
in agreement
Number of BMS
disagreed
\0.5 10 93 (93%) 7 (7%)
0.5–2 8 73 (91%) 7 (9%)
2–10 7 49 (70%) 21 (30%)
[10 5 42 (84%) 8 (6%)
CONCLUSION. For those patients with a reported PCT\0.5 ng/ml or PCT[10 ng/ml, we
show a good correlation between reporters. Conversely, PCT of 0.5–2 ng/ml and 2–10 ng/ml
show greater variation. This is a signiﬁcant ﬁnding as we know that mortality increases when
PCT rises above 1 ng/ml (1) and our study has shown that 30% of BMS would have reported
such results in the range outside this value (implying a more severe illness and worse
prognosis). This range where there was considerable error for reporting is probably the most
important of the 4 values as the transition from 0.5–2 to 2–10 also represents a change from
moderate systemic inﬂammatory response to severe response most likely due to infection. The
difﬁculty experienced when interpreting those bands appears to be because the band colour is
frequently non monochromatic making correlation with the reference card problematic. It is
imperative to realise this is only semi-quantitative and therefore it is open to individual
interpretation.
REFERENCE(S). 1. Jensen JU et al, Heslet L et al, Jensen TH et al, Espersen K et al,
Steffensen P et al; Tvede M et al; Procalcitonin increase in early identiﬁcation of critically ill
patients at high risk of mortality. Crit Care Med 2006;34;2596–02.
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INTRODUCTION. In septic shock, both adrenal insufﬁciency and inadequate plasma con-
centrations of arginine vasopressin (AVP) may contribute to the failure to restore vascular
tone, respectively (1, 2). Infusion of a vasoconstrictor hormone like AVP increases arterial
blood pressure in septic shock (3). Measurement of endogenous plasma concentrations of
AVP could answer the question whether such an AVP therapy reverses an endogenous
deﬁciency or simply constitutes a pharmacological intervention to increase peripheral vas-
cular tone.
METHODS. In this prospective, controlled study, we measured AVP and copeptin plasma
concentrations in 50 patients with sepsis or septic shock and in ten patients with infection but
no systemic inﬂammation during the ﬁrst seven days after intensive care unit (ICU) or
hospital admission. Hemodynamic, laboratory and clinical data were recorded daily in all
patients during the ﬁrst seven days after ICU or hospital admission. At the same time points
blood was withdrawn to determine plasma AVP (radioimmunoassay) and copeptin (immu-
noluminometric assay) concentrations. A mixed effects model was used for statistical
analysis.
RESULTS. The AVP response was different between the three study groups (p\0.001), but
did not change over time (p = 0.12). While patients with sepsis and septic shock had sig-
niﬁcantly higher AVP levels than patients with infection (both p\0.001), there was no
difference in AVP concentrations between patients with sepsis and septic shock (p = 0.98).
No difference in AVP concentrations was observed between survivors and non-survivors at
day 28 (p = 0.87). In patients with sepsis, serum osmolarity (p\0.001), arterial pH
(p = 0.001) and PaO2 (p = 0.04) were indirectly associated with the course of AVP plasma
levels, while it was serum osmolarity alone in patients with septic shock (p = 0.03). Plasma
AVP concentrations were correlated with copeptin (r = 0.476, p\0.001), but this correla-
tion was inﬂuenced by continuous veno-venous hemoﬁltration (p\0.001).
CONCLUSION. Sepsis induced a stronger AVP response than infection without systemic
inﬂammation. However, a lacking difference in AVP plasma concentrations between patients
with and without shock indicates comprehensive dysfunction of the AVP system in sepsis.
Our data support the hypothesis that an impaired AVP response is at least partly responsible
for the failure to restore vascular tone in septic shock.
REFERENCE(S). 1. Annane D, Bellissant E, Cavaillon JM: Septic shock. Lancet 2005;
365:63–78.
2. Landry DW, Oliver JA: The pathogenesis of vasodilatory shock. N Engl J Med 2001;
345:588–595.
3. Mutlu GM, Factor P: Role of vasopressin in the management of septic shock. Intensive
Care Med 2004; 30:1276–1291.
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INTRODUCTION. Decrease in monocyte HLA-DR (mHLA-DR) in ICU patients has been
proposed as a marker of immunity associated with poor prognosis but never evaluated in a
large multicentric population. Objective: To test mHLA-DR as a marker of mortality and
secondary infection risk in a large multicentric population of patients in septic shock with at
least 2 organ dysfunction.
METHODS. Prospective multicentric study (4 ICU units). Evaluation of mHLA-DR (ﬂow
cytometry, normal values: 21955 ± 12088 AB/C), SAPSII, SOFA at D0, D1, D2, D7, D14,
D21, D28; D7 and D28 mortality. Diagnosis of secondary infection according to CDC criteria.
Predictive model for outcome and secondary infection: general clinical characteristics and
mHLA-DR tested by univariate analysis (t-test) then multiple logistic regression.
RESULTS. 221 patients included with a delay of 12 h 19 min (± 7 h 12 min) after second
organ failure occurence (91% in shock). Age 61 y.o. ± 17, 64% males, SAPSII 47 ± 14,
SOFA D0 8 ± 3, 24% in surgical context. Mortality 25% at D7, 38% at D28. mHLA-DR at
D0-D2 decreased in all patients but was not predictive of mortality rate, when SAPSII
(p\0.0001) and SOFA (p = 0.0009) were. First-week evolution of mHLA-DR (difference:
D7 value- minimal value (D0-D2)) was predictive of mortality after D7 (p = 0.03). In sur-
vivors after D7 (n = 175), 138 presented at least one infection. Low initial mHLA-DR (D2)
was associated with secondary infection occurrence (p = 0.03).
CONCLUSION. In our population of septic patients with at least 2 organ failures, mHLA-
DR was not a marker for prognosis at admission, but a ﬂat recovery of mHLA-DR during the
ﬁrst week was predictive of late death. Low mHLA-DR is associated with secondary infection
risk during ICU stay. As a consequence, our results questioned the beneﬁt of immunity
stimulation (as with interferon gamma) to prevent secondary infections.
GRANT ACKNOWLEDGEMENT. PHRC 2002 APHP (AOR02006).
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INTRODUCTION. Sepsis related inﬂammatory response syndrome and multiple organ
dysfunctions are common causes of death in intensive care units. The effect of sepsis on
markers of tissue repair is only partly understood.
METHODS. Blood samples were collected during a 10 day period following the ﬁrst organ
dysfunction and after 3 and 6 moths. Procollagen type I and III aminoterminal propeptides
(PINP, PIIINP) as well as cross-linked telopeptides of type I collagen (ICTP) were measured.
The median age of the 44 patients with severe sepsis was 63 years (25th–75th percentile 56–
71). The median of APACHE II score on admission was 26 (22–30). The 30-day mortality
was 25%. 15 volunteers were used as controls.
RESULTS. PIIINP concentration was elevated in septic patients (8.8[25th –75th 6.8–26.0])
compared to controls (3.0[25th –75th percentile, 2.7–3.3], P\0.001) on the ﬁrst day. The
maximum serum PIIINP concentrations during sepsis were higher in non-survivors compared
to survivors (26.1[18.7–84.3] vs. 15.1[9.6–25.5], P = 0.033) as well as in multiple organ
failure compared to multiple organ dysfunction syndrome (24.2[13.4–48.2] vs. 8.9[7.4–19.4]
P = 0.002). Although the PINP concentration of septic patients remained within the labo-
ratory reference values during sepsis, the maximum values were higher in non-survivors than
in survivors (118.5[52.4–195.5] vs. 64.0[41.7–109.7] P\0.001) and in multiple organ failure
than in multiple organ dysfunction syndrome (44.3[35.9–103.4] vs. 84.1[53.5–150.0],
P\0.001). ICTP levels were elevated in septic patients compared to controls (19.4[12.0–
29.8] vs. 4.1[3.4–5.0] P\0.001) on the ﬁrst day.
CONCLUSION. Markers of collagen synthesis and degradation are increased in patients with
severe sepsis and may be used as markers of disease severity and outcome. Fibrosis may be
one mechanism in the pathogenesis of organ dysfunctions.
GRANT ACKNOWLEDGEMENT. The study was supported by a grant from Instrumen-
tarium Foundation and from Oulu University Hospital, Finland.
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INTRODUCTION. In CONSCIOUS-1, a dose-ﬁnding study, intravenous clazosentan (1, 5,
and 15 mg/h vs. placebo) signiﬁcantly and dose-dependently reduced angiographic vaso-
spasm in patients with aSAH. A trend towards a decreased incidence of morbidity/mortality
was also observed in a post-hoc analysis, using centrally-assessed computed tomography
scans and a morbidity/mortality endpoint that included neurological deterioration, rescue
therapy and hypodensities due to vasospasm on computed tomography. These ﬁndings sup-
port the notion that decreasing vasospasm may improve clinical outcome in aSAH patients
and led us to design the CONSCIOUS-2 trial.
METHODS. CONSCIOUS-2 is a randomized, double blind, placebo controlled study to
investigate the effect of intravenous clazosentan in reducing vasospasm-related morbidity and
all-cause mortality after aSAH. Patients are randomized 2:1 to clazosentan (5 mg/hr) or
placebo, to start within 56 h of aSAH and continuing until Day 14 post aneurysm rupture.
RESULTS. Main Inclusion criteria: (1) 18–75 years, (2) aSAH due to a ruptured saccular
aneurysm, secured by surgical clipping, (3) ‘‘diffuse’’ clot (long axis, greater or equal to
20 mm), (4) WFNS grades I-IV.
Primary endpoint: Vasospasm-related morbidity/mortality (composed of: death from any
cause; new cerebral infarcts due to vasospasm, delayed ischemic neurological deﬁcit due to
vasospasm; neurological signs or symptoms in the presence of angiographic vasospasm
requiring administration of valid rescue therapy) within 6 weeks of aSAH; assessed by central
reviewers. Based on the CONSCIOUS-1 results, the placebo rate for the primary endpoint has
been estimated to be 40%.
Secondary endpoints: Clinical outcome (Glasgow Outcome Scale) at Week 12 and the total
volume of new cerebral infarcts of all etiologies at Week 6.
CONCLUSION. CONSCIOUS-2 will recruit 765 patients from approximately 100 sites in N.
America, Europe and Asia Paciﬁc.
GRANT ACKNOWLEDGEMENT. Actelion Pharmaceuticals.
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INTRODUCTION. Therapeutic hypothermia protects from neurological sequels and death
after out-of-hospital cardiac arrest [1, 2] and it is recommended in the ERC Guidelines [3].
The Hypothermia Registry is a database on the Internet designed to enable evaluation of
patients treated with intensive care after cardiac arrest.
METHODS. Data on patient and cardiac arrest characteristics, hypothermia treatment,
adverse events, clinical investigations and general intensive care was registered. Outcome was
documented as neurological score at ICU and hospital discharge and at six months using the
Cerebral Performance Category (CPC) scale [4]: CPC 1–2 representing a good outcome and
3–5 a bad outcome. Only centres reporting all cardiac arrest patients were included.
RESULTS. Between October 2004 and March 2007 1109 patients from 37 centres in 7
countries were entered in the Registry of which 952 were treated with therapeutic hypo-
thermia (TH) and 157 without. In this abstract the TH group is described. The median age was
63 years, 73 % were men and in 68% the initial rhythm was VT/VF. The time to initiation of
TH was 90 minutes and the time to achieve core temperature less than 34 C was 240 minutes.
Overall cooling rate was 0.6 degrees C/h. All patients, except 9, reached the target temper-
ature. 38% developed pneumonia, 5% had a bleeding requiring transfusion and 29 % had a
serious event of arrhythmia during the ICU stay. Data at 6 month was evaluated for 931
patients. 52 % were alive at follow up and 92 % of them had a good neurological outcome; in
the groups with initial rhythm asystole/PEA and VT/VF good outcome was 26 % and 60 %
respectively.
CONCLUSION. Our results indicate that half of the patients in an unselected cardiac arrest
population admitted to intensive care for TH are alive at 6 months and they survive with a
good neurological function. Patients with asystole and PEA have a better outcome than
previously reported. The safety aspects compare well with previous studies on TH. Thera-
peutic hypothermia was feasible to use in all centres.
REFERENCE(S). 1. Bernard S et al. Treatment of comatose survivors of out of hospital
cardiac arrest with induced hypothermia, N Engl J Med 2002; Vol 346, No 8: 557–563.
2. The Hypothermia after Cardiac Arrest study group. Mild therapeutic hypothermia to
improve the outcome after cardiac arrest. N Engl J Med 2002; Vol 346, No 8: 549–556.
3. Nolan J et al. European Resuscitation Council Guidelines for Resuscitation 2005, Sec-
tion 4, Adult Advanced Life Support. Resuscitation 2005; 67S1 39–86.
4. Safar P. Resuscitation after Brain Ischemia, in Grenvik A and Safar P Eds: Brain Failure
and Resuscitation, Churchill Livingstone, New York, 1981; 155–184.
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INTRODUCTION. To avoid complications of the volume load, used for the cerebral per-
fusion support in brain trauma, we tried to determine volume responsiveness in these category
of patients.
METHODS. We examined 30 patients with severe brain trauma. (GCS score\8, sedation,
artiﬁcial ventilation). The stroke volume (SV) and its variability (SVV) were determined by
the bioimpedans method. Additionally we determined the variability of other haemodynamic
parameters: BP, HR, CI, EF and peripheral pulse, which reﬂect the type of central autonomic
regulation (were showed in our previews works) . Especial attention were paid to the P4 (0.2–
0.5 Hz) bands of SVV, which predominantly connect with breathing, as a main marker of
hypovolemia. All the comparisons were made before and after increasing of PEEP to 5 and
then to 10 cm H2O. These were made before and after infusion of Stabisol (app. 10 ml\kg).
RESULTS. All patients were divided in two groups: A-18 patients (responders on volume
load by the increasing SV) and B-12 patients (nonresponders: not only the absents of SV
increasing, but in some cases - worsening the type of central regulation of haemodynamic). In
group A the increasing PEEP to 5 and 10 cm H2O before volume load showed the decreasing
of BP, rising HR and the grate increasing of P4 SVV. After volume load the same changes
were only if PEEP was 10 cm H2O. It’s probably related with no complete compensation of
hypovolemia. In group B the same PEEP increasing before volume load did not revealed any
changes in haemodynamic. After volume load PEEP increasing to 10 cm H2O induced some
increasing of SV.
CONCLUSION. PEEP may be used in severe brain trauma for evaluation of the range of
hypovolemia and volume responsiveness prediction. PEEP—the test that allows to estimate if
addition volume expansion is needed and help to avoid the exertion of regulatory systems in
other cases.
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INTRODUCTION. The Ventilator Bundle—elevation of the head of the bed, daily sedation
vacations, peptic ulcer prophylaxis and DVT prophylaxis—has been promoted by the IHI as
‘‘a series of interventions that, when implemented together, will achieve signiﬁcantly better
outcomes than when implemented individually.’’ However, rigorous evidence for the bundle
approach is weak. In May 2006, the Welsh Critical Care Improvement Programme (WCCIP)
launched implementation of care bundles at the national level. By August 2006, the Ventilator
Bundle had not only been introduced in all 14 critical care sites in Wales, but WCCIP-
monitored compliance rates indicated national compliance of over 95%. To date, no evalu-
ation of patient outcomes has been attempted. Opportunistically, 13 critical care units from 12
of the 14 sites participate in the Case Mix Programme, the national comparative audit of
critical care, enabling a comparison of outcomes before and after implementation and
achieving high compliance.
METHODS. Data covering the implementation date were available from 10 of the 13 units.
Data were extracted for all admissions, since 2002, who were ventilated during the ﬁrst 24 h
following admission. The effect of implementation of the Ventilator Bundle on hospital
mortality (for all ventilated admissions) and on unit length of stay (for unit survivors) was
assessed using multilevel models adjusted for time trends, seasonality and predicted risk of
death (ICNARC model). Implementation of the Ventilator Bundle was modelled including a
lag of two months following implementation, to allow for the observed delay in reaching
maximal compliance.
RESULTS. 10,656 admissions were included in the analysis. Units had a median of
51 months data pre-implementation (range 2–54) and 19 months post-implementation (range
11–33). Most units implemented the Ventilator Bundle between March and August 2006,
although two units had implemented it previously. Crude hospital mortality for ventilated
admissions was 42.0% pre-implementation and 42.8% post-implementation. Mean unit length
of stay for survivors was 7.1 days pre-implementation and 6.3 days post-implementation.
Implementation of the Ventilator Bundle was not associated with any signiﬁcant reduction in
hospital mortality (odds ratio 0.96, 95% conﬁdence interval 0.81–1.14) or in unit length of
stay for survivors (ratio of geometric means 0.98, 0.88–1.10).
CONCLUSION. Despite widespread implementation and high levels of compliance across
Wales, no signiﬁcant impact on patient outcomes was identiﬁed. Possible reasons for lack of
impact may include: that 1.5 years is too early to detect impact; that compliance does not
necessarily equate to delivery of bundle elements (consideration and rejection of an individual
element equates to compliance); or that the evidence base for bundles is weak – both for
individual elements and collectively. While the failure to identify any demonstrable effect on
patient outcomes in our study may disappoint those that support the bundle approach to
quality improvement, it should not detract from the importance of following current best
practice in the management of these patients.
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INTRODUCTION. Unintended tube removals (UTR) are frequently observed adverse events
in ICUs and potentially involving serious complications. We monitored UTR in our ICU for a
2-year period to assess the incidence, the patient conditions at the time of event occurrence to
analyze the system factors associated with UTR and to evaluate the effect of targeted
interventions.
METHODS. Demographic and clinical information was prospectively collected on all
patients admitted in our ICU. Additional information was collected for patients who expe-
rienced an UTR. A dedicated staff analyzed the UTR bi-monthly using a system-factor
approach to inform the ICU team on the rate and the potential cause of events and to propose,
implement and improve care management protocols. A conditional logistic regression strat-
iﬁed on length of stay was used to identify risk factors of tube removals. Segmented linear
regression analysis was conducted to test for the effect of the improvement interventions.
RESULTS. From a total of 2007 patients (12256 patient-days), 193 (9.6 %) patients expe-
rienced 270 UTR. Patients characteristics, including pain, psychiatric background, or ethylism
was mentioned in 181 reports, inappropriate sedation in 55 reports. The team was involved in
118 events (lower surveillance 41, lack of surveillace during handover 40, lack of secure
ﬁxation 20). The management was mentioned in 136 adverse events, and for 90 of them the
care staff considered there was an important workload at the time of the incident. Clinical or
therapeutic consequences were observed in 46 (17%) of the events and concerned 38 (1.8%)
of the patients. UTR was more frequent when coma was the cause of admission (OR = 2.4,
95% CI [1.7 – 3.4], P\0.0001), and for the youngest patients (age less than 60 OR = 1/0.71,
95% CI [0.52 – 0.98], P = 0.04). Entering in the ward after the program start was found as a
protective factor for suffering a tube removal (OR 0.82, 95% CI [0.73 – 0.93], P = 0.002).
Segmented regression results conﬁrmed a predicted drop of 15.8 percent (95% CI [–25.1; -
6.5];p = 0.001) of UTR the weeks after improvement program introduction. The system
factor analysis revealed its major implication in the occurrence of UTR.
CONCLUSION. UTR is a frequent complication. A continuous quality improvement pro-
gram is able to reduce unintended tube removal in ICUs.
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INTRODUCTION. NICCIMS is a prospective regional audit study designed to analyse
occurrence of adverse events in intensive care units (ICUs). An anonymous database has been
installed in seven ICUs since September 2007 facilitating central analysis of all reported
incidents in N.Ireland. The ﬁrst NICCIMS report revealed that incidents relating to airway
and central venous catheters were the events with highest potential impact as well as marked
variability in frequency between the 7 units.
METHODS. Following collation of data related to these events we examined if effective
local policies exist. Questionnaires were sent to the lead consultants, lead nurses and edu-
cational supervisors in the participating ICUs. The questions were related to the presence or
absence of policies, and their content, regarding securing of airway devices and management
of central venous catheters. Responses were compared between staff within units to assess
agreement.
RESULTS. 100% response rate was achieved. 5 out of 7 units claimed to have a written
policy regarding endotracheal tube (ETT) ﬁxation. However there was disagreement as to the
existence of a policy between the lead clinicians and lead nurses in 4 out of 5 units. In 5 out of
the 7 units, percutaneous tracheostomies are performed in more than 80% of cases, but in 2
units surgical tracheostomies are performed in 70–98%. There appears to be more adverse
events reported related to tracheostomies from the latter 2 units. All units claimed to have
written policies related to central venous catheters, but in 2 units there was disagreement
between staff as to the existence of a policy. 57% respondents stated the policy is only
followed ‘most of the time’. If staff were aware of a policy they said subclavian was the
primary site of choice but staff unaware of a policy said they were using the internal jugular
site.
CONCLUSION. A wealth of information regarding adverse events has been collected
through NICCIMS. The presence of effective policies is likely to reduce the possibility of an
incident as it provides staff with an agreed management approach. However, effective policies
do not appear to be present in all ICUs. Discordance between clinicians and nursing staff
regarding the existence of policies suggest an ineffective policy as staff are unaware of it, and
therefore are highly unlikely to achieve the aim of the policy which may give rise to increased
adverse events. There is an opportunity for regional policies to be agreed between units to
simplify and unify our approach to enhancing safety.
REFERENCE(S). 1. Rothschild JM et al. Crit Care Med 2005;33:1694–700.
2. Beckmann U et al. Anaesth Intensive Care 1996;24:314–319.
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AUDIT OF AUDITS: A RETROSPECTIVE REVIEW OF CLINICAL AUDIT IN A
TEACHING HOSPITAL INTENSIVE CARE UNIT
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INTRODUCTION. Clincal audit is a core component of clinical governance. The National
Institute for Clinical Excellence in the United Kingdom (NICE) has expressed concern that
‘‘Clinical audit has a mixed history in the NHS, and for every success story there are just as
many projects that have run into the ground without demonstrating any signiﬁcant contri-
bution to quality of services.’’ To improve this process, the Clinical Governance Support
Team of the NHS has designed an Audit Project Assessment Tool (APAT) which assesses
individual projects against national guidelines for good clinical audit. A maximum of 25
points are available and audit projects scoring more than 16 are regarded as good projects.
This study examined whether the audit programme our institution was effective and associ-
ated with improved clinical governance.
METHODS. Presentations from clinical audit meetings from a 24 month period were ret-
rospectively reviewed by two independent investigators and the following questions assessed.
(1) How many of the projects were true audits? (2) Were the audit projects prospective or
retrospective? (3) How many re-audits had been performed? (4) If re-audit showed
improvements in performance? (5) What were the APAT scores of the projects?
RESULTS. Twenty-nine audit projects were presented during this period of which 25 were
available for review. Of the projects reviewed, 22/25 (88%) were considered to be true audit
projects of which 2/22 (9%) had a research overlap. 22/22 (100%) were retrospective and
there were 4 (16%) re-audits during the period of investigation. Of the re-audits, 3 showed an
improvement in performance and 1 showed deterioration. The APAT scores ranged from 9/25
to 21/25. Eleven projects (50%) scored greater than the 16 points required to be considered a
good audit. It was noted that there was a paucity of multi-disciplinary audit projects in the
cohort studied.
CONCLUSION. This study shows that a well-coordinated active audit programme was in
place at the above institution. However, objective evidence of clinical governance beneﬁt was
lacking and 50% of the audits would have been rejected if the APAT tool had been used
prospectively. We believe the results of this study are likely to be similar to other institutions
experiences and to improve future performance, we suggest all new projects are prospectively
assessed using the APAT tool at outset, and poorly scoring studies rejected. In addition, a
database of past and proposed audit projects should be constructed to facilitate re-audit where
performance improvement is indicated and to highlight deﬁcits in areas (such as a lack of
multidisciplinary audits). Clinical leads need to be identiﬁed to provide coherence to the
process and to report to unit governance meetings.
REFERENCE(S). 1. A Practical Guide for Clinical Audit. Guidelines Provided by the NHS
Clinical Governance Support Team. Graham Copeland, 2005.
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HOW OFTEN TO MEASURE OUTCOME?
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INTRODUCTION. Variable Life Adjusted Display (VLAD) is an easy-to-understand
method to monitor outcomes (1) and a powerful tool to show developments in clinical practice
(2). It has been seen as a promising tool for real-time outcome monitoring (3). Constant data
delivery is a fundamental issue for the VLAD usability within a benchmarking project. A
constant reporting cycle helps the units to routinely follow outcomes compared with those of
similar units.
METHODS. Intensive Care Units (ICU) in Finland have measured their performance and
quality of care since 1994. At present 24 Finnish ICUs compare continuously their perfor-
mance within the Finnish Intensive Care Quality Consortium (FICQC). Data covering the
ICU stay are delivered to the centralized benchmarking database both manually (4 units) and
with an interfacing software (20 units), presenting 15 and 85% of IC period records
respectively. The hospital discharge data and long-term status data are delivered with an
internet application. Primary admissions from 2007 (N = 17,517) were included. Hospital
discharge status was selected as a primary outcome parameter.The reconstructed ﬁgure
(Fig 1) shows the data accumulation at 1st September 2007 and the actual data delivery
differences between ICUs.
RESULTS. Sixty four percent (64%) of HDD was recorded within 30 days and 83% within
60 days. Average delay from hospital discharge to hospital discharge data (HDD) recording
was 31.2 days (95% CI 30.6–31.8). Delays to register HDD were signiﬁcantly shorter
(24.5 days, SD 32.9) for dead patients than for survivors (32.5 days, SD 39.2). Mean HDD
delivery after hospital discharge varied between units from 6.4 (SD 20.4) days to 63.7 days
(SD 40.1).
CONCLUSION. Short and known reporting delays from ICU discharge and hospital dis-
charge status recordings shorten the benchmarking reporting cycle and improve the report
usability. Faster non-survivor data delivery is due to the data delivery protocol. Local pos-
sibilities to organize the data delivery cause variation between the ICUs. The recording delays
and the variation between ICUs should be taken into account when benchmarking the ICU
performance and outcome.
REFERENCE(S). 1. Cockings et al, Critical Care (10) 2004,R28 2) Afessa et al, BMC
Emergency Medicine (7)2007, 10, 3) Hofer, TM, Critical Care (10) 2004:133.
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INCIDENCE AND DURATION OF PATIENT INSTABILITY ON A STEP-DOWN
UNIT BEFORE AND AFTER IMPLEMENTING AN ELECTRONIC INTEGRATED
MONITORING SYSTEM–RAPID RESPONSE SYSTEM IMPACT
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INTRODUCTION. Early discharge from Intensive Care Units toStep-Down Units (SDUs) has
increased, and patients are at increasing risk of developing instability that can be undetected and
under-treated in this lower intensity monitoring environment. Failure to ﬁnd and treat instability
adversely affects outcome. Using an electronic integrated monitoring system (IMS) to contin-
uously integrate individual minimally invasive monitoring parameters into a single index value
with central station alarm capability may improve nurses’ ability to detect, recognize, and attend
to instability. We evaluated the ability of an IMS to improve nurses’ ability to both detect
cardiorespiratory instability according to Medical Emergency Team (MET) call criteria in
patients on a SpO2 and ECG monitored SDU and shorten duration of instability.
METHODS. Prospective, longitudinal study of monitored patients (24 bed trauma SDU) in 3
phases. An IMS (Visensia
TM) received continuous input from bedside monitors and used 4
vital signs (VS) (HR, RR, BP, SpO2) to develop a single neural networked value, the Visensia
Index (VSI). Phase 1 (P1; 8 wks) VSI was not displayed; patients received standard care; VSI
and VS trends were background recorded. Phase 2 VSI was displayed on bedside and central
station monitors; staff educated on use. Phase 3 (P3; 8 wks) staff used a clinical algorithm for
response to alert of VSI C 3.2. Detection of VS parameter changes meeting MET trigger
values deﬁned instability. P1 to P3 analyses: descriptive, Chi-square and Students t-test.
RESULTS. Admissions (326 in P1; 308 in P3) and continuous monitoring hours (18,258 in P1
and 18,314 in P3) were similar. 74.8% (n = 244) of P1 and 79.5% (n = 245) P3 patients were
never unstable. Similar percentages of P1 and P3 patients achieved minimal MET call criteria
(METmin) (25.2% P1 and 20.5% P3; p = .306). However, the mean duration of instability per
METmin patient decreased from P1 to P3 (113.4 to 61.5 min/METmin patient, p = .046). The
percentage of patients who developed serious and persistent instability which should have
resulted in MET activation (METfull) decreased (17.8% P1 vs. 5.2% P3; p\0.0001). There
were fewer missed events where the MET should have been called as the ratio of patients with
METfull who actually had a MET activation fell from 8.3:1 in P1 to only 1.7:1 in P3.
CONCLUSION. IMS improved detection of instability as compared to conventional four
channel monitoring in a SDU and decreased both the total number of unstable patients and the
instability duration. Use of the IMS also increased the probability that MET activation would
be called for serious instability. Further study will determine the relationship between
improved detection and treatment approaches for unstable patients.
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INTRODUCTION. Adverse events due to medication errors are signiﬁcant and costly cause
of injury during hospitalization. Patient Information Management System (PIMS) in Intensive
Care Unit (ICU), although expensive, may contribute to a reduction in medication errors and
lead to improvement in clinical practice1, 2. However, there are so far no cost-beneﬁt analysis
that can substantiate the need for PIMS in Intensive Care Units. This prospective study was
designed to assess if PIMS may be effective in reducing error rate in a polyvalent ICU.
METHODS. In a 10-bed polyvalent ICU located in a 1400 bedded community and teaching
hospital a PIMS (Centricity Critical Care Clinisoft; G.E. healthcare) was introduced on June
1st 2005. Before the implementation of the PIMS ﬂuid and medication orders were written by
hand by the physicians on a daily medication chart. After the implementation, drug pre-
scriptions were entered via the keyboard. The system was developed to supply pre-deﬁned
ﬂuids and medication protocols, as well as default medication dosages and drug interaction
warnings.To compare the frequency of medication errors before and after the implementation
of the PIMS, data of two periods of 15 days each (30 to 15 days before and 60 to 75 days after)
were prospectively collected and analyzed. For each period, 150 patient/days were considered.
No one of the staff members, but the ICU director, was made aware of the ongoing study.
Patients charts were daily revised between 7.00 and 8.00 AM by two independent physicians,
not directly involved in patients care. Fluids and medication orders were revised looking for
medication errors. The ICU director was immediately notiﬁed about any identiﬁed error, to
allow immediate correction during the ward round. Errors were classiﬁed as Type 1 (clinically
relevant and potentially dangerous) or Type 2 (registration errors without clinical relevance).
RESULTS. 2912 medical prescriptions were analyzed: 1408 pre-PIMS and 1504 after PIMS
implementation. Results are shown in Table 1. A highly signiﬁcant (p\0.01) reduction in
medication errors (from 3.69% to 0.86%) was observed, mainly related to the Type 1 errors
(2,34 vs. 0%)
TABLE 1 MEDICATION ERRORS PRE-PIMS AND AFTER PIMS
Before PIMS
Nr of errors
Before PIMS %
of errors
With PIMS
Nr of errors
With PIMS %
of errors
Medical Prescriptions 1408 1504
Tipe 1 (potentially harmful) 33 2,34% 0 0%
Type 2 (registration error) 19 1,35% 13 0,86%
Overall medication errors 52 3.69% 13 0,86%
CONCLUSION. the implementation of a PIMS in ICU was followed by a highly signiﬁcant
reduction in medication errors. Although PIMS are expensive, they may lead to a dramatic
amelioration in the quality of care. The economic impact of the reduction in medication errors
needs to be further investigated.
REFERENCE(S). 1. J G Kuperman, R F Gibson (2003). Computer physician order entry:
beneﬁts, costs and issues.Ann Intern Med 139 : 31–39.
2. A Dellermalm, A Djurberg (2004) Patient information management system as a clinical and
administrative tool. Int J of Intensive Care.
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ONLINE HELP WITH THE USE OF ULTRASOUND IN ANESTHESIA, INTENSIVE
CARE AND EMERGENCY: WWW.ECHOREA.ORG
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INTRODUCTION. While echography has become an essential tool in anesthesiology and
intensive care, its learning remains in France dependant of personnal volunteering: degrees,
seminars ou rare IMF courses. Learning imaging technicals can easily be made through in-
formatic communication, and it has been shown that elearning allows enrichment (1) and
improved quality of teaching (2). In this context, it seemed relevant to create a website about
echography in the ICU, accessible 24/24, recalling the fundamentals (main measures, normal
and pathological values), illustrated by images and videos. This work reports the initial con-
ditions of use.
METHODS. Echorea.org is a free website, with intuitive ergonomy. It consists of ﬁles
organized into three categories allowing three possible approaches: by diagnoses, by ultra-
sound signs, or by clinical signs. Practical clinical cases complement theory. Most assertions
are justiﬁed by bibliographic references at the bottom of sheet with pubmed link.
The dates, times and origins of visits has been collected day by day by an online software.
RESULTS. Echorea.org is available online since October 2006. Echorea.org now receives an
average of 750 visits per month, 24 connections per day. 73% are new visitors and 27%
previously known visitors. 7.2 pages are viewed on average per connection. There are 2
attendance peaks in the day: 16–18 and 21–22 h (and 37.5% of the connections at night). The
week/weekend ratio is 77%/23%. Visitors come from all over France, university hospitals,
general hospitals or otherwise. Foreign visitors (29.1%) come from 48 countries on 5 con-
tinents. 61% connect via search engines, 27% directly and 11% through links from referrals.
CONCLUSION. The pace of consultation to echorea.org is continuing but presents 2 par-
ticular peaks which appear to correspond to the search for timely information out of senior
coaching (afternoon, custody). The number of connections reported to the medical presence is
higher at night and on weekends. The chosen support seems therefore to satisfy two conditions:
– A virtual companionship (3) by a modern and easily accessible support dealing with the
complexity and magnitude of knowledge to be retained, particularly when people lack
accompaniment, especially in custody (37.5% of connections at night and 23% at WE).
Thus, 27% of visitors have already visited at least once.
– Ease of access to dense but illustrated information. Internet allows a wide, fast and free
diffusion(1), maintaininga rateof newcomersto thesiteof 73%.Connections was initiated
by thehospital, thefaculty, andthe home. Echorea.org is visited throughout Francebut also
abroad. The translation into English is one of the main projects in the short term.
REFERENCE(S). 1. Postgrad Med J. 2007; 83: 212–216.
2. Med Teach 2007; 29: p. 490–4.
3. Curr Opin Anaesthesiol, 2006; 19: p. 645–9.
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INTRODUCTION. PaCO2 is often grossly estimated from end tidal CO2 (EtCO2), which
substantially underestimate its value. EvitaXL (Dra ¨ger Medical) proposes a continuous
monitoring of expired CO2, and this value is used as a safety limit in an automated ventilation
system (SmartCare
 ). Long expirations allow EtCO2 to reach values closer to PaCO2. We
wondered whether taking the maximal value instead of the mean EtCO2 value over ﬁxed
intervals would result in a more reliable estimate of PaCO2. This study, approved by the
Erasme Hospital ethical committee, compared etCO2 values averaged over 2 or 5 min versus
the maximal value only and compared to PaCO2 at different times.
METHODS. Breath by breath EtCO2 was continuously recorded during SmartCare (SC)
sessions in 34 mechanically ventilated patients (median duration 70 min, interquartiles: 59–
97 min). Data were collected simultaneously from SmartCare recordings on a ventilator
(every 2 or 5 min) and stored in a computer through the VentView software (Dra ¨ger) to
compare maximum and averaged values. PaCO2 was measured from 107 blood samples
performed for clinical purposes (3.7 ± 1.1 blood samples per patient) in 29 patients: Mean
PaCO2 per pt was 43.3 ± 10.6 mmHg. The maximum EtCO2 were determined over 5 or
10 minutes around the PaCO2 sampling.
RESULTS. We ﬁrst compared, for 1158 sequences of SC recordings, the mean EtCO2 with
the corresponding Max EtCO2; 10 aberrant values needed to be discarded. We then calculated
the differences between mean EtCO2 or maximum EtCO2 and PaCO2 over different periods.
Comparisons were performed only when mean and/or maximum EtCO2 were available
shortly before and after the blood gas sampling.
TABLE 1
EtCO2 difference (mmHg) Mean ± sd Median
(1st; 3rd quartile)
Mean* EtCO2-Max* EtCO2 (N = 1158) -3 ± 6 -2( -4; -1)
Mean* EtCO2-PaCO2 (N = 74) -11 ± 13 -9( -13; -6)
Max EtCO2 (5 min) -PaCO2 (N = 68) -7 ± 12 -6( -10; -4)
Max EtCO2 (10 min)  -PaCO2 (N = 94) -6 ± 11 -5( -8; -3)
(*) Over 2 min or 5 min/( ) Max determined within an interval of 2 min 30 before to 2 min 30
after gas measurement/(  ) Max determined within an interval of 5 min before to 5 min after
gas measurement
CONCLUSION. Use of maximal EtCO2 over 5 or 10 min can reduce the difference between
EtCO2 and PaCO2. Few aberrant values (0.9%) must be discarded.
GRANT ACKNOWLEDGEMENT. Dra ¨ger Medical (Lu ¨beck, Germany).
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COMPARISON OF CARDIAC OUTPUT (CO) AND BLOOD VOLUME MEASURE-
MENTS BY ULTRASOUND DILUTION AND TRANSPULMONARY
THERMODILUTION METHODS
G. Galstyan*, M. G. Alexanyan, V. M. Gorodetsky
Critical Care, National Center for Hematology, Moscow, Russian Federation
INTRODUCTION. Recently a new ultrasound dilution (UD) method was introduced that
uses insitu arterial and venous catheters to measure COUD and Central Blood Volume (CBV).
The method is based on measurement of decrease in blood ultrasound velocity caused by
injecting isotonic saline. The purpose of the study was to compare UD measurements with
transpulmonary thermodilution (TT) measurements (COTT & Intrathorathic Blood Volume
ITBV, parameter analogous to CBV).
METHODS. Eight adult patients (age 34–64) with hematological malignancies were inclu-
ded in the study. Indications for invasive monitoring were: sepsis and acute lung injury (3);
ARDS (1); septic shock (2); acute congestive heart failure (1); intracranial hemorrhage (1).
For TT measurements 3 injections of 20 ml cold 5% dextrose were performed into 5Fr PiCCO
femoral arterial catheter. For UD measurements, an extracorporeal AV loop was connected
between insitu A-V catheters. Reusable UD sensors were clamped on the arterial and venous
limbs of the loop. Pump circulated blood from the artery to the vein at 8–12 ml/min for 5–
7 min. Three UD readings (COstatus, Transonic Systems Inc., USA) were obtained by
injecting 20–30 ml of body temperature isotonic saline. At the end of the session, the system
was ﬂushed with heparinized saline until the next measurement session.
RESULTS. 51 pairs of averaged data were obtained for comparison. For CO, correlation was
R = 0.94; COUD = 1.07*COTT–0.40 L/min; bias was 0.32 L/min and the error (2SD/Mean
of TT) was 18%. For volumes, correlation was R = 0.90; CBV = 0.76*ITBV + 80 ml; bias
was 401 ml (CBV\ITBV) and the error was 21%. Loss of thermal indicator could possibly
lead to overestimation of ITBV. The % error for both CO and volumes is considered clinically
acceptable (\30%).
CONCLUSION. First clinical comparison of UD vs. TT produced close agreement in adult
hematology patients. New UD method works off existing catheters; is quick to set up and
involves no blood loss.
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ELECTRICAL MUSCLE STIMULATION: A TOOL TO PREVENT CRITICAL
ILLNESS POLYNEUROMYOPATHY? PROSPECTIVE RANDOMIZED STUDY
V. Gerovasili*, L. Karatzanos, K. Stefanidis, K. Vitzilaios, E. Anastasiou, G. Mitsiou,
A. Antelli, D. Zervakis, S. Nanas
1st Critical Care Department, National and Kapodistrian University of Athens, Athens,
Greece
INTRODUCTION. Critically ill patients are characterized by increased loss of muscle mass,
partially attributed to sepsis and multiple organ failure, as well as immobilization, which may
lead to the presentation to critical illness polyneuromyopathy (CIPNM).Recent studies have
shown that electrical muscle stimulation (EMS) may be an alternative to active exercise in
COPD and CHF patients.Our aim was to investigate the EMS effect on muscle mass pres-
ervation of critically ill patients with the use of ultrasonography (US).
METHODS. In this prospective study 29 critically ill patients (age:56 ± 21 yr) (APACHE
score:20 ± 5) (SOFA score:9 ± 3) were randomized after stratiﬁcation upon admission to
receiveEMSsessions(45-min/5 daysperweek)ofvastuslateralis,vastusmedialisandperoneus
longus muscles of both lower extremities (EMS–group) or to the control group (non-
EMS).Nineteenpatientswereﬁnallyevaluated,8patientsinthenon-EMSand11patientsinthe
EMS group.Muscle mass was evaluated with US, by measuring the Cross Sectional Diameter
(CSD) of the quadriceps muscle (rectus femoris-vastus intermedius).US images were obtained
using a GE Vivid 7 model ultrasound scanner with a 7.5 LHz linear probe.The position of the
probe was selected at the midway between the anterior superior iliac spine and the midpoint of
the patella and was placed ventral to the transverse plane and perpendicular to the skin.The
measurementswereperformedonthe2ndand7thdayfo11owingadmission.TheMRCscalefor
theclinicalevaluationofmusclestrengthwasusedforthediagnosisofCIPNM(cutoff\48/60).
RESULTS. Rectus femoris CSD decreased signiﬁcantly in the non-EMS group (from
1.48 ± 0.42 to 1.24 ± 0.35 cm, p\0.05).In the EMS group the CSD of rectus femoris
decreased although not signiﬁcantly (from 1.37 ± 0.43 to 1.33 ± 0.40 cm, p[0.05), how-
ever there was a signiﬁcant between-group difference in the CSD decrease (EMS group:
0.04 ± 0.19 cm vs. non-EMS: 0.23 ± 0.11, p\0.05).Vastus intermedius CSD decreased in
both groups, however the decrease was not signiﬁcant in the EMS-group (EMS group: from
0.75 ± 0.35 to 0.73 ± 0.34 cm, non-EMS: from 1.39 ± 0.63 to 1.05 ± 0.48 cm).There was
a signiﬁcant difference (p\0.05) in the vastus intermedius CSD between EMS-group (-
0.26 ± 0.19 cm) and non-EMS (0.34 ± 0.20 cm). In the non-EMS group 25% of the patients
were diagnosed with CIPNM as compared to none in the EMS-group.
CONCLUSION. This is the ﬁrst prospective randomized study for the evaluation of EMS for
the preservation of muscle mass in critically ill patients and for the prevention of CIPNM.
These preliminary data imply that EMS may preserve the muscle mass of critically ill patients
and could have a decisive role for the prevention of CIPNM
GRANT ACKNOWLEDGEMENT. This research project (PENED) is co-ﬁnanced by E.U.-
European Social Fund and the Greek Ministry of Development (GSRT).
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INTRODUCTION. There is a need to determine the modiﬁcation of the function as an
indicator of the use of respiratory physiotherapy. The Method Functional Approach suggests
that the action of the physiotherapist is based on the prioritization of signs and symptoms as
functional markers in the interpretation of functionality.
Objective: To determine the incidence of pneumonia and atelectasis in two groups of
patients in the postoperative care of cardiac surgery undergone.
METHODS. Prospective,randomized,controlled and blinded. The study was conducted at the
Unit for Post-Operato ´rio of Heart Surgery (UPC), Hospital Portuguese - Salvador/BA. 150
included in the study, patients must be 18 years old, that had hemodynamic stability. All
patients were evaluated by physical therapists trained in both the pre about in the postoper-
ative. After randomization, patients in Group I (control) were treated with NCPAP 20 cm/
H2O, 30 min of 4/4 h until the time of discharge from the UPC, the patients in group II
(experimental) were treated in accordance with the routine of Physical Therapy, Method
Functional Approach.
RESULTS. The length of stay in UPC, 73.52 ± 36.33 h (about three days). There was no
statistically signiﬁcant difference between the groups studied. 9.8% had a diagnosis of ate-
lectasis and 5.0% were diagnosed with pneumonia and was hired in group I, 12.7% had a
diagnosis of atelectasis and 5.7% were diagnosed with pneumonia and were in Group II, there
was no statistically signiﬁcant difference between groups. Patients in group II, 64.7% of the
interventions made was kinesiotherapy, appear drills active and walking, there was a rela-
tively low frequency with regard to the need for interventions linked to respiratory.
CONCLUSION. The Method Functional Approach had the same efﬁciency as compared to
prophylactic application of CPAP in preventing atelectasis and pneumonia in patients in the
postoperative period of cardiac surgery. Considering the risk and cost beneﬁt Functional
Aproach obtained greater efﬁciency.
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IS THRESHOLD USEFUL IN ACCELERATING WEANING FROM MECHANICAL
VENTILATION?
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INTRODUCTION. Threshold can be used as a physiotherapic tool in order to increase
muscle strenght. This effect can be useful in weaning patients. However there are still con-
troversies considering its advantages during weaning from mechanical ventilation (MV). This
study aims to evaluate the effects of the threshold in such situation.
METHODS. Patients under MV for more than 48 h and prone to weaning were randomly
assigned to control or to the threshold group (trained twice daily). They were followed until
extubation, tracheotomy or death. All cardiorrespiratory variables, maximal inspiratory and
expiratory pressures (MIP and MEP), length of weaning and success or failure were regis-
tered. Statistical analysis was performed using ANOVA, Mann-Whitney U test and Chi-
Square test, where appropriate. It was considered a signiﬁcant level of 0.05.
RESULTS. Eighty-six patients were studied (52% men, mean age 63 ± 17 years, 48% with
chronic obstructive pulmonary disease). No differences were observed when comparing initial
versus ﬁnal cardiorrespiratory variables in both groups, with exception of the MIP (varied
from -33,72 ± 13,5 cmH2O to -40,81 ± 12,67 cmH2O in the threshold group and from -
37,67 ± 10,49 cmH2O to -34,19 ± 10,85 cmH2O in the control group, p\0,001), MEP
(varied from 25,47 ± 12,48 cmH2O to 29,65 ± 12,02 cmH2O in the threshold group and
from 29,65 ± 11,97 cmH2O to 26,86 ± 11,6 cmH2O in the control group, p\0,05) and
tidal volume (varied from 386,16 ± 236,56 ml to 436,16 ± 228,39 ml in the threshold group
and from 361,91 ± 168,81 ml to 357,14 ± 121,35 ml in the control group, p\0,05). No
differences were observed in length of weaning (1,36 days with threshold group versus
1,98 days in control group, p[0,05) and weaning success (83,7% with threshold group
versus 76,7% in control group, p[0,05).
CONCLUSION. Threshold during weaning from MV can cause an increase in MIP, MEP
and tidal volume. However, in this group of patients it was not associated with a decrease in
length of weaning or an increase in weaning success.
GRANT ACKNOWLEDGEMENT. FIPE.
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INTRODUCTION. The negative effects of mechanical ventilation and the associated bed
rest are well documented (1). To counteract these effects there has been an increasing move
towards early rehabilitation on Intensive Care units (ICU), with some evidence suggesting
shortened lengths of stay (LOS) in response to these interventions (2). Following an earlier
study at Manchester Royal Inﬁrmary, which highlighted a signiﬁcant reduction in LOS in
response to early rehabilitation (3), a structured rehabilitation programme was implemented
with the aim of decreasing overall length of stay and subsequently improve outcomes such as
overall mortality. This study aimed to determine the effect of the introduction of a structured
rehabilitation programme for patients admitted to critical care.
METHODS. The structured rehabilitation programme was implemented at the beginning of
2004. Physical function is improved by each patient having an individualised programme that
starts in ICU as soon as the patient is conscious and is adjusted accordingly throughout the
remainder of his or her hospital stay. Primary outcome measures used were mean ICU and
post ICU LOS, with secondary measures of mortality. Baseline data was obtained retro-
spectively, with annual ﬁgures presented for the three years following the introduction of the
rehabilitation programme. Data were analysed using students t-test.
RESULTS. In the year prior to the introduction of the structured rehabilitation programme
the mean LOS on ICU was 9.8 days. Initially on introduction although a mean reduction of
0.9 days was observed this was not statistically signiﬁcant. However in the following two
years a signiﬁcant reduction in LOS was then observed, with mean LOS falling to 8 days in
2005 (p\0.05) and 7.7 days by 2006 (p\0.01). Overall mortality also signiﬁcantly fell
from 45% in 2003 to 35% in 2006 (P\0.01).
TABLE 1
Mean ICU
LOS (days)
Mean Ppost
ICU LOS
(days)
ICU
mortality
(%)
Post ICU
in-pt mortality
(%)
Total
mortality
(%)
2003 9.8 34 25 20 45
2004 8.9 40.6 25 15 40
2005 8.0 34.7 22 14 36
2006 7.7 27.8 19 16 35
CONCLUSION. Structured programmes of rehabilitation can signiﬁcantly decrease length of
stay on ICU, with resulting reductions in overall mortality for patients admitted to critical
care. However, It is acknowledged that numerous variables need to be considered when
interpreting these results.
REFERENCE(S). 1. Jones C, Grifﬁths RD (2000) Identifying post intensive care patients
who may need physical rehabilitation. Clin Intensive Care 11:35–38.
2. Chang et al, (2006) Effects of Physical Training on Functional Status in Patients With
Prolonged Mechanical Ventilation. Physical Therapy, 86; 9: 1271–1281.
3. McWilliams DJ, Pantelides KP (2007) Does Physiotherapy led early mobilization affect
length of stay on ICU. Intensive Care Medicine. 33; 2.
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THE EFFECTS OF HYPOXIC HYPOXIA AND SYSTEMIC HYPOPERFUSION ON
EX VIVO JEJUNUM MOTILITY
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INTRODUCTION. Critical tissue oxygen availability may affect jejunal motility, and this
can further be modiﬁed by nitric oxide. We studied ex vivo jejunum motility after exposure to
two different conditions of low oxygen availability: hypoxic hypoxia and cardiac tamponade.
We hypothesized that cardiac tamponade and hypoxic hypoxia decrease jejunal motility.
METHODS. 24 anesthetized and mechanically ventilated pigs were randomized to cardiac
tamponade (CT, n = 8), hypoxia (HH, n = 8) or control (C, n = 8). In CT, cardiac output
was reduced in 6-h steps to reach 50, 40 and 30 ml kg
-1 min
-1. In HH, FiO2 was reduced in 6
hrs to reach a PaO2 of 50–60 mmHg and then at 12 h to\50 mmHg. The lowest levels were
maintained until 24 h or until death occurred. Cardiac output was measured by thermodilution
and regional blood ﬂows by Doppler ultrasound. At the end of the animal experiment, jejunal
samples were analyzed by the tissue bath method. Acetylcholine (1–100 lM) and sodium
nitroprusside (SNP, from 1 to 100 lM) effects were tested by constructing dose response
curves. Maximum force and maximum relaxation values were calculated. Vascular reactivity
data from the same animals are presented in another abstract.
RESULTS. Cardiac output decreased in CT from 77 ± 14 to 44 ± 12 ml/kg/min, increased
in HH from 75 ± 15 to 113 ± 26 ml/kg/min, and did not change in controls (time-group
interaction; p = 0.001 [ANOVA for repeated measurements]). Superior mesenteric artery
blood ﬂow decreased by 30 ± 5% in CT, and increased by 2 ± 17% in HH and 22 ± 15% in
controls (p = 0.04). Acetylcholine dose response is presented in ﬁgure 1. Maximal acetyl-
choline responses were 119 (105–137)%, 160 (137–165)%, and 142 (124–181)% in CT, HH
and C, respectively (p = 0.06). There were no differences in sodium nitroprusside-induced
relaxation between the groups.
CONCLUSION. Jejunum motility is preserved after exposure to CT and HH. Ex vivo jejunal
motility is not related to tissue oxygen delivery within the range of this experiment. The role
of regional mediators should be addressed in further, larger series.
GRANT ACKNOWLEDGEMENT. Supported by grant 3200BO/102268 from the Swiss
National Fund and a grant from Novartis.
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THE INFLAMMATORY RESPONSE TO ACUTE RENAL FAILURE
A. C. Brøchner*
1, F. Dagnæs-Hansen
2, R. Steffensen
2, P. Toft
1
1Dep.of anesthesiology and intensive care, University Hospital of Odense, Odense,
2Institute
of microbiology and immunology, University of A ˚rhus, A ˚rhus, Denmark
INTRODUCTION. Acute renal failure (ARF) is a common complication seen in 10–23% of
patients admitted to the intensive care unit. When occurring, ARF leads to an increased
mortality rate. The primary causes of death in this group of patients are extra renal, including
infection, shock, sepsis, and respiratory failure. Post mortem examinations in these patients
reveal cellular inﬁltration of lungs and kidneys. It is possible that ARF elicits an extra renal
inﬂammatory reaction responsible for the increased mortality. We therefore investigated the
effect on the immune system of renal ischemia/reperfusion (I/R) compared with I/R of the
hind legs in mice.
METHODS. 80 mice in 4 groups A, B, C, D. A were subjected to I/R of the kidneys. B had
unilateral nefrectomy. C were only anaesthetized. D had I/R to the hind legs. In each group, 2
and 24 h following the primary intervention, 10 mice were sacriﬁced and humoral inﬂam-
matory markers, lung and kidney tissue was obtained. The measured parameters included the
adhesion molecule of CD11b, TNF-alfa, and MHCII on monocytes. In lungs and kidneys,
TNF-alfa and myeloperoxidase (MPO) was measured.
RESULTS. In all the I/R groups we observed an up-regulation of CD11b and a down-
regulation of MHC II. As illustrated in the ﬁgure, a pronounced increase in MPO was
observed in the kidneys following I/R of the kidneys as compared to I/R of the extremities. In
contrast the concentration of MPO in the lungs was more pronounced in the group exposed to
I/R of the extremities.
CONCLUSION. Reperfusion following ischemic injury results in increased levels of
inﬂammatory markers. Upon I/R of the hind legs, the inﬂammatory response in the lungs was
more pronounced than following induction of I/R in the kidneys.
GRANT ACKNOWLEDGEMENT. Danielsens foundation.
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DIFFERENT CONTRIBUTION OF SPLANCHNIC ORGANS TO INCREASING
SYSTEMIC LACTATE FLUX IN INFLAMMATORY VS. LOW PERFUSION STATE
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INTRODUCTION. While increased arterial lactate concentrations in sepsis have been
attributed both to inadequate tissue oxygen delivery and impairment of oxygen extraction
capabilities, they are the consequence of decreased hepato-splanchnic perfusion when cardiac
output is low. We hypothesized that tissue oxygen delivery is adequate in sepsis, and
therefore, the contribution of hepato-splanchnic lactate exchange to systemic lactate ﬂux is
not increased.
METHODS. 24 anesthetized pigs were randomized to fecal peritonitis (P), cardiac tam-
ponade (CT), or to serve as controls (n = 8 per group). Systemic (thermodilution) and
regional (ultrasound transit time) ﬂows and lactate concentrations were measured and oxygen
transport and lactate exchange were calculated over 24 h.
RESULTS. Cardiac output increased in P (116 ± 37% of baseline) and decreased in CT
(59 ± 18% of baseline), hepatic arterial blood ﬂow increased in P and remained unchanged in
CT, and portal ﬂow decreased in CT and remained unchanged in P (time-group interaction: all
p\0.03). In CT but not in P, hepatic oxygen consumption decreased (60 ± 38% of baseline
and 101 ± 44% of baseline, respectively; p: 0.049). Lactate data are shown in the table.
TABLE 1
Arterial Lactate* Hepatic vein lactate* SLF (% from
baseline)*
HLE/SLF (%)*
Baseline End Baseline End End Baseline End
C 0.6 ± 0.2 1 ± 0.2 0.3 ± 0.1 0.4 ± 0.2 141 ± 54 16 ± 81 6 ± 6
P 0.6 ± 0.2 2 ± 0.6 0.4 ± 0.1 1 ± 1 295 ± 117 18 ± 81 2 ± 7
CT 0.6 ± 0.2 4 ± 2 0.3 ± 0.1 5 ± 2 486 ± 239 14 ± 43 2 ± 8
*ANOVA repeated measurements, time-group interaction: p\0.01.Units: lactate, mmol/L
CONCLUSION. Increasing systemic lactate ﬂux in peritonitis is a consequence of an early
increase in regional, extra-splanchnic lactate production without signs of tissue hypoxia but
with a failure to increase hepatic lactate extraction. In cardiac tamponade, regional, extra-
splanchnic lactate production is accompanied by hepatic tissue hypoxia and net hepatic lactate
production.
GRANT ACKNOWLEDGEMENT. Supported by grant 3200BO/102268 from the Swiss
National Fund.
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INTRODUCTION. Mortality in critically ill patients with acute renal failure (ARF) is
unacceptably high. Acute circulatory and respiratory failure at admission to an intensive care
unit have been identiﬁed as the most important risk factors for the development of ARF. The
aim of this study was to assess the effect of acute reduction of either cardiac output or arterial
oxygen saturation on renal oxygen transport and kidney function.
METHODS. Prospective, randomized, controlled study in 24 anesthetized, mechanically
ventilated pigs (weight: 42 ± 3.2 kg). In cardiac tamponade (CT; n = 8), cardiac output and
blood pressure were reduced by ﬁlling the pericardial sac with HES 6%. In hypoxic hypoxia
(HH; n = 8), FiO2 was reduced. Systemic (thermodilution) and renal (ultrasound Doppler)
blood ﬂow were measured at baseline and at 6 and 12 h. 8 animals served as controls.
Differences between groups were assessed by repeated measurements ANOVA [RMA], all p-
values are time-group [T 9 G] interaction).
RESULTS. Control animals remained stable. Cardiac index decreased in CT from
72.5 ± 14.2 to 57.3 ± 11.7 mlkg-1 min-1 and increased in HH from 71.5 ± 14.4 to
106.2 ± 27.4 mlkg-1 min-1 (p\0.001). Arterial blood pressure remained stable in HH,
while decreasing in CT from 73.6 ± 12.7 to 58 ± 14.9 mmHg (p\0.06). In HH, arterial
oxygen saturation decreased from 97 ± 0.0 to 68 ± 11 (p\0.001). Renal blood ﬂow and
oxygen delivery decreased in CT from 4.9 ± 0.7 to 3.5 ± 1.0 ml kg
-1 min
-1, and from
0.64 ± 0.15 to 0.43 ± 0.12 ml kg
-1 min
-1, respectively (both p\0.04). Renal perfusion
pressure decreased in CT from 68.29 ± 13.9 to 47.14 ± 15.97 (p\0.025). In HH, arterial
and renal venous oxygen content decreased from 118.5 ± 6.6 to 89.0 ± 17.6 ml/l, and from
82.83 ± 12.4 to 50.9 ± 12 ml/l (both p\0.05), while renal blood ﬂow and oxygen delivery
were maintained. In CT, creatinine clearance and urinary output decreased from 43.65 ± 8.45
to 27.25 ± 12.13 dl/hr (p = 0.09) and from 1.23 ± 0.7 to 0.48 ± 0.3 ml/kg/h (p = 0.08),
respectively, and fractional sodium excretion from 2.03 ± 2.12 to 0.41 ± 0.2 (p = 0.035).
These variables remained unchanged in HH and in controls.
CONCLUSION. Reduced renal blood ﬂow and blood pressure but not reduced renal oxygen
content are associated with ARF. Over the short term, severe arterial hypoxemia
(SpO2 B 70%) seems to be well tolerated when systemic hemodynamics are not
compromised.
GRANT ACKNOWLEDGEMENT. Supported by grant 3200BO/102268 from the Swiss
National Fund and by a grant from Novartis.
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INTERLEUKIN-8 (IL-8) EVALUATION DURING ACUTE NORMOVOLEMIC
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INTRODUCTION. In recent years there has been increasing evidence that resuscitation
strategy with different ﬂuids can have divergent impacts on the immune response and cyto-
kines release. This study was undertaken to measure the IL-8 in the serum samples and
bronchoalveolar lavage ﬂuid (BALF) during acute normovolemic hemodilution (ANH) per-
formed with hydroxyethyl starch (HES), normal saline solution (NSS) or gelatin (GEL).
METHODS. Twenty eight pigs were anesthetized, instrumented and randomized into four
groups: Control, ANH + HES, ANH + NSS and ANH + GEL. Animals in the ANH group
were submitted to acute normovolemic hemodilution to a target hematocrit of 15% with
volume replacement performed with HES 130/0,4, GEL both at a 1:1 ratio or with NSS at a
3:1 ratio. The withdrawn blood was returned to the animals 120 minutes after the end of
hemodilution. Cardiac Index (l/min/m2) was determined at the following time points: before
ANH (Baseline), after instrumentation (INST), immediately after ANH (H), 60 minutes after
ANH (60H), 120 minutes after ANH (120H), 60 minutes after blood infusion (60BI) and 120
minutes after blood infusion (120BI). The measurement of IL-8 (pg/ml) was performed with
blood samples collected at the femoral vein immediately after ANH (H) and in the BALF
after the end of the experiment. The cytokine IL-8 quantiﬁcation was determined by Enzyme
Linked Immuno Sorbent Assay (ELISA). One-way Analysis of Variance (ANOVA) was
performed to evaluate differences among groups. A p value of 0.05 was considered statisti-
cally signiﬁcant.
RESULTS. Cardiac Index (CI) was signiﬁcant higher in groups ANH + HES (7.3 ± 1.2;
p\0.05) and ANH + GEL (7.7 ± 1.0; p\0.01) when compared to Control (5.6 ± 0.8)
immediately after HNA. Sixty minutes after blood infusion, CI differed only in the
ANH + GEL (8.3 ± 1.2; p\0.01) when compared to Control (5.6 ± 0.8). When serum IL-8
was analysed, there were no signiﬁcant differences at time point H. The same was observed
with regard to IL-8 in BALF, following the values: Control (88.33 ± 24.51), ANH + HES
(124.69 ± 29.47), ANH + NSS (106.87 ± 29.74) or ANH + GEL (126.43 ± 52.65).
CONCLUSION. Fluid replacement immediately after induced ANH increased cardiac index
and inﬂammation expressed by Interleukin-8 release without signiﬁcant differences among
them.
GRANT ACKNOWLEDGEMENT. LIM 08/Laboratory of Anesthesiology; FAPESP (05/
58987-9).
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EFFECT OF HIGH VOLUME CVVH ON GENE EXPRESSION
L. Di Donato*, F. Bifulco, E. D’Amico, V. Narni Mancinelli, C. Russo, M. Vargas,
G. Servillo
Anaesthesia and Intensive Care Medicine, University of Naples Federico II, Naples, Italy
INTRODUCTION. Sepsis is a major clinical problems in ICU. Many critically ill patients
with severe sepsis develop ARF (acute renal failure) as a part of multiple organ failure
(MOF). Sepsis is characterised by an uncontrolled immune response with release of pro-
inﬂammatory and anti- inﬂammatory cytokines, such as Il-6, TNF-\alpha, Il-10. A potential
application of high volume continuous veno-venous haemoﬁltration is the extracorporeal
removal of inﬂammatory mediators in septic patients, which can lead to an immunomodu-
latory effect. Aim of our study is to investigate the effect of high volume continuous
haemoﬁltration on the transcriptional activity of mononuclear cells (PBMC).
METHODS. We enrolled 10 medical and surgical patients from our ICU suffering severe
sepsis or septic shock. High ﬂux CVVH was carried out and blood samples were obtained
before the beginning of CVVH (T0), after 12 h (T1) and daily (T2-T4). Primary outcome
measure was trend of IL-6 gene expression in our patients during CVVH.
RESULTS. Figure 1 shows trend of IL-6 gene expression. We observed Il-6 mRNA drop
after 12 h of treatment (T1), then a progressive increase at 24, 48, 72 h.
CONCLUSION. Our data show an improvement of transcriptional activity of PBMCs in
septic patients treated with high ﬂux CVVH. These data could represent an expression of
attenuation of sepsis-related immunoparalysis.
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EVALUATION OF ENTERIC DYSFUNCTION IN CRITICALLY ILL PATIENTS
WITH MULTIORGAN DYSFUNCTION IN A MEDICAL AND SURGICAL ICU
SETTING
M. Martı ´nez-Rebollar*, J. Ruiz Moreno, R. Corcuera Romero, O. Garcia-Trallero, J. Vil-
lasenin
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INTRODUCTION. Multiple organ dysfunction syndrome (MODS) is the leading cause of
death in intensive care units (ICU). Little attention has been given to the status of gastroin-
testinal tract despite gut dysfunction occurs frequently among critically ill patients (CIP).The
gut has often been suggested to be one of the essential factors in the pathogenesis of MODS
and, CIP are susceptible to injury of the gastrointestinal tract. The aim of this study is to
identify enteric dysfunction (ED) at admission and discharge, its association to other organ
dysfunctions (OD), according to OD is acute or chronic, primary or secondary, its evolution to
organ failure (OF) or not, and its relations to severity and outcome.
METHODS. Setting: Medical/Surgical ICU belonging to a 350 acute care teaching hospital.
Study: Data of 603 CIP admitted consecutively to the ICU were collected prospective and
descriptively from September’03 to July’04. SOFA has been used to identify OD and OF. To
deﬁne ED the following diseases have been considered: diet intolerance[3 days & ileus,
stress ulcus, acute pancreatitis, non lithiasis cholecystitis, and peritonitis. Acidosis by itself is
not considered as dysfunction. Chronic health and SOFA have been used to establishing when
OD was previous.
RESULTS. 100 patients presented ED, prevalence 16.5%. Mean age: 71.1 years. Gender:
men 62%. Length of stay: 7.7 days. Mortality: Global: 20%. SOFA: 13. Surgical CIP mor-
tality: 45% (9), Medical CIP mortality: 55% (11). Case-mix: Medical CIP: 32%, Surgical CIP:
68%, Elective Surgery: 61%, Urgent Surgery 38%, Sepsis: 22%, Tumor: 38%, Invasive
ventilated CIP: 48%. At admission: 86 CP with ED: 9 only 1 OD; 89,5%(77) with MOD: 25
(29%) with 2 OD, 22 (25.5%) with 3 OD, 20 (23.2%) with 4 OD, 8 (9.3%) with 5 OD and 1
with 6 OD and 7 OD. Mean SOFA:3.74. Type of OD (acute/chronic): Cardiovascular: 35 (21/
14); Respiratory: 53 (49/5); Renal: 34 (26/8); Enteric: 86 (60/26); Hepatic: 19 (14/5),
Haematologic: 25 (17/8), Neurologic: 6 (2/4). Acidosis: 30.23%. At discharge (OD developed
during ICU stay): 14 CIP with ED, all with MOD: 3OD: 21.4%, 4OD 28.5%, 5OD 21.4%,
6OD 21.4% and 1 with 7 OD. Evolution to OF (total and OF): Cardiovascular: 11/7,
Respiratory: 13/6, Renal: 11/4, Enteric: 14/5, Hepatic: 7/3, Haematologic: 6/3, Neurologic: 3/
2. Primary dysfunction was identiﬁed in 66 CIP: Cardiovascular: 8 (12.2%), Respiratory: 10
(15.5%), Enteric: 37 (56.1%), Hepatic 8 (12.1), Renal 2 (3.1%), Haematologic 0, Neurologic
1 (1.5%).
CONCLUSION. Prevalence of ED is considerable. Its inﬂuence in overcome and severity is
important. ED is the most prevalent primary OD. The majority of CP with ED presented
MODS. Cardiovascular, respiratory and renal OD were mostly associated to ED. The asso-
ciation of ED to sepsis, tumor, metabolic acidosis and invasive ventilation is clinically
relevant.
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ADRENAL INSUFFICIENCY AND ITS PROGNOSIS OF SEPTIC SHOCK
PATIENTS IN INTENSIVE CARE UNIT
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INTRODUCTION. The objective of this study was to evaluate efﬁcacy of corticosteroid
therapy in a broad population of patients with septic shock not only who had relative adrenal
insufﬁciency (RAI) but also who did not have RAI according to the results of high or low dose
corticotropin stimulation tests.
METHODS. A retrospective study was conducted in an intensive care unit of Severance
hospital, Seoul, South Korea, between June 2005 and December 2007. The study included 132
critically ill patients who underwent a short corticotropin test because of prolonged septic
shock.
RESULTS. Among 132 patients, 79 patients were given high dose corticotropin (250ug) test
and 53 patients were given low dose (1ug) corticotropin test. Among 79 patients, 36(45.6%)
patients (22 in corticosteroid group and 14 in conservative group) showed and 43(54.4%)
patients (12 in corticosteroid group and 31 in conservative group) did not show RAI. On the
other hand, among 53 patients, 29(54.7%) patients (20 in corticosteroid group and 9 in
conservative group) showed and 24(45.3%) patients (8 in corticosteroid group and 16 in
conservative group) did not show RAI. At 28 days, in high dose corticotropin stimulation test
group, there was no signiﬁcant difference in mortality between corticosteroid group and
conservative group within the patients with RAI (36.4% vs. 28.6%; P = 0.74) and patients
without RAI (8.3% vs. 29.0%; P = 0.18) There was also no signiﬁcant difference in mortality
between corticosteroid group and conservative group within the patients with RAI (30% vs.
11.1%; P = 0.42) and patients without RAI (25% vs. 31.2%; P = 0.66) in low dose corti-
cotropin stimulation test group.
TABLE 1
Steroid 36 Conservative 43 P value
High dose corticotropin stimulation test
Overall 9/34(26.5%) 13/45(29.9%) 0.83
Relative adrenal insufﬁciency (+) 8/22(36.4%) 4/14(28.6%) 0.74
Relative adrenal insufﬁciency (-) 1/12(8.3%) 9/31(29.0%) 0.18
N Steroid 28 Conservative 25 P value
Low dose corticotropin stimulation test
Overall 8/28(28.6%) 6/25(24%) 0.67
Relative adrenal insufﬁciency (+) 6/20(30%) 1/9(11.1%) 0.42
Relative adrenal insufﬁciency (-) 2/8(25%) 5/16(31.2%) 0.66
CONCLUSION. Corticosteroid did not improve survival of septic shock patients regardless
of RAI. Moreover, whether low or high dose of corticotropin stimulation test was applied did
not show any difference in survival. Therefore, short corticotropin stimulation test would not
be helpful in identifying which patients to be given corticosteroid.
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ADRENAL RESPONSE IN PATIENTS WITH SEPTIC SHOCK TREATED WITH
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INTRODUCTION. The hypotalamic-pituitary-adrenal axis is a major determinant of the
host’s response to stress and its dysfunction can be present in septic shock. Adrenal dys-
function has been associated to higher mortality (1). However, the evaluation of the adrenal
response is difﬁcult (2) and substitutive use of low dose of steriods in septic shock is con-
troversial (3). The objective of the study is to evaluate the prognostic value of the adrenal
response to corticotropin in patients with septic shock treated with hydrocortisone.
METHODS. Prospective, observational study in a medical-surgical ICU. All adult patients
admitted in the ICU last year with septic shock were consecutively included, except those
already treated with steriods. Epidemiologic and treatment data using sepsis bundles were
collected. Cortisol level at To, the response to the corticotropin test (250 micrograms) and the
initial lactate were measured during the ﬁrst 24 h. All patients received hydrocortisone
300 mg/day until the result of the corticotropin test and it was suspended when delta cortisol
was greater or equal to 9 mcg/dl. The prognostic value of the adrenal response to corticotropin
was studied comparing data between survivors and non survivors by Student’s t test for
continous variables and X
2 or Fisher exact test for categorical variables. ROC curve and
Youden’s index were used to select the cortisol level at To that better discriminated mortality.
RESULTS. 83 patients with septic shock were included (age 65 ± 16 years, APACHE II
19 ± 9, hospital mortality 30%). Patients that did not survive to septic shock were mainly
men with abdominal sepsis, had higher lactate (54.8 ± 51.2 vs. 40.3 ± 26.3 mg/dl;
p = 0.165) and were less compliant with the resuscitation bundle (0 vs. 11.3%; p = 0.082).
Nonsurvivors had stastistically higher cortisol at To (44.5 ± 18.3 mcg/dl vs. 36.5 ± 17.2
mcg/dl; p = 0.049) and a tendency to lower response to the corticotropine test (23.8 vs.
41.9%; p = 0.158). Cortisol at To greater than 28 mcg/dl was the level that best discriminates
mortality (sensibility 80% and speciﬁcity 42%). The subgroup of patients with cortisol at To
greater than 28 mcg/dl and nonresponse to the corticotropin test had higher mortality than the
rest (46.5 vs. 21.6%; p = 0.02).
CONCLUSION. The evaluation of the adrenal response to corticotropin is useful to dis-
criminate patients with septic shock and a higher mortality risk, even if they are treated with
hydrocortisone.
REFERENCE(S). 1. Annane D, Bellissant E. JAMA 2000;284:308–9.
2. Annane et al. AJRCCM 2006;174:1319–26.
3. Sprung CL et al. NEJM 2008;358:111–24.
0796
SYSTEMIC INFLAMMATORY RESPONSE IS ASSOCIATED WITH INCREASED
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INTRODUCTION. Inﬂammatory markers have been used in the diagnosis and follow-up of
VAP, but their potential role in predicting the risk to develop VAP is unknown. This capacity
has been proved in the case of community-acquired pneumonia. We prospectively assessed
the evolution of inﬂammatory markers in mechanically-ventilated (MV) patients and their
predictive and diagnostic role for VAP.
METHODS. Sequential measurements of C-reactive protein (CRP), procalcitonin (PCT) and
cytokines (IL-1, IL-6, IL-8, IL-10 y TNF-alpha) were done in 44 MV patients. Exclusion
criteria were active infection at ICU admission and subsequent extrapulmonary infection.
RESULTS. Patients were divided into three categories: patients without VAP suspicion (n
24), patients with clinical suspicion of VAP but without microbiologycal conﬁrmation (n 11)
and patients with microbiologically-conﬁrmed VAP (n 9). At admission, demographics,
severity scores, and clinical and standard laboratory values were similar in the 3 groups, but
serum levels of IL-6 and IL8 were higher in patients with conﬁrmed VAP (526 ± 221 for IL-
6 and 68 ± 38 for IL-8 pg/mL) compared with those without suspicion or non-conﬁrmed
suspicion of VAP (174 ± 39 and 185 ± 55, respectively for IL-6, p = 0.041, and 4 ± 2 and
15 ± 3, respectively for IL-8, p = 0.022). At onset of VAP, serum levels of IL-6
(1232 ± 343 pg/mL) and IL-8 (52 ± 11 pg/mL) were also higher in patients with conﬁrmed
VAP, compared with those without suspicion or non-conﬁrmed suspicion of VAP (151 ± 44
and 364 ± 147, respectively for IL-6, and 12 ± 2 and 34 ± 4, respectively for IL-8,
p\0.001 both). Serum levels of CRP and PCT, as well as CPIS and SOFA Score, were also
highest in patients with conﬁrmed VAP. The BAL levels of cytokines were similar between
conﬁrmed and non-conﬁrmed VAP.
CONCLUSION. Increased systemic inﬂammatory response at admission might predispose
patients to develop VAP. Serum biomarkers can be helpful in VAP diagnosis.
GRANT ACKNOWLEDGEMENT. CibeRes (CB06/06/0028), 2005 SGR 00822.
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EVLWI IN CRITICALLY ILL PATIENTS WITH SIRS/SEPSIS
L. Ihrman*, M. S. Chew, J. Du ¨ring, A. Ersson
Dept of Intensive Care Medicine, Malmo ¨ University hospital, Malmo ¨, Sweden
INTRODUCTION. PiCCO catheterization has gained widespread use in ICUs worldwide.
However there is a relative paucity in underlying evidence for its use and this study aims to
investigate EVLW as a prognostic marker and assess its relationship to other clinical and
pulmonary parameters.
METHODS. A prospective observational one-centre cohort-study in a mixed-bed ICU of a
university hospital. 38 consecutive patients with SIRS and circulatory failure. Outcome
parameters were time in ventilator, ICU-length of stay, ICU-mortality and 6 month-mortality.
The clinical parameters investigated were PF-ratio, PEEP, APACHE- and SOFA-score. CI,
ITBVI and P-lactate were also analysed.
RESULTS. There were no differences between survivors and non-survivors in EVLWIbas-
eline and EVLWImax. EVLWI did not correlate signiﬁcantly to the clinical parameters. When
divided into subgroups according to EVLWImax, a low and a very high EVLWImax were
associated with high mortality, whereas the middle group had a lower mortality. When further
analysed, the non-survivors with low EVLWImax were signiﬁcantly older than the rest of the
study material. For patients\70 yo, EVLW was increased in the non-survivor group.
Regardless of age, all patients with EVLW[20 did not survive.
CONCLUSION. EVLWI can be used as a prognostic marker in younger patients with SIRS/
sepsis and values above 20 mL kg-1 indicates a bad prognosis. In patients with advanced age,
however, it should be interpreted more carefully.
REFERENCE(S). 1. Sakka, S.G., et al., Prognostic value of extravascular lung water in
critically ill patients. Chest, 2002. 122(6): p. 2080–6.
2. Martin, G.S., et al., Extravascular lung water in patients with severe sepsis: a prospective
cohort study. Crit Care, 2005. 9(2): p. R74–82.
3. Kuzkov, V.V., et al., Extravascular lung water determined with single transpulmonary
thermodilution correlates with the severity of sepsis-induced acute lung injury. Crit Care Med,
2006. 34(6): p. 1647–53.
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TEMPORAL CHANGES OF OXIDATIVE STRESS INDEX AND TOTAL ANTIOX-
IDANT POTENTIAL OF PLASMA: MARKERS FOR SURGICALY PATIENTS
WOUND HEALING
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INTRODUCTION. Hemodynamic management,in surgical patients,is associated some-
times,to progressively decreasing of Hb oxygen saturation(SaO2Hb),because of the stagnant
ischemia (surgical stress),or hemodylution,following the hyper volemic repletion[2].Our
study intended to observe the local O2 metabolism alteration[5],as a source for oxidative
stress(OxS)production,and to verify the effects of antioxidant therapy.The study was
approved by the Ethical Committee of UMF Craiova
METHODS. a prospective study realized upon 70 patients from Plastic and Reparatory
Surgery (Emergency Hospital Craiova) who needed of reparatory interventions to the distal
part of the limbs:duration of 4 ± 1 h.Patients were divided into three groups A:good healing
of wound (40cases), B:bad or nonhealing (30 cases),and control (10 cases),without surgical
interventions.We noted the evolution of the local morpho-clinical aspects induced by the
stagnant ischemia,after the cuff inﬂation at the site of intervention.We prelevated the samples
of blood at (T1), preoperative at 48 h postoperative (T2) and to the outcome (T3), to
determine the following values: lactate, C-reactive protein (CRP), procalcytonin (PCT),
SaO2Hb [3], oxidative stress index (OSI) and total antioxidant potential (TAOP). We have
correlated these values to the SOFA and APACHE scores
RESULTS. Statistical analysis(t test and ANOVA)evidentiated that CRP,PCT,correlated to
the two scores could be used as predictive indicators for endothelial and blood cells evolu-
tion.The seric level of antioxidant potential (TAOP) was:goup A:good healing of surgical
wounds 551,7(107,4)and B:nonhealing:502, 3(102,8) lmol Trolox echiv./L (p\0.05).The
values of OSI was:3, 43(1,50):group B vs.2,42 (1,30) group A (p\0.001).
CONCLUSION. Tissular exposure to the oxidative status induces a variability of local
cellular reactions, representing the kind of their adaptability. To recognize the local mecha-
nism of OxS production could be used to verify the adequate therapy and to predict the quality
of wound healing.
REFERENCE(S). 1. Girardis M (2003) Muscle perfusion and oxygen consumption by near
infrared spectroscopy in septic shock and nonseptic patients.Int care Med.29:1173–1176.
2. Hummler HD,Engelmman A (2006) Decreased accuracy of pulse oximetry measurements
during low pwerfusion caused by sepsis.Is the perfusion index of any value?Int care Med.DOI
doi.Org-10.1007.s00134-006-0254-y.
3. Jubran A (2004) Pulse oximetry,Int care Med.30:2017–1020.
4. Lima A, Bakker J (2005) Noninvasive monitoring of peripheral perfusion.Int Care
Med.31:1316–1326.
5. Praagman M (2003) Muscle oxygenation consumption,determined by NIRS,in relation to
external force and EMG.J.Biomech 36:905–912.
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SEPTIC SHOCK AND ACUTE RENAL FAILURE. WHEN SHOULD WE START
RENAL DEPURATION?
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INTRODUCTION. Sepsis and specially patients with septic shock, have a high morbi-
mortality, because of its quick evolution to multiorgan dysfunction syndrome (MODS). Acute
renal failure (ARF) is common and continuous renal replacement therapies (CRRT) play an
important role in the clinical management of septic patients.
Nowadays optimal CRRT in criticallly ill patients are directed to achieve depuration
doses[35 ml/kg/h (high volume hemoﬁltration-HVHF). The timing of these techniques is
still controversial but many authors suggest that an early initiation of CRRT in septic patients
is related to a better outcome. The objective of our study was to analyze the impact of an early
CRRT strategy in patients with septic shock and ARF.
METHODS. We included 32 patients with septic shock and ARF admitted to an intensive
care unit (ICU) in a prospective and observational study. CRTT with HVHF was initiated in
all patients. Two different groups were studied attending to the time of HVHF initiation
(based on RIFLE score). Group I: HVHF initiated in early stages of RIFLE score (Risk and
Injury). Group II: HVHF initiated in Failure stage of RIFLE score.
Group I: 9 patients were included (n = 9); mean age 58 ± 16 years, 5 were males, mean
APACHEII 24 ± 8. 90% of these patients were on mechanical ventilation (MV) at the
beggining of HVHF, 22% had disseminated intravascular coagulation (DIC) and 22% had
liver failure. Mean ultraﬁltrate dose was 43,5 ± 6 ml/kg/h.
Group II: 23 patients were included (n = 23); mean age 61 ± 13 years, 17 were males, mean
APACHE II 29 ± 9. 100% of these patients were on MV, 61% had DIC and 39% liver
failure. Mean ultraﬁltrate dose was 43,7 ± 6 ml/kg/h.
RESULTS. We did not observe adverse effects related to HVHF.
28 day survival was 89% in group I and 30% in group II with an important statistical
signiﬁcance (p\0,004).
Days on HVHF were 6 ± 3 days in group I and 7 ± 6 days in group II.
CONCLUSION. Early initiation of HVHF in septic shock patients with ARF seems related to
a better survival in our study.
We need further and much larger studies to conﬁrm our results.
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SENSIBILITY AND SPECITIVITY OF PROCALCITONIN IN PATIENTS WITH
CARDIOGE ´NIC SHOCK AND SEPSIS
C. Diaz Mendoza*, M. Fernandez Arroyo, A. Villanueva Ortiz, M. Sanchez Palacios
ICU, Hospital Materno-Insular, Las Palmas GC, Spain
INTRODUCTION. Some patients with cardiogenic shock present during their evolution a
systemic inﬂammatory response syndrome (SIRS) that can be interpreted erroneously as
septic shock.In this study we attempt to establish the usefulness of procalcitonin in those
patients with cardiogenic shock and associated SIRS with suspicion of sepsis.
METHODS. A group of patients with cardiogenic shock and suspicion of sepsis were studied
prospectively.We compare patients with cardiogenic shock and proved associated sepsis(G1)
with those that they did not develop it(G2).The diagnostic of sepsis was established according
sepsis criterions deﬁned by ACCP and by microbiologic results.We analyzed :age,sex,-
APACHE II and SAPS index,procalcitonina (PCT)and C-reactivates protein(PCR)
levels,leukocyte count,lactate levels,type of shock according to hemodynamic parame-
ters,focus of sepsis, isolated germens, mechanical ventilation days,ICU days and
mortality.The Fisher Test and Spearman correlation was used for the study of the variables.A
p\0,05 was considered statistically signiﬁcant.
RESULTS. A total of 32(100%)patient with cardiogenic shock and suspicion of sepsis were
studied,11(34%) had associated sepsis conﬁrmed with positive cultures(G1),while 21
(66%)did not present it(G2).The PCT test was positive for bacterial infection in 91%(10)of
G1 while was negative in 95%(20)of G2,only 1 patient on this group has a false positive
result(p = 0.006).The ﬁnal PCT sensibility was 91% with a 95% of specitivity (prevalence
34.4%,PPV 90.9%, NPV 95.2%, LR + :19.08,LR -:0.1).Instead of there no were signiﬁcant
differences with PCR value, serum level of PCR was superior in G1(21 +14.36)compared
with G2 (8 + 4.79). Multivariate analyses shown that days in mechanical ventilation, days in
ICU and cardiac catheterization are risk factors for develop sepsis. Distributive hemodynamic
pattern was frequent in G1 (82 % G1, 24% G2, p = 0.015). There no were differences among
others studied variables.
CONCLUSION. In our study sepsis is a frequent complication observed in cardiogenic shock
patients and associated SIRS with distributive hemodynamic pattern.The PCT level is a
usefulness diagnostic test with high sensibility and specitivity for diagnosis of severe sepsis in
this kind of patients.The accomplishment of cardiac catheterization, days in ICU and MV are
risk factors for the development of sepsis in this group of patients.
Poster Sessions
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INTRODUCTION. Off-pump coronary artery bypass grafting (OPCAB) can be accompa-
nied by hemodynamic and respiratory disorders and postoperative pain, requiring adequate
monitoring and treatment. Epidural anesthesia (EA) using continuous infusion of local
anesthetics combined with fentanyl can provide effective analgesia and reduce the number of
perioperative complications in thoracic surgery. However, the role of EA as a component of
multimodal patient controlled analgesia (PCA) in OPCAB still remains disputable. Thus, the
main goal of our study was to assess the efﬁcacy of high thoracic EA followed by postop-
erative patient-controlled epidural analgesia with infusion of ropivacaine/fentanyl mixture in
OPCAB patients.
METHODS. We enrolled 35 patients, who underwent elective OPCAB during anesthesia
with propofol and fentanyl, in an ongoing prospective study. The patients were randomized
into three groups with hemodynamics guided by PiCCOplus monitor (Pulsion Medical Sys-
tems, Germany) and postoperative pain control aiming at a visual analog scale (VAS) score in
rest\30 mm. All groups received lornoxicame 8 mg IV before OPCAB and every 8 h
postoperatively. The control group (n = 11) received fentanyl postoperatively at an initial
infusion rate of 0.7 mcg/kg/h IV. The epidural infusion (EI) group (n = 13), after placing the
epidural catheter at Th2–Th4 level before OPCAB, received EA with ropivacaine 0.75%
1 mg/kg and fentalyl 100 mcg followed by postoperative continuous EI of ropivacaine 0.2%
and fentalyl 2 mcg/ml at an infusion rate of 5–10 ml/h. The epidural infusion/PCA (EI/PCA)
group (n = 11) received the same regimen of EA followed by EI combined with PCA using a
programmable infusion pump (Graseby 3300, UK) with bolus 1 ml and lock-out interval
12 min. The measurements included hemodynamics, blood gases, VAS, and drug con-
sumption throughout 24 h after OPCAB. Data were assessed using \chi
2 test or ANOVA
followed by Scheffe’s test or test of contrasts when appropriate. p\0.05 was regarded as
statistically signiﬁcant.
RESULTS. Demographic data did not differ signiﬁcantly between the groups, as well as
mean VAS scores (within 20 mm in rest and 40 mm in coughing in all groups). The con-
sumption of propofol, fentanyl, and nitroglycerin was signiﬁcantly lower in both EA groups.
The incidence of colloid administration was 86% during EA vs. 36% in the control group
(p = 0.04). Mean arterial pressure and extravascular lung water were reduced in the EI and
the EI/PCA groups (p\0.05). In parallel, EA increased the PaO2/FiO2 ratio (p\0.05). The
duration of mechanical ventilation tended to decrease in the EI/PCA group (p = 0.1).
CONCLUSION. The perioperative epidural administration of ropivacaine/fentanyl provides
adequate analgesia, attenuates arterial hypertension, decreases extravascular lung water, and
increases arterial oxygenation thus improving lung function in OPCAB.
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SEVOFLURANE SEDATION USING ANESTHETIC CONSERVING DEVICE IN
POSTOPERATIVE ABDOMINAL SURGERY PATIENTS IN ICU—COMPARISON
TO AN INTRAVENOUS PROPOFOL-BASED REGIMEN
K. D. Ro ¨hm*, A. Mengistu, J. Boldt, S. N. Piper
Anaesthesiology and Intensive Care Medicine, Klinikum Ludwigshafen, Ludwigshafen,
Germany
INTRODUCTION. Since the approval of the Anaesthetic Conserving Device (ACD), the use
of volatile anaesthetics in the intensive care unit (ICU) has become a more cost-effective and
easy way of sedation than vaporizer techniques (1). Inhalational sedation has been studied
with isoﬂurane (2,3), but sevoﬂurane has scarcely been evaluated to date (4,5). We studied the
efﬁciency and practicability of a postoperative inhalational sedation with sevoﬂurane using
the ACD compared to propofol in the ICU.
METHODS. After approval from the ethical and governmental committee, 70 patients fol-
lowing major abdominal, vascular or urological surgery were allocated to this prospective,
randomized, single-blinded study, to either receive sevoﬂurane (n = 35) via the ACD (end-
tidal 0.5–1 Vol%) or intravenous propofol (n = 35) for postoperative sedation up to 24 h.
Primary endpoint was extubation time from termination of sedation. Further focus was set on
sedation quality using Richmond Agitation Sedation Scale (RASS) and BIS values, recovery
times and the consumption of anaesthetics.
RESULTS. Both study groups were similar in terms of demographic and perioperative data.
Time of sevoﬂurane and propofol sedation was similar (mean 10 h). Mean sevoﬂurane
consumption was 3.7 ± 1.1 ml/h to obtain endtidal sevoﬂurane concentrations of
1.1 ± 0,4Vol%. Mean administration of propofol was 2.5 ± 0.7 mg/kg/h during sedation.
Sedation quality including RASS and BIS values were similar in both groups throughout the
time of sedation (50–65), and during recovery from sedation to extubation. Mean extubation
times were signiﬁcantly shorter (p\0.001) with sevoﬂurane than with propofol
(24.7 ± 31.8 min vs. 81.6 ± 45.8 min), as well as eye opening (11.1 ± 18.8 min vs.
32.5 ± 32.4 min) and following commands (10.9 ± 9.4 min vs. 40.6 ± 37.6 min). Ventila-
tor time was signiﬁcantly shorter (p\0.01) in the sevoﬂurane group (10.2 ± 4.5 h vs.
13 ± 5.7 h). Length of ICU and hospital were comparable between the groups.
CONCLUSION. Postoperative sevoﬂurane sedation using the Anaesthetic Conserving
Device appears to be a valid and safe alternative to the commonly used intravenous propofol-
based regimen. Sevoﬂurane provided a comparable sedation quality to propofol at end-tidal
concentrations of 1.1 Vol% (0.54 MAC). Patients showed a faster and more predictable return
of recovery after sevoﬂurane, and shorter times of mechanical ventilation.
REFERENCE(S). 1. Enlund M. Acta Anaesth Scand 2002; 46:506–11.
2. Sackey PV. Crit Care Med 2004; 32:2241–6.
3. Belda JF. Anesth Analg 2008;106:1207–14.
4. Ro ¨hm KD. Crit Care 2008;12(Suppl2):P270.
GRANT ACKNOWLEDGEMENT. The study was an investigator-initiated trial granted by
the hospital and department sources of the Klinikum Ludwigshafen, Germany.
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HIGHER EFFICACY OF INSULIN ASPART VERSUS HUMAN SOLUBLE INSULIN
IN INTRAVENOUS TREATMENT OF HYPERGLYCEMIA
P. Zeidler*, B. M. Steinlechner, H. Koinig, M. J. Hiesmayr
Anaesthesia and Intensive Care, Division of Cardiothoracic and Vascular Anaesthesia and
Intensive Care, Vienna, Austria
INTRODUCTION. Hyperglycemia typically occurs after major surgery due to alterations in
glucose metabolism. Maintenance of normoglycemia prevents morbidity and reduces mor-
tality in the critically ill (1). The objective of this study was to determine whether human
soluble insulin (Actrapid , Novo Nordisk) or insulin analogon insulin aspart (NovoRapid ,
Novo Nordisk) allows a better glycemic control.
METHODS. Prospective, randomized double blind study. We included 50 ICU patients after
elective cardiac surgery. Actrapid (n = 25) or NovoRapid (n = 25) was given as a contin-
uous infusion according to a protocol. The study ended 48 h after admission. Blood glucose
concentrations and insulin consumption were calculated for 8 intervals (6 h each). ANOVA
for repeated measurements was performed to compare glucose concentrations and insulin
consumption.
RESULTS. No difference was found in glucose concentrations (p = 0,481). A difference was
found in the amount of insulin necessary. The patient group administered insulin aspart
needed less international units/h (IU/h) of insulin compared to the group administered human
soluble insulin (p = 0.032).
CONCLUSION. Our results indicate a higher efﬁcacy of insulin aspart versus human soluble
insulin in intravenous treatment of hyperglycemia.
REFERENCE(S). 1. Van den Berghe G et al. N Engl J Med 2001, 345:1359–1367.
GRANT ACKNOWLEDGEMENT. Partial educational grant from Novo Nordisk.
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INTRODUCTION. When we use opioid antagonists to restore intestinal motility after opioid
treatment we assume a uniform drug effect on small bowel and colonic motility. To exclude
possible regional differences experimental studies are necessary. This study uses two different
settings to evaluate the effect of naloxone and remifentanil on small bowel as well as colonic
motility.
METHODS. Small bowel motility(1): A tissue bath with mounted guinea pig small bowel
segments allows the evaluation of the pressure threshold (PT)—the intraluminal pressure
necessary to trigger a peristaltic contraction. A drug-induced increased PT reﬂects inhibition
of peristalsis, while a decreased PT reﬂects stimulation of peristalsis.
Colonic motility(2): A tissue bath with guinea pig colonic segments ﬁxed on a polyacrylic
tray allows the evaluation of the transit time (TT)—the time necessary for a wooden pellet to
perambulate. A decrease of the TT reﬂects stimulation, and an increase inhibition of peri-
stalsis.
After stable peristaltic activity in both settings the effect of increasing concentrations of
remifentanil and naloxone alone were evaluated. In the second step naloxone and remifentanil
were given together. Dose response curves were constructed, two way ANOVA (Sigma Stat)
was used for statistics, p values B 0.05 were considered signiﬁcant.
RESULTS. Remifentanil has a concentration-dependent inhibitory effect on small bowel as
well as colonic motility. Naloxone per se does not affect small bowel motility, but the
inhibitory effect of remifentanil is antagonized. On colonic motility naloxone has a moderate
inhibitory effect and the inhibitory effect of remifentanil is mitigated and not antagonized
(ﬁgure).
CONCLUSION. This study clearly demonstrates a regional different effect of naloxone
alone and in combination with remifentanil on small bowel and colonic motility.
REFERENCE(S). 1. Fruhwald S. et al. Crit Care Med 2000.
2. Cavic T. et al. ESICM 2007.
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INTRODUCTION. Multiple organ failure syndrome (MOFS) derived by intra-abdominal
hypertension, has been called abdominal compartment syndrome (ACS) the epidemiology and
the characteristics of which, have not been thoroughly determined. High degree of suspicion,
continuous patient monitoring and bladder pressure measuring are the most helpful tools in
making early diagnosis.
METHODS. From 2005 to 2007 in 45 patients (Median age 57,2 years, M/F 24/21) was
posed the diagnosis of intra-abdominal hypertension (Median pressure 30 cm H2O). 16 of
them were multitrauma patients (7 developed ACS), 9 had abdominal aorta aneurism rupture
(4 developed ACS), 13 small bowel ischemical necrosis (3 developed ACS), and 7 acute
pancreatitis (2 developed ACS). In 16 (35,6%) of them (Group A) ACS was conﬁrmed
(Median pressure 42 cm H2O), while in 29 (64,4%) (Group B) only intra-abdominal
hypertension was occurred (Median pressure 30 cm H2O).
RESULTS. Bladder pressure measurements were obtained at 4 h intervals. In all patients
abdominal decompression was performed and a cover bag was placed. In Group A, 9
(56,25%) patients died (3 multitrauma, 2 with ruptured abdominal aorta aneurism, 1 with
small bowel ischemical necrosis, and 2 with acute pancreatitis). In Group B, 6 (20,68%)
patients died (2 multitrauma, 2 with ruptured abdominal aorta aneurism, 1 with small bowel
ischemical necrosis, and 1 with acute pancreatitis) AvsB p\0,005 (Chi-square test).
CONCLUSION. Abdominal Compartment Syndrome is occurred more frequently than it has
been expected. Mortality is still high, even with continuous patient monitoring, and early
abdominal decompression. Further studies regarding physiopathological meccanisms may be
determinant in treating this syndrome deﬁnitely.
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INTRA-ABDOMINAL PRESSURE MONITORING WITH THE FOLEYMANOME-
TER DOES NOT INCREASE URINARY TRACT INFECTION
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INTRODUCTION. Little is known about the risk for urinary tract infection (UTI) in relation
to intravesicular pressure monitoring as estimate for intra-abdominal pressure (IAP) (1). No
data with regard to the FoleyManometer has been published so far. The FoleyManometer is a
closed sterile system that uses freshly produced urine as IAP transmitting medium compared
to other techniques that use saline (2).
METHODS. Retrospective database review of 5890 patients admitted to the 12-bed medical
ICU of a tertiary hospital between 1/1/2000 and 31/12/2007. Four time periods with regard to
IAP measurements were compared: period 1 (2000–2001) where IAP was measured in 28
patients, period 2 (2002–2003) with 146 patients, period 3 (2004–2005) with 422 patients and
ﬁnally period 4 (2006–2007) with 501 patients. The following IAP measurement methods were
used: a modiﬁed Cheatham technique (period 1 and 2), the 1st version FoleyManometer with
35 mL reservoir (period 3), and the FoleyManometer LowVolume (LV) with less than 10 mL
infusion volume (period 4). The UTI rates were adjusted for disease severity by multiplying
each crude rate by the ratio of control (group 1) versus study (groups 2–4) patient SAPS II
probability of mortality. The standard Foley catheter used was the 14Fr Bard Biocath and urine
drainage tubing, collection bags and FoleyManometers were replaced every 10 days.
RESULTS. Table 1 summarizes the patient data. The number of patients admitted decreased
over the 4 periods but ICU length of stay increased from 4.1 tot 7.1 days. The total number of
urine cultures taken and the number per patient increased from 915 to 1896 and from 0.5 to
1.7, respectively. The chance of identifying a UTI per urine culture sample remained stable at
around 11%. The crude and adjusted UTI rates per 1,000 catheter days did not change
signiﬁcantly over time, although the FoleyManometer LV seems to decrease the UTI risk.
TABLE 1
PERIOD 1
Control
(2000–2001)
PERIOD 2
(2002–2003)
PERIOD 3
(2004–2005)
PERIOD 4
(2006–2007)
Patients (n) 2046 1480 1261 1103
Age (years) 66 ± 17.5 65 ± 16.2 65 ± 16.3 63 ± 18.7
SAPS II mortality
probability
16.5 ± 23.8% 20.5 ± 25% 21.2 ± 25.6% 24.3 ± 26.3%
UTI/1000 catheter
days (crude)
3.8% 3.6% 6.4% 4.5%
UTI/1000 catheter
days (adjusted)
3.8% 2.9% 5% 3.1%
CONCLUSION. Intravesicular pressure monitoring as estimate for IAP either via a closed
transducer or the closed FoleyManometer technique (especially the LV version) is safe and
does not alter the risk of urinary tract infection in critically ill patients.
REFERENCE(S). 1. Cheatham ML, Sagraves SG, Johnson JL, White MW (2006) Intrave-
sicular pressure monitoring does not cause urinary tract infection. Intensive Care Med
32:1640–3.
2. Malbrain ML (2004) Different techniques to measure intra-abdominal pressure (IAP): time
for a critical re-appraisal. Intensive Care Med 30:357–71.
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IMMEDIATE TRACHEAL EXTUBATION OF LIVING DONOR LIVER TRANS-
PLANT RECIPIENTS IN THE OPERATING ROOM
T. Matsusaki*, H. Morimatsu, M. Hayashi, T. Sato, K. Sato, M. Matsumi, K. Morita
Department of Anesthesiology and Resuscitology, Okayama University Medical School,
Okayama, Japan
INTRODUCTION. Immediate tracheal extubation of selected adult patients after liver
transplantation (LT) is common practice. Historically, most of liver transplant patients have
been extubated, within 10–12 h following surgery in our hospital. Today, new drugs and
techniques, advanced monitoring and improved perioperative patient care contribute to rapid
and uneventful recovery from surgery, fewer postoperative complications, shorter hospital-
ization, increased patient satisfaction and a better outcome. Recently, we tried to extubate
aggressively in the operating room (OR) rather than in the intensive care unit (ICU). We
hypothesized that selected patients may be safely extubated in the OR after living donor liver
transplantation (LDLT) and avoid potentially deleterious effects of artiﬁcial ventilation and
sedation.
METHODS. After May 2006, we chose immediate extubation in the OR unless a speciﬁc
contraindication was identiﬁed. We have excluded emergent cases. Charts of all patients
undergoing elective LDLT between January 2004 and December 2007 were reviewed to audit
safety and outcome of this approach. At ﬁrst, we identiﬁed 20 patients extubated in the OR
(Group A). Then, we made the matched control group (Group B) using age, operation time,
the amount of bleeding, and MELD score as matching variables. Patients in the Group B were
extubated in the ICU after 10–12 h after LDLT. We have analyzed postoperative liver
function tests, such as aspartate aminotransferase (AST), alanine aminotransferase (ALT) and
prothrombin time (PT) taken at postoperative day 1, 2, 4 and 7. We have also collected
respiratory complication, the incidence of reintubation, ICU stay, and hospital stay.
RESULTS. We could not ﬁnd any signiﬁcant differences in the patient characteristics and
background between two groups. 20 patients were extubated in the OR safely. All patients did
not need reintubation during postoperative course. In the group A, we had only one patient
needed non-invasive positive pressure ventilation within 72 h after extubation. About the
postoperative liver function test, mean AST and ALT were not signiﬁcantly different between
two groups. However, a mean PT-INR in the Group A was signiﬁcantly decreased compared
with Group B on POD 1, 2, 4, 7. (p value:\0.0001). We have also found that T-Bil at POD
4, 7 were lower in the Group A compared with the Group B (p value: 0.04, 0.03). We could
not ﬁnd any signiﬁcant differences about the respiratory complication, such as effusions and
pneumonia. We also could not ﬁnd any differences in postoperative complications and
clinical outcomes between two groups.
CONCLUSION. Our early experience with 20 LDLT recipients extubated immediately after
surgery showed good emergence from anesthesia safely. Postoperative liver function tests
were better in the early extubation group than in the control group. Early extubation in an OR
might facilitate the recovery of liver function after LDLT.
0808
RECTAL DICLOFENAC REDUCES MORPHINE REQUIREMENTS IN THE
IMMEDIATE POST-OPERATIVE PERIOD FOLLOWING CORONARY ARTERY
BYPASS GRAFTING
P. Cowlishaw, A. Hutton, N. Howes, M. Nickson, S. Rafferty, P. Robbins*
South West Cardiothoracic centre, Derriford Hospital, Plymouth, United Kingdom
INTRODUCTION. This study was to investigate the role and safety of Voltarol  Diclofenac
100 mg suppositories in patients following routine coronary artery bypass surgery. Non-
steroidal anti-inﬂammatory drugs have been used post-operatively as part of a multi-modal
analgesia regime in many types of surgery. With the aim to reduce ventilator dependency
postoperatively and to reduce the morbidity and time spent in hospital by patients after
CABG(1), it was hypothesised that by using rectal paracetamol and a rectal NSAID there
would be a reduction in opioid requirements, that would facilitate earlier extubation.
METHODS. Eighty patients were intended for inclusion, powered on detecting a 20%
reduction in morphine use over the ﬁrst 48 h post-operatively. After hospital ethics approval
and informed consent, patients fulﬁlling the inclusion criteria were randomised to recieve
Diclofenac (A) or placebo (P)combined with Paracetamol, if the attending clinician deemed
the patient to be ‘fast-trackable’ (planned extubation within 90 minutes). The physicians and
data collectors were blinded to the content of the active component in the suppository until the
end of the trial. After transfer to CITU patients were commenced on a morphine patient
controlled analgesia protocol which was initially nurse administered, 1 mg boluses and a
1 min lock out. The patient was assessed and extubated in accordance with the standard
Derriford Fast Policy. Following extubation the PCA was reprogrammed to 1 mg bolus and a
5 minute lockout. All patients were prescribed regular Paracetamol orally or per rectum and
received Aspirin 75 mg the day after surgery. Morphine use, and a 10 cm Visual Analogue
Score were recorded at various time points. Secondary outcomes were drain losses, blood
product use, change in creatinine level, need for renal support and hospital stay.
RESULTS. Sixty one patients were recruited who were eligible for the trial and full data were
available for 55 patients. Recruitment was stopped early due a change in prescribing policy
with the introduction of intravenous paracetamol into the hospital formulary. The 24 h
morphine use was lower in the active group 24.8 mg (15.8), compared with 33.8 mg (17.8) in
the control group (total morphine (SD)). There was no difference in pain scores during the
trial period. Extubation times were not signiﬁcantly different although there was a trend
towards earlier extubation in the active group. There were no differences in drain losses over
the 24 h period nor rise in serum creatinine levels.
CONCLUSION. This study shows that the use of rectal Diclofenac following cardiac surgery
reduces the 24 h morphine requirements. The use of NSAIDs appears to be safe with no
alterations in post operative bleeding, renal function or post opeartive drains loss. There was
no signiﬁcant reduction in extubation time. A larger trial would be needed to decide if a
signiﬁcant reduction in extubation time was possible.
REFERENCE(S). 1. Cheng DCH, Karski J, Peniston C et al Early extubation after coronary
artery bypass surgery reduces cost and improves resource use: A prospective randomised
controlled trial Anesthesiology 1996, 85; 100–1310.
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INTRODUCTION. Acid-base disorders are frequently observed in cirrhotics; however,
modiﬁcations during hepatectomy and their impact on prognosis have never been investi-
gated. The aim of this study was to examine modiﬁcations of acid-base balance of cirrhotic
patients undergoing hepatectomy for hepatocellular carcinoma (HCC).
METHODS. Two hundred and two hepatectomies for HCC on cirrhosis were reviewed.
Arterial blood samples were collected immediately before and at the end of resection. Pre-
resection and postresection acid-base parameters were compared and related to patient
characteristics and postoperative course. The accuracy of acid-base parameters in predicting
postoperative liver failure, deﬁned as an impairment of liver function after surgery that led to
patient death or required transplantation, was assessed using receiver operating characteristic
analysis (ROC).
RESULTS. All patients showed a signiﬁcant reduction in pH, bicarbonate, and base excess at
the end of hepatectomy (P\0.001 in all cases), worsened by intraoperative blood loss
(P\0.010) and preoperative Model for end-stage liver disease score C 11 (P\0.010). ROC
curve analysis identiﬁes patients with postresection bicarbonate\19.4 mmol/L at high risk
for liver failure (50.0%) whereas levels[22.1 mmol/L did not lead to the event (0%;
P\0.001). Postoperative prolongation of prothrombin time and increases in bilirubin, cre-
atinine, and morbidity were also more frequent in patients with lower postresection
bicarbonate, resulting in a longer in-hospital stay.
CONCLUSION. In cirrhotic patients, a trend toward a relative acidosis can be expected
during surgery and is worsened by the severity of the underlying liver disease and intraop-
erative blood loss. Postresection bicarbonate level lower than 19.4 mmol/L is an adverse
prognostic factor.
GRANT ACKNOWLEDGEMENT. Support was provided solely by departmental sources.
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PERI-OPERATIVE CENTRAL VENOUS OXYGEN SATURATION FOLLOWING
MAJOR LIVER RESECTION
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INTRODUCTION. Central venous oxygen saturation (ScvO2) reﬂects the balance between
tissue oxygen delivery and consumption(1). A recent study has suggested there may be a link
between derangements in ScvO2 and outcome in the high risk surgical patient (2). It was
postulated this may be due to ﬂuid depletion despite ‘‘normal’’ values of other parameters.
During liver resection, patients are deliberately ﬂuid restricted to assist surgery. We would
therefore expect this patient group to be at high risk of developing a low ScvO2. Those
patients may be at high risk of peri-operative morbidity. We therefore aim to ascertain the
incidence of low ScvO2 (\65%) in patients having a liver resection.
METHODS. An observational study collecting physiological data normally recorded as part of
standard practice: heart rate, blood pressure, central venous pressure and pulse oximetry. Blood
samples are also taken for ScvO2. Recordings are made at the time of placement of the central
venous catheter,whenthe liver resectionis completed,onarrival onthe intensive care unit(ICU)
and then 6hr, 12hr and 18hr after arrival on the ICU. We intend to recruit 40 patients.
RESULTS. We have so far recruited 27 patients into the study. 62% of patients have an
ScvO2 less than 65% in the early post-operative period.
TABLE 1
Insertion
of CVC
End of
liverresection
1h
ICU
6h
ICU
12 h
ICU
18 h
ICU
Mean ScvO2 (%) 83.6 83.7 73.7 71.7 67 66.9
Incidence ScvO2\65% 0% 0% 8% 26% 36% 32%
TABLE 2
Patient group ICU length
of stay (h)
Hospital length
of stay (days)
Hospital
mortality (%)
ScvO2\65% 118* 17* 12.5*
ScvO2 C 65% 53.6 12.2 0
*Non-signiﬁcant difference
CONCLUSION. 62% of patients have a low ScvO2 in the early post-operative period. We
need to identify whether this group have an increase in post-operative morbidity once the
study is completed. A further study using goal directed therapy in the early post operative
period is warranted.
REFERENCE(S). 1. Rivers EP, Anders DS, Powell D. Central venous oxygen monitoring in
the critically ill patient. Curr Opin Crit Care 2001;7:204–11.
2. Pearse RM, Dawson D,Fawcett J, Rhodes A, Grounds RM, Bennett ED. Changes in central
venous saturation after major surgery and association with outcome. Crit Care
2005;9(6):R694–9.
21st ESICM Annual Congress – Lisbon, Portugal – 21–24 September 2008 S2070811
MANAGEMENT OF PHAEOCHROMOCYTOMA AND CRITICAL CORONARY
ARTERY DISEASE
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INTRODUCTION. We describe the management of a patient with critical coronary artery
disease and poor left ventricular (LV) function who also had phaeochromocytoma. Although a
staged approach to surgery for coronary artery disease and phaeochromocytoma has previ-
ously been described
1, this rare problem has never been described for patients with poor LV
function.
METHODS.A59-year-oldmanwithseveretriplevesseldisease,including90%leftmainstem
stenosis, poor LV function (EF 10%) and an apical LV aneurysm following a previous myo-
cardial infarction, was admitted for coronary artery bypass grafting (CABG) and
aneurysmectomy. Following induction in anaesthesia, the operation was abandoned due to
uncontrolled hypertension, and he was admitted to our intensive care unit (ICU) where a pul-
monary artery catheter (PAC) thermodilution showed cardiac index (CI) 1.6 l min
-1 m
-2 and
systemic vascular resistance (SVR) 3205 dynes s
-1 cm
-5. Urinary catecholamines were ele-
vated and a CT scan showed an adrenal phaeochromocytoma. The patient was pre-optimised
with long acting (T 24 h) alpha-adrenergic blocker phenoxybenzamine followed by eta-
blockade with carvedilol and rehydration. A multidisciplinary meeting was called to plan
treatment and a combined adrenalectomy-CABG was decided to be the safest approach. The
phenoxybenzamine was stopped 2 days prior to readmission to the ICU where a PAC was used
for calculations of cardiac output and SVR. Initial measurements revealed pulmonary capillary
wedge pressure of 4 mmHg, CI 2.6 l.min
-1 m
-2 and SVR 1548 dynes.s
-1 cm
-5. Infusion of
short acting (T 19 min) alpha-blocker phentolamine was started initially at 0.2 and gradually
increased over the next three days to 0.6 lg.kg
-1 min
-1 aiming at SVR of 1200
dynes.s
-1 cm
-5. Before anaesthetic induction an intraortic balloon pump (IABP) was inserted
and used throughout the perioperative period. A sternolaparotomy was performed followed by
adrenalectomy,withexcellenthaemostasispriortosystemicheparinisation.Bloodpressurewas
controlled without problems. Once the adrenal tumour was removed the phentolamine infusion
was stopped and cardiopulmonary bypass (CPB) established. CABG and left ventricular
aneurysmectomy were performed. During this time (bypass 59 minutes) the effects of phen-
tolamine had substantially reduced, and CPB was weaned using dopamine 5.8 lgk g
-1 min
-1
andvasopressin0.01U kg
-1 min
-1.TheinitialreadingsinITUpost-operativelyshowedPCWP
9 mmHg, CI 4.9 l.min
-1 m
-2 and SVR 418 dynes.s
-1 cm
-5. The CI was maintained above
3 l.min
-1 m
-2andtheIABP,dopamineandvasopressinwereslowlyweanedoverthenext48h.
RESULTS. The patient was discharged home on day 10. At follow-up the patient was
asymptomatic, but left ventricular function although improved remained poor
CONCLUSION. The key to success is likely to be the multidisciplinary approach and the
staged use of vasoactive medication in the ITU which allowed controlled systemic vascular
resistance by means of short acting alpha-blocker infusion in the pre-operative period and
vasopressin in the post-operative period.
REFERENCE(S). 1. To AC, Frost C, Grey AB, Croxson MS, Cooper J. Combined coronary
artery bypass grafting and phaeochromocytoma excision. Anaesthesia 2007;62(7):728–33.
0812
DOXAZOSIN IN PREOPERATIVE PREPARATION OF PATIENTS WITH
PHEOCHROMOCYTOMA
L. Aucella, G. Di Palma, L. Vivona, G. Ruggiero*, M. Di Fraia, G. De Simone, G. Vivona
1
1Dipartimento di anestesia e rianimazione e terapia intensiva, Universita ` degli Studi di Napoli
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INTRODUCTION. Preoperative preparation with pheochromocytoma makes the patients
safe for surgical removal of the tumor. It usually performed by alpha-adrenergic blockers. In
this study we reviewed the antihypertensive efﬁcacy of Doxazosin when used in monotherapy
or in association with a beta-blocker, Atenolol
METHODS. We enrolled 22 patients with pheochromocytoma into two groups. D GROUP
(11 patients) received only Doxazosin (1 mg-8 mg /day, taken orally) for two weeks. D + A
GROUP (11 patients) was prepared for two weeks with the use of Doxazosin (2 mg-16 mg/
day) plus Atenolol (50–100 mg daily). We measured pre-, intra- and post-operative blood
pressure, heart rate, volume replacements and catecholamines levels .
RESULTS. After treatment, the both groups had a mean blood pressure value of 128/
86 mmHg with a regular heart rate of 75 beats/min. Intraoperative hypertension occurred in 4
patients in the D Group (37 %) and in 3 patients in D + A GROUP (28 %) .There was no
signiﬁcant difference among the two groups . No dysrhythmia was seen until removal of the
tumor. The operative and postoperative volume replacements were similar into two groups.
Urinary and plasma cathecolamines levels decreased during both Doxazosin and Doxazosin
plus Atenolol therapy.
CONCLUSION. We conclude that Doxazosin is a efﬁcacious agent used alone or in asso-
ciation with Atenolol for preoperative preparation in patients with pheochromocytoma.
GRANT ACKNOWLEDGEMENT. Universita ` degli Studi di Napoli ‘‘Federico II’’.
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EFFECTIVENESS AND SAFETY OF REMIFENTANYL IN MAXILLO-FACIAL
SURGERY
D. Arias*, E. Curiel, M. Prieto, J. Mun ˜oz, G. Quesada
Intensive Care Unit, Carlos Haya Hospital, Ma ´laga, Spain
INTRODUCTION. Post-surgery pain is the cause of undesirable physiopathologic effects, of
an increase in morbility, mortality and in costs applied to processes. Pain control with
remifentanyl, an opioid agonist of u receptors, with a short mean life, is an adequate option.
The analgesia efﬁcacy and the safety of remifentanyl in maxillo-facial surgery patients is
analyzed.
METHODS. All consecutive adult patients who underwent maxillo-facial surgery, admitted
to the Intensive Care Unit (ICU) along 2007, were included in this study. Remifentanyl
(0.15mcg.Kg-1.min-1) perfusion was initiated at admission and progressive weaning acquired
before patients were discharged. We compiled hemodynamic (heart rate and blood pressure)
and respiratory (respiratory rate and mixed blood oxygen saturation) parameters, the degree of
sedation and post-anaesthetic recovery (Ramsey and Campbel scales), postoperative pain
severity through elementary verbal (EVS) and visual analogical (EAV) scales at admission,
30 and 60 minutes after, and 6 h later; its side effects and the need for rescue analgesia. Data
were registered as percentage or median. We applied ANOVA with multiple measures to
compare cuantitative mean variables.
RESULTS. Fifty six patients were included (30 of them male) with a median of 63 years old.
Surgery was due to tumour pathology in 43 patients (78%). Twenty seven (48%) were in the
ASA III range group, most of them males (p\0.008). The median length of mechanical
ventilation in these patients was of 4 h. An EVS\2 in 91% and an EAV\4 in 100% was
attained, being the sedation level 2–3 (Ramsay scale) and 0–1 (Campbel scale) the most
frequently measured. There were no statistically signiﬁcant differences in the measure of
systolic blood pressure (p = 0.124), nor in cardiac rate (p = 0.39), neither in respiratory rate
(p = 0.14) in the different cutting points.
Six patients (10.7%) suffered side effects, most of them (7%) described as bradycardial -
hypotensive status, and the same percentage (10.7%) needed rescue analgesia, usually non-
steroid anti-inﬂammation drugs.
CONCLUSION. Remifentanyl was effective for the management of pain in the inmediate
postoperative period in patients who underwent maxillo-facial surgery patients. Hemody-
namic and respiratory parameters maintained stable along its administration, not showing
statistical differences in the cutting points of the study. An adequate pain control was attained
(EVS\2 and EAV\4) and the side effects were limited.
REFERENCE(S).1. Payen JF, Chanques G, Mantz J, et al. Current practices in sedation and
analgesia for mechanically ventilated critically ill patients: a prospective multicenter patient-
based study. Anesthesiology 2007;106:687–95.
GRANT ACKNOWLEDGEMENT. To ﬁrst PANDI.
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SPONTANEOUS AORTIC RUPTURE IN EHLERS-DANLOS SYNDROME TYPE IV
UNDIAGNOSED PATIENT
N. Freitas*, C. Carreira, F. Costa, A. A. Martins, M. Martins, M. Seixas, H. Martinho,
C. Loureiro, J. Nunes
Anesthesiology, Coimbra University Hospitals, COIMBRA, Portugal
INTRODUCTION. We report a clinical case of spontaneous aortic rupture and emergency
surgery of a 32-y old parturient patient, 10-day after c-section, previously healthy, with
intensive care management for 72 h postoperatively in the post anesthetic care unit. Family
history, phenotype characteristics and the clinical onset of this emergency episode foster the
suspicion of vascular type of Ehlers-Danlos Syndromes (EDS sub-type IV). This vascular type
represents 5% to 10% of all cases of EDS which have an estimated prevalence of 1/10,000 to
1/25,000 in general population. The intensive care management of potential fatal complica-
tions of EDS presents special challenges for anesthesiology and intensive care teams.
METHODS. Female patient, 32 years old, 10th day after labour (c-section dued to fetal bra-
dycardia), transferred from a district hospital with hipovoelemic shock and angioCT diagnosing
aortic rupture. An emergent laparotomy and intensive care procedures were instituted (invasive
pressures, ﬂuid and blood therapy, anesthesic and analgesia drugs, monitoring and register). The
surgery revealed an aortic spontaneous dissection with difﬁcult placement of 2 different aortic
graft anasthomosis dued to extreme tissue fragility. The patient was heavily sedated with pro-
pofol 10–20 ml/h and remifentanyl 1–3 mcg/kg/min during 72 h postoperatively for clinical
control and evaluation. Blood pressure limits were deﬁned and maintained along with hemo-
dynamics and physiologic normal range variables. Additional measures included non-invasing
monitoring (CT angiography, ultrasound for CVP and pleural effusions, X-rays and echocar-
diography), prudent management of invasive procedures, diagnostics tests—histology, skin
ﬁbroblasts and DNA (COL3A1) and clinical ﬁndings (facial dismorphy, ecchymoses and hae-
matomas, bruising, pale thin skin with visible subcutaneous vessels).
RESULTS. All clinical criteria for EDS type IV were met—positive family history, acrogeric
patient and ﬁrst instance arterial complication. CVP was withdrawn on the 4th day postop-
eratively. No intensive care related complications were found.
CONCLUSION. The vascular type of Ehlers-Danlos syndrome, known autossomic dominant
connective tissue disorder, in an undiagnosed young parturient was responsible for a spon-
taneous aortic dissection with speciﬁc anesthetic and intensive care management. The disease
frequently involves the proximal branches of the aortic arch, the descending thoracic aorta
and the abdominal aorta. Potentially fatal complications of vascular EDS are increased by
pregnancy, even during post-partum period.
REFERENCE(S). 1. Germain DP. Ehlers-Danlos syndrome type IV. Orphanet J Rare Dis.
2007 Jul 19;2:32.
2. Solan K, Davies P. Anaesthetic and intensive care management of a patient with Ehlers-
Danlos type IV syndrome after laparotomy. Anaesthesia. 2004 Dec;59(12):1224–7.
3. Lane D. Anaesthetic implications of vascular type Ehlers-Danlos syndrome. Anaesth
Intensive Care. 2006 Aug;34(4):501–5.
4. Pepin M, Schwarze U, Superti-Furga A, Byers P. Clinical and genetic features of Ehlers–
Danlos syndrome type IV, the vascular type. New England Journal of Medicine 2000; 342:
673–80.
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INTRODUCTION. After Rivers’s study, central venous O2 saturation (ScvO2) has been
widely used as resuscitation goal in critical pts, although criticisms have arisen. The Surviving
Sepsis Campaign (SSC) recommends to achieve ScvO2[70% by increasing DO2. However,
ScvO2 reﬂects DO2/VO2 adequacy in superior vena cava territories. The maneuver of
sedation and connection to MV may markedly decrease VO2 with variable effects on
DO2.[50% of Rivers’s study patients were ventilated during the ﬁrst six h but causes,
timing or impact of MV were not speciﬁed. SSC bundles do not include this intervention. We
conducted a prospective observational multicentric study to determine the effect of this
maneuver on ScvO2 in critically ill patients. We hypothesized that this isolated intervention
may contribute signiﬁcantly to achieve ScvO2[70% in most patients.
METHODS. During 6 months all consecutive ICU patients with a central venous catheter in
place, and in whom intubation and connection to MV was decided were included. We eval-
uated immediately before and 15 minutes after intubation the following parameters: HR, RR,
MAP,lactate, ABGs,arterial O2 sat (StO2),ScvO2andO2 extraction(O2 ER).Demographics,
SOFA, APACHE and concurrent inotropic or vasopressor use were also registered. Results are
expressed as mean + SD. Statistical analysis included Chi square test, t test and ANOVA.
RESULTS. 103 patients were included (age 58 ± 17; severe sepsis 46%; APACHE II
26 ± 7; SOFA 9 ± 8; mortality 32%; more frequently intubated for shock or respiratory
failure). ScvO2 increased in 81% (mean 7.08 ± 8.55) and was associated with a signiﬁcant
decrease in O2 ER. In a subgroup of 24 pts fulﬁlling Rivers’s admission criteria (hypotension
or lactate[4 mmol/l), 21 pts (87.5%) increased dramatically their ScvO2 (mean
9.5% ± 7.43 (57.7–67.2%)) and 10 pts (41.7 %) achieved a ScvO2[70% with this sole
maneuver. We found no correlation between changes in StO2 and ScvO2.
CONCLUSION. The isolated maneuver of sedation and connection to MV is highly effective
in increasing ScvO2 and decreasing O2 extraction in critically ill patients. Almost 90% of
septic patients increase dramatically ScvO2 with normalization in 41.7%. This maneuver
should be considered earlier in resuscitation protocols and probably tested in future trials
against protocols considering only increases in DO2.
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INTRODUCTION. The diagnosis of heparin-induced thrombocytopenia (HIT) is notoriously
difﬁcult in the critically ill. When the pretest probability according to the 4T scoring system is
high, heparin anticoagulants are stopped and pre-emptive treatment with alternative non-
heparin anticoagulants is started awaiting test results. The decision to start alternative non-
heparin anticoagulants in patients with low or intermediate pretest probability is questioned.
Moreover, continuation of heparin anticoagulants does not disturb the diagnostic process in
case of spontaneous recovery of the platelet count. We investigated the safety of withholding
non-heparin anticoagulants in low and intermediate pretest probability awaiting the test
results.
METHODS. Case–control study of critically ill patients suspected of HIT with low and
intermediate pretest probability in whom HIT-antibody testing was performed between Jan-
uary 2006 and December 2007. Ideally, we use a strictly structured diagnostic and therapeutic
strategy. If the pretest probability is low, HIT is considered unlikely, no laboratory testing is
done and heparin anticoagulants are continued. If intermediate, HIT is considered possible,
HIT-antibody (ELISA) testing is done and heparin anticoagulants are continued. If high, HIT
is considered likely, HIT-antibody testing is done and heparin anticoagulants are stopped and
fondaparinux 2.5 mg/day is started pre-emptively awaiting the test results (bridging therapy).
We compared continuation of heparin anticoagulants with fondaparinux bridging therapy.
Primary endpoints were the occurrence of new thromboembolic complications (TEC) and
new bleeding complications during the period awaiting the test results.
RESULTS. In 30 patients, 8 tests were performed for low pretest probability and 23 tests
were performed for intermediate pretest probability. The median duration of waiting for the
test results was 2 days (range 1–9 days). In sixteen cases heparin anticoagulants were con-
tinued and in 15 cases fondaparinux bridging therapy was started. Two new TEC occurred (1
during heparin versus 1 during fondaparinux; Fisher exact p = 1.0). Six new bleeds occurred
(5 during heparin versus 1 during fondaparinux; Fisher exact p = 0.17).
CONCLUSION. Fondaparinux can be safely withheld as bridging therapy in patients with
low and intermediate pretest probability without increased risk of new TEC.
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INTRODUCTION. Intra-abdominal hypertension (IAH) and abdominal compartment syn-
drome (ACS) have been increasingly recognised as causes of signiﬁcant morbidity and
mortality over the past decade
1.
The aim of the study was to analyse the incidence and treament methods of ACS in the
general ICU of Tartu University Hospital.
METHODS. Retrospective analysis of prospectively stored data and patients’ charts.
RESULTS. Of 1374 patients admitted to the ICU from January 1, 2004 to December 31, 2007
intraabdominal pressure was measured in 556. The case-mix does not include cardiac surgical
and neurosurgical patients. ACS developed in 21 cases (1,5% of all patients). Primary ACS
occurred in 18 and secondary in 3 cases. Tertiary ACS developed in 5 patients (altogether 7
episodes). APACHE II score of the ACS patients on admission was 17,9 ± 6,9 (mean ± sd),
and SOFA score 9,8 ± 2,9 (mean ± sd). Mortality rate was 61,9% (overall ICU mortality
24,4%). ACS was documented in clinical diagnosis in 2 cases (both from 2007). In 10 cases
ACS was mentioned in the patients notes. Despite that all patients received at least one
method of conservative treatment
2. Nasogastric aspiration was used in 21, laxatives and
additional sedatives or analgesia in 15, CVVHD in 13, neuromuscular blockade in 8, enema in
6, paracentesis in 4, rectal gas tube in 2 and negative ﬂuid balance in 2 patients. 14 patients
were operated at least once during their disease; in 7 tension-free abdominal closure with
nylon mesh was used. 2 operations were performed speciﬁcally for ACS, decompressive
laparotomy and tension-free abdominal closure was performed.
CONCLUSION. ACS occurs seldom but mortality is high. More aggressive conservative
treatment can be recommended. Tension free abdominal closure should be applied after
laparotomy in all patients with or at risk of ACS.
REFERENCE(S). 1. Malbrain ML, Cheatham ML, Kirkpatrick A et al. Int Care Med (2006)
32:1722–1732.
2. Cheatham ML, Malbrain ML, Kirkpatrick A et al. Int Care Med (2007) 33:951–962.
GRANT ACKNOWLEDGEMENT. This work was supported by Estonian Science Foun-
dation grant no. 6950.
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EFFECTIVENESS OF ANTITHROMBIN SUPPLEMENTATION IN SEPTIC SHOCK
CASES WITH A DIAGNOSIS OF ACUTE-PHASE DIC ACCORDING TO JAAM
(JAPANESE ASSOCIATION FOR ACUTE MEDICINE)
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INTRODUCTION. The diagnostic criteria of acute-phase disseminated intravascular coag-
ulation (DIC) were reported by the Japanese Association for Acute Medicine (JAAM) in
2005.The relation between the JAAM diagnostic criteria of acute- phase DIC and the
effectiveness of antithrombin (AT) supplementation in septic shock patients has not been
reported.
METHODS. A retrospective analysis was performed in 32 septic shock patients diagnosed to
have DIC according to the JAMM DIC criteria, who were admitted to our intensive care unit
from July 2005 to February 2007. The patients were separated into two groups for analysis:
the AT group (21 cases), in which the patients were treated with AT within 24 h of the DIC
diagnosis, and the non AT group (11 cases), in which no AT treatment was administered.
RESULTS. The average Acute Physiology and Chronic Health Evaluation (APACHE) II
score (AT group, 27.8 ± 8.0; non AT group, 31.0 ± 7.5) and the average sepsis-related organ
failure assessment (SOFA) score (AT group, 11.5 ± 4.3;. non AT group, 14.9 ± 5.3) were
not signiﬁcantly different between the two groups. The AT group showed a good outcome
(Figure), with signiﬁcant improvement of the PAI-1 (day 0, 144.9 ± 58.2 ng/ml; day3,
59.9 ± 39.4 ng/ml; p\0.0001) and protein C (day 0, 33.5 ± 9.9%; day3, 50.8 ± 30.2%;
p = 0.0104) levels.
CONCLUSION. Early institution of AT treatment after conﬁrmation of the diagnosis
according to the by JAAM DIC criteria seems to be an effective strategy in the management
of septic DIC. And we suggested that AT treatment was effective for improvement of
coagulation factor that connection with the septic shock was reported.
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DISSEMINATED INTRAVASCULAR COAGULATION DIAGNOSED BY NEW
CRITERIA FOR CRITICALLY ILL IS A HIERARCHICAL CONTINUUM TO
OVERT DISEMINATED INTRAVASCULAR COAGULATION IN PATIENTS WITH
SEPSIS
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INTRODUCTION. Sepsis is the most common disease associated with disseminated intra-
vascular coagulation (DIC). To test the hypothesis that DIC diagnosed by the Japanese
Association for Acute Medicine (JAAM) DIC scoring system constitutes a dependent con-
tinuum to the International Society on Thrombosis and Haemostasis (ISTH) overt DIC in
patients with sepsis, we conducted a retrospective study.
METHODS. The databases from two prospective, multicenter clinical investigations were
analyzed. The inclusion criteria comprised patients with sepsis-related DIC, who met the
JAAM DIC criteria.
RESULTS. The present study enrolled 166 patients, of whom 67 met the ISTH overt DIC
criteria. All patients with sepsis who developed to overt DIC during the study period could be
identiﬁed by the JAAM DIC diagnostic criteria in the ﬁrst study. While the overall 28-day
mortality was 31.3%, mortality (40.3%, p = 0.0040) and the incidence of multiple organ
dysfunction syndrome (70.1%, p = 0.008) of the patients with overt DIC was approximately
one and a half times that of the patients associated with only the JAAM DIC. A stepwise
increase in the ISTH DIC scores and the incidence of overt DIC were also observed in
accordance with the increase in the JAAM DIC scores.
CONCLUSION. DIC diagnosed based on the JAAM DIC diagnostic criteria exists in a
hierarchical continuum to overt DIC in patients with sepsis, enabling them to receive early
treatment.
REFERENCE(S). 1. Gando S, et al. A multicenter, prospective validation of disseminated
intravascular coagulation diagnostic criteria for critically ill patients: Comparing current
criteria. Crit Care Med 2006; 34:625–31.
2. Gando S, et al. Natural history of disseminated intravascular coagulation diagnosed based
on the newly established diagnostic criteria for critically ill patients: results of a multicenter,
prospective survey. Crit Care Med 2008; 36:145–50.
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Japanese Association for Acute Medicine.
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COLLAGEN SYNTHESISIS DEPRESSED IN SKIN BLISTERS IN PATIENTS WITH
SEVERE SEPSIS
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INTRODUCTION. Collagen synthesis is a central feature of tissue repair. In sepsis coag-
ulation, inﬂammation and tissue regeneration are activated aiming to restore homeostasis.
Skin is essential barrier in maintaining a stable internal environment. It is not known whether
the massive host response in sepsis alters skin collagen synthesis.
METHODS. In this prospective observational study experimental blisters were induced on
abdominal skin four times: within the ﬁrst 48 h from the ﬁrst organ failure, on the ﬁfth day
after the ﬁrst set of blisters and at 3 and 6 months. To evaluate skin collagen synthesis,
aminoterminal propeptides of collagens I and III (PINP, PIIINP) were measured from blister
ﬂuid. 44 patients with severe sepsis were enrolled. The median age was 63 years (25th–75th
percentile 53–71). The median APACHE II score on admission was 26(22–30). 30-day
mortality was 25%.15 healthy adults were used as controls.
RESULTS. PIIINP and PINP levels in septic patients were lower in comparison with controls
in the early blister (40.8[25th–75th percentile 22.2–77.1] vs. 69.6[47.2–104.7], P = 0.028 and
69.9[32.4–112.7] vs. 243.2[82.3–342.9], P\0.001, respectively), as well as in the late blister
(38.8[19.9–68.5] vs. 69.6[47.2–104.7], P\0.001 and 90.0[35.1–138.8] vs. 243.2[182.3–
342.9], P\0.001, respectively). In long time survivors PIIINP and PINP levels were
increased at 3 and 6 months compared to levels in sepsis.
CONCLUSION. Skin collagen synthesis is depressed during severe sepsis and is followed by
a compensatory response at 3 and 6 months after the onset of sepsis.
GRANT ACKNOWLEDGEMENT. This study has been ﬁnancially supported by Instru-
mentarium Foundation and Oulu University Hospital EVO Grant
0821
EOSINOPHILIA IN THE SEVERE BURN PATIENT. WHAT DOES IT MEAN?
R. Ferna ´ndez-Tajuelo*, M. Sa ´nchez, A. Garcı ´a-de-Lorenzo, M. Mateo, E. Martı ´n, P. Araujo,
A ´. Marba ´n, M. Oliveros, J. Lo ´pez, M. Jime ´nez-Lendı ´nez
Intensive Care Unit, Hospital Universitario La Paz, Madrid, Spain
INTRODUCTION. Eosinophilia has an important role in skin reparation as it has been
published in numerous studies. However its incidence and the meaning in the critical burn
patient have not been reported up to now.
METHODS. We present a prospective study including 178 critical burn patients (total body
surface area over 20%) between March 2003 and December 2006. Blood samples were taken
for eosinophilia detection and the relation with burn characteristics, patient evolution, drugs,
surgery, skin grafts, concomitant diseases and blood transfusions was studied.
RESULTS. 33 patients (18.5%) showed eosinophilia over 700/lL (range 700–4300/lL).
Patients presented the following characteristics: 22 were male and 11 female, being mean age
43 ± 21 years old. Mean total body surface area was 41.57% ± 21. Mechanism was ﬂame in
73%, scald in 12% and electric in 12%. Main depth affected was papillary dermis in 2%,
reticular dermis in 66% and subcutaneous layer in 32% of the patients. Days under
mechanical ventilation and ICU stay were 1.7 ± 22.8 and 46 ± 28 respectively.
Eosinophilia started 17 ± 14 days after admission with a mean of length of 8 ± 11 days. The
higher eosinophils account was recorded on day 20 ± 17. 19% of the patients showed a
second peak in their eosinophilia starting on day 30.6 ± 14.5; 5% of the patients had a third
episode and one of them showed a fourth peak.
Multivariate analysis was done, and no correlation was found with drugs, burn characteristics
or mechanism, total body surface area, anaemia, renal insufﬁciency, suprarenal impairment,
diabetes mellitus, respiratory disease, blood transfusions, days of stay and mortality. Relation
with surgery or autologous skin grafts and Biobrane could not be demonstrated although there
was a trend for eosinophilia to show on 5 to 10 days after surgery. Eosinophilia levels were
higher the latest days of stay at the ICU, remaining elevated in 27% of the patients at
discharge.
CONCLUSION. Eosinophilia is frequent in burn patients. Its late apparition suggests that
eosinophils stimulus is related with the activation of several skin recovery mechanisms that
favour cutaneous reparation. Further studies must be done, investigating possible relations
with promyelocytic cells pathways and skin biopsies should be taken to deepen in the
appropriate meaning of the eosinophilia.
REFERENCE(S). Sade K, Mysels A, Levo Y, Kivity S. Eosinophilia: A study of 100
hospitalized patients. Eur Jour Int Med 2007 May;18:196–201. Avniel S, Arik Z, Sagte A
et al. Involvement of the CXCL12/CXCR4 pathway in the recovery of skin following burns. J
Inverst Dermatol. 2006 Feb;126:468–76.
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CLINICAL PROFILE OF HELLP SYNDROME IN AN INTENSIVE CARE UNIT
M. Chaparro, M. M. A. Prieto, E. E. Banderas*, E. E. Curiel
Untensive Care Unit, Carlos Haya Hospital, Ma ´laga, Spain
INTRODUCTION. HELLP syndrome is a life-threatening obstretric complication consid-
ered by many to be a variant of pre-eclampsia. HELLP is an abbreviation of Hemolytic
anemia, Elevated Liver enzymes and Low Platelet count. It is considered one of pre-
eclampsia’s manifestations. It is believed that represents a vasculopathy mediated by an
abnormal concentration of vascular growth factors, but, nowadays, controversies in the
diagnosis and management of HELLP syndrome persist. We report our experience within our
Gynecological ICU.
METHODS. Prospective study from January-2001 till December-2007. Data from all woman
admitted in our ICU, suffering from HELLP syndrome, were recorded (clinical, obstetrical
and demographical data, complications, fetal and maternal mortality and stay in the ICU) and
were expressed in percentage, median or mean. T-test and chi-square test were used in a SPSS
program.
RESULTS. We recorded 43 patients with HELLP syndrome.Demographical and clinical data
are registered in Table 1.Delivery was caesarean section (97.7%) and vaginal labor (2.3%).
The maternal deaths were due to accute liver failure and multiorganic failure. Fetal deaths
were related (p = 0.001) to low birthweight (\1 kg).Gestational age in fetal deaths is lower
than in fetal survival (p = 0.001).The length of stay was 7 days.(Table1.PreHBP:previous
high blood pressure; Gestati.Week:Gestational Week; SBP/DBP:systolic blood pressure/dia-
stolic blood pressure; m:mean; M:median)
TABLE 1 DEMOGRAPHICAL AND CLINICAL DATA
Risk Factors Age Obesity Smoker PreHBP Primipara
30.21(m) 2.3% 2.3% 14% 69.8%
Clinical Data Edemas Proteinuria SBP/DBP Hemoglobin Platelets
86.6% 93% 159.6/95.3 10.8(m) 90860
Complication 11.6(%) Seizures RenalFailure LiverFailure HeartFailure DIC
7 4.7 1 4.7 7
Mortality (%) Maternal Fetal
4.7 23.3
CONCLUSION. Our patients with HELLP syndrome are mostly primipara, 30.21 years old,
in the gestational week 30.9, with clinical data of high blood pressure (159/95 mm Hg),
edemas, proteinuria, with moderately severe thrombocytopenia (class II in Mississippi clas-
siﬁcation), elevated liver enzymes (ALT[300; AST[200) and low hemoglobina (10.8 gr).
The mean length of stay is 5 days. They suffered elective cesarea section. The most frequent
maternal complication was DIC and seizures. Fetal mortality was associated with low fetal
weight and with gestational age. Maternal mortality was due to multiorganic failure and
hepatic failure.
REFERENCE(S). 1. Hellp syndrome: the state of the art. J.K.Baxter. Obstetrical and
Gynecological Survey 2004;12:838–45.
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PRO-ATRIAL NATRIURETIC PEPTIDE DOES NOT PREDICT SURVIVAL IN
PATIENTS WITH SEPSIS
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2Anaesthe-
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INTRODUCTION. To evaluate the concentration of pro-atrial natriuretic peptide in patients
with sepsis, severe sepsis and septic shock. To assess the diagnostic and prognostic value of
mid-regional pro-atrial natriuretic peptide (ANP) levels with these diagnoses. To assess the
correlation of pro-ANP levels with those of interleukin-6, interleukin-8, interleukin-10,
procalcitonin, lipopolysaccharide-binding protein and physiological scores
METHODS. Serum concentrations of pro-ANP was determined using the immunolumino-
metric assay in 28 patients admitted to the medical intensive care unit for sepsis(6), severe
sepsis(7), and septic shock(15). Pro-ANP levels as well as those of procalcitonin, interleukin-
6, interleukin-8, interleukin-10 and lipopolysaccharide binding protein were measured on day
1 and during the course of the stay at the intensive care unit. The diagnostic and prognostic
value of pro-ANP was compared with that of the Acute Physiology and Chronic Health
Evaluation (APACHE II) and SOFA score. Mid-regional pro-ANP was detected in serum
using immunoluminometric assay (ILMA). Pro-ANP was also determined in 15 healthy
adults.
RESULTS. No signiﬁcant differences of pro-ANP levels were found in patients with sepsis,
severe sepsis and septick shock (385,3 pmol/l, resp. 209 pmol/l, resp. 888 pmol/l). On the day
of admission, pro-ANP levels were not signiﬁcant different in survivors compared to non-
survivors(396,4 pmol/l, resp. 816,8 pmol/l, p = 0,077). Pro-ANP levels on the day of
admission were signiﬁcant lower than pro-ANP levels taken on the last day of the stay on ICU
(816,8 resp 1254,4 pmol/l, p = 0,0108) in the group of non-survivors . In a receiver operating
characteristic curve analysis for survival, the cut - off 664 pmol/l on the day of admission on
ICU had a sensitivity of 41,7% and speciﬁcity of 87,5%.The area under the curve(AUC) for
pro-ANP was 0,625. The cut-off 503,4 pmol/l on the last day of the stay on ICU was found to
have a sensitivity of 83,3% and speciﬁcity of 68,7%. The area under the curve was 0,797. We
found the correlation between pro-ANP, SOFA and APACHE II score in survivors. In non-
survivors only pro-ANP and APACHE II correlation was found. The correlation was deter-
mined between pro-ANP and procalcitonin in non-survivors. No correlation was found
between pro-ANP and IL-6,IL-8,IL-10 and lipopolysaccharide binding protein.
CONCLUSION. We did not ﬁnd statistically signiﬁcant differences of pro-ANP levels in
patients with sepsis, severe sepsis and septic shock. Pro-ANP levels on the day of admission
were not signiﬁcant different in survivors and non-survivors. Pro-ANP levels on the day of
admission were signiﬁcant lower than the last pro-ANP levels in the group of non-survivors .
Further studies are necessary for the evaluation of pro-ANP as a diagnostic and/or prognostic
parameter in patients with sepsis.
Poster Sessions
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PASSIVE REWARMING IS ASSOCIATED WITH BETTER NEUROLOGICAL
OUTCOME IN PATIENTS TREATED WITH INDUCED MILD HYPOTHERMIA
AFTER CARDIAC ARREST
L. B. M. Robillard*, A. C. de Pont, A. W. den Hartog, M. J. van Dam, M. J. Schultz, J. Horn
Adult Intensive Care Unit, Academic Medical Center, Amsterdam, Netherlands
INTRODUCTION. Induced mild hypothermia (IMH) has improved neurological outcome in
patients after cardiac arrest. However, the prediction of outcome in the ﬁrst days remains
challenging. After stopping active cooling, there is a wide variation in normalization of
temperature. Some patients must be actively rewarmed because of slow spontaneous
rewarming, probably due to cerebral injury. Rapid normalization of temperature after stop-
ping active cooling might reﬂect an intact brain stem function. Therefore, we studied whether
the mode of rewarming (active versus passive) was prognostic of neurological outcome in a
population of resuscitated patients treated with IMH.
METHODS. We retrospectively studied the data of all consecutive patients treated with IMH
in our mixed medical and surgical intensive care unit between January 2006 and January
2008. Inclusion criteria were: (1) treatment with IMH after resuscitation for cardiac arrest, (2)
target temperature of 32–34 C achieved. Patients whose condition necessitated premature
stopping of IMH were excluded. Patients were divided into two groups according to the mode
of rewarming: active or passive. Neurological outcome was determined according to the
Glasgow Outcome Scores at ICU and hospital discharge (GOSic and GOShp). GOS ranges
from 1 to 5: 1 = death, 2 = vegetative state, 3 = severe disability, 4 = moderate disability,
5 = good recovery. A GOS of 4–5 was deﬁned as favorable and a GOS of 1–3 as poor. The
groups were compared by means of Pearson’s Chi-square test and relative risk (RR). A
p\0.05 was considered statistically signiﬁcant.
RESULTS. Ninety-six patients met the inclusion criteria. Sixty-six patients were passively
rewarmed and 30 actively. The median duration of rewarming to 36 C was 775 minutes
(approximately 13 h). As shown in the table, 44% of the passively rewarmed patients had a
good neurological outcome at ICU discharge, compared with 20% of the actively rewarmed
patients (p = 0.02). The relative risk for a good neurological ICU outcome was signiﬁcantly
lower in the actively rewarmed group (RR 0.73, 95% CI 0.57–0.94). For hospital outcome,
there was a strong trend to a better neurological state in the passively rewarmed group.
Unfortunately, the difference did not reach statistical signiﬁcance, probably because of the
small number of patients.
TABLE 1
Neurological outcome PASSIVE (N = 66) ACTIVE (N = 30) p-value
GOSic good (%) 29(44) 6(20) 0.02
GOSic poor (%) 37(56) 24(80)
GOShp good (%) 28(42) 7(23) 0.07
GOShp poor (%) 38(58) 23(77)
CONCLUSION. In patients treated with mild therapeutic hypothermia after cardiac arrest,
passive rewarming was associated with a better neurological outcome.
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TIME REQUIRED TO REACH TARGET TEMPERATURE WITH MILD HYPO-
THERMIA AFTER CARDIAC ARREST IS NOT RELATED TO OUTCOME
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INTRODUCTION. Mild hypothermia (MH) is a key component of treatment of patients
after cardiac arrest [1]. Although a short time to reach target temperature (33 0C) is likely to
be an essential aspect of MH, the HACA trial showed survival beneﬁt even when target
temperature of 33 0C was reached beyond 12 h after cardiac arrest [2]. We hypothesized time
required to reach target temperature to be related to (neurological) outcome.
METHODS. Retrospective multicenter observational study on consecutive patients admitted
after cardiac arrest to 3 intensive care units (ICU) in the Netherlands from April 2006 – April
2007. Neurological outcome was deﬁned as ‘‘good’’ when the Glasgow Outcome Score
(GOS) was 4/5 or ‘‘unfavourable’’ with a GOS of 2/3 at hospital discharge, respectively.
Statistical analysis: data are presented as medians [IQR] or means (range) where appropriate;
patients were dichotomized according to\5 vs.[5 h to reach target temperature.
RESULTS. MH was applied in 82 patients; data of 68 patients were analysable. Admission
temperature was 35.4 (32.3 C – 39.0) C. Median time required to reach target temperature
was 5.0 [2.5 – 6.4] h. Time required to reach target temperature was not related to neuro-
logical outcome (time as a continuous variable, Mann Whitney U p = 0.4; dichotomized,
table, Pearson X
2 p = 0.4).
TABLE 1
Outcome at
hospital discharge
Time to reach
target t /\5h
Time to reach
target t /[5h
Number of patients N = 40 N = 28
Demographics Age, years 65 57
Temperature on admission, 0 C 35.1 35.8
Coronary artery interventions, N (%) 7 (18%) 13 (46%)
Intra–aortic balloon pump, N (%) 6 (14%) 13 (46%)
Outcome Alive, N (%) 20 (50%) 17 (60%)
Good neurological outcome, N (%) 17 (43%) 15 (54%)
Unfavourable neurological outcome, N (%) 3 (7%) 2 (6%)
Dead, N (%) 20 (50%) 11 (40%)
CONCLUSION. Time required to reach target temperature with MH in our ICU conﬁrms
results from others [3]. We found no relation between time required to reach target tem-
perature with MH and (neurological) outcome. However, since there were signiﬁcant
differences in case–mix, larger studies are needed.
REFERENCE(S). 1. Nolan JP et al., ALS Task Force. Therapeutic hypothermia after cardiac
arrest. An advisory statement by Advanced Life Support Task Force of the International
Liaison Committee on Resuscitation. Resuscitation 2003;57:231–235.
2. The Hypothermia After Cardiac Arrest Study Group. Mild therapeutic hypothermia to
improve the neurologic outcome after cardiac arrest. N Engl J Med 2002;346:549–556.
3. Oddo M et al. From evidence to clinical practice: Effective implementation of therapeutic
hypothermia to improve patient outcome after cardiac arrest. Crit Care Med 2006;34:1865–1873.
0826
TREATMENT WITH INDUCED HYPOTHERMIA AFTER OUT-OF-HOSPITAL
CARDIAC ARREST HAS A HIGH INCIDENCE OF LOWER RESPIRATORY
INFECTIONS
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INTRODUCTION. Induced hypothermia (IH) has shown a beneﬁcial effect on neurological
outcome in out-of-hospital cardiac arrest (OHCA)victims in recent trails. Hypothermia
increases the risk on infections due to immune suppression. The aim of the study was to
evaluate the incidence of lower respiratory infection (LRI) in the ﬁrst 5 days in OHCA
patients treated with IH and the possible effect on the outcome.
METHODS. Retrospective cohort study in a university hospital in the period between Jan-
uary 2005 and June 2007. An endovascular cooling technique was used (Alsius CoolGard
TM
System). During 24 h IH was installed at a temperature between 32–33 C. LRI was deﬁned
by the presence of at least 2 of the following: fever[38 C, witnessed aspiration, new
pulmonary inﬁltrate on chest radiography and isolation of a respiratory pathogen in an
endotracheal aspirate. Data was collected on demographics, initial rhythm, incidence of LRI,
isolated microorganisms in endotracheal aspirate, lenght of stay on ICU, ICU- and In-hospital
mortality and neurological outcome at discharge ICU (Pittsburgh cerebral-performance cat-
egory, CPC 1–2 was deﬁned as good outcome).
RESULTS. 82 OHCA victims were treated with IH. Isolated microorganisms in endotracheal
aspirate are presented in Table 1.LRI was present in 88%. Antibiotics were overall prescribed in
89%. Length of stay on ICU was prolonged in the presence of LRI (LRI 8.5 ± 5.1 days; no LRI
4.0 ± 1.4 days). There was no obvious inﬂuence of LRI on mortality or neurological outcome.
TABLE 1
N = 82 Total (%) Mort. ICU (%) Mort. In-Hospital (%)
Total induced hypothermia 100 36.6 45.1
No endotracheal aspirate 11 77.8 77.8
No isolated organism 18.3 33.3 46.7
Stafylococcus aureus 31.7 26.9 34.6
Streptococcus pneumoniae 12.2 20 40
Hemophilus inﬂuenzae 13.4 18.2 18.2
Escherichia coli 12.2 60 70
Klebsiella spp 8.5 42.8 57.1
Pseudomonas aeruginosa 4.9 50 75
Candida albicans 12.2 0 10
Others 18.3 46.7 46.7
Monomicrobial isolate 37.8 29 35.5
Polymicrobial isolate 32.9 33.3 44.4
Gram-positive bacteria 39 28.1 37.5
Gram-negative bacteria 45.1 35 43.2
CONCLUSION. LRI is a very common problem in patients treated with IH. Length of stay
on ICU is prolonged in the presence of LRI but there is no obvious inﬂuence on mortality or
neurological outcome. The most common isolated microorganisms in the endotracheal
aspirate are S.aureus, S.pneumoniae, H.inﬂuenzae and E.coli. Polymicrobial isolates and the
presence of Gram-negative bacteria are associated with a higher mortality. Antibiotic therapy
is very common and the choice of antibiotics in OHCA should include activity against the
most common isolated microorganisms.
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AUDIT ON COOLING TARGETS IN THERAPEUTIC HYPOTHERMIA
P. J. McKendry*, M. Reid
Anaesthetic Department, The Ulster Hospital, Belfast, United Kingdom
INTRODUCTION. Mortality rate following out-of hospital cardiac arrest lies between 65
and 95%. Severe neurological symptoms are present in up to half of survivors.
1,2
Following landmark studies in the NEJM in 2002
3,4 the International Liaison Committee on
Resuscitation (ILCOR) published guidelines on the use of Therapeutic Hypothermia (TH) to
improve neurological outcome post-arrest. They advised that comatose patients with return of
spontaneous circulation (ROSC) following out-of-hospital (OOH) VF arrest should be cooled
to 32–34C for 12–24 h.
5 Uptake of TH by UK ICUs has been limited by concerns over the
need for specialised equipment.
6
Practice in our ICU has been to use simple, inexpensive techniques such as ice packs, fans and
damp sheets to induce TH. This audit aimed to assess their efﬁcacy.
METHODS. We identiﬁed all patients admitted to our unit between Jan 2005 and Dec 2007
with ROSC after OOH cardiac arrest. Cooling targets were assessed using the 2003 ILCOR
guidelines as a standard. Mortality rate and gross neurological outcome were also reviewed.
RESULTS. 28 patients were identiﬁed with VF as an initial rhythm. TH was attained in 92%,
within 8 h in 70%. TH was maintained for 12–24 h in 86%, with overcooling to less than
32 C in only 4.5%. Survival rate in the VF group was 54.5%, similar to that found in major
trials.
3,4 Four patients were lost to follow-up, but of the remainder 87.5% had a positive
neurological outcome, classed as discharge from hospital to their original level of care.
Outcomes post non-VF arrest (10 patients) are presented separately.
CONCLUSION. Our results reﬂect that TH is achievable and effective through simple
techniques that could be implemented in all UK ICUs.
REFERENCE(S). 1. Holzer M et al. Hypothermia for neuroprotection after cardiac arrest:
Systematic review and individual patient data meta-analysis . CCM 2005;33(2):414–418.
2. Bernard SA. Outcome from prehospital cardiac arrest in Melbourne, Australia. Emerg Med
1998; 10: 25–9.
3. Holzer et al. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac
arrest. NEJM 346;8: 549–556.
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MILD THERAPEUTIC HYPOTHERMIA AFTER CARDIO-PULMONARY RESUS-
CITATION; PATIENTS OVER THE AGE OF 75
L. E. M. van Lelyveld*, D. H. T. Tjan, A. R. H. Zanten van
Intensive Care, Gelderse Vallei Hospital, Ede, Netherlands
INTRODUCTION. Therapeutic hypothermia (TH) is gaining acceptance as a treatment
modality for cerebral protection in post cardiac arrest coma. The Netherlands has a population
of almost 17 million people. The mean age is 78 years for men and 82 years for women. A
quarter of the population is over 65 years of age [1–2].
The aim of this study was to compare the outcome of elderly patients treated with TH
(C75 years) versus younger patients (\75 years).
METHODS. We analysed the outcome of all patients treated with TH since the imple-
mentation of TH in relation to their age.
RESULTS. In the period between April 2005 and December 2007 seventy eight patients were
treated with TH on our ICU. The hospital mortality in the elderly group was 92% and in the
younger group 85%, p = 0.32. Mechanical ventilation days, ICU and hospital LOS showed
no signiﬁcant difference between the groups. Neurological outcome in the elderly survivors
was almost as good as in the younger survivors (CPC after six months 1.9 ± 1.3 vs.
1.47 ± 0.9).
TABLE 1 OUTCOME AFTER TH IN RELATION TO AGE
75- 75+ p
N4 4 3 4
Male 30 (68%) 20 (59%) 0.40
Age 60.5 ± 12.9 [19.1–73.9;65.9] 83.2 ± 5.5 [75.0–95.60;82.2]
Survival 12 (15%) 6 (8%) 0.32
CPC 3.7 ± 1.7 [1.0–5.0;5.0] 4.1 ± 1.5 [1.0–5.0;5.0] 0.30
CPC after 6 months 1.47 ± 0.9 [1.0–4.0;1.0] 1.90 ± 1.3 [1.0–4.0;1.0] 0.37
Mechanical
Ventilation (days)
6.03 ± 4.65 [1.0–27.0;5.5] 5.59 ± 4.80 [1.0–24.0;4.0] 0.71
LOS hospital (days) 7.34 ± 5.72 [1.0–30.0;6.0] 7.17 ± 6.20 [1.0–26.0;5.0] 0.90
LOS ICU (days) 14.97 ± 16.84 [1.0–71.0;8.0] 12.00 ± 15.29 [1.0–79.0;6.0] 0.45
(mean ± sd)[range,median] or N (%)
CONCLUSION. Patients[75 years admitted to ICU after cardiac arrest age did not show a
worse outcome compared to younger patients. Based on these observations no age-related
limitations for TH should be used.
REFERENCE(S). 1. RIVM and CBS.
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SPONTANEOUS HYPOTHERMIA IS RELATED TO WORSE NEUROLOGICAL
OUTCOME IN PATIENTS AFTER CARDIAC ARREST
A. W. den Hartog*, A. C. de Pont, L. Robillard, M. van Dam, M. J. Schultz, J. Horn
Department of Intensive Care Medicine, Academic Medical Center at the University of
Amsterdam, Amsterdam, Netherlands
INTRODUCTION. Induced mild hypothermia (IMH) is a recommended strategy to limit
neurological damage after cardiac arrest. Although pre-hospital cooling is not practiced in the
Netherlands, patients may arrive in the intensive care unit (ICU) with spontaneous hypo-
thermia. It is known that patients with spontaneous hypothermia due to trauma or sepsis have
a higher mortality rate. The aim of the current study was to examine if admission temperature
of patients after cardiac arrest is related to neurological outcome.
METHODS. Consecutive patients resuscitated for cardiac arrest and treated with IMH in our
ICU between January 2006 and January 2008 were eligible for this retrospective study.
Patients were excluded if cardiac arrest was a result of trauma, intracranial bleeding or
drowning. To evaluate the neurological outcome, the ICU and hospital Glasgow Outcome
Scores (GOSic and GOShp) were retrieved A GOS of 1–3 was deﬁned as poor, and 4–5 as
good neurological outcome. Patients were divided according to their admission temperature
into a spontaneous hypothermia group (\35.1 C) and a normothermia group (C 35.1 C). The
groups were compared by means of Pearson’s X
2 and relative risk (RR). A P\0.05 was
considered statistical signiﬁcant.
RESULTS. From a total of 215 patients treated with IMH, 102 patients were excluded. The
remaining 113 had a median admission temperature of 35.1 C (32–38 C). Spontaneous
hypothermic patients had a worse outcome (table). The RR for good neurological outcome
was signiﬁcantly lower in the hypothermia group (OR 0.71, 95%CI 0.53–0.95).
TABLE 1
Neurological outcome Hypothermia n = 54 (%) Normothermia n = 59 (%) P value
Good GOSic 14 (26) 28 (47) \0.02
Good GOShp 15 (28) 27 (46) \0.05
CONCLUSION. Patients resuscitated for cardiac arrest arriving in the ICU with spontaneous
hypothermia have a worse neurological outcome than normothermic patients.
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INTRODUCTION. In 2007 mild therapeutic hypothermia (TH) after cardiopulmonary
resuscitation (CPR) was introduced in our hospital. Early and fast cooling after restoration of
spontaneous circulation remains a challenge during the ﬁrst hours after CPR. But no less
important during these ﬁrst hours are the optimal intensive care and timely cardiac inter-
ventions to diagnose and to treat (PTCA,CABG etc.) the reason of cardiac arrest (CA). An
analysis was made to evaluate our ﬁrst year results and the protocol we had used.
METHODS. A retrospective cohort study of 20 TH patients between February 2006 and
January 2008 . Different cooling methods were combined: an external cooling technique with
ice-cold bags, intravenous cold saline infusion and intravascular cooling catheter method
(Alsius Coolgard) were used depending in wich department the patient ﬁrst arrived and if any
other invasive procedure was done during the ﬁrst hours post CPR. Intravascular cooling, with
target temperature 32–33 degrees Celsius for a period of up to 24 h was started in the
intensive care unit (ICU). Additionally to the hospital mortality and neurological outcome we
studied also the rate of hyperglycemia, hypokalemia, hemodynamic instability, arrhythmias
and bleeding disorders during the period of TH.
RESULTS. 20 patients, with a mean age 62,7 (27–80) years, male 18/20.
Primary rhythm VF-8, asystolia-8, PEA-4.Acute myocardial infarction was diagnosed 17/20.
Mean time of the transportation to the hospital was 48 (0–114) min, to the ICU 83 (0–175)
min and cooling with intravascular cooling catheter was started 205 (75–305) min after CA.
During the cooling period an insulin infusion was used 13/20; hypokalemia (K\3,5 mmol/l)
was seen 9/20, additional antiarrhythmic therapy was used 9/20, vasoactive drugs or inotropes
were infused 13/20 cases. Muscle relaxants to avoid shivering were used 16/20. there were
diagnosed pneumonia 4/20, bleeding disorders 3/20.Percutaneous coronary angiography was
done to the 12/20 patients. 4 patients were treated with PTCA and 2 patients with CABG.
Mortality of our patients was 50 % (10/20) but in the subgroup of patients having a PCI it was
42% (5/12). There was a good neurological outcome (Cerebral Performance Score 1–2)
7 days after CA in the survival group.
CONCLUSION. Our ﬁrst year experience of TH is comparable with results published in
literature. It is important to start with cooling as fast as possible and to build up the inhospital
treatment algorithms for intensive care and PCI after CA.
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HYPOTHERMIA AFTER CPR ARE WE DOING IT RIGHT?
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INTRODUCTION. Hypothermia is a common treatment after CPR to avoid brain cell
apoptosis. In some children after severe hypoxia and prolonged cardiopulmonary resuscitation
(CPR) treated with 24 h hypothermia we detected cerebral hyperperfusion (low Resistance
Index RI and high systolic and diastolic cerebral blood ﬂow) by transcranial Doppler-
Ultrasound(DU)during re-warming (0.1 degree Celsius/h). These children who developed
hyper-perfusion under re-warming died or were severely brain damaged. Prior to the re-
warming their cerebral structure and ventricle size was normal indicating that there was no
brain oedema or swelling. Under re-warming they showed hyperperfusion RI 0.3–0.5, a
hyperdense echogenity of the brain tissue, and decreasing ventricle sizes and pre-ﬁnal an RI
of 1,0 and at the end now ﬂow. We interpreted this as reperfusion injury well known from the
beginning of the era of hypothermia used for cardiac surgery. We needed to question: we were
we doing it right?
METHODS. After CPR four children aged between 2 and 16 years, pH 6.5–7.0,lactate 100–
200 mg/dl, were treated with hypothermia. CPR duration times were 15, 20, 60 and 90
minutes. Three children needed magnesium and enoximone to re-establish cardiac function on
top of standard treatment according to EPLS guidelines. After 48 h they were re-warmed
under Doppler-Ultrasound (DU)steering as described in the following: If the cerebral vascular
Resistance Index (RI), taken every 6 h after beginning of the re-warming, was[0.65
warming up was continued (0.1 degree/h).
Patients with decreased RI\0,6 were cooled down by 0.5–1.0 C until the RI was above 0.65
again and kept at that temperature for 24 h, than re-warming was restarted by 0.05 –0.1/h
under DU and down again if necessary, if the RI was between 0.60 and 0.65 re-warming was
withhold for 24 h.
RESULTS. Two patients were cooled down by 0.5 to 1.0 degrees during the re-warming to
reach a normal cerebral perfusion. In one child (CPR 15 minutes) the RI decreased to 0.54. A
second child (CPR 90 minutes, lactate 200 mg/dl) had three decreases in RI to 0.54, 0.56,
0.58. The later was cooled and re-warmed three times until no more signs of cerebral hyp-
erperfusion under re-warming could be detected. The shortest hypothermia treatment duration
took 3 days the longest 9 days. All four children survived without any neurologic defects.
CONCLUSION. Despite the fact, that this is a very small number, we believe that reper-
fusion injury after hypothermia should not be underestimated and furthermore that in the past,
even holding the right treatment in our hands we might have destroyed the success of
hypothermia on the one hand by not cooling not long enough and on the other hand not by re-
warming slow enough.
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DIVING ACCIDENTS ARE NOT ALWAYS CAUSED BY DECOMPRESSION
SICKNESS
A. F. van der Sluijs*, J. Horn
Intensive Care, Academic Medical Center, Amsterdam, Netherlands
INTRODUCTION. Decompression sickness (DCS) is a possible life-threatening complica-
tion of scuba (self-contained underwater breathing apparatus) diving and requires early
recompression therapy (with hyperbaric oxygen) when severe symptoms are present. During
diving nitrogen is absorbed into bodily tissues, which expands during decompression leading
to air bubbles. These bubbles may cause local tissue damage or secondary ischaemia when air
bubbles enter the circulation. However, not all patients who collapse during or shortly after
diving have decompression sickness and recompression therapy might lead to a signiﬁcant
delay in diagnostics. This possibly results in serious deterioration of the patient’s clinical
condition.
METHODS. We present two diving fatalities, treated with hyperbaric oxygen for suspected
DCS.
RESULTS. CASE I: a 46-year-old female diving instructor developed shortness of breath
during scuba diving and lost consciousness when she reached the surface. Basic Life Support
was performed for at least 10 minutes. Due to pulmonary edema, probably as a result of
aspiration of water, the patient had to be ventilated with high pressures to ensure oxygenation.
A chest CT-scan showed small amounts of air in the left internal jugular vein and in the vena
cava superior, raising the suspicion of DCS. She was treated with recompression therapy for 5
h. The patient remained in an anoxic-ischaemic coma after cardiopulmonary resuscitation and
eventually she died. Retrospectively, she had complained of dyspnoea, swollen legs and
muscle cramps since three weeks. She was diagnosed with hyperthyroidism
(TSH\0,01 mE/l, FT4[70 pmol/l) and a dilated cardiomyopathy with acute decompen-
sation during diving. The air bubbles in the venous system seen on CT-scan were caused by a
peripheral drip system.
CASE II: a 28-year-old male with a family history of arterial dissections developed a dys-
arthria while playing underwater-polo. Shortly after climbing out of the pool he lost
consciousness and was presented on our ER. Brain CT-scan showed no abnormalities and
DCS was considered. After consultation of specialized diving physicians, recompression
therapy with hyperbaric oxygen was initiated to treat a possible cerebral artery gas embolism.
During this treatment his neurological condition deteriorated dramatically. Repeated imaging
by CT and MRI showed ischaemic lesions in the brainstem and cerebellum, together with an
irregularity of the right vertebral artery. 48 H later the patient was brain dead and supportive
treatment was withdrawn. Post-mortem examination showed multiple dissections in the
vertebro-basilar arteries.
CONCLUSION. These two cases clearly show that loss of consciousness or other neuro-
logical symptoms occuring during or shortly after diving are not always caused by DCS.
Treating physicians have to consider all possible options and seriously seek for other
explanations.
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NEUROLOGICAL OUTCOME AND MORTALITY AFTER CARDIAC ARREST
AND PROTECTIVE HYPOTHERMIA
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INTRODUCTION. According with previous studies, protective hypothermia (PH) seems to
improve neurological outcome and long-term mortality after ventricular ﬁbrillation (VF). It
seems to be useful when another rythm is present.
METHODS. We analyzed retrospectively every patient admitted at a 22-beds medical ICU
after successful cardiopulmonary resuscitation between January 2000 and December 2007.
Multivariate analysis was used to evaluate factors associated with mortality and neurological
outcome.
RESULTS. 84 patients were included. 59.5% were males. The mean age was 64 years.
Because of the characteristics of our ICU, the most frequent cause of cardiac arrest (CA)
(44%) was a respiratory failure. 18 patients (21.4%) suffered the CA in the out-of-hospital
area. Between in-hospital CA, 25 took place in the Emergency Room, 16 in the ICU, and 25
in other hospital areas. 49 patients (58.3%) presented asistolia as the ﬁrst rythm, 20 (23.8%)
electromechanical dissociation and 15 (17.9%) ventricular ﬁbrillation. 27 patients (32%)
received PH treatment. ICU mortality was 60.7% and hospital mortality 73.8%. Among
patients who were treated with PH, the ICU mortality was as high as 74%. The only factor
associated with mortality in ICU was the total time (in minutes) of CPR (OR 1.1, p = 0.01),
whereas ICU mortality between patients who received PH was associated with the delay (in
hours) to reach\34 C (OR 0.6, p = 0.03). In-hospital mortality in the total sample was
associated with the use of PH (OR 4.4, p = 0.03) and with APACHE II score at admission
(OR 1.7, p = 0.09) while, among patients who received PH, in-hospital mortality was only
associated with the delay in receiving CPR. The only factor associated with good neurological
outcome (Glasgow Outcome Scale score of 4–5) was the treatment with PH (OR 0.2,
p = 0.08).
CONCLUSION. In our study, PH was associated with better neurological outcomes. It was
associated with a mild increase in mortality, probably caused by the previous patients fea-
tures. Its beneﬁts in CA, wich has poor neurologic outcomes between survivors, have to be
conﬁrmed in larger prospective studies.
REFERENCE(S). 1. Bernard SA et al. Treatment of comatose survivors of out-of-hospital
cardiac arrest with induced hypothermia. N Engl J Med 2002;346:557–63.
2. Hypothermia After Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve
the neurologic outcome after cardiac arrest. N Engl J Med 2002;346:549–56.
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INTRODUCTION. Purpose of the study. To identify possible predictors for the outcome
(fail/pass/instructor potential) of the candidates (doctors/nurses) participating to the European
Resuscitation Council (ERC) Advanced Life Support (ALS) provider course (1).
Type of study: observational cohort study.
Setting: University Teaching/Training Centre
METHODS. At the end of the ERC ALS course candidates were tested on their practical
ability to manage a simulated standardised cardiac arrest testing scenario as team leaders.
Candidate knowledge was evaluated immediately before and after the course using a stan-
dardised 120-item multiple-choice quiz (MCQ)(2). Candidate demographic and professional
data as well as the pre-course MCQ scores were analysed as predictors of the course outcome
(Fail/Pass/Pass with Instructor Potential [IP]) using Chi and Mann-Whitney tests.
RESULTS. Three-hundred and six candidates (58.8% female) were included. Nine (2.9%) of
them did not pass the ﬁnal test, 267 (87.3 %) passed the ﬁnal test and 30 (9.8%) were
identiﬁed as having IP. Failed candidates were older (mean age 40.4 vs. 35 years) had a
signiﬁcantly lower median score at pre-course test (73 vs. 83, p = 0.05), none of them was an
instructor in other medical disciplines and none of them worked into an intensive care unit
(ICU) (p = 0.03). hose candidates having IP had a signiﬁcantly higher score at ﬁnal MCQ
(mean 92.5 vs. 89.0, p = 0.01), were more frequently nurses (13.3% vs. 4.3%; p\0.05) and
had more frequently a specialty in anaesthesiology, cardiology and emergency medicine (69.2
vs. 46.2; p = 0.03) and more frequently worked in ICU (56.7 vs. 29.9%; p\0.01).
CONCLUSION. Conclusions: candidates having a specialty in anaesthesiology, cardiology
and emergency medicine and those working in ICU are signiﬁcantly more likely to pass the
ERC ALS provider course and to obtain instructors status. Older age and low scores at pre-
course MCQ are associated to an increased risk of course failure.
REFERENCE(S). 1. Perkins G, Lockey A.The advanced life support provider course.BMJ
2002;325(7364):S81.
2. Ringsted C, Lippert F, Hesselfeldt R, Rasmussen MBet al. Assessment of Advanced Life
Support competence when combining different test methods–reliability and validity.
Resuscitation. 2007;75:153–60.
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SIGNIFICANCE AND IMPLICATIONS OF TROPONIN I ELEVATION IN CRITI-
CALLY ILL TRAUMA PATIENTS
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INTRODUCTION. Troponin I (TnI) is a sensitive and speciﬁc marker of myocardial injury.
Its diagnostic value has been extended beyond ischemic syndromes, like sepsis, pulmonary
embolism and chronic renal insufﬁciency. TnI elevation in non-traumatic acute brain injury
has been associated to worse prognosis. We proposed to examine TnI elevation in severe
trauma patients and in particular traumatic brain injury (TBI) and its prognostic signiﬁcance.
METHODS. Cohort of trauma patients admitted in the emergency room (ER) over a 5 year-
period with serial TnI measurements as part of a screening trauma protocol. A subpopulation
with isolated TBI and intensive care unit admission (ICU) was studied. Patients with shock
(systolic pressure\90 mmHg or lactate[4) were excluded. TnI measurement C 0.07 lg/dl
was considered positive. Univariate and multivariate logistic regressions were performed to
determine prognostic signiﬁcance of TnI elevation as well as to determine independent factors
related to its positivity.
RESULTS. There were 1199 patients admitted to the ER, 20.8% female, 79.2% male, with
median age 41y. 93.3% resulted from blunt trauma and the main cause was motor vehicle
accident (57.1%), followed by falls (29.2%). Mean RTS was 5.99, 83.1% patients had
ISS[15 and 77.2% TRISS C 50%. Overall mortality was 28.8%.
Most of the patients (51.1%) had positive TnI on admission. Mean value was 0.33 lg/dl
(SD = 1.25) and maximum measurement occurred (mean 0.67 lg/dl; SD = 2.43) on the 4th
h after-admission. TnI positivity was independently related to trauma severity, ISS (OR 1.02,
p = 0.049). When multivariate regression was performed, several variables had independent
relation with TnI elevation, namely: thoracic trauma (OR 1.45, p = 0.049), rhabdomyolysis
(OR 3.57, p\0.001) and shock (OR 1.92, p = 0.001). TnI positivity was an independent
factor for mortality (OR1.559, p = 0.02) after correction for background variables and
severity.
Only 162 patients had isolated TBI who did not differ from the politrauma population above
described. Elevated TnI occurred in 28.1% isolated TBI patients and no statistically signiﬁ-
cant difference was observed in ICU-stay (7 days vs. 8 days, p = 0.185) or mortality (33.3%
vs. 29.9%, p = 0.667), compared with patients with normal TnI values.
CONCLUSION. The results suggest that the association between TnI elevation and mortality
is dependent on multiple factors, such as the presence of rhabdomyolysis, shock and thoracic
trauma. TnI is a valid predictor of mortality in politrauma population. However, this prog-
nostic value was not observed in isolated TBI. Further studies with larger number of TBI
patients are needed to allow more accurate conclusions.
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INTRODUCTION. The choice of hyperosmolar solution for elevated intracranial pressure
(ICP) decreasing is still under discussion. We have evaluated and compared the effects of
different hypertonic solutions on the intracranial and cerebral perfusion pressures in multi-
center study of Russian Federation of Anaesthesiologists and Reanimatologists.
METHODS. 25 patients with intracranial hemorrhage and GCS 4–9 enrolled in the study. All
patients had invasive ICP and central hemodynamic monitoring (PICCO plus or Swan –
Ganz). ICP elevation higher than 20 mm Hg was an indication for the treatment. We used
15% mannitol –400 ml (n = 38), 10% NaCl – 200 ml (n = 17) and HyperHAES (7,2% NaCl
in 6% HES 200/0,5) – 250 ml (n = 31) to decrease ICP. ICP and cerebral perfusion pressure
(CPP) were registrated before infusion and 5, 30, 120 minutes after it.
RESULTS. PaO2, PaCO2 and blood temperature were comparable between groups during
the investigation. Mannitol infusion decreased ICP from (M ± SD) 30 ± 6m m H g t o
17 ± 6m mH g( p\0,05). After 30 min ICP was 17 ± 7m mH g( p\0,05), but after
120 min more than 20 mm Hg (24 ± 9 mm Hg). The same results were obtained during the
10% NaCl infusion. ICP decreased from 30 ± 8m mH gt o1 6± 4m mH g( p\0,05). After
30 min ICP was 15 ± 5m mH g( p\0,05), but after 120 min - 22 ± 5 mm Hg. HyperHAES
decreased ICP from 28 ± 5m mH gt o1 6± 6m mH g( p\0,05). After 30 and 120 min ICP
was in normal ranges (12 ± 6m mH g( p\0,05) and 16 ± 8m mH g( p\0,05)).
The 15% Mannitol infusion increased CPP from 73 ± 18 mm Hg to 90 ± 21 mm Hg
(P\0,05). After 30 and 120 min CPP was 89 ± 21 mm Hg (P\0,05) and 80 ± 18 mm
Hg. 10% NaCl increased CPP from 74 ± 17 mm Hg to 90 ± 30 mm Hg. After 30 and
120 min CPP was 90 ± 26 mm Hg (p\0,05) and 81 ± 18 mm Hg. HyperHAES markedly
increased CPP from 72 ± 16 mm Hg to 94 ± 14 mm Hg (p\0,05). After 30 and 120 min
CPP was 92 ± 15 mm Hg (P\0,05) and 87 ± 17 mm Hg (p\0,05).
CONCLUSION. Infusion of 15% Mannitol, 10% NaCl and HyperHAES (7,2% NaCl in 6%
HES 200/0,5) is an effective method of ICP management, but HyperHAES has the most
prolong effects on the intracranial and cerebral perfusion pressures.
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INTRODUCTION. The presence of nasal ﬂaring is related to severe respiratory failure, but
only few studies in healthy adults have demostrated the relationship between alae nasi muscle
activity and hypercapnia and between this sign and an imposed respiratory load. Other studies
questioned the usefulness of respiratory rate to assess dyspnea severity, as this measurement is
difﬁcult and poorly reproducible in the Emergency department scenario.
The aim of our study was to evaluate the utility of nasal ﬂaring detection in the assessment of
severity in patients with dyspnea.
METHODS. Prospective observational study of 50 patients attended in the Emergency
Department (ED) with dyspnea as major symptom and triage level II or III in the SAT
(Sistema Andorra ` de Triatge). We recorded vital signs, oxygen saturation, arterial blood gases
and nasal ﬂaring presence at ED arrival. We recorded hospital admission necessity, UCI
admission, mechanical ventilation and lenght of hospital stay (LOS).
RESULTS. 7 patients were excluded (respiratory rate not recorded) and 43 patients were
analyzed. Only 7 patients (15%) had evident alae nasi activity. Patients with nasal ﬂaring were
more taquipneic (Respiratory rate 25 ± 6 vs. 38 ± 5 breaths/min, p\0,05) and acidotic (pH
7,42 ± 0,05 vs. 7,34 ± 0,12, p\0,05), and had lowest level of bicarbonate (HCO3
30,5 ± 7,1 vs. 22,0 ± 5,6 mEq/L, p\0,05). There was no signiﬁcant differences in PaO2 or
PaCO2 between groups.
29 patients in the no nasal ﬂaring group (80,5%, LOS 8 ± 7 days) and 6 patients in the nasal
ﬂaring group do (85,7%, LOS 9 ± 8 days)needed hospital admission.
CONCLUSION. Evident alae nasi muscle activity at ED arrival in patients with dyspnea
could be a non invasive indicator of metabolic acidosis.
Poster Sessions
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INTRODUCTION. To evaluate differences among different orotracheal tubes regarding its
capability to maintain cuff pressure in a normal range between its measurements.
METHODS. Prospective and observational study including all patients intubated in six ICU.
It was follow up over one week. The cuff pressure was measured with a Mallinckrodt
manometer Hi-LoTM. With a target of cuff’s pressure 25–30 cm H2O. Low cuff pressure was
deﬁned as values\20 cm H2O.
The statistical analysis was performed with SPSS 11.0.
RESULTS. A total of 53 intubated patients admitted to Intensive Care Unit were included.
Admission diagnosis was medical in 24 (45.3%), surgical in 22 (41.5%) and trauma in 7
(13.2%). 660 measurements were analyzed. Mallinckrodt Hi-Contour tubes were used in 129
measurements (19.5%), Mallinckrodt Hi-Lo tubes in 180 (27.3%) and Rusch tubes in 351
(53.2%). A higher frequency of measurements with cuff pressure\20 cm H2O in the
Mallinckrodt Hi-Contour tube were observed when compared to Mallinckrodt Hi-Lo tube
(73.6% vs. 58.3%, p\0.05), and to Rusch tube (73.6% vs. 42.4%, p\0.05). When com-
paring Mallinckrodt Hi-Lo and Rusch tubes difference was found (58.03% vs. 42.4%,
p\0.05).
TABLE 1 CUFF PRESSURE AND DIFFERENT TYPES OF OROTRACHEAL TUBES
Mallinckrodt Hi-Contour Mallinckrodt Hi-Lo Rusch
\20 cm H2O 73.6% 58.3% 42.4%
Normal Range 26.3% 41.6% 57.5%
CONCLUSION. The adequate control of cuff pressure is inﬂuenced by the tube choise.
In spite of adequate cuff control, types of tubes may inﬂuence aspiration risk and Ventilator-
Associated Pneumonia (VAP) incidence.
GRANT ACKNOWLEDGEMENT. Supported by FISS PI O7/90960 (FADO-2) and AI 07/
90031.
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CONFUSION ASSESSMENT METHOD FOR THE INTENSIVE CARE UNIT (CAM-
ICU). TRANSLATION, RETRANSLATION AND VALIDATION INTO SWEDISH
INTENSIVE CARE SETTINGS
C. Larsson*
1, A. Granberg-Axell
2, A. Ersson
1
1Department for Intensive Care Medicine, Malmo University Hospital, Malmo,
2Inst. of
Neurobiology, Nursing and Society, Karolinska Institutet, Stockholm, Sweden
INTRODUCTION. Patients in intensive care sometimes have strange and frightening
experiences and may show symptoms of acute confusion or delirium. CAM-ICU, the Con-
fusion Assessment Method for the Intensive Care Unit is a concept of diagnosing ICU
delirium. In Sweden there is no commonly used instrument or method to test the development
of the ICU delirium. The aim of this study was to translate, retranslate and validate CAM-ICU
for use in Swedish ICU settings.
METHODS. The translation of the instrument was done according to the guidelines sug-
gested by The Translation and Cultural Adaptation group. In the validation process the
applicability of the Swedish version of the instruments was tested in a Swedish intensive care
unit.
RESULTS. Fourteen adult patients were included in the study, forty paired tests were carried
out, and eighty CAM-ICU instruments were completed. The participating patients were given
CAM-ICU ratings at least twice during the patients’ stay in ICU. Interrater reliability was
very good. In our material we recognized a delirium rate of 48 %, which is in accordance with
previous studies.
CONCLUSION. The translation of the instrument CAM-ICU showed good correlation with
the original version and could therefore be applicable in a Swedish ICU setting. Although
there are limitations in using CAM-ICU, previous studies reveal a need for a homogeneous
screening instrument making it possible to detect and determine ICU delirium; and from this
basis are able to implement and make the necessary decisions required in medical and nursing
care practice preventing ICU delirium.
0840
HAND HYGIENE BY HEALTH CARE WORKERS IN AN ICU
H. Kickbusch*, H. Kruger, I. Hagenauw, C. Wolters, R. Spanjersberg
Anesthesiology, University Medical Centre Groningen, Groningen, Netherlands
INTRODUCTION. Hand decontamination is crucial to the prevention of nosocomial
infections. The aim of this study is to evaluate the compliance of the local guidelines for hand
hygiene.
METHODS. A point in time observational study without advanced notice for 3 h/daily, on a
level 3 intensive care unit. Simultaneously we collected data through a postal survey about the
knowledge of content of the guidelines for hand hygiene among nurses and medical staff.
RESULTS. A total of 281 opportunities for hand hygiene were observed. Overall compliance
with hand hygiene recommendations was 25 %.
There is a negative association between glove use and subsequent hand hygiene.
Survey
28 (50 %) nurses and 7 (50%) physicians answered 13 questions about the local guidelines for
hand hygiene. The outcome of the postal survey showed a lack of knowledge of the content of
the local guidelines, although the medical workers believed that they had a good under-
standing of the content of the local guidelines.
TABLE 1
Hand hygiene
opportunities
(N)
Overal
compliance,
%
gloves use
opportunities
(N)
Hand hygiene
comp before
gloves use
Hand hygiene
comp after
gloves use
Nurses 211 51 (24%) 82 8 (10%) 50 (60%)
Physicians 18 6 (33%) 7 0 (0%) 4 (57%)
Consultants 52 9 (7%) 21 0 (0%) 9 (43%)
Total 281 69 (25%) 110 8 (7%) 63 (58%)
CONCLUSION. Despite local guidelines for hand hygiene the compliance with hand
washing is low. We recommend further research to explore the effectiveness of problem-
based and task-orientated education programs to improve hand hygiene compliance among
medical health workers.
0841
A QUESTIONNAIRE FOR POST-ICU FOLLOW UP
E. M. Akerman*
1, B. Fridlund
2, A. Ersson
3, A. Granberg Axell
4
1Department of Intensive Care Medicine, Malmo University Hospital, Malmo,
2Department
of health science and social work, Va ¨xjo ¨ university, Va ¨xjo ¨,
3Department of intensive care
medicine, Malmo ¨ University Hospital, Malmo,
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INTRODUCTION. Current studies reveal a lack of consensus for the evaluation of physical
and psychosocial problems after ICU-stay and their changes over time. The aim of this study
was to develop and evaluate the validity and reliability of a questionnaire for assessing
physical and psychosocial problems over time of patients following ICU-recovery.
METHODS. The questionnaire was constructed after a review of the literature in three sets,
physical problems, psychosocial problems and follow-up care. It was tested for face, content,
construct, concurrent validity as well as stability and internal consistency reliability. Thirty-
nine patients completed the questionnaire, 17 were re-tested.
RESULTS. Face and content validity were tested by nurses, researchers and patients and
seem to be satisfying. The questionnaire showed good construct validity in all three sets and
had strong factor loadings (explained variance[70%, factor loadings[0.5) for all three
sets. There was good concurrent validity compared with the SF12 (rs 0.5). Internal consis-
tency was shown to be reliable (Cronbach’s a 0.70–0.85). Stability reliability on retesting was
good for the physical and psychosocial sets (rs 0.5).
CONCLUSION. The 3-set 4P questionnaire was a ﬁrst step in developing an instrument for
assessment of former ICU-patients’ problems over time. The overall validity was good, but
some items must be modiﬁed to obtain stronger validity. Regarding reliability test–retest
showed good correlation in two of the three sets. Since the sample size was small, further
studies are needed to conﬁrm the questionnaire.
0842
DAILY MANAGEMENT DECISIONS OF CHARGE NURSES AND PHYSICIANS AT
THE ICU - ON WHAT INFORMATION GROUNDS?
H. Lundgren-Laine*, E. Kontio, R. Danielsson-Ojala, S. Salantera ¨
Department of Nursing Science, University of Turku, Turku, Finland
INTRODUCTION. The primary processes of intensive patient care are quite well supported
with information technological devices. However, the secondary processes of ICU daily
activities like stafﬁng and patient ﬂow management still lack this support. The purpose of the
present study was to investigate what decisions charge nurses and physicians made and what
information they needed when managing daily activities of the ICU.
METHODS. This unstructured observation study was conducted in two medical-surgical
university hospital ICUs during April and June in 2007. It included 12 charge nurses and 8
physicians acting as a shift leaders managing daily activities. The think-aloud technique was
used as a study method and voluntary participants were observed during one shift. Verbal-
izations of thoughts were recorded while study subjects performed their tasks. Protocol
analysis with the ﬁrst and the second verbalization levels was applied to the analysis (1) and
software program NVivo7
  was used in the data analysis.
RESULTS. Altogether 92 h and 26 minutes of saturated data was recorded. Both charge
nurses and physicians made more second level decisions than the ﬁrst level which meant that
they needed more information or reasoning before their decisions. Decisions and information
about human resources were mostly emphasized by the nurses and medication by the phy-
sicians. The general patient information with information about patients’ vital signs was
highly needed in both groups.
CONCLUSION. Charge nurses and physicians at the ICUs are making several decisions per
day concerning the ﬂuent patient care ﬂow and managing a vast amount of information related
to their decisions. The processes of decision making differed from each other but the infor-
mation needs were quite similar. While most of the information was stored in the units
database most of the decisions and information were managed via papers and with the help of
the decision makers’ own memory.
REFERENCE(S). 1. Ericsson K.A. & Simon H.A. (1993) Protocol Analysis. Verbal Reports
as Data. The MIT Press, Massachusetts Institute of Technology, Massachusetts, USA.
GRANT ACKNOWLEDGEMENT. Finnish Funding Agency for Technology and Innova-
tion (Tekes 40020/07), Finnish Cultural Foundation.
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TRACHEOSTOMY IN NEUROCRITICALLY ILL PATIENTS
J. Ciro*, P. Jaramillo, A. Guerra, C. Zuluaga, M. Massaro, H. Delgado, O. Hernandez,
J. Arango
Neurointensive Care Unit, Instituto Neurologico de Antioquia, Medellin, Colombia
INTRODUCTION. Tracheostomy is a common procedure in critical care units, particularly
in neurointensive care units (NICU), due to its impact in morbidity, mortality and length of
stay. The purpose of this study was to compare, according to the employed technique and time
of its fulﬁllment, tracheostomies done during one year in neurocritically ill patients in a
neurologic institution in Colombia and its impact on the clinical outcomes.
METHODS. Retrospectively, all neurologic and neurosurgical critically ill patients who were
subject to tracheostomy between March 2007 and April 2008, were included. The following
were evaluated: indication for tracheostomy, time lapse until tracheostomy (early if done
before 8 days of mechanical ventilation or late as anytime thereafter), tracheostomy technique
(percutaneous or surgical), duration of mechanical ventilation, length of stay, respiratory
infections, complications, decanulation and in-hospital mortality.
RESULTS. Eighty-three trachostomies were evaluated; 54.2% of the patients were males;
average age 49 years old. Diagnosis patient on whom the procedure was assessed were:
traumatic brain injury (26.5%), after endovascular treatment of intracranial aneurysms
(14.5%), hemorrhagic stroke (12%), acute ischemic stroke (12%) and after neurosurgical
clipping of aneurysms (9.6%). The procedure indications were: 95.2% for airway protection,
3.6% for neuromuscular dysfunction and only one airway obstruction. Percutaneous trache-
ostomy was done in 77.1% and 45.8% were early tracheostomies. 15.7% of the patients
presented some type of complication; the immediate ones were: hemorrhage (4.8%) and false
way (2.4%); early complications were stoma infection (4.8%) and accidental decanulation
(1.2%) and late complications: stenosis (1.2%) and tracheal granuloma (1.2%). 59% of the
patients were successfully in-hospital decanulated; the majority of the nondecanulated ones
had a vegetative state (77.7%). Mortality in this group of neurocritical tracheostomized
patients was 20.5%. The length of stay in the NICU and mean time of mechanical ventilator
support, were signiﬁcantly less in those patients with early tracheotomy compared with late
tracheostomy (12.54 ± 7.62 versus 18.96 ± 7.68; p: 0.000; and 10.61 ± 6.97 versus 17.36 ±
7.11; p: 0.000, respectively). Hospital length of stay, incidence of ventilator associated
pneumonia and tracheitis after tracheostomy and in-hospital mortality were not signiﬁcantly
different neither according to the employed technique or timing of tracheostomy.
CONCLUSION. For neurocritically ill patients, early tracheostomy decreases length of stay
in the NICU as well as days on mechanical ventilation, without major risks for the patients.
0844
CLINICAL AND LABORATORY PREDICTORS OF BOWEL ISCHEMIA AND
NECROSIS IN ACUTE BOWEL OBSTRUCTION
H. Markogiannakis, N. Memos, A. Larentzakis*, D. Dardamanis, K. G. Toutouzas,
D. Theodorou, S. Katsaragakis
Surgical Intensive Care Unit, 1st Department of Propaedeutic Surgery, Hippokrateion Hos-
pital, Athens Medical School, University of Athens, Athens, Greece
INTRODUCTION. Although acute bowel obstruction is a common emergency, immediate
and correct diagnosis is essential, and appropriate treatment is of utmost importance, accurate
early recognition of bowel strangulation in these patients still remains a difﬁcult problem. The
aim of this study was to identify clinical and laboratory predictors of bowel ischemia and
necrosis in bowel obstruction.
METHODS. Prospective study of all adult patients with acute small or large bowel
obstruction in a one-year period (n = 206). Operated patients (n = 87, 42.2%) were divided
in Ischemia Group (n = 30, 14.6%) and Non-ischemia Group (n = 57) and additionally into
Necrosis (n = 20, 9.7%) and Non-necrosis Group (n = 67) according to the presence of
intestinal ischemia (reversible and irreversible) and necrosis, respectively. Comparison
between Ischemia and Non-ischemia Group was performed to identify predictive factors of
ischemia and between Necrosis and Non-necrosis Group for predictors of necrosis. Data
analyzed were: age, sex, initial vital signs, symptoms as well as clinical examination ﬁndings
and blood results (WBC, LDH, CPK, phosphate, amylase, base deﬁcit, metabolic acidosis) on
presentation at the emergency department, time between symptoms onset and arrival and
between arrival and operation, and obstruction cause.
RESULTS. In univariate analysis, heart rate (p = 0.002), WBC (p = 0.004), constant
abdominal pain (p = 0.01), and hernias (p = 0.003) were associated with ischemia, while
heart rate (p = 0.001), systolic arterial blood pressure (p = 0.003), WBC (p = 0.007),
constant pain (p = 0.005), rebound tenderness (p = 0.002), and hernias (p = 0.01) with
necrosis. Moreover, ICU admission, morbidity and mortality rates were signiﬁcantly higher in
Ischemia and Necrosis Group in comparison to Non-Ischemia and Non-necrosis Group,
respectively. Multivariate analysis identiﬁed age (p = 0.05; OR:1.04; 95% CI: 1.002–1.082),
heart rate (p = 0.02; OR:1.06; 95% CI: 1.010–1.122), WBC (p = 0.05; OR:1.02; 95% CI:
1.001–1.043), and hernias (p = 0.02; OR:4.75; 95% CI: 1.202–18.808) as independent pre-
dictors of ischemia, whereas heart rate (p = 0.01; OR:1.09; 95% CI: 1.029–1.165), rebound
tenderness (p = 0.04; OR:8.87; 95% CI: 1.098–71.678), and hernias (p = 0.05; OR:5.46;
95% CI: 1.371–30.788) for necrosis.
CONCLUSION. High intestinal ischemia and necrosis rates were identiﬁed. Age, heart rate,
WBC, and hernias were independent predictors of ischemia while heart rate, rebound ten-
derness, and hernias of necrosis. In contrast, other traditional, commonly used parameters
such as constant abdominal pain, hypotension, temperature, base deﬁcit, and metabolic aci-
dosis were not predictors of strangulation in patients with acute bowel obstruction.
0845
INTRAHOSPITAL TRANSPORT OF NEUROCRITICALLY ILL PATIENTS
A. Guerra*, C. Zuluaga, P. Jaramillo, J. Ciro, O. Hernandez, J. Arango, H. Delgado,
M. Massaro
Neurointensive Care Unit, Instituto Neurologico de Antioquia, Medellin, Colombia
INTRODUCTION. Intrahospital transport of critically ill patients from intensive care unit to
any other place of the hospital for diagnostic or therapeutic procedures has implicit hazards;
his physiologic reserve is poor and minor adverse issues can produce serious complications.
The aim of this study was to describe the characteristics and immediate consequences of the
transport of neurointensive care unit (NICU) patients to computerized tomography unit for
non invasive diagnostic procedures with the use of guidelines for transportation of the In-
stituto Neurologico de Antioquia (INDEA) in Colombia.
METHODS. Prospective study between March 2007 and April 2008. TISS-28 and FOUR
Score were assessed before transport; cardiovascular, respiratory, neurological and thera-
peutical conditions were monitored and reported at the beginning of transport, every ﬁve
minutes during transportation and 1 h after return the patient to the NICU.
RESULTS. Two hundred ninety-three intrahospital transports of neurocritically ill patients
were evaluated; the average duration of transport was 24 ± 7.56 minutes. Diagnosis patients
on whom the transport was done were: traumatic brain injury (41.3%); after neurosurgery of
central nervous system tumors (19.1%); after endovascular treatment of intracranial aneu-
rysms or vascular malformations (11.2%); after neurosurgical clipping of aneurysms (10.2%)
and hemorrhagic stroke (8.8%). TISS-28 was 38 ± 6.1 points and FOUR Score was 9 ± 3.3
points. The transport team included: nurse in chief and nurse assistant in 100% of trans-
portations, respiratory therapist in 81.3% and medical doctor in 1%. Rates of medical
problems with clinical signiﬁcance during the evaluated period of transport were: intracraneal
pressure higher than 20 mmHg in 53%; cerebral perfussion pressure lower than 60 mmHg in
26.3%; alteration of partial pressure of end-tidal carbon dioxide in 21.3%; alteration of
systolic blood pressure in 5.8%; alteration of heart rate in 1.7% and decrease of oxygen
saturation in 0.6%; only one medical complication was life-threatening. None of technical
complications (12.3%) was life-threatening.
CONCLUSION. Rate of adverse outcomes generated by the transportation of neurologic and
neurosurgical critically ill patients can be minimized through use of guidelines for trans-
portation: careful planning, selection of appropriate transport equipment, specially qualiﬁed
team and proper patient evaluation and stabilization.
0846
PROGNOSIS AND RISK FACTORS OF EARLY ONSET PNEUMONIA IN VENTI-
LATED PATIENTS WITH GUILLAIN BARRE ´ SYNDROME
D. Orlikowski*
1, T. Sharshar
1, R. Porcher
2, D. Annane
1, J. Raphael
1, B. Clair
1
1Intensive Care, Raymond Poincare ´ Hospital APHP, Garches,
2Biostatistics and Medical
Computer Science Department, Saint Louis Teaching Hospital, Paris, France
INTRODUCTION. Invasive mechanical ventilation is required in 30% of patients with
Guillain-Barre ´ syndrome (GBS) and is associated with pneumonia and increased mortality.
Our objective was to determine the incidence, characteristics, outcomes, and risk factors of
pneumonia in GBS patients receiving mechanical ventilation.
METHODS. Design: Study of a prospective database.
Setting: Intensive care unit in a university hospital.
Patients: 81 patients who required intubation for GBS were included. Neurological ﬁndings,
vital capacity (VC), and signs of respiratory distress were recorded at admission and at
intubation. A score predicting the risk of intubation (0–4) was calculated for each patient.
Pneumonia was diagnosed based on predeﬁned criteria and retrospectively conﬁrmed by two
observers. Early-onset pneumonia was deﬁned as pneumonia diagnosed within 5 days after
intubation.
RESULTS. Mean vital capacity was 57 ± 22% of predicted at admission and 33 ± 11% at
intubation. Pneumonia developed in 63 (78%) patients, including 48 with early-onset pneu-
monia. Bacteria were consistent with aspiration. Of the 63 patients with pneumonia, 11 (18%)
had septic shock, 6 (10%) had ARDS, and 9 (14%) died. In the univariate analysis, milder
weakness, a lower risk of intubation (score\2), and time from admission to intuba-
tion[2 days were associated with early-onset pneumonia. Time from admission to intubation
was the only independent predictor (P = 0.0009) in the multivariate logistic regression
model.
CONCLUSION. Early-onset pneumonia is a common and severe complication that is related
to aspiration in patients with GBS. Delaying intubation may increase the risk of early-onset
pneumonia.
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USE OF CLONIDINE FOLLOWING THE WEANING PHASE IN PATIENTS
UNDERWENT ELECTIVE ON-PUMP CARDIAC SURGERY: A PILOT STUDY
S. Caroleo*
1, F. Onorati
2, G. Santarpino
2, A. Renzulli
2, E. Santangelo
1, B. Amantea
1
1Reanimation,
2Cardiac Surgey Unit, University of Catanzaro, Catanzaro, Italy
INTRODUCTION. Alpha-2 adrenergic agonists reduce mortality and myocardial infarction
following vascular surgery. During cardiac surgery, they reduce ischemia and may also have
effects on mortality and myocardial infarction(1,2,3,4,5). Few data exist about the effects of
Clonidine following the weaning in this setting.
METHODS. Design: Analysis of a prospective, randomized and double blinded collected
database. Setting: Intensive Care Unit (ICU) in an University Hospital. Patients: A total of 40
patients aged 30–80 (31 M, 9 F; ASA II-III) submitted to elective on-pump cardiac surgery
from August 2007 to January 2008. Randomization: On ICU admission, once obtained a
preoperative informed consent, the patient was assigned to group 1 (Clonidine, intervention
group) or group 2 (Placebo, control group). Interventions: The patients of Group 1 received
intravenous (IV) bolus of Clonidine 0.5 microg/kg followed by continuous infusion of 1–2
microg/kg/h all over the weaning protocol phase. The patients of Group 2 received IV
continuous infusion of Sodium Chloride 0.9% all over the weaning phase. Data collection:
We evaluated hemodynamic parameters, Troponin I (TnI) blood levels, weaning parameters,
Delirium Detection Score (DDS) (6), weaning duration and ICU length of stay. The patients
were evaluated preoperatively, on ICU admission, after 6 h and 30 minutes after the start of
weaning protocol (7).
RESULTS. The preoperative and operative variables were comparable between the two
groups (p = NS for all measurements). The incidence of postoperative atrial ﬁbrillation was
lower in group 1 (p = 0.001). Following the weaning phase, Heart Rate, Central Venous
Pressure, Mean Pulmonary Arterial Pressure and Pulmonary Arterial Occlusion Pressure were
lower in group 1 (respectively p = 0.001, p = 0.001, p = 0.017 and p = 0.034). The TnI
levels was lower in group 1 (p = 0.05). The ratio of respiratory rate and tidal volume (RR/
TV) and the product of RR and pressure support (RR 9 PS) were lower in group 1 (both
p\0.001); the ratio of PaO2 and FIO2 (PA/FI) and PaCO2 blood levels were higher in the
treatment group (respectively p = 0.004 and p\0.001). DDS was lower in group 1
(p = 0.003). Weaning duration and ICU length of stay were similar in the two groups
(p = NS).
CONCLUSION. The use of Clonidine in this setting seems to reduce the stress-response
during the weaning phase, improving hemodynamic stability and myocardial protection.
REFERENCE(S). 1. Wijeysundera DN et al Am J Med. 2003 Jun 15;114(9):742–52.
2. Shirvinskas EK et al. Anesteziol Reanimatol. 2005 Nov-Dec;(6):56–8.
3. Myles PS et al. Anaesth Intensive Care. 1999 Apr;27(2):137–47.
4. Shilling AM et al. Anesthesiol Clin. 2006 Jun;24(2):365–79.
5. Boldt J et al. Heart 1996;76:207–213.
6. Otter H. et al. Neurocrit Care. 2005;2(2):150–8.
7. Mekontso-Dessap A et al. Intensive Care Med. 2006;32:1529–36.
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POST-INTUBATION TRACHEAL RUPTURE: A LITERATURE META-ANALYSIS
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INTRODUCTION. Various single cases and consecutive series of patients suggest that there
are risk factors related with post-intubation tracheal rupture. However we do not know the
association degree between them. The purpose of this study was to apply metaanalysis
methodology to evaluate risk factor related with post-intubation tracheal rupture and to study
prognostic variables.
METHODS. The design was a systematic review and a meta-analysis. The data source was
MEDLINE, years 1966 to 2006.Two independent reviewer screened studios for inclusion and
extracted data. Results are expressed as relative risk with 95% conﬁdence intervals. The
statistical signiﬁcance was assessed by the Pearson’s Chi-squared test with signiﬁcance
interpreted as a p value\0.05.
RESULTS. 51 studies totalling 182 patients met inclusion criteria. Sixty nine of patients were
diagnosed after surgical procedure and the rest of the cases were diagnosed during surgical
intervention. Females were more frequently reported but males showed a tendency towards
higher mortality than females (RR 2.38; 95% CI: 0.84–6.72; p = 0.09). Patients who died
were older than survivors although this association was not signiﬁcant. Post-intubation tra-
cheal rupture length was not associated with prognosis. Emergency intubations increased the
mortality in global population (RR 5.23; 95% IC: 2.19–12.60; p\0.05) and in extra-surgical
group (RR 5.07; 95% IC: 1.93–13.30; p\0.05). The absence of emphysema increased the
mortality risk (RR 3.93; CI: 1.53–10.12, p\0.05).
CONCLUSION. Post-intubation tracheal rupture is rare but potentially life-threatening
complication. The early diagnosis and treatment are inﬂuential in prognosis. Emergency
intubation is a risk factor which increases ﬁvefold the mortality risk. The training of physi-
cians who manage the air way may decreased the risk of post-intubation tracheal rupture.
0849
TWO-YEAR EXPERIENCE WITH SIMULATION-BASED TRAINING ON AIR-
WAYS MANAGEMENT
B. Zawadzki*, S. Gelbvaks, D. Paoli, B. Subsky, F. E. Nacul
CME, Centro de Treinamento Berkeley, Rio de Janeiro, Brazil
INTRODUCTION. Endotracheal intubation and ventilation can be life saving for a patient in
respiratory distress. Airways management is among the key requirements of appropriate
therapy in emergency and critically ill patients. Medical simulation used in combination with
traditional training methods can provide a comprehensive learning opportunity that allows the
clinician to safely learn, practice, and repeat the procedure until proﬁciency is achieved. Our
objective was to address the use of medical simulation as a way for medical learners to
acquire and maintain skills needed to manage difﬁcult airways; to evaluate the students
satisfaction with the course.
METHODS. The study was performed at Berkeley Training Center – Brazil, between August
2005 and February 2007, with a total number of 311 trainees. Trainees received a baseline
evaluation followed by an 8 h-training sessions that involved an introdutory lecture, a
computer-enhanced mannequin simulator, clinical scenarios for training procedural skills in a
difﬁcult airway algorithm, and instructor-facilitated debrieﬁngs. After ﬁnishing the course, the
trainees were retested and completed a numerical scale survey of their perceptions about our
course (1 = poor, 2 = fair, 3 = good, and 4 = excellent)
RESULTS. Performance improved signiﬁcantly after simulator training (48.5% vs. 72.7%,
p\0.001); 75% of participants scored less than 60% in the baseline evaluation while 25%
scored less than 65% in the retest; the course was considered excellent by 70% of the
participants and good by 29%.
CONCLUSION. The positive response to simulation–based training on airways management
found in this pilot study suggests that this training modality may be valuable in the training of
medical students and physicians. Most students considered the course excellent. Simulation-
based training is expected to become routine in many health care settings in the coming
decade.
REFERENCE(S). 1. Caplan R, Benumof J, Berry F. Practice guidelines for management of
the difﬁcult airway: a report by the American society of Anesthesiologists Task Force on
Management of the difﬁcult airway. Anesthesiology 1993; 78:597–602.
2. Hagberg CA. Instruction and learning of airway management skills. Anesthesiology 2000;
93: 1208A.
3. Rosen P, Sloane C, Ban KM, Lanigra M, Wolfe R. Difﬁcult airway management.Intern
Emerg Med. 2006;1(2):139–47.
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INTRODUCTION. Hospital acquired pneumonia are a common and severe complications of
Guillain Barre Syndrome, mainly related to aspiration and probably a delayed beginning of
mechanical ventilation. We reasoned that a strategy of early mechanical ventilation may
prevent pneumonia in these patients.
METHODS. Monocentre, randomised and controlled study. Inclusion criteria were: vital
capacity (VC)\60 % of predicted values, impossibility to lift the head, onset of symp-
toms\7 days. The exclusion criteria were: Presence of signs of respiratory distress, age\18-
years, coma, haemodynamic instability, pneumonia, pregnancy. Patients were randomised to
early ventilation (EV) or to ‘‘classic ventilation’’ (CV). Early ventilation strategy consisted in
proposing non invasive ventilation (NIV) if no swallowing impairment were identiﬁed or
invasive (IV) if swallowing impairments were present at inclusion. If non invasive ventilation
was used ﬁrst, secondary apparition of swallowing trouble indicated intubation. In classic
ventilation group, indication for intubation was let to physician’s judgement.
RESULTS. 39 patients were included, 22 in the EV group (11 NIV/11IV) and 17 in the CV
group (10IV/7 Not ventilated). Neurological presentation was similar in the two groups.
Global percentage of pneumonia was 48 % (54 % in the EV group and 42 % in the CV group).
No signiﬁcant difference was identiﬁed between the group EV and the ventilated patients in
the CV group (54 % vs. 70 %, p = 0.8). The percentage of early pneumonia was 32% in the
EV group and 29 % in the CV group. There was no difference between the groups, CV and
EV, concerning the durations of invasive and no invasive ventilation, also for the duration of
hospitalisation in ICU and mortality.
CONCLUSION. At this stage the EV strategy is not associated to an increase of the fre-
quency of pneumonia. There remains possible that it allows decreasing them. The study will
thus be pursued until 50 patients are included as previously calculated.
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IS TONGUE WEAKNESS AN INDICATOR OF BULBAR DYSFUNCTION AND
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INTRODUCTION. Because swallowing impairment may worse respiratory weakness and
conduct to respiratory complications as aspiration pneumonia in Guillain–Barre ´ syndrome
(GBS), we prospectively evaluate how tongue weakness could be an early indicator of bulbar
dysfunction and respiratory failure in severe GBS patients.
METHODS. Tongue protrusion strength (using a force transducer), dysphagia and respira-
tory parameters (vital capacity, maximal inspiratory and expiratory pressures) were
prospectively measured in 16 GBS patients at ICU admission and discharge and in 7 controls.
RESULTS. Tongue strength was decreased in the GBS patients (279 ± 226 versus
745 ± 147 g, P = 0.0006). At admission, patients with dysphagia (199 ± 165 versus
537 ± 166 g, P = 0.021) and those requiring MV (198 ± 185 versus 414 ± 202 g,
P = 0.0393) had greater tongue weakness. All the patients with initial tongue strength less
than 150 g both had dysphagia and required MV during ICU stay. Tongue strength also
correlated signiﬁcantly with respiratory parameters: Vital capacity (r
2 = 0.505, P = 0.0001),
Pemax (r
2 = 0.366, P = 0.0017) and strongly with Pimax (r
2 = 0.597, P\0.0001).
CONCLUSION. This study conﬁrm that monitoring bulbar dysfunction is a major challenge
in respiratory evaluation in GBS. Tongue weakness is present early in severe GBS. Tongue
strength lower than 150 g may indicate higher respiratory risk. Tongue strength measurement
may help to identify bulbar dysfunction and patients at high risk for respiratory complications.
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EMERGENCY AIRWAY MANAGEMENT USING THE BONFILS INTUBATION
FIBERSCOPE
R. M. Corso*, G. Gambale
Emergency Dept., Anaesthesia and intensive Care Section, Ospedale GB Morgagni-Pieran-
toni, Forlı `, Italy
INTRODUCTION. Emergency physicians are frequently called on to provide quick airway
interventions for extremely severe patients, with acute respiratory failure or unclear airway
from different causes. Direct laryngoscopy remains the mean way for securing the airway
patency in emergency. Standard tracheal intubation, however, may not provide a deﬁnitive
airway in every patient with a difﬁcult airway. We evaluated the feasibility of the Bonﬁls
ﬁberscope intubation for emergency airway management.
METHODS. The Bonﬁls intubation ﬁberscope (Karl Storz GmbH,Tuttlingen, Germany) is a
reusable, rigid, straight ﬁberoptic device with a 40  curved tip, 40 cm long and 5 mm in
diameter. A ﬂexible eyepiece is mounted on the handle of the scope. The ﬁberscope has a
connector that ﬁts onto the 15-mm tracheal tube adapter and thereby allows oxygen insuf-
ﬂation. A cold light source or a small battery handle can be attached to the stylet handle. The
tip of the Bonﬁls intubation ﬁberscope is positioned just proximal to the tip of the attached
endotracheal tube, thereby preventing the lens to be soiled with some amount of blood and/or
secretions. We report our experience of use of the Bonﬁls intubation ﬁberscope in emergency
department (ED) in patients with difﬁcult airway.
RESULTS. During one year, 10 adult patients underwent endotracheal intubation (cardiac
arrest n = 2, multiple injuries n = 2, acute respiratory failure n = 6) with the Bonﬁls intu-
bation ﬁberscope. At the ﬁrst attempt all intubations were successfully completed, even in two
patients (1 cardiac arrest and 1 with multiple injuries) with difﬁcult airway (Cormack-Lehane
grade 4 under direct laryngoscopy). In trauma patients, with cervical immobilization, collar
did not need to be unfastened or removed for endotracheal intubation. In all cases we
administered a ﬂow of 6 liter/min of oxygen throught the appropriate channel to decrease the
fogging of the view. The procedure time ranged from 20 to 35 seconds.
CONCLUSION. Despite these promising series, physicians should be trained with Bonﬁls
device in elective situations (for example in OR) before the use in emergency. The learning
time seems to be short and the presence of a supervisor instructor is sufﬁcient to achieve
adequate skillness. The Bonﬁls intubation ﬁberscope conﬁrms to be an additional airway
management device in emergency setting too.
REFERENCE(S). 1. Bein B, Yan M, Tonner PH, PH, Scholz J, Steinfath M, Do ¨rges V.
Tracheal intubation using the Bonﬁls intubation ﬁbrescope after failed direct laryngoscopy.
Anaesthesia 2004;59:1207–1209.
2. C. Byhahn, D. Meininger, F. Walcher, C. Hofstetter, B. Zwissler. Prehospital emergency
endotracheal intubation using the Bonﬁls intubation ﬁberscope. European journal of Emer-
gency Medicine 2007,14:43–46.
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INTRODUCTION. Unconscious patients are in a state that is difﬁcult to deﬁne, are they
alive or dead? Van Gennep (1960) termed situations that cannot be deﬁned into a clear cut
known category as ‘‘liminal state’’.In neurosurgical intensive care units, nurses commonly
take care of unconscious patients. There is limited research regarding attitudes of nurses
towards the unconscious patient.
Purpose of the study. To identify how nurses, in neurosurgical intensive care units, deﬁne the
state of the unconscious patient and what are their attitudes and coping strategies in caring for
these patients.
METHODS. A questionnaire was constructed, based on Van Gennep theory, literature
review and the clinical experience of the researchers and was distributed to nurses, working in
neurosurgical intensive care units in 4 medical centers .
RESULTS. Main RESULTS. 56 responded to the questionnaire (50% response rate). 62% of
nurses have academic degree, 43% work over 10 years in neurosurgery ICU and 70% non
religious.
The majority of the nurses (66%) deﬁne the unconscious patient as being alive, 2% as dead
and 32% as ‘‘not dead and not alive’’ meaning ‘‘liminal state’’. In spite of considering the
unconscious patient as being alive, nurses have negative attitudes and feelings towards the
patient. Positive statistical correlations (p\0.01) were found between negative feelings and
attitudes and coping strategies of the nurses, such as avoidance. Coping strategies are learned
between the nurses in the unit and seniority is a major factor.
CONCLUSION. Nurses have complex feelings towards the unconscious patient and in spite
of knowledge and experience, they have a great need to develop coping strategies and
behavioral norms, in order to continue to deal with theses patients and to maintain the unit
cultural structure.
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INTRODUCTION. Inefﬁcient pain control is a major issue after burns. Side effects of
opioids are often reported. The present study aimed at measuring the impact in burns of a
protocol driven prescription of opioids including hypnosis on the intensity of pain, and the
patients’ anticipation of the painful treatments. The study also aimed at quantifying the
various parts of the process through standardization of pain assessment, opioid drugs and
doses.
METHODS. Before and after trial design, including paired cases, matched for sex, age,
burned %BSA and inhalation. Inclusion criteria: age[18 years, ICU stay[24 h, and to
accept hypnosis. Pain treatment: standardized opioid prescription with a pain control objec-
tive based on multiple daily visual analog scale (VAS) assessments. Opioids were converted
to morphine equivalents: procedural and basal opioids were recorded separately. Clinical
outcome variables as well as economical data were recorded.
RESULTS. 46 patients aged 36 ± 14 years and burned 27 ± 15 %BSA were included—the
groups were well matched. The ﬁrst hypnosis session was carried out as a median after
9 days: as a mean 3.6 preparation sessions per patient were required before a painful pro-
cedure could be carried out. Pain and opioid treatment could be quantiﬁed: the protocol
resulted in the delivery of higher early opioid doses during the ﬁrst 10 days in the ICU, and a
latter reduction of the requirements. It was associated with a signiﬁcant reduction of pain
scores in the intervention group. Hypnosis resulted in signiﬁcant reduction of number of
procedures under anaesthesia, of mean daily VAS, and of procedural related anxiety with
trends to shorter stay in ICU and hospital. Total grafting requirements were signiﬁcantly
reduced (p = 0.014), as were hospital costs per patient.
CONCLUSION. The pain protocol improved pain treatment in burned patients, reduced
anxiety, and was associated with better wound healing, trends to shorter ICU and hospital stay
and reduced costs. The systematic assessment and structured prescription of opioids improved
patient care without side effects.
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SUBGLOTTIC STENOSIS POST OROTRACHEAL INTUBATION
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INTRODUCTION. Long-term airway management is a complex problem, and the subject of
unresolved controversy. The literature suggests that translaryngeal intubation, considered the
standard initial airway support may be associated with a higher incidence of infectious
complications, longer weaning times from the ventilator and with damage to the trachea and
laryngeal structures. The cricothyrotomy is indicated in emergency airway in situations when
translaryngeal intubation can0t be achieved.
METHODS. A 20 years old man with personality disorders was envolved in a motor vehicle
collision. Because of severe craniofacial injury the pre hospital medical team performed a
translaryngeal intubation and was transported to hospital. He had a Traumatic brain injury, C7
spinal fracture, multiple face bone fractures, and open fracture of the left femur. Was admitted
in ICU, staying entubated and ventilated for 10 days. Was transferred on the 12th day to the
orthopedics department extubated and in spontaneous ventilation. At the 57th day he began
respiratory and stridor that did not respond to pharmacologic therapy. He developed severe
respiratory acidosis and progressive confusion. Facing this problem we have decided to
proceed to an orotracheal intubation. Despite presenting a grade 1 laryngoscopy the oro-
tracheal tube didn0t progress below the vocal cords. Several attempts were made with smaller
size orotracheal tubes (including TTn 3), but none of them passed the cords. Progressively the
patient became difﬁcult to ventilate.
RESULTS. Suddenly he had a cardiopulmonary arrest (CPA), with pulseless electrical
activity (PEA); advanced life support (ALS) maneuvers were started and cricothyotomy was
performed. After 30 min of ALS algorithm, he regained pulse with sinus rhythm and was
transferred to the O.R to perform tracheostomy. During this procedure the patient has new
CPA that reversed after 5 cycles of ALS. Transferred to ICU being discharged after 48H with
good evolution. He was conscious cooperative oriented in space and time, without focal
neurological deﬁcits. The endoscopic examination revealed a subglottic stenosis (degree V).
CONCLUSION. Early experience revealed that prolonged translaryngeal intubation is
associated with irreversible damage to laryngeal and vocal cord structures. The most common
cause of the trachea stenosis in adults is by iatrogenic injury after intubation. The stridor
appears when the lumen of the trachea is less than 5 mm.
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INTRODUCTION. Neurogenic pulmonary edema (NPE) is a well recognised complication
of subarachnoid hemorrhage (SAH) and severe traumatic brain injuries. The incidence of NPE
was reported to be 6% in a serie of 457 patients with SAH [1]. NPE is characterized as an
acute, protein-rich lung edema occuring shortly after cerebral injury. NPE may compromise
hemodynamic, decrease cerebral blood ﬂow and increase cerebral vasospasm witch increase
the morbidity of SAH. Yet, the precise pathogenetic mechanisms remain unclear, but the role
of sympathic storm may be the most important cause.
METHODS. We report two patients with neurogenic pulmonary edema and cardiac failure
after subarachnoid hemorrhage treated with intra-aortic balloon pump counterpulsation
(IABP) therapy.
RESULTS. Case 1: A 51 year old man was admitted in cardiac intensive care unit for cardiac
arrest with pulmonary edema. Coronarography was normal. CT scan showed an extensive
SAH with intraventricular hemorrhage and secondary hydrocephalus. Initial Glasgow coma
scale was 3 (Hunt & Hess grade V). Cerebral angiography showed an aneurysm of the anterior
communicant artery. Chest radiograph showed frank pulmonary edema. Echocardiography
showed acute severe left ventricular dysfunction (ejection fraction (EF) 25%) associated with
left ventricular apical ballooning (takotsubo-like myocardial dysfunction). The PaO2/ FIO2
ratio was 75 on admission. Despite conventional treatment (mechanical ventilation, dobuta-
mine) IABP was necessary to treat cardiac failure and pulmonary edema. Four hours after the
insertion of IABP, PaO2/ FIO2 ratio was 315. Left ventricular EF reached 50% 12 h after
insertion. The IABP was removed after 17 hours. Despite embolization of the aneurysm and
treatment of intracranial hypertension by decompressive craniectomy, the patient death
occurred at day 8.
Cas 2 :A 46 year old woman was admitted in ICU for SAH (Hunt & Hess grade IV). Her
medical past history included diabetes, hypertension, coronaropathy (EF 50%)and she was
treated with clopidogrel and acetyl salicilyc acid. Ten hours after admission, she developed
arterial hypotension and pulmonary edema (cardiogenic and neurogenic). PaO2/ FIO2 ratio
was 150. At day two, despite conventional therapy (mechanical ventilation and high dose of
dobutamine, norepinephrine, epinephrine), EF was less than 20%. IABP was inserted to
optimize hemodynamic function. Three hours after the insertion of the IABP, infusion of
dobutamine, norepinephrine, epinephrine was stopped. Than the IABP was removed after four
days. The patient was extubated at day 13, and was discharged of the ICU at day 18 with EF
45% and a good cardiac and neurologic outcome.
CONCLUSION. These two cases illustrate the potential usefulness of the intra-aortic balloon
pump counterpulsation as an adjunctive therapy in neurogenic pulmonary edema and cardiac
failure after subarachnoid hemorrhage.
REFERENCE(S). 1. Solenski NJ, Haley EC Jr, Kassell NF, Kongable G, Germanson T,
Truskowski L, et al. Medical complications of aneurysmal subarachnoid hemorrhage : a
report of the multicenter, cooperative aneurysm study. Participants of the Multicenter
Cooperative Aneurysm Study. Crit Care Med 1995; 23: 1007–17.
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INTRODUCTION. Intensive insulin therapy (IIT) to achieve normoglycemia in ICU
remains controversial, especially because of the risk of severe hypoglycemia (\2.2 mmol/l),
which appeared to be statistically associated with poor outcome (1,2).
METHODS. In our ICU, an insulin algorithm aimed to reach strict glucose control
(\6.1 mmol/l) in patients under mechanical ventilation (MV) is part of our standard practice.
Patients with an effective duration of MV C 48 h were consecutively included during two
periods between November 2006 and August 2007. Continuous intravenous (IV) insulin
infusion was administered without a dedicated perfusion line during the ﬁrst period (DPL-
period) and on a dedicated perfusion line during the second period (DLP + period). Insulin
administration on a dedicated perfusion line with no additional catheter was made possible by
using the multilumen connector Octopus
  (Vygon, Ecouen France) directly connected to the
hub of the peripheral catheter or one of the perfusion lines of a central venous catheter.
RESULTS. 100 patients were included, 50 during the DPL- period and 50 during the
DPL + period. Age (66 in the DPL- group vs. 64 in the DPL + group), admission SAPS II (52
vs. 55), percentage of medical patients (78% vs. 80%) and patients with prior history of
diabetes (22 vs. 22%) or requiring vasopressors (66% vs. 78%), and glucose level at
admission (9.8 vs. 8.7 mmol/l) were not signiﬁcantly different between the 2 groups. Nor-
moglycemia (deﬁned by a mean glucose level B 6.1 mmol/L during IIT strategy) was
obtained in 76 and 80% of the patients of the DPL- group and DPL + group, respectively
(p = 0.81). Episodes of severe hypoglycemia (24 in the DPL-group vs. 4 in the DPL + group,
p = 0.01) and percentage of patients with at least one episode of severe hypoglycemia (22%
vs. 6%, p = 0.02) were signiﬁcantly reduced in the DPL + group. ICU mortality was similar
between the 2 periods (36% vs. 40%).
CONCLUSION. In patients under IIT strategy, a dedicated perfusion line to administer
insulin infusion signiﬁcantly reduced the incidence of severe hypoglycemia.
REFERENCE(S). 1. Van den Berghe G, et al. Intensive insulin therapy in the medical ICU.
N Engl J Med 2006; 354: 449–61.
2. Brunkhorst FM, et al. Intensive insulin therapy and pentastarch resuscitation in severe
sepsis. N Engl J Med 2008; 358: 125–39.
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INTRODUCTION. Recent clinical trials demonstrated that tight glycemic control improved
the modality and mortality in critically ill patients (1,2). The present study was aimed at
examining whether hyperglycemia would augment bacterial translocation through abnormal
alterations of intestinal microﬂora by using a quantitative real-time RT-PCR method in en-
dotoxemic rats.
METHODS. Twenty-one male Wister rats (200–250 g), intravenously infused of lipopolysac-
charide(4 mg/kg)afterpreparatorysurgery,wererandomly assignedtothreegroups:salinegroup
(Group S: n = 6) receiving saline solution, hyperglycemia group (Group G: n = 7) receiving
40% glucose solution, and glucose-insulin group (Group GI: n = 8) receiving 10% glucose
solution with insulin (0.5 IU/kg/h). All solution was infused at 10 ml/kg/hr for 3 hrs. After
laparotomy was performed under sterile condition, mesenteric lymph nodes (MLNs) and cecal
contents were collected and RNA was extracted for quantitative real-time RT-PCR analysis (3).
RESULTS. Total counts of bacteria in MLNs were signiﬁcantly higher in Group G versus
Group S (Figure). Those in Group GI appeared to be reduced versus Group G, but did not
reach to statistical signiﬁcance. No signiﬁcant differences in total cell counts of intestinal
microﬂora (log10counts/g-contents) were found among three groups (Group S 10.3 ± 0.6,
Group G 10.2 ± 0.3, Group GI 10.8 ± 0.1). Each component of microﬂora including Clos-
tridium, Bacteroides, Biﬁdobacterium, Lactobacillus, Enterobacteriacae, Enterococcus,
Staphylococcus and Pseudomonas was not signiﬁcantly different between the study groups.
CONCLUSION. Hyperglycemia is a major contributor to the augmentation of bacterial
translocation not via modulating intestinal microﬂora in endotoxemia.
REFERENCE(S). 1. N Engl J Med 2001;345:1359.
2. N Engl J Med 2006;354:449.
3. Appl Environ Microbiol 2007;73:32
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INTRODUCTION. The aim of this study was to assess the effect of glutamine dipeptide-
supplemented TPN (Glu-TPN) on tight glycemic control in critically ill patients compared
with a standard TPN (S-TPN) using a time series analysis.
METHODS. Entry criteria: Adult patients in ICU requiring TPN for 3or more days and
APACHE II score[12. Exclusion criteria: Malnutrition or obesity, chronic renal or hepatic
failure, immunocompromised patients and poor life expectancy. Both groups received iso-
nitrogenous and isocaloric TPN. Nutritional needs were calculated: 0.25 g N kg
-1 d
-1 and
25 kcal kg
-1 d-1. Glu-TPN group received 0.5 g kg-1 d-1.of glutamine dipeptide and the S-
TPN group a similar amount of aminoacids. Vitals, sepsis and septic shock on admission, type
of patient and daily calories administered. A tight glycemic control protocol was placed using
a target plasmatic glycemia of 120 mg/dL. Hourly glycemia and the hourly dose of insulin
was recorded at least 15 times a day. After an exploratory analysis, glycemia and insulin
values were depurated. We apply six different time series models to ﬁnd the model that better
ﬁts using the Root Mean-Square Error (RMSE) between patients and individual determina-
tions. A hierarchical mixed model, with two levels, patient and measurement, was applied to
identify the effect of insulin dose and the type of diet. A lineal and sinusoidal model was used
to assess the circadian rythm.
RESULTS. 117 patients received any intervention, 53 assigned to Glu-TPN and 64 to S-TPN.
Baseline characteristics were similar in both groups. Plasmatic glycemia was 149 ± 46 in
Glu-TPN and 155 ± 51 in S-TPN group (p\0.04) and mean hourly insulin dose was
4.3 ± 3.3 in Glu-TPN and 4.7 ± 3.7 in S-TPN group (p\0.001). The best model of ﬁtness
was an ARMA (1,2) with a RMSE of 24.5. The effect of insulin dose on plasmatic glycemia
was best measured using a regression model with autocorrelation with one previous mea-
surement (b =- 0.94; p\0.0001). When looking to the effect of the different diets, Glu-
TPN group needed lesser insulin than the S-TPN group (b S-TPN minus b Glu-TPN = –0.54;
p\0.0001), that means a 54% reduction of the amount of insulin for the same levels of
plasmatic glycemia. We were unable to ﬁnd circadian differences between the dose of insulin
in both groups.
CONCLUSION. Glutamine dipeptide supplemented parenteral nutrition for more than
3 days signiﬁcantly reduces the needs of insulin (54%) to obtain a tight glycemic control in
critically ill patients.
GRANT ACKNOWLEDGEMENT. Supported by an unrestricted grant from Fresenius
Kabi Spain.
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INTRODUCTION. Intensive insulin therapy (IIT) has been shown to decrease the morbidity
and mortality in patients in the intensive care unit (ICU). However, application of IIT is
associated with an increased risk of severe hypoglycemia. Therefore adequate and precise
assessment of glucose levels is a prerequisite when implementing IIT.
The aim of the present study was to assess the effect of time between sampling and the
measurement of blood glucose levels.
METHODS. In a prospective study, 15 consecutive patients were included. From every
patient blood was simultaneously collected in three different containers: 2 ml sodium ﬂuo-
ride/potassium oxalate, (Greiner ); 4 ml lithium heparin, (Greiner
 ); and 3 ml arterial blood
sampler with balanced heparin (70 IU), (Bayer
 ). Blood glucose levels were measured
immediately after sampling and 10, 20, 30, 45 and 60 minutes thereafter.
Changes in glucose levels on several time points per container type and differences of glucose
levels between the three containers were analyzed using Friedman’s and Mann Whitney U
tests. A p-value\0.05 was considered statistically signiﬁcant.
RESULTS. The median blood glucose level of all 15 patients at baseline was 5.8 mmol/L.
Subsequently it decreased to 5.7, 5.6, 5.6, 5.4, and 5.2 mmol/L at T = 10, 20, 30, 45 and 60
minutes, respectively (p\0.01). This signiﬁcant decrease in time was observed in all three
container types (p\0.01). There were no signiﬁcant differences between the three different
container types at the different time points.
CONCLUSION. The level of blood glucose decreases signiﬁcantly with increase in time
between sampling and assessment of samples. This ﬁnding is of major importance in the ICU
when applying IIT. We therefore recommend that only point of care glucose measurements
should be used.
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INTRODUCTION. Glucose is routinely monitored and treated with insulin to reduce hyper-
glycemia. With the availability of advanced point-of-care equipment it is possible to
simultaneously determine glucose and lactate in arterial samples taken for glucose control.
Glycolysis converts glucose into pyruvate, and pyruvate can be converted into lactate. Thus
changes in glucose levels can affect lactate levels. The relation between glucose and lactate has
not been studied in detail. Since lactate is of prognostic importance in several classes of critically
ill patients, distinguishing a relation with glucose levels may be of relevance. We evaluated the
relationoflactatewithglucoseinacohortofpatientsadmittedtotheICUafteropenheart surgery.
METHODS. From May 2007 through February 2008 all ﬁrst admissions to the thoracic ICU
after coronary artery bypass and/or valve replacement were evaluated. Glucose was regulated
with the GRIP-computer program that adjusts the insulin infusion in order to aim at glucose
levels of 4.0–7.5 mmol/L. Glucose and lactate were determined in samples from arterial lines
with a Radiometer 800 series analyzer. To discern if a relation between glucose and lactate
might vary according to duration of ICU stay, two phases were deﬁned: early: from 0 h tot
12 h after ICU admission and late: from 12 h to 2 days. For each patient, the mean glucose
and mean lactate over these phases were calculated before further analysis. For both phases
we assessed the relation between glucose and lactate with univariate analysis after which
multivariate analysis was performed. Hospital survival was used as outcome measure.
RESULTS. Over the study period 542 patients (70% males) with a mean age of 65 ±
13 years were included. Hospital mortality was 3.5%. A total of 4304 paired glucose and
lactate measurements were available during the ﬁrst 48 h. Glucose decreased from 8.4 ±
1.5 mmol/L to 6.8 ± 0.8 mmol/L from the early to the late phase (p\0.001). Lactate
decreased from 1.4 ± 1.1 to 1.2 ± 0.5 mmol/L for the early and late phase(p\0.001). The
Spearman coefﬁcient for the correlation between glucose and lactate was 0.44 and 0.25 for the
early and late phase (both p\0.001). Upon multivariate analysis including phase, mean
glucose, maximum glucose, age and sex, only phase of ICU stay and mean glucose were
independent determinants of lactate. During the early phase glucose was 8.4 ± 1.4 and
10.5 ± 3.8 in survivors and non-survivors respectively (p\0.001). Lactate levels for these
groups were 1.4 ± 0.6 and 3.9 ± 4.5 mmol/L respectively (p\0.001).
CONCLUSION. Lactate levels are positively related with glucose levels after open heart
surgery. This may result from a direct metabolic relation between glucose and lactate or it
may result from an association between hyperglycemia and impaired hemodynamics.
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THE CGAO SOFTWARE IMPROVES GLYCAEMIC CONTROL IN INTENSIVE
CARE PATIENTS WITHOUT INCREASING THE INCIDENCE OF SEVERE
HYPOGLYCAEMIA NOR THE NURSE WORKLOAD
O. Gontier, M. Hamrouni, T. Lherm*, G. Monchamps, A. Ouchenir, P. Kalfon
Re ´animation polyvalente, Centre Hospitalier de Chartres, Chartres, France
INTRODUCTION. Acute hyperglycaemia associated with insulin resistance is common in
critically ill patients. Tight control of blood glucose is considered important, although difﬁcult
to perform in routine care. Moreover, concerns remain about the risk for severe hypoglyca-
emia, with reported rates up to 20% and the increased nurse workload due to frequent check
of the blood glucose level imposed by usual protocols for achieving tight glycaemic control
with hourly measurements when the blood glucose target is not reached. We demonstrated
elsewhere that the software CGAO was more effective for achieving tight glycemic control
than a conventional method based on daily medical prescriptions. The software CGAO does
not only recommend an insulin rate but also the time for the next control of the blood glucose
level with an interval between 30 min to 4 h. The aim of the study was to evaluate the use of
the software CGAO during routine care in terms of efﬁcacy, safety and nurse workload.
METHODS. Since May 2006, we used routinely the software CGAO, a preliminary version
based on a PID (Proportional Integral Derivative) controller (LK2, Saint-Avertin, France). All
the blood glucose levels with the date and time of the measurement, the insuline rates actually
applied by the nurse, and all the quantitative changes of the nutritional intake were auto-
matically stored in a database permitting to calculate numerous parameters for each stay in the
ICU, such as the mean and the standard deviation of the blood glucose level, the hypergly-
caemic index calculated above 6.1 mmoles/l, the fraction of time with hyperglycaemia[6.1
mmoles/l, and the mean daily insulin requirement during the whole stay. The nurse workload
was quantitatively evaluated by the mean sampling interval for the blood glucose control. The
results are presented as mean ± standard deviation and/or median and interquartile range.
RESULTS. Between July 2006 and October 2007, we analysed 546 ICU stays during which
the software CGAO was used (mean age: 62.7 ± 18.4 years, SAPS 2: 42.5 ± 20.6). There
were a total of 30,366 glucose measurements (mean blood glucose level of 7.0 ± 2.6 mmoles/
l) representing 86,773 h of operation and 3,490 patient days. With the ICU stay being the unit
of analysis, the fraction of time above 6,1 mmoles/l was 55 ± 24% (median and interquartile
range : 58 % [40–70%]) and the mean daily insulin requirement was 64 ± 54 UI. There was
only 40 episodes of severe hypoglycaemia (\2.2 mmoles/l) representing 1.3/1000 mea-
surements occurring in 36 patients (6.6 %). The mean sampling interval for the blood glucose
control was 166 ± 35 min.
CONCLUSION. The software CGAO improves glycaemic control in critically ill patients
with a relatively low incidence of severe hypoglycaemia and without increasing the nurse
workload. The benchmarking of different computerized glucose control systems should
include criteria permitting to explore these three ﬁelds : efﬁcacy, tolerance, and nurse
workload.
REFERENCE(S). 1. Van den Berghe G et al, Intensive insulin therapy in the medical ICU. N
Engl J Med 2006;354:449–61.
2. Kalfon P et al, Improvement of glycemic control in critically ill patients with the software
CGAO. Intensive Care Med 2007; 33 supp 2, SP197 (ESICM 2007).
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TIGHT GLYCAEMIC CONTROL IN CRITICALLY ILL PATIENTS – FEASIBILITY
TRIAL OF CLINICIP CS-2 DECISION SUPPORT SYSTEM
J. Cordingley*
1, N. Dormand
1, S. Squire
1, L. Chassin
2, M. Wilinska
2, M. Wufka
3,
D. Roethlein
3, N. Kachel
3, C. Morgan
1, R. Hovorka
2
1Adult Intensive Care Unit, Royal Brompton Hospital, London,
2Department of Paediatrics,
University of Cambridge, Cambridge, United Kingdom,
3, B Braun, Melsungen, Germany
INTRODUCTION. Tight blood glucose (BG) control reduces morbidity and mortality in
critically ill patients (1) but is difﬁcult to achieve safely with current insulin administration
algorithms. A software enhanced model predictive control algorithm (eMPC) that provides
advice on insulin infusion rate and time to next glucose measurement (running on a bedside
computer) has been shown to be safe and effective over 72 h in critically ill patients (2). This
study investigated the effectiveness over 24 h of a decision support system (CLINICIP CS-2)
that comprises the eMPC algorithm integrated into a device that includes infusion pumps for
enteral and parenteral feeding and insulin (B Braun Space system). The decision support
system provides automatic transfer of data concerning carbohydrate and insulin administra-
tion from the infusion pumps to the algorithm and is controlled via a graphical user interface
that includes a display of glucose concentration history and reminder alarms.
METHODS. 10 adult patients admitted to ICU at RBH after elective cardiac surgery (mean age
64.5 yrs, weight 80.5 kg, APACHE II med 13) with hyperglycaemia (glucose[6.7 mmol/L),
were treated with intravenous insulin infusion as advised by the decision support system. The
decision support system requires input of bodyweight, carbohydrate input, current insulin
requirements and BG concentration. The system advises time to next BG measurement, (max-
imum 4 h) and insulin infusion rate targeted to maintain BG at 4.4–6.1 mmol/L.
RESULTS.
TABLE 1
• BG, study entry* (mmol/L) 7.5 (0.5)
• BG, mean* (mmol/L) 5.8 (0.3)
• HGI ([6.1)* (mmol/L) 0.4 (0.2)
• BG\3.3 mmol/L (n) 3
• BG\2.2 mmol/L (n) 0
• Study time* (hrs) 21.2 (3.1)
• Time to target range* (mins) 194 (160)
• % time in target range* (%) 48.2 (25.0)
• BG sampling interval* (mins) 87 (10)
* mean (SD), HGI - hyperglycaemic index
CONCLUSION. The CS-2 decision support system provided effective blood glucose control
with an acceptable glucose sampling interval.
REFERENCE(S). 1. Van den Berghe G, et al. Intensive insulin therapy in the critically ill
patients. N Engl J Med. 2001;345:1359–67.
2. Pachler C, et al.Tight glycaemic control by an automated algorithm with time-variant
sampling in medical ICU patients. Intensive Care Med. 2008 Feb 23; [Epub ahead of print].
GRANT ACKNOWLEDGEMENT. CLINICIP-EC 6th Framework integrated project
(www.clinicip.org).
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INTENSIVE INSULIN THERAPY INCREASES 28-DAY AND HOSPITAL MOR-
TALITY IN LEAST SEVERELY ILL PATIENTS
P. Wiesen*
1, P. Devos
1,C .M e ´lot
2, J. C. Preiser
1
1Department of General Intensive Care, University Hospital Centre, Liege,
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INTRODUCTION. Tight glucose control by Intensive Insulin Therapy (IIT) failed to
improve survival in two large multi-centre randomized controlled trials (1,2). Nevertheless,
the lack of efﬁcacy of IIT on the global population does not exclude possible beneﬁts on
subgroups with a given severity at admission.
METHODS. In the prospective randomized Glucontrol controlled trial, patients older than
18 years admitted in one of the 21 European participating intensive care units (ICU) were
randomized into two groups: IIT (glucose target 80–110 mg/dl) or conventional group (CIT,
glucose target: 140–180 mg/dl). The patients were stratiﬁed according to the APACHE II
score at admission into 6 strata, score\11 (n = 165), 11–15 (n = 269), 16–20 (n = 171),
21–25 (n = 123), 26–30 (n = 62), score[30 (n = 39)). ICU, hospital and day 28 mortality
have been compared by treatment group stratiﬁed by APACHE II score (Mantel-Haentzel
test) and within each stratum (chi square).
RESULTS. The comparative analysis of the data from 829 patients (mean age
61.6 ± 16.6 years, men 63.5%, median APACHE II: 15 (6–43), ICU and hospital length of
stay (10.5 ± 12.6 and 24.7 ± 26.8 days)) showed an higher hospital and 28-day mortality in
the IIT patients than in the CIT patients of the APACHE II 11–15 stratum (table). However,
the comparison stratiﬁed by APACHE II score did not demonstrate signiﬁcant differences
between treatment groups (respective p-values by Mantel-Haentzel = 0.22, 0.09 and 0.07).
ICU
mortality
CIT Hospital
mortality
CIT 28-day
mortality
CIT
IIT IIT IIT
APACHE II 11–15 10.4 5.2 18.5 9.7* 13.4 5.2*
APACHE II 16–20 18.0 16.7 21.6 22.0 20.5 19.5
APACHE II 21–25 29.7 29.3 42.2 34.5 34.4 28.1
APACHE II 26–30 46.2 27.8 56.0 33.3 38.5 22.2
*p\0.05 (chi square)
CONCLUSION. These data suggest a worsened outcome in a low severity group receiving
IIT. Although no causal relationship can be deducted from these data, detrimental Effects of
treatment-induced hypoglycaemia can be suggested. In any case, the present data do not
support the recommendation of widespread tight glucose control by IIT.
REFERENCE(S). 1. N Engl J Med 2008; 358:125.
2. Intensive Care Med 2007; 33:S189 (abstract).
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PROGNOSTIC FACTORS OF KETOACIDOSIS IN A MEDICAL INTENSIVE CARE
UNIT
S. Motaouakkil*, A. Hachimi, A. Benslama, B. Charra
Medical Intensive Care Unit, Ibn Rochd University Hospital, Casablanca, Morocco
INTRODUCTION. The diabetic ketoacidosis represents a frequent cause of hospitalization
in medical ICU. The purpose of this study is to specify the prognostic factors of diabetic
ketoacidosis.
METHODS. It is a prospective study performed during 2 years (2006–2007). The inclusion
criterions were diabetic patients hospitalized in MICU who had dehydration, GCS\13 with
glycemia[2,5 g/L, pH\7,35, massive glucosuria and qualitative ketonuria. The clinic,
biologic, therapeutic and evolutive data have been collected. We identiﬁed two groups:
survivors and dead patients. The quantitative variables are expressed on average ± standard
derivation, and the qualitative variables by percentage. The univariate analysis was based on
Chi-square test for the qualitative variables and Student test for the quantitative variables. A
multivariate analysis using the models of logistic regression has been also realized. The
statistic analysis has been based on SPSS 11.0.
RESULTS. During the period of study, 100 patients have been hospitalized for diabetic
ketoacidosis. The mean age was 42 ± 17,6 with a sex-ratio (F/M) of 1,4. The mortality rate
was 13 %. At univariate analysis, we have identiﬁed the following prognostic factors: low
systolic arterial pressure (p = 0,4), APACHE II (p = 0,03), SAPS II (p\0,001), length of
stay (p = 0,001), quantity of isotonic saline (p\0,001) and septic shock (p = 0,02). The
independent prognostic factors were SAPS II\17 (OR = 0,81; CI (95 %): 0,67–0,98;
p = 0,03), length of stay\3 days (OR = 0,53; CI (95 %): 0,31–0,89; p = 0,01) and
quantity of isotonic saline\3 l (OR = 0,26; CI (95 %): 0,07–0,95; p = 0,04).
CONCLUSION. The factors that we conclude from our study as being the factors of bad
prognosis permit a better understanding of the causes of death and so, a better management of
the patients.
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BLOOD GLUCOSE CONTROL ON ICU: COMPARISON OF DIFFERENT INSULIN
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INTRODUCTION. In cardiac-surgery patients intensive insulin therapy and maintaining
blood glucose (BG) levels within normoglycaemia markedly reduces mortality. We compared
the effectiveness of three published insulin protocols: absolute glucose value based approach
(Mathias Protocol; MP), relative glucose change approach in combination with four glucose
ranges (Bath Protocol; BP) and the new fully automated model predictive controller (eMPC2)
algorithm with variable sampling interval.
METHODS. 120 consecutive post-cardiac surgery patients were investigated for 48 h on
admission to ICU. Forty patients were randomized to each of the three protocols. The target
BG range for all three protocols was 4.4–6.1 mmol/L. Arterial BG samplings were taken
according to each protocol.
RESULTS. The algorithms showed the differences in the effectiveness of BG control. While
there was no difference between MP and BP in entire study mean BG (6,7 ± 0,8 resp.
6,5 ± 1,0 mmol/l), eMPC2 algorithm performed signiﬁcantly better (5,9 ± 0,8 mmol/l;
p\0,05). Also time to normoglycaemia was signiﬁcantly shorter for eMPC2 (10,9 ± 6,1 vs.
12,3 ± 9,2 vs. 8,8 ± 5,4 h; p\0,5). In normoglycaemia maintaining after reaching target
range both BP and eMPC2 protocols performed equally (5,8 ± 0,7 vs. 5,2 ± 0,8 mmol/l)
compare to MP (6,2 ± 0,7 mmol/l), there were no signiﬁcant difference in sampling interval
(2,1 ± 0,3 vs. 1,8 ± 0,6 vs. 2,3 ± 0,3 h), in clinically important hypoglycemic events (1 vs. 2
vs. 0 event), but in % of time under target range (10,9 ± 8,8 vs. 13,1 ± 7,9 vs. 22,2 ± 4,6 %
of time; p\0,05).
CONCLUSION. First, all evaluated insulin protocols were safe with respect to hypoglyca-
emia. Secondly, both absolute glucose value based approach and relative glucose change
approach were comparably effective in BG management, while signiﬁcantly more effective
control of BG showed predictive eMPC2 algorithm. The higher % of time under target range
in eMPC2 group did not show any clinical importance in our study, but further studies in
larger cohorts of patients are needed to determine whether such hypoglycaemia is out of any
clinical importance.
REFERENCE(S) 1. Laver S, Preston S, Turner D, et al: Implementing intensive insulin
therapy: development and audit of the Bath insulin protocol. Anaesth Intensive Care. 2004
Jun;32(3):311–6.
2. Hovorka R, Kremen J, Blaha J, et al: Blood glucose control by a model predictive control
algorithm with variable sampling rate versus a routine glucose management protocol in
cardiac surgery patients: a randomized controlled trial. J Clin Endocrinol Metab. 2007
Aug;92(8):2960–4.
GRANT ACKNOWLEDGEMENT. This study was supported by grant of Charles Uni-
versity in Prague – GAUK 44407.
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EFFICACY AND USER ACCEPTANCE OF AN AUTOMATED ALGORITHM
[EMPC] IN AN INTERACTING INFUSION PUMP SYSTEM FOR THE ESTAB-
LISHMENT OF GLYCAEMIC CONTROL
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INTRODUCTION. The presence of hyperglycaemia in hospitalised patients indicates an
increased risk for mortality and morbidity. Single-center trials have demonstrated that tight
blood glucose improves prognosis for ICU patients. However, normoglycaemia is not easy to
establish in this environment and multicenter trials were stopped due to the increased rate of
hypoglycaemia. The objective of the present trial was to investigate the performance of a
newly developed decision support system for the establishment of tight glycaemic control in
medical ICU patients for a period of 72 h.
METHODS. The study was conducted as a single-center, open, non-controlled clinical
investigation in ten mechanically ventilated patients. After admittance to the ICU blood
glucose values were monitored and the CS-1 Decision Support System (interacting infusion
pumps with integrated algorithm eMPC controlled via a graphical user interface) was used to
adjust the infusion rate of intravenously administered human soluble insulin to normalize
arterial blood glucose (4.4–6.1 mM).
RESULTS. Percentage of time in target and mean blood glucose under treatment with the
CS-1 System were 47.04% (± 13.05) and 6.08 mM (± 0.73), respectively. The average
hourly insulin need was 4.2 IU (± 2.78) and the carbohydrate content of enteral and par-
enteral nutrition 7.47 g/h (± 1.98). No single hypoglycaemic episode (\2.2 mM) occurred.
Eleven times (1.5% of all given advice) the nurses did not follow and, thus, overruled the
advice of the CS1 system. According the results of a conducted survey the majority of nurses
(19 vs. 2) stated that glucose control was more efﬁcient to handle as using the regular
protocol. Several technical malfunctions of the device (repetitive error messages and missing
data in the data log) owing to communication problems between the new hardware compo-
nents were shortcomings of the present version of the device.
CONCLUSION. The performance of this prototype CS-1 Decision Support System was from
a clinical point of view already effective in maintaining tight glycaemic control and well
accepted by the ICU nursing staff. With improvement of technical stability the CS1 system
has the capacity to serve as a reliable tool for routine establishment of glycaemic control for
critical ill patients
GRANT ACKNOWLEDGEMENT. CLINICIP-EC 6th Framework integrated project
(www.clinicip.org).
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LIMITED EVIDENCE OF MAJOR COMPLICATIONS OF HYPOGLYCEMIA DUE
TO TIGHT GLYCEMIC CONTROL. A SYSTEMATIC REVIEW OF THE
LITERATURE
H. F. Borggreve*, J. G. Zijlstra, J. J. M. Ligtenberg
Department of Critical Care, University Medical Center Groningen, Groningen, Netherlands
INTRODUCTION. It has been shown that tight glycemic control (TGC) results in reduced
morbidity and mortality in intensive care in selected patient groups. Concern about the
associated increase in hypoglycemia limits the implementation of TGC and was one of the
reasons to discontinue 2 multi-centre trials to the effects of TGC. We wonder if the effects of
incidental hypoglycemia in ICU-patients justify us to be anxious to implement TGC. To solve
this question, we review the literature for observed consequences of hypoglycemic episodes in
critically ill patients.
METHODS. We performed a search of the PubMed and Embase databases for full text
papers of clinical trials to glycemic control in ICU-setting mentioning possible consequences
of hypoglycemia. In case one or more eligible studies used the data of the same study-group,
only the most relevant paper was selected.
RESULTS. 23 full text papers, concerning 12,023 patients, were judged to be appropriate for
our systematic review. Though hypoglycemia is common, the episodes were often reported to
be short. Possible severe adverse effects were described in 17 of 609 (2.8%) patients expe-
riencing hypoglycemia in 16 studies - a certain relation between the hypoglycemia and the
event could not be ascertained. Seven other studies stated over 726 hypoglycemic episodes in
6,359 patients and did not result in any complications. Hypoglycemia coincided with a higher
mortality; nevertheless, we did not ﬁnd sound evidence that conclude TGC-induced hypo-
glycemia was directly responsible for the higher mortality.
CONCLUSION. We found little evidence in the literature of severe adverse effects of
hypoglycemia associated with TGC in ICU-patients that might offset the beneﬁts of TGC.
A high quality and safe TGC-protocol is always needed to limit the number and duration of
hypoglycemic episodes. Fear of possible severe consequences of hypoglycemia should not
keep us from further studying TGC.
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INTRODUCTION. Increased blood glucose levels are frequently observed in patients
undergoing cardiac surgery procedures, with or without diabetes. Intensive insulin therapy
decreases mortality, length of hospitalization and number of complications as it has been
shown in recently published studies. Many protocols have been developed to implement tight
glycaemic control. The aim of this study was to compare blood glucose control by the
automated model predictive algorithm with variable sampling interval (eMPC2) with a rou-
tine glucose management protocol (RP) in the peri- and postoperative period in cardiac
surgery patients.
METHODS. Sixty patients were included in this study (41 men, 19 women, mean age
69 ± 7, BMI 27.9 ± 2.6 kg/m
2). Duration of the study was 72 h. All patients underwent an
elective cardiac surgery procedure and were treated from the beginning of the surgery with a
continuous insulin infusion to maintain glycaemia in a target range of 4.4–6.1 mmol/l. 30
patients were randomized for treatment using the eMPC algorithm and 30 patients for routine
protocol management. Blood glucose was measured in 1- to 4-h intervals as requested by each
algorithm during surgery and postoperatively. Statistical analysis - the patients from different
groups were compared using ANOVA followed by Holm-Sidak test, Student t-test or Mann–
Whitney U-test as appropriate. The signiﬁcance level was set at p = 0.05.
RESULTS. Mean blood glucose was signiﬁcantly lower in the eMPC group vs. RP group
(5.99 ± 0.32 vs. 6.54 ± 0.47 mmol/l, p\0.05). Percentage of time in the target range was
signiﬁcantly higher in eMPC group vs. RP group (60.9 ± 9.5 vs. 45.1 ± 12.3 %, p\0.05).
No signiﬁcant difference was found in average insulin infusion dose - eMPC group vs. RP
group (3.21 ± 1.66 vs. 3.4 ± 1.55 IU/hour, p = 0.7) or in average sampling interval - eMPC
group vs. RP group (2.04 ± 0.17 vs. 1.96 ± 0.17 hour, p = 0,09). No severe hypoglycaemia
(deﬁned as a blood glucose level of 2.2 mmol/l or less) in either group occurred during the
study.
CONCLUSION. eMPC algorithm is comparably safe as compared to a routine glucose
management protocol with respect to hypoglycaemia. The results of our study suggest that
eMPC algorithm is more effective in maintaining euglycaemia in peri- and postoperative
periods in patients undergoing cardiac surgery procedure.
REFERENCE(S). Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy
in the surgical intensive care unit. N Engl J Med 2001; 345:1359–1367.
GRANT ACKNOWLEDGEMENT. This study was supported by grant of Charles Uni-
versity in Prague – GAUK 44407.
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INTRODUCTION. Strict glucose control has been shown to decrease mortality in intensive
care patients, with maximum beneﬁt being seen in those patients who achieve the target of 4.4
– 6.1 mmol/l (1). However, concerns about hypoglycaemia have resulted in some commen-
tators recommending the use of wider target ranges.
This survey was designed to map current practice in UK adult intensive care units.
METHODS. All UK adult intensive care units (ICUs) in the Directory of Critical Care (2007)
were contacted by telephone (between October 2007 and February 2008). The nurse in charge
of the unit was surveyed using a predeﬁned questionnaire.
RESULTS. 283 (99%) of the 286 UK ICUs took part in this survey. Of these, 243 (86%) had
a written policy for glucose control. The upper limit for the glucose target range is shown in
Table 1. Insulin was given by intravenous infusion by all but one unit which used intravenous
boluses. 255/264 (97%) ICUs used arterial blood glucose monitoring. Of 9 that did not use it,
8 used capillary monitoring and 1 used venous monitoring. Bedside glucometers were used by
153/264 (58%) units. Of these 75 (49%) used them exclusively, though 76 (50%) combined
them with use of the blood gas machine. 110 (42%) units used the blood gas machine alone.
Laboratory assays were used by only 5 (3%) units and always in conjunction with either a
glucometer or blood gas machine.. 126 (52%) of units used a sliding scale to determine insulin
dose, whilst 90 (37%) used algorithms (dynamic protocols) that adjusted dose according to
rate of change of blood glucose. Of the remainder the insulin dose was decided by the nurse at
the bedside in 25 (10%) units and 2 units used other methods.
TABLE 1
Upper limit of blood glucose target range (mmol/l) Number (%) of units
\= 6.1 80 (32%)
6.2–7.0 83 (33%)
7.1–8.3 67 (27%)
[8.3 18 (7.3%)
CONCLUSION. The vast majority of UK ICUs have a written policy in place for imple-
menting strict glucose control, and for most the upper limit of the blood glucose target range
is B7 mmol/L. Arterial blood glucose is monitored by almost all ICUs, most commonly using
bedside glucometers though blood gas analysers are also used. Wide variation exists in the
methods used to determine insulin dose, with most units using simple sliding scales.
REFERENCE(S). 1. Van den Berghe G, Wilmer A, Milants I, Wouters PJ, Bouckaert B,
Bruyninckx F, Bouillon R, Schetz M (2006) Intensive insulin therapy in mixed medical/
surgical intensive care units: beneﬁt versus harm. Diabetes 55: 3151–9.
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CARDIOPULMONARY BYPASS EFFECTS ON MICROCIRCULATION AS
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INTRODUCTION. Patients undergoing cardiac surgery with cardiopulmonary bypass (CBP)
may develop a systematic inﬂammatory response syndrome in the post-operative period,
considered to be the result of a complex immunologic reaction consisting of humoral, cellular
and hemostatic factors, caused by an imbalance of pro and anti inﬂammatory mechanisms.
Vascular endothelial cells perform a pivotal role in mediating the response to this systemic
inﬂammation and the cross talk between coagulation and inﬂammation. The effect of this
inﬂammatory response on the peripheral microcirculation per se has yet to be thoroughly
investigated. The purpose of our study was to assess the potential effects of CBP on the
microcirculation of cardiac surgery patients, as assessed non-invasively by Near Infrared
Spectroscopy (NIRS).
METHODS. We compared parameters of the microcirculation as obtained with the help of In
Spectra Model 325 Near-Infrared Spectrometer (NIRS) in 12 cardiac surgery patients
(Standard Euroscore 6 ± 4, Logistic Euroscore 9.1 ± 11.5), before the surgical procedure
and 6 h post-operatively. Tissue oxygen saturation (StO2%) values of the thenar, deltoid and
masseter muscles were noted and the brachial vascular occlusion technique was utilized to
better assess the endothelial function, with the calculation of the oxygen consumption rate
(CR), the reperfusion rate (RR) and the vascular reactivity (VR). Haemodynamic parameters
were obtained with the use of a Swan-Ganz catheter.
RESULTS. The patients’ baseline haemodynamic values post-operatively were
MAP 82 ± 10 mmHg, CVP 8 ± 4 mmHg, PCWP 11 ± 4 mmHg, MPAP 23 ± 6 mmHg, CI
2.5 ± 1.2 L/min/m2, SVR 1427 ± 535 dyne x s/cm5, PVR 247 ± 134 dyne 9 s/cm5, HR
93 ± 18 bpm, Hb 11.9 ± 1.4 g/dl, lactate 2.6 ± 2 mg/dl, ScvO2 75 ± 8 %, SvO2 70 ± 4
%. The microcirculation parameters at baseline post-operatively were CR 19 ± 10%/sec, RR
246 ± 188%/s, VR 38 ± 21%*sec, thenar StO2 80 ± 9%, deltoid StO2 64 ± 27%, masseter
StO2 65 ± 26%. We found a statistically signiﬁcant decrease in the CR values post-opera-
tively (CR 19 ± 10%/s versus 32 ± 16 %/s pre-operatively, P = 0.005). As the h after
surgery progressed, the CR improved and six h post-operatively did not differ signiﬁcantly
from preoperative values. A similar difference was noted in RR (246 ± 188%/sec versus
640 ± 263 preoperatively, P = 0.004), with the value at 6 h not differing statistically from
preoperative values.
CONCLUSION. The microcirculation of patients having undergone cardiac surgery with
CBP, as assessed by NIRS, is affected, and tends to return to the preoperative state as time
from surgery progresses. As the inﬂammatory process occurring during CBP has been
associated with a serious increase in morbidity and mortality, the potential introduction of a
non-invasive monitoring technique of the microcirculation to perioperative monitoring could
possibly aid in the better understanding and management of this condition.
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POSTOPERATIVE PLATELET COUNT DECLINE IS A PROGNOSTIC MARKER
IN CARDIAC SURGERY
D. Filipescu*
Cardiac ICU, Institute of cardiovascular diseases, Bucharest, Romania
INTRODUCTION. Platelet count decline occurs frequently after on-pump cardiac surgery
(1). Decline in platelet count in intensive care unit (ICU) patients provides prognostic
information (2). The aim of our study is to investigate the platelet count decline post cardiac
surgery and the correlation with the perioperative risk scores.
METHODS. We prospectively studied consecutive cardiac patients operated on pump during
the year 2007. The data registered were: age, gender, type of surgery, EUROSCORE, daily
platelet count during ICU stay, APACHE II score on admission in ICU and daily SOFA.
Patients with preoperative thrombocytopenia (platelet count\150 9 109cells/L) were
excluded. Results were expressed as mean value and standard deviation. For statistical cor-
relations the Pearson test was used.
RESULTS. 318 patients with on pump cardiac surgery were analyzed: 214 (67.3%) males and
104 (32.7%) females, age 55.5 ± 14.7 years. 202 (63.5%) patients developed postoperative
thrombocytopenia. The evolution of postoperative platelet count is illustrated in ﬁg.1. Mean
platelet count declined 27.8% in day 1, 33.4% in day 2, 36.2% in day 3 and 29.1% in day 4
compared to the preoperative value. The peak platelet decrease in postoperative day 3 was
higher in female than in male patients: 40.5% versus 32.8% (p\0.05). Older patients
([65 years) had a decrease of the platelet count of 42.1% compared to 35.3% in younger
patients (p\0.05). The percentage decrease of the platelet count in postoperative day 3
compared with preoperative values is signiﬁcantly correlated with EUROSCORE, APACHE II
score on admission and SOFA score (p\0.01). Patients with EUROSCORE 0–2 have a 30%
decreaseof theplateletcountinday3, SOFAscore2.2 ± 2.2 andAPACHEII score7.1 ± 3.6.
Patients with EUROSCORE 3–5 have a 35.5% decrease of the platelet count, SOFA score
2.8 ± 2.4 and APACHE II score 9.1 ± 4.1. Patients with EUROSCORE[6 have a 46.2%
decrease of the platelet count, SOFA score 4.7 ± 3.0 and APACHE II score 11.7 ± 4.4.
CONCLUSION. In our postoperative cardiac patients the highest percentage of platelet count
decline was registered in day 3(36.2%). Older patients and female patients had a higher
decrease of the platelet count. The percentage of platelet count decline is correlated with
EUROSCORE, APACHE II and SOFA scores. Postoperative platelet count decline could be a
prognostic marker in cardiac surgery.
REFERENCE(S). 1. Warkentin TE. et al. Ann Thorac Surg 2003;76(6):2121.
2. Moreau D. et al. Chest 2007;131:1735.
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IMPACT OF DISSEMINATED INTRAVASCULAR COAGULATION AFTER CAR-
DIOPULMONARY BYPASS ON POSTOPERATIVE EXCESSIVE BLOOD LOSS
AND PULMONARY MORBIDITY; BASED ON INTERNATIONAL SOCIETY ON
THROMBOSIS AND HAEMOSTASIS (ISTH) SCORING SYSTEM
S. Yoon*
1, Y. Jeon
2, J. H. Bahk
2, Y. J. Lim
2, C. S. Kim
2, S. I. Lee
1
1Anesthesiology, Korea University,
2Anesthesiology, Seoul National University, Seoul, South
Korea
INTRODUCTION. The stimulation of ﬁbrinolysis during cardiopulmonary bypass (CPB)
appears to contribute to the postoperative coagulopathy. Widespread vascular injury fol-
lowing CPB may result in uncrolled platelet activation, thrombin generation. However, it is
difﬁcult to deﬁne the occurrence of disseminated intravascular coagulopathy (DIC) after CPB
due to the absence of diagnostic criteria of DIC. Recently, ISTH has proposed an overt and
nonovert DIC scoring system, based on the outcome of several laboratory tests (1).
Therefore, the aim of present study was to investigate the incidence of overt DIC after CPB
using ISTH scoring system. And another aim of the study was to examine whether the overt
DIC after CPB was related to the post CPB excessive blood loss and morbidity.
METHODS. To estimate the ISTH score FDP, ﬁbrinogen, prothrombin time, and platelet
count were measured in (a) Time 1; before initiation of CPB, (b) Time 2; on admission to
ICU, and (c) Time 3; 1st postoperative day. The occurrence of over DIC was determined
when the ISTH score was 5. The 24-h postoperative blood loss and transfusion requirement
were documented. The deﬁnition of excessive blood loss (EB) in ICU was greater than 1L
blood loss for 24 h. The D-dimer levels before and after the CPB, postoperative oxygen index,
intubation time, ICU stay were also documented.
RESULTS. DIC was not occurred at time point 1 and 3 in all enrolled patients. In time point
2, ISTH score was over 5 in 31 patients (D group), below 5 in 63 patients (C group). The D-
dimer level after CPB, intubation time, and ICU stay were signiﬁcantly higher in D group.
The oxygen index on 1st postoperative day was lower in D group. The incidence of EB and
proportion of patients transfused were higher in D group.
CONCLUSION. The overall incidence of post-CPB DIC was 33%. The post-CPB DIC was
related to post-operative pulmonary morbidity and blood loss
REFERENCE(S). 1. Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M. Towards deﬁ-
nition, clinical and laboratory criteria, and a scoring system for disseminated intravascular
coagulation. Thromb Haemost. 2001;86(5):1327–30.
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DETERMINANTS OF ACUTE RENAL FAILURE AFTER SURGERY
S. M. Quevedo*, F. J. Abelha, M. Botelho
Anaesthesia, Hospital de Sao Joao, Porto, Portugal
INTRODUCTION. Development of Acute Renal Failure (ARF) during perioperative period
is associated with increases in morbidity and mortality. Our aim was to evaluate incidence,
determinants and outcome in patients with previous normal renal function who developed
ARF in the immediate postoperative period.
METHODS. Observational, prospective study conducted in a post-anesthesia care unit
(PACU) with 5 intensive care beds from March to August 2006. Patients were followed for
the development of ARF deﬁned as creatinine blood levels higher than 20mg L
-1 during the
ﬁrst 24 h after PACU admission. Patients’ demographics, intra- and postoperative data were
collected. We also recorded PACU and hospital length of stay (LOS) and mortality.
RESULTS. A total of 326 patients were studied. Eleven patients developed ARF. Age (OR
11.6, 95%CI 1,46–91.51, p = 0.020 for age C 65 years), high risk surgery (OR 4.05, 95%CI
1.06–15,57, p = 0.042), ischemic heart disease (OR 3.88, 95%CI 1.11–13,54, p = 0,034),
ASA physical status (OR 7.61, 95%CI 2.07–28.0, p = 0.002 for ASA IV/V patients) and total
Revised cardiac Risk Index (RCRI) sore (OR 1.93, 95%CI 1.17–3.19, p = 0.011) were found
to be independent predictors for development of ARF in the immediate postoperative period.
Score of Acute Physiology Score II (SAPS II) was signiﬁcantly higher in ARF patients
(p\0.001). In hospital mortality of these patients was higher (27% vs. 4%, p = 0,001).
CONCLUSION. This study shows that age, high risk surgery, ischemic heart disease, ASA
physical status and RCRI score are risk factors for the development of ARF in the ﬁrst 24 h in
patients needing intensive care after surgery. ARF has serious impact in hospital and PACU
mortality.
REFERENCE(S). 1. Anesthesiology 2007;107:892–902.
2. J Vasc Surg 1993;17:357–368.
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EXTENDED INVESTIGATIONS OF THE PRODUCT CHARACTERISTICS DEM-
ONSTRATE THAT THE STATE-OF-THE-ART PROTHROMBIN COMPLEX
CONCENTRATE OCTAPLEX
 IS STABLE WHEN STORED AT ROOM
TEMPERATURE
L. Hoffer*
1, J. Weinberger
2, C. Kannicht
1, L. Pichler
3, T. Svae
3,J .R o ¨misch
1
1Research and Development,
2Quality Control,
3International Market Access, Octapharma
PPGmbH, Vienna, Austria
INTRODUCTION. The state-of-the-art prothrombin complex concentrate Octaplex
  has
been used safely and successfully for the prophylaxis and treatment of acquired deﬁciency of
factors of the prothrombin complex. Storage of the product at room temperature (RT) is
desirable, promoting increased transport and storage convenience. Therefore, formal stability
studies and extended biochemical characterisations were performed to demonstrate product
integrity.
METHODS. Octaplex
  stability studies for 36 months at RT were conducted according to
ICH guidelines. Octaplex
  (containers, freeze-dried product) stored at RT was compared with
product containers kept cold (+2 to 8 C). Beyond investigation of prothrombin factors and the
proteins C and S, physicochemical parameters and markers of activation were performed. In
addition, the rabbit Wessler stasis model, an assay for the assessment of thrombogenic
properties was used to demonstrate the absence of elevated thrombogenic activity.
RESULTS. Throughout the entire study period all parameters assessed revealed excellent
stability complying with the product speciﬁcations. Samples stored at RT were indistin-
guishable from samples stored at +2 to 8 C. At a dose of 400 IU/kg body mass no signs of
thrombotic activity were found in the Wessler model.
CONCLUSION. The integrity of Octaplex
  was demonstrated upon storage for 36 months at
RT, substantiated by extended physicochemical and biochemical studies. Moreover, the
Wessler stasis model, did not indicate any elevated thrombogenic potency. Octaplex
  RT
storage for 2 years was recently granted in Germany.
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NEW METHOD DIAGNOSTICS COAGULATION DISORDERS AFTER SURGERY
O. A. Tarabrin*
1, B. S. Zaporozhchenko
2, V. N. Mazur
1, A. A. Gorbunov
2, A. A. Suhanov
1,
S. S. Shcherbakov
1
1Department of Anesthesiology and Intensive Care,
2Department of Surgery, Odessa Medical
University, Odessa, Ukraine
INTRODUCTION. Despite the evidence of perioperative hypercoagulability in cancer
patients, there are no consistent data evaluating the extent, duration, and speciﬁc contribution
of platelets and procoagulatory proteins by in vitro testing. This study compared efﬁcacy of
haemoviscoelastography versus thromboelasthgraphy for monitoring of coagulation
imbalance.
METHODS. 128 Patients undergoing surgery for abdominal cancer we examined the efﬁcacy
of a variety of coagulation tests. A complete coagulation screening, thromboelasthgraphy
(TEG) and haemoviscoelastography (HVG) were performed before and at the end of surgery.
RESULTS. We calculated the elastic shear modulus of standard MA (Gt) and HVG MA
(Gh), which reﬂect total clot strength and procoagulatory protein component, respectively.
The difference was an estimate of the platelet component (Gp). There was a 14% perioper-
ative increase of standard MA, corresponding to a 48% increase of Gt (P\0.05) and an 80–
86% contribution of the calculated Gp to Gt. We conclude that serial standard thrombo-
elastography and HVG viscoelastic test may reveal the independent contribution of platelets
and procoagulatory proteins to clot strength. Using multiple linear regression, all coagulation,
TEG and HVG variabities were used to model postoperative hypercoagulation. Results
showed that some components of the TEG failed to identify hypercoagulation (r\0.2,
P[0.75). All components of the HVG test reﬂect postoperative coagulopaties.
CONCLUSION. Hypercoagulability is not reﬂected completely by standard coagulation
monitoring and TEG and seems to be predominantly caused by increased platelet reactivity.
HVG provides a fast and easy to perform bedside test to quantify in vitro coagulation, may be
usefull in determining the coagulation status of cancer patients perioperatively.
REFERENCE(S). 1. Samama C. M. Anesthesiology 2001; 94: 74–8.
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EFFECTS OF PLATELET TRANSFUSION EVALUATED WITH ROTATIONAL
THROMBOELASTOMETRY
M. Engstro ¨m*
1, M. Rundgren
2, P. Flisberg
2
1Department of Anaesthesia and Intensive Care, Halmstad Central Hospital, Halmstad,
2Department of Anaesthesia and Intensive care, Lund University Hospital, Lund, Sweden
INTRODUCTION. Thrombocytopenia is a common complication of hematologic malig-
nancies, but it also accompanies other conditions, e.g. major blood loss. The clinical effects of
platelet transfusions has been debated and several efforts to evaluate the effects of such
transfusions. Previous evaluations have frequently focussed on the increase in platelet count
and on the viability of the transfused platelets after transfusions, while studies evaluating the
coagulation system after platelet transfusions are lacking. We have used ROTEM to evaluate
the effects of platelet transfusions given to thrombocytopenic patients.
METHODS. Ten patients suffering from leukemia and thrombocytopenia with a platelet
count below 50x10
9 /l scheduled for insertion of a central venous catheter (CVC) were
included in the study. The patients were planned to recieve one unit of platelets prior to
insertion according to hospital guidelines. Hb, platelet count, PT, aPTT and ROTEM analyses
were performed before and after transfusion of one unit of platelets. ROTEM analysis was
performed according to the INTEM procedure using the contact activator ellagic acid for
initiation of the coagulation process. Maximum Clor Firmness (MCF), Clot Formation Time
(CFT and Clotting Time (CT) were analysed.
RESULTS. Platelet count increased from a median value of 31,5 to 43 9 10
9/l. The ROTEM
parameter MCF was increased from 42 to 51.5 mm after transfusion (p = 0.005) and CFT
was decreased from 181.5 to 123 s (p = 0.005) while CT was unchanged. PT and aPTT were
unchanged.
CONCLUSION. MCF is primarily a measure of platelet activity so this study indicates a
positive effect of platelets when given to patients with a low platelet count. CFT reﬂects in
part platelet activity, but is is affected also by humoral coagulation factors. As PT and aPTT
together with the ROTEM parameter CT are unaffected it is likely that the effect on CFT is
also an effect of the increased platelet count.
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TROMBOELASTORGAPHIC DETECTION OF RECOMBINANT ACTIVATED
FACTOR VII EFFICACY
E. M. Shulutko*
ICU, National Research Center for Hematology, Moscow, Russian Federation
INTRODUCTION. During treatment of bleedings, related with different hemostasis
abnormalities, the average recommended dose of the rFVIIa (NovoSeven) medication
(90 mg/kg) may be inadequate or excessive. In the published papers it is possible to ﬁnd the
recommended doses from 60 up to 300 mg/kg. Serious adverse events (thrombosis) associated
with rFVIIa use occure than 1%. Nevertheless we need the objective method for the efﬁcacy
and safety control of this medication.
METHODS. In this study tromboelastography was used during the therapy of bleedings by
rFVIIa in the patients with different hemostasis abnormalities (thrombocytopenia, hemophilia
A with inhibitor to factor VIII, warfarin’s coagulopathy, hepatic coagulopathy, factor VII or
factor 9 deﬁciency) or without them. Blood samples of 47 patients were measured before,
15 min and 2 h after injection of the rFVIIa at average dose 90 mg/kg (60–160 mg/kg). The
dynamic of several TEG properties were measured: time to clot initiation (R), clot propa-
gation (K and a angle), clot tracings - maximum amplitude (MA) and the 30 minutes
ﬁbrinolysis. At the same time the platelet count, activated partial thromboplastin time
(APTT), prothrombin time (PT), thrombin time (TT) and ﬁbrinogen were controlled.
RESULTS. The improvement of the TEG indices was registered in 30 patients (64%), the
effect’s absence in 4 patients (8,5%), decreasing in 13 patients (27,5%). Two patients (4%)
have showed the excessive superﬂuous effect - signs of hypercoagulation. Fibrinolysis acti-
vation was registered in 2 patients (4%). The maximal improvement of the TEG indices was
showen in hemophilic patients with inhibitor to factor VIII, in patients with factor VII
deﬁciency and coagulopathy associated with oral anticoagulants intake or liver disease.
Signiﬁcant effect was obtained in patients with moderate thrombocytopenia (PLT[209109/
l). Absence or minimal effect was occurred in cases with severe thrombocytopenia
(PLT\209109/l), hypoﬁbrinogenemia (ﬁbrinogen\1,5 g/l) and particularly in cases of
combination of these conditions. In this cases transfusion of platelets and ﬁbrinogen-con-
taining medications, in addition to injections of rFVIIa, considerably improved the TEG
indices. The absence of the effect in 3 patients was due to acidosis and hypothermia. The
clinical effect did not always coincide with the TEG data: in 6 patients (13%) the break or
decrease of bleeding’s pace was noted while the laboratorial dates were not improve.
CONCLUSION. The effect of injection of the standard doses of rFVIIa is not always pre-
dictable as it correlates with several factors. TEG can be used as the complementary method
for the efﬁcacy estimation and for dose selection of rFVIIa, for the choice of optimal com-
bination with other means of hemostasis correction and to reveal undesirable effects as
hypercoagulation, hemostasis depletion, ﬁbrinolysis, their correction and prophylaxis.
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POINT OF CARE PLATELET MONITORING IN THE OPERATING THEATRE
S. Agarwal*, D. Royston
Department of Anaesthesia, Hareﬁeld Hospital, Uxbridge, United Kingdom
INTRODUCTION. Platelet dysfunction during cardiac surgery leads to increased blood loss
and transfusion requirements and may result in reopening of patients. Dysfunction may be due
to many causes including the effect of anti platelet medication (aspirin and clopidogrel). Point
of care monitoring of platelet function may help to identify those patients at risk and guide
appropriate therapy.
METHODS. We assessed platelet function in the operating theatre in ten patients having off
pump coronary artery bypass grafting using two methods—the plateletMapping TEG
TM (Hae-
moscope, IL) and the Multiplate analyzer (Dynabyte, Munich). The multiplate analyser is a
multiple electrode whole blood aggregometer which uses a single test cell with 2 separate
impedance sensors per test. Aggregation was triggered with ADP (6.4 mcmol, ADP test) and
Arachidonic Acid (0.5 mM, ASPI test). Platelet function was quantiﬁed by the Area Under the
aggregation Curve (AUC).The plateletMapping TEG
TM is a modiﬁcation of the TEG
TM which
allows the calculation of the percentage of platelets inhibited by ADP receptor antagonists or
aspirin. It uses factor XIIIa and reptilase to form a clot without thrombin generation in hepa-
rinised blood. The resulting maximum amplitude of the clot is dependant on platelet agonists
(either ADP or Arachidonic Acid) added to the blood. These agonists attempt to stimulate
platelet aggregation and clot formation. If the platelets are inhibited aggregation will not occur.
Platelet function was quantiﬁed by the percentage of platelets inhibited.
RESULTS. The instruments gave results which correlated well with each other particularly
when looking at the dysfunction due to aspirin. As expected those who had stopped aspirin for
5 days had near normal function, whilst those who had only stopped it for a day had almost
completely inhibited platelets. The ADP results were less conclusive—2 patients had stopped
clopidogrel 5 days before but were shown on both tests to have inhibition of platelet function.
TABLE 1 PLATELET FUNCTION DEMONSTRATED BY TEG AND MULTIPLATE
(NA, NEVER TOOK CLOPIDOGREL)
Patient
number
TEG AA
inhibition (%)
AA
AUC
Days stopped
aspirin
TEG ADP
inhibtion (%)
ADP
AUC
Days stopped
clopidgrel
1 7.8 538 5 51.4 442 5
2 9.4 461 5 8 478 NA
3 10.8 510 5 76.3 286 NA
4 20.3 382 5 94.9 0 5
5 25.3 402 5 15 126 NA
6 56.4 247 3 9 468 NA
7 61.6 461 3 96.9 4 5
8 83.5 0 3 11 452 NA
9 95.7 0 1 12 468 NA
AA correlation =-0.91, p = 0.001, ADP correlation =-0.73, p = 0.01, selection of
result
CONCLUSION. In this small pilot study we have demonstrated that both of these instruments
have potential to be used as point of care monitors of platelet in the perioperative setting when
looking at the effects of anti platelet medication. This testing has potential to be used in the pre
operative setting to identify those patients at risk of severe bleeding and plan accordingly
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BASE DEFICIT IS RELATED TO MORTALITY IN MASSIVE TRANSFUSED
TRAUMA PATIENTS UNDERGO TO DAMAGE CONTROL SURGERY AND 1:1
RED BLOOD CELLS/FRESH FROZEN PLASMA RATIO TRANSFUSION
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INTRODUCTION. Damage control surgery is an accepted approach for severe trauma
patients management. Recent retrospective reports have shown a probable decreased mortality
with 1:1 red blood cells (RBC)/fresh frozen plasma (FFP) ratio transfusion. Our objective was
to determine which factors were associated to mortality in massive transfused trauma patients
undergo to damage control surgery in a population subjected systematically to coagulopathy
correction with the 1:1 strategy.
METHODS. DAMACON is a prospective registry of severe trauma patients subjected to
damage control surgery in a I trauma level hospital in Colombia between 2000 and 2007.
Patients receiving more than 5 red blood cells packs in the ﬁrst 24 h were identiﬁed as
massive transfused and included for analysis. General demographic variables, type of trauma,
volume of blood derivates, physiologic and laboratory variables at ICU admission and 24 h
after, and 30 day mortality were collected. Data were tested for normality and analyzed by
unpaired t tests or Mann-Whitney U test as appropriated. Results are expressed as means or
medians. Variables with p value\0.03 in the univariate analysis were included in a multi-
variate logistic regression for further analysis of predictors of mortality.
RESULTS. Fifty three patients subjected to damage control surgery and receiving poli-
transfusion registered in DAMACON database were identiﬁed and included for analysis.
30 days mortality was 41.5%. Signiﬁcant differences for RTS and PT and base deﬁcit at 24 h
were observed for survivors and non survivors. No signiﬁcant differences in ATI, ISS, trauma
mechanism, RBC/FFP ratio and other physiologic and laboratory variables at ICU admission
and 24 h after trauma were found. After multivariate analysis only base deﬁcit maintained
signiﬁcant difference (OR 0.62, 95%IC 0.43–0.91).
TABLE 1
Survivors, n = 31 Non survivors, n = 22 p
ATI (IQ 25–75) 25 (20.5–38.0) 33 (20.5–48.5) 0.22
ISS (IQ 25–75) 26 (19.5–34.0) 34 (25.0–38.0) 0.09
RTS (IQ 25–75) 7.84 (7.84–7.84) 7.55 (6.38–7.84) 0.004
Penetratingtrauma, n% 24 (77.4) 16 (72.7) 0.75
PT 24 h (IQ 25–75) 13.5 (12.0–15.0) 16.0 (13.0–19.0) 0.02
RBC/FFP ratio 1.35 (0.87–2.06) 1.38 (0.66–2.57) 0.92
BE 24 h (IQ 25–75) -6.3 (-8.2 to -4.4) -12.4 (-20.12 to -9.1 \0.001
CONCLUSION. In patients with severe trauma subjected to damage control surgery and to a
1:1 RBC/FFP ratio transfusion strategy, persistent acidosis demonstrated by base deﬁcit at 24
h was associated with a higher mortality. Future research efforts should be carried out
focusing on the early improvement of perfusion variables.
0881
CLINICAL SIGNS AND RISK FACTORS OF ACUTE DEEP VEINS THROMBOSIS
OF LOWER EXTREMITIES IN PATIENTS AFTER ABDOMINAL SURGERY FOR
CANCER. EFFICIENCY AND SAFETY OF DIFFERENT TYPES OF ANTICOAG-
ULANT THERAPY
O. A. Tarabrin*
1, V. V. Suslov
2, V. N. Mazur
1, A. A. Suhanov
1, S. S. Shcherbakov
1
1Department of Anesthesiology and Intensive Care, Odessa Medical University, Odessa,
2Department of Anesthesiology and Intensive Care, Kiev Medical University, Kiev, Ukraine
INTRODUCTION. Background of our research was to conduct the retrospective analysis of
clinical signs and risk factors of acute deep veins thrombosis (ADVT) of lower extremities,
and to compare effectiveness and safety of therapy of LMWH enoxaparin and UFH in patients
after abdominal surgery for cancer.
METHODS. For period from 2003 to 2008 the diagnosis of ADVT was set for 318 patients,
among them 156 (49.4%) men and 162 (50.6%) women. Among patients with ADVT with
primary localization in ileofemoral and popliteal segments which treated in the departments
of vascular surgery prevailed senior persons more than 60 years old (62.7%). All of patients
with ADVT got therapy with anticoagulants. Enoxaparin sodium was prescribed in 240
(74.9%) cases, UFH in 56 (17.3%) and in 22 (7.8%)—others LMWH. Were have analysed
efﬁciency and complications after antithrombotical therapy in a hospital period. A complete
coagulation screen, activated clotting time(ACT), thromboelasthography (TEG) and lowfre-
quency haemoviscoelasthography (HVG) were performed to reveal coagulation disturbances.
RESULTS. In 82.6% cases the most frequent symptoms of disease are an edema of extremity
(in 79.1%) and pain syndrome 74.1% wich at a monosymptomal variant (37.7% patients), are
marked in 67.5% and 46.4% accordingly. Most frequent risk factors (RF) they had the
prolonged (more than 8 days) immobilization and malignant tumors. Therapy of UFH and
LMWH was effective (on the average a good result is got in more than in 75% cases) enough.
Enoxaparin treatment was related to considerably less of hemorrhagic complications, than
treatment of UFH (p\0.05), that concerned all of types of such complications.
CONCLUSION. Efﬁciency of anticoagulant therapy (decreasing of the number of ascending
thrombosis, recurrent DVT, and episodes of pulmonary embolism (PE) was identical at
enoxaparin and UFH groups, however in cases of enoxaparin application regress of clinical
signs in was rapider. Treatment of with enoxaparin as compared to UFH accompanied with
reduced frequency of all hemorrhagic complications in 2.1 times, serious in 2.7 times and
moderate in 3.1 times. HVG is effective point-of-care monitor for routine clinical practice and
clinical research.
REFERENCE(S). 1. Samama C.M. Anesthesiology 2001:94:74 – 8.
2. Tarabrin O. EJA 2006:23: Suppl 37:84.
GRANT ACKNOWLEDGEMENT. European Union, European Society of Intensive Care
Medicine.
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EFFECTS OF MORPHINE AND DEXMEDETOMIDINE ON COAGULATION IN
POSTOPERATIVE PATIENTS
M. Cengiz*, M. Yilmaz, L. Dosemeci, A. Ramazanoglu
Anesthesiology and ICU, University of Akdeniz, Antalya, Turkey
INTRODUCTION. Inﬂammation impacts the initiation, propagation and the inhibitory
phases of blood coagulation. In this respect, the analgesic agents which inhibit inﬂammatory
response may have impact on the coagulation status in postoperative patients. Dexmede-
tomidine and morphine are frequently used for postoperative analgesia and their anti-
inﬂammatory effects were shown in animal models. The aim of this study is to evaluate the
impact of dexmedetomidine and morphine on coagulation in postoperative patients admitted
to ICU.
METHODS. Twenty patients who underwent orthopedic, reconstructive or abdominal sur-
gery using a standardized anesthesia protocol were included in to the study after admission to
the ICU. The criteria for exclusion were hemodynamical instability, acidosis, hypothermia
and bleeding requiring transfusion of blood products. Morphine (n = 10) or dexmedetomi-
dine (n = 10) were used for 8 h postoperatively with the infusion rates of 60 mic.gram/kg/h
and 0.5 mic.gram/kg/hour, respectively. Blood coagulation analysis was performed with
venous bloods which were taken before the initiation of analgesic regimen and after 8 h of
infusion. Thromboelastography (ROTEG analyzer- Pentapharm GMBH, Munich, Germany)
and coagulation screening tests like prothrombin time (PT)/partial thromboplastin time (PTT)/
international normalized ratio (INR) were performed to evaluate blood coagulation.
RESULTS. Tromboelastography analyses revealed a decrease at clotting time (CT) after 8 h
in morphine (168 ± 52 sec vs. 153 ± 26 sec) and dexmedetomidine (219 ± 82 s vs.
177 ± 36 s) groups but the differences were not signiﬁcant (p[0.05). Cloth Formation Time
(CFT), Maximum Clot Firmness (MCF) and Alpha-angle (AA) values were not changed after
8 h of morphine or dexmedetomidine infusion. There was no difference in terms of trom-
boelastography parameters and coagulation screening tests between morphine and
dexmedetomidine groups performed after 8 h of infusion.
CONCLUSION. The coagulation proﬁle of the postoperative patients was not changed after
8 h of morphine or dexmedetomidine infusion.
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IS RECOMBINANT FACTOR SEVEN FRIEND OR FOE DURING INTRA– AND
POSTOPERATIVE BLEEDING?
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INTRODUCTION. Intra- and post-operative haemorrhage is a frequent and difﬁcult to treat
complicationduringandafterprolongedandtraumaticoperations.Theoff-licenseadministration
of activated Recombinant Factor VII (rFVIIa) to treat haemorrhage in surgical patients without
haemophilia has been investigated, but understanding over potential proﬁt or adverse events
hasn’t been achieved [1,2]. This report describes some mistakes during rFVIIa’s administration.
ETHODS: 7 patients with massive intraoperative blood loss (mediana 80 ml/kg, min 69 ml/kg,
max 126 ml/kg), postoperative bleeding above 10 ml/min (mediana 12 ml/min, min 10 ml/min,
max 14 ml/min) and clotting time above 30 min were included in study group. All patients
received rFVIIa (mediana 119 mkg/kg, min 103 mkg/kg, max 129 mkg/kg) after fresh frozen
plasma(FFP) administration and RBCtomaintainHct above27.Weinvestigatedspeed ofactive
bleeding and clotting time after rFVIIa administration, early outcome and FFP volume.
RESULTS. a. Active bleeding has been stop and clotting time decreased after rFVIIa
administration in four cases. The FFP volume was above 40% for blood loss in this patients.
All of them discharged from ICU. b. Active bleeding increased in spite of clotting time
decreased in one case. Bleeding was stopped by surgery. The FFP volume was above 41% for
blood loss in this case. Patient discharged from ICU. c. Active bleeding and clotting time
increased in spite of rFVIIa administration in the other two cases with FFP volume under 35%
for blood loss. Bleeding stopped after FFP administration in one case. And one patient died
from disseminated intravascular coagulation (DIC).
CONCLUSION. RFVIIa may stop hypocoagulation bleeding inducing by massive intraoper-
ative blood loss only after plasma volume compensation more than 40% for blood loss. The
rFVIIa maybe initiate DIC syndrom during clotting factor deﬁcit (especially platelets) induced
by massive intraoperative blood loss. RFVIIa can not stop surgical bleeding of course.
REFERENCE(S). 1.Stanworth SJ, Birchall J, Doree CJ, Hyde C Recombinant factor VIIa for
the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database
Syst Rev. 2007 Apr 18;(2):CD005011.
2.Warren OJ, Alcock EM, Choong AM, Leff DR, Van Herzeele I, Darzi AW, Athanasiou T,
Cheshire NJ. Recombinant activated factor VII: a solution to refractory haemorrhage in
vascular surgery? Eur J Vasc Endovasc Surg. 2008 Feb;35(2):145–52.
GRANT ACKNOWLEDGEMENT. The authors thank nurses and laborants for their team-
work and understanding.
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INTRODUCTION. 123 ICU Nutrition Day 2007 was the pilot study of a project that has the
aim to develop the tools and infrastructure to run a multi-centre cross-sectional audit in all
national languages about nutritional care and outcome in European ICU’s. Sixty-four ICUs
from different European countries participated.
METHODS. We have used the data from the 44 ICUs that provided 60 day outcome for more
than 75% of the patients. Patients were analysed as Parenteral Group (PG), the Enteral Group
(EG), and the Oral Group (OG). Based on SAPS2, we calculated the predicted mortality of
each patient and the O/E ratio with 95% conﬁdence intervals.
RESULTS. The quality data sample of NutritionDay 2007 included 666 patients. The three
groups were made of 94 (PG), 172 (OG), and 207 (EG) patients and the median predicted
mortality was respectively 17.3%, 16.7% and, 19.6%. The observed mortality for each group
was 24 (25.53%), 31 (18.02%) and 40 (19.32%) patients. O/E ratios and upper/lower limit CIs
are shown in Figure.
CONCLUSION. The following data has shown patients that received oral and enteral
nutrition has had a better mortality rate than expected. Patients that received parenteral
nutrition showed a worse mortality rate.
GRANT ACKNOWLEDGEMENT. ESPEN, European Society of Clinical Nutrition and
Metabolism
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PREVALENCE OF VITAMIN DEFICIENCIES ON ADMISSION AND THEIR
ASSOCIATION WITH HOSPITAL MORTALITY IN CRITICALLY ILL PATIENTS
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INTRODUCTION. Vitamin deﬁciency is believed to be common in critical illness. Water
soluble and antioxidant vitamins are those most frequently used for supplementation in these
patients. There is no data to conﬁrm the prevalence of vitamin deﬁciencies in high-risk
emergently admitted intensive care patients, nor their association with hospital mortality.
METHODS. 129 consecutive, critically ill patients who were emergently admitted to
intensive care were enrolled in this prospective observational cohort study. Patient data
including diagnosis, source of admission and severity of illness scores were prospectively
collected. Within the ﬁrst 48 h of admission, concentrations of C-reactive protein, vitamins
A,E,B1,B12 and folate were measured on arterial blood. Multivariate stepwise logistic
regression modelling was performed to examine the association of vitamin concentrations
with hospital mortality. Separate models were calculated for all patients [Model A], and for
those who had received thiamine supplementation prior to admission[Model B].
RESULTS. 55 (43%) had a biochemical deﬁciency of one of the ﬁve vitamins on admission
to the ICU. A total of 18 patients died (14.0%) during their hospital stay (15 of those in the
ICU). Moderate correlations with C-reactive Protein (CRP) concentrations were demonstrated
for Vitamins B12, A and E (Spearman’s r = 0.309, -0.541 and -0.299, p = 0.001, 0.001
and 0.007 respectively).Hospital mortality was signiﬁcantly associated with age, APACHE II
score, admission and maximum SOFA scores, and admission source in the univariate anal-
yses, but only APACHE score was signiﬁcant on multivariate analysis (OR 1.180 (1.06–1.3),
p = 0.001), for either Models A or B.
CONCLUSION. Deﬁciencies of water soluble and antioxidant vitamins are common on
admission in unplanned or emergent admissions to the ICU, but they are not independently
associated with hospital mortality.
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COMPARISON OF THREE ENTERAL FORMULAS TO GLYCEMIC AND INFEC-
TIOUS CONTROL IN CRITICALLY ILL PATIENTS UNDER MECHANICAL
VENTILATION: HIGH-PROTEIN, HIGH-PROTEIN DISEASE-SPECIFIC AND DIS-
EASE-SPECIFIC DIET SUPPLEMENTED WITH GLUTAMINE
M. Juan*, A. Serrano, A. Mesejo, N. Chafer, S. Martı ´n, M. Garcı ´a, J. Pineda, O. Rodrı ´guez
Intensive Care Unit, Hospital Clinico Universitario, Valencia, Spain
INTRODUCTION. Infectious complications in critically ill patients determine high mor-
bidity and mortality. Glycemic control with disease-speciﬁc diets, insulin therapy and
immunonutrients (glutamine) may reduce these complications. We aimed to:1) Evaluate if the
administration of a disease-speciﬁc enteral formula supplemented with glutamine reduces
infectious complications compared to a disease-speciﬁc high-protein formula and to a con-
ventional high-protein enteral formula.2) Determine metabolic control with the three diets.
METHODS. Prospective, randomized, single-blind and independent samples study. 150
patients were estimated to detect, with a power of 90%, a 15% reduction in infectious
complications. Three groups were established: A: conventional high-protein formula, B:
disease-speciﬁc high-protein formula, C: disease-speciﬁc formula supplemented with gluta-
mine (0.5gr/Kg/day). Eligibility criteria: age C 18 years, enteral nutrition C 5 days.
Exclusion criteria: acute kidney failure (creatinine[3 mg/dl), liver failure (bilirru-
bin[3 mg/dl) APACHE II score\10 or[30, obesity (BMI[35Kg/m2). Target level for
blood glucose was established between 110–150 mg/dl by insulin continuous infusion. The
Harris-Benedict formula with a stress factor of 1.2 was used to calculate caloric needs.
Volume ratio, glycemic control and gastrointestinal and infectious complications were
evaluated every day. An intention-to-treat analysis was performed and data analysis was done
by: Fisher exact test, Ji-square and ANOVA analysis corrected by Bonferroni method.
RESULTS. Preliminary communication with the ﬁrst 42 patients. Age(years):
59.52 ± 14.98. Sex (male): 59.5%. APACHE II score on admission: A 20.33 ± 6.07, B
22.70 ± 6.99,C 21.71 ± 4.37. Mortality: A 40%, B 40%, C 29.4%. Days of mechanical
ventilation: A 13.87 ± 12.66, B 17.30 ± 19.96, C 9.88 ± 4.44 (n.s). ICU length of stay
(days): A 17.67 ± 13.09, B 19 ± 19.48, C 14.82 ± 6.40 (n.s). There were no signiﬁcant
differences either in infectious complications or in Homeostasis Model Assessment (HOMA).
Metabolic control (Table 1).
TABLE 1
A( n= 15) B (n = 10) C (n = 17)
Plasma glucose
level mg/dl
142.62 ± 36.67 142.60 ± 34.01 (n.s) 133.10 ± 32.00*
Capillary glucose
levl mg/dl
131.86 ± 33.76 134.26 ± 27.80 (n.s) 131.88 ± 29.06 (n.s)
Insulin (UI)/day 24.24 ± 31.96 24.81 ± 23.77 (n.s) 19.85 ± 26.53 (n.s)
Insulin/gr CHO received 0.13 ± 0.18 0.16 ± 0.17 (n.s) 0.16 ± 0.37 (n.s)
p-value: n.s non signiﬁcant; (*) p\0.05
CONCLUSION. (1) A signiﬁcant reduction in plasma glucose level on group C has been
shown. (2) Target level of plasma and capillary glucose has been achieved in three groups. (3)
A tendency to reduce days of mechanical ventilation in group C is appreciated.
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DOES INTRAVENOUS IRON INDUCE INFLAMMATION AND OXYDATIVE
STRESS IN A MOUSE MODEL OF PERITONITIS?
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INTRODUCTION. Blood loss, leading to iron loss, plays an important role in ICU anemia;
but iron is rarely proposed, because of his supposed toxicity (1). We recently demonstrated
that spleen iron is mobilizable at day 5, in a mouse model of ICU anemia, based on Zymosan
(Z) peritonitis (2). The aim of this study was to evaluate the effect of iron on inﬂammation
and oxydative stress, in mice with Z peritonitis.
METHODS. We compared the effect of high dose (3 mg) and low dose (0.3 mg) intravenous
(iv) iron in control (C) mice and of low dose in Z mice at day 5. Mice were killed at 1, 2 and
24 h post iv. We measured blood levels of iron, IL-6 (by ELISA) and AOPP (Advanced
Oxidation Protein Product). Data are expressed as mean ± sd, and compared with a Kruskall-
Wallis test.
RESULTS. There is a positive correlation between iron and AOPP levels (r2 = 0,27,
p = 0,01). High iron doses are associated with high iron levels, till H24 (H1 381 ± 181, H2
273 ± 179, H24 47 ± 10 lmol/l) compared with C (25,6 ± 3 lmol/l, p\0,05). Iv iron is
associated with an early IL-6 induction for the low dose and with a late induction for high
dose; but surprisingly not in Z mice. AOPP are increased in high dose only (table).
TABLE 1
C (+NaCl)
n = 5
Z (+NaCl)
n = 8
Z + Iron
(0.3 mg)
n = 10
C + Iron
(0.3 mg)
n = 9
C + Iron
(3 mg)
n = 15
IL-6 (ng/ml) H1 53 ± 23 252 ± 1* 9 9± 45 876 ± 357 * 152 ± 16
H2 128 ± 90 278 ± 106 * 275 ± 238 *
H24 139 ± 190 39 ± 44 162 ± 166 505 ± 181 *
AOPP(lmol/l) 54 ± 34 15 ± 33 8 ± 15 83 ± 17 211 ± 9*
H2 39 ± 44 7 ± 11 264 ± 290 *
H24 61 ± 25 18 ± 7* 2 4± 47 1 ± 27
*p\0.05 vs. control; C = control; Z = Zymosan
CONCLUSION. In our mice Zymosan model low dose of iron (equivalents to 300 mg for
human) are not associated with induction of inﬂammation or oxidative stress. Nevertheless,
tissue examination and long term analysis are required before proposing iv iron in ICU
clinical setting.
REFERENCE(S). 1- Javadi P CCM 2004;32:1178–1185.
2- Lasocki S CCM 2008 (in press).
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ENERGY EXPENDITURE DURING WEANING FROM MECHANICAL VENTILA-
TION USING INDIRECT CALORIMETRY
L. J. Santos, G. Friedman, S. R. Vieira*
Intensive Care Unit, Hospital de Clı ´nicas de Porto Alegre, Porto Alegre, Brazil
INTRODUCTION. Indirect calorimetry (IC) can be useful in the evaluation of metabolic
status from critical care patients, especially during weaning from mechanical ventilation
(MV) when energy expenditure can increase. The goals from this study were to compare the
energy expenditure (EE) from patients during weaning from MV comparing pressure support
ventilation (PSV) and T tube (TT) using IC as well as to compare these ﬁndings with results
calculated with Harris-Benedict equation.
METHODS. Patients clinically ready to discontinue MV support were evaluated from
August 2006 to January 2007. They were studied, in a random order, during PSV and TT.
Measurements from EE were registered during 20 minutes in both methods. Indirect calo-
rimetry was registred using a speciﬁc metabolic monitor (Datex-Ohmeda/M-COVX). EE was
also estimated using Harris Benedict equation with and without activity factor. Results are
shown in mean and standard deviation. Statistical analysis was done with paired T test,
Pearson correlation coefﬁcient and Bland and Altman. Signiﬁcance level was p\0.05.
RESULTS. Forty patients were enrolled. Mean age was 56 ± 16 years, APACHE II score
was 23 ± 8 and the majority of patients were male (70%). Mean EE during TT was 14,43%
greater than during PSV (p\0.001). Mean EE estimated by Harris-Benedict equation was
1455,05 ± 210,4 Kcal/24 h and, considering the activity factor, 1608 ± 236,14 Kcal/24 h.
Both calculated values showed correlation with measured by IC during PSV (r = 0,647) and
TT (r = 0,539). The agreement limits comparing measured and estimated EE with the Bland
and Altman analysis suggest that Harris-Benedict equation underestimates EE during TT.
CONCLUSION. Comparing EE during PSV and TT, using IC, we observed that during TT
there was, as expected, an increase in EE (14,43%). The results also suggest that Harris-
Benedict equation underestimates EE during TT.
REFERENCE(S). 1. Haugen HA et al. Indirect calorimetry: a practical guide for clinicians.
Nutrition in Clinical Practice. 2007;22(4):377–88.
2. Cheng CH et al. Measured versus estimated energy expenditure in mechanicallhy ventilated
critically ill patients. Clinical Nutrition. 2002;21(2):165–72.
GRANT ACKNOWLEDGEMENT. This work was supported in part by the CNPq-Brazil
and by Medicalway company.
0889
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INTRODUCTION. The role of early enteral immuno-nutrition in critically ill patients and
especially in the sub-group of severe traumatic brain injury (TBI) is highly disputed. Optimal
nutrients constitution, dose scheme, starting point and duration still remain subjects of debate.
Recent data from microdialysis studies argue for a role of NO metabolism (closely related to
arginin’s). The goal of this study was to compare the effects of an early immuno-enhancing
enteral diet in TBI patients VS standard feeding formula in terms of clinical indices/outcome
and parameters of nutritional and immunological status.
METHODS. Prospective, randomized, controlled trial, with consecutive patients. Two
groups: A = standard enteral feeding 1 kcal/ml (Nutrison STD) and B = immuno-enhancing
feeding, 13 g/L Arginine (Impact, Novartis, oral/enteral). 30 days follow up, clinical/nutri-
tional assessment (1–7 days,30th day), immunological proﬁle—cytokines, pre-albumin, NO
derivatives (admission, 1st, 4th, 7th day), DNA analysis (sample on admission), std labs
(every day), hormone proﬁle—cortisol (admission, 1st, 4th, 7th day) severity scores (Apache-
II, GCS, GOS)and mortality to 30 days. Results analysed with SPSS.
RESULTS. From Sep.2007 to Apr.2008, 33 patients enrolled (A = 16, B = 17, M/F = 25/8,
Age 34 ± 12, GCS 9 ± 4, Apache II score 18 ± 5), enrollment continues. We had 1 death by
the 30th day. 52% of patients started enteral feeding before the 2nd day and 83% by the 3rd
day post-admission, 75% met their theoretical nutritional needs (Harris Beneddict). The two
groups were comparable regarding demographics and severity of TBI (both scores). Primary
end points of this study : infections percentage and timing, length of mechanical ventilation
(7 ± 6V S8± 7 days) and laboratory proﬁle were not different between the two groups (A,
B) with the exheption of pre-albumin levels at the 7th day (in favor of immuno, 13.8 ± 2V S
17.8 ± 9.2, p\0.05). ANOVA (separate for the 2 groups) did not reveal any signiﬁcant
variance over time (1st, 3rd, 7th day) in WBC and pre-albumin level. Results from cytokines
and NO metabolism are pending.
CONCLUSION. It seems that early enteral immunonutrition (based mainly on high Arginine
content) is not clearly beneﬁcial in a small group of critically ill ventilated patients with TBI.
Awaited results will further enlight us concerning the immunological/biochmeical/hormonal
mechanisms involved.
GRANT ACKNOWLEDGEMENT. Immunonutrition project YGEIA 1104/22 is co-funded
by the Research Promotion Foundation, Cyprus.
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ENERGY NEEDS OF CRITICALLY ILL PATIENTS
A. D. M. Marinho*, L. Silva, M. N. Oliveira, M. Oliveira, J. P. Pinho
Intensive Care Service, Centro Hospitalar do Porto, Porto, Portugal
INTRODUCTION. Accurate measurement of resting energy expenditure (REE) is helpful in
determining the energy needs of critically ill patients requiring nutritional support. Currently,
the most accurate clinical tool used to measure REE is indirect calorimetry, which is
expensive, requires trained personnel, and has signiﬁcant error at higher inspired oxygen
concentrations.
Objective: The purpose of this study was to compare REE measured by indirect calorimetry
with REE calculated by Harris-Benedict equation (H.B.E.).
METHODS. Prospective study conducted in a polyvalent ICU. REEs of 197 patients [mean
age 57,35 ± 19,12 years and mean length of stay 16,44 ± 20,52 days] receiving mechanical
ventilation were measured by using indirect calorimetry and compared with REEs calculated
from H.B.E.
RESULTS. we performed 587 measurements of I.C. (median time of useful measurement –
14 h). Mean estimated energy requirements using H.B.E. –1462,09 ± 238,4(20,92 Kcal/kg/
day)) and mean energy requirements by I.C. – 1849,74 ± 394,66 (27,34 Kcal/kg/day).
Trauma patients had the higher energy requirements (31,28 ± 7,81 Kcal/kg/day) and the
schedule surgery (25,61 ± 6,51 Kcal/kg/day)and liver transplant (22,63 ± 4,93 Kcal/kg/day)
had the lower energy requirements. The Estimate Stress Factor varies between 0,96 (liver
transplant) and 1,31 (trauma patients).
CONCLUSION. Traditionally, the Harris-Benedict equation (HBE) has been the accepted
standard for determining the energy requirements of critically ill patients. But the accuracy of
the HBE is limited in ventilator-dependent patients, patients who are either morbidly obese or
severely malnourished and underweight, transplant patients, and patients with marked ﬂuid
overload, ascites, extensive limb amputations, or paraplegia. In critically ill patients indirect
calorimetry, if available, remains the most appropriate clinical tool for accurate measurement
of REE. Indirect calorimetry offers a scientiﬁcally-based approach to customize a patient’s
energy needs and nutrient delivery to maximize the beneﬁts of nutrition therapy. With recent
advances in technology, indirect calorimeters are easier to operate, more portable, and
affordable. Increased utilization of indirect calorimetry would facilitate individualized patient
care and should lead to improved treatment outcomes.
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FEEDING ELDERLY CRITICALLY ILL PATIENTS: IS IT A PROBLEM?
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INTRODUCTION. Critically ill elderly patients are at high risk to develop protein-energy
malnutrition. Their optimal recovery depends on an adequate nutritional state. To prevent and
treat malnutrition is fundamental to provide good patient care, yet providing nutritional
support (NS) to the critically ill elderly is a major challenge. The goal of this study was to
compare NS between elderly (C 65 years old) and non-elderly (\65 years old) critically ill
patients.
METHODS. Prospective analysis of consecutively admitted patients in two mixed ICU.
Exclusion criteria were: NS for\2 days, age\16 years and length-of-stay (LOS)\3 days.
Patients were followed for the ﬁrst 7 days of NS. Data collection included: demographic data,
NS (route, target volume (TV) and delivered volume), reasons for suspension and reduction of
NS. Chi-square, Mann-Whitney U and T-test were used in statistical analysis.
RESULTS. Forty of the one hundred and two patients studied were C 65 years old mainly
male (60%) with a mean SAPS II score 54,8 ± 16,1. Most of the elderly were medical
patients (60%) followed by surgical (22,5%) and trauma (17,5%). Although not statistically
signiﬁcant (p = 0,088) NS was started earlier in the elder 30,2 ± 17,1 h after ICU admission,
mostly by enteral route (82,5% vs. 93,5%; p = 0,105). TV achievement was similar in both
groups (47,5% vs. 38,7%; p = 0,380). We analyzed 687 nutrition days (ND) with statistical
difference (p\0,001) between the two studied populations (Table 1). In elderly patients NS
was suspended in 22,6% of the days (22,6% vs. 24,0%; p = 0,675) due to gastrointestinal
dysfunction (GI) (42,6%), diagnostic and therapeutic procedures (29,5%), airway manage-
ment (8,2%) and lack of route delivery (4,9%). GI dysfunction was less frequently responsible
for enteral nutrition reduction in elderly than in non-elderly patients (7.4% vs. 9.4%;
p = 0.374). More than 90% of prescribed NS was delivered in a signiﬁcantly higher number
of ND in the elderly group (64,1% vs. 52,7%; p = 0,003). Median ICU LOS was 20 days
with a higher ICU mortality in the elderly (45,0% vs. 12,9%: p\0,001).
TABLE 1 NUTRITION DAYS DISTRIBUTION
Total
ND (%)
Enteral
nutrition
(EN) (%)
Parenteral
nutrition
(PN) (%)
Mixed
nutrition
(MN) (%)
No NS
(%)
C 65 years old 270 (39,3) 212 (78,5) 41 (15,2) 13 (4,8) 4 (1,5)
\65 years old 417 (60,7) 371 (89,0) 28 (6,7) 9 (2,2) 9 (2,2)
CONCLUSION. In this study we observed that NS in elderly critically ill patients does not
seem to be a problem. In this group of patients NS was started earlier, PN was more frequently
used and C 90% of the NS prescribed was delivered in a higher number of ND. No differ-
ences were found regarding NS suspension or reduction between the two groups.
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INTRODUCTION. When selecting an appropriate enteral formulation both formula char-
acteristics and patient-speciﬁc factors should be considered in nutrition support (NS). Recent
data suggest that whole protein formula should be used. The goal of our study was to
determine if the speciﬁcity of the enteral formulation (standard vs. non-standard) has impact
on critically ill patients enteral feeding.
METHODS. Prospective analysis of consecutively admitted patients in two mixed intensive
care units (ICUs). Exclusion criteria were: NS for\2 days, age\16 years and length-of-
stay (LOS)\3 days. Patients were followed for the ﬁrst 7 days of NS. Data collection
included: demographic data, NS (route, target volume (TV) and delivered volume), reasons
for suspension and reduction of NS. Chi-square, Mann-Whitney U and T-test were used in
statistical analysis.
RESULTS. One hundred and two patients (687 nutrition days (ND): enteral (EN) 84,9%,
parenteral (PN) 10% and mixed (MN) 3,2%) were studied: mainly male (69,6%) with a mean
age 57,9 ± 17,8 and a mean SAPS II score 49,6 ± 14,4. The most frequent reason for ICU
admission was medical (52%) followed by trauma (26,5%) and surgical (21,6%). NS was
started 34 ± 18,3 h after ICU admission most times by enteral route (89,2%). TV was
achieved in 42,2% of the cases. EN was started in 81,3% of the patients with a polymeric
standard formulation. We analyzed 605 enteral feeding days (EN 583 and MN 22): 464 were
with a polymeric standard formulation (SF) and 141with a non standard formulation (NSF).
EN was suspended in 23,6% of the days with no differences between SF and NSF concerning
the incidence (22,2% vs. 28,4%; p = 0,131) and the motives (p = 0,486). However, the
incidence of EN reduction was signiﬁcantly lower in SF days (7,8% vs. 16,3%; p = 0,003).
Gastrointestinal intolerance (GI) was higher in NSF but the difference did not reach statistical
signiﬁcance (20,6% vs. 14,4%; p = 0,081). No differences were found between the two
groups regarding the NS percentage delivered to the patients (SF 91,5% vs. NSF 93,84%;
p = 0,919) and ICU length of stay (SF 19,5 days vs. NSF 18 days; p = 0,068). The use of a
NSF was associated with a signiﬁcantly higher ICU (36,2% vs. 17,7%; p\0,001) and
hospital mortality (47,5% vs. 33%; p = 0,002).
CONCLUSION. In this study, the use of a polymeric non standard formulation was asso-
ciated with a higher enteral feeding reduction, a higher GI intolerance and a signiﬁcantly
higher ICU and hospital mortality. No correlation was found between the type of formulation
used and the incidence of EN suspension as well as the NS percentage delivered to the
patients.
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SOME PECULIARITIES OF LIPID METABOLISM IN SEVERE SEPSIS
O. G. Malkova*, I. N. Leiderman, A. L. Levit, S. P. Nitenko
ICU and anesthesiology, Regional Clinical Hospital N 1, Ekaterinburg, Russian Federation
INTRODUCTION. During last 5–7 years we found increasing number of publications and
trials devoted to lipid metabolism in SIRS patients and role of lipids as precursors of SIRS and
sepsis mediators –eicosanoids.
METHODS. After the resolution of local Ethical Committee in 2005–07 yy we investigated
serum levels of triglycerides (TG), IL-6, IL-8, NO, arterial lactate, glucose on 1,3,5,7,10 day
by « Immulite » DPC in 56 septic patients, including bacterial peritonitis (20 pts), endome-
tritis (20 pts), skin infections (4 pts), endocarditis (3 pts), urological sepsis (2 pts), meningo-
encephalitis (2 pts). Mean age of patients was 37,9 ± 2,05. Mean APACHE-II score after
admission was 17,5 ± 0,83 and SOFA score - 6,6 ± 0,58, MURREY score -1,8 ± 0,16
balls. All patients demonstrated 3 and more signs of SIRS. LOS in ICU was 11,6 ± 0,98 days
and in the hospital-27,9 ± 2,67.28 days. Total 28 days mortality was 26,8%. We used
descriptive statistics and estimate the p by t-student for continue variables.
RESULTS. Normal serum levels of TG 1,3 ± 0,1 mmol/l) corresponded with lower con-
centrations of IL-8–68,3 ng/ml (p\0,05). In the group with high TG (2,9 ± 0,2 mmol/l) we
found out increased IL-8 concentrations (613 ng/ml) . On day 7 in high TG group IL-8 levels
decreased. In normal TG group IL-6 concentrations also decreased on day 10, and in high TG
group IL-6 levels increased on day 5 and decreased on day 7 (p\0,05).High TG levels were
closely connected with hyperglycemia, high serum concentrations of NO and lactate. It is
important to emphasize that 28 days mortality was 50% in high TG group in comparison with
normal TG group -23,5% (p\0.01).
CONCLUSION. Increased serum TG concentrations in severe sepsis are closely connected
with negative clinical outcome. Clariﬁcation of relationship between pro and anti-inﬂam-
matory mediators synthesis and lipid metabolic alterations in severe sepsis may become one
the most perspective issues of future investigations.
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ARE QUALITY NUTRITIONAL INDICATORS (QNI) MARKERS OF NUTRITION
MANAGEMENT AT THE ICU?
E. Valencia*
1, A. Marin
2
1Intensive Care Unite, CICRET-Rosary Clinic-IPS U de A,
2ICU, IPS U de A, Medellin,
Colombia
INTRODUCTION. Indicators are instruments for the improvement of quality as such
monitoring them should never be considered end in and of itself. In other words the measuring
stage is necessary and sometimes essential to determine the level of the quality of care and it
enables us to take action to improve the weak points in the system and to select the most
effective course of action. Aim: Evaluate eight QNI providing a point of reference (standards)
with which to compare our practice.
METHODS. We did a prospective observational research study from March 2007 to
December 2007. Sixty hundred and seventy admitted patients were included. Indicators were
evaluated according to SEMICYUC (Spanish Society of intensive and Critical Care and
coronary units) provides for the development of instruments to aid in the continual
improvement of the quality of care. Indicators for nutritional support are as follows (Standards
are in parenthesis): 1.Complications of Total parenteral Nutrition as hyperglycemias (25%)
and liver dysfunction (\10%), 2.Maintaining appropriate levels of glycaemia (80%),
3.Severe Hypoglycaemia (0.5%), 4.Identiﬁcation of Nutritional (100%), 5.Assessment of
Nutritional Status (100%), 6.Early Enteral Nutrition (100%), 7.Monitorization of Enteral
Nutrition (100%), 8.Calorie and Protein Requirement (100%).
RESULTS. Standards were calculated according to the score and the outcome as follows:
TABLE 1 NAME OF THE INDICATOR
Indicator We got (Average) Standards (%)
Complications of total parenteral
nutrition
Hyperglyc 20% (Average 5.75%) 25
Maintaining appropriate
control of glycaemi
20% 80
Severe hypoglycaemia 0–1% (Average 0.25%) 0.5
Identiﬁcation of nutritional risk (17.2–76.7%) (Average 42.4%) 100
Assessment of nutritional status (6.6–100%) (Average 83.7%) 100
Early enteral nutrition (5.8–100%) (Average 44.8%) 100
Monitorization of enteral nutrition (79.1–100%) (Average 94.8%) 100
Calorie and protein requirement (92.3–100%) (Average 98.3%) 100
CONCLUSION. According to our results was difﬁcult to get a complete attachment to the
indicators, probably due to deﬁcit of computer systems to collect the information, however,
result show us if our nutritional group should be alert about any management out of standards
of quality, and analyze what we do and how we do it in order to help us determine those
aspects that reduce complications and mortality
REFERENCE(S). 1. Quality of indicators in critically ill patients (SEMICYUC) 2008.
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NUTRITIONAL SCORE RISK FOR MORTALITY IN CRITICALLY ILL PATIENTS
E. Valencia*
1, A. Marin
2
1Intensive Care Unite, CICRET-Rosary Clinic-IPS U de A,
2ICU, IPS U de A, Medellin,
Colombia
INTRODUCTION. The hospital malnutrition is a universal problem that currently can be
detected routinely and consequently combat effectively. It is observed both in developed
countries and in the so called third world, unfortunally in ICU there is nothing universally
accepted to do nutritional diagnosis, therefore, the aim of our study has been applying a
nutritional score risk to mortality in critically ill patients.
METHODS. We did a prospective observational research study from April 2004 to
December 2006. Two hundred and twenty eight admitted patients were included, the surveys
were ﬁlled by the near relative who lived with the patient, at that moment that the relative
showed non-coexistence with the patient and/or ignorance of its pattern of food ingestion
during the newspaper the survey was discarded. Critically ill patients were selected at random
with pathologies (neurocritical, Sepsis, trauma, patients, obstetrics critics, etc.) in 2 units of
adult intensive cares. Patients were evaluated according to Nutritional Risk Score *NSR): Has
food intake declined due to los of appetity, digest problems 2 points, How many full meals
does the patient eat daily, less than two 3 points, At least one serving of dairy products, one
serving of fruits and vegetables 2 points, takes more than 3 prescription drugs per day 1 point,
how much alcohol per week 2 points, mode of feeding unable to eat without assistance 2
points, weigh loss or increase in the last 6 months 2 points, Economical level for eating 4
points Statistical analysis: A validation of the data was used to assess the ability to the new
Nutritional Risk Score to predict mortality in ITU based receiver operating characteristic
(ROC) analysis. The statistical analysis was carried out with the SPSS 10 package, and
p\0,05 was considered statistically signiﬁcant.
RESULTS. Age average 48.8 ± 21.5 and NSR 5.48 ± 3.73. ROC analysis were done for
mortality according to NSR[7 shows a sensibility of 57.9% (IC: 40.8–73,3) and speciﬁcity
of 72,8% (IC: 64.5–80.1) with a +LR: 2.13, -LR: 0.58 : +PV: 34.7, AUC: 0.66, SE: 0.053, IC:
0.59–0.735, p = 0.0017. Our study demonstrated that the alterations of the NSR can be
observed in all ages, established by not having a direct correlation between the age and the
found NSR (r = 0.15, p = 0.018). In addition, was found that suffering chronic diseases that
alter the conditions of ingestion it would feed suitable is an isolated parameter signiﬁcant to
increase the death probability if the patient is in the ICU (p = 0.002).
CONCLUSION. The Nutritional Risk Score should be included in the Nutritional assessment
for critically ill patients at admission to the intensive care unit in order to detect mortality by
nutritional risk.
REFERENCE(S). 1. Valencia E, Marin A. Nutrition Hospitalaria 2008; In Press.
0896
INSULIN ENHANCES RENAL POTASSIUM EXCRETION IN CRITICALLY ILL
PATIENTS
M. Hoekstra*
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Nijsten
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INTRODUCTION. Insulin is regularly applied to lower elevated serum potassium levels.
This action of insulin is effected by increasing the cellular uptake of potassium. Whether the
potassium lowering effect of insulin is also effected by changes in renal potassium secretion is
unclear. Since the therapeutic goal in hyperkalemia is to remove potassium from the body, it
is of relevance if insulin inhibits renal potassium excretion. Most studies in human volunteers
have suggested that insulin has an antikaliuretic effect [1]. These studies are however ham-
pered by insufﬁcient control of decreased serum potassium levels. In our ICUs we have a
computer supported system called GRIP-II (Glucose and potassium Regulation Intensive care
Patients) that strictly regulates potassium levels with periodic adjustments of continuous
potassium infusion. Such a form of regulation approaches potassium clamping. In this setting
we studied the effect of insulin and potassium on renal potassium excretion.
METHODS. In a 12-bed surgical ICU unit in a tertiary teaching hospital we routinely
collected 24-h urine samples that were analyzed for potassium concentration. Calculated 24 h
renal potassium excretion was compared with the total daily amounts of potassium and insulin
that were administered by syringe pump, both of which were determined by GRIP-II. The
time-averaged daily mean blood potassium and glucose levels were also determined. Multi-
variate regression analysis with potassium excretion as the dependent variable was performed
with the amount of insulin administered, mean blood glucose, mean serum potassium, mean
glucose administration, mean potassium administration and ICU day as independent variables.
RESULTS. 297 patients with 2,078 24 h urinary samples were analyzed. Mean ± sd serum
potassium was 4.2 ± 0.4 mmol/L, mean blood glucose 6.8 ± 0.9 mmol/L with a mean
amount of potassium administered of 69 ± 48 mmol/d and mean insulin dose of 41 ± 39 U/
d. The mean potassium excretion was 105 ± 58 mmol/d. Upon multivariate analysis the
plasma potassium, potassium administration, insulin administration and ICU days were
independent predictors of potassium excretion with a correlation coefﬁcient of 0.57 (R
2 0.331;
p\0.001).
CONCLUSION. In contrast with previous reports that were only performed in healthy
subjects under partially controlled circumstances, under conditions with strict potassium and
glucose control, the administration of insulin was associated with increased renal excretion of
potassium in critically ill patients.
REFERENCE(S). 1. DeFronzo RA, Codie CR, Andres R, et al. The effect of insulin on renal
handling of sodium, potassium, calcium and phosphate in man. J Clin Invest 1975;55:845–
855.
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CRITICAL NUTRITION: 24 HOURS AND COUNTING…
B. E. Robinson*, A. L. Jukes
Nutrition and Dietetics, University Hospital of Wales, Cardiff, United Kingdom
INTRODUCTION. It is widely accepted that enteral nutrition (EN) is preferable to paren-
teral – preserving gut integrity, incurring fewer serious complications and lower cost. ESPEN
recently reached consensus that haemodynamically stable critically ill patients who have a
functioning GI tract should be fed within 24 h of admission to Critical Care (1); a recom-
mendation supported by ASPEN (2). The guidelines also support strategies to optimise feed
delivery, such as feeding protocols and prokinetics. This review was carried out to assess to
what extent current practice on critical care complies with these recommendations.
METHODS. Data was collected over a 4-week period for patients (level III) entering critical
care fed via a nasogastric tube(NG). Exclusions included patients requiring parenteral
nutrition, where nasojejunal tube or jejunostomy tubes were placed prior to admission, or
where length of stay was less than 48 h.
RESULTS. The 20 patients recorded were admitted via A&E (10), theatre (5) or hospital
ward/transfer (5), and presented from Neurosciences (9), Medicine (6) and Surgery (5). The 8
men and 12 women had an average age of 53 years (R = 23–76yrs), average actual body
weight of 71 kg (R = 45–110 kg, 18 patients), average ideal body weight of 57 kg (R = 43–
75 kg, 10 patients), and an average BMI of 27 kg/m2 (R = 16–48 kg/m2, 10 patients). Prior
to admission 1 patient reported weight loss, 2 had poor intake (3 days, and 3–4 months), 4
were nil by mouth for an average of 2.75 days (total days 13), whilst 14 reported no prior
weight loss and normal intake; 4 were alcohol-related admissions. Feed commenced an
average of 14.45 h (total h 289, R = 1–52 h) after admission. 20 patients were fed using a
standard whole-protein (1.0 kcal/ml) enteral feed. 19 patients (1 died prior) achieved target
rate after an average of 21.7 h (total h 12, R = 4–68 h), during which time additional ﬂuids
were provided. Prokinetics were administered in 5 cases—3 receiving metoclopromide, and 2
with erythromycin in addition. 13 patients were prescribed laxatives to stimulate bowel
function. At the close of the study period, 8 patients took oral diet in addition to NGF, were
extubated or transferred from the unit; 8 patients continued NG only; 3 patients had died.
CONCLUSION. This data supports the recommendation that haemodynamically stable
critically ill patients can successfully commence early EN within the ﬁrst 24 h, achieving
adequate energy, protein and micronutrient provision with minimal need for prokinetic
agents. Although limitations exist, patients admitted to critical care may have better nutri-
tional status than previous described.
REFERENCE(S). 1. ESPEN guidelines on enteral nutrition: intensive care (ESPEN 2006).
2. Canadian clinical guidelines for nutriton support in mechanically ventilated critically ill
adult patients (ASPEN 2003).
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THE INCIDENCE AND CHARACTERISTICS OF PATIENTS WITH VENTILATOR-
ASSOCIATED PNEUMONIA AFTER HEART SURGERY
D. Mijuskovic*, I. Ilic, M. Filipovic, V. Tesic, M. Lukic, S. Jerotic, B. Krivokapic, M. Jovic
Anesthesiology and Intensive Care, Dedinje Cardiovascular Institute, Belgrade, Serbia
INTRODUCTION. Ventilator-associated pneumonia (VAP) is the most common and fatal
nosocomial infection of intensive care.It affects between 9% and 27% of intubated patients
and doubles the risk of dying /1/.Different intensive care units (ICU) populations may have
different incidences of VAP. Patients undergoing heart surgery have a high frequency of VAP
(7,87%)/2/.Our aim was to determine the frequency, etiology, and risk factors of VAP in
patients who have undergone heart surgery in order to direct more extensive prophylactic
measures for the high risk population.
METHODS. Design: Prospective study. Setting: Heart surgery intensive care unit. Patients:
Intubated heart surgical patients. Criteria: Centers for Disease Control and Prevention (CDC).
National Healthcare Safety Network Deﬁnition for VAP.
RESULTS. Total of 198 patients were screened during one month after major heart surgery.
The frequency of VAP was 3,03% (6 patients).No one patient died during the study. All VAP
patients had joined signiﬁcant preoperative chronic disease or risk factor (diabetes,low
ejection fraction, emergency surgery,advanced age,obesity,renal failure,HOBP, cerebrovas-
cular event)and postoperative complication (bleeding,myocardial infarction,pericardial
tamponade). Average duration of mechanical ventilation till the VAP onset was 5,00 days.
CONCLUSION. Our population of patients has lower incidence of VAP than other studies
for cardiac surgery patients had shown. Tailoring strict infection control (nonpharmacological
and pharmacological) for patients with multiplied (two or more) risk factors is strongly
recommended. Infections surveillance cultures and risk stratiﬁcation in that group could be
studied further.
REFERENCE(S). 1. Klompas M.Does This Patient Have Ventilator-Associated Pneumo-
nia?JAMA.2007;297(14):1583–93.
2. Bouza E,Pe ´rez A,Mun ˜oz P et al.Ventilator-associated pneumonia after heart surgery:a
prospective analysis and the value of surveillance.Crit Care Med.2003;31(7):1964–70.
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VENTILATOR ASSOCIATED PNEUMONIA IN PATIENTS WITH TRAUMATIC
BRAIN INJURY
M. Sartzi*, G. Kalitsi, M. Charitidi, K. Michas, F. Tsidemiadou, P. Clouva
ICU, Thriassio Hospital Eleusis, Athens, Greece
INTRODUCTION. We studied the factors which may inﬂuence the development of Ven-
tilator Associated Pneumonia (VAP) in patients with Traumatic Brain Injury (TBI).
METHODS. Retrospective analysis of prospectively gathered data of 141TBI patients ven-
tilated[48 h in the last 4 years. TBI Patients with VAP(Group I) where compared with TBI
patients (Group II) without VAP. We registered: prior illness,patients characteristics, GCS,
surgical procedure, vital signs- laboratory parameters- dislocation of the middle shift at ICU
admission, duration of mechanical ventilation(MV) and intubation(TT) before and during
ICU stay, day of VAP onset, MODS and Clinical Pulmonary Infection Score (CPIS) measured
at the onset of VAP, isolated microorganisms, colonization data, length of stay (LOS) in the
ICU and hospital, and patients outcome (ICU and hospital.) We deﬁned haemodynamic
instability as low mean blood pressure and support with vasoactive and/or inotrop drugs and
hypoxaemia as PaO2\80 mmHg or FiO2[0.5. Statistical evaluation was performed using
univariate and multivariate logistic regression, Students t-test, Pearson’s chi square and
Fisher’s exact statistic.
RESULTS. From the 141 studied patients 32–22.6% (4 women and 28 men) aged(-
mean ± sd) 44.1 ± 9.3 years, with APACHE II score 21.8 ± 4.9, GCS 6.1 ± 1.5, time of
tracheal intubation 31.3 ± 14.5 days,duration of mechanical ventilation (in the ICU)
29.51 ± 17.5 days, MV time before ICU admission 5.06 ± 1.5 days, developed VAP after
10.2 ± 3.1 days. On the day of VAP detection CPIS was 7.3 ± 0.9 and MODS 9.4 ± 0.8.
Patients who did not develop VAP were 38.8 ± 7.9 years old, had a APACHE II score
19.06 ± 2.3, a GCS score 7.8 ± 1.9, were intubated 23.2 ± 6.5 days and ventilated before
ICU admission 2.3 ± 1.2 days and in the ICU 21.51 ± 11.0 days. Most cases of VAP were
caused by MDR Gram negative microorganisms, except 3 patients in whom VAP was caused
by MRSA. Age (p\0.03), APACHE II (p\0.04), GCS (p\0.05), middle shift dislocation
(p\0.02), haemodynamic instability (p\0.01), hypoxaemia (p\0.01) and longer time of
mechanical ventilation before ICU admission (p\0.001) were the strongest associated
factors of VAP development. Patients who developed VAP did not have higher ICU (p\0.4)
or hospital (p\0.3) mortality, but had a longer duration of intubation (p\0.002),
mechanical ventilation (p\0.001) and hospitalization (p\0.02). Bacterial colonization
(with Gram negative bacteria) was an independent risk factor for VAP. Prior illness, surgical
procedure, temperature, laboratory parameters were not associated with VAP appearance.
CONCLUSION. Age, APACHE II, GCS, middle shift dislocation, hypoxaemia, hemody-
namic instability and prolonged time of mechanical ventilation before ICU admission are
directly related to the development of VAP. VAP does not inﬂuence mortality of TBI patients
but contributes to longer duration of intubation, mechanical ventilation and hospitalization.
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A THREE-YEARS RETROSPECTIVE STUDY OF LOCAL MICROBIOLOGICAL
PROFILE IN ICU
P. Vita*
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INTRODUCTION. The identiﬁcation of local clinical and microbiological proﬁles are
essential to develop institution-speciﬁc guidelines when selecting empiric treatment for
community and hospital-acquired infections.
METHODS. Retrospective analysis of bacterial isolates in 1142 consecutive patients
admitted to 12 bed mixed ICU, during January 2005 to December 2007. Product sites with
fewer than 25 isolates were excluded and only ﬁrst isolates of the agent were considered.
Bacterial agents with fewer than 25 isolates are collectively considered as a category.
RESULTS. A total of 1035 ﬁrst isolates were considered. Tracheal aspiration, bronchial
alveolar lavage and aspiration represented 60.0%. Urine, blood, abscess pus, peritoneal ﬂuid
and CVC’s tips account for the remaining. The most prevalent were P. aeruginosa (16.8%),
MRSA (10.8%), MSSA (9.9%), E. coli (9.8%) and Haemophilus sp. (7.9%). Using logistic
regression, S. pneumoniae (p\0.001), Haemophilus sp. (p\0.001), MSSA (p\0,001), E.
coli (p = 0.001), E. faecalis (p = 0.016), S. epidermidis (p = 0.016) and Klebsiella sp.
(p = 0.019) were manly isolated in the ﬁrst 72 h. MRSA, P. aeruginosa and A. baumannii
appeared in later isolates. Using cluster tree analysis, 4 distributions were deﬁned
(p\0.001): (1) respiratory; (2) urine; (3) peritoneal ﬂuid and abscess pus and (4) blood
cultures and cvc tips. Respiratory isolates were P. aeruginosa (22.4%), MSSA (14.2%) and
MRSA (12.1%). E. coli (19.1%) and E. faecium (15.3%) were more frequent in peritoneal
ﬂuid and abscess pus isolates. E. faecalis (22.3%) and E. coli (21.5%) were more prevalent in
urine. Non-aureus Staph represented 33.1% of isolates in blood cultures and CVC’s. A
difference (p = 0.002) was detected concerning A. baumannii prevalence that has declined
abruptly from 2005 to 2007. In 2007, a total of 389 patients were admitted and 304 were
considered for analysis. Age was 53.3 ± 19.4 years and 208 were males (68.4%) and 96
(31.6%) females. SAPS II average was 43,6 ± 16.5 points. Delay was 9.7 ± 8.5 days.
Mortality rate was 23.4%. Admissions were classiﬁed in: medical –46.9%; urgent post-
operatory –24.2% and trauma –28.9%. No association between admission type and mortality
was found. During 2007, 398 cultures were positive (177 patients). A difference was found
(p = 0.003) between the isolates and admission type. Medical were associated with P.
aeruginosa (22.4%) and MRSA (13.1%). Urgent post-operatory were associated with E. coli
(17.2%) and P. aeruginosa (10.2%). Trauma were associated with MSSA (18.3%), Hae-
mophilus sp. (18.3%) and P. aeruginosa (16.3%). The overall impact of P. aeruginosa is
mostly related to ventilator-associated pneumonia.
CONCLUSION. Analysis of the microbiological data is considered as one of the most
important activities to improve the outcome of patients by adequate initial empirical selection
of antibiotics. The study deﬁnes the framework to achieve it.
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AUDIT OF A CARE BUNDLE FOR VENTILATED PATIENTS WITHIN THE
DEPARTMENT OF CRITICAL CARE, QUEEN ALEXANDRA HOSPITAL
PORTSMOUTH
M. J. Chandy*, M. Williams, G. Amarasinghe, K. Tilbrook, L. Stratton
Department of Critical Care, Queen Alexandra Hospital, Portsmouth, United Kingdom
INTRODUCTION. Ventilator associated pneumonia (VAP) causes signiﬁcant morbidity and
mortality amongst critically ill patients. In a Europe wide study, VAP was the most frequent
infection accounting for 45% of Intensive Care infections
1. High Impact Interventions
2 were
introduced to encourage best practice in ‘‘reducing infection, delivering clean and safe care’’.
HII No.5 is a care bundle for ventilated patients aimed at preventing VAP. In our department
we use a modiﬁed ventilator care bundle based on these guidelines. An audit of compliance
was undertaken in December 2007.
METHODS. We collected data from bedside paper and electronic patient records. We
recorded if an element of care had been prescribed on the patients’ bedside chart and if the
element had been performed. Data was summarised as a % compliance, with a target of 100%
for each element. The results were presented at a multi-disciplinary departmental meeting.
RESULTS. 33 patient observations were made. Areas of poor performance were found in bed
head elevation (30% compliance) and daily sedation holding (39% compliance). Gastric ulcer
and deep vein thrombosis prophylaxis (85 and 79% compliance respectively) were provided
in the majority of patients. The target of 100% compliance was not achieved for any elements.
TABLE 1 RESULTS OF COMPLIANCE FOR ELEMENTS OF CARE (N = 33)
Element of care Performed
signed
Performed
not signed
Not
performed
signed
Not
performednot
signed
Clinically
exempt
Elevation of head
no. patients (%)
5(15.1) 17(51.5) 2(6.1) 8(24.2) 1(3.1)
Ulcer prophylaxis
no. patients (%)
20(60.6) 8(24.2) 4(12.1) 1(3.1) 0(0)
DVT prophylaxis
no. patients (%)
17(51.5) 9(27.3) 5(15.2) 2(6.0) 0(0)
Sedation break
no. patients (%)
6(18.2) 7(21.2) 3(9.1) 4(12.1) 13(39.4)
CONCLUSION. Lack of awareness and incomplete data recording for all elements by
medical and nursing staff were highlighted as probable causes of the poor compliance
observed. This audit has allowed our department to identify and focus upon areas for
improvement in care provision. We have instigated a programme of education for all staff.
New IT systems are being considered to allow improved documentation of patient observa-
tions. The departments’ care bundle will be reviewed in light of recommendations to be
published by the National Institute of Clinical Excellence in September, 2008. We will re-
audit following implementation of these recommendations.
REFERENCE(S). 1. Vincent JL et al. The prevalence of nosocomial infection in intensive
care units in Europe. Results of the European Prevalence of Infection in Intensive Care
(EPIC) Study. Journal of American Medical Association 1995, 278:639–644.
2. www.clean-safe-care.nhs.uk. Department of Health.
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ASSESSMENT OF SEVERITY IN ICU PATIENTS WITH COMMUNITY-
ACQUIRED PNEUMONIA USING PIRO-BASED SCORE
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INTRODUCTION. None of the available scores accurately stratify risk in ICU admitted
patients with severe Community-acquired Pneumonia (CAP).The objective of this study was
to develop a severity assessment tool for patients admitted with community-acquired pneu-
monia in intensive care unit.
METHODS. A Secondary analysis of prospective, observational cohort study in 33 ICU’s. A
severity assessment score was deﬁned based on the PIRO concept including the presence of
the following variables: Comorbidities (COPD, immunocompromise); age[70 years; mul-
tilobar opacities in chest x-ray; shock, severe hypoxemia; acute renal failure; bacteremia and
ARDS. CAP PIRO score was obtained at ICU within 24 h from admission and one point was
given for each present feature (range 0–8 points). Statistical analysis was performed with
SPSS 11.0.
RESULTS. We have included 529 patients with CAP diagnosis. The mean CAP PIRO score
was signiﬁcantly higher in non-survivors than in survivors (4.6 ± 1.2 vs. 2.3 ± 1.4). Con-
sidering the observed mortality for each CAP PIRO score the patients were stratiﬁed in four
levels of risk: (a) Low; 0–2 points, (b) Mild; 3 points, (c) high; 4 points and d) Very high; 5 to
8 points. Mild risk (HR 1.8;95%CI = 1.1–2.9;p\0.05), high risk (HR 3.1;95%CI = 2.0–
4.7;p\0.001) and very high risk level (HR 6.3;95%CI = 4.2–9.4;p\0.001) were signiﬁ-
cantly associated with higher risk of death in Cox proportional hazards regression analysis.
Moreover, analysis of variance showed that higher levels of CAP PIRO score were signiﬁ-
cantly associated with higher 28-day and ICU mortality (p\0.001), prolonged length of ICU
stay (p\0.001) and days of mechanical ventilation (p\0.001). ROC curves showed CAP
PIRO score (AUC = 0.88) outperformed the ATS/IDSA criteria (AUC = 0.80,p\0.001)
and APACHE II (AUC = 0.75,p\0.001) to predict 28-day and ICU mortality.
CONCLUSION. The PIRO score performed well as a severity and 28-day mortality
assessment tool in CAP patients requiring ICU admission. Moreover, PIRO score also is
associated with increased health-care resource utilization in CAP patients admitted in ICU.
GRANT ACKNOWLEDGEMENT. CIBERes 06/06/0036 and AGAUR (05/SGR/920).
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PROCALCITONIN: PREDICTOR OF POSITIVE MICROBIOLOGICAL CUL-
TURES IN CRITICALLY ILL PATIENTS ON THE ICU : AN INVESTIGATIONAL
STUDY
H. T. T. Nguyen*
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1, J. F. Schoonderbeek
1
1Intensive Care Unit,
2Microbiological Laboratory, Ikazia Hospital Rotterdam, Rotterdam,
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INTRODUCTION. Procalcitonin is widely reported as a useful biochemical marker to dif-
ferentiate sepsis from other non-infectious causes of systemic inﬂammatory response
syndrome (SIRS). The course and duration of antibiotic therapy is often an empirical choi-
ce.This investigational study is performed to examen if there is a link between procalcitonin
and positive microbiological cultures together with the course of disease in critically ill
patients.
METHODS. In total 26 patients were analyzed with sepsis with at least one organfailure. We
compared series of procalcitonin with CRP and the course of disease together with positive
microbiological cultures and the course of antibiotic therapy.
RESULTS. In total 105 procalcitonin-samples has been performed in series, in 68.5% of the
samples the procalcitonin-level (PCT) was[2 ng/mL, (PCT 2–5 ng/mL: 17,1%, PCT 5–
10 ng/mL: 31.4%, PCT[10 ng/mL: 20%). Positive bloodcultures were found in 34.6% of
the patients, 88.9% of these patients had a procalcitonin[2 ng/mL (PCT[10 ng/mL:
44.4%, PCT 5–10 ng/mL: 22.2%, PCT 2–5 ng/mL: 22.2%) . Only 1 patient with a positive
bloodculture had a procalcitonin between 0.5 and 2 ng/mL. In general only 15.2% of the total
amount of microbiological cultures (sputum, urine, woundﬂuids, cathetertips, etc.) was
associated with a procalcitonin-level below 0.5 ng/mL, and most of these cultures were
positive with candida-species (not bacterial). This means that 84.8% of the total amount of
microbiological cultures was linked with a procalcitonin above 0.5 ng/mL.
In total 10 patients died, 100% of them had a procalcitonin[2 ng/mL.The course of anti-
biotic therapy was in the beginning of the critically illness adapted on empirical grounds, later
adapted based on the microbiological cultures in combination with the procalcitonin-level.
CONCLUSION. It seems that a procalcitonin-level above the treshold can predict positive
microbiological cultures in critically ill patients on the ICU. Positive bloodcultures seem to be
associated with high procalcitonin-levels.
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INTRODUCTION. Epidemiologic control in an ICU environment is a key-component
leading to a more successful prevention of nosocomial infections. We conducted this study in
order to identify 1. bacterial contamination on inanimate surfaces and hands of healthcare
workers 2. colonization or infection in patients.
METHODS. At a given day, ICU surfaces (ventilator tube surfaces, bedrails, bedside
monitors, cardiograms, dressing trolleys, sinks, telephones, wall oxygen humidiﬁers)were
screened and cultured by using sterile cotton swabs inoculated into thioglucolate broth and
incubated aerobically at 37 C for 48 h. At the same day, hand impressions were taken from all
ICU staff and also blood, bronchial secretions and urine were cultured from all patients.
Microorganism identiﬁcation was performed by the VITEK-II method (Biomerieux-
FRANCE) and susceptibility testing by the disk diffusion testing according CLSI. Some were
further evaluated by E-test. Production of extended spectrum beta-lactamases (ESBLs) was
determined by the double disk synergy test (DDST) and metallo-beta-lactamase (MBLs)
production by the EDTA-synergy test.
RESULTS. Colistin-resistant, MBL positive Klebsiella pneumoniae strains with an identical
resistant phenotype were isolated from blood and ventilator tube surface of the same patient.
Multiresistant K. pneumoniae strains with the same phenotype and production of ESBLs and
MBLs were isolated from bedrails and bedside monitor of another patient. Multiresistant,
carbapenem resistant Pseudomonas aeruginosa of an identical phenotype were cultured from
bronchial secretions and ventilator tube of a patient, ventilator tube of another and bronchial
secretions of a third patient. Environmental sampling also revealed the presence of 11
Enterococcus strains 3 of which were Vancomycin resistant, a multiresistant Pseudomonas
putida and also Candida parapsilosis from a dressing trolley shelf. A multiresistant Acine-
tobacter baumanii was also cultured from the hands of a healthcare worker.
CONCLUSION. The bacteriological proﬁle of the ICU revealed the presence of highly
resistant microorganisms exhibiting multiple and complicated resistance mechanisms. The
fact that identical phenotypes were observed, is an indication of a possible genetic relation
among some of these strains. These isolates will further be analysed by PCR and PFGE
methodology. Hand antisepsis and infection control measures were encouraged. Cooperation
between intensivists and the laboratory is of vital importance for the prevention of nosocomial
infections.
GRANT ACKNOWLEDGEMENT. European Union, European Society of Intensive Care
Unit, International Sepsis Forum.
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INTRODUCTION. To evaluate attributable cost, ICU Length Of Stay (LOS) prolongation
and outcome of Bloodstream Infection (BSI) and Ventilator-Associated Pneumonia (VAP)
among ICU patients in a 1200-bed tertiary Greek hospital.
METHODS. All patients, uninfected at admission, treated in our unit more than 48 h,
between 1/1/2007 and 1/7/2007, were prospectively studied. ICU treatment prolongation
relevant to BSI or VAP, attributable cost (estimated by the method bottom down) and patient
outcome were assessed.
RESULTS. 74 patients were screened for inclusion in our study. In 25 patients (33,8%) more
than one infections occurred during their ICU stay and were excluded. 10 out of 74 (13,5%)
suffered a single BSI episode (6 male, 4 female, age 59,6 ± 22,9 years, admission APACHE
II score 12,8 ± 6,4) and 9 out of 74 (12,1%) suffered a single VAP episode (7 male, 2 female,
age 53,1 ± 16,8 years, admission APACHE II score 13 ± 4). Finally, 30 patients (14 male,
16 female, age 52,1 ± 19,3 years, admission APACHE II score 12,6 ± 7,1) remained
uninfected during their ICU stay. In patients with BSI, ICU LOS was 24,8 ± 9,37 days,
prolongation of ICU LOS relevant to infection was 7,4 ± 3,1 days and attributable cost was
7178 € /patient (antibiotic use contributed to 16,6% of the total cost). In patients with VAP,
ICU LOS was 21,6 ± 7 days, prolongation of ICU LOS relevant to infection was
6,4 ± 1,6 days and attributable cost was 6251 € /patient (antibiotic use contributed only to
15,7% of the total cost). Patients without infection had an ICU stay of 7,2 ± 3,6 days and a
mortality rate of 13,3%, while in patients with BSI, mortality was as high as 40% and in
patients with VAP 22,2%.
CONCLUSION. Patients with BSI or VAP have a longer ICU stay, a higher mortality rate
and a higher treatment cost compared to uninfected ICU patients. Adequate staff availability,
infection control protocols implementation and microbiological surveillance in the ICU may
save important resources and affect patient outcome.
0906
COMMUNITY ACQUIRED ACUTE BACTERIAL MENINGITIS IN AN INTENSIVE
CARE UNIT VS THE REST OF MEDICAL UNITS IN SPAIN
R. Amaya Villar
1, E. Garcı ´a Cabrera*
2, E. Sulleiro
3, P. Fernandez-Viladrich
4, A. Coloma
5,P .
Catala ´n
6, C. Rodrigo
7, D. Fontanals
8, J. Pachon
2, G. Prats
3
1Intensive care Unit,
2Infectious Disease, Hospital Universitario Virgen del Rocı ´o, Seville,
3Clinical Microbiology, Hospital Universitario Vall d’Hebron,
4Infectious Disease, Hospital
de Bellvitge,
5Infectious Disease, Hospital de Sant Pau, Barcelona,
6Infectious Disease,
Hospital Gregorio Maran ˜on, Madrid,
7Infectious Disease, Hospital Germans Trias i Pujol,
Seville,
8Clinical Microbiology, CS Parc Taullı ´, Barcelona, Spain
INTRODUCTION. The aim of this study is to know the different of epidemiology, clinical
features, management and outcome between patients with community-acquired acute bacte-
rial meningitis (ca-ABM) who was admitted to the intensive care unit (ICU) vs. patients with
ca-ABM admitted to the rest of medical units.
METHODS. A descriptive, prospective, and multicenter study carried out in 9 hospitals of
the Spanish Network for the Research in Infectious Diseases (REIPI) between 1/11/2003 and
31/07/2006. Patients were diagnosed on the basis of a compatible clinical (fever, neck
stiffness, meningeal signs, and/or low altered mental status [GCS\14]); and cerebrospinal
ﬂuid (CSF) ﬁndings (pleocytosis C 100/mm
3, hipoglycorrachia\40 mg/dL or CSF/blood
glucose ratio\40%, and increased protein level[100 mg/dL);and microbiological criteria
(positive CSF Gram-stain, positive culture of CSF and or hemoculture). An adverse clinical
outcome was deﬁned as death or cure with disabilities. An univariant and multivariate sta-
tistical analysis was performed.
RESULTS. Two hundred and ninety-seven adult patients with ca-ABM were included; 163
(54.8%) were attend in ICU and 134 (45.2%) in the rest of medical units. The median
age ± IQR of patients ICU admitted was 54.38 ± 33 years old vs. 62.77 ± 31 years old
patients in the rest of units (p = 0.01). The principal etiological agent in ICU patients vs. rest
of unit was: S. pneumoniae 78/163 (48%) vs. 49/134 (36%); N. meningitidis 46/163 (28%) vs.
15/134 (11%); Listeria monocytogenes 15/163 (9%) vs. 27/134 (20%) (p[0.001). The
classic triad of fever, neck stiffness and altered mental status was present in 90/163 (55%) in
ICU patients vs. 54/134 (40%) (p = 0.010). The mean Glasgow Coma Score (GCS) at ICU
admission was 11 vs. 14 (p[0.0001). The median of delayed to start antibiotic treatment in
ICU was 5 h 34 min vs. 7 h 52 min in the rest of units (p = ns). Dexamethasone was used in
138/163 (85%) in ICU patients vs. 94/132 (71%) in the rest of units patients (p = 0.003). The
mortality rate in ICU was 33/163 (20%) vs. 18/134 (13%) (p = ns). In the multivariate model
risk factors for unfavorable outcome were age C 65 years old (OR: 0.967; 95%IC:0.953–
0.981; p\0.001); classic triad (OR: 2.43; 95%IC:1.43–4.14; p = 0.001); Streptococcus
pneumoniae agent (OR:2.01; 95%IC:1.18–3.40; p = 0.009); and independent risk factors
associated to mortality were renal failure (OR:9.67; 95% IC:1.41–66.1; p = 0.021), and
age C 65 years old (OR 1.04; 95%IC:1.022–1.067; p\0.001).
CONCLUSION. Community-acquired acute bacterial meningitis in patients admitted in ICU
present more severe clinical vs. patients attend in the rest of medical units. The antimicrobial
treatment was earliest initiated in those cases admitted to UCI. However, this entity also
remains a serious disease that carries high morbidity and mortality rates, specially in patients
over 65 years old.
GRANT ACKNOWLEDGEMENT. Spanish Network for the Research in Infectious Dis-
eases (REIPI).
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INTRODUCTION. Cytomegalovirus (CMV) is an important cause of morbidity and mor-
tality in immunocompromised patients. Some observational studies have suggested a high
prevalence of viremia in immunocompetent septic patients in intensive care units. CMV
inﬂuence on the outcome of immunocompetent critically ill patients is still not well under-
stood. The objective of the study was to determine the prevalence and clinical signiﬁcance of
CMV viremia in a population of immunocompetent adult critical care patients with prolonged
length of stay (LOS).
METHODS. Between May 2006 and September 2007, we screened adult patients admitted to
our academic 24-bed medico-surgical intensive care unit (ICU). Patients were enrolled, after
informed consent was given, if they stayed more than ten days in ICU and were not
immunocompromised. Patients receiving steroids were not excluded. Blood samples for CMV
serology (House IgG and IgM ELISA) and serum CMV Polymerase Chain reaction (PCR,
Cobas Amplicor CMV Monitor TM, Roche) were collected at study entry (on day 10 of ICU
admission) and weekly thereafter until the patient was discharged to the ward or after one
month of ICU stay. Predetermined demographic, physiological and laboratory data were
collected and descriptive statistics were computed. Data are presented as Mean ± standard
deviation.
RESULTS. During the study period, 50 consecutive patients were enrolled: 36 men and 14
women with a mean age of 46.2 ± 22.9 years. The length of stay was 23 ± 11 days,
APACHE II score was 20 ± 6 and the overall mortality was 14%. 50% were trauma patients,
and the others were medical (25%) and surgery (25%) patients. Most patients (92%) received
antibiotics for a mean duration of 18 ± 12 days, 22% received antifungal drugs and only 1
patient received acyclovir. Corticosteroids were used in 36% of patients. 96% of patients were
on mechanical ventilation for a mean duration of 19.2 ± 12.7 days. Serology for CMV (IgG)
was positive in 44% of the patients. A total of 169 samples for CMV-PCR were collected. Of
the 144 PCR results available at this time, only 4(2.8) were positive in two different patients
(Table 1). One of them had three consecutive positive results over a 3 weeks period.
TABLE 1
Positive Negative
ELISA CMV- IgG, n (%) 22(44%) 28(56%)
ELISA CMV- IgM, n (%) 6(12%) 44(88%)
CMV-PCR, n (%) 4(2.8%) 140(97.2%)
CONCLUSION. In our non-immunocompromised ICU population with prolonged LOS,
prevalence of CMV viremia remains low. Accordingly, our data does not support empiric
screening of non-immunocompromised intensive care patients in the absence of clinical
suspicion for CMV infection. Further studies in more speciﬁc subgroups such as sicker septic
patients should be considered.
GRANT ACKNOWLEDGEMENT. The CMV-PCR kits were provided by Roche.
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INTRODUCTION. Well known parameters for diagnostic and valuation the degree of
inﬂammation and for stress are: high sensitive C reactive protein (hs-CRP), prokalcitonin,
lactate, ﬁbrinogen, D-dimmer, and number of leukocytes, but they are not always available for
valuation of sepses, septic shock, and for anticipation of the risk from unexpected develop-
ment after spacious cardio surgical interventions. Prevention, diagnostic and early antibiotic
treatment is highly signiﬁcant. The aim of this study was to show that the level of Interleukin
6 (IL6) in serum can be used for an early valuation of bacterium infection in patients.
METHODS. 57 patients were evaluated in the Unit of intensive care, after cardio surgical
intervention. We measured the level of IL6 in serum and we chose and statistically evaluated
20 patients: I group 10 patients with clinical and laboratory signs of infection, II group 10
patients without clinical and laboratory signs of infection. We measured the level of IL6
before, 4 h, 24 h, and 72 h after the intervention. The patients serums were kept on – 70 C
degree before testing. The level of IL6 was measured by hemiluminiscence immunity test on
immunochemical analyzer ‘‘Access’’ (Immunoassay Systems Access), Beckman Coulter, in
the immunology laboratory at the Institute for cardiovascular diseases. The parameters for
statistical analysis were: arithmetic center, linear trend and Fishers test of reliability.
RESULTS. The level of IL6 starts to increase 4 h after the tissue damage. The highest level
of IL6 was after 24 h (the middle value IL6 for I group of patients with infection was 54,
16 pg/ml, and the highest value in the II group of patients without infection was 25, 70 pg/
ml). The increase of the level of IL6 in I group was for 79, 31% higher than in the II group.
CONCLUSION. In 72 h the value of IL6 in the II group became normal, and in I group they
were still high. As a result of preliminary analysis on a small number of patients, and due to
literature information’s, changes of the level IL6 in serum and his increase can be one of the
early signs of infection and it makes possible to start with appropriate antibiotic treatment and
to valuate the result of cardio surgical interventions.
GRANT ACKNOWLEDGEMENT. Institute of immunology and mycrobiology, Institute
for biochemical analyzing.
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INTRODUCTION. Nurses are critical for implementation of infection control measures in
ICU. Nurses in India have no specialized training in Critical Care and mostly learn on the job.
Despite this ICU outcomes can be comparable to the western world. (1) High rates of ICU
acquired infections have been reported from India. (2) Education is an effective tool to
improve infection control in ICU. (3) No published Indian data is available regarding nurses’
awareness of infection control measures or effect of educational intervention thereof.
METHODS. Awareness of infection control measures amongst critical care nurses of Fortis
Escorts Hospital and Research Center, Faridabad, India was assessed using a multiple choice
questionnaire (MCQ). Education levels and length of total and ICU experience was also
recorded. The nurses were subjected to a month long focused education initiative regarding
the infection control measures using both didactic lectures and bedside hands on training.
Thereafter changes in awareness levels were reassessed using the same MCQ. The results
were statistically analyzed.
RESULTS. Sixty eight nurses were evaluated initially with the MCQ. Only mean ±- SD 41.8
± 14.13 % questions were answered correctly. After a month long education initiative only 53
of these nurses could be reevaluated. A mean of 57.0 ± 14.9% questions were answered
correctly as compared to a base line of 42.1 ± 15.2 % (p = 0.78) in this subset of 53 nurses.
Only 8 out of these 53 nurses were nursing degree (BSc.) holder while the rest had a diploma
(GNM). The number of former was too small for meaningful subset analysis based on
qualiﬁcation. Theses nurses had 33.26 ± 17.27 (range 4–103) months of total post qualiﬁ-
cation experience and 16.43 ± 15.31 (range 1–60) months of ICU experience. No signiﬁcant
correlation was observed with quantum of either total or ICU nursing experience with
awareness levels at either the baseline (0.07 (p = 0.61) and 0.18 (p = 0.21) respectively) or
post education initiative period (0.22 (p = 0.10) and 0.06 (p = 0.64) respectively).
CONCLUSION. Despite no specialized training in intensive care nursing and low average
total and ICU experience, the nurses could answer a mean of 41.8 ± 14.13 % (42.1 % in the
subset of 53 subsequently followed up) questions correctly. There was a trend towards
improvement after only a month long focused education initiative although this did not reach
signiﬁcance. This study highlights the need for intensive nurse educational initiative, perhaps
for longer duration, to improve awareness regarding infection control measures in the ICU.
REFERENCE(S). 1. Intensive Care Med 2007; 33 (Suppl 2): 115 s.
2. J Hosp Infect. 2007; 67(2):168.
3. Clin Infect Dis 2007; 45: 704.
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INTRODUCTION. Acute cholecystitis can be seen in the Intensive Care Unit (ICU) patients
with the two distinct forms the calculous and acaclculous. Acalculous cholecystitis accounts
for approximately 4–8% of all cases of acute cholecystitis and is typically seen in critically ill
patients and can results in signiﬁcant morbidity and mortality. The aim of this study was to
evaluate the cases of the acute cholecystitis in the ICU patients.
METHODS. During 2-year period we examined retrospectively the ICU patients who
developed acute cholecystitis during their treatment. We examined the epidemiologic char-
acteristics of the patients, the form of acute cholecystitis, the diagnostic criteria, the
management and ﬁnally the outcome.
RESULTS. From 153 consecutive patients, 15 of them developed acute cholecystitis during
their treatment in the ICU. 7 patients presented calculous cholecystitis, while the rest of them
acalculous. The diagnosis performed with ultrasound. High index of suspicion warranted in all
cases where the main symptom was the unexplained fever. The ultrasound ﬁndings were
thickening of the gallbladder wall, subserosal oedema, and fragmentation of gallbladder wall.
Surgical treatment was required in 4 cases. The rest of them responded well to antibiotic
therapy. There was no mortality as a result of cholecystitis.
CONCLUSION. Half of the cases of acute cholecystitis in ICU patients represent the a-
calculous form. In cases of fever of unknown origin acute cholecystitis with the two distinct
forms must be in mind. Aggressive management may be required if did not respond to
antibiotic therapy.
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INTRODUCTION. The aim of this study is to analyse the epidemiological, clinical features,
management and outcome of patients with community-acquired acute bacterial meningitis
(ca-ABM) admitted to the intensive care unit (ICU) of nine Spanish hospitals
METHODS. A descriptive, prospective, and multicenter study carried out in 9 hospitals of
the Spanish Network for the Research in Infectious Diseases (REIPI) between 1/11/2003 and
31/07/2006. Patients were diagnosed on the basis of a compatible clinical, cerebrospinal ﬂuid
(CSF) ﬁndings and microbiological criteria (positive CSF Gram-stain, positive culture of CSF
and or hemoculture). An adverse clinical outcome was deﬁned as death or cure with dis-
abilities. Outcome predictors were identiﬁed through logistic-regression analysis.
RESULTS. Two hundred and ninety-seven adult patients diagnosed by ca-ABM were
included and, 163 (54.8%) were attend to the ICU. The median age ± IQR of ICU patients
was 54.38 ± 33 years old. The principal etiological agents were: S. pneumoniae 81 patients
(48%), N. meningitidis 47 (28%), Listeria monocytogenes 15 (9%), Streptococcus agalactiae
4 (2%); Escherichia coli 2 (1%), Haemophilus inﬂuenzae 2 (1%), others 8 (5%), and without
isolate 10 (6%). Predisposing conditions were: oto-mastoiditis or sinusitis in 37 patients
(22%), previous immunosuppression 21 (12%), diabetes 22 (13%), CSF leak 15 (9%) and
alcoholism 15 (9%). The clinical symptoms most frequent were: fever 146 (87%), Glasgow
Coma Scale (GCS) B 14 137 (81%), neck stiffness 128 (77%), cephalea 124 (75%). The
classic triad (fever, altered mental status and meningeal sings) was present in 94 patients
(55%). The most frequent cause which these patients were admitted to the ICU was altered
mental status (the median value of GCS was 11). Seventy patients (41%) received empirical
antimicrobial monotherapy with third-generation cephalosporins, the rest of the cases com-
bination of 2 or more antibiotics. Dexamethasone was used in 144 cases (85%), 79 patients
(47%) receiving phenytoin and 45 patients (27%) mannitol. Seventy-eight patients requiring
(50%) mechanical ventilation. The median length of stay in ICU was 4 days (1–88). The
mortality rate was 20% (33 of 163 patients) and 27 (16%) developed adverse clinical outcome
(neurological and/or auditory sequels). In the multivariate model risk factors for unfavorable
outcome were: alcoholism (OR 6.98; CI 95%: 1.19–40.8; p = 0.031); age C 65 years old
(OR 3.24; 95%IC:1.28–8.19; p = 0.013); mechanical ventilation (OR 11.0; 95%IC:4.38–
27.9;p\0.001); and therapy with mannitol (OR 0.36; 95%IC: 0.13–0.95; p = 0.042).
CONCLUSION. S pneumoniae was the most common pathogen in patients with ca-ABM
admitted to the ICU. Altered mental status was the principal cause at admission. Age,
alcoholism, mechanical ventilation and therapy with mannitol were risk factors associated
with unfavorable outcome in these critical patients.
GRANT ACKNOWLEDGEMENT. Spanish Network for the Research in Infectious Dis-
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INTRODUCTION. Provision of nutritional support is seen as a therapeutic tool to attenuate
disease severity and to modulate the immune response. Heat sterilisation of glucose-containing
ﬂuids promotestheformationofcompoundstermedglucose degradation products(GDPs).Many
of the GDPs have been identiﬁed and their biological toxicity has been characterized. Several
clinical studies demonstrate that the removal of GDPs from the peritoneal dialysis ﬂuids leads to
a preserved peritoneal function, decreased inﬂammation, decreased peritonitis incidence, and
preserved residual renal function and a signiﬁcant survival advantage.
METHODS. In order to investigate whether infusion ﬂuids contain toxic GDPs and if these
GDPs are found in patients, we included 11 patients undergoing surgery (55% women). All
patients received a standard ﬂuid therapy consisting of 1.7 L glucose containing infusion ﬂuids.
Blood samples and urine werecollectedand analyzedfor GDP content.The inﬂuence ofinfusion
ﬂuids on cell viability and secretion of cytokines was investigated on human neutrophils. The
effect of these ﬂuids on cell growth was investigated on murine L929 ﬁbroblasts.
RESULTS. The results demonstrate that all investigated infusion ﬂuids contained high concen-
trationsofGDPs.3-DGincreasedrapidlyinthe seruminthe patientsafterreceivingﬂuidtherapy
(Figure 1),andseveraloftheGDPswerenotrecoveredintheurine.TheconcentrationofGDPsin
mostofthetestedﬂuidswaslethaltoneutrophilsandimpairedtheirimmunomodulatoryfunction.
Furthermore, several of the ﬂuids exhibit a negative impact on cell growth.
CONCLUSION. These ﬁndings indicate that normal preoperative ﬂuid treatment involves
infusion of potentially dangerous ﬂuids into the patients. A reduction of GDPs in the infusion
ﬂuids, which may be easily obtained through altered manufacturing processes, could improve
patient outcome within ICU.
GRANT ACKNOWLEDGEMENT. Gambro Lundia AB.
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INTRODUCTION. Therapeutic hypothermia (33–34C) is induced in comatose survivors of
cardiac arrest. Sedation is required, but complicated by hypothermia and critical illness, factors
increasing elimination half-lives and serum concentrations of drugs. This study explored the
disposition of morphine and midazolam during therapeutic hypothermia (33–34C).
METHODS.Prospective,open,non-randomisedstudywhere15hypothermic(33–34C)patients
treated with therapeutic hypothermia following cardiac arrest were compared to 6 normothermic
(36–38C)criticallyillcontrols.AllpatientsweresedatedtoaMAAS-scoreof0–1.Atleast8hafter
theirstart,continuousinfusionsofmorphine and midazolamwerereplacedwithequivalent doses
of fentanyl and propofol. A series of 13–15 blood-samples for validated quantitative analysis of
morphine and midazolam were drawn 0–8 h after the switch. The groups were compared using a
two-tailed t-test for two independent samples with unequal variances (Table 1).
TABLE 1
Hypothermia
(33–34 C)
Normothermia
(36–38 C)
95% CI for
difference
of mean
Age (years) 61.1 (10.5) 66.7 (6.3) (–13.4, 2.5) n.s.
Male sex (male/total) 12/15 6/6
Duration of morphine/
midazolam infusion (min)
909 (261) 1024 (269) (-406, 177) n.s.
SAPS-II score 24 h
after admission
68.9 (8.5) 57.0 (15) (-3.8, 27.7) n.s.
Morphine terminal
elimination half-life (min)
250 (53) 177 (30) (34, 113) p = 0.001
Midazolam terminal
limination half-life (min)
392 (105) 530 (285) (-438, 160) n.s.
Values are given as mean (± SD). ‘‘n.s.’’ = non-signiﬁcant (p[0.05)
RESULTS. The terminal half-lives for morphine were 177 and 250 minutes for the normo-
and hypothermic groups (p = 0.001), respectively. The corresponding values for midazolam
were 530 and 392 minutes (p = 0.296).
CONCLUSION. Elimination of morphine but not midazolam was decreased in patients treated
with therapeutic hypothermia. The lack of difference in terminal half-life for midazolam may be
explained by the known inhibitory effect of fentanyl and propofol on midazolam metabolism.
Compared to critically ill controls, the increased half-life by 40% in the hypothermic group may
indicate that the infusion rate of morphine during hypothermia should be reduced.
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INTRODUCTION. The importance of pharmacogenetics in the metabolism of drugs in
critically ill patients is untested. Three cytochrome P450 enzymes and their numerous iso-
enzymes account for over 60% of all drug metabolism. The CYP450 enzymes have a number
of functional alleles with varying clinical signiﬁcance. Midazolam is an established in-vivo
probe of cytochrome P4503A (CYP3A) activity in healthy volunteers. This study investigates
whether a single plasma midazolam concentration acts as an accurate predictor of total
midazolam clearance in critically ill patients with a view to more complex in-vivo studies of
the effects of critical illness on the metabolic activity of CYP3A.
METHODS. Patients admitted to the adult intensive care unit were excluded if they had;
acute or chronic liver failure, received benzodiazepines in the past 24 h or were pregnant. I.V.
Midazolam (1 mg) was given at time 0 and serum was collected at
5,15,30,60,120,180,240,300,360 and 480 mins. Serum midazolam concentration was deter-
mined by mass spectrometry (HPLC/MS/MS). Area under the curve (trapezoid rule) was
correlated (Spearman rank) to serum 4 h midazolam concentration.
RESULTS. 20 patients (13 male). Age 75 (50–87). Mean APACHE 18. 4 h midazolam
correlated with AUC; r = 0.956, p\0.0001 (graph).
CONCLUSION. Single point determination of midazolam concentration four h after
administration accurately predicts the metabolic rate of midazolam metabolism in critically ill
patients. In accordance with previous studies this probe can now be used as a method of
studying the effects of genotype variation and critical illness on drug metabolism.
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AMINO-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE IN CRITICAL ILL-
NESS: ASSOCIATION WITH ORGAN FUNCTION AND MORTALITY
I. Dimopoulou*, P. Karsaliakos, I. Mavrou, P. Kopterides, M. Tzanela, E. Papadomichelakis,
M. Theodorakopoulou, E. Botoula, I. Tsangaris, M. Lignos, I. Ikonomidis, I. Ilias,
A. Armaganidis, S. Orfanos, A. Kotanidou
Critical Care Medicine, Athens University, Athens, Greece
INTRODUCTION. The association between amino-terminal pro-brain natriuretic peptide
(NT-pro-BNP) levels, organ function and mortality in a general ICU population has not been
well characterized.
METHODS. To investigate this issue a total of 233 consecutive critically ill patients (109
men) having a median age of 60 years, with a wide range in admitting diagnoses were studied.
Blood samples were drawn on admission in the ICU to determine NT-pro-BNP levels.
Severity of critical illness and organ function were assessed by APACHE II and SOFA scores
respectively. Receiver Operator characteristics (ROC) curves were constructed to determine
diagnostic performances. Multiple logistic regression analysis was performed to identify
variables that independently predicted ICU mortality. The following possible prognostic
factors were entered: age, APACHE II and SOFA scores on admission in the ICU, the
presence of sepsis, and two categories in admission NT-pro-BNP (based on the best cutoff
point). NT-pro-BNP levels were compared with regard to PaO2/FIO2, platelet count, creat-
inine, total bilirubin, and the use of inotropic agents. For this purpose, patients were divided in
two groups according to the SOFA subscores: those with a subscore of 1 to 2 and those with a
subscore of 3 to 4.
RESULTS. Nonsurvivors (n = 98) had signiﬁcantly higher NT-pro-BNP levels than survi-
vors (n = 135) on admission in the ICU (2074 vs. 283 pg/ml, p\0.001). ROC analysis
showed that the area under the ROC curve in predicting ICU mortality was 0.70 for APACHE
II and 0.77 for admission NT-pro-BNP (p = 0.08). The cutoff in admission NT-pro-BNP that
best predicted outcome was 941 pg/ml. Multiple logistic regression analysis revealed that
APACHE II score (O.R. = 1.06, p = 0.007), and the best cutoff point in admission NT-pro-
BNP (O.R. = 7.74, p\0.001) predicted independently ICU mortality. Elevated NT-pro-
BNP was associated with thrombocytopenia (platelet count lower than 50x103/microl), renal
failure (creatinine[3.5 mg/dl) and cardiac dysfunction as reﬂected by the requirement in
inotropic agents (p\0.02 to 0.03). Furthermore, admission NT-pro-BNP levels were pre-
dictive for renal failure (Cr[3.5 mg/dl).
CONCLUSION. In a large diverse cohort of ICU patients elevated NT-pro-BNP concen-
trations are associated with increased morbidity and mortality. In particular, patients with
admission NT-pro-BNP plasma levels[941 pg/ml are 7 times more likely to die in the ICU
than patients with lower values.
0916
PANTOPRAZOL VS RANITIDINE AS PROPHYLAXIS FOR ACUTE GASTRIC
MUCOSAL LESIONS IN CRITICALLY ILL PATIENTS
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INTRODUCTION. To describe the incidence of acute gastric mucosal lesions (AGML) in
critically ill patients under mechanical ventilation for at least seven days and receiving
pantoprazole or ranitidine as prophylaxis.
METHODS. We prospectively studied all adult patients admitted to our ICU who received
prophylatic treatment for AGML and were under mechanical ventilation for at least seven
days since admission. Preventive treatment for AGML was 40 mg pantoprazole i.v. once
daily or 50 mg ranitidine i.v. every eight h. Treatment was decided by the physician in charge.
After obtaining informed consent we performed a ﬁbrogastroscopy between days 7 and 9 in
the ICU to determine the presence or absence of AGML. Gastric pH, hemoglobin and
hematocrit were determined daily. Data concerning blood transfusion requirements, SAPS II,
APACHE II, sex, age, reason for admission, number of days in ICU, number of days on
mechanical ventilation and outcome were also recorded.
RESULTS. From a total of 695 patients admitted to our ICU between June 2006 and January
2008, we screened 225 patients under mechanical ventilation for at least 7 days. Six patients
were excluded due to previous gastric haemorrhage. Forty-seven patients needing mechanical
ventilation for over seven days completed the study. We excluded patients with gastroin-
testinal bleeding or ulcer history, extubated patients, those who died before seven days and
cases without informed consent. Mean age was 65 ± 12 years, 10 (21.3%) were males and 37
(78.7%) females. APACHE II was 20.0 ± 7.1 and SAPS II was 49.6 ± 14.5 at ICU
admission. Thirty-three patients received pantoprazole and 14 ranitidine. Eighteen (54.5%)
patients receiving pantoprazole and 8 (57.1%) on ranitidine had AGML at ﬁbrogastroscopy
(P = NS). Three patients on ranitidine and 1 on pantoprazole had gastric ulcer. None of the
47 patients presented active gastric bleeding during ICU admission. The study was stopped
due to lack of patients included in the ranitidine group.
CONCLUSION. The incidence of AGML was similar in critically ill patients treated with
pantoprazole or ranitidine and was high despite this prophylactic treatment. Pantoprazole
could be a valid alternative to ranitidine for prophylaxis of ALGM.
GRANT ACKNOWLEDGEMENT. We would like to thank Carolyn Newey for editorial
assistance and all nurses in our ICU for their help.
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INTRODUCTION. We aimed at clarifying the prognostic value of cortisol response to
ACTH in a broad population of septic shock.
METHODS. Relation between cortisol response to ACTH and mortality was tested with
nonlinear models in 487 CORTICUS1 pts.
RESULTS. In logistic regression, basal cortisol (p = 0.0005) and delta cortisol (p = 0.01)
were independent predictors of death. Nonlinear modelling showed increased mortality with
increasing cortisol or decreasing delta cortisol.
CONCLUSION. Septic shock mortality may vary positively with basal cortisol and nega-
tively with delta cortisol.
REFERENCE(S). 1. Sprung et al. NEJM 2008,358:111.
GRANT ACKNOWLEDGEMENT. European Union, ESICM, ISF.
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INTRODUCTION. In intensive care (ICU) patient’s anemia is frequently associated with
serum iron status disturbance. It may be due to two major phenomenons: inﬂammatory
response and red blood cell loss. However, few studies described the serum iron status
evolution in these patients and particularly those in shock state. We therefore explored the
serum iron status of patients admitted in ICU for septic shock (SS) or in trauma patients (TR)
METHODS. Patients admitted in ICU for TR (ISS[16) or SS (Bones criteria) were pro-
spectively included. Blood samples were obtained on admission (day 1), day 3 and day 5 after
admission. Serum iron (Fe), transferrin (Tf), ferritin, and soluble transferrin receptor (rTf)
were measured. Usual clinical and biological parameters were assessed. Statistical analysis
consisted in ANOVA for repeated measurements and Mann-Whytney test.
RESULTS. Twenty ﬁve patients were included (13 SS, 12 TR). Mean age was 57 ± 13,
mean SAPS II was 51 ± 18 and mean ISS was 33 ± 15 for TR. Serum iron status parameters
were corrected with protidemia. Serum iron was signiﬁcantly lower in SS and TR compared to
laboratory usual range. This diminution was observed at day 1 for SS whereas it occured at
day 3 for TR. (p = 0.0425). Ferritin rates rised signiﬁcantly in both groups (SS p = 0,0025;
TR p = 0.0098) compared to laboratory usual range. Tf rate are signiﬁcantly more elevated in
TR (p = 0.0073). No differences were observed in rTf rates.
CONCLUSION. There is an acute decrease of serum iron during SS and TR. Difference
between TR an SS may be explained by the delay between the beginning of the pathology (SS
or TR) and sample.
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OXYGEN CONSUMPTION IS DEPRESSED DURING HUMAN BIGUANIDE-ASSO-
CIATED LACTIC ACIDOSIS
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INTRODUCTION. Lactic acidosis during animal biguanide intoxication may be due to
mitochondrial damage
1. Mitochondria account for[90% of human body oxygen con-
sumption (VO2). Aim of the study was to verify if VO2 is impaired in patients suffering from
biguanide-associated lactic acidosis.
METHODS. We retrospectively studied 10 ICU-admitted patients with biguanide-associated
lactic acidosis, undergoing renal replacement therapy. VO2 was estimated as arterio-central
venous difference in oxygen content (AVDO2; normal value: 3.0–5.0 ml/dl). In 5 patients
having their cardiac index monitored, VO2 was also calculated (normal value: 110–160 ml/
min/m
2). Data collected during the ﬁrst 5 days were analyzed using a one-way repeated
measures ANOVA.
RESULTS. Main results are presented as mean ± sd in table.
TABLE 1
Day 1 Day 2 Day 3 Day 4 Day 5 p
pH 7.04 + 0.12 7.36 + 0.07 7.41 + 0.06 7.44 + 0.05 7.44 + 0.04 \0.001
Lactate (mM) 16 + 7 4 + 3 2 + 1 2 + 1 1 + 1 \0.001
AVDO2 (ml/dl) 1.8 + 1.2 2.8 + 0.7 3.0 + 0.6 3.9 + 0.9 3.5 + 0.2 \0.001
VO2 (ml/min/m2) 75 + 22 111 + 31 127 + 45 128 + 47 116 + 24 0.009
CONCLUSION. AVDO2 and VO2 are abnormally low in biguanide-intoxicated patients and
return to normal during recovery. This ﬁnding suggests that the associated lactic acidosis may
be due to mitochondrial damage.
REFERENCE(S). 1. El-Mir et al., J Biol Chem 275:223–8.
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DOES NICOTINE REPLACEMENT THERAPY AFFECT MORTALITY IN CRITI-
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INTRODUCTION. Nicotine Replacement Therapy (NRT) has been advocated to prevent
withdrawal in hospitalised smokers; however data from the ICU population are sparse. [1] We
undertook a retrospective case control study to assess the effect of NRT on ICU and hospital
mortality.
METHODS. Cases were identiﬁed from a 30 bed general ICU as all those who had been
prescribed NRT over 18 months (n = 73,); controls included adult smokers admitted during
the same period who were not prescribed NRT, matched for age and weight (n = 86). The
probability of receiving NRT was calculated via a propensity score (including APACHE2
mortality risk, sex, alcohol use and number of sedatives required), which was then used as an
adjustment variable in two further logistic regression models examining ICU and hospital
death as the outcomes.
RESULTS. The NRT group had both lower unadjusted ICU (8.2 vs. 22.1%) and hospital
mortality (15.1 vs. 31.4%).The propensity score discriminated well (AUC 0.768), identifying
that patients who received NRT were more likely to have a lower APACHE mortality risk, a
history of alcohol use, be female, and require more sedatives. After adjustment for both
propensity score and mortality risk, NRT therapy was no longer associated with ICU mortality
(OR 0.41, 95% CI 0.13 – 1.25, p = 0.12); however there was a borderline association
between NRT and lower hospital mortality (OR 0.40, 95% CI 0.16 – 1.00, p = 0.05). Both
models discriminated adequately (AUC 0.74 and 0.72) and were well calibrated (X2 = 2.13
and 5.62).
CONCLUSION. Contrary to a previous report [1], NRT therapy may be associated with a
reduction in hospital, but not ICU mortality. This requires conﬁrmation in a larger dataset.
REFERENCE(S). 1. Lee AH, Afessa B. The association of nicotine replacement therapy
with mortality in a medical intensive care unit. Crit Care Med. 2007;35(6):1517–1521.
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INTRODUCTION. The adverse impact of cachexia and muscle wasting on patient outcome
has long been acknowledged. In this context several physical and laboratory parameters of
muscle mass have been evaluated in different patient groups. Creatinine is the irreversible and
stable product of muscle degradation and dietary meat intake. Since creatinine is excreted into
the urine, measurement of urinary creatinine excretion in 24 h urine samples (UCE) has been
a widely accepted method for muscle mass estimation. Although UCE was studied in out-
patients, no studies have been performed in critically ill patients. We evaluated if UCE at ICU
admission, as a marker of muscle mass, is associated with patient outcome.
METHODS. In this observational study in a 12-bed surgical ICU in a tertiary teaching
hospital, we used our hospital database to analyse 24-h urine and serum samples of all patients
admitted from 2000–2006. Samples were collected on the ﬁrst 3 days after ICU admission.
UCE and creatinine clearance were calculated. Since muscle mass is sex and age dependent,
these factors were also recorded. Patients who were discharged within 24 h of admission, had
a diuresis\400 ml/day or serum creatinine levels[250 umol/L, or had received renal
replacement therapy (RRT) were excluded. Hospital mortality and length of stay were used as
outcome measures.
RESULTS. Of a total of 3505 patients admitted during the study period, 1514 patients with
3757 samples were analyzed. There were 63% male and 37% female patients. 432 Patients
were excluded due to severe oliguria, serum creatinine levels above cut-off level or RRT.
Mean creatinine excretion in 24 h-urine samples was 13.5 ± 5.3 and 8.6 ± 3.8 mmol/day for
males and females respectively (p\0.001). Hospital mortality was 18%. After univariate
analysis UCE was strongly correlated with hospital mortality, with different relations for
males and females. After multivariate logistic regression analysis with UCE, baseline serum
creatinine, sex, and age, UCE and age were independently associated with mortality
(p\0.001). When UCE was expressed in equal quintiles, patients in the lowest UCE quintile
had a 4-fold increased mortality risk compared to patients with the highest UCE quintile.
Likewise, ICU and hospital length of stay for patients patients in the lowest UCE
quintile were 2-fold increased compared to patients with the highest UCE quintile.
CONCLUSION. Urinary creatinine excretion after ICU admission is approximately 50%
higher in critically ill male patients compared to female patients. For both sexes urinary
creatinine excretion as a measure of muscle mass is strongly associated with patient mortality.
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INTRODUCTION. Central pontine and extrapontine myelinolysis is an osmotic demyelin-
isation disorder precipitated by an agressive correction of a dysosmolar state. It is often
caused by a rapid correction of hyponatremia. Clinical manifestations usually develop 2–
7 days after the electrolyte disturbance had occured, the severity of symptoms differs with the
most severe being quadriplegia and coma. Once the symptoms have developed, the neuro-
logical prognosis is unfavourable. Several modes of therapy have been reported as effective
once the neurological symptoms had occured (plasmapheresis, corticosteroids, immuno-
globulins and thyreotropin releasing hormone - TRH), all were reported only as individual
case reports. Through a search of literature we found 3 case reports of succesfull treatment
with TRH followed by a prompt neurological recovery.
METHODS. A case report and a literature review.
RESULTS. A 61-year old man was admitted with a severe hyponatremia, which was too
rapidly corrected. Six days later he developed a progressively worsening neurological
symptomatology (quadruparesis, dysartria, bulbar symptomatology). Central pontine and
extrapontine myelinolysis was conﬁrmed on MRI. The patient remained virtually unrespon-
sive with a severe quadruparesis and a severe bulbar symptomatology for 4 weeks. The only
sign of his consciousness was a tiny movement of his ﬁngers on verbal comand. Therapy with
TRH was started 4 weeks since the onset of symptoms in a daily dose of 2 mg i.v. for
30 days. A dramatic neurological improvement began within a few days and continued
through the full course of therapy. He was discharged 6 weeks after the end of therapy with
TRH. The patient made a practically complete recovery with only a slight residual neuro-
logical symptomatology. He returned to his work as manager 6 months later. Thyroid
function tests were repeatedly within normal limits and no side effects were observed.
CONCLUSION. Our case is, according to literature, a fourth reported treatment with TRH
followed by a neurological improvement. TRH appears to be a safe and beneﬁcial treatment
of central pontine and extrapontine myelinolysis. Compared to other therapies, which are all
immunosupresive, it appears to have no apparent side effects.
REFERENCE(S). 1. Brown W. Osmotic demyelinisation disorders: central pontine and
extrapontine myelinolysis. Curr Opin Neurol 2000, 13(6),691–7.
2. Chemaly R. et al. Myelinolyse extra-pontine:traitement par TRH. Revue Neurologique
1998, 154(2):163–5.
3. Konno S et al. A case report of central pontine myelinolysis associated with serum
hyperosmolality after open heart surgery. Kyobu Geka - Japanese Journal of thoracic Surgery
1993, 46(2):150–4.
4. Wakui H. et al. Dramatic recovery from neurological deﬁcits in a patient with central
pontine myelinolysis following severe hyponatremia. Japanese Journal of Medicine 1991,
30(3):281–4.
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INTRODUCTION. Critically ill patients have a reduced secretion of melatonin (M), both in
nocturnal peaks and in baseline daily levels. The oral M supplementation has been hypoth-
esized useful for its sedative, anti-oxidant and oncostatic properties. This study is designed to
deﬁne both the enteral absorption and the daily pharmacokinetic of M in critically ill patients.
METHODS. 9 high-risk patients (2 cardiac arrest, 4 polmonitis, 3 septic shock, 1 pulmonary
edema) were enrolled in this prospective trial: mean age was 73.1 ± 4.9, mean SAPSIII
69.8 ± 5.3. During their third and fourth days of ICU, they undergo in two series of repeated
blood samples at these times: 20:00 (t0), 20:05 (t1), 20:10 (t2), 20:20 (t3), 20:30 (t4), 20:45
(t5), 21:30 (t6), 24:00 (t7), 03:00 (t8), 06:00 (t9), 14:00 (t10), to detect serum M levels by
radio-immuno-essay. One tablet containing M 3 mg (manufactured by Procemsa - Torino,
Italia - with the pure M produced by Helsinn - Biasca, Switzerland) was gave at 20:00 of the
fourth day, immediately after t0 sampling, by pounding the tablet in a pestle and adminis-
tering it by a naso-gastric tube. To build the pharmacokinetic curve were used the serum M
values of the fourth (exogenous) minus the third (endogenous) day.
RESULTS. All basal values of serum M were found below the normal level, frequently under
the lower detection limit of 3 pg/ml. The serum M values (all in pg/ml) describing the enteral
absorption were: t0 = 8.2 ± 4.5; t1 = 4729.3 ± 541.5; t2 = 11888.9 ± 8290.0;
t3 = 11479.3 ± 7835.1; t4 = 7923.1 ± 6030.4; t5 = 6806.5 ± 6125.2; t6 = 6504.2 ±
3068.2; t7 = 2283.6 ± 2094.1; t8 = 693.1 ± 586.5; t9 = 169.2 ± 100.6; t10 =
86.2 ± 83.9. Pharmacokinetic values: Cmax = 13811.41 ± 7337.83 pg/ml; Tmax =
15.0 ± 8.4 minutes; half life = 31.1 ± 14.7 minutes.
CONCLUSION. Critically ill patients have reduced serum M levels. By administration of
exogenous M 3 mg, supraphysiologic levels are reached already after 5 minutes, with a serum
peack of 13811 pg/ml reached after 15 minutes, showing a satisfactory enteral absorption
even during the early phase of critically illnesses. The decrease of serum M level become
signiﬁcant after midnight, even maintaining supraphysiological levels until 06:00.
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INTRODUCTION. Stress reaction of the body is a stereotype pattern of neuro-humoral
response. The key role in this ,,ﬁght-or-ﬂight’’ reaction is based in activation of the axis of
cerebral cortex-hypothalamus-adrenal medulla, and resulting secretion of adrenaline. One of
many actions of adrenaline includes glycolysis escalation and hence elevated blood lactate
levels. Hyperlacticaemia may not necessarily only mirror tissue hypoxia. The aim of our study
was to: 1) determine potential relationship between blood lactic acid levels and urinary
adrenaline levels at the time of admission to the ICU; 2) utilize lactate plasma levels and
urinary adrenaline levels as a marker to measure stress severity.
METHODS. We have ran the assay in 57 patients – 45 males and 12 females, median age
51 years (17–80), out of them 33 trauma patients and 24 non-trauma patients, median
APACHE II score – 20 points (11–30). The investigation was performed from the ﬁrst urine
sample taken at admission, in average 45 minutes (25 – 70 minutes) after the insult. At the
same time we assayed lactate levels in the arterial blood. Excluded were those patients who
had been administered dopamine, adrenaline and/or noradrenaline in the pre-hospital setting,
and patients with preexisting kidney disease. Adrenaline was assayed using a validated high-
performance liquid chromatography method with electrochemical detection (HPLC-ECD).
Thus determined adrenaline levels were recalculated relative to urinary creatinine levels. This
concentration ratio compensates for the inﬂuence of variable urine output and corresponds
with blood catecholamine levels at the moment of urine production.
RESULTS. 1. Urinary adrenaline/creatinine ratio was signiﬁcantly elevated in non-surviving
vs. surviving patients, 64 vs. 24 nmol/mmol of creatinine (Z =- 3.38, DF = 1, p = 0.0007).
2. Lactate plasma levels were signiﬁcantly elevated in non-surviving vs. surviving patients,
4.3 vs. 2.8 mmol/l (Z =- 2.93, DF = 1, p = 0.0034).
3. There was signiﬁcant correlation between lactate plasma levels and urinary adrenaline
levels (r = O.31, t = 2.43, p = 0.018).
CONCLUSION. Association between plasma lactate levels and urinary adrenaline levels
may suggest non-hypoxic cause of hyperlactataemia in the initial stage of stress response. The
efforts to reach normal plasma lactate levels may thus be not the most appropriate therapeutic
strategy. Elevated urinary adrenaline and plasma lactate levels in the non-surviving group
may suggest higher stress burden of this group.
REFERENCE(S). Cori CF, The inﬂuence of insulin and epinephrine on the lactic acid
content of blood and tissues, 1929.
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INTRODUCTION. Burn patients often receive far more resuscitation ﬂuid than predicted by
usual formula. Even few of them need support with vasopressor agents to achieve classic
resuscitation end points (urinary output, mean arterial pressure). These variations are related
with negative consequences described in the literature such as abdominal compartmental
syndrome and progression of burn necrosis. Some of the factors related with the increased
requirements of ﬂuids are known (electrical buns, inhalational injury). In cases where these
circumstances do not concur other factors are unknown.
Adrenal failure is common in critically ill conditions. The diagnosis of relative adrenal failure
(RAF), and its treatment with low doses of corticosteroids, showed reduction of vasopressor
support, shock reversal and improved survival in septic shock. Our main objective is to know
the prevalence of relative adrenal failure in the resuscitation phase of major burns. Secondly
we study its implication as a possible factor of increased requirements in burn resuscitation
METHODS. Descriptive study of the prevalence of RAF in major burns carried on in
Hospital Virgen del Rocı ´o, a tertiary hospital regional reference centre for major burns. From
March 2007, major burns accomplishing criteria were included. After written consent, 250
micrograms of Tetracosactrin (synthetic corticotrophin) was IV administered within the ﬁrst
48 h of resuscitation. Measures of cortisol were obtained before and 60 minutes after
administration. Every patient included received resuscitation following Parkland formula.
Resuscitation volume (predicted and real), 24 h diuresis, use of vassopresors and demo-
graphic data were collected. We deﬁned RAF as an increase in post-administration cortisol
RESULTS. 14 subjects were included. The mean burn surface area was 52%. The prevalence
of RAF was 31%. RAF was statistically signiﬁcant associated with young age group (RAF
27 years [21–30] vs. non RAF 41 years [37–46]). Increased resuscitation volume
(real[predicted) and use of vassopresors were not related with RAF. It seems that mean
burn surface area (BSA) and RAF are related but it does not reach statistical signiﬁcance
(RAF 65[45–78] % BSA vs. non RAF, 42[27–45] % BSA).
CONCLUSION. Prevalence of RAF in resuscitation phase of major burns is relevant. Its
association with increased resuscitation volume, use of vassopresors and BSA, however not
being statistically signiﬁcant, shows a marked trend that a major sample size probably would
strengthen.
Poster Sessions
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IMPACT ON PROCESS-OF-CARE AND MORTALITY OF A NATIONAL EDUCA-
TIONAL PROGRAM (EDUSEPSIS STUDY). EFFECTIVENESS ACCORDING
PROCESS-OF-CARE AT BASELINE
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INTRODUCTION. A national educational effort based on the Surviving Sepsis Campaign
(SSC) guidelines in Spain to promote bundles of care for severe sepsis and septic shock in
adults (Edusepsis study) resulted in improved guideline compliance and lower hospital
mortality (1). The objective of the study was to analyze the impact of baseline care on the
effectiveness of this intervention.
METHODS. Measurement of baseline compliance with the recommendations of the SSC
guidelines in a pre-intervention cohort (2 month period: November-December 2005) and re-
measurement in a post-intervention cohort (4 month period: March-June 2006). Intervention:
The educational program consisted of training physicians and nursing staff from the ED,
medical and surgical wards, and ICU in the deﬁnitions of severe sepsis and sepsis shock, their
early recognition, and the treatments included in the guidelines. Setting: 59 medical-surgical
adult ICUs located throughout Spain. ICUs were classiﬁed in 3 categories by percentiles
depending on the process-of-care at baseline, measured by the number of tasks included in the
bundles completed. Main Outcome Measure: Hospital mortality. Secondary outcome mea-
sures: Differences in adherence to process-of-care variables (sepsis care bundles). Patients:
All admissions to the ICU from the emergency department (ED) or from wards and all ICU
patients were actively screened daily for the presence of severe sepsis or septic shock.
Statistic analysis: To compare continuous variables during study periods, we used Student’s t
test and to analyze categorical variables v2 analysis was employed.
RESULTS. Baseline care of patients treated in Category 1 ICUs (20 ICUs) complied with
less than 4 tasks; baseline care in Category 2 ICUs (19 ICUs) complied with 4 to 5 tasks; and
baseline care in Category 3 ICUs (20 ICUs) complied with more than 5 tasks. No differences
in APACHE II between pre-intervention cohort and post-intervention cohort were observed in
any category. The educational program improved the process-of-care in all 3 categories of
ICUs (relative improvement of tasks completed of 36.0% en ICUs Category 1, 12.2% in
Category 2 and 9.3% in Category 3) but only reduced mortality in Category 1 ICUs (48.0 vs.
39.3%; p = .046).
CONCLUSION. There is a possible relationship between baseline compliance with the
guidelines and the effect of the educational program, suggesting that educational efforts are
most effective when applied in ICUs with low baseline compliance with the guidelines.
REFERENCE(S). 1. R. Ferrer and Edusepsis investigators. Intensive Care Med 2007;33:S5.
GRANT ACKNOWLEDGEMENT. Supported by the Spanish Society of Intensive Medi-
cine and Coronary Units (SEMICYUC) and the Surviving Sepsis Campaign.
S236 21st ESICM Annual Congress – Lisbon, Portugal – 21–24 September 20080927
SURVIVING SEPSIS GOALS ACHIEVED AND MORTALITY
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INTRODUCTION. Severe sepsis (SS) is the leading cause of death in the ICU. The Sur-
viving Sepsis Campaign (SSC) recommends a package of evidence based interventions
known as the sepsis resuscitation bundles and the sepsis treatment bundles. The aim is to
ensure that eligible patients receive all appropriate treatments in a timely fashion, utilising
protocol driven prescriptions. The SSC was implemented in our ICU February 2006. We
studied the relation of implementation and outcome.
METHODS. A prospective cohort study was performed in all (266) ICU-patients with SS
between January 2006 and September 2007. Patient demographics, sepsis origin (abdominal,
pulmonary, urogenital or otherwise), APACHE-II score, SSC goals achieved and hospital
mortality were recorded. SSC-points were given for every SSC-goal reached.
RESULTS. Total SSC compliance changed from 80.0% to 86.1% (p = 0.004). This change
was attributable to improvement in Resuscitation Bundle goals (p = 0.005). Severity of
illness did not change over time. No SS mortality change was noted overall.
TABLE 1 SSC GOALS
1 arterial lactate taken
2 cultures taken before antibiotics
3 anitbiotics started
4 volume resuscitation cvp 8–12 mmHg
5 ScvO2[70%
6 steroids given
Mortality varied among categories: abdominal 22 vs. 37%, pulmonary 45 vs. 37%, urogenital
0% vs. 0% and other 33% vs. 19%. Overall mortality was 38%. A clear trend to better
outcome was observed in the optimal implementation group (5–6 SSC points) with mortality
32% versus the suboptimal group (\4 points) mortality 44% (p = 0.05) without differences
in APACHE II score (p = 0.58).
CONCLUSION. Our hospital mortality of 38% is in range with the reported mortality of
severe sepsis-patients. A signiﬁcant better outcome after successful implementation of SSC
guidelines was demonstrated (mortality 44% vs. 32%; p = 0.05). Enrolling more patients and
combining data from other Dutch centers into our national SSC database should prove the
ultimate effect of implementation on outcome. Time delay data and goals not reached are
relevant to plan actions to improve the SSC guidelines implementation.
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POST-MORTEM FINDINGS IN 243 SURGICAL INTENSIVE CARE PATIENTS
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INTRODUCTION. While detailed analyses of the post-mortem ﬁndings of various critically
ill patient groups were published, no such study has been performed in patients with sepsis.
Detailed knowledge of post-mortem ﬁndings in these patients could not only improve our
understanding and treatment of sepsis, but also direct at future research strategies. This
retrospective cohort study reviews the post-mortem examinations of surgical intensive care
unit (ICU) patients who died from sepsis or septic shock.
METHODS. Between 1997 and 2006 the ICU database and autopsy register of a tertiary
university teaching hospital were reviewed for patients who were admitted to a twelve bed
surgical ICU because of sepsis/septic shock or who developed sepsis/septic shock at a later
stage during their ICU stay and subsequently died because of sepsis/septic shock. Clinical
data and post-mortem ﬁndings were documented in all patients. Descriptive statistical
methods were applied to evaluate the frequency of single organ pathologies. Chi
2-test was
used to compare the frequency of organ pathologies between the two most frequent clinical
causes of death or during the observation period.
RESULTS. Post-mortem results of 243 patients (87.7%) were available for statistical anal-
ysis. The main causes of death were refractory multiple organ dysfunction syndrome (50.6%)
and uncontrollable cardiovascular failure (36.6%). Pathologies of the lungs, kidneys/urinary
tract, cardiovascular system, gastrointestinal tract, liver, spleen, central nervous system, and
pancreas were detected in 89.7, 59.7, 53.9, 53.1, 47.3, 32.1, 18.5, and 9%, respectively.
Myocardial ischemia (88.6% non-occlusive; 11,4% occlusive) was the most frequent cardiac
pathology. In 182 patients (74.9%) the autopsy revealed an ongoing septic focus. The most
frequent ongoing foci were pneumonia (39.9%), tracheobronchitis (28.8%), peritonitis
(22.6%), uterine/ovarial necrosis (9.2% of female patients), intra-abdominal abscesses (9.1%)
and pyelonephritis (6.2%). Of the seventy-one patients who were admitted to the ICU because
of sepsis/septic shock and treated for longer than seven days an ongoing septic focus was
observed in 63 cases (88.7%).
CONCLUSION. Relevant post-mortem ﬁndings explaining death in surgical ICU patients
who died because of sepsis/septic shock were an ongoing septic focus in 80% and cardiac
pathologies in 50%. The most frequently affected organs were the lungs, the abdomen, and
the urogenitary tract. More diagnostic, therapeutic and scientiﬁc efforts should be launched to
identify and control the infectious focus in patients with sepsis and septic shock.
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IMPACT OF INTENSIVE INSULIN THERAPY ON SEPTIC PATIENTS IN A
MEDICAL SURGICAL ICU
S. M. Al Qahtani*, H. Tameen, Y. Arabi
Intensive Care Unit, King Abdulaziz Medical City, Riyadh, Saudi Arabia
INTRODUCTION. Hyperglycemia or relative insulin deﬁciency (or both) during critical
illness may directly or indirectly confer a predisposition to complications, such as severe
infections, multiple-organ failure, and death.
METHODS. In a closed medical –surgical ICU, university afﬁliated at the Kingdom of Saudi
Arabia. we prospectively planned sub analysis of a randomized controlled trial evaluating the
effect of Intensive Insulin Therapy (IIT) versus Conventional Insulin Therapy (CIT) on
morbidity and mortality in critically ill patients. The effects of this intervention on patients
admitted with sepsis were assessed.
A total of 122 consecutive septic patients[18 years of age and had serum glucose
level[6.1 mmol/L (110 mg/dL) during the ﬁrst 24 h of ICU admission. We excluded
patients with type I diabetes, diabetic ketoacidosis, hypoglycemia on ICU admission, brain
death, (DNR) status, terminal illness, post cardiac arrest, seizures within past 6 months,
pregnancy, liver transplantation, burn victims, readmission to ICU within the same hospi-
talization, expected ICU length of stay (LOS) of less than 24 h, no consent or enrollment in a
competing trial.
The primary end point was ICU mortality. Secondary endpoints included hospital mortality,
ICU or hospital length of stay (LOS), mechanical ventilation duration as well as the rate of
hypoglycemia (deﬁned as BG B 2.2 mmol/L or 40 mg/dL).
RESULTS. Among 122 patients with a mean APACHE II score of 27.6 ± 7.6 (IIT) and
28.6 ± 7.5 (CIT), P- value = 0.48 There was no difference between the two group in ICU
mortality 32.7% (IIT) and 22.4% (CIT) Adjusted Hazard Ratio (AHR) = 1.6, P = 0.2.
Among non-diabetics, mortality was higher in the (IIT) group 42% than the (CIT) group 31%,
AHR = 4.0, P = 0.01; similar ﬁnding was observed in patients with inclusion blood
sugar B 10 mmol/L. Hypoglycemia occurred more frequently with IIT (46 events/100
treatment days vs. 3 events/100 treatment days, P\0.0001).There was no difference between
the IIT and CIT in any of the other secondary endpoints.
CONCLUSION. In septic medical surgical ICU patients, IIT had no mortality difference
from those on CIT. However, IIT was associated with higher mortality in non-diabetics and in
patients with inclusion blood sugar B 10 mmol/L. Also, IIT increased the occurrence of
hypoglycemia. Further studies are needed to explore the beneﬁt of this intervention in this
category of patients. Prevention and early detection of hypoglycemia is major concern when
implementing this therapy.
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INTRODUCTION. The purpose of the study was to describe the effectiveness of the Sur-
viving Sepsis Campaign (SSC) bundles with regard to both implementation and outcome in
patients with septic shock.
METHODS. This was a single-center prospective observational study of patients admitted to
the medical-surgical ICU of an urban tertiary care teaching hospital fulﬁlling criteria for the
international sepsis deﬁnitions. After a widespread 2 months educational program, imple-
mentation of SSC Resuscitation Bundles (RB) and Management Bundles (MB) were
accomplished. Patients were recruited from September 2005 to February 2008. We deter-
mined the rate of compliance and the prognostic value of the RB, the MB and of each bundle
element.
RESULTS. We analyzed 295 consecutive episodes of septic shock. The main sources of
infection were: abdomen 34.8%, lung 34.8%, and UTI 12.6%. The mean age was 64 ± 15,
APACHE II 23 ± 7, SOFA 9.5 ± 3, and global hospital mortality 40.3%. The rate of
compliance with the RB was 32%. There were signiﬁcant differences in mortality between
compliant (C) and non compliant (NC) groups despite the similar characteristics and the
severity of septic shock. Mortality rate was 46.7% in the NC group and 27.7% in the C group.
Compliance rate with MB was only 16%, there were not differences in mortality between C
and NC groups (48.4 vs. 55.50%). When the inﬂuence of age, severity, emergency department
origin, and ICU admission delay was controlled by multivariate analysis, compliance with RB
was independently associated with survival (OR = 0.49, 95% CI 0.26–0.94, p = 0.03). We
only found differences in mortality between C and NC groups in three bundle elements: serum
lactate measured before 6 h (35.2 vs. 54.2%; p\0.01), early broad-spectrum antibiotics use
(34% vs. 47.3%; p = 0.02), and treatment with activated protein C when indicated (25 vs.
55.5%; p = 0.04). In the multivariate analysis, compliance with the three early goal-directed
therapy endpoints, age, SOFA score, and mechanical ventilation were independently asso-
ciated to mortality.
CONCLUSION. Implementation of resuscitation bundle was associated with decreased
mortality in patients with septic shock. Among all sepsis bundle elements, compliance with
the three early goal-directed therapy endpoints was the only independent predictor of survival.
Compliance rate with management bundles was poor and had no impact on survival.
GRANT ACKNOWLEDGEMENT. Supported by IFIMAV and Instituto de Salud Carlos
III. Expte. PI070723.
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AWARENESS AND PRACTICE OF SURVIVING SEPSIS CAMPAIGN AMONGST
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INTRODUCTION. The surviving sepsis campaign aims to achieve globally a 25% reduction
in mortality due to severe sepsis. The campaign is in its third phase, and aims to inform,
implement and check the compliance, improvement and outcomes of the resuscitation bun-
dles. In UK, patient with severe sepsis are identiﬁed usually by the Registrars and referred to
Intensive therapy unit team. Therefore for compliance with the Resuscitation Bundle, it is
essential to identify sepsis, severity of sepsis and initiate resuscitation measures.
METHODS. A questionnaire was designed for online access. Questions tried to elicit
knowledge about awareness of the campaign, its aims and practise. Recent experience in
Intensive therapy unit was elicited. The e mail links were sent to Registrars across UK.
RESULTS.(1) 182 Registrars completed the survey, completion rate 54.00%. (2) 52.20 %
were aware of the surviving sepsis campaign. (3) Awareness by Specialty, 15.58% Obstetrics
and Gynaecology 12/77, 35.71% Surgical specialty 10/28, 66.60% Medical specialty 8/12,
100.0% Emergency Medicine 11/11, 00.0% Anesthesia 54/54. (4) 23.62%(43/182) knew the
aim of the Surviving Sepsis Campaign. (5) 29.12% (53/182) knew that individual hospitals
should use the bundles to create customized protocols and pathways speciﬁc for their insti-
tutions. (6) 25.27% (46/182)knew,Sepsis Resuscitation bundle needed to be achieved in 6 h.
(7) Of those who worked in ITU in last one year,
(a) 45.45% (25/55) knew Sepsis Resuscitation Bundle needs delivery in 6 h.
(b) 40.00% (22/55) knew Sepsis Management Bundle needs delivery in 24 h.
CONCLUSION. Awareness of Surviving Sepsis Campaign, has not fully reached beyond the
specialties of Emergency Medicine and Anaesthesia. To achieve the realistic targets of 25%
reduction in mortality due to severe sepsis, there needs to be a greater emphasis on targeted
education. Trainees in Acute care specialties need to build greater awareness of the campaign,
its purpose, initiatives, and knowledge of the care bundles.
REFERENCE(S). 1. Surviving Sepsis Campaign: International guidelines for.
2. Management of severe sepsis and septic shock: 2008, Crit Care Med 2008 Vol. 36, No. 1.
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INTRODUCTION. Among factors postulated to affect outcome in sepsis is the gender of the
patient, with a suggestion that females may have lower mortality. We sought to evaluate
whether gender is associated with differences in intensive care unit (ICU) mortality in patients
with severe sepsis/septic shock.
METHODS. Concurrent data collection on patients with severe sepsis admitted to our ICU
from December 2001 to November 2007. Data was collected regarding demographic char-
acteristics of the patients, comorbidities, focus of infection, number of organ dysfunctions,
severity of sepsis, SAPS II, ICU and hospital length of stay (LOS) and mortality.
RESULTS. During the study period, 1031 patients admitted to our ICU, more men than
women (66 vs. 34% for all admissions, p = 0.025). In the group of patients admitted with the
diagnosis of severe sepsis/septic shock (214 patients, of whom 64% had septic shock) no
signiﬁcant differences were found between man and women, regarding age (57 vs. 61,
p = 0,157), SAPS II score (45 vs. 48, p = 0,202), comorbidities (no comorbidities 65 vs.
64%, p = 0,801), septic shock (62 vs. 66%, p = 0,497), ICU (9 vs. 9, p = 0,844) and
hospital (19 vs. 16, p = 0,607) LOS and ICU (38% vs. 29%, p = 0,165) and hospital (40 vs.
36%, p = 0,575) mortality. Men have more pneumonia (70 vs. 52%, p = 0,008) and central
nervous system infection (7 vs. 0%, p = 0,012). Women have more urinary infection (10 vs.
3%, p = 0,028) and intra-abdominal infection (27% vs. 16%, p = 0,047).
CONCLUSION. Our results indicate a signiﬁcantly smaller number of female patients
requiring intensive care. This difference might be because illness progresses differently for
men and women. There are signiﬁcant differences regarding focus of infection without dif-
ferences in chronic comorbidities like respiratory chronic disease that could explain the higher
incidence of pneumonia in men. The reason for this difference in focus of infection still needs
clariﬁcation.
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INTRODUCTION. Improving early and accurate diagnosis was one of the six point action
plan to reduce global mortality from severe sepsis by 25% by 2009. Statistics and epidemi-
ologic variables about sepsis, SIRS and sepsis campaign criteria (SCC) have been unknown at
South America (1). Aim: Our objective was to analyse the difference about admission criteria
of sepsis and severe sepsis in order to identify any signiﬁcant differences between reduced
parameters of SIRS vs. ampliﬁed SCC criteria and reduction of mortality from a South
America country
METHODS. We performed a prospective observational research study from March 2007 to
December 2007. Of six hundred and seventy patients admitted to the ICU, 342 patientes on
SIRS, 369 on sepsis diagnosis and 359 patientes with diagnosis of severe sepsis were
included. Interventions: Data were collected based on sepsis campaign criteria (2004) and
SIRS criteria (1992). Statistical analysis: A descriptive analysis was performed, data are
presented as mean ± sd. The statistical analysis was carried out with the SPSS 10 package
and p\0.05 was signiﬁcant
RESULTS. The study included six hundred and seventy critical ill patients, mean age of
63.3 ± 18.4 yrs, APACHE II score 14 ± 6.6. 64% of the patients with SIRS, 66.7% with
sepsis criteria and 69.9% with severe sepsis according to sepsis campaign criteria of admitted
patients. The common diagnosis at admission was septic shock 13.3%, Aortic aneurism 8.5%,
Community Pneumonia 4.6%, post-operative brain trauma resection 4.2% and hypovolemic
shock 3.7%. From the total of patients mortality was 30.9%. Statistics analysis showed no
signiﬁcant correlation between three kinds of sepsis classiﬁcations and mortality in our
critically ill patients independent of signiﬁcant differences between mortality in each group
(Table).
TABLE 1
Variable clasiﬁcation Death yes Death not p
SIRS 135 (39.8%) 204 (60.1%) 0.00001
Sepsis 148 (40.4%) 218 (59.5%) 0.00001
Severe Sepsis 150 (42.2%) 205 (57.7%) 0.000003
CONCLUSION. In Colombia there is not an educational sepsis campaign program. The
changing of sepsis classiﬁcation was created to increases sensitivity of sepsis diagnosis and
ﬁnally reduces mortality. We could not demonstrate that increasing diagnosis of sepsis will
affect the mortality because Colombia is far from the developed countries in sepsis campaign
educative program focus on treatment and outcomes
REFERENCE(S). 1. Critical Care Med 2004; 32: 858–873.
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INTRODUCTION. Evidence suggests that early, timely and aggressive resuscitation for
patients with septic shock can have a signiﬁcant impact on both morbidity and mortality.
However, even with the widespread awareness of the Surviving Sepsis Campaign (SSC)
guidelines, adherence varies widely. It has been shown that clinical decision support systems
can help clinicians improve various aspects of clinical practice, particularly when they are
integrated into clinical practice and present at the point of care. Protocol Watch (PW) was
developed as a bedside tool to assist clinicians with both implementation of and compliance
with the SSC guidelines. The purpose of this research was to measure the impact that using
PW had to adherence to the SSC guidelines.
METHODS. Participants were critically ill patients in two large university-afﬁliated teaching
hospital intensive care units in the United States. Prior to the installation of PW, imple-
mentation of the SSC was done using a paper-based system of standing orders. Base line data
on compliance with the SSC guidelines were collected. Protocol Watch, which offers an
electronic version of the guidelines and is resident on the bedside patient monitor, was then
installed in all critical care beds. The post PW installation data collection is currently being
collected.
RESULTS. Preliminary results show improvements in compliance with the resuscitation
bundle, and a decreased time for completion of both the resuscitation and management
bundles. In addition, the feedback from the clinical users has been extremely positive.
TABLE 1 MEAN VALUES FOR AGE, APACHE II, AND RESUSCITATION/MAN-
AGEMENT BUNDLE COMPLETE
Age APACHE
II
Resuscitation
Bundle
Complete
Time to
completion
hr
Management
Bundle
Complete
Time to
completion
mi
Group 1
(N = 39)
Prior to
PW
67.6 (14.4) 21.2 (8.1) 61.5% 11.6 (17.1) 85.2% 21.1 (16.5)
Group 2
(N = 46)
After PW
imple
61.7 (17.6) 21.6 (6.3) 72.1% 9.1 (6.0) 85.3% 16.3(9.7)
CONCLUSION. If the ﬁnal data analysis supports the preliminary ﬁndings, PW could
emerge as an important method for assisting in the implementation of the SSC guidelines,
thus making a valuable contribution in the care of critically ill patients with sepsis.
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SEVERE SEPSIS AND SEPTIC SHOCK IN AN INTENSIVE CARE UNIT: PRO-
NOSTIC FACTORS AND MORTALITY
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R. Albertos, J. Lo ´pez, M. Huguet
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INTRODUCTION. Sepsis is the main cause of mortality in our intensive care medicine
(ICU) units. There are numerous factors related to mortality in these patients. In the last years
many therapeutic interventions have been studied, most of them based on new approaches in
sepsis phisiopatology. Most of them have failed to improve sepsis survival.
Our objective in this study was to deﬁne the mortality predictor factors in our septic patients
and to analize our global mortality.
METHODS. In our third level hospital ([1000 beds), we analized 285 ICU patients with
severe sepsis-septic shock in a prospective observational study developed between 2005 and
2007 with three different periods. Sepsis incidence in our ICU was 45%.
n = 285 patients, mean age 59 ± 15 years; males 68%; APACHE II 22 ± 8; septic shock
65%; mechanical ventilation 61%. We deﬁned three different groups based on the initial
infection location: emergency(32%), ﬂoor room(27%) and ICU(41%).
Sepsis ethiology was: pneumonia 47%, abdominal 27%, meningitis 5%, soft tissues 5%,
urinary tract infection 4%, catheter 3%.
RESULTS. Univariant analysis identiﬁed as unfavourable outcome factors: Lactate[
3 mmol/L (p\0,00001); Glucose\4, 1 mmol/L (p\0,00001); platelets\100.000x10.9/
L(p\0,0012); coagulopathy INR[1.5 (p\0,0001); leucopenia\3500x10.9/L
(p\0,002); bilirrubin[36 umol/L (p\0,007); creatinine[177 umol/L (p\0,004);
albumin\25 gr/L(p\0,005); shock (p\0,006); hypotension (p\0,002); use of steroids
(p\0,016); bicarbonate\24 mmol/L (p\0,045).
Favourable outcome factors were: correct hemodynamic resuscitation (p\0,045); pneu-
monia as infection ethiology (p\0,05).
Multivariant analysis (cox-regresion)only identiﬁed as independent pronostic factors: Lac-
tate[3 mmol/L (HR:3,04 (1,74–5,32)p\0,00001); trombocythopenia (HR:2,32 (1,25–
4,31)p\0,0015); hypoglucemia (HR:2,94 (1,41–6,2)p\0,04) and leucopenia (HR:1,86
(1,04–3,3)p\0,04).
Global survival at 28 days was 58,8%.
CONCLUSION. Sepsis incidence in our ICU enviroment is high (45%).
We identiﬁed four major unfavourable outcome independent factors: lactate[3 mmol/L,
trombocythopenia, hypoglucemia and leucopenia.
Our 28 day survival rate was 59%.
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INTRODUCTION. Since the publication of the guidelines for the management of septic
patients, many efforts have been done to systemize the treatment, specially the hemodynamic
resuscitation within the ﬁrst 6 h. The acomplishment of these guidelines in the hospital
enviroment is increasing but it is necessary to study the ﬁnal impact on mortality. Our goal
was to analyze the impact on mortality in a third level hospital of the educational campaign
based on different bundles of resuscitation within the ﬁrst 6 and 24 h.
METHODS. We studied 285 septic patients divided in three groups depending on the edu-
cational period. Fase I (2005-preeducational period): 56/285. Fase II (2006-post ﬁrst
educational campaign): 161/285. Fase III (2007-post second educational campaign): 69/285.
We deﬁned different diagnostic and therapeutic goals as a good predictors of accomplishment.
First line bundles within the 6 ﬁrst h from the begining of the infection: lactate determination
(Q1), blood culture before antibiotherapy (Q2), early antibiotherapy during the ﬁrst 3 h in an
emergency unit and room ﬂoor, and in the ﬁrst h in ICU (Q3), properly haemodynamic
resuscitation (Q4), to reach a central venous pressure C 8 mmHg (Q5) and a venous mixed
saturation[70% (Q6). Second line bundles within the ﬁrst 24 h from the beginning of the
infection: steriod therapy (Q7), glucose blood level[4,1 mmol/L (Q8), protective ventila-
tion (Q9). We analyzed the impact of the educational campaign on the acomplishment of the
guidelines and the impact on mortality.
RESULTS. Only two predictor goals reached the statistic signiﬁcation when we compared
the outcomes of the different fases: glucemia control during the ﬁrst and second fase
(p = 0,023) and during the second and third fase (p = 0,01), and the protective ventilation
durind the second and third fase (p = 0,01). Survival rate after 28 day was: Fase I 55%. Fase
II 63%. Fase III 46%. These differences between fases as the location of presentation did not
achieve statistic signiﬁcation.
TABLE 1
FASE I (%) FASE II (%) FASE III (%)
Q 1 25 20 28
Q 2 25 20 28
Q 3 50 56 44
Q 4 60 59 64
Q 5 50 47 58
Q 6 22 19 29
Q 7 41 22 41
Q 8 34 47 51
Q 9 65 60 82
CONCLUSION. We observe a trend to acomplish the guidelines although there is any
statistic signiﬁcance. Despite of this trend we have not been able to demonstrate an impact on
mortality.
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WHAT ABOUT OUTCOME OF SEVERE SEPSIS IN THE ELDERLY?
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1UCIP, Hospital Geral Santo Anto ´nio,
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INTRODUCTION. Sepsis is an increasingly common and lethal medical condition that
occurs in people of all ages. The effect of age on outcome of adults patients with sepsis it is
not completely understood.We sought to evaluate whether if age is associated with differences
in clinical outcomes of severe sepsis patients.
METHODS. Concurrent data collection on patients with severe sepsis admitted to our ICU
from December 2001 to November 2007. Data was collected regarding demographic char-
acteristics of the patients, comorbidities, focus of infection, number of organ dysfunctions,
severity of sepsis, SAPS II, ICU and hospital length of stay (LOS) and mortality. To
investigate of the inﬂuence of age, we chose a cut-off of 65 years.
RESULTS. During the study period 1031 patients were admitted to our ICU, with a mean age
of 54 ± 19 years. In 214 patients admitted with diagnosis of severe sepsis (64% had septic
shock). Patients aged C 65 were more post surgery (33 vs. 19%, p = 0.035), had higher
SAPS score (52 vs. 42, p\0.001), more septic shock (74 vs. 55%, p = 0.004). No difference
was found in the number of comorbidities in the two groups but, when we considerer the
comorbidities in particular, regarding long and short steroid therapy, chemotherapy, radio-
therapy, AIDS, chronic hepatic, heart, respiratory, haematological and cancer diseases, more
AIDS was found in the younger group (0 vs. 6%, p = 0.016 for both). Regarding the focus of
infection, there is a signiﬁcantly higher incidence of pneumoniae and meningitides in the
younger group (69% vs. 55%, p = 0.031, and 8 vs. 0%, p = 0.005, respectively) and of intra-
abdominal infection in the elderly (32 vs. 10%, p\0.001). Elderly patients have higher ICU
mortality (47 vs. 25%, p = 0,001) and hospital mortality (53 vs. 26%, p\0,001).
CONCLUSION. Elderly patients have more severe illness that translates in higher mortality
in ICU and hospital. Apparently there is a relationship between age and focus of infection.
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INITIAL RESUSCITATION OF SEVERE SEPSIS IN AN EMERGENCY UNIT
A. Estella Garcı ´a*, L. Perez Bello Fontain ˜a, I. Sanchez Angulo, D. Toledo, D. Del Aguila,
F. Valenzuela Sanchez
Emergency and Critical Care Unit, Hospital Jerez, Jerez, Spain
INTRODUCTION. Early diagnosis and treatment of severe sepsis has been shown to
improve outcome. The initial resuscitation in the emergency department should not be
delayed pending ICU admission.
METHODS. The initial recommendations (during the ﬁrst 6 h) include: 1.Serum lactate
measured. 2. Blood cultures obtained prior to antibiotic administration. 3. Broad-spectrum
antibiotics administered within 3 h. 4. In the event of hypotension: Minimum of 20 ml/kg of
crystalloid (or 7 ml/kg of colloid) delivered. For hypotension not responding to volume
resuscitation, vasopressors employed to maintain mean arterial pressure (MAP)[65 mm Hg.
5. In the event of persistent arterial hypotension refractory to volume resuscitation (septic
shock) and/or initial lactate[4 mMol/L (36 mg/dl): Central venous pressure (CVP)
of[8 mm Hg achieved. Central venous oxygen saturation (ScvO2) of[70% achieved. An
educational program on sepsis addressed at doctors and nurses working in the emergency
department was developed.
Consecutive patients with severe sepsis or septic shock admitted in ICU from the OU between
july 2007 and april 2008 were registered. Age, ICU length of stay, source of infection,
isolated bacteria, blood lactate concentration, APACHE II score and mortality were collected.
To assess the implementation of the Surviving Sepsis Campaign recommendations in the
initial resuscitation of patients with severe sepsis or septic shock admitted in the Observation
Unit (OU), and to describe the clinical outcome of patients admitted in ICU from the
emergency department.
RESULTS. 42 septic patients were admitted in ICU during the time of study, global mortality
was 38,1%. 23 patients were admitted in ICU from medical and surgical wards and 19 patients
from the OU. In this subgroup the median time from emergency department to ICU admission
was 5 h. Recommendations of Survival Sepsis Campaign 1,3 and 4 were performed in the
emergency department before admission in ICU in all the patients. Recomendation 2 was
performed in 12 patients (63%). Recommendation 5 was not performed in the Observation
Unit, monitoring of central venous pressure was early performed at admission in the ICU. The
mean age was 64,6 years (9 males, 10 females), ICU length of stay was 8,84 ± 7 days, the
mean APACHE II score at admission in ICU was 19,05 ± 7,42. Urinary tract infection, 7
cases (36,8%), and abdominal infection, 7 cases (36,8%) were the commonest causes of
severe sepsis, other causes were pneumonia, 4 cases (21,1%) and unknown 1 case (5,3%).
Seven patients (36,8%) had a positive bacterial culture, the mean baseline lactate level was
3,9 ± 2,52 mMol/l. Mortality in the subgroup of patients stem from OU was 21,1%.
CONCLUSION. 1. Mortality was lower in the group of patients admitted in ICU from the
emergency department than the group admitted from medical and surgical wards. 2. Edu-
cational program improves the management of severe sepsis in the emergency department.
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THE PIRO - CONCEPT: DESCRIPTIVE CLASSIFICATION OF PATIENTS WITH
SEPSIS
S. Tafelski*, I. Nachtigall, C. Spies
Anaesthesiology and Intensive Care Medicine, Charite Universita ¨tsmedizin Berlin, Berlin,
Germany
INTRODUCTION. A classiﬁcation—concept for septic patients was published in 2003
based on the TNM classiﬁcation system consisting of 4 items: P for predisposition, I for
infection, R for response, O for Organdysfunction. This study evaluates the practical use of
PIRO in a University-hospital setting.
METHODS. This observational study was approved by the local Ethics Review Board and
the data safety authorities. 474 patients were included who experienced treatment on 5 ICUs
(1 cardiosurgical, 1 neurosurgical, 2 interdisciplinary, 1 intermediate care) for at least 2
consecutive days. Data were analysed retrospectively for PIRO - criteria: Predisposition [age,
gender, immune suppression], infection [SIRS of non-infectious origin, low- risk, high-risk,
infection with special pathogens], response [adapted, anergia, hypergia], organdysfunction
[using SOFA-Score]. Univarate statistic was calculated using Chi2- test (alpha = 0.05).
RESULTS. All patients were classiﬁed using the PIRO criteria. Total mortality was 9.5%
[45/474]. Signiﬁcant differences in mortality were demonstrated between the categories
‘‘infection’’ (I0 2.9%, I1 3.8%, I2 14.1%, I3 24.4%; p\0.001) ‘‘response’’ (R0 2.5%, R1
7.5%, R2 35.1%; p\0.001) and ‘‘organ dysfunction’’ (O0 3%, O1 3.2%, O2 25%;
p\0.001). Mortality in ‘‘predisposition’’ groups did not differ signiﬁcantly in our population.
CONCLUSION. Expected differences in mortality in the PIRO categories were reproduced
except for predisposing factors. In concordance to other publications the PIRO system reﬂects
qualitative differences in individual courses of infections. Therefore it may lead to a better
distinction of patients with sepsis and could help to differentiate responders for therapeutic
options. More analysis for concrete parameters is necessary for assessing factors to establish a
consented system for research projects.
REFERENCE(S). 1. Vincent JL et al., Contrib Nephrol. 2007;156:64–74.
2. Martin GS et al., N Engl J Med. 2003; 348(16): 1546–1554.
3. Angus DC, Vincent JL, Gerlach H, Critical Care 2003; 7:248–264.
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ACIDBASE.ORG: ONLINE DECISION SUPPORT IN COMPLEX ACID-BASE
DISORDERS USING THE STEWART APPROACH
P. W. G. Elbers*
1, R. Gatz
2
1Anesthesiology and Intensive Care, St. Antonius Hospital, Nieuwegein, Netherlands,
2Anesthesiology and Intensive Care, Skaraborg Central Hospital, Skovde, Sweden
INTRODUCTION. The use of the quantitative approach to acid base disorders continues to
increase in critical care medicine. Introduced in the 1980 s by the late Peter A Stewart (1), it
has now evolved to be the method of choice. While the quantitative approach and the tra-
ditional Henderson-Hasselbalch method do not mathematically exclude one another, the
Stewart approach may provide better mechanistic insight in complex acid-base disturbances.
However, the approach may be cumbersome in daily practice because of its preceived
complexity and required calculations. This is why we developed an online tool which may
facilitate its use.
METHODS. We used a comination of HTML-, JavaScript- and PHP: Hypertext Preprocessor
programming languages to create the software. In consists of several scripts that interact with
a MySQL database. Both are hosted on a Linux server and are accessed via an Apache web
server. The software is based on the Figge-Fencl modiﬁcation of the Stewart approach (2).
Users may reach the application at www.acidbase.org with any modern web browser. Users
must enter acid-base, case description and chemical data. Cases can be saved anonymously
for later review by the submitter and others. A tool is provided to run hypothetical scenarios
by changing different physiological parameters. The application was tested using historical
data from the authors hospital. For additional testing, the sites address was given to members
of the CCM-L (critical care) and GASnet (anesthesiology) mailing lists.
RESULTS. The acidbase.org website now features the tool. Initial testing using historical and
new clinical data lead to technical improvements in the scripts. Anesthesiologists and critical
care physicians from the CCM-L and GASnet mailing lists that accessed the application using
real patient data (n[10) generally found it helpful, especially the simulation tool. The
application has been online since January 2008. Without advertising, over 200 doctors
worldwide have used the software generating a total of 8000 pageviews as of March 2008.
Feedback by users is voluntary but already yielded over 10 very positive responses indicating
a change in diagnostic and/or therapeutic strategies.
CONCLUSION. We have shown that is feasible to build an online software application that
aids in the interpretation of complex acidbase disorders using the Stewart approach. In
addition this tool enables the clinician to judge the impact of possible intervention by using
simulation based on the entered case data. Initial experience seems positive. We will next set
out to investigate the impact of exposure to this decision support tool on clinical patient
management.
REFERENCE(S). 1. Stewart, PA; How to Understand Acid-Base; www.acidbase.org.
2. Fencl V et al., Am J Respir Crit Care Med. 2000 Dec;162(6):2246–51.
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ALTERATIONS IN URINARY ANION GAP IN CRITICALLY ILL PATIENTS WITH
METABOLIC ACIDOSIS
F. D. Masevicius, G. Tuhay, M. C. Pein, E. Ventrice, A. Dubin*
1Terapia Intensiva, Sanatorio Otamendi y Miroli, Buenos Aires, Argentina
INTRODUCTION. The renal response to metabolic acidosis is the modiﬁcation of urinary
anion gap ([GAP]urine = [Na
+]+[ K
+] - [Cl
-]), that should become negative
1. Our hypothesis
was that the failure to increase the urinary excretion of [Cl
-] might be a common manifes-
tation of renal dysfunction in critically ill patients.
METHODS. 590 patients admitted to the ICU during a period of 16 months were screened.
Only patients with simple metabolic acidosis were included. Exclusion criteria were associ-
ated acid-base disorders, use of diuretics, or creatinine[1.7 mg%. Ten normal volunteers
were also studied. On admission, arterial blood gases and arterial and urinary electrolytes
were measured. Plasma and urine [AG] and differences between the modiﬁcations of [AG]
and [HCO3
-] from normal values (Delta[AG]-Delta[HCO3
-]) were calculated. Patients were
grouped according to positive o negative [AG]urine.
RESULTS. 98 patients were included. [AG]urine was negative in 12 patients (12%) and
positive in 86 (88%). Patients with negative [AG]urine showed higher [HCO3
-], base excess
[BE], [AG]plasma, Delta[AG]-Delta[HCO3
-] and lower [Cl
-]plasma.
TABLE 1
Normal
volunteers
n = 10
Negative
[AG]urine
(n = 12)
Positive
[AG]urine
(n = 86)
pH 7.41 ± 0.03* 7.34 ± 0.02 7.33 ± 0.03
[bicarbonate] (mmol/l) 26 ± 1* 20 ± 21 8 ± 3*
[base excess] (mmol/l) 2 ± 1* -5 ± 2 -7 ± 3*
[AG]plasma (mmol/l) 12 ± 1* 20 ± 61 7 ± 4*
Delta[AG]- Delta[bicarbonate] (mmol)/l -1 ± 1* 1 ± 5 -3 ± 3*
[Chloride]plasma (mmol/l) 106 ± 2 105 ± 5 111 ± 3*
*p\0.05 vs. the other groups
CONCLUSION. Most patients showed an inadequate renal response, evidenced by positive
[AG]urine and higher [Cl
-]plasma. On the other hand, patients with negative [AG]urine had
positive Delta[AG]-Delta[HCO3
-]. This ﬁnding is usually considered indicator of associated
metabolic alkalosis. Nevertheless, it might represent the normal renal response to simple
metabolic acidosis.
REFERENCE(S). 1. Kellum JA: Determinants of blood pH in health and disease. Crit Care
2000; 4:6–14.
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DOES HYPERCHLOREMIC METABOLIC ACIDOSIS CONTRIBUTE TO ACUTE
KIDNEY INJURY IN CRITICALLY ILL PATIENTS?
A. Grover*, L. Kevin, J. Laffey, J. Bates
Anaesthesia and Intensive Care, University College Hospital, Galway, Galway, Ireland
INTRODUCTION. Hyperchloremic metabolic acidosis (HMA) is a frequent occurrence in
the critically ill. There is evidence to suggest that HMA impairs splanchnic perfusion (1) and
has a detrimental effect on renal function (2). We hypothesised that the presence of HMA at
ICU admission would predict the subsequent renal outcomes.
METHODS. We conducted a single centre, retrospective analysis of 718 patients with a
length of stay of at least 3 days in a mixed medical and surgical ICU over a period of 2 years.
The relationship between HMA and subsequent renal outcome was studied.
RESULTS. 81 patients (11.3%) had HMA at admission deﬁned by Cl C 110 and base deﬁcit
of\-5. There was no signiﬁcant correlation between admission HMA and day 3 or day 5
glomerular ﬁltration rate (GRF) or between admission HMA and change in GFR over the ﬁrst
5 days of ICU stay. Admission HMA was not a predictor of day 3 or day 5 RIFLE score, of
progression of RIFLE score over days 1–5, or of the requirement for renal replacement
therapy at any time during ICU stay. Serum chloride alone was similarly not a predictor of the
above measures.
CONCLUSION. Alhough HMA is suggested to have detrimental renal effects we could ﬁnd
no such association in a study involving over 700 patients.
REFERENCE(S). 1. O’Malley C, Frumento R.J, Hardy M A et al: A randomized, double
blind comparison of lactated Ringer’s solution and 0.9% NaCl during renal transplanta-
tion.Anesthesia Analgesia 2005; 100: 1518–24.
2. Wilkes NJ, Woolf R, Mutch M et al: The effects of balanced vs. saline based- hetastarch
and crystalloid solutions on acid base and electrolyte status and gastric mucosal perfusion in
elderly surgical patients. Anaesthesia and Analgesia;2001; 93:811–16.
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IS STEWART’S APPROACH USEFUL IN EVALUATION OF ACID-BASE DISOR-
DERS IN CRITICAL CARE PATIENTS?
D. Enescu*, S. Boet, O. Collange, G. Freys, T. Pottecher
Anesthesia and Intensive Care, University Hospital Hautepierre, Strasbourg, France
INTRODUCTION. Evaluation of metabolic acid-base disturbances based on the traditional
analysis of dependent variables (pH, bicarbonate, BE) and anion gap is compared with
Stewart’s approach analysing the independent variables (SID, nonvolatile weak
acids,PaCO2).
METHODS. Prospective observational study, in the critical care unit of a university hospital,
during three months, including single measurements admission data of the patients (arterial
blood samples for gases, Na + , K+ , Ca2+ , Mg2+ , Cl-, inorganic phosphate, albumin,
lactate). Bicarbonate, base excess (BE), anion gap(AG), anion gap adjusted for albu-
min(AGa), Cl corrected for water excess/deﬁcit, apparent and effective strong ion difference
(SIDa and SIDe) and strong ion gap (SIG) were calculated.Respiratory disturbances were not
analysed.
RESULTS. 121 patients were included. 114 patients present a metabolic acidosis, according
with traditional analysis (bicarbonate, BE and AGa) .
Stewart’s approach identiﬁed a metabolic acidosis in 117 patients (including 2 of the 3
patients having a normal bicarbonate, BE and AGa), a metabolic alkalosis in 2 patients and a
normal status in 2 patients.
Hypoalbuminemia was present in 98 patients, hyperchloremia in 62patients and hyperlac-
tatemia in 63 patients. Among these 63 cases of hyperlactatemia, 60 patients had a high SIG
and 62 patients a high AGa.
The traditional approach failed to identify 4 cases of metabolic acidosis (2 patients are
considered normal and 2 having an alkalosis). For these four patients, the short term evolution
was toward acidosis(2), alkalosis(1) and unchanged (1). One of the 2 normal patients in
Stewart’s approach had a metabolic acidosis in the traditional approach.
TABLE 1
Metabolic acid-base
status: number of patients
Stewart’s
approach
Acidosis
Stewart’s
approach
Alkalosis
Stewart’s
approach
Normal
Total
patients
Traditional approach Acidosis 113 1 114
Traditional approach Alkalosis 2 2 4
Traditional approach Normal 2 1 3
Total patients 117 2 2 121
CONCLUSION. Stewart’s approach is close to traditional method associating the AGa in
identifying the acid-base disorders but allows the detection of different and opposite partic-
ipating mechanisms.
REFERENCE(S). 1. Fencl V,Jabor A, et al. Diagnosis of metabolic acid-base disturbances in
critically ill patients.Am J Respir Crit Care Med 2000;162:2246–2251.
2. Stewart PA.Modern quantitative acid-base chemistry. Can J Physiol Pharmacol
1983;61:1444–1461.
3. Kellum JA.Clinical review: Reuniﬁcation of acid-base physiology. Critical Care
2005;9:500–507.
0944
PROGNOSTIC VALUE OF UNMEASURED ANIONS IN CRITICALLY ILL
PATIENTS
M. M. Boniatti*, P. C. Cardoso, R. K. Castilho, S. R. R. Vieira, G. Friedman, S. P. Ribeiro,
L. Fialkow
Critical Care, Hospital de Clı ´nicas de Porto Alegre, Porto Alegre, Brazil
INTRODUCTION. Disorders of acid-base equilibrium are common in critically ill patients.
The Stewart methodology has been found to be useful in explaining these disorders, where
conventional analysis was deﬁcient. However, much uncertainty remains about the usefulness
and clinical meaning of this new approach. The objectives of our study are to verify whether
the identiﬁcation of unmeasured anions using the Stewart methodology is related to the
mortality in intensive care unit (ICU) and compare its prognostic value to the traditional acid-
base variables such as lactate, standard base excess (SBE) and anion gap (AG).
METHODS. This is a prospective study with all the patients admitted in the ICU of Hospital
de Clı ´nicas in Porto Alegre, Brazil between February and May 2007. Sodium, potassium,
calcium, magnesium, chloride, lactate, phosphorus, albumin, pH and arterial carbon dioxide
were measured in all patients. Afterwards, bicarbonate, SBE, AG, anion gap corrected for
albumin (AGcorr) and strong ion gap (SIG) were calculated. Unmeasured anions were
identiﬁed if SIG[2 mEq/L. Patients who did not have the required tests for the proposed
analysis were excluded.
RESULTS. 176 patients were included. Metabolic acidosis (SBE B- 5.0) was found in 103
(58.5%) patients. Unmeasured anions were present in 149 (84.7%) patients. There was no
difference of lactate and AG among survivors and non-survivors. Non-survivor patients
presented signiﬁcantly AGcorr (20.8 vs. 18.7; p = 0.013), SIG (7.8 vs. 5.9; p = 0.013) and
SBE (-8.6 vs. -5.7; p = 0.005) higher than survivors. However, for the discrimination of
survivors and non-survivors only AGcorr and SIG presented an acceptable accuracy, with
area under receiver operating characteristic curve (AUROC) of 0.62 (CI 95% 0.54 – 0.71) for
both variables. AGcorr and SIG showed a very good self-correlation (r2 = 0.84; p\0.001).
CONCLUSION. The identiﬁcation of unmeasured anions, through either SIG or AGcorr
calculation, discriminates survivors from non-survivors among critically ill patients more
accurately than the traditional acid-base variables. Because of its simplicity and excellent
correlation with the complex calculation of SIG, AGcorr must be used in clinic practices.
REFERENCE(S). 1. Kaplan LJ, Kellum JA. Initial ph, base deﬁcit, lactate, anion gap, strong
ion difference, and strong ion gap predict outcome from major vascular injury. Crit Care Med
2004; 32:1120–1124.
2. Martin M, et al. Diagnosis of acid-base derangements and mortality prediction in the
trauma intensive care unit: the physiochemical approach. J Trauma 2005; 58:238–243.
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RETROSPECTIVE CASE STUDY OF METFORMIN-ASSOCIATED LACTIC ACI-
DOSIS IN ORIENTAL POPULATION
I. C. P. Chan*, K. I. Law, T. S. Y. Lam, K. L. Lee, Y. S. Poon, J. T. Liong
Intensive Care Unit, United Christian Hospital, Hong Kong, Hong Kong Special Adminis-
trative Region of China
INTRODUCTION. Metformin is an oral hypoglycaemic with proven beneﬁt in diabetic
patients. It is relatively safe. However, a potential complication is its rare association with
lactic acidosis, a condition that has approximately 50 percent mortality rate from overseas
data. Oriental data concerning this complication is limited. The objective of this study is to
review the initial presentation, disease severity and outcomes of oriental patients, who were
suffering from metformin-associated lactic acidosis (MALA)and required intensive care.
METHODS. This study was conducted as a single-arm observational case series review in a
regional hospital in Hong Kong. It had been approved by the Hong Kong Hospital Authority -
Research Ethics Committee. The clinical data of patients who were admitted to the Adult
Intensive Care Unit of United Christian Hospital between 1-12-2004 and 1-12-2006 with
diagnosis of metformin-associated lactic acidosis (blood pH\7.35;HCO3\22 mmol/
L;anion gap[14mmo/L;serum lactate[5 mmol/L and renal failure without other contrib-
uting causes of lactic acidosis)were retrieved from the Clinical Data and Reporting System
and the Clinical Management System of the Hospital Authority. Clinical information will be
analysed and presented by using descriptive statistics.
RESULTS. Nine cases were identiﬁed (3 males and 6 females) with mean age 67 ± 6 years
old. Two patients had past medical history of renal impairment. All patients had been taken
metformin for more than 6 months with mean dose 2.25 g ± 0.93 g per day. None had recent
metformin dosage change. Majority had non-speciﬁc gastrointestinal symptoms (89%) and
precipitating factors (78%). Sepsis was not uncommon (44%). Patients were seriously ill on
admission to ICU (worst Cr 986umol/L, urea 51.5 mmol/L, K 7.7 mmol/L, lactate
23.7 mmol/L within ﬁrst 24-h ICU admission). All patients received renal replacement
therapy by continuous veno-venous haemoﬁltration. Seven out of 9 patients (78%) were given
sodium bicarbonate infusion. But no signiﬁcant changes of blood pH (P = 0.055) was noted
after NaHCO3 infusion. Despite high APACHEII score (Mean 29.9 ± 5.7) and expected
mortality rate (mean 67.5 ± 13.9), the observed 30-day mortality rate was 11%. No survivors
required long-term dialysis.
CONCLUSION. Patients suffered from MALA usually presented with non- speciﬁc com-
plaint and often had precipitating event. Sepsis should not be overlooked. The observed
outcome seemed better than the outcome predicted by the severity score and non-oriental
data. Management includes cessation of offending drug, ﬂuid resuscitation, identify and treat
the precipitating event, organ support when necessary. The role of sodium bicarbonate
infusion is still debatable. Further large-scale study to understand underlying pathophysiology
and optimize management is fruitful.
REFERENCE(S). 1. Gowardman JR. Fatal metformin induced lactic acidosis: case report. N
Z Med J 1995;108:230–11.
2. Gan SC, Barr J, Arieff AI, Pearl RG. Biguanide-associated lactic acidosis. Case report and
review of the literature. Arch Intern Med 1992;152:2333–6.
3. Bailey CJ, Turner RC. Metformin. N Engl J Med 1996;334:574–9.
4. Lee AJ. Metformin in noninsulin-dependent diabetes mellitus. Pharmacotherapy
1996;16:327–51.
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CONTINUOUS RENAL REPLACEMENT THERAPY WITH REGIONAL CITRATE
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G. Zick*
1, C. Wilms
2, L. Renders
3, J. Schulz
1, I. Frerichs
1, J. Scholz
1, N. Weiler
1
1Department of Anaesthesiology and Intensive Care Medicine,
2Department of General
Surgery and Thoracic Surgery,
3Division of Nephrology and Hypertension, University
Medical Centre Schleswig-Holstein, Campus Kiel, Kiel, Germany
INTRODUCTION. Regional citrate anticoagulation has been established as a safe alterna-
tive to heparin anticoagulation for continuous renal replacement therapy (CRRT). Since the
metabolism of citrate is impaired in patients with liver failure it is unclear whether this
therapeutic approach can be safely applied in this patient group as it may result in citrate
intoxication with metabolic acidosis, decreased ionized calcium and increased total calcium.
METHODS. The study was designed as a prospective observational study. 24 critically ill
patients (13 male, 11 female) with acute renal failure undergoing CRRT with regional citrate
anticoagulation were included and assigned to two groups according to their bilirubin levels
either above or below 3 mg/dl. All patients were treated with continuous venovenous he-
modiaﬁltration (CVVHDF) with a CRRT device that is designed for citrate anticoagulation
(Multi Filtrate, Fresenius Medical Care, Bad Homburg, Germany) using a high ﬂux ﬁlter and
a CVVHDF dose of 2 l/h. The ﬁlters were routinely changed after 72 h. 4% trisodium citrate
solution was infused proximal to the extracorporeal circuit to obtain ionized calcium levels of
0.25 to 0.35 mmol/l for anticoagulation. Systemic calcium (1.7 mmol/l) infusion was targeted
to maintain systemic ionized calcium from 1.12 to 1.20 mmol/l. The calcium levels and blood
gases were measured every 4 h. Citrate therapy was discontinued when set goals in calcium
levels and acid base metabolism could not be met or total calcium exceeded 3 mmol/l. We
compared the ionized systemic calcium, the ionized calcium in the extracorporeal circuit
(postﬁlter) and the demand of citrate and calcium between the two groups. Statistical analysis
was performed using the Mann Whitney test.
RESULTS. The group with liver failure consisted of 8 patients with a mean bilirubin level of
8.8 mg/dl, the other group of 17 patients with a mean bilirubin level of 0.7 mg/dl. 98 ﬁlters
were used in 60 episodes of therapy. In the group with liver failure, total calcium exceeded
3 mmol/l in one patient and in the group without liver failure, severe alkalosis with HCO3
levels over 40 mmol/l occurred in one patient requiring the termination of citrate therapy. No
signiﬁcant differences between the two groups were found in the levels of ionized systemic
calcium and the calcium and citrate demands. Although the ionized postﬁlter calcium levels
differed signiﬁcantly, the respective 95% conﬁdence interval was well within the targeted
range of 0.25 to 0.35 mg/dl meaning the difference was not relevant.
CONCLUSION. With appropriate monitoring, regional citrate anticoagulation for CRRT is a
safe therapy even in patients with liver failure.
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MONTHS OF SLED TREATMENTS: A SINGLE-CENTRE EXPERIENCE
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INTRODUCTION. Renal dysfunction in critical ill patients remains an important and
independent marker of mortality. In the last few years a new dialysis method has emerged to
substitute kidney function: Slow Extended Dialysis (SLED). This therapy combines the
advantages of intermitent Hemodialysis (IHD) and Continuous Renal Replacement Treatment
(CRRT). We show the experience with SLED in the last 17 months in our University Hospital
Intensive Care Unit.
METHODS. We performed a retrospective study in patients who initiated SLED between
October 2006 and March 2008 (17 months). We registered the following data for each patient:
age, sex, severity of disease using the SAPS II score, mortality rate, co-morbidities, diagnostic
group, causal factors, RIFLE classiﬁcation, length of stay in the Intensive Care Unit (ICU)
and renal outcome. SLED therapy consisted in a minimum of 6 h per treatment at least 6 times
per week sessions, with dialyzed ﬂows of 300 ml/min.
RESULTS. 72 patients initiated SLED in this period. 654 SLED treatments were done,
representing an average of 9,08 treatments per patient. Mean patient age was 62 years, 62,5%
were male. Surgical patients represented 29,2% (n = 21) of the group. Sepsis was the major
cause of kidney injury (58,3%; n = 42 patients). The most prevalent co-morbid disease was
hypertension; 44,4% (n = 32) had chronic kidney disease and 25% (n = 18) had end-stage
renal disease (ESRD). All patients without previous ESRD started SLED in the failure stage
of RIFLE classiﬁcation. The ICU length of stay was 19,7 days (2–240 days). The initial SAPS
II score was 57 with a predicted mortality of 61,9%. Twelve patients (16,67%) developed
ESRD. The mortality rate was 40% (n = 29).
CONCLUSION. These results show that SLED constitute a safe renal replacement therapy
despite its short duration and its lower intervention by ICU staff compared to CRRT. Its
safety, effectiveness and low cost constitute a good alternative to ‘‘classic’’ dialysis strategies
in ICU. The mortality rate in this study seems lower than predicted by SAPS II score.
Prospective studies comparing different renal replacement modalities are needed and will be
very helpful in the future to tailor renal replacement therapies in the Intensive Care Unit.
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INTRODUCTION. Alcohol intoxication (methanol, ethanol and ethylene glycol) may result
in metabolic acidosis with increased anion gap, increased serum osmolal gap, and neurologic
abnormalities ranging from drunkenness to coma, and death. The mortality and morbidity
rates remain very high despite intensive care therapy. The toxicity of methanol and ethylene
glycol is clearly correlated to the degree of metabolic acidosis. The established treatment of
severe methanol and ethylene glycol intoxication is ethanol administration and hemodialysis
(HD). By inhibiting the main metabolic pathway of methanol and ethylene glycol (alcohol
dehydrogenase), ethanol prevents the formation of major toxic metabolites (formic acid,
glycolic acid and oxalic acid). Conventional HD can reduce serum methanol, ethanol and
ethylene glycol and its metabolites rapidly, but high-ﬂux membranes should be capable of
removing more toxic per hour of HD.
METHODS. In this report, we describe 14 cases of life-threatening alcohol intoxication (11
methanol, 1 ethanol, and 2 ethylene glycol) who were treated successfully with supportive
care, ethanol infusion (methanol and ethylene glycol), and early HD with a high-ﬂux dialyser.
RESULTS. The median pH was 7.04 ± 0.06 (range 6.60–7.33), median bicarbonate
9.9 ± 1.9 mmol/l (range 1.4–25), and median base deﬁcit 18.4 ± 2.6 mmol/l (range 2–33).
The median anion gap was 29.1 ± 2.3 mmol/l (range 16–45) and the median osmolal gap was
119 ± 47 mOsm/l (range 16–402). On admission there was an excellent linear correlation
between the serum toxic alcohol concentrations and the osmolal gaps (R
2 = 0.98,
p = 0.0006). In all cases early HD corrected metabolic acidosis and osmolal abnormalities.
The mortality was 7 % (1 from 14).
CONCLUSION. We conclude that pre-emptive HD should be performed in severe intoxi-
cations to remove both the parent compound and its metabolites. The HD prescription should
include a large surface area dialyser with high-ﬂux membrane, a blood ﬂow rate in excess of
250 ml/min, a modiﬁed bicarbonate bath enriched with phosphorus and potassium, and a long
time session. The phosphorus and potassium-enriched bicarbonate-based dialysis solution
used in patients with normal phosphorus and potassium serum levels avoided HD-induced
hypophosphatemia and hypopotassemia. HD as implemented in these cases is a safe and very
effective approach to the management of alcohol poisoning.
REFERENCE(S). 1. Kraut JA, Kurtz I. Toxic alcohol ingestions: Clinical features, diag-
nosis, and management. Clin J Am Soc Nephrol 3:208–225, 2008.
2. Barceloux DG, Krenzelok EP, Olson K, Watson W. American Academy of Clinical
Toxicology Practice Guidelines on the Treatment of Ethylene Glycol Poisoning. Ad Hoc
Committee. J Toxicol Clin Toxicol 37:537- 560, 1999.
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INTRODUCTION. Peritoneal dialysis (PD) is the renal replacement therapy (RRT) of
choice in children with acute kidney injury (AKI) after congenital heart disease surgery.
Advantages of PD over other RRT include better haemodinamic stability and no vascular
access requirement. The aim of this study was to describe our experience in the treatment of
AKI using PD following cardiac surgery and to investigate factors associated with poor
survival.
METHODS. We retrospectively analysed 23 patients from January 2000 to March 2008 and
collected demographic, renal function and intensive care course data.
RESULTS. The incidence of AKI treated with PD was 2,3% (23/998). Thirteen patients were
male, mean age 29 ± 48,4 months (7 days to 165 months) and mean weight 9,1 ± 8,1 kg.
Mean PRISM II score 19,3 ± 6 and 22% with RACHS score C 4. The indications for PD
initiation were oliguria (13 patients), anuria (9 patients) and acidosis (1 patient). The time
between cardiac surgery and AKI was 4,8 ± 16,8 h and between AKI and PD initiation
12 ± 16,8 h. Patients were treated for a mean of 4,8 ± 3,8 days. In 18 patients the initial
dwell volume was[10 ml/kg and in 20 the dwell time[20 minutes. The mean ultraﬁl-
tration rate was 23 ± 20 ml/kg/day and 13 patients needed hypertonic solutions. Two patients
developed peritonitis and 1 patient mechanical dysfunction of PD catheter. Ten patients
survived with complete recovery of renal function. Patients who died presented lower mean
arterial pressure (p = 0,02) and urinary output (p = 0,04), longer bypass time (p = 0,02),
length of hospital stay (p = 0,03) and time between AKI and PD initiation (p = 0,03).
CONCLUSION. We conclude that PD is a safe and efﬁcacious RRT for the treatment of AKI
in children undergoing cardiac surgery, and that early initiation of PD may have a favourable
impact in the prognosis of patients.
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INTRODUCTION. It has been suggested that continuous renal replacement therapy (CRRT)
has several advantages over Intermitent Renal Replacement Therapy (IRRT) including better
haemodynamic stability (blood pressure control and blood circulation), improved survival and
greater likelihood of renal recovery. But in the last years Sustained low-efﬁciency daily
dialysis (SLED) has been suggested as an alternative treatment for critically ill patients with
kidney injury.
Objectives: Compare SLED with CRRT focusing on severity of illness and mortality rate.
METHODS. Observational, prospective, multicenter study (3 ICUs in two different Hospi-
tals). During 1 year all patients who started RRT in 3 polyvalent ICUs were enrolled. We
collected demographic data, severity score at admission and when started the treatment, type
of modality chosen, criteria to initiate RRT, R.I.F.L.E criteria, mortality rate.
RESULTS. We enrolled 106 patients: 38 SLED (age –59 ± 16,4, SAPS II – 53,2 ± 15,6;
SOFA—10,8 ± 5,4) and 68 with CRRT (age 60,3 ± 15,5, SAPS II—49,1 ± 15,2, SOFA—
9,9 ± 3). Type of admission: medical – 41(31 CRRT, 10 SLED), surgical—48 (27 CRRT, 21
SLED), trauma—3 (2 CRRT, 1 SLED), liver transplant—14 (8 CRRT, 6 SLED). Criteria to
initiate RRT-ﬂuid overload (61, 7% CRRT and 76, 3% SLED), RIFLE criteria—failure (60,
3% CRRT, 60, 52% SLED). Creatinine when we started RRT: SLED—4,6 ± 2,7; CRRT -
3,5 ± 1,9. Haemodynamic instability: SLED - 47,4%; CRRT - 52,9%. Overall mortality rate
47,2% (SLED—31,6% and 55,9% CRRT).
CONCLUSION. In our study patients populations were similar but mortality rate were lower
with SLED. In spite the small amount of patients enrolled we do not found any reason to
choose CRRT in our patients when we can perform SLED with the same or even higher
quality and with signiﬁcantly lower cost.
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INTRODUCTION. Whether acute renal failure (ARF) is associated with increased mortality
in intensive care unit (ICU) remains unclear. Results of available studies are confounded by
the lack of a standard deﬁnition for ARF and clear indications for renal replacement therapy
(RRT), and the many differences in baseline characteristics and in-ICU events (organ failures,
sepsis) between patients with and those without ARF. Our aim was to accurately investigate
the impact of ARF on ICU mortality by using recent consensus deﬁnition criteria and con-
trolling for confounding factors. Particularly, we assessed the role of RRT.
METHODS. We performed a multicenter, prospective, cohort study. End stage renal disease,
and decision to withhold or withdraw life-sustaining treatments were exclusion criteria. ARF
was deﬁned according to the RIFLE class F criteria. Patients with ARF were matched to
controls by age, SAPS II, Mc Cabe class, admission category, center and period of inclusion.
Multivariate conditional logistic regression was used to examine the association between ARF
and ICU mortality. Results are presented as odds ratios (OR) and 95% conﬁdence intervals
(CI).
RESULTS. A total of 7142 patients were analyzed. ARF occurred in 2247 (31.5%) patients,
of whom 382 (17%) received RRT. Crude ICU mortality was signiﬁcantly higher in patients
with than in those without ARF (31.6% vs. 10.2%, p\0.0001). After matching and con-
trolling for confounding factors, ARF remained associated with increased mortality (OR:
1.87, 95% CI: 1.57–2.26, p\0,0001). This excess in mortality was observed both for ARF
without RRT (OR: 1.78, 95% CI: 1.44–2.21, p\0,0001) and for ARF with RRT (OR: 2.21,
95% CI: 1.50–3.25, p\0,0001).
CONCLUSION. ARF is an independent risk factor for ICU mortality. The lack of beneﬁcial
effect of RRT needs further investigations.
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INTRODUCTION. A 53 year old lady with a history of depression presented to the psy-
chiatric outpatient unit of a tertiary hospital with worsening apathy and signiﬁcant weight loss
(6 kg) within the last 3 month. Her major complaints included bone and abdominal pain.
Initial investigations revealed drastically elevated total serum calcium (6,08 mmol/l) and the
patient was immediately admitted to the medical ward. During the following 48 h serum
calcium increased despite volume expansion and treatment with diuretics, calcitonin, zoled-
ronic acid and the patient developed an acute kidney injury. Because of the development of
severe sepsis associated with pancreatitis and a deteriorating mental state the patient had to be
intubated and transferred to the medical intensive care unit of the university hospital of
Innsbruck.
The CT-scan showed an adenoma of 3.3 9 3.5 x 6.1 cm next to right lobe of the thyroid
gland, an enlarged liver and bilateral pulmonary inﬁltrates. Together with a highly elevate
PTH (2217 ng/l) these results conﬁrmed the diagnosis of primary hyperparathyroidism. At
that time the patient was anuric.
METHODS. To enable resection of the adenoma under safe conditions normalization of
serum calcium was required before surgery. First intermittent hemodialysis was initiated
which reduced serum calcium during each treatment session but a rebound occurred within a
few h. Consequently, we switched the patient to CVVHD using citrate anticoagulation with
the intention to normalise serum calcium by constant chelation and elimination of calcium.
Regional citrate anticoagulation was performed by infusing 4,0% tri-sodium citrate into the
extracorporeal circuit using a calcium free dialysate solution with reduced sodium
(133 mmol/l) and bicarbonate content (20 mmol/l) applying a dialysate ﬂow of 2000 ml/h.
Calcium substitution was reduced to ﬁfty percent of the usually applied dose.
RESULTS. With this method we were able to normalize elevated serum calcium within 48 h.
Surgery had to be deferred until pneumonia and sepsis resolved. Serum calcium was kept
stable between 2.3 and 2.5 mmol/l with CVVHD over the entire period.
On day 14 after admission to the ICU the adenoma could be successfully removed. One
month later the patient could be transferred back to the referring hospital already mobilized
but still requiring intermittent hemodialysis, however, already gaining urine output.
CONCLUSION. This case demonstrates the ability of CVVHD with regional citrate anti-
coagulation to easily control severe hypercalcaemia without adverse events.
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INTRODUCTION. Patients with ARF related to sepsis requiring renal replacement therapy
(RRT) have an excess of mortality and need a higher level of care owing to a higher
requirement for diagnostic and therapeutic interventions. Early goal direct therapy (EGDT)
has been shown safe and efﬁcacious for patients with renal failure (ARF) resulting in
reduction of both morbidity and mortality. This protocol includes resuscitation to goals of
central venous pressure (CVP) between 8 and 10, mean arterial pressure (MAP) between 65
and 90 mmHg and central venous oximetry (ScvO2) greater than 70%. Regarding ScvO2,
there is no study showing that it accurately reﬂects mixed venous oxygen saturation (SvO2)
during renal replacement therapy. Of particular interest are the possible effects of blood ﬂow
rate and dialysate and replacement solution ﬂow rate during dialysis in monitoring SvO2. The
aim of this study is to compare simultaneous measurements of SvO2 and SvcO2 obtained
from distal ports of pulmonary arterial catheter (PAC)and dialysis catheter in a patient with
septic shock and ARF during hemodiaﬁltration.
METHODS. It was a prospective clinical trial comparing individual oxygen saturation value
as wel as the trend of values from de superior vena cava obtained from dialysis catheter and
from artery pulmonar obtained from PAC during hemodiaﬁltration.
RESULTS. Fifteen patients were evaluated during hemodiaﬁltration, 120 paired measure-
ments of SvO2 and SvCO2 were collected.All the patients were on mechanical ventilation and
vasopressor therapy. Mean Apache was 18. Mortality was 66%.
The mean blood ﬂow rate was 152 ml/min, the mean dialysate rate was 1759 ml/h and the
mean replacement solution rate was 500 ml/min.The mean value of SvO2 was 78,6 ± 1,2 and
SvO2c was 79,4 ± 1,1(p = 0,003). Regression analysis for the pooled measurements of
SvCO2 and SvO2 showed a correlation R 0,52. In contrast, correlations between changes over
time of SvO2 and SvCO2 values were clinically acceptable R = 0,712.
CONCLUSION. In this sample of patients, exact numeric values of SvO2 and SvCO2 during
hemodiaﬁltration are not equivalent.However for clinical purposes, the trend of SvCO2 may
be substituted for the trend of SvO2. A clinical trial using a dialysis catheter with continuous
measurement of SvCO2 during hemodiaﬁltration of acute renal failure patients with severe
sepsis and septic shock is still lacking.
Poster Sessions
Respiratory failure: Therapeutic strategies
and measures: 0954–0966
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INTRODUCTION. Pulmonary blood ﬂow redistribution induced by inhaled nitric oxide
(INO) can improve oxygenation. We previously hypothesized that this may be a composite
effect of vasoconstriction in poorly ventilated lung units and vasodilation in well-aerated
areas of the lung (1). The aim of this study was to further investigate whether endothelin-1
(ET-1), as a potential mediator of vasoconstrictive responses to INO, is involved in the
pulmonary blood ﬂow redistribution induced by INO. We hypothesized that a dual endothelin
antagonist may blunt the blood ﬂow redistribution induced by INO.
METHODS. In an animal model of endotoxin induced lung injury, we exposed 8 piglets
(27 ± 1.9 kg) to 40 ppm INO and, subsequently infused the dual endothelin antagonist Te-
zosentan. Pulmonary blood ﬂow distribution was assessed by single photon emission
computed tomography (SPECT) in supine position in 5 of the 8 animals, (a) after lung injury
was established, (b) with INO and (c) after Tezosentan infusion has been added to INO for
45 min. Oxygenation was assessed using PaO2/FiO2 ratio. ANOVA was used for hemody-
namic comparisons and paired t-tests to compare between SPECT perfusion proﬁles.
RESULTS. INO tended to improve oxygenation from 223 ± 85 mmHg during lung injury, to
316 ± 70 mmHg (p = 0.07). Oxygenation deteriorated again to 181 ± 38 mmHg (p = 0.01)
similar to pre INO levels by the subsequent infusion of Tezosentan. Mean pulmonary artery
pressure increased with lung injury from 19 ± 1.7 mmHg to 38 ± 6 mmHg (p = 0.01), and
decreased with INO to 29 ± 5 mmHg. The addition of Tezosentan led mean pulmonary
artery pressure to 24 ± 4 mmHg. SPECT data demonstrated that pulmonary blood ﬂow
redistribution induced by INO was abolished after 45 min of Tezosentan infusion. (Gravi-
tational plane p\0.001; Horizontal plane p\0.001). Pulmonary blood ﬂow shifts were
more accentuated in the dependent to non-dependent direction than in the horizontal plane.
CONCLUSION. Our ﬁndings further support the hypothesis, that a vasoconstrictive ET-1
mechanism may have an important role in the oxygenation response to INO. We conclude that
the mechanism of action of INO in this acute lung injury model consists of two distinct
mechanisms, one being vasodilation by INO in ventilated lung regions, the other being
vasoconstriction mediated by ET-1 in non-ventilated regions.
REFERENCE(S). 1. Eur J Anaesth, Vol 23, Suppl. S37; 2006 p75.
GRANT ACKNOWLEDGEMENT. This work is part of the project: ‘‘Inﬂuence of Endo-
thelin activity on response to inhaled nitric oxide on ventilation perfusion distribution in acute
lung injury’’ that was rewarded with The Alain Harf Award on Applied Respiratory Physi-
ology 2006.
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INTRODUCTION. Acid aspiration, a common cause of ALI/ARDS, is associated with a
severe deterioration of gas exchange and lung mechanics as well as with endogenous sur-
factant impairment. We evaluated the effects of surfactant replacement in a previously
characterized (1) murine model of unilateral acid-induced lung injury, with a spontaneous
ﬁbrotic evolution, after the acute essudative phase, of the injured lung region.
METHODS. We instilled 1.5 ml/kg BW of 0.1 M HCl in the right bronchus of anesthetized
mice. Six h after injury, mice were randomised to receive in the injured lung, a single bolus of
porcine surfactant (80 mg/kg; Curosurf ; Chiesi Farmaceutici, Parma, Italy) or sterile saline
(0.9% NaCl, control group). After the injury- and the treatment-procedures, mice were
mechanically ventilated (Vt 8–10 ml kg-1 BW, RR 130 min-1, and PEEP of 2.5 cmH2O) for
10 min, then kept in an oxygenated chamber until full awakening. Speciﬁc compliance of the
respiratorysystemandbloodgasanalysiswereassessedbothinacute(24hrsfrominjury)andin
late (2 weeks) phase, whereas Broncho-Alveolar Lavage (BAL) was performed only at 24 hrs.
RESULTS. In acute phase, surfactant instillation decreased neutrophilic inﬂux in BAL, since
the differential white blood cell count showed a signiﬁcantly reduced percentage of PMN in
surfactant treated group compared to control (45% vs. 68%) (p\0.05). Moreover oxygen-
ation was signiﬁcantly better (PaO2 78 ± 11 mmHg) in surfactant treated group than in the
control group (64 ± 14 mmHg) (p\0,05); no effect was present in late phase (respec-
tively,127 ± 24 mmHg and 137 ± 22 mmHg). The surfactant treated group showed a
signiﬁcantly better respiratory system compliance at both at 24 h and at 2 weeks, when
compared to control groups (p\0.05).
TABLE 1 RESPIRATORY SYSTEM COMPLIANCE
NaCl 24 h
(n = 7)
Surfactant
24 h (n = 7)
NaCl 2 weeks
(n = 11)
Surfactant
2 weeks
(n = 11)
Resp compliance (ml/cmH2O)/Kg 1.1 ± 0.1 1.3 ± 0.2* 1.6 ± 0.1 1.8 ± 0.3*
*p\0.05 vs. NaCl group
CONCLUSION. Our preliminary results show that surfactant replacement with an instillation
six h after injury resulted in reduced neutrophilic inﬂux in BAL ﬂuid, better oxygenation and
improved lung mechanics in the acute phase (24 h). Moreover in late phase (2 weeks) sur-
factant treatment determined an improvement of respiratory system compliance, suggesting a
reduction of the ﬁbrotic process.
REFERENCE(S). 1. Amigoni M. et al. Anesthesiology, June 2008.
GRANT ACKNOWLEDGEMENT. this study was supported by Chiesi Farmaceutici S.p.A.
(Parma, Italy).
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INTRODUCTION. Despite advances in mechanical ventilation, treatment of severe
refractory hypoxemia has remained one of the greatest challenges in intensive care. Inhaled
nitric oxide (NO) is commonly used for the treatment of refractory hypoxemia in acute
respiratory distress syndrome (ARDS). However, it has never been shown to decrease mor-
tality, has substantial cost and has potential side effects. Prostacyclin analogues have also
been used in small trials. The phosphodiesterase inhibitor milrinone is a potent pulmonary
vasodilator that has been used with success as an inhaled therapy for pulmonary hypertension
and therefore is a potential alternative to actual treatment. We designed a prospective pilot
study in ARDS patients, comparing inhaled nitric oxide with epoprostenol and inhaled
milrinone.
METHODS. In our academic 24-bed medico-surgical intensive care unit, patients were
screened for the study from March 2006 to January 2008. Adult patients were enrolled after
informed consent was obtained if they had refractory hypoxemic failure meeting standard
ARDS criteria and had a Swan-Ganz catheter. We randomly and sequentially nebulized NO
(at 20 ppm) and eproprostenol (10ug/ml) and thereafter nebulized milrinone (1 mg/ml) alone
and in association with NO. After 20 minutes of nebulisation for each drugs, a 30 minutes
pause was allowed. The following parameters were measured after each step: systemic and
pulmonary pressures, cardiac output, blood gaz. The following parameters were calculated:
peripheral and pulmonary vascular resistances (SVR et PVR), PVR/SVR Ratio, transpul-
monary gradient, PaO2/FiO2, shunt and oxygenation Index. All results are express in
median(IQR).
RESULTS. During the study period, 14 patients were enrolled: 12 men and 2 women with a
mean age of 56.0 ± 17.4 years. Their APACHE II score was 22 ± 5. All ARDS were from
pulmonary cause and pneumonia (n = 9) was the leading diagnosis. The mean baseline PaO2/
FiO2 ratio was 138 ± 40. We observed a PaO2 increase of 6.9(15.6), 6.0(17.1), 6.0(14.3) and
6.4(18.6) mmHg respectively using NO, epoprostenol, milrinone and combination of NO and
milrinone. We also observed an improvement in the iPVR in the four groups: -29.5(180.4),
-61.3(199.5), -9.5(92.4) and -26.1(94.0) dyne/sec/cm-5 respectively with NO, epoprost-
enol, milrinone and combination of NO and milrinone. The difference in iPVR responses
observed between the NO and the other groups did not reach statistical signiﬁcance.
CONCLUSION. Inhaled milrinone improved oxygenation and decreased PVR in this ARDS
cohort. Further studies need to be done in larger and various ICU population of ARDS
patients and effects of repeated doses need to be assessed.
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INTRODUCTION. To analize the clearance proﬁle of pulmonary edema provoked by saline
solution instillation after induction of a lung injury by oleic acid infussion.
METHODS. Experimental study in which three groups of pigs (weight 31 ± 3 kg) where
assigned to different methods of experimental pulmonary edema (PE). Group A (n = 8):
lesional-PE produced by oleic acid iv infussion (0.1 ml/kg). Group B (n = 10): PE by saline
solution tracheal instillation (4 ml/kg). Group C (n = 7): oleic acid iv infussion (0.1 ml/kg)
followed by saline solution tracheal instillation (4 ml/kg). Anesthetized and under mechanical
ventilation for 4 h. PE clearance proﬁle registered by measurement of extravascular lung
water by thermodilution (PiCCO , Pulsion, Germany) every 30 minutes. Mann-Whitney test
for cuantitative variables was used and a p\0.05 was considered signiﬁcative.
RESULTS. PE clearance proﬁle in group A differs from that observed in groups B and C,
showing increase in the last 2 h. In group B, a continuous clearence was noted with 24 ml/h
rate in the ﬁrst 2 h, and 6 ml/h in the second part of the experiment. In group C, althoug the
clearance rate was stable (12–16 ml/h), total clearance was similar as observed in group B.
There were not found signiﬁcative differences between groups B and C in any measurement.
CONCLUSION. Clearance proﬁle of PE produced by saline solution instillation over a lung
injury model is similar than the one due only to saline solution.
GRANT ACKNOWLEDGEMENT. F.I.S. 06/1097.
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INTRODUCTION. Chronic Obstructive Pulmonary Disease (COPD) is predicted to be the
third leading cause of death in the United States by 2020. Approximately 125,000 people die
yearly from acute exacerbations of the disease. Once intubation and mechanical ventilation
become necessary the death rate increases. To avoid the need for ventilator use we have
developed a new device (the Hemolung), which is an integrated pump/oxygenator that
functions at low blood ﬂow rates (300–500 mL/min) equivalent to those used in renal dialysis.
The small priming volume (190 ml), reduced membrane surface area (0.5 m2), and use of a
percutaneously inserted dual lumen venous catheter (15 Fr) to provide blood inﬂow and
outﬂow make the entire system suitable for repetitive use in patients with hypercapnic acute
respiratory failure. We report here 7-day animal data stressing the hemocompatibility and gas
exchange capabilities of the device.
METHODS. The venous catheter was inserted into the right exterior jugular vein of 7 adult
sheep and connected to the saline-primed Hemolung circuit. Hollow ﬁber membranes were
coated with siloxane and heparin to prevent plasma wetting and to increase biocompatibility.
Animals were minimally anticoagulated with heparin (ACT 150). Blood ﬂow, CO2 exchange,
blood gases and key hematological parameters were measured over 7 days. Necropsy was
performed on termination.
RESULTS. Removal of CO2 (normalized to a pCO2 of 45 mmHg) remained steady over
7 days averaging 66 ± 13 mL/min at blood ﬂows of 350–400 mL/min. As venous PCO2 rose
or fell so did the level of CO2 removal. One animal was terminated after 3 days due to
accidental disconnection of a blood tube. No plasma wetting was noted over the 7 days. Two
devices were replaced after 4 days due to bearing malfunction, however, the animals suffered
no permanent side effects from this intervention. Hematocrit remained stable in all animals
and no blood products were required. Initial platelet counts dropped to 241,000/uL ± 84,000
by the second day, but recovered to baseline values on day 4 and remained stable. Necropsy
showed no signs of thromboembolism or organ damage.
CONCLUSION. A simple alternative to mechanical ventilation for patients with COPD and
hypercapnic respiratory failure has been successfully tested in animals. Human trials are
planned for 2008 to determine what role ‘‘respiratory dialysis’’ will have in this patient
population.
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VENTILATOR-INDUCED LUNG INJURY AMONG MAMMALS: A UNIFYING
HYPOTHESIS
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INTRODUCTION. To investigate the mechanisms of ventilator-induced lung injury (VILI),
many mammals have been employed in experimental models comparing the effects of dif-
ferent ventilatory settings. Despite the solidity of the data, a high variability of the time course
and the severity of VILI have been observed among different models. Inspiratory airway
pressures, tidal volume (VT) per body weight (bw), and more recently, alveolar stress
(transpulmonary pressure, PL) and strain (delivered VT on the lung resting volume) have been
considered as possible predictors of VILI. Our aim was to ﬁnd, by a retrospective analysis of
the available literature, a unifying relationship between ventilatory settings and time of
achievement of a preterminal lung injury.
METHODS. A medline research was performed. Articles in which healthy animals were
aggressively ventilated until death or the achievement of preterminal lung injury were
selected. Criteria for preterminal injury were PaO2\50 mmHg, PaO2/FiO2\150, reduc-
tion of functional residual capacity (FRC)[50% of baseline, increase of respiratory system
elastance[150% of baseline. VILI group included terminal-injured, control group (CG) non-
terminal injured animals. Mean values of VT/bw, peak/plateau inspiratory pressure, positive
end-expiratory pressure (PEEP) and time of ventilation were analyzed. Alveolar strain was
computed as the ratio between end inspiratory-lung volume (VT + PEEP-volume) and FRC.
PEEP-inﬂated volume was calculated by using respiratory system compliance (Crs). When
Crs and FRC were not measured, they were estimated from physiological studies on each
species. PL was estimated from values of peak/plateau airway pressure and data on the
partitioned respiratory mechanics.
RESULTS. Sixteen articles were selected, including 6 different species (sheep, pigs, dogs,
rabbits, rats, mice). Time of achievement of lung injury was markedly variable among dif-
ferent studies, ranging from 18 to 2784 minutes. Duration of ventilation was highly correlated
with alveolar strain according to an exponential decay function: y = y0 + a*exp(-b*x)
(r2 = 0.84, p\0.01). Of note, most of the values of CG animals appeared to be leftward and
downward-shifted as compared to the VILI group. No such relationship was found between
other parameters and time. When duration of ventilation was normalized on alveolar strain
applied, large animals showed a greater resistance to VILI as compared to small species (610
[260/1838] vs. 17 [4/59] min. – median[25/75%], p\0.01).
CONCLUSION. From this preliminary and retrospective analysis, alveolar strain appears to
have a key role for a better comprehension of VILI among mammals. A higher susceptibility
to VILI may be typical of small animals.
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PULMONARY FUNCTION AND EXPIRATORY FLOW LIMITATION IN
PATIENTS WITH ACUTE CERVICAL CORD INJURY
V. Alvisi
1, C. Volta*
1, E. Marangoni
1, S. Zannoli
1, G. Belloni
2, M. Uneddu
2, R. Uggento
2,
R. Ragazzi
1, R. Alvisi
1
1Dipartimento di Scienze Chirurgiche, Anestesiologiche e Radiologiche, Sezione di Anestesia
e Rianima, University of Ferrara, Ferrara,
2Intensive Care Unit, Montecatone Rehabilitation
Institute, Imola, Italy
INTRODUCTION. Patients with spinal cord injuries can develop alterations of respiratory
mechanics responsible of infective complications, which represents the most important cause
of increased mortality and morbidity. The most relevant alteration of respiratory mechanics is
the reduction of functional residual capacity (FRC). The latter can be responsible of a
reduction of the expiratory ﬂow able to provoke the development of expiratory ﬂow limitation
(EFL). The clinical consequences are the inability to cough and the cyclic opening/closure of
the peripheral airways responsible of a chronic lung inﬂammation. Aim of our study was to
evaluate whether the FRC reduction could lead to EFL.
METHODS. 31 consecutive patients with spinal cord injury at C4-C5 level were studied
(age: 38 ± 18y; weight: 70 ± 13Kg; days from trauma: 66 ± 46). The following data were
recorded, both seated and supine: 1) parameters from pulmonary function test, such as
inspiratory capacity (IC), FEV1, FEV1/FVC 2) EFL by the NEP test, which is based on the
application at the airways opening of a negative pressure of 3 cmH2O 4) difference between
the expiratory ﬂow during tidal ventilation and the expiratory ﬂow of the ensuing breath (NEP
test) at 50% of the expired volume (DELTA V’).
RESULTS. The main result of our study is that 32% of the patients developed EFL in supine
position, while this percentage is only 7% in seated position. Moreover, the presence of EFL
was statistically related to the age of the patients (32 ± 16 years without EFL VS
60 ± 12 years with EFL). Interestingly, the DELTA V’ was markedly reduced in supine
(0.16 ± 0.12 l/s) than in seated position (0.28 ± 0.16 l/s). Both values were much lower than
those of normal subjects ([0.7 l/s, personal observation). On the contrary, patients in supine
position showed better spirometric parameters.
CONCLUSION. The clinical implications of the reduction of the expiratory ﬂow are a) the
inefﬁcacy of the cough to clean the secretions and b) a chronic lung inﬂammation due to the
presence of EFL. Indeed the FEV1/FVC ratio was 0.60 ± 17 in seated position, value that
implies the presence of obstructive lung disease even in very young patients. Hence, although
the patients with spinal cord injuries exhibited a better spirometric parameters in supine
position, the need of avoiding the pro-inﬂammatory mechanisms due to reduction of expi-
ratory ﬂow, implies the maintenance of these patients in semirecumbent position.
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INTRODUCTION. With our improved lung volume algorithm we aimed to evaluate the
ability of Absolute EIT to detect and quantify changes in individual lung ventilation.
METHODS. We studied 8 patients undergoing oesophagogastrectomy using the 8 electrode
Mk3.5 Shefﬁeld EIT system in the anaesthetic room before surgery. This uses 8 stick-on
electrodes evenly spaced around the thorax, 5 cm above the level of the xiphoid process. For
an oesophagogastrectomy the patient is intubated with a double-lumen endotracheal tube to
allow independent lung ventilation. EIT recordings were taken during bilateral lung venti-
lation Vt 800 ml. Each lung was then individually ventilated with volumes of Vt 400, 300 and
200 ml, with the opposite lumen of the double-lumen endotracheal tube open to air.
RESULTS. Examination of lung air volume graphs produced by EIT of the 4 lung quadrants
(ﬁg) showed that EIT recognised bilateral and single lung ventilation in all cases (100%).
Analysis of the contralateral lung during single lung ventilation revealed a small antiphase
waveform, suggesting compression of the non-ventilated lung by the ventilated side. Bilateral
lung ventilation tidal volume calculations by EIT were accurate to 19.0% (mean percentage
error). Single lung ventilation tidal volume calculations were accurate to 19.4% for the left
lung, and 21.9% for the right.
CONCLUSION. Absolute EIT can identify unilateral lung ventilation. EIT is now able to
calculate tidal ventilation lung volumes during unilateral and bilateral ventilation with a mean
percentage error of close to 20%. Research is ongoing to improve the performance of EIT as a
bedside monitor capable of indicating individual lung behaviour in mechanically ventilated
patients on the ICU.
GRANT ACKNOWLEDGEMENT. EPSRC, Shefﬁeld Hospitals Charitable Trust.
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PRONE POSITION GUIDED BY LUNG ULTRASOUND IN ARDS PATIENTS; THE
TIME COURSE RESPONSE OF OXYGENATION IMPROVEMENT
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INTRODUCTION. Prone position may improve oxygenation and the outcome of patients
with severe ARDS. Oxygenation improvement with prone position is related to the etiology of
the ARDS (pulmonary or extrapulmonary), the onset (early or late) and the time the patients
remain in the prone position. Lung ultrasound may provide valuable information on lung
consolidation or lung collapsed areas at the dependent parts of the lung, susceptible to expand
with prone position.
METHODS. During a 4 year- period, all ARDS patients (PaO2/FiO2\150) prospectively
turned prone for 24 h based on clinical and lung ultrasound criteria of lower lobes consoli-
dation or atelectasis. The ventilatory settings for all patients included plateau pressures less
than 30 cm H2O and PEEP of 5–20 cmH2O. Gas exchange data and lung mechanics were
evaluated in the supine position and after turned prone, every hour for the ﬁrst 3 h, every 6 h
for the remaining 24 h and after turning in the supine position. The time course response of
the gas exchange improvement was correlated with the time of the onset of ARDS. The cause
of death (pulmonary or non-pulmonary) was noted. ANOVA was used for statistical analysis
(p\0,05).
RESULTS. 42 patients (30 M and 12 F) with ARDS (14 of extrapulmonary and 28 of
pulmonary etiology), with a mean age of 41 years (min 17, max 74) included in the study. The
onset of the ARDS was 3,7 days (min 1 day, max 14 days) and their initial PaO2/FiO2 and
PaCO2 in the supine position were 85 ± 41 and 45 ± 11 mmHg, respectively. All patients
increased substantially their PaO2/FiO2 and decreased their PaCO2 after 24 h in the prone
position [to 220 ± 90 and 39 ± 6 mmHg (p\0.01)], compared to the supine position. Lung
compliance did not change signiﬁcantly from the supine to prone position (from 33 ± 12 to
36 ± 11 ml/cmH2O) but signiﬁcantly improved when turned supine again (from 33 ± 12 to
37 ± 12). No relationship was found between the onset of ARDS or the etiology (pulmonary
or extrapulmonary) and the time course improvement of PaO2/FiO2. Oxygenation continued
to improve overtime in prone position and in some patients recruitment of lung units was
observed after 16 h after they had turned prone. Mortality of the entire group of patients was
32%, but the mortality attributed to the ARDS was 20%.
CONCLUSION. Lung ultrasound may identify ARDS patients susceptible to improve their
gas exchange by prone position. Response to prone position may be delayed as much as 16 h.
Prone position may improve survival in patients with severe ARDS.
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CONTINUOUS LATERAL ROTATION THERAPY AND DEAD SPACE
VENTILATION
F. van Beers*, B. Speelberg
Intensive Care, St.Elisabeth Hospital Tilburg, Tilburg, Netherlands
INTRODUCTION. In order to minimize dead space ventilation, adjustment of breathing
frequency and tidal volume may be necessary. Also reduction of anatomical dead space, by
means of reducing ventilatory tube length, is favourable for the artiﬁcial ventilation of ICU
patients. Not yet investigated is the possibility of improvement of blood ﬂow to unperfused
alveoli. In this way physiological dead space could be reduced. We investigated the effect of a
continuous lateral rotation bed on dead space ventilation compared to routine manual turning.
METHODS. 21 consecutive patients were investigated. 9 patients were treated with con-
tinuous lateral rotation therapy (CLRT) and 12 patients received standard care. In the standard
care group the patients were turned in the lateral position each 4 h manually on a TOTAL
CARE
  bed (Hillrom
 ). Lateral rotation was performed as lateral as possible. In the CLRT
group the patients were turned every 20 minutes automatically as lateral as possible on a
SpO2-RT bed (Hillrom
 ). PaCO2, PeCO2, minute volume were recorded before start of
treatment (t = 0) and after 24 h (t = 24). Dead space ventilation was calculated as: Vd/
Vt = (PaCO2 – PeCO2)/PaCO2. The difference of Vd/Vt of the two time points was used for
calculation. A nonparametric Mann-Whitney U test was used for analysing differences
between the two groups. A signiﬁcance level of\0.05 was considered signiﬁcant.
RESULTS. Dead space ventilation on t = 0 in the control group was 0.17 ± 0.11 vs. 0.29 ±
0.28 in the CLRT group; not statistically different. However after 24 h the Vd/Vt was 0.11 ±
0.08 in the standard treated group and 0.28 ± 0.14 in the CLRT group (p\0.005). The
differences between t = 24 and t = 0 in the both groups did not differ signiﬁcantly, control
group -0.07 ± 0.14, CLRT group 0.01 ±0.14.
CONCLUSION. Dead space was not signiﬁcantly reduced after CLRT treatment when
compared to standard rotation every four h. When 24 h after treatment, dead space in both
groups were studied, dead space was signiﬁcantly higher in the CLRT group. CLRT seemed
to have a worse effect on dead space. The number of patients studied was small. Further study
is warranted.
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INTRODUCTION. Positional therapy is of particular importance in the treatment of ICU
patients. Not only for the prevention of decubitus, but also for the prevention of ventilator
associated pneumonia and atelectatic lung disease. We investigated the role of a new con-
tinuous lateral rotation treatment (CLRT) bed, on static lung compliance.
METHODS. After approval of the study protocol by the ethical committee, 21 patients were
examined. Patients were randomised for standard therapy (n = 12) or CLRT (n = 9) by
means of a SpO2-RTTM bed (Hillrom  ). In the standard therapy group, patients were
manually rotated every 4 h as lateral as possible. In the CLRT group, patients were rotated
automatically with the use of a self-inﬂating mattress, every 20 minutes. All patients suffered
from ARDS and were pressure controlled ventilated with the use of a Servo 300(A)
  and
Servo-i
  ventilator (Maquet). Static lung compliance was measured on the ventilator. Static
compliance was measured before therapy and 4, 8, 16, 24 h after start of therapy. Delta-static
compliance was calculated as the difference of static compliance on the different time points
minus pre-treatment values for the individual patients. Non parametric Kruskal-Wallis test
was used to analyse the differences in both treatment groups. A signiﬁcance level of\0.05
was considered as signiﬁcant.
RESULTS. When the 2 treatment groups were compared, CLRT treatment was superior on
time point 4 h (p = 0.002), 8 h (p = 0.03) and 16 h (p = 0.04) when compared to baseline.
TABLE 1 INCREASE IN STATIC LUNG COMPLIANCE
Standard therapy mean SD CLRT mean SD
-3,08 4,83 6,33 7,3
-1,42 6,32 6,00 8,79
-1,00 6,66 5,89 10,19
-0,67 10,69 7,33 8,28
CONCLUSION. We demonstrated an improvement in static lung compliance with CLRT in
ventilated patients. The number of studied patients in this study was small. The improvement
seemed to disappear after 24 h. Unfortunately we did not do any further measurements.
Further study is necessary to investigate the cause of this improvement in lung compliance.
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EARLY GAS EXCHANGE AFTER PRONE POSITIONING AND CLINICAL OUT-
COME IN PATIENTS WITH SEVERE ACUTE RESPIRATORY DISTRESS
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INTRODUCTION. Ventilating patients with acute respiratory distress syndrome (ARDS) in
the prone position has been shown to improved arterial oxygenation, but various studies
showed the debatable results regarding on the predictor of outcome according to gas exchange
patterns after the prone position in ARDS. Moreover, there has been few clinical data on the
early gas exchange and clinical outcome in ARDS patients with the prolonged prone position.
We evaluated the early gas exchange and clinical outcome in severe ARDS patients, who
underwent prolonged prone positioning.
METHODS. This retrospective study was performed from 1 January 2000 to 31 July 2006.
We studied adult patients who were diagnosed as severe ARDS and placed in prone posi-
tioning for C 12 h in the medical intensive care unit (ICU) until the positioning change from
prone to supine because of the improved (PaO2/FiO2 C 200 or FiO2\0.5, and improved
chest radiographic ﬁnding) or worsen (with no improvement of gas exchange by the prone
positioning) patients’ clinical status. All clinical data and gas exchange variables before and
after the prone position were collected. Severe ARDS was deﬁned as PaO2/FiO2 B 150 with
a positive end-expiratory pressure of at least 8 cm H2O, bilateral chest radiograph inﬁltrate,
and the absence of clinical evidence of cardiac failure. The ‘‘PaO2 responders’’ and ‘‘PaCO2
responders’’ were those patients who increased the PaO2/FiO2 more than 20 mmHg and
decreased the PaCO2 C 1 mmHg at ﬁrst 8–12 h after the prone position, respectively. Pri-
mary end-point was 28-day mortality.
RESULTS. A total 96 patients (mean age 60.1 ± 15.6, 75% men) were enrolled. Their mean
admission SAPS (Simpliﬁed Acute Physiology Score) II score was 42.2 ± 13.9, and the mean
length of ICU and hospital stay were 21.7 ± 18.5 and 35.2 ± 32.8 days, respectively. The
28-day mortality rate after ICU admission was 56.3%. At entry into the study, there was no
difference in clinical data between survivors and nonsurvivors on day 28. After prone posi-
tioning, the PaO2 responders were 62.5%, and associated with an improved 28-day outcome
compared with nonresponders by analyzing Kaplan Meier survival estimates (p\0.05 by the
log-rank test). The PaCO2 responders were 53.1%, but not associated with 28-day outcome. A
Cox proportional hazards model demonstrated that the PaO2 responders (95% CI 0.297–
0.970, p\0.05) and serum creatinine on prone position day (95% CI 1.039–1.878, p\0.05)
was the important independent predictor of the 28-day mortality.
CONCLUSION. The PaO2 responders after prone positioning with lower serum creatinine
on prone position day would be a good prognostic factor in severe ARDS with prolonged
prone positioning.
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INTRODUCTION. Spinal cord injury is still a big medical challenge. It is well known that
patientswithpartialorcompletetransectionatorbelowthefourthcervicalcordsegmentexhibit
weaknessandspasticparalysisbelowthelevelofthelesion.Thisimpairstherespiratorymuscle
function so that the ability to cough and to clear the airways from bronchial secretions is
reduced. The stasis of bronchial secretions may predispose to the development of pulmonary
infections which are the primary cause of death in those patients. Aim of this study is to
investigate inspiratory and expiratory muscles function in patients with injury level at C4-C5.
METHODS. 31 consecutive patients with spinal cord injury at C4-C5 level were studied (age
38 ± 18y; weight: 70 ± 13Kg; days from trauma: 66 ± 46). The following data were
recorded, both seated and supine: (1) maximum inspiratory pressure (MIP) as the maximal
force developed against an occluded airway (2) maximum expiratory pressure (MEP), (3)
P0.1 as index of neuromuscular respiratory drive 4) inspiratory resistance.
RESULTS. The main result of our study was that MIP and MEP are markedly reduced in
both positions. MIP was reduced of about 60% (% normal value) in supine position (44 ± 15
cmH2O) and this value was even lower in seated position (37 ± 15 cmH2O); the reduction of
MEP is quite constant both in supine (24 ± 11 cmH2O) and in seated position (22 ± 12
cmH2O) and proportionally bigger than the reduction of MIP (85% of the normal value).
Furthermore P0.1 and inspiratory resistance exhibited a huge increase compared to normal
(316 and 236%, respectively).
CONCLUSION. The huge reduction of MEP indicates an important impairment of expiratory
muscle function which can be associated with a reduction of the efﬁcacy of the cough. The
stasis of secretions in the airways not only implies a predisposition to pulmonary infection, but
canfurther increasesﬂowairway resistances, thatare higher intetraplegic patientsowing tothe
reduction of functional residual capacity (FRC). To the increased inspiratory resistance cor-
responds an increased work for the inspiratory muscles that could not always be performed
becauseof thereductionof MIP. Thelatter is betterin supinepositiondueto diaphragmmuscle
ﬁbers which operates on a more favorable portion of their length-tension curve. However, the
higher decrease of FRC in this position implies a reduction of expiratory ﬂow and a cyclic
opening/closure of the peripheral airways which are responsible of a chronic lung inﬂamma-
tion. The latter could be avoided by keeping these patients in semirecumbent position.
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INTRODUCTION. Acute kidney injury (AKI) has been shown to be associated with a worse
outcome in critically ill patients and patients with severe sepsis. However, results of these
studies are hardly comparable, since different deﬁnitions for AKI were used. Recently, a new
consensus deﬁnition of AKI was proposed (Metha et al. Crit Care 2007; 11(2)). This deﬁnition
uses a ﬁxed time interval (48 h) in which AKI may develop. Aim of our study was to
investigate the new deﬁnition and the impact of AKI according to this deﬁnition on outcome
in a large cohort of patients with severe sepsis and septic shock.
METHODS. Data from the multicentric VISEP trial (Brunkhorst et al. NEJM 2008; 358: 125–
39) were analyzed for the ﬁrst 48 hrs after enrolment of patients. Complete data on the new AKI
deﬁnitions were available in 521/537 of patients. AKI was deﬁned as an increase in serum
creatinine from baseline of more than or equal to 0.3 mg/dl, a percentage increase in serum
creatinine of more than or equal to 50%, or a reduction in urine output of less than 0.5 ml/kg per
hour for more than six h. Patients were divided into the AKI group and the non-AKI group.
RESULTS. 227/521 (44%) patients were classiﬁed as AKI and 294/521 (56%) as non-AKI.
Patients with AKI were older, had a higher APACHE II score, higher lactate levels and a lower
plateletcount.Meanarterialpressure (MAP)and CrPlevelswere not different (Table 1). 28- and
90-day mortality and mean SOFA scores were signiﬁcantly higher in patients with AKI. Length
of stay (LOS) in the ICU was not different (Table 2). After multivariate logistic regression, AKI
remained a signiﬁcant risk factor for 28-day mortality (OR: 3.058; CI: 1.938–4.824; p\0.001)
and 90-day mortality (OR: 2.853; CI: 1.894–4.295; p\0.001), and organ dysfunction.
TABLE 1 BASELINE CHARACTERISTICS OF PATIENTS WITH AND WITHOUT
AKI (MEDIAN AND INTERQUARTILER)
Age
(years)
APACHE
II points
Creatinine
(mg/dl)
Lactate
(mmol/l)
platelets
(G/l)
MAP
(mmHg)
CrP
(mg/dl)
AKI 69 (60–76) 21 (17–26) 1.6 (1.0–2.3) 2.8 (1.7–5.0) 146 (94–230) 74 (67–83) 200 (128–290)
non-AKI 65 (55–74) 18 (14–22) 1.1 (0.8–1.8) 2.0 (1.3–3.4) 199 (130–274) 76 (68–85) 199 (126–286)
p-value 0.014 \0.001 \0.001 \0.001 \0.001 0.148 0.799
TABLE 2 MORTALITY AND MORBIDITY IN PATIENTS WITH AND WITHOUT AKI
(PERCENTAGES; MEDIAN INTERQUARTILER)
28-day
mortality
90-day
mortality
Mean SOFA
score
ICU-
LOS
AKI 41% 54% 9.1 (6.4–11.6) 18 (7–32)
non-AKI 14% 25% 6.0 (4.4–7.9) 13 (8–26)
p-value \0.001 \0.001 \0.001 0.220
CONCLUSION. The new AKI criteria are useful to predict outcome in a well deﬁned cohort
of patients with severe sepsis and septic shock. AKI occurs in almost half of these patients and
has a tremendous impact on 28-day and 90-day mortality.
GRANT ACKNOWLEDGEMENT. This study was supported by the Federal Ministry of
Education and Research (BMBF) grant No: 01 KI 0106.
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1, R. W. Chang
2
1Departments of Critical Care and Nephrology, Guy’s and St Thomas’ Foundation Hospital,
2Department of Nephrology and Transplantation, St George’s Hospital, London, United Kingdom
INTRODUCTION. The Acute Kidney Injury (AKI) Network proposed a new classiﬁcation
for AKI distinguishing between 3 grades of severity (AKI I, AKI II and AKI III) based on
changes in serum creatinine and whether renal replacement therapy was initiated. The aim of
this study was to validate the criteria in a large ICU population and to evaluate the impact of
AKI in the context of other risk factors.
METHODS. Using the Riyadh Intensive Care Program database we applied the AKI clas-
siﬁcation to 22,303 adult patients admitted to 22 Intensive care units (ICUs) in United
Kingdom and Germany between 1989 – 1999 who stayed in ICU for C 24 h and did not have
end-stage dialysis dependent renal failure before admission to ICU.
RESULTS. Multivariate analysis conﬁrmed that AKI I and AKI III were independent risk factor
for ICU mortality [Odds ratio (OR) 1.21 for AKI I, OR 1.01 for AKI II, OR 2.11 for AKI III]. Other
independent risk factors for ICU mortality were age (OR 1.02), SOFA score on admission to ICU
(OR 1.03), APACHE II score on admission to ICU (OR 1.09), presence of pre-existing end-stage
chronic illness (OR 1.13), admission after emergency surgery (OR 1.99), mechanical ventilation
(OR 2.64), maximum number of failed organ systems (OR 2.65) and non-surgical admission (OR
2.79). AKI II and RRT were not independently associated with increased ICU mortality.
TABLE 1
No AKI
n=13,491
AKI I
n=4,307
AKI II
n=1,493
AKI III
n=3,012
Mean age 60.4 62.5 60.5 61.1
Median APACHE II on admission to ICU 13 16 17 21
Median SOFA score on admission to ICU 5 6 7 9
Maximum organ failure on admission to ICU 1 1 2 2
Mechanical ventilation 57.2% 78.1% 82.2% 87.2%
ICU mortality 9.3% 20.97% 24.9% 49.0%
Hospital mortality 15.9% 29.3% 34.7% 57.5%
Practice of RRT was very variable between different centers. Without using RRT as a cri-
terion for AKI, 5.2% of patients with AKI III would have been classiﬁed as AKI II, 5.3% as
AKI I and 13.1% would not have fulﬁlled the criteria for any AKI category.
CONCLUSION. The AKI classiﬁcation as proposed by the AKI network correlated with ICU
outcome. However, without clear guidelines for the management of RRT, using RRT as a
criterion for AKI III may have a confounding effect on the predictive power of the classiﬁ-
cation system as a whole.
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EARLY MORTALITY AFTER CARDIAC SURGERY DUE TO ACUTE RENAL
FAILURE: RIFLE WITHIN 7 DAYS OR SERUM CREATININE CHANGES WITHIN
48 HOURS?
A. Lassnigg*
1, D. Schmidlin
2, T. Neugebauer
1, M. Hiesmayr
1
1Cardiothoracic and Vascular Anaesthesia and Critical Care, Meduniwien Vienna General
Hospital, Vienna, Austria,
2Cardiovascular Anaesthesia and Intensive Care, University
Hospital, Zurich, Switzerland
INTRODUCTION. We demonstrated recently that a minimal change in the serum creatinine
concentration within 48 hrs (DCrea) after cardiothoracic surgery was associated with
increased mortality within 30 days. In this investigation, we analyzed whether relative
changes, as in the RIFLE classiﬁcation within 7 days, confer a different prognostic
potential(1).
METHODS. Based on data from 4118 consecutive patients in the University Hospital
Vienna, we attributed patients to the RIFLE criteria within 7 days and to DCrea groups within
48 h and 30 day mortality were calculated.
RESULTS. Based on RIFLE within 7 days, acute kidney injury occurred in 323 (8%). RIFLE
did not differentiate as good as DCrea – classiﬁcation between the lowest risk group (DCrea-;
containing 2242 patients; 54% of all patients), and groups with increased mortality. Appli-
cation of RIFLE resulted in a very large reference group (3795 patients; 92%) with 3%
mortality rate as compared with only 2% mortality in the reference group DCrea – (table).
TABLE 1
Total n:4118 DCreatinine RIFLE-
Mortality
GroupD–:
199 (5%)
GroupD-:
2242 (54%)
GroupD+:
1477 (36%)
GroupD++:
200 (5%)
RIFLE
R-None:3795 (92%) 197 (5.2%) 2205 (58%) 1361 (36%) 32 (0.8%) 116 (3%)
R-Risk:203 (5%) 2 (1%) 26 (13%) 73 (36%) 102 (50%) 49 (24%)
R-Injury:78 (2%) 0 6 (1.7%) 33 (42%) 39 (50%) 30 (38%)
R-Failure:42 (1%) 0 5 (12%) 10 (24%) 27 (64%) 17 (40%)
DCrea Mortality 16 (8%) 47 (2%) 84 (5.7%) 65 (32.5%) n:212
CONCLUSION. In the studied cardiac surgical population, RIFLE criteria misclassiﬁed a
large number of patients whereas DCrea-Groups identiﬁed a higher proportion of patients with
poor prognosis. DCrea-deﬁnition has the appeal of simplicity and enhanced accuracy in
predicting mortality when compared with consensus deﬁnitions.
REFERENCE(S). 1. Lassnigg A. Crit Care Med 2008; 36,(4).1129–37.
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END STAGE RENAL FAILURE PATIENTS ADMITTED TO ICU HAVE A BETTER
PROGNOSIS THAN ICU PATIENTS WITH SEVERE ACUTE KIDNEY INJURY
M. Ostermann*
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2
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Kingdom
INTRODUCTION. Patients with end stage dialysis dependent renal failure (ESRF) and
patients with severe acute kidney injury (AKI) are characterised by loss of renal function per
se as well as signiﬁcant associated comorbidities. The aim of our study was to compare the
outcome of ESRF patients admitted to ICU with that of ICU patients with severe AKI and to
identify confounding factors.
METHODS. Retrospective analysis of The Riyadh Intensive Care Program database which
contains demographic and daily physiologic data of 41,972 adult ICU patients admitted to 22
ICUs in United Kingdom and Germany between 1989–1999. Severe AKI was deﬁned
according to the AKI classiﬁcation by the AKI network (serum creatinine C 354 lmol/L,
treatment with renal replacement therapy (RRT) or rise in serum creatinine by[300% from
baseline).
RESULTS. In patients with severe AKI and ESRF, mortality rose with increasing number of
associated organ failure. In a multivariate analysis, independent risk factors for ICU mortality
were mechanical ventilation [Odds ratio (OR) 3.05], maximum number of failed organs (OR
2.58), non-surgical admission (OR 1.59), emergency surgery (OR 1.39), APACHE II score on
admission to ICU (OR 1.05) and age (OR 1.02). RRT was not independently associated with
ICU mortality.
TABLE 1
Severe AKI without
RRT n=1,177
Severe AKI with
RRT n=1,836
ESRF n=797
Mean age 62.6 60.1 55.3
Number of failed organs
on admission to ICU
12 0
Maximum organ failure in ICU
(excluding renal failure)
12 0
Mechanical ventilation 80.5% 91.4% 60.9%
Cardiac surgery 8.8% 12.9% 11.4%
ICU mortality 41.5% 53.8% 20.8%
Hospital mortality 51.5% 61.4% 34.5%
Days in ICU [median] 7 10 2
CONCLUSION. ESRF patients admitted to ICU had a better outcome than ICU patients with
advanced AKI, mainly due to differences in co-morbid risk factors and age.
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NEW ONSET ACUTE KIDNEY INJURY IN A MULTIDISCIPLINARY INTENSIVE
CARE UNIT: A PROSPECTIVE OBSERVATIONAL STUDY
J. Srinivas*, A. S. Arunkumar, S. S. Prabhu, M. Vakamudi
Anesthesiology and Critical care, Sri Ramachandra University, Chennai, India
INTRODUCTION. AKI is associated with high mortality and morbidity in the ICU. There is
limited data on AKI in ICU from India. Hence we evaluated the incidence and predictors of
new onset Acute Kidney Injury (AKI) developing in intensive care unit (ICU) and to assess its
impact on mortality.
METHODS. This study was performed from June 2007 to Mar 2008. All patients with ICU
length of stay (LOS) more than 48 hrs and who fulﬁlled study criteria were included. AKI was
classiﬁed and diagnosed according to RIFLE CRITERIA. Primary outcome analysed was
hospital mortality. Statistical analysis was done using Chi-square test or Fisher’s exact test,
Student’s t-tests and multivariate logistic regression.
RESULTS. Of 1250 ICU admissions during study period, 615 patients met study criteria.
AKI occurred in 184 [29.9%] patients. As per the RIFLE criteria our patients fell into the
following category—Risk [63.04%], Injury [6.52%] and Failure [30.43%]. Renal function
improved in 55.17% of Risk group, 58.33% of Injury group and in 12.5% of Failure group.
Mortality in AKI and those without AKI (NON AKI) were 57.6% and 24.1% (p\0.05)
respectively. 17.93% of AKI patients underwent Renal Replacement Therapy (RRT) and
mortality in this sub group was 87.87% (compared to 70.19% in non RRT group, p = 0.049).
AKI signiﬁcantly increased ICU LOS (8.1 ± 5.3 vs. 5.29 ± 3.9 days, p\0.001) and dura-
tion of ventilation (6.65 ± 5.4vs 3.1 ± 4.1 days, p\0.001). In AKI group non survivors had
higher APACHE II (12.37 ± 4.9 vs. 8.85 ± 3, P\0.001), SOFA (8.19 ± 2.9 vs. 5 ± 2
p\0.001), incidence of sepsis (49.4% vs. 11.8% p\0.001) and lower pH (7.27 ± 0.1 vs.
7.31 ± 0.1 p\0.003) and PF ratio (223 ± 49 vs. 239 ± 35 p\0.014) when compared with
survivors. Sepsis (OR 5.6), vasopressors (OR 2) and comorbid conditions (OR 2.13) were risk
factors for AKI on multivariate analysis.
TABLE 1 PREDICTORS FOR NEW ONSET AKI BY UNIVARIATE ANALYSIS
AKI NONAKI P value
APACHE 2 (mean ± sd) 10.8 ± 4.6 8.42 ± 4.2 0.001
SOFA (mean ± sd) 6.88 ± 3.02 5.5 ± 2.4 0.001
Vasopressors/Inotropes (%) 92 8 0.001
Sepsis (%) 78 22.5 0.001
Blood products (mean ± sd) 1.35 ± 3.4 0.62 ± 1.9 0.001
Heart Rate (mean ± sd) 117 ± 14 107 ± 14 0.001
Mean arterial pressure (mean ± sd) 77 ± 98 1 ± 7 0.001
pH (mean ± sd) 7.29 ± 0.1 7.34 ± 0.08 0.001
PF ratio (mean ± sd) 230 ± 44 241 ± 44 0.004
Lactate (mean ± sd) 3.47 ± 1.71 2.8 ± 1.1 0.001
p\0.05 signiﬁcant
CONCLUSION. Nearly one third of patients in our study group developed new onset AKI
which was associated with increased mortality and morbidity.
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RISK OF RECEIVING RENAL REPLACEMENT THERAPY IN SEPSIS BY
CHARACTERISTICS AT ADMISSION TO INTENSIVE CARE
S. Harris*
1, C. Welch
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2, K. Rowan
2
1Centre for Anaesthesia, University College London Hospital,
2ICNARC, Intensive Care
National Audit and Research Centre, London, United Kingdom
INTRODUCTION. Patients in the Intensive Care Unit (ICU) with sepsis are at risk of Acute
Kidney Injury (AKI). A proportion of these patients will receive Renal Replacement Therapy
(RRT). We sought to describe the risk of receiving RRT in sepsis, and identify those factors
(present at admission to intensive care) associated with that risk.
METHODS. We analysed data from the Intensive Care National Audit & Research Centre
Case Mix Programme (Version 3.0). All patients with a diagnosis of sepsis or severe sepsis
but without a history of chronic renal failure were included. Patients were classiﬁed as
receiving RRT if they haemodialysed/haemoﬁltered on one or more days. Regression analysis
was performed on acute physiology, chronic health, and demographic characteristics.
RESULTS. 6695 patients were identiﬁed with sepsis of which 3354 (50.1%) met the criteria
for AKI
1, and 1152 (17.2%) patients received RRT. The odds for receiving RRT are increased
for males (OR 1.3 (1.1–1.5), and Black or Asian ethnicity (P = 0.030), but fall as age
increases above 40 years (P\0.001). Admission type (emergency surgery or medical) was
not associated with RRT (P = 0.21). Acute physiology parameters are described in Table
(below).
TABLE 1
Acute kidney injury Risk/Stage 1 Injury/Stage 2 Failure/Stage 3
- OR (95%CI) 2.3 (1.8–3.1) 3.0 (2.3–4.0) 5.7 (4.0–7.9)
Urine Output (24 hrs) 1000–1999 mls 500–999 mls B500 mls
- OR (95%CI) 2.2 (1.2–4.0) 4.3 (2.3–8.1) 8.2 (4.4–15.4)
Lung Injury (P:F) - ALI (200–300 mmHg) ARDS (B200 mmHg)
- OR (95%CI) 2.2 (1.2–4.2) 3.2 (1.8–6.0)
Mean Arterial Press - 50–69 mmHg B50 mmHg
- OR (95%CI) 1.2 (1.0–1.4) 1.0 (0.8–1.3)
Serum Lactate 2.0–3.9 (mmol/l) 4.0–5.9 (mmol/l) 6.0–7.9 (mmol/l)
- OR (95% CI) 1.3 (1.0–1.5) 1.4 (1.1–1.9) 2.0 (1.4–2.8)
Acute Physiology and associated Odds Ratios for RRT during ICU admission
CONCLUSION. Almost one in six septic patients receive RRT. Severity of shock was not
associated with RRT. However, renal (creatinine, urine output) and non-renal factors (lactate,
P:F ratio, age, ethnicity) can be identiﬁed which are associated with the use of RRT. These
admission factors may allow prospective identiﬁcation of patients likely to receive RRT,
which may be relevant from a research and clinical standpoint.
REFERENCE(S). 1. Mehta RL et al. (2007) Acute Kidney Injury Network: report of an
initiative to improve outcomes in acute kidney injury. Crit Care 11:R31.
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CAUSES AND OUTCOME OF ICU ADMISSIONS OF RENAL TRANSPLANT
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INTRODUCTION. Increased long-term graft survival and life-long immunosuppression
expose renal transplant recipients (RTR) to an increased risk of life-threatening complica-
tions. The aim of our study was to analyze the incidence, causes and outcome of RTR-ICU
admissions.
METHODS. Retrospective analysis of all consecutive RTR admitted between January 2004
and December 2007 in a Medical ICU of a University Hospital.
RESULTS. Ninety cases (83 patients, mean aged: 57 ± 14 years, SAPS II: 41 ± 15), at
55 ± 71 months after renal transplantation, were analyzed. From 2004 to 2007, the incidence
of ICU admissions increased from 14% to 54% (p\0.05). A high prevalence of co-mor-
bidities was observed: hypertension (83%), diabetes (37%) and coronary artery disease (27%).
The four main reasons for ICU admission were: acute respiratory failure (42 %), acute
circulatory failure (29%), coma (9%) and acute renal failure (8%). Sepsis was present at
admission in 76% and associated with pulmonary infection in 48 % and with urinary infection
in 28%. The three main causes of acute respiratory failure were: bacterial pneumonia (34%),
pneumocystis pneumonia (32%) and cardiogenic pulmonary oedema (24%). Fifty percent of
the micro-organisms isolated in bacterial pneumonias were resistant to empirical antibio-
therapy. Seventy three percent of the patients suffering from respiratory failure required
mechanical ventilation. Non invasive ventilation (NIV) was used initially in 46% of the
patients (n = 13). In 7/13 patients NIV failed and patients required intubation. Eighty eight
percent of the patients admitted for acute circulatory failure (n = 26) suffered from septic
shock. Pyelonephritis and intra-abdominal sepsis were diagnosed respectively in 43 and 26%.
Acute renal failure was present at admission and/or during ICU stay in 67% of the cases.
Acute renal failure needed renal replacement therapy in 70% of them. Median ICU and
hospital length of stay were respectively 5 [2–48] and 20 [2–208] days. ICU and hospital
mortality was 19 and 24%. Acute respiratory failure was associated with a 34% hospital
mortality rate and pneumocystis pneumonia with a 58% hospital mortality.
CONCLUSION. From 2004 to 2007 an increased incidence of medical ICU admission of
RTR was observed in our institution. Acute respiratory failure was the leading cause of
admission and was associated with a poor prognosis. Due to the high incidence of pneu-
mocystis pneumonia and resistant micro-organisms in pulmonary infections a microbiological
pulmonary analysis was always required. The high incidence of pneumocystis pneumonia
pleads for prophylaxis. The high incidence of NIV failure raises concerns about its use in
RTR presented for respiratory failure.
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INCIDENCE OF CONTRAST-INDUCED NEPHROPATHY IN INTENSIVE CARE
PATIENTS UNDERGOING CONTRAST-ENHANCED CT STUDIES
C. McIntyre*, C. J. Gilhooly
Anaesthesia and Intensive Care, Glasgow Royal Inﬁrmary, Glasgow, United Kingdom
INTRODUCTION. Contrast Induced Nepropathy (CIN) is a potentially avoidable morbidity
in critically ill patients who require Computerised Tomography (CT) scanning. Kidney injury
is a common problem in critically ill patients and carries a signiﬁcant cost burden and
increases length of stay. Our aim was to identify the incidence and consequences of CIN in
our Intensive Care Unit (ICU)over a one year period.
METHODS. All 312 ICU patients admitted between 1/6/06 and 31/5/07 were included for a
retrospective analysis. We identiﬁed those had undergone CT scans and noted if they had
received contrast for the procedure, analysed any change in renal function over 96 h following
CT, and identiﬁed those who met the deﬁnition for CIN, and any patients who subsequently
required dialysis.
RESULTS. Of the 312 admissions 87 (28%)underwent CT. A total of 135 CTs were per-
formed: 79 contrast-enhanced scans,44 plain scans,12 missing data. The incidence of Acute
Kidney Failure requiring dialysis over for all the 312 admissions was 17%.
TABLE 1 CHANGE IN RENAL FUNCTION IN PATIENTS UNDERGOING CT
Contrast
n=79
No Contrast
n=44
25% increase in Creatinine
(no signiﬁcant difference)
11 (14%) 6 (14%)
No 25% increase in Creatinine
(no signiﬁcant difference)
65 (82%) 37 (84%)
Died in interim 3 (4%) 1 (2%)
Required Dialysis in ICU 8 (10%) 1(2%)
Required Dialysis post ICU 2(3%) 0
Chi-squared = 0.014 with 1 deg. freedom. 2 tailed p=0.9053
CONCLUSION. We identiﬁed an incidence of CIN of 14%, however there is no difference
between the incidence of deterioration in renal function to the accepted criteria of CIN in
patients undergoing CT in our unit whether they received contrast or not. Some of the patients
who develop CIN required ongoing renal support following their ICU admission. We iden-
tiﬁed a group of patients who may beneﬁt from therapeutic manoevers to prevent CIN.
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SEVERITY OF ACUTE KIDNEY INJURY AND OUTCOME IN SEPSIS
S. Harris*
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INTRODUCTION. Acute Renal Failure in Intensive Care Unit (ICU) patients has recently
been classiﬁed by international consensus into stages of Acute Kidney Injury (AKI).
1,2
Hospital mortality among general ICU patients appears to be associated with increasing
severity of AKI.
3 We have examined the relationship between AKI and Hospital Mortality
among patients with sepsis.
METHODS. We analysed data from the Intensive Care National Audit & Research Centre
(ICNARC) Case Mix Programme (Version 3.0). All patients with a diagnosis of sepsis or
severe sepsis but without a history of chronic renal failure were included. Baseline creatinine
was not available and hence was estimated by the Modiﬁcation of Diet in Renal Disease
(MDRD) equation as recommended.
1 Patients were classiﬁed according to their highest
creatinine within 24 h of ICU admission into Stage 1/‘‘Risk’’, Stage 2/‘‘Injury’’, Stage 3/
‘‘Failure’’.
RESULTS. 6695 patients with sepsis were identiﬁed from 34 111 admissions in the ICNARC
V3.0 database of which 3354 (50.1%) met the criteria for AKI and 1596 (47.6%) of these died
within hospital. Hospital mortality by AKI Stage is presented in Table 1 (below). Acute
Kidney Injury was associated with age (Odds Ratio (OR) 1.41 (95% CI 1.37–1.46) per
10 year increase), male sex (OR 1.16 (1.04–1.29)), APACHE II score (OR 1.07 (1.06–1.08)
per point), and ICNARC Physiology score (OR 1.06 (1.05–1.07) per point). Cardiovascular
(OR 2.1 (1.9–2.4)), Haematological (OR (2.6 (2.2–3.0) but not Respiratory (OR 1.1 (1.0–1.3))
Organ Dysfunction were associated with AKI.
TABLE 1
No AKI Stage 1/Risk Stage 2/Injury Stage 3/Failure
Number (%) 3341(49.9) 1337 (20.0) 958 (14.3) 1059 (15.8)
Male Sex (%) 1739 (52.1) 780 (58.3) 514 (53.7) 562 (53.1)
Age 58.0 (18.8) 66.6 (15.5) 68.7 (14.1) 67.4 (14.0)
APACHE II 16.7 (6.1) 20.1 (6.7) 23.4 (6.8) 25.4 (7.2)
ICNARC Score 17.8 (8.0) 24.4 (9.1) 29.4 (9.7) 30.1 (9.3)
Hospital
Mortality %,
(95% CI)
28.5 (26.9–30.1) 44.0 (41.3–46.8) 58.2 (55.0–61.4) 53.4 (50.3–56.5)
Data presented as Mean (Standard Deviation) unless otherwise speciﬁed
CONCLUSION. Hospital mortality in sepsis is markedly increased among patients with
AKI. Previous studies have demonstrated increased mortality by AKI stage in unselected
(septic and non-septic) populations using either admission or ‘worst’ creatinine.
3 However,
mortality does not increase progressively with AKI stage when classiﬁed using admission
creatinine in this septic population.
REFERENCE(S). 1. R. Bellomo et al., Critical care (London, England). 8, R204–12 (August
2004).
2. R. L. Mehta et al., Critical care (London, England). 11, R31 (2007).
3. R. Bellomo, J. A. Kellum, C. Ronco, Intensive care medicine. 33, 409–13 (March 2007).
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INTRODUCTION. Acute Kidney Injury (AKI) is an independent predictor of mortality in
the critically ill (1). We conducted this prospective study to look at the incidence of and
outcomes from AKI in our multidisciplinary intensive care unit.
METHODS. We prospectively studied all patients with acute renal failure admitted to our
unit during a 4 month period between August and November 2007. Patients were classiﬁed
according to the RIFLE criteria (2). The APACHE II score was used to assess baseline
severity of illness. Other data collected included ventilation days, ICU days, days on renal
replacement therapy (RRT) and ICU survival.
RESULTS. There were 75 patients who had AKI by the RIFLE criteria out of 502 admissions
during the study period (14.9%). Fourteen patients were at ‘‘Risk’’, 23 had ‘‘Injury’’ and 38
were in ‘‘Failure’’ by the RIFLE classiﬁcation of AKI. Twenty one patients underwent RRT.
Sixteen patientsunderwent SlowLowEfﬁciency Daily Dialysis(SLEDD)for 6 to 8 h at a time,
4 patients underwent conventional haemodialysis for 4 h at a time and one patient underwent
continuous veno-venous haemodiaﬁltration. Fifty two (69.3%) patients survived. Out of the 21
patients who underwent RRT, there were 15 (71.4%) survivors. Mean duration of RRT was
7.9 ± 5.4 days. Mean APACHE II score of all patients was 20.3 ± 8.9. Eighteen patients
(24%) required mechanical ventilation; the mean duration of mechanical ventilation in these
patients was 6.7 ± 5.9 days. On multiple logistic regression analysis, increasing APACHE II
score was related to increased mortality (oddsratio: 1.16,95% conﬁdence interval: 1.07 to 1.27
p\0.0005). Increased severity of AKI by the RIFLE criteria was not associated with
increased mortality (odds ratio: 0.86, 95% conﬁdence interval: 0.42–1.76, p = 0.68).
CONCLUSION. AKI was common in our multidisciplinary intensive care unit, and carried a
signiﬁcant mortality. SLEDD was the most commonly employed modality of RRT. Increasing
APACHE II score was related to increased mortality. However, worsening kidney injury by
the RIFLE criteria did not predict increased mortality.
REFERENCE(S). 1. Levy EM, Viscoli CM, Horwitz RI: The effect of acute renal failure on
mortality. A cohort analysis. JAMA 1996; 275:1489–1494.
2. Bellomo R, Ronco C, Kellum JA, et al: ADQI workgroup. Acute renal failure—Deﬁnition,
outcome measures, animal models, ﬂuid therapy and information technology needs: The
Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI)
Group. Crit Care 2004; 8:R204–R212.
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INTRODUCTION. Acute kidney injury (AKI) is a recognized complication of cardiac
surgery. For this group the mortality range is 10–83% depending on the different series, using
different criteria for diagnosis and classiﬁcation of AKI. Mortality exceeds 50% when AKI is
associated MODS or dialysis. The Acute Dialysis Quality Initiative (ADQI) proposed con-
sensus-based classiﬁcation criteria for AKI based of incremental changes in maximum serum
creatinine or hourly urine output. The AKI classiﬁcation is deﬁned by the RIFLE acronym:
Risk, Injury, Failure (severity stages), Loss and End-stage Kidney disease (prognostic stages).
This study analyzed the incidence of AKI in a cohort of patients following cardiac surgery,
the RIFLE categories, the association with mortality, length of stay and DRG-based costs.
METHODS. We have carried out a retrospective cohort study of 1552 patients undergoing
cardiac surgery with cardiopulmonary bypass, admitted to our ICU in the period from 2000 to
2006. We analysed the incidence of AKI, in base of RIFLE classiﬁcation, lenght of stay,
mortality and associated costs. Patients with preoperative dialysis, cardiac surgery without
cardiopulmonary bypass and the RIFLE categories loss and end-stage renal disease were
excluded. The difference between the highest creatinine in ICU and baseline creatinine
deﬁned AKI ICU. We use score APACHE II to determine the severity. Cuantitative variables
were studied with T Student, cualitative variables with Chi-square test and logistic regression
for statistical signiﬁcants results. Costs were calculated using DRGs.
RESULTS. We analyzed 1552 patients ﬁnding AKI at 20.1% of them (11.5% risk, 34.5%
injury and 4.1% failure). The APACHE II score was higher in the patients with AKI. We are
observed mortality of 10%, (3,8% in ICU and 6,2% hospital mortality). The mortality
increased correlated with the severity of AKI determined by RIFLE stages just as the length of
stay (LOS). Kaplan-Meier survival curves according to RIFLE classiﬁcation were done.
TABLE 1 APACHE II, ICU/HOSPITAL LOS AND ICU/HOSPITAL MORTALITY
ACCORDING TO AKI STAGE.
N APACHE
II
ICU
LOS
(days)
HOSPITAL
LOS (days)
ICU
MORTALITY
HOSPITAL
MORTALITY
NO AKI 1263 (79,9%) 10 (8–13) 1,67 26,60 15/1243 (1,2%) 34/1229 (2,8%)
AKI RISK 181 (11,5%) 15 (12–18) 3,51 34,31 10/171 (14.1%) 17/164 (10,4%)
AKI INJURY 72 (4,6%) 15 (12–18) 7,08 37,74 16/56 (28,6%) 21/51 (41,2%)
AKI FAILURE 64 (4,1%) 15 (12–18) 12,17 38,86 19/45 (42,2%) 24/40 (60%)
CONCLUSION. RIFLE classiﬁcation identiﬁes correctly AKI syndrome, including slight
and moderate forms. This study showed a strong association of this three stages of AKI with
mortality, length of stay and costs, that increases with the severity of RIFLE stage.
REFERENCE(S). 1. Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J.
Independent association between acute renal failure and mortality following cardiac surgery.
Am J Med 1998; 104: 343–8.
2. Kuitunen A, Vento A, Suojaranta-Ylinen R, Pettila V. Acute renal failure after cardiac
surgery: evaluation of the RIFLE classiﬁcation. Ann Thorac Surg 2006; 81: 542–6.
3. Dasta FD, Kane-Gill SL, Durtschi AJ, Pathak DS, Kellum JA. Costs and outcomes of acute
kidney injury (AKI) following cardiac surgery. Nephrol Dial Transplant 2008; 0: 1–5.
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PROGNOSIS OF PATIENTS WITH SEVERE ACUTE KIDNEY INJURY IN ICU
DEPENDS ON THE NUMBER AND TYPES OF ASSOCIATED ORGAN FAILURE
M. Ostermann*
1, R. W. Chang
2
1Departments of Critical Care and Nephrology, Guy’s and St Thomas’ Foundation Hospital,
2Department of Nephrology and Transplantation, St George’s Hospital, London, UK
INTRODUCTION. The outcome of patients with acute kidney injury (AKI) depends on
several factors, including associated organ failure. The aim of our study was to evaluate
whether the speciﬁc types of failed organ systems also affected prognosis.
METHODS. Retrospective analysis of The Riyadh Intensive Care Program database which
contains demographic and daily physiologic and treatment data of 41,972 adult patients
admitted to 22 ICUs in United Kingdom and Germany between 1989–1999. AKI was deﬁned
according to the AKI classiﬁcation as proposed by the AKI network which distinguishes
between 3 different grades of AKI.
RESULTS. 39.5% of patients had AKI (AKI I 19.3%, AKI II 6.7%, AKI III 13.5%).
Associated organ failure (OF) was more common in patients with more severe AKI (Table 1).
ICU mortality was higher in patients with more associated organ failure (Table 2).
Associated respiratory failure, alone or in combination, was the most common associated
organ failure in patients with AKI (incidence 65%, ICU mortality 39.5%), followed by
cardiovascular failure (incidence 43.2%, ICU mortality 48.6%). Associated liver failure
occurred in only 4.3% patients with AKI but the associated ICU mortality was 73%. Asso-
ciated neurological failure occurred in 13.6% of patients with an ICU mortality of 60.9%.
TABLE 1
Incidence of maximum
associated OF
No AKI AKI I AKI II AKI III
No OF 42.6% 19.7% 9.1% 7.5%
1 OF 39.7% 41.7% 38.7% 24.1%
2 OF 14.4% 28.7% 37.2% 37.3%
3 OF 2.7% 8.2% 11.7% 20.6%
[3 OF 0.5% 1.7% 3.2% 10.5%
TABLE 2
ICU mortality No AKI AKI I AKI II AKI III
No OF 1.7% 3.4% 2.9% 7.6%
1 OF 7.6% 11.6% 12.3% 27.1%
2 OF 26.5% 34.2% 31.3% 50.9%
3 OF 49.3% 53.7% 50.3% 67.3%
[3 OF 75% 71.6% 72.9% 86.1%
CONCLUSION. The number and speciﬁc types of organ failures are major modiﬁers of
prognosis of patients with all the three degrees of AKI.
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ACUTE KIDNEY INJURY IN CRITICALLY ILL PATIENTS REDUCES THE
HEPATIC METABOLISM OF DRUGS VIA THE CYTOCHROME P450 3A
ENZYMES: A PILOT STUDY
C. J. Kirwan*
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2, I. MacPhee
3, B. Philips
1
1General Intensive Care,
2Analytical Unit,
3Renal Medicine, St George’s University of
London, London, United Kingdom
INTRODUCTION. The cytochrome P450 3A enzyme system (CYP3A) plays a signiﬁcant
role in drug metabolism. Studies suggest that chronic renal failure impairs hepatic CYP3A
drug metabolism, an effect not reversed by haemodialysis. Midazolam may be used as an in-
vivo probe of CYP3A activity. The impact of acute kidney injury (AKI) on hepatic drug
metabolism is untested. This pilot study demonstrates an effect of AKI on midazolam
metabolism in critically ill patients.
METHODS. Patients admitted to the adult intensive care unit were excluded if they had
received a benzodiazepine in the previous 24 h, were diagnosed with acute or chronic hepatic
failure, were pregnant or were receiving major CYP3A inhibitors. 1 mg midazolam (i.v.) was
given time 0 and serum collected at 4 h. Serum midazolam concentration was determined by
mass spectrometry (HPLC/MS/MS). AKI was deﬁned by an acute change in the eGFR prior
to entry into the study. The estimated glomerular ﬁltration rate (eGFR) was determined using
the modiﬁed diet in renal disease (MDRD) equation.
RESULTS. 16 patients (10 male). Age 75(53–87). Median APACHE 18. Patients were
separated into two groups; normal renal function, (8 pts) or those with AKI. Median (IQR) 4
hr midazolam concentrations were 2.86 (1.5–3.5) ng/ml and 3.97 (3.18–5.07) ng/ml respec-
tively and differed signiﬁcantly (t-test) p = 0.028.
CONCLUSION. This pilot study suggests that in the critically ill patient, AKI causes a
reduction in the metabolism of midazolam by the CYP3A enzymes. A bigger, more com-
prehensive study needs to take place to conﬁrm these ﬁndings and also investigate the relative
importance of AKI on CYP3A activity in critically ill patients.
0980
ICU: HOW TO EVALUATE THE RENAL FUNCTION IN THE CRITICAL SEPTIC
PATIENT?
J. P. Baptista*
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2Nephrology, Coimbra University Hospital, Coimbra, Portugal
INTRODUCTION. An estimate of Glomerular Filtration Rate (GFR) has not been validated
in critical patient, and a ‘‘gold standard’’ method is not always available in the ICU. The aim
of this study was to compare between 5 evaluation parameters of renal function in critical
septic patients: Creatinine (Cr), Blood Urea Nitrogen (BUN), Cockroft-Gault (CG), 4-variable
(MDRD) and 6-variable (MDRD2) ‘‘Modiﬁcation of Diet in Renal Disease’’ formula.
METHODS. This study was carried out on 72 critical septic patients (P), 40% with septic
shock (28P), 54 men (75%), average age 51 ± 21 yrs, average APACHE II and SAPS II of
16.3 and 59.6 respectively. Reference methods (RM) for comparison: 1 - Cr Clearance
(CLcr); 2 - Average between CLcr and BUN clearance (CLcr_bun). Acute Renal Failure
(ARF) deﬁned as GFR\60 ml/m/1.73m2. P with serum (s) Cr above 2 mg/dl on hospital
admission were excluded.
RESULTS. Average GFR: 116.7, 107.1, 100.2, 90.1 and 80.6 ml/m/1.73m2 respectively to
CLcr, CG, MDRD, MDRD2 and CLcr_bun. The sensibility to ARF diagnosis was 11, 33, 22
and 35% respectively to Cr(s), CG, MDRD, MDRD2, with RM 1 (CLcr); and 30, 40, 50 and
50% respectively with RM2 (CLcr_bun). Cr(s) speciﬁcity was 100%. The Cr and BUN
amount in the 24-h urine in P with/without ARF was 67.5/161.7 g and 571.9/1468.5 g for
CLcr (p\0.05); 90.6/185.9 g and 955/1625.9 g for CLcr_bun (p\0.05). Correlation (r)
between BUNs, CG, MDRD, MDRD2 and CLcr was 0.42/0.45/0.32/0.38 and between those
and CLcr_bun was 0.47/0.49/0.40/0.46. Correlation did not exist when GFR was above 90 ml/
m/1.73 m2. To the 3 GFR estimate methods (CG, MDRD, MDRD2) Bland-Altman analysis
showed a precision (standard deviation) of 53/57/55 ml/m/1.73m2 related to CLcr, and 40/42/
47 ml/m/1.73m2 related to CLcr_bun; The mean difference (bias) ranged from -10 to -
27 ml/m/1.73 m2 (CLcr) and from 9 to 26 ml/m/1.73 m2 (CLcr_bun); the Area Under the
Curve to Crs, BUNs, CG, MDRD MDRD2 was 0.65/0.71/0.76/0.76/0.80 (CLcr) and 0.63/
0.72/0.77/0.76/0.81 (CLcr_bun), respectively.
CONCLUSION. MDRD2 showed the best sensibility to ARF diagnosis (35–50%). The 3
GFR estimate methods (CG, MDRD, and MDRD2) are moderately correlated to 2 reference
methods, namely the pairs CG/CLcr_bun and MDRD2/CLcr_bun. Bias, precision and
agreement limits are far from ideal, but the performance seemed better with MDRD2 and
CLcr_bun. Generally MDRD2 formula appears to be the best GFR estimate for critical
septic P.
Poster Sessions
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PRE-TREATMENT WITH TRANS-NASAL COOLING FOR THE INDUCTION OF
THERAPEUTIC HYPOTHERMIA IN PATIENTS WITH CARDIAC ARREST
LEADS TO A SIGNIFICANT FASTER ACHIEVEMENT OF TARGET TEMPERA-
TURE DURING SYSTEMIC COOLING
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INTRODUCTION. In industrialized countries out-of-hospital sudden cardiac death (SCD) is
a frequent cause of death and occurs in 375,000–500,000 citizens per year in Europe. Survival
rates remain low, despite increasing efforts in intensive care. Clinical and experimental
investigations have demonstrated improved neurological outcome following the treatment
with therapeutic mild hypothermia after successful resuscitation. Following the publication of
controlled studies, therapeutic hypothermia moved into the topical international guidelines.
Time course, duration to achieve target temperature and control of temperature are important
factors that inﬂuence patient’s outcome. Recent investigations in animal models showed
improved neurological short-term outcome after an accelerated cooling time. In the pre-
hospital setting, immediate cooling is difﬁcult to realize. For immediate induction of thera-
peutic hypothermia we tested a new trans-nasal cooling device after cardiac arrest and
compared this new method with our standard cooling procedures.
METHODS. A total of 66 patients were examined after successful resuscitation. In 15
patients a new trans-nasal cooling device to induce therapeutic hypothermia was used. Ret-
rospective data of 51 patients served as historic control group. After admission in the cath lab
of the university hospital of Freiburg, initial temperature, course of temperature reduction and
duration of cooling to achieve target temperature were documented. After admission to the
ICU, both groups were immediately connected to an endovascular cooling device and were
cooled to a target temperature of 33 C (bladder or rectal temperature).
RESULTS. The average temperature at admission did not differ in the historic control group
compared to the trans-nasal cooling group (35.7 ± 0.8 C vs. 35.4 ± 1 C, p = n.s.). In the
control group 41 patients (80%) were cooled in a combined method with an initial 4 C cold
saline infusion followed by endovascular cooling. In 10 patients (20%) only endovascular
cooling was performed. In patients ﬁrst treated with cold saline be, target temperature could
be reached signiﬁcantly faster (-38%) than with endovascular cooling alone (125 ± 85 vs.
203 ± 84 min; p = 0.03). Pre-treatment with the trans-nasal device showed a cosimilar
decrease of systemic temperature after the start of endovascular cooling (-32%) compared to
the combined method (138 ± 96 vs. 125 ± 85 min; p = n.s.). In the group treated with trans-
nasal cooling, target temperature in the brain, measured via tympanic temperature, was
reached in 74 ± 44 min without any documented severe device-related adverse events.
CONCLUSION. Pre-treatment with trans-nasal cooling or cold saline infusion for the
induction of therapeutic hypothermia in patients with cardiac arrest leads to a signiﬁcantly
faster achievement of target temperature during systemic cooling. The combined methods are
feasible and offer the possibility for immediate introduction and realization of mild hypo-
thermia in the ﬁeld. Pre-hospital cooling could be beneﬁcial for these critical ill patients, but
deﬁnitive studies have not yet been completed.
GRANT ACKNOWLEDGEMENT. Industry sponsored trail.
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A COMPARISON OF FENOLDOPAM VS. SODIUM NITROPRUSSIDE FOR BLOOD
PRESSURE CONTROL DURING SURGICAL EXCISION OF THE
PHEOCHROMOCYTOMA
L. Aucella, G. Di Palma, L. Vivona, G. Ruggiero*, M. Di Fraia, G. De Simone, G. Vivona
1Dipartimento di anestesia e rianimazione e terapia intensiva, Universit, Napoli, Italy
INTRODUCTION. We compared the antihypertensive efﬁcacy of Fenoldopam vs. Sodium
Nitroprusside on opposing excessive release of catecholamines during surgical manipulation
of the adrenal mass.
METHODS. We enrolled 18 patients (10 F and 8 M), mean age 64 ± 10 years, ASA II/III,
undergoing unilateral adrenalectomy by laparoscopic. The patients were divided in a random
into two groups : SNP GROUP (n = 9) and FNP GROUP (n = 9). SNP GROUP has raised
intraoperative blood pressure and received a Sodium Nitroprusside infusion at 3 mcg/kg/min
in increments of 0,15 mcg/kg/min as needed. The intraoperative rise of blood pressure in FNP
GROUP was controlled by intravenous infusion of Fenoldopam at 0,2 mcg/kg/min. The
Fenoldopam dose was rapidly increased to 0,4 mcg/kg/min and was stopped just before tumor
excision. Monitoring consisted of a radial artery cannula for blood pressure control just before
general anesthesia, at induction, at intubation, during tumor manipulation, after infusion of
one of two therapeutic options and at the end of surgery. Side effects and perioperative urine
output were evaluated. Renal blood ﬂow, creatinine clearance and sodium excretion were
measured postoperatively.
RESULTS. In both groups we observed maximum increase of MAP during surgical
manipulation (+25% of baseline) . Reducing MAP after drug infusion was more fast in SNP
GROUP. The SNP GROUP has shown metabolic acidosis and abnormal ventilation related
thiocyanide toxicity . The FNP GROUP resulted devoid of side effects . Also diuresis was
higher in FNP GROUP than SNP GROUP (100 ml/h vs. 80 ml/h in SNP GROUP). In the
postoperative period renal blood ﬂow and creatinine clearance were lower in SNP GROUP
and were higher in FNP GROUP. The FNP GROUP has shown an increase in natriuresis.
CONCLUSION. The two antihypertensive agents are equivalent in controlling and main-
taining intraoperative blood pressure. Sodium Nitroprusside is somewhat quicker, but
Fenoldopam is much easier to titrate, has limited side effects (and no thiocyanide toxicity) and
offers a very favourable renal protection in patients undergoing surgical excision of the
pheochromocytoma.
GRANT ACKNOWLEDGEMENT. Universita ` degli Studi di Napoli ‘‘Federico II’’.
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OUTCOME OF POST-RESUSCITATION CARDIOGENIC SHOCK PATIENTS IS
NOT IMPROVED BY LEVOSIMENDAN THERAPY
P. Soos*, D. Becker, G. Barczi, G. Szabo, E. Zima, G. Fulop, L. Geller, A. Apor, B. Merkely
Heart Center, Semmelweis University, Budapest, Hungary
INTRODUCTION. Calcium sensitizer levosimendan enhances myocardial contractility
which could be advantageous in patients with myocardial ischemia requiring inotropic sup-
port. During three years 3852 patients with high risk acute coronary syndrome (ACS)
underwent percutaneous coronary intervention (PCI) in our department. In 106 cases ACS
was complicated with cardiogenic shock (mean age: 68.6 ± 1.2), moreover in 26 cases
patients had to be resuscitated (CPR). Short and long term effects of levosimendan on cardiac
functions and on survival of cardiogenic shock and post CPR patients were analyzed.
METHODS. Levosimendan was administrated in 39 of 106 cases as add-on therapy for
patients with impaired left ventricular function, by extensive wall motion abnormality and by
high blood cardiac enzyme concentration. Levosimendan therapy was started in most cases on
the second or third day and applied 6 h long as continuous infusion (0.1 microg/kg/min).
The mean time spent in the primary cardiac care center (in hospital time) was 6.0 ± 0.4 days,
and the whole follow-up was 204.6 ± 29.9 days long.
RESULTS. In the post CPR patient group there was no signiﬁcant difference in survival
according to levosimendan treatment during short term (36.5% vs. 40.0%, p = 0.790) and
during long term follow-up (15.6% vs. 15.0%, p = 0.754). On the other hand, by not
resuscitated patients survival rates were signiﬁcantly higher in the levosimendan treated
patient group during short term (84.4% vs. 57.9%, p\0.001) and during long term (47.3%
vs. 23.0%, p\0.001) follow-up.
Time interval between the onset of myocardial infarction and PCI did not inﬂuence the effect
of levosimendan on short and long term mortality.
CONCLUSION. In summary, levosimendan may improve cardiac function and decrease
short term and even long term mortality in cardiogenic shock patients independently of time
interval of myocardial infarction. This positive effect of levosimendan may be abolished by
post CPR patients.
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PLATELET ADP RECEPTOR BLOCKING EFFECT OF HIGH DOSE CLOPIDO-
GREL IN PATIENTS WITH ACUTE CORONARY SYNDROME
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INTRODUCTION. A large degree of evidence suggests that a 300 mg loading dose of
Clopidogrel may not be sufﬁcient to inhibit platelet reactivity leading to a signiﬁcant pro-
portion of morbidity and mortality in patients with acute coronary syndrome. The aim of our
study is to determine the effect of high dose clopidogrel(900 mg) on platelets ADP receptors
compared to the conventional 300 mg dose.
METHODS. Thirty patients admitted with acute coronary syndrome were included in this
study. Fifteen patients received 300 mg and 15 received 900 mg after admission. Routine
clinical and laboratory evaluation was done. The degree of inhibition of ADP receptors was
mwasured by platelet aggregometry after giving the loading dose by 12h, 24 h, 48 h, 3 days,
5 days and one week.
RESULTS. The 900 mg loading dose caused a greater inhibition of platelets ADP receptors
at all time intervals as compared to the 300 mg dose (P\0.005). It was associated as well
with a lower incidence of cardiac complications and a better 30 day outcome than the 300 mg
dose (P\0.005). Patients who received the high loading dose showed a higher percent of
ECG normalization compared with the lower dose group (76.6% vs. 33.3%) (P\0.005).The
high dose clopidogrel was associated with higher incidence of bleeding events; however they
were minor and had no effect on the mortality and morbidity (P\0.005).
CONCLUSION. The high loading dose of 900 mg clopidogrel causes a more signiﬁcant
inhibition of platelet aggregation than the conventional 300 mg dose. It is associated as well
with lower cardiac complications and a better 30 day motality and morbidity in patients with
acute coronary syndrome.
0985
FIBRINOLITIC THERAPY IN PULMONARY EMBOLISM. CLINICAL EXPERI-
ENCE IN A GENERAL INTENSIVE CARE UNIT
J. Lo ´pez*, M. Huguet, E. Santafosta, X. Pe ´rez, J. Sabater, X. Labad, J. Bruna, T. Casanovas,
R. Albertos, E. Jubert
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INTRODUCTION. Pulmonary embolism (PE) is the most serious complication of deep
venous thrombosis (DVT) and presents a broad clinical spectrum which difﬁcults diagnosis.
In the last decade the aplication of new diagnostic tools, like computed tomography (CT), and
the use of new therapies such as thrombolytic therapy (TT), have both changed the clinical
management. The objective of our study was to analyse factors related with the severity of PE
and identify those patients with PE who would beneﬁt from TT.
METHODS. In a prospective and observational study from 2000 to 2008, we studied 78
patients (n = 78) with PE who were admitted in our general intensive care unit(ICU)(third
level universitary hospital). Mean age was 55,6 ± 17 years; 44 were men; APACHEII
15 ± 2. Only 13% were surgery patients and 8% were trauma patients. At admission they had
presented: 95% dispnea, 47% chest pain, 42% deep venous thrombosis signs and 34% syn-
cope. 54% presented shock. Mean heart rate 108 ± 25 bpm, mean PaO2/FiO2 215 ± 9, mean
pCO2 29 ± 15 mmHg, mean lactate 3,76 ± 3,3 mmol/L; D-dimer test[1000 ug/L in 71%,
positive troponin I ([0,2 ug/L) 51%. EKG and torax X-ray showed classical PE signs in 60%
and 30% respectively. Ecocardiography was practiced in 53% of patients with evidence of
right ventricle failure in 70% of patients. CT was practiced in 70% of our patients (59% were
reported as massive). Anticoagulation was initiated in 97% of our patients. 61,8% were on
standard heparin and 38,2% were on low molecular heparin. TT was practiced on 43%.
Sistemic TT 60% and 40% local TT. 42% required mecanical ventilation, 61% were on
inotropic-vasopressor drugs. DVT was diagnosed in 52% and 16% of our patients required
venous cava ﬁlter.
RESULTS. 28 day mortality rate was 27%. The most common complication was bleeding
(17 episodies: 6 digestive, 4 lung, 2 brain, 1 hemorragic shock, and 4 others) but not stat-
iscally signiﬁcant relationship was found between bleeding and TT. Statistical analysis
showed that the mortality predictor factors were metabolic acidosis pH\7,31 (p\0,04),
leucocitosis[15000x10.9/L (p\0,023), renal dysfunction with creatinine[160 umol/L
(p\0,037), and hypotension with mean arterial pressure\65 mmHg (p\0,02). TT
improved outcome in massive PE (PE with hemodynamic inestability) but statiscal signiﬁ-
cance in mortality rate with TT (p\0,029) was only found in patients with both clinical
massive PE and massive radiologic PE conﬁrmed by CT.
CONCLUSION. Patients with both massive clinical PE and massive radiologic PE (con-
ﬁrmed by CT) beneﬁt from TT with statiscally signiﬁcant higher survival rate. CT could play
an important role on TT indication but further studies are needed to conﬁrm our ﬁndings.
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PROGNISTIC ROLE OF PREOPERATIVE ECHOCARDIOGRAPHY IN PATIENTS
WITH ISCHEMIC OR NON-ISCHEMIC DILATED CARDIOMYOPATHY UNDER-
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INTRODUCTION. Today mitral valve surgery (MVS) is considered a valid alternative
surgical treatment for patients with ischemic or non-ischemic dilated cardiomyopathy because
of shortage of donors which strongly limited heart transplantation. In this particular ﬁeld,
preoperative echocardiography plays an important role both in the scheduling of candidate
and in the prognosis assessment. Our study was aimed to better depict this role.
METHODS. From January 1990 to October 2004, 195 patients were submitted to MVS by a
single surgeon (AMC); 130 out of them were ischemic and 65 were non-ischemic. Average
NYHA class at the admission was 3.3 ± 0.6. Left ventricle ejection fraction (EF), end-
diastolic (EDV) and end-systolic volume (ESV), MR grade were 29 ± 5%, 135 ± 42 ml/m2,
88 ± 34 ml/m2 and 3.3 ± 0.7, respectively. Right ventricular function was assessed by
means of tricuspid annular plane systolic excursion (TAPSE): 15.2 ± 5.1 mm. The outcome
was deﬁned as 5-year survival (1st month included). The follow up ended on February 2007
and was 100% completed.
RESULTS. MV repair was achieved in 154 (79%) cases whereas MV replacement in 41
(21%). Early Median follow up of survivors was 51 months (29–216). Forty-eight patients
died during the follow up with a median follow up of 7.5 months; 12 out of them within the
ﬁrst postoperative period Five-year actuarial survival was 77.5 ± 4.5%. Cox analysis is
reported in the table.
TABLE 1
Cox analysis Survival
HR - p
EF (%) 0.9–0.001
LVEDV (ml/m2) 1.1–0.035
LVESV (ml/m2) 1.1–0.026
TAPSE (mm) 0.7–0.001
EF = ejection fraction, LVEDV = left ventricular end-diastolic volume, LVESV = left ve
CONCLUSION. Both left and right ventricular function as well as left ventricular volume
should accurately evaluated in preoperative assessment of patients with dilated cardiomy-
opathy undergoing mitral valve surgery. In case of more dilated ventricles with poorer LV
function, the indication to MVS should be carefully evaluated. The right ventricular function
has to be necessarily assessed in all cases.
GRANT ACKNOWLEDGEMENT. SIAARTI.
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A RANDOMISED CONTROLLED TRIAL OF LEVOSIMENDAN VERSUS ENOX-
IMONE IN CARDIOGENIC SHOCK: A PILOT STUDY
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INTRODUCTION. Acute decompensated cardiogenic shock (ADCS) causes substantial mor-
bidityandmortality.Levosimendanisanovelpharmacologicalagentthatexertspositiveinotropic
effects in a calcium dependant manner independent of beta-adrenergic receptors. Despite a large
volume of evidence in ADCS, no work has compared Levosimendan to Enoximone.
1
METHODS. A double blind randomised pilot study was conducted in a mixed surgical/
medical Critical Care Unit. Within 24 h of presenting in ADCS, patients were commenced on
a 24 h infusion of levosimendan or enoximone. 12 patients were recruited, 6 per group.
Cardiovascular parameters were measured at time 0, 30 mins, 1, 4, 6 and 24 h, along with
baseline demographics and survival outcomes.
RESULTS. The groups were well matched for age, sex and illness severity. In each group, 5
patients completed the 24 h infusion, with 1 patient in each group withdrawn due to clinical
deterioration suspected to be due to the trial drug. In both groups, the mean increase of
Cardiac Index at 6 h was 37% (Enoximone) and 38% (Levosimendan).There were no sig-
niﬁcant differences between the groups for other cardiovascular parameters. Similarly, there
were no survival differences (Fig 1).
CONCLUSION. Levosimendan could be considered as an alternative to standard pharma-
cological agents in ADCS. It appears to be as well tolerated as Enoximone.
REFERENCE(S). 1. Russ MA et al. Crit Care Med 2007 35 2732–2739.
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PRIOR HISTORY OF HEART FAILURE IS A STRONGER PROGNOSTIC MARKER
THAN CARDIAC TROPONINS IN AN INTENSIVE CARE UNIT SETTING
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INTRODUCTION. Heart failure (HF) is associated with worse outcomes in intensive cor-
onary care units, as high troponin I (TNI) levels. We sought to analyze the impact of prior HF
and TNI elevation in patients admitted in a medical intensive care unit (ICU).
METHODS. A total of 111 consecutively patients admitted in a single medical ICU were
studied. We excluded all admissions primarily due to decompensated HF. Two groups were
formed: A – with prior HF history; B – no HF history. A 60-day follow-up was conducted and
Kaplan-Meier analysis performed.
RESULTS. GroupApatientsweresigniﬁcantlyolder(71.2 yearsvs.55.2 years,p\0.001)and
had higher Acute Physiologyand Chronic HealthEvaluation(APACHE II) scores (18.0 vs. 15.4,
p = 0.083). There was also more frequently prior history of chronic obstructive lung disease
(odds-ratio(OR)6.4,p = 0.001),stroke(OR3.6,p = 0.041),hypertension(OR4.4,p = 0.001),
diabetes (3.7, p = 0.038) and atrial ﬁbrillation (OR 9.9, p\0.001). Regarding admission labo-
ratoryparameters,groupApatientshadhigherBNP(849.8vs.286.9 ng/mL,p = 0.020),platelet
count(266.1vs.201.8,p = 0.044),glycemia(154.9vs.121.1 mg/dL,p = 0.02),kalemia(4.2vs.
3.8 mmol/l, p = 0.012) and lower PO2 (73.2 vs. 106.5 mmHg, p = 0.0) under mechanical
ventilation.TherewasatrendtowardsadmissionTNIbeingalsohigheronthesepatients(1.90vs.
0.73 ng/mL, p = 0.230), but did not predict in-hospital or post-dischargesurvival.Onadmission
echocardiography, group A patients had larger left atria (48.4 vs. 36.7 mm, p = 0.01) and lower
left ventricular ejectionfraction(34.1 vs. 43.4%,p = 0.01).Nodifferenceswerefoundregarding
in-hospital mortality (25.0% vs. 26.8%, p = 0.845), but after discharge, group A patients had a
signiﬁcantly higher 30-day mortality (33.3% vs. 8.5%, Log-Rank p = 0.040).
CONCLUSION. Although none of our study patients was admitted with a formal diagnosis
of decompensated HF, among critically ill patients, prior HF history (but not TNI elevation)
was a strong determinant of post-discharge mortality. As one-third of these patients died
during the ﬁrst month, special care should be given to this population, especially shortly after
discharge.
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MULTICENTRE RANDOMIZED CONTROL TRIAL OF A COMPUTERIZED
CIRCULATORY GUIDANCE SYSTEM IN POST OPERATIVE CARDIAC SURGI-
CAL PATIENTS: NAV-1 STUDY
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INTRODUCTION. Navigator is an innovative, computerized circulatory guidance system to
aid delivery of targeted CO and MAP. It is based on three fundamental determinants of
circulatory variables which guide therapeutic interventions: volume state, heart performance,
and resistance(ref) . The study’s primary objective was to measure the impact of Navigator on
the attainment and maintenance of physician determined MAP and CO targets.
METHODS. This prospective, open, controlled study was conducted in post cardiac surgery
patients receiving 1:1 nursing care, in seven Australian tertiary ICUs. Following admission to
the ICU, patients were randomized by centralized telephone system to receive either: clinical
guidance using Navigator or standard hemodynamic care. Patients remained connected to
Navigator until CO monitoring was ceased by the medical team. CO was measured contin-
uously (Edwards, Vigilance PAC) in both groups. The Navigator system provided guidance to
staff for patients in the treatment arm in the intervention period but not the control group. The
primary endpoint of the study was a measure of the difference between the targeted values
and the actual values for CO and MAP averaged over the study period – the Average
Standardized Distance (ASD). The lower the ASD, the better the therapeutic control.
RESULTS. 112 patients were randomized. Primary outcome data was available for 105
patients (57 Nav; 48 Control). The mean ASD for the treatment group was 1.73 and the
control group 1.95, an improvement in control in the treatment group of 11.5% (95% CI -
4.5% to +27.5%, p = 0.157). The lowest ASD recorded in the total population was 0.89. The
treatment effect was stronger in the early period of monitoring: ASD for the ﬁrst 15 h was
1.65 in the treatment arm and 1.93 in the control arm, an improvement of 14.3% (p = 0.064)
and was signiﬁcant when adjusted for differences between centers 16.3% (p = 0.049). In the
ﬁrst 15 h, the proportion of time CO and MAP readings were in the target range was 39.5% in
the treatment arm and 32.5% in the control arm (improvement: 21.5%, p = 0.064). SOFA
scores, atrial ﬁbrillation, and serious adverse event rates were not different between the
groups. There were no device failures. There was one death (treatment arm).
CONCLUSION. We have demonstrated in a multi-centre post-operative cardiac patient
group that continuous automatic therapeutic guidance is possible and Navigator-guided
hemodynamic control is the same or better than standard care, with post hoc evidence of
superiority. Navigator-guided hemodynamic control was safe.
REFERENCE(S). Parkin W.G. Volume State Control- A New Approach. Critical Care &
Resus 1999;1:311–321.
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HEMODYNAMIC INSTABILITY ACCOMPANYING PULMONARY ENDARTER-
ECTOMY FOR CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
IS ASSOCIATED WITH HIGHER ARTERIAL CONCENTRATIONS OF INTER-
LEUKIN-6 AND INTERLEUKIN-8
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INTRODUCTION. Pulmonary endarterectomy (PEA) is an effective treatment for chronic
thromboembolic pulmonary hypertension (CTEPH). The perioperative course is frequently
complicated by profound systemic vasodilatation that is sometimes resistant to vasopressor
therapy. The present study tested the hypothesis that systemic inﬂammatory response, as
determined by circulating cytokine levels, may contribute to the difﬁculty of controlling
arterial blood pressure after PEA.
METHODS. The prospective cohort study on 36 patients with CTEPH (22 males and 14
females, mean age being 56.5 ± 11.9 year.). Their mean pulmonary artery pressure was
58 mm Hg. All the tested patients underwent PEA using cardiopulmonary bypass (CPB) and
deep hypothermic circulatory arrest (DHCA). Plasma concentrations of tumor necrosis factor-
\alpha (TNF\alpha), interleukin (IL)-1\beta, IL-6 and IL-8 were measured repeatedly in
arterial blood samples drawn before operation, after sternotomy, after the last DHCA, after
separation from CPB, and 12, 18, 24, 36 and 48 h after the end of surgery. Inﬂammatory
parameters were compared with the vasopressor support and hemodynamic parameters - mean
pulmonary arterial pressure (mPAP), mean pressure in the main pulmonary artery, cardiac
index (CI), ejection fraction, and pulmonary vascular resistance (PVR).
RESULTS. TNF\alpha, IL-1\beta, IL-6 and IL-8 increased after PEA and reached a maxi-
mum within 0–12 h after the end of surgery. After PEA operation, there was a considerable
improvement of hemodynamic parameters including mPAP, CI and PVR. There was a sig-
niﬁcant correlation between norepinephrine support and IL-6 plasma concentrations at the end
of surgery (k = 0.742) and 12 h after the end of surgery (k = 0,801) as well as between
norepinephrine support and IL-8 concentrations 12 h after the end of surgery (k = 0,782).
Patients requiring dobutamine support postoperatively considering the low CI revealed sig-
niﬁcantly higher maximum arterial levels of IL-6 and IL-8.
CONCLUSION. Hemodynamic instability after PEA has been associated with higher post-
operative plasma concentrations of IL-6 and IL-8. Positive correlation between inﬂammatory
cytokines and vasopressor support is in conformity with a thesis that cytokine activation may
be among neurohumoral factors responsible for the systemic vasoplegia in CTEPH patients
after undergoing PEA.
GRANT ACKNOWLEDGEMENT. This study was supported with a grant
MSM0021620819 of the Ministry of Education, Czech Republic.
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INCREMENTAL POWER OF PROCALCITONIN FOR THE EARLY DIAGNOSIS
OF INFECTIVE ENDOCARDITIS
H. Michalopoulou*, P. Stamatis, A. Bakhal, J. Vaitsis, D. Stamatis
Cardiology Department, Metaxa Hospital, Athens, Greece
INTRODUCTION. Infective endocarditis (IE) causes problems in the diagnosis because
of its variable clinical presence. Procalcitonin (PCT) is a new marker of severe infection.
The aim of our study was to evaluate the usefulness of serum PCT to diagnose patients (pts)
with IE.
METHODS. We conducted a prospective study in 38 patients admitted to our hospital with
the suspicion of IE. IE was conﬁrmed in 18 pts based on the Duke criteria. 20pts with
bacteremia (non-IE) and 20 healthy controls were studied PCT levels were measured on the
day of admission.
RESULTS. Procalcitonin was signiﬁcantly higher in pts with IE (7,62 ng/ml) than in those
with other ﬁnal diagnoses (0,62 ng/ml) p\0,001.
The median values of PCT were higher in cases with IE and non-IE related to gram negative
bacteria than those related to gram positive (P\0,04). Using ROC curve the optimum
concentration of PCT for the calculation of positive and negative predictive accuracy was
3 ng/ml. With this cut off, the sensitivity of PCT was 78%.
Its speciﬁcity 92%.
Its negative predictive value 95%
Its positive predictive value 75%
The sensitivity of PCT in comparison to C-Reactive Protein was found to be lower (78% vs.
88%) but its speciﬁcity was determined to be higher (92% vs. 72%.
CONCLUSION. Procalcitonin may be a valuable diagnostic marker for infective endocar-
ditis, in addition to the major criteria for its high speciﬁcity and negative predictive value.
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GUIDELINE FOR HAND HYGIENE: CLEAN HANDS ARE SAFER
E. Bustamante Munguira*, G. Perarnau Manau, M. Martinez Plata, S. Gamez Cantero, M. Ros
Martinez, F. Colomar Ramon, G. Garcia Hernan, E. Escudero Cuadrillero, P. Merino de Cos,
P. Medina Garcia
Intensive care, Hospital Can Misses, Ibiza, Spain
INTRODUCTION. Infections related with sanitary attention in developed countries affect
about 5–10% of hospitalized patients. These infections acquired in hospitals increase the
morbility of the illness itself. When it comes to critical patients, at least 25% acquire one or
more of these infections. There is a substancial evidence that hand-washing reduces the
incidence of health care-associated infections and hygiene is a basic action for ensuring
patient safety, is the best method to prevent the transference of microorganisms between staff
and patients, and also between patients to patients in hospitals. This effectiviness of reducing
the dispersion of microorganisms depends on three fundamental factors: 1. The occasion,2.
The product used,3. The hand-washing tecknique. The main problem of hand hygiene does
not depend on obtaining good products.
METHODS. During 2006, we formed a multidisciplinary team composed of a doctor, a nurse
and an intensive care auxiliary nurse. We reviewed bibliography and CDC recommendations.
After that, we elaborated a guideline for hand hygiene, in which we described different types
of hand-washing, different handrubs, glove use and the presentation of alcohol-based
handrubs to improve hand disinfection.During this period we observed that personnel didn0t
comply with the guidelines. Before training personnel, we did an observational, prospective
and descriptive study during two months at the intensive care unit. We evaluated hand-
washing in all staff in contact with patients. Afterwards we compared it to results after
theoretic and practical training. We ﬁrst trained our intensive care unit and then the other
departaments. The theoretic training consisted of a video recorded by ourselves at the
intensive care unit, which contained concepts about hand hygiene, handrubs and glove use.
After that we divided the class into groups and practiced with them the different types of hand
hygiene and use of alcohol-based handrubs, correct procedures were evaluated by use of an
ultraviolet lamp. All participants received written guidelines and tip sheet, after training, we
installed dispensers for hand hygiene and we continuously remind the staff to wash their
hands in hospital and health centers in our area.
RESULTS. We did a second evaluation in our unit six months after the training. Results
showed a 35% hand hygiene adherence, if there was a big improvement immediately after the
training, it slowly disappeared.Due to this, we have decide to do frequent refreshment
training.
CONCLUSION. If we want to improve, it is necesary frequent refreshment training.
Our situation is similar to other hospitals.
REFERENCE(S). Guideline for handwashing and hospital enviromental control. Center for
diseases control. CDC 2002.
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EICOSANOIDS AS RISK AND PROGNOSTIC FACTORS FOR ACUTE RESPIRA-
TORY DISTRESS SYDROME IN SEPSIS PATIENTS
G. Takahashi*, S. Shibata, N. Sato, Y. Suzuki, S. Endo
Critical Care Medicine, Iwate Medical University, Morioka, Japan
INTRODUCTION. Although a number of studies have reported elevated level of eicosa-
noids in acute lung injury with sepsis, the possibility that eicosanoids may act as risk and
prognostic factors for sepsis patients who develop acute respiratory distress syndrome(ARDS)
remains poorly studied. To clarify this aspect, we measured the levels of eicosanoids and used
logistic regression analyses and receiver operating characteristic(ROC) curves to investigate
whether eicosanoids could act as risk and prognostic factors for sepsis patients who develop
ARDS.
METHODS. We conducted a case–control study comparing 13 sepsis patients with ARDS
and 23 sepsis patients without ARDS. The plasma levels of leukotriene B4 (LTB4), 6-keto-
prostaglandin F1a(6-keto-PGF1a) and thromboxane B2(TXB2) were measured by radioim-
munoassays as substitutes for the plasma levels of PGI2 and TXA2, which are unstable.
RESULTS. The levels of eicosanoids in sepsis patients with ARDS were signiﬁcantly higher
than those in sepsis patients without ARDS. Logistic regression analyses revealed that LTB4
was the only risk factor for sepsis patients with ARDS (odds ratio, 1.10; P = 0.02). The area
under the ROC curve values for all eicosanoids were signiﬁcantly greater than 0.5
(P\0.001), and the likelihood value for the TXB2 levels was higher than those of the other
eicosanoids.
CONCLUSION. We conclude that LTB4 may be an important risk factor for sepsis patients
with ARDS, while TXA2 may be an important prognostic factor for sepsis patients with
ARDS.
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POST BURN ITCH
S. M. Tahir*
Plastic & Burn Surgery, Liaquat University of Medical & Health Sciences, Jamshoro,
Pakistan
INTRODUCTION. Burn injury, whether limited or widespread, frequently leads to long-
lasting physical, aesthetic, functional, psychological, and social consequences. One of these is
the problem of post burn itch. This would have been as old as the burn itself however it was
ﬁrst focused in 1988 when, Gordon wrote ‘‘Burn-related pruritus is a serious problem that
often receives little attention, even though it continues to aggravate burn patients during their
rehabilitation1. At the same time; Bell, et al., added, ‘‘No succinctly deﬁned method of
treatment for post burn itch is found in the literature2. Still we know very little about the exact
mechanism of post burn itch that can be attributed to the complex nature of the injured skin
and the nerves of the skin3-,9, but it must also be emphasized that very little research have so
far been done on this subject.
METHODS. A total of 80 patients were included in the study, and equally divided into 2
groups. Group A received oral antihistamines with topical Ibuprofen while Group B received
olive oil massage followed by wearing of compressive garments. The demographic data and
initial assessment of the severity of itch on linear descriptive scale was made by the research
team; while subsequent data for the entire study period was obtained by the attending burn
clinician who was blind to the allocated regimen. Results were analyzed using computer
statistical software SPSS .
RESULTS. Group A included 40 patients with 23 males and 17 females having mean age of
28.13 (SD ± 13.03) and mean body surface area affected 15.387% (SD ± 5.408) and mean
itch scale of 5.500 (SD ± 2.219). Group B comprised of 40 patients with 21 males & 19
females with a mean age of 29.38 (SD ± 14.35) with mean affected body surface area of
16.150% (SD ± 5.555) and mean itch scale of 5.350 (SD ± 1.762). The main outcome
measure was the improvement in burn itch. The results after 12 weeks of treatment for both
groups showed a remarkable improvement in Group B when compared to Group A (p-value
0.000 and 0.365, respectively).
CONCLUSION. The non-pharmacological measures are superior to the pharmacologic
measure with respect to their clinical efﬁcacy and their improvement shows highly signiﬁcant
after 4 weeks of treatment.
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INFECTIONS IN A SURGICAL INTENSIVE CARE UNIT OF A UNIVERSITY
HOSPITAL IN GREECE
A. Larentzakis*, H. Markogiannakis, K. G. Toutouzas, D. Theodorou, E. Theodoraki,
S. Katsaragakis
Surgical Intensive Care Unit, 1st Department of Propaedeutic Surgery, Hippokrateion Hos-
pital, Athens Medical School, University of Athens, Athens, Greece
INTRODUCTION. Our aim was the evaluation of clinical and microbiological features of
patients developing ICU-acquired infection in our Surgical Intensive Care Unit (SICU) and
the identiﬁcation of predictors of infection acquisition and infection-related mortality.
METHODS. Prospective study of all patients hospitalized in our SICU from 2002 to 2004.
Patients with ICU-acquired infection were compared with those without infection to identify
predisposing factors for infection. Comparison between patients with infection that survived
and those that died was performed to identify predictive factors of mortality. Only variables
occurring before infection were analyzed as possible risk factors for infection while all
variables were used for infection-associated mortality.
RESULTS. Among 683 consecutive patients, 123 (18%) developed 241 infections (48.3
infections/1000 patient-days). Mean age of these patients was 66.7 ± 3.8 years, APACHE II
score on SICU admission 18.2 ± 2.4, and SOFA score on the day of infection 8.8 ± 2
(women: 51.2%). Infections were: bloodstream (36.1%), ventilator associated pneumonia
(VAP: 25.3%; 20.3/1000 ventilator-days), surgical site (18.7%), central venous catheter
(10.4%; 7.1/1000 central venous catheter-days), and urinary tract infection (9.5%; 4.6/1000
urinary catheter-days). Most common organisms were: Acinetobacter baumannii (20.3%),
Pseudomonas aeruginosa (15.7%), Candida albicans (13.2%), Enterococcus faecalis (10.4%),
Klebsiella pneumoniae (9.2%), Enterococcus faecium (7.9%), and Staphylococcus aureus
(6.7%). High resistance to the majority of antibiotics was identiﬁed. Complication and
mortality rate was 58.5% and 39%, respectively. Multivariate analysis identiﬁed APACHE II
(p = 0.01, OR: 4.63, 95% CI: 2.685–5.261), acute peritonitis as the underlying hospital
admission diagnosis (p = 0.03, OR: 1.85, 95% CI: 1.029–3.253), acute pancreatitis
(p = 0.02, OR: 2.27, 95% CI: 1.046–3.753), aminoglycoside use before infection (p = 0.03,
OR: 2.84, 95% CI: 1.061–5.137), and mechanical ventilation (p = 0.01, OR: 3.26, 95% CI:
2.427–6.148) as predictors for infection development. Moreover, age (p = 0.03, OR: 1.16,
95% CI: 1.014–1.328), APACHE II on SICU admission (p = 0.02, OR: 2.53, 95% CI: 1.768–
3.412), SOFA score on infection day (p = 0.02, OR: 2.88, 95% CI: 1.849–4.017), and VAP
(p = 0.03, OR: 1.32, 95% CI: 1.037–1.849) were identiﬁed as predictors of infection-asso-
ciated mortality.
CONCLUSION. Infections are an important problem in SICUs due to high rate, multi-
resistance, morbidity, and mortality. Recognition of clinical and microbiological features of
these patients and identiﬁcation of the risk factors for infection development and infection-
related mortality are essential for prevention and treatment.
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INTRODUCTION. Sepsis, in particular nosocomial sepsis, is an increasingly common cause
of morbidity and mortality, particularly among critically ill patients. The speed and appro-
priateness of therapy administered in the initial h after severe sepsis develops is likely to
inﬂuence the outcome. Several circulating bioactive molecules have been proposed as useful
markers of the presence, severity and clinical course of sepsis. Many studies have shown that
C-Reactive Protein (CRP) is a good marker of infection, however there are some contro-
versies about its use as a prognostic marker in sepsis. The aim of this study was to evaluate
CRP as prognostic marker of sepsis.
METHODS. During a 14 month period, we prospectively included all the patients admitted to
anIntensiveCare Unitwho were C 18 years old and stayedfor at least 48 h (N = 260). Patients
were categorisedfor sepsis according tothe ACCP/SCCM Consensus Conference criteria. Acute
Physiology and Chronic Health Evaluation II (APACHE II), Simpliﬁed Acute Physiology Score
II (SAPS II) and sequential organ failure assessment (SOFA) scores, CRP, white cell count
(WCC) and body temperature were determined. Data of the day of sepsis diagnosis was entered
in the analysis. A subgroup of patients with documented sepsis was analyzed.
RESULTS. One hundred and ﬁfty eight consecutive patients (mean age 59 years, 98 men,
ICU mortality 34 %) were studied. The area under the curves (AUC) of the receiver operating
characteristics curves of APACHE II, SAPS II, SOFA, CRP, WCC and body temperature as
prognostic markers were 0.75 (95% conﬁdence interval (CI): 0.666–0.833), 0.821 (95% CI:
0.748–0.893), 0.8 (95% CI: 0.723–0.876), 0.55 (95% CI: 0.454–0.647), 0.456 (95% CI:
0.352–0.561), 0.482 (95% CI: 0.382–0.583), respectively. The AUC of SAPS II was signif-
icantly higher than the other studied variables (p\0.05) with the exception of SOFA. The
mortality rate of septic patients with CRP\10, 10–20, 20–30, 30–40 and[40 mg/dl was
20%, 34%, 30.8%, 42.3% and 39.1%, respectively (p = 0.703). In the subgroup of patients
with documented sepsis (N = 76) there were also no differences between survivors and
nonsurvivors in what regards CRP levels, WBC, temperature and APACHE II score. Only the
SAPS and SOFA score were signiﬁcantly higher in nonsurvivors.
CONCLUSION. Our results demonstrate that despite CRP being a sensitive marker of sepsis, it
poorly predicts the outcome in terms of survival. The complexity of sepsis requires new perspec-
tives toallow anintegrated understandingof the intricate interactions occurring during the disease
process. Future studies of biomarkers in sepsis involving larger patient population are needed.
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ISOLATION OF ACINETOBACTER SPECIES IN CRITICALLY ILL PATIENTS
S. K. R. Bindroo*, K. A. Dalal, I. P. Raut, M. H. Patel, J. D. Sunavala
Critical Care Medicine, jaslok Hospital and Research Centre, Mumbai, India
INTRODUCTION. Acinetobacter spp are frequently the etiologic agent of nosocomial infections.
An infection caused by this bacterium is more common in patients with severe underlying diseases,
and after multiple courses of antibiotic treatment.
METHODS. A 2-year retrospective observational study conducted in the open ICU of a tertiary care
hospital at Mumbai, India. Patients admitted to the intensive care unit for more than 2 weeks and
developing signs of systemic infection were subjected to tracheal secretion, blood and other relevant
cultures. Patients whose cultures were positive for acinetobacter species were included in the study.
The incidence of isolation at different sites, risk factors and mortality were assessed from the data.
RESULTS. From Feb 2006 to Jan 2008, Acinetobacter spp. was isolated from different sites in 123
critically ill patients. The mean incidence of isolation was 17/1000 admissions.
The incidence of isolation was highest in tracheal secretion (73.98%). 13% of cultures were positive
from the blood while, as 17.07% of cultures were positive from multiple sites. The main risk factors
for isolation of acinetobecter were malignancy (32.5%) and neurological diseases requiring prolonged
ventilation (17.88%). Crude mortality was 40%.
TABLE 1 SITES OF ISOLATION OF ACINETOBACTER SPECIES
Site of isolation No. of patients Percentage
Tracheal Secretion 91 73.98
Blood 16 13
Indwelling Catheters 16 13
Swabs 11 8.94
BAL 03 2.4
CSF 02 1.6
Multiple sites 21 17.07
TABLE 2 RISK FACTORS ASSOCIATED WITH ACINETOBACTER
Risk Factors No. of patients Percentage
Malignancy 40 32.5
Neurological disorders requiring prolonged
mechanical ventilation
22 17.88
End-stage renal disease (ESRD) 10 8.13
GI sepsis/Pancreatitis 10 8.13
Chronic Liver Disease (CLD) 05 4.06
Others 36 29.26
CONCLUSION. Acinteobacter is a common nosocomial cause of infection in critically ill patients
admitted to Intensive Care Unit of our hospital. The main underlying risk factor is immuno-sup-
pression due to various causes as well as prolonged ventilation. If not promptly recognized and
adequately treatment, mortality remains high.
REFERENCE(S). 1. Lortholary O, Fagon J Y, Buu Hoi A et al; Colonization by Acineto-
bacter baumanii in intensive-care-unit patients. Infection control and Hospital epidemiology
1998; 19: 188–190.
2. Webster C, Towner KJ, Humphreys H. Survival of Acinetobacter on three clinically related
inanimate surfaces. Infect Control Hosp Epidemiol 2000; 21:246.
3. Marchaim D, Navon-Venezia S, Schwartz D, et al. Surveillance cultures and duration of
carriage of multidrug-resistant Acinetobacter baumannii. J Clin Microbiol 2007; 45:1551–5.
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PNEUMONIA DOES NOT AFFECT MORTALITY IN PATIENTS WITH TRAU-
MATIC BRAIN INJURY (TBI)
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INTRODUCTION. Pneumonia is an important cause of ITU morbidity and mortality, mainly
after TBI. Recognized patients with TBI and pneumonia makes possible premature inter-
ventions at ITU. Aim: To determine factors that inﬂuence mortality in patients who are
affected by TBI and pneumonia.
METHODS. Wedid a retrospectiveresearch studyandthirtycriticalill patients admittedtothe ITUwith
severeTBIdiagnosis.Investigatedriskfactorsincludedage,APACHEIIscore,SOFAscore,antibioticused,
adequate antimicrobial therapy(deﬁned basedonbacterial susceptibilityfrommicrobiologicinformation),
CPIS[6after72 daysoftreatment,PaO2/FIO2,microorganismsisolatedfromthroatswabsatadmission
(Any aerobicGram-negative bacilliconcentration, E coli,andMRSA.MSSA andC albicans[10(5)cfu/
ml), and microorganisms grew from endotracheal aspirates when pneumonia was suspected on clinical
grounds (new chest X-ray inﬁltrate, together with at less two of the following: fever; leukocytosis and
purulent tracheal secretion). Microbiological conﬁrmation of pneumonia was deﬁned by in endotracheal
aspirates[10(5)cfu/ml.Statisticsanalysisofdata(meanandstandarddeviation,±2)wereperformed,chi2
and independent t test were used. SPSS 10 was used and p\0,05 was statistically signiﬁcant.
RESULTS. Death was the outcome variable that was studied. Of 30 patients, Their average age was
43 ± 17.2 y. APACHE II score 17.6 ± 6.7, SOFA score 8.7 ± 1.9, ITU days stay 10.4 + 7.4, days on
mechanicalventilation8.4 ±6.3,Glasgowscore6.27 ±1.5,PaO2/FIO2268 + 60,initialCPIS5.92 ±
1.9. The overall mortality rate was 40%. S. Viridans were isolated on 30%, Klebsiella P 13.3% and
MSSA13.3%onthegroupofsamplestakenfromthroat.Moreover,S.Viridanswereisolatedon16.6%,
Klebsiella P16.6%and MSSA40%.On samplestakenfromendotracheal aspirates(EA).Patients were
empirically treated with Ceftriaxone-Clindamicin 50%, and without any antibiotic 50%. Statistics
analysisshowedthatAPACHEIIscore,Glasgowscore,andITUstayweresigniﬁcantlydifferentonthe
group of death.
TABLE 1 MORTALITY RISK FACTORS DIFFERENCES BETWEEN GROUPS)
Variable Death/Yes Death/Not p
Antibiotic used (%) 66.7 33.3 0.003
Non Antibiotic used (%) 15.4 84.6 0.016
Adequate antimicrobial therapy (%) 52.6 47.4 0.063
CPIS[6 (%) 25 75 0.38
S Viridans from throat (%) 44.4 55.6 0.74
S Viridans from EA (%) 60 40 0.31
MSSA from EA (%) 41.7 58.3 0.87
SOFA 9 8.5 0.45
APACHE II 21.1 14.9 0.006
Glasgow 5.42 6.83 0.010
CONCLUSION.Thisﬁndingprovidesbetterknowledgeofthepathophysiologyofpneumoniainpatients
under TBI. Lung infections and inadequate treatment with antibiotic were not risk of death. Results
demonstratedasigniﬁcantdominanceofvariablesaffectedbytraumasuchusacutechangesonAPACHE
II, and causes of low Glasgow. Therefore, the effort should be focus on low GCS prevention before ER.
REFERENCE(S). 1. ICM 2005 31(4): 510–6.
2. Curr Opin Crit Care 2005 11(1): 37–42.
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INTRODUCTION. We have recently shown that a proactive bowel management with aid of
the Zassi/Hollister Bowel Management System (BMS) represents an economical and clini-
cally advantageous practice for the fecal management of burn patients unable to effectively
defecate independently or with assistance (1). A question that has been queried often, but not
deﬁnitely answered is whether or not patients with bleeding complications, including platelet
and coagulation abnormalities, could have bleeding diathesis potentially associated with a
proactive BMS on insertion and while it remains in place? We undertook a retrospective sub-
analysis of complicated burn/wound intensive care (ICU) patients who had a proactive BMS
in place. Based on anecdotal evidence from our larger study population and ongoing data
bases, we believed that the incidence would be predictably low (Null Hypothesis).
METHODS. A retrospective analysis of our previous population of patients evaluated with a
proactive BMS, all with complicated burns/wounds, were included in the initial evaluation.
Sixty-nine patients met the criteria to be included in the study. Their records were queried for
coagulation and thrombocytopenia abnormalities at BMS insertion and all subsequent events
while the apparatus was in place, until removal. If gastrointestinal (GI) complications were
documented, they were reviewed extensively for association with the proactive BMS.
RESULTS. Sixty-nine patients, 48 males, 21 females, mean age 50.8 years (range 19–87),
with a mean TBSA of 30.5% (range 0–80) and a mean length of stay of 47.5 days (7–208)
were evaluated. Thrombocytopenia was documented either at insertion or while the BMS was
in place a mean of 10.7d (range 0–46d). Prothrombin (PT), Partial Thromboplastin (PTT) and/
or Fibrinogen was abnormal during insertion or while the BMS was dwelling for a mean of
13.7d (range 0–113). Sixty-three patients (92.7%) at high risk for bleeding problems did not
experience any bleeding or GI complications. Five patients (7.3%) had documented GI
abnormalities; however, only one (1.4%) could be directly related to the BMS. This patient
had a simple rectal ulceration, topically treated, with rapid resolution.
CONCLUSION.TheZassi/Hollisterproactivebowelmanagementsystemhaspreviouslybeen
proven to be cost-effective and provide overall reduction in infectious complications and
breakdownincomplicatedburns.Thecurrentﬁndingsrevealthattheplacementofthisproactive
BMSincomplicatedICUpatientsissafe,eveninthesettingofcontinuedrisksofbleedingdueto
coagulation and/or thrombocytopenia abnormalities. The implications of this data are far-
reaching and would suggest that other patient populations at risk for multi-organ dysfunction
couldsafelyundergo proactiveBMSplacement.Futureresearchshouldinclude theseandother
groupsofpatientsinlarger,multicenterevaluations,inthehopethatwecancontinuetoimprove
the already monumental task of nursing care for burns and other critically ill patients.
REFERENCE(S). 1. Echols, et. al. Clinical and economic implact of introducing a BMS. J
WOCN. 2007; 34: 667–670.
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IMPACT OF LABORATORY ABNORMALITIES ON OUTCOMES OF COMMU-
NITY ACQUIRED BACTEREMIA ADMITTED TO THE ICU
A. Mofredj*, H. Bahloul
Service de re ´animation, Centre hospitalier ge ´ne ´ral, Salon de provence, France
INTRODUCTION. Laboratory abnormalities are frequent, but non-speciﬁc, during sepsis.
Several papers have emphasized on the impact of some biomarkers on the outcomes of
infected patients. The study was designed to investigate the potential role of abnormal lab-
oratory ﬁndings on the prognosis of adult patients admitted to ICU with the diagnosis of
community acquired bacteremia.
METHODS. The study included 49 patients admitted to the ICU during a four-years period.
Retrospective chart review recorded admission’s value of platelets and WBC numbers, pH,
CO2 arterial pressure, bicarbonates, cratinin, ASAT, ALAT, glucose and proteins serum
levels. For each of the criteria studied, the mortality rate was assessed and compared to the
overall mortality.
RESULTS. The overall mortality rate was 34.7% in this study. Thrombocytopenia (\150
000/mm3), increased creatinin ([150 lmol/L) and ASAT ([80 IU/L) serum level, hyp-
oprotidemia (\60 g/L), leucocytosis ([12 000/mm3) and acidemia (pH\7.36) are the
most common abnormalities. These were found in 36, 24, 19, 21, 18 and 18 patients
respectively. However, bicarbonates serum level under 15 mmol/L was found only in 7
patients. ASAT serum level over 120 IU/L was found in eight patients. The mortality rates for
each of these abnormalities were: thrombocytopenia (63.8%), increased creatinin (37.5%),
ALAT (62.5%) and ASAT (52.6%) serum level, hypoprotidemia (47.6%) leucocytosis
(66.7%) and acidemia (44%).
CONCLUSION. Abnormal laboratory ﬁndings are frequent during community acquired
bacteremia. Thrombocytopenia, leucocytosis and elevated ALAT serum levels at admission
were associated with higher mortality rates in adult patients with community acquired bac-
teremia. Acute renal injury did not impact the prognosis of our patients.
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NOSOCOMIAL INFECTION IN PATIENTS WITH EXTERNAL VENTRICULAR
DERIVATION SYSTEM
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INTRODUCTION. To know the ICU’ population that need external ventricular device
(EVD), the incidence of EVD and the infection rate (IR).
METHODS. Prospective study performed through out 3 months per year during 2 consec-
utive years (2006 and 2007) using the methodology and database of the ENVIN-HELICS
study. The characteristics of patients with EVD are analysed. IR are shown per 100 patients
and per 1000 days of ICU’ stay. In addition to the infections usually monitored, there were
several of them speciﬁcally studied: VAP (ventilator associated pneumonia, urine infection
related to urinary catheter (UC), and primary and vascular catheter related bacteremia (PB
+CB).
RESULTS. 424 (1,75%) out of 24.137 evaluated patients had a EVD. Mean age: 55 years.
APACHE II score: 18,1 (7,0). The cause for admission (the primary illness on admission) was
(%): coronary 1,5; medical 60; elective surgery 29,4 and trauma 8,9. Immune system alter-
ations: 10,8%. Extrinsic risk factors: mechanical ventilation (MV) 82,7 %:, central venous
catheter (CVC): 95,9%. UC: 97,1%. Total parenteral nutrition (TPN): 11,2%. Emergency
surgery: 28,6%. Antibiotics prescribed before admission: 25,2%, and into the ICU: 76,1%. IR
related with EVD, mean ICU stay and mortality are shown in table. In addition to the 270
device related infections, another 178 infections were reported related to other focus,
including 68 of the CNS (104 infections x 100 pts). Infections caused sepsis in 53,7%, severe
sepsis in 21,4% and septic shock in 4%. The micro organisms involved were: GP 27,5%, BGN
79,4%, fungi 21,5%. Colonization-infection was reported in 4,7% by MRSA, in 8,5% by
Acinetobacter, in 5,2% by P aeruginosa, and in 3,3% of the patients by BLEE.
TABLE 1
ICU-Acq
Inf % pat
ID
0\/S VAP
%p t
UTI
% pat
PB+CRB
%pat
LOS
days
Mortality
%
ALL 14,2 19,6 6,1 14,1 3,8 7,5 10
EVD 63,1 36 31,3 16,9 12,5 17,6 27,5
CONCLUSION. Patients with EVD were less than 2% of the total admissions in the ICU.
They were younger than the average, with predominance of the medical aetiology. They had
long stay, high instrumentation and high nosocomial IR.
GRANT ACKNOWLEDGEMENT. Aventis.
Poster Sessions
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NEAR-INFRARED SPECTROSCOPY MICROCIRCULATION ASSESSMENT IN
SEPTIC PATIENTS: A PILOT STUDY
K. Planas*, T. Lisboa, M. Magret, A. Rodrı ´guez, D. De Mendoza, E. Dı ´az, J. Rello
Critical Care Department, University Hospital Joan XXIII, Tarragona, Spain
INTRODUCTION. Microcirculatory derangements drive to situations of dysoxia and to
acute organ dysfunction in critical ill patients. The development of new techniques to
determine tissue oxygenation, such as the near-infrared spectroscopy (NIRS) is a non invasive
way to infer the grade of alteration in microcirculation. Our hypothesis is to determine
whether NIRS technique allows to recognize alterations in the muscular tissue saturation of
oxygen (StO2) in the critical care patients. Our objective is to determine the utility of NIRS in
the evaluation of StO2 in critical care settings.
METHODS. Observational, prospective and controlled study conducted in a twenty-two bed,
university hospital Intensive Care Unit (ICU). Reference values were obtained from StO2
measurements by NIRS in healthy volunteers in the forearm zone. These measurements were
compared with those obtained in critical patients. Basal measurements at admission in ICU
and during the ﬁrst 48 h were obtained, as well as conventional hemodynamic indexes.
Mortality was considered as the main outcome. Continuous variables are expressed as
mean ± sd. Student’s t-test was used to compare data. Statistical signiﬁcance was deﬁned as
p\0.05.
RESULTS. Reference values were obtained from 20 healthy volunteers. Nine patients with
sepsis or septic shock were included to the study. Signiﬁcant differences between healthy
volunteers and critical ill patients were observed in forearm StO2 determinations
(68.79 ± 4.27 vs. 51.67 ± 13.30, p\0.001). Almost 70% of the patients included died.
Comparing survivors vs. non-survivors, signiﬁcant differences were observed in StO2 base-
line at admission (65.6 ± 11.3 vs. 44.6 ± 7.4, p = 0.01) and in the following determinations
obtained (12 h 67.3 ± 3.8 vs. 51 ± 8.9, p = 0.02; 24 h 67 ± 3 vs. 52.3 ± 9.3, p = 0.03 and
48 h 64 ± 5.6 vs. 49.8 ± 5.4, p = 0.02). No differences were observed in hemodynamic
data. Pulmonary artery catheter showed no differences except for systemic vascular resistance
index (SVRI) at 24 h of admission (1814.6 ± 418.6 vs. 1242.3 ± 214, p = 0.02). Major
doses of norepinephrine were used in non-survivors patients (24 h 0.12 ± 0.21 vs.
0.86 ± 0.50, p = 0.05). Differences were observed in base deﬁcit (24 h 2.3 ± 4.46 vs.
10.9 ± 2.06, p\0.01) and arterial pH (24 h 7.39 ± 0.05 vs. 7.23 ± 0.10, p = 0.04).
CONCLUSION. Early StO2 determination by NIRS in the forearm region is a predictor of
outcome, outperforming conventional hemodynamic data.
GRANT ACKNOWLEDGEMENT. Supported in part by CIBER CB06/060036, SGR 06/
920.
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THENAR OXYGEN SATURATION MEASURED BY NEAR-INFRARED SPEC-
TROSCOPY: A MORTALITY PREDICTOR IN SEPTIC PATIENTS
J. Mesquida*, M. Martinez, A. Artigas, F. Baigorri
Critical Care Center, Hospital de Sabadell., Sabadell, Spain
INTRODUCTION. Tissue hypoperfusion, deﬁned as elevated lactate and/or low central
venous oxygen saturation (ScvO2), is associated with increased mortality in septic patients,
also in those patients presenting without hypotension. Inclusion of these markers of tissue
oxygenation in resuscitation algorithms has improved patients outcome (1). These measure-
ments require repeated blood withdrawal and/or central venous catheter placement. A rapid
and non-invasive measure of tissue oxygenation would be useful. Near-infrared spectroscopy
(NIRS) allows the measurement of tissue oxygen saturation (StO2) at skeletal muscle. In a
previous study, our group demonstrated a good correlation between StO2 and ScvO2 in
patients with severe sepsis and septic shock with normalized blood pressure (BP), and found
that StO2 values below 75% predict low ScvO2 with high speciﬁcity (2). The objective of the
present study was to analyze whether StO2 below 75% is useful as mortality predictor in
patients with severe sepsis or septic shock with normalized BP.
METHODS. Prospective observational study. Patients admitted to the ICU in the early phase
of severe sepsis and septic shock, after normalization of blood pressure with ﬂuids and/or
vasoactive drugs. We recorded demographic data, severity score (SAPS III), hemodynamic
data, hemoglobin (Hb), blood lactate, as well as ScvO2 and StO2 measured simultaneously on
inclusion. Mann-Whitney test was used to compare groups on categorical variables, and
Fisher’s exact test for continuous variables.
RESULTS. 41 patients were included. No differences in age, SAPS III, Hb, mean arterial
pressure and lactate were found between survivors and non-survivors. Non-survivors showed
lower StO2 and ScvO2 values than survivors, but they did not reach statistical signiﬁcance (p
0.06). When analyzing a StO2 cut-off value of 75%, there were statistical differences between
survivors and non-survivors (p 0.013; Table 1). A StO2 value below 75% predicts mortality
with a sensitivity of 0.53, and a speciﬁcity of 0.93.
TABLE 1
StO2 survivors non-
survivors
[75% 21 (51%) 8 (20%)
\75% 3 (7%) 9 (22%)
CONCLUSION. In patients with severe sepsis and septic shock with restored BP values,
StO2\75% is associated with increased mortality. Thus, StO2 can be used as a rapid, non-
invasive measure of severity in septic patients. Future studies may clarify the role of StO2 as
an endpoint for resuscitation in severe sepsis and septic shock.
REFERENCE(S). 1.- Rivers et al.(2001) Early goal-directed therapy in the treatment of
severe sepsis and septic shock. New Engl J Med 345: 1368–1377.
2.- Mesquida et al. Tissue oxygen saturation measured by near-infrared spectroscopy as a
non-invasive predictor of low central venous oxygen saturation: a useful parameter in our
resuscitation algorithm? (accepted for presentation at 2008 ATS Annual Meeting. Toronto,
Canada).
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EFFECTS OF ACTIVATED PROTEIN C ON MICROCIRCULATION ASSESSED BY
NEAR INFRARED SPECTROSCOPY
J. F. Georger*, A. Chaari, C. Richard, J. L. Teboul
Medical Intensive Care, CHU De Bice ˆtre - Assistance Publique - Hopitaux De Paris,
Le Kremlin Bice ˆtre, France
INTRODUCTION. The near infrared spectroscopy (NIRS) assesses the haemoglobin satu-
ration in the tissue (StO2). Induction of transient ischemia followed by hyperaemia (forearm
occlusion and release) provides additional information on the ability of microvessels to be
recruited through the analysis of the StO2 re-ascension slope. Activated protein C (APC) is an
anti-thrombotic and anti-inﬂammatory agent used as an adjuvant therapy of patients with
septic shock. One previous study showed an improved sublingual microperfusion with APC
(1).
OBJECTIVE. To examine if APC was able to affect microcirculation assessed by NIRS
parameters in septic shock patients.
METHODS. We included 11 patients with septic shock and at least two organs failures
considered for administration of APC and equipped with a PiCCO’’ monitoring system. The
thenar muscle StO2 was continuously measured with Inspectra’’ model 650 (Hutchinson
Technology) before and during pneumatic arm cuff inﬂation (until StO2 by 40% is reached)
and after deﬂation, which allowed calculating the StO2 re-ascension slope.
Mean arterial pressure (MAP), cardiac index (CI), central venous oxygen saturation (ScvO2),
dose of norepinephrine (NE) and StO2 measurements were performed before and 4 h after
starting APC infusion (24 lg/kg/h). We also collected MAP, StO2 and StO2 re-ascension
slope in 15 healthy volunteers.
RESULTS. In healthy volunteers the MAP was 89 mmHg (68–101), StO2 was 82% (75–90)
and re-ascension slope was 2.29%/s (1.46–3.36).
APC increased StO2 from 77 (65–90) to 82% (67–92) (p\0.05) and the re-ascension slope
from 1.5 (0.62–3.35) to 1.9 %/s (0.84–3.00) (p\0.05). APC decreased the NE dose from 2.5
(0.5–9.5) to 2 mg/h (0.5–8.0) (p\0.05). The other studied parameters were not changed by
APC: PAM from 80 (73–87) to 86 mmHg (71–111), CI from 3.2 (1.0–5.3) to 3.0 L/min/m
2
(1.3–5.3) and ScvO2 from 72 (50–81) to 70% (55–81).
CONCLUSION. In septic shock patients with at least two organs failures, the APC infusion
resulted in an increase in StO2 and in the StO2 re-ascension slope (4 h after starting the
infusion) despite the absence of any change in CI and MAP. This suggests a proper effect of
APC on the thenar muscle microcirculation.
REFERENCE(S). 1 De Backer D et al, Crit Care Med 2006.
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REFLECTANCE SPECTROPHOTOMETRY: A NOVEL DIAGNOSTIC APPROACH
TO ASSESS INTESTINAL MUCOSAL OXYGENATION IN PATIENTS WITH
MESENTERIC ISCHEMIA
A. Fournell*
1, S. Pourhassan
2, K. Franke
3, O. Picker
1, L. A. Schwarte
4, W. Sandmann
2
1Department of Anesthesiology,
2Department of Vascular Surgery,
3Department of Surgery,
Heinrich Heine University, Duesseldorf, Germany,
4Department of Anesthesiology, VU
Academic Medical Center, Amsterdam, Netherlands
INTRODUCTION. Deﬁnitive diagnosis of mesenteric ischemia usually requires invasive
testing, e.g., splanchnic angiography. However, angiographic ﬁndings frequently are not
conclusive and do not correlate with clinical symptoms. The aim of the study was to evaluate
the potential of reﬂectance spectrophotometry to assess non-invasively oxygenation in
splanchnic mucosa (lHbO2) for the detection of clinical important mesenteric ischemia.
METHODS. Five patients presenting with hitherto unexplained abdominal pain and/or
weight loss were enrolled consecutively in a pilot study. lHbO2 was assessed in the upper
gastrointestinal (GIT) tract to diagnose and grade mesenteric ischemia preoperatively, as well
as during and after revascularization; the values were compared to clinical, angiographic and
endoscopic ﬁndings.
RESULTS. In 4 patients lHbO2 was B 60% at least in some parts of the GIT before
revascularization and increased to values[60% after surgical therapy. These results corre-
lated well with the disappearance of clinical symptoms of mesenteric ischemia. The 5th
patients did not undergo revascularization because he presented with clinically not clear cut
ﬁndings and showed only in 1 of 5 measuring sites lHbO2\60%.
CONCLUSION. We suggest that lHbO2 values[60% probably represent the cut-off point
of physiologic lHbO2 as values below this range were associated with clinical symptoms of
mesenteric ischemia. Moreover, lHbO2 values but not endoscopic ﬁndings correlated with
clinical signs of mesenteric ischemia. We suggest that reﬂectance spectrophotometry has the
potential to serve as an appropriate additional assessment tool for diagnosing and grading
intestinal ischemia, and may be useful to identify the indication of surgical revascularization.
GRANT ACKNOWLEDGEMENT. Departmental funds.
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MICROCIRCULATORY ALTERATIONS IN SUBLINGUAL AND INTESTINAL
MUCOSA DURING HYPEROXIA IN PIGS
Z. Turek*, V. Cerny, R. Parizkova, P. Dostal
Department of Anesthesiology and Intensive Care Medicine, University Hospital Hradec
Kralove, Charles University in Prague, Faculty of Medicine Hradec Kralove, Hradec Kralove,
Czech Republic
INTRODUCTION. Pathophysiological effects of hyperoxia such as breath depression, acute
hyperoxic lung injury, atelectasis induction or cardiac output decrease have been investigated
in details many times. Effect of normobaric hyperoxia on intestinal microcirculation was
intensively investigated last years with some evidence of positive effects on micovascular
ﬂow index (MFI) and functional capillary density (FCD) especially in model of I/R injury (1).
The goal of this study was to evaluate changes in FCD and MFI of sublingual and ileal
mucosa induced by short-term hyperoxia and to compare changes in FCD of sublingual and
intestinal microcirculation revealed by Sidestream dark-ﬁeld imaging (SDF).
METHODS. Microcirculatory network of sublingual mucosa and of terminal ileum was
visualized via an ileostomy by SDF imaging in 8 anesthetized pigs. Four sequences of
microcirculatory status from sublingual and intestinal mucosa were recorded on-line at
baseline conditions, after surgical preparation and stabilization (FiO2 0,40), immediately after
preceeding 15 min hyperoxia (FiO2 1,0) and 60 minutes after the end of hyperoxia(hyperoxia
group, n = 4). The same measurements were performed in control group, n = 4, with con-
stant FiO2 0,40 throughout the study. Macrohemodynamic values were recorded
continuously, microcirculatory parameters were analyzed off-line.
RESULTS. No difference has been detected between the groups at the baseline. There was
statistically signiﬁcant increase (p\0,001) of FCD and MFI in the ileal mucosa after 15
minutes of hyperoxia in contrast to sublingual area where signiﬁcant decrease in FCD was
observed and MFI remained unchanged (p\0.01). These changes were not observed in
control group. Thus, no correlation between FCD values from sublingual and ileal mucosa
was detected in terms of hyperoxia. Microcirculatory effects of hyperoxia were still signiﬁ-
cant 60 minutes after the hyperoxia was ﬁnished.
CONCLUSION. We have demonstrated positive effect of short-term hyperoxia with 100%
oxygen on intestinal microcirculation in healthy anesthetized mechanically ventilated pigs.
These ﬁndings correspond with previous studies assuming redistribution of cardiac output into
the splanchnic region and attenuation of inﬂammatory pathways with maintainig microcir-
culation patent. Positive effect of supplemental oxygen on tissue oxygen tension in healthy
and anastomotic colon was described previously, this effect was not reached using aditional
krystalloid ﬂuid. Trends and values obtained from ileal mucosa does not correspond with
those obtained from sublingual mucosa, where decrease in FCD is propably due to oxygen
induced vasoconstriction.
REFERENCE(S). Weisman D et al.: Am J Physiol Heart Circ Physiol, 2003.
GRANT ACKNOWLEDGEMENT. Research project MZO 00179906.
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MICROVASCULAR DYSFUNCTION IN TRAUMA HEMORRHAGIC SHOCK:
ASSESSMENT WITH NEAR INFRARED SPECTROSCOPY DURING OCCLUSION
TESTS
J. Pottecher*, O. Mathe, C. Laplace, M. Mesnil, X. Repe ´sse ´, D. Benhamou, J. Duranteau
De ´partement d’Anesthe ´sie-Re ´animation, CHU Bice ˆtre, Le Kremlin-Bice ˆtre, France
INTRODUCTION. The aim of this study was to assess microvascular dysfunction in trauma
hemorrhagic shock (HS) patients by recording near-infrared spectroscopy (NIRS) signal
during arterial occlusion tests.
METHODS. After approval from our local IRB, trauma patients with HS were included in
this prospective study. As soon as hemodynamic stabilization was obtained, NIRS-derived
StO2 signals (InSpectra , Hutchinson, USA) were recorded on the thenar eminence during
3 min brachial artery occlusion (Figure). The same trial was applied in ten healthy volunteers.
Demographic, hemodynamic data, SAPSII and ISS scores were gathered. Data are median
[IQR] are were analyzed with Mann-Whitney and Spearman tests.
RESULTS. Nineteen HS patients aged 32 [23–56], SAPS II : 43 [32–63], ISS : 34 [24–44]
were included after hemodynamic stabilization : MAP : 75 [62–78] mmHg.
NIRS-derived values neither correlated with hemodynamic data nor with clinical scores.
Occlusion and recovery slopes differed between HS patients and volunteers (Table 1).
TABLE 1 NIRS-DERIVED STO2 VALUES DURING OCCLUSION TESTS IN HEM-
ORRHAGIC SHOCK AND VOLUNTEERS
Hemorrhagic
shock n = 19
Healthy volunteers
n=1 0
P value
Basal StO2, % 80 [71–84] 81 [77–85] NS
Occlusion slope, %/min 7 [7–10] 11 [10–12] 0.039
StO2 min, % 45 [38–56] 47 [38–50] NS
Recovery slope, %/min 79 [54–142] 208 [204–219] 0.0003
Hyperemic area, %.min 15 [9–21] 16 [11–21] NS
CONCLUSION. Reduced occlusion and recovery slopes in trauma HS patients compared to
healthy volunteers may reﬂect reduced oxygen consumption and impaired capillary recruit-
ment respectively. Further patients are needed to conﬁrm those results and study the time
frame of this microvascular dysfunction.
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CONSEQUENCES OF HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY
ON SYSTEMIC AND TISSUE PERFUSION (THENAR EMINENCE): DURING
GENERAL ANAESTHESIA ASSOCIATED OR NOT WITH THORACIC EPIDURAL
ANAESTHESIA
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INTRODUCTION. Hyperthermic intraperitoneal chemotherapy (HIPEC), associated with
cytoreductive surgery is the only therapy prolonging survival for patients with peritoneal
carcinomatosis. Objective: To evaluate the impact of transient acute hyperthermia on sys-
temic hemodynamic and micro-oxygenation of thenar eminence under general anaesthesia
(GA) alone or associated with thoracic epidural anaesthesia (TEA).
METHODS. 20 patients (nov 2006-dec 2007), ASA1 or 2, 9F/11 M, 53 y.o. (20–68), with
peritoneal carcinomatosis. GA alone (n = 13) or associated to TEA (n = 7, T8-T9, ropi-
vacaı ¨ne 2 mg/ml + sufentanyl 0. 5mcg/ml) settled before induction. Monitoring included:
invasive blood pressure (BP, radial artery), BIS (30–40, Astect Medical System ), oesoph-
ageal temperature (Tyco Healthcare ), continuous central SvO2 measurement (Edwards
Lifesciences ), cardiac output (CO, Doppler TE, Doptek ). Muscle haemoglobin saturation
measurements (StO2, thenar eminence, non blocking area) by NIRS (Hutchinson ) and
during occlusion test. Timing of measurements: viscerolysis, chemohyperthermia (HIPEC,
oxaliplatin, 30 min, 42 C), end of the procedure. Statistics: non parametric tests.
RESULTS. Procedure duration: 11 h (7–14) with a large ﬂuid loading (15.5 ml/kg/h, range
7.1–28) with crystalloids (1/3 0.9% saline, 2/3 ringer lactate), comparable in both anaesthesia
techniques. 3 patients required norepinephrine infusion. Hyperthermia: 1) under GA, BP, CO,
ScvO2 or StO2 did not change;2) under GA + TEA, pre-hyperthermia CO tended to be higher
than in GA (median TEA = 8.0 vs. GA = 6.6 L/min, p = 0.08); TEA modiﬁed the response
to hyperthermia with PB decrease (p\0.05) without change in CO (intense vasodilatation)
but with more reﬂex tachycardia (80 to 98 b/min, p\0.05). This sympathetic stimulation
targeted the area unblocked by TEA (thenar eminence). The decrease of StO2 during arterial
occlusion with TEA (median -0.30 to -0.45 %/sec, p\0.05) versus GA (-0.37 to -0.41
%/sec, NS) was faster (oxygen demand). The StO2 reperfusion slope (vascular reserve)did not
differ between GA and TEA. In the TEA group, the more rapid was the drop of occlusion
slope (rapid ischemia), the more rapid the reperfusion slope (vascular recruitment) (regression
R = 0.67, Spearman test p = 0.04).
CONCLUSION. Before hyperthermia, TEA + GA induced hyperkinetic syndrome. Only in
TEA + GA, hyperthermia induced a large vasodilatation that mainly concerns the unblocked
area, as suggested by the remarkable rapid ischemia during arterial occlusion, which deter-
mined the vascular recruitment during reperfusion. The beneﬁt of TEA associated with GA
compared to GA alone remains to be demonstrated in postoperative period especially for
inﬂammatory parameters.
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MILD LACTIC ACIDOSIS AND HYPERCHLORAEMIC ACIDOSIS DURING THE
SECOND 24 HOURS OF CRITICAL CARE ARE BOTH ASSOCIATED WITH
INCREASED MORTALITY
S. Vamadevan*, C. Barrera-Groba
Intensive Care, Royal Sussex County Hospital, Brighton, United Kingdom
INTRODUCTION. Lactic Acidosis
1 and decreased lactate clearance in early critical care
2
have been demonstrated to be prognostic of increased mortality from critical illness. Fluid
resuscitation that aims to avoid lactic acidosis may create a hyperchloraemic metabolic
acidosis but its impact on outcome is controversial
3.
METHODS. This is a cohort analysis of a prospectively collected observational database on
all-comers to a single mixed ICU. We evaluated the prognostic value (on ICU mortality) of
the maximum chloride (Cl) and maximum lactate levels in the 2nd 24 hrs of their stay.
RESULTS. 1760 of the 2847 consecutive patients admitted over a four year period (Oct
2002- Oct 2006) had blood lactate and acid-base proﬁle measured and recorded on day two.
When the worst lactate recorded in the second 24 h is just C 2 there is an increased risk of
ICU death (vs.\2: RR 2.82, 95% CI 2.37–3.86). Furthermore poor lactate clearance within
the ﬁrst 24 h of treatment is an indicator of adverse outcome (Day 1 minimum lactate C 2
vs.\2: Mortality 46.63 vs. 19.77%, OR 3.53, 95% CI 2.56 – 4.85). Any chloride level[115
on day 2 indicates an increased risk of death (vs. Cl\115: RR 1.8, 95% CI 1.52–2.13).
Although there was no correlation between peak day 2 [Cl] and lactate (r = 0.09), as a
confounder, there was a 0.5 higher mean lactate in the high Cl group (2.47 vs. 1.98, 95% CI
0.3 – 0.7).
TABLE 1 DAY 2 PEAK LACTATE (MMOL/L)
\2 (n = 1091) C 2 (n = 669) OR
a/Mean difference
b (95% CI)
ICU Mortality 13.93% 39.31%
a4 (3.16–5.04)
Lactate (mean) mmol/l 1.1 3.79
b2.69 (2.53–2.89)
Base deﬁcit (mean) 1.8 4.8
b3 (2.47–3.53)
Age (mean) years 63 63.8
TABLE 2 DAY 2 PEAK CHLORIDE (MMOL/L)
\115
(n = 1142)
C 115
(n = 561)
OR
a/Mean
Difference
b (95% CI)
ICU Mortality 18.74% 33.69%
a2.2 (1.75–2.77)
Chloride (mean) 109.3 119.1
b10.2 (9.8–10.6)
Base Deﬁcit (mean) 1.7 6.3
b4.9 (4.37–5.43)
Albumin (mean) g/l 24 18
b6 (5.3–6.7)
Peak Sodium (mean) mmol/l 139 144
b5 (4.5–5.49)
CONCLUSION. An apparently mild peak lactate of just C 2 at any point in the second
twenty four h of stay confers a profound survival implication. Also failure to clear serum
lactate to below 2 in the ﬁrst 24 h, and (albeit for some confounders) a maximal day 2 [Cl]
of C 115 are associated with a signiﬁcant increase in mortality. Therefore, a mild lactic
acidosis and hyperchloraemic acidosis in the second twenty four h are both prognostic
indicators of mortality in critically ill patients.
REFERENCE(S). 1. Trzeciak S et al. Intensive Care Medicine, 2007; 33: 970–7.
2. Nguyen HB, et al. Critical Care Medicine 2004; 32: 1637–42.
3. CG Morris et al. Anaesthesia 2008; 63: 396–411.
1010
DOES RED BLOOD CELL TRANSFUSION IMPROVE TISSUE OXYGENATION IN
CRITICALLY ILL PATIENTS?
A. Neves*, A. Ventura, V. Boreli, F. Zattar, J. Creteur, J. Vincent
Department of Intensive Care, Erasme Hospital, Brussels, Belgium
INTRODUCTION. Red blood cell (RBC) transfusions are commonly used in critically ill
patients. A number of factors that can determine oxygen availability to the cells may not be
reliably assessed from global hemodynamic measures. Near infrared spectroscopy (NIRS) has
been proposed to assess tissue metabolism and oxygenation. We proposed to study the effect
of RBC transfusion on muscle tissue metabolism and oxygenation using the NIRS in he-
modynamically stable critically ill patients.
METHODS. Hemodynamically stable ICU patients with anemia requiring RBC transfusions
were included. Thenar muscle oxygenation (StO2) and tissue hemoglobin index (THI) were
continuously measured using NIRS (InSpectraTM Model 325, Hutchinson Technology Inc,
Hutchinson, MN) before, during and after upper limb ischemia induced by a rapid pneumatic
cuff inﬂation around the upper arm. The rate of StO2 desaturation during the arterial
occlusion (desaturation rate; %/min) and the StO2 reperfusion rate immediately after the
arterial occlusion (reperfusion rate; %/sec) were calculated. These different NIRS variables
were collected before and after RBC transfusion.
RESULTS. We studied 11 septic (3 with and 8 without shock) and 20 non-septic (12 patients
after major surgery and 8 medical patients). RBC transfusion increased hemoglobin con-
centrations in both groups. The NIRS variables were comparable in both groups before and
after transfusions.
TABLE 1
Septic
patients
Before
Septic
patients
After
Non-septic
patients
Before
Non-septic
patients
After
StO2 (%) 86 ± 98 5 ± 98 3 ± 10 86 ± 8
THI 15 ± 51 4 ± 51 4 ± 31 3 ± 3
Desaturation rate (%/min) -23 ± 14 -28 ± 25 -19 ± 9,4 -22 ± 8
Reperfusion rate (%/sec) 3,5 ± 2,1 3,0 ± 2,6 3,0 ± 1,6 3,4 ± 1,6
Hemoglobin (g/dl) 7,3 ± 0,9 8,1 ± 1,5 7,2 ± 0,6 8,2 ± 0,7
CONCLUSION. RBC transfusion does not inﬂuence muscle metabolism and oxygenation in
hemodynamically stable anemic critically ill patients.
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POSTOPERATIVE SUBLINGUAL MICROCIRCULATION IS SPECIFICALLY
IMPAIRED IN PATIENTS UNDERGOING ESOPHAGECTOMY BUT CAN BE
RESTORED WITH DOBUTAMINE
M. E. van Genderen*, J. van Bommel, C. Ince, D. Gommers
Intensive Care, Erasmus MC, Rotterdam, Netherlands
INTRODUCTION. Esophagectomy with gastric tube reconstruction is the surgical treatment
for patients with esophageal cancer and is associated with high morbidity and mortality rates.
Complications of these operations are leakage and stenosis of the distal anastomosis, which
may be due to compromised local microvascular blood ﬂow. We have shown that the sub-
lingual microvascular perfusion is impaired on the ﬁrst day after esophagectomy and therefore
the aim of this study was to determine if this impairment also occured after Whipple pancreas
resection, and if these changes could be prevented with dobutamine.
METHODS. We included a total of 30 patients in this study. We randomized the 20
esophagectomy patients over 2 groups: an intervention and a control group. The intervention
group received dobutamine 2–3 mcg/kg/min directly postoperative until the second day after
surgery whereas the control group did not. On the day before surgery (T-1), the day of surgery
(T0), and two days after surgery (T1, T2) hemodynamic data were collected and the sub-
lingual microcirculation was analyzed using a Sidestream dark-ﬁeld (SDF) imager. Similar
measurements were performed in 10 patients undergoing a Whipple pancreas resection. SDF
data was analyzed according to the semi-quantitative analysis described by Boerma et al.1 and
expressed as Microvascular Flow Index (MFI).
RESULTS. The results are presented in the ﬁgure.
CONCLUSION. Sublingual microvascular perfusion is signiﬁcantly reduced on the ﬁrst day
following esophagectomy, whereas not after Whipple pancreas resection, and the adminis-
tration of dobutamine prevented this decrease.
REFERENCE(S). 1 Boerma EC, Mathura KR, van der Voort PH, Spronk PE, Ince C.
Quantifying bedside- derived imaging of microcirculatory abnormalities in septic patients: a
prospective validation study. Crit care 2005, 9:R601–6.
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QUANTIFICATION OF SUBLINGUAL MICROCIRCULATORY ALTERATIONS
D. De Backer*, A. Neves, D. Simion, K. Donadello, J. Vincent
Intensive Care, Erasme University Hospital, Brussels, Belgium
INTRODUCTION. Microvascular alterations can be visualized at the bedside but quantiﬁ-
cation remains challenging. In the sublingual region, two semi-quantitative scores are used:
Proportion of perfused vessels and the Mean Flow Index (MFI). We compared the scores in
patients with severe sepsis.
METHODS. Using Sidestream Dark-Field imaging (Microvision Medical, Amsterdam,
Netherlands) we evaluated the sublingual microcirculation in 43 patients with severe sepsis.
At each evaluation, 5 sequences of 20 s each were recorded. An investigator blinded to the
patient’s clinical course and sequence order calculated the scores for each image, focusing on
vessels less than 20 lm in diameter. Perfused vessel density was calculated as the proportion
of perfused vessels crossing 3 vertical and 3 horizontal lines. For the MFI score, the image
was divided into 4 quadrants and the predominant ﬂow type in each quadrant assessed
(0 = absent, 1 = intermittent, 2 = sluggish, 3 = normal); the values of these 4 quadrants
were then averaged. Linear regression was used to evaluate the relationship between the
scores.
RESULTS. We evaluated 490 video sequences. Globally there was good correlation between
the scores (MFI = 0.0447 x – 0.974; R
2 = 0.75, p\0.001)(Figure 1). However, there was
great variability, as an MFI of 3 (normal) was associated with perfusion ranging from 70
(markedly abnormal) to 98% (normal).
CONCLUSION. Although related, the 2 scores are not equivalent. Measuring the proportion
of perfused vessels allows a more precise evaluation of the microcirculation.
REFERENCE(S). 1. De Backer et al Crit Care 2007.
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THE PROGNOSTIC VALUE OF SUBLINGUAL PCO2 IN PATIENTS WITH
SEVERE SEPSIS
J. Creteur*, A. Neves, G. Ospina, T. Oliveira Silva, D. De Backer, J. Vincent
Intensive Care Department, Hopital Erasme, Brussels, Belgium
INTRODUCTION. Effective resuscitation is considered as a critical component of sepsis
management. Despite adequate resuscitation, microcirculatory alterations may persist and be
associated with a poorer outcome. Sublingual capnometry has been proposed to track mi-
crocirculatory alterations. We tested the hypothesis that sublingual PCO2 (PslCO2) can
remain elevated following resuscitation in some patients and that this is associated with a
worse outcome.
METHODS. We included 30 patients admitted in the ICU with early severe sepsis treated
according to the Surviving Sepsis Campaign guidelines. Central venous oxygen saturation
(ScvO2) and PslCO2 were simultaneously measured every hour, during the ﬁrst 6 h of
resuscitation. PslCO2 was measured using a microelectrode CO2 sensor (Capnoprobe SL
Model 2000 Sensor, Optical Sensor Inc, MN, USA). PslCO2gap was calculated as the dif-
ference between PslCO2 and arterial PCO2. ScvO2 was measured in blood samples drawn
from a central venous catheter.
RESULTS. Of the 30 patients, (APACHE score: 23 ± 7), 15 had signs of shock. Mortality
rate was 43% (13/30). There was no difference between survivors and non-survivors in the
use of vasopressors (8/17 vs. 7/13) and the amount of ﬂuids during the ﬁrst 6 h of resuscitation
(3.0 ± 1.2 L vs. 3.1 ± 1.1 L). The time course of ScvO2 was similar in survivors and non-
survivors, but the time course of PslCO2gap differed (*ANOVA: p\0.005): PslCO2gap
decreased over time in survivors but not in non-survivors (Table; data are presented as median
and interquartile ranges).
TABLE 1
Baseline 2 hrs 4hrs 6 hrs
ScvO2 (%) Survivors 68 (58–75) 72 (60–75) 70 (68–77) 72 (68 – 78)
ScvO2 (%) Non-survivors 64 (57–70) 66 (59–71) 70 (65–72) 72 (67–74)
PslCO2gap (mmHg); Survivors 18 (13–20) 12 (10–17)* 10 (5–12)* 10 (7–15)*
PslCO2gap (mmHg); Non-survivors 24 (17–36) 27 (21–32) 22 (16–31) 20 (16–33)
CONCLUSION. Despite seemingly adequate early resuscitation, the persistence of high
PslCO2gap is associated with a worse outcome. Sublingual capnometry could be used to
identify and further resuscitate patients with persistent microcirculatory alterations.
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TISSUE OXYGEN TENSIONS IN A RODENT MODEL OF CONTROLLED HAEM-
ORRHAGE AND RESUSCITATION
A. Dyson*, M. Singer
1Department of Medicine and Wolfson Institute for Biomedical Research, University College
London, London, United Kingdom
INTRODUCTION. High ﬂow, high concentration oxygen therapy is given ubiquitously as
part of the standard ABC resuscitation strategy in shocked patients. However, we recently
reported that hyperoxia during uncontrolled haemorrhage was detrimental compared with
normoxia, causing reduced blood ﬂow and increased hyperlactataemia (1). We sought to
determine haemodynamics and tissue oxygen tension (an index of the local O2 supply/demand
balance) in various organ beds in a rodent model of controlled haemorrhage followed by
resuscitation in either room air (21% O2) or 100% O2.
METHODS. Under isoﬂurane anaesthesia, male Wistar rats underwent left common carotid
and right jugular venous cannulation for blood sampling/BP monitoring and ﬂuid/blood
administration, respectively. Ultrasonic ﬂow probes measured blood ﬂow in the descending
aorta. Tissue PO2 (tPO2) was determined using Oxylite probes (Oxford Optronix, UK) placed
in thigh muscle, liver, renal cortex and within the bladder lumen. After 30 mins stabilisation,
rats were subjected to a 30 ml/kg haemorrhage (40% estimated circulatory volume). After a
30 minute period of shock, shed blood was re-infused ± hyperoxia (100% O2).
RESULTS. Data shown as mean (± SE). n = 4/group,
*p\0.05 comparing normoxia and
hyperoxia,
#p\0.05 compared to baseline. B = baseline, S = shock, R = resuscitation.
Statistics were performed using a RM two-way ANOVA and post-hoc Tukey’s test.
Group MAP
(mmHg)
Global
DO2
(l/min)
Muscle
tPO2
(kPa)
Bladder
tPO2
(kPa)
Liver
tPO2
(kPa)
Kidney
tPO2
(kPa)
Lactate
(mmol/l)
21% O2:B 89 (3) 6.0 (1.2) 4.6 (0.3) 8.6 (0.3) 2.7 (1.0) 1.7 (0.4) 1.4 (0.2)
21% O2:S 49 (4)
# 1.9 (0.6)
# 3.6 (0.4)
# 7.3 (1.4) 0.1 (0.1)
# 1.3 (0.4) 6.4 (0.4)
#
21% O2:R 102 (4)
# 5.4 (0.2) 5.4 (0.2) 9.5 (1.0) 3.3 (1.1) 2.9 (0.7) 2.1 (0.2)
100% O2:B 91 (3) 5.5 (0.7) 5.6 (1.7) 8.3 (0.6) 2.4 (0.8) 1.1 (0.2) 1.4 (0.0)
100% O2:S 50 (3)
# 1.8 (0.3)
# 2.9 (0.1))
# 6.5 (1.8) 0.0 (0.0)
# 0.9 (0.3) 7.5 (0.5)
#
100% O2:R 121 (6)
*# 3.7 (0.4)
*# 14.9 (1.7)
*# 26.7 (0.0)
*# 6.9 (0.9)
*# 11.5 (3.9)
*# 2.2 (0.5)
CONCLUSION. Controlled haemorrhage caused variable decreases in tPO2 responses across
the organ beds measured, with liver the most severely affected. Resuscitation with 100% O2
had a profound vasoconstrictor effect resulting in decreased global oxygen delivery. While
this did not appear to compromise tissue oxygenation or lactate levels in this short-term
model, the utility of high ﬂow, high concentration O2 as a beneﬁcial therapeutic intervention
during haemorrhagic shock is questionable.
REFERENCE(S). 1. Dyson et al. (2007) Intensive Care Med; 33(Suppl.2):8.
GRANT ACKNOWLEDGEMENT. This work is supported by the Medical Research
Council (UK).
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EFFECTS OF HYPOXIC HYPOXIA AND SYSTEMIC HYPOPERFUSION ON EX
VIVO SPLANCHNIC VASCULAR REACTIVITY
J. Gorrasi*
1, L. Tovar
1, B. Balsiger
1, H. Bracht
1, S. Brandt
2, F. Porta
1, J. Takala
1, S. Jakob
1
1Intensive care medicine,
2Anesthesiology, Bern University Hospital -Inselspital and Uni-
versity of Bern, 3010 Bern, Switzerland
INTRODUCTION. Low cardiac output and severe hypoxemia states are frequently treated
with vasoactive drugs. The interaction between cardiovascular adaptations and drug effects in
these situations has been explored only insufﬁciently. The aims of this study were 1) to
investigate the hepato-splanchnic blood ﬂow adaptations in a model of low systemic blood
ﬂow vs. low oxygen content and 2) to test afterwards the in-vitro vascular reactivity of gut-
and liver-supplying vessels to vasoconstricting and vasodilating drugs.
METHODS. We studied 24 anesthetized and mechanically ventilated pigs randomized to
cardiac tamponade (CT, n = 8), hypoxia (HH, n = 8) and control (C, n = 8). In CT, cardiac
output was reduced in 6-hr steps to reach 50, 40 and 30 ml.kg-1.min-1. In HH, FiO2 was
reduced in 6 hrs to reach a PaO2 of 50–60 mmHg, and then at 12 hrs to\50 mmHg. The
lowest levels were maintained until 24 hrs. At the end of the animal experiment, vascular
samples from hepatic (HA) and superior mesenteric arteries (SMA) were analyzed by the
tissue bath method. Contractility was assessed using norepinephrine (dose-response curve),
and relaxation using adenosine and sodium nitroprusside (percent of peak contraction,
baseline 100 ± 0%). Dose-response curves were constructed for norepinephrine, sodium
nitroprusside (SNP) and adenosine. Variables were compared using one-way and repeated
measures ANOVA. Jejunum motility data from the same animals are presented in another
abstract.
RESULTS. Cardiac output decreased in CT from 77 ± 14 to 44 ± 12 ml/kg/min, increased
in HH from 75 ± 15 to 113 ± 26 ml/kg/min, and did not change in controls (time-group
interaction; p = 0.001). Superior mesenteric artery blood ﬂow decreased by 30 ± 5% in CT
and remained unchanged in HH (p = 0.04), while hepatic artery blood ﬂow decreased by
11 ± 15% in CT and increased by 103 ± 52% in HH and by 50 ± 26% in controls
(p = 0.09). In-vitro norepinephrine maximal contraction was similar in all groups. SNP-
induced relaxation was 64 ± 26%, 61 ± 30% and 47 ± 23% in CT, HH and C, respectively,
in the hepatic artery (p = 0.002) and 69 ± 19%, 62 ± 22% and 51 ± 32% in CT, HH and C,
respectively, in the SMA (p\0.001). Maximal adenosine relaxation was 20 ± 22%,
28 ± 17% and 30 ± 25%, in CT, HH and C, respectively (hepatic artery, NS), and
24 ± 23%, 14 ± 19% and 8 ± 15% in CT, HH and C, respectively (SMA, p\0.001).
CONCLUSION. Both CT and HH were associated with increased fractional hepatic arterial
perfusion, whereas for SMA, this was only the case in CT. In SMA, maximal relaxation in
response to both SNP and adenosine was increased, whereas in the hepatic artery this was
only the case for SNP. Neither CT nor HH modiﬁed the maximal contraction to norepine-
phine. Whether the in-vitro ﬁndings have implications for the administration of vasodilating
drugs in vivo should be tested in further experiments.
GRANT ACKNOWLEDGEMENT. Supported by grant 3200BO/102268 from the Swiss
National Fund and from Novartis grant.
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PREOPERATIVE PULMONARY VASOREACTIVITY IN CTEPH PATIENTS
UNDERGOING PEA
F. Mojoli*
1, V. Emmi
1, A. D’Armini
2, F. Capra Marzani
1, S. Mariconti
1, M. Vigano `
3,
A. Braschi
4
1Servizio di Anestesia e Rianimazione I,
2Divisione di Cardiochirurgia, Fondazione IRCCS
Policlinico S. Matteo,
3Cattedra di Cardiochirurgia,
4Cattedra di Anestesiologia e Riani-
mazione, Universita ` degli Studi, Pavia, Italy
INTRODUCTION. Aim of the study was to analyze the relationship between preoperative
response to inhaled Nitric Oxide (iNO) in Chronic thromboembolic Pulmonary Hypertension
(CTEPH) patients and the outcome of pulmonary endarterectomy (PEA).
METHODS. Nineteen consecutive CTEPH patients, in whom spiral CT excluded a distal
pattern, underwent 2 right heart catheterizations: preoperatively to assess basal hemody-
namics and response to iNO and postoperatively to assess outcome of PEA.
RESULTS. At basal hemodynamic assessment, Cardiac Output (CO) was 4.3 ± 1.6 l/min,
mean Pulmonary Artery Pressure (mPAP) 45 ± 14 mmHg and Pulmonary Vascular Resis-
tance 826 ± 371 dynes*s*cm-5. Inhaled NO decrease mPAP to 37 ± 10 (-18%) and PVR to
707 ± 304 (-15%). Four patients (21%) were high responders to iNO and 15 patients (79%)
were low responders according to a PVR decrease C or\200 dynes*s*cm-5, respectively.
High responders had also higher basal PVR (1213 ± 222 vs. 723 ± 335; p\0.01) but not
signiﬁcantly higher PVR during NO inhalation (839 ± 167 vs. 672 ± 327) than low
responders. PEA decreased mPAP to 25 ± 8( -44%), PVR to 248 ± 103 (-63%) and
increased CO to 5.4 ± 2.0 (+26%). The 4 high responders had worse PEA outcomes: 1
patient experienced severe postoperative pulmonary hypertension and right heart failure,
required ECMO and ﬁnally died 4 days after the operation; in the other 3 high responders,
mean postoperative PVR was signiﬁcantly higher than that observed in low responders
(370 ± 97 vs. 223 ± 87; p\0.005).
CONCLUSION. In CTEPH patients, a preoperative high response to NO inhalation may
suggest that a signiﬁcant portion of pulmonary vascular resistances is not correctable by
pulmonary endarterectomy.
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THE LOCATION AND TIMING OF EXTUBATION IN PAEDIATRIC CARDIAC
SURGICAL PATIENTS – CAN WE SAFELY MOVE OUT OF PICU?
K. J. Parkins
1, P. Ritson*
2, R. Hill
1, J. Richardson
1
1Paediatric Intensive Care,
2Physiotherapy, Royal Liverpool Children’s NHS Trust, Liver-
pool, United Kingdom
INTRODUCTION. To identify location and timing of extubation in cardiac surgical patients
admitted to PICU.
Fast track extubation is deﬁned as extubation in theatre/on arrival to PICU.
Early extubation is deﬁned as extubation within 4 h.
METHODS. Inclusion criteria: Patients extubated post-cardiac surgery between 26 June
2006 and 19 March 2008 admitted to PICU.
Data was collected for patient characteristics; length of time ventilated; extubation failure
within 48 hrs; failure reason.
RESULTS. 414 patients were eligible for inclusion. Data was missing for 30 patients
(7.25%), leaving 384 patients for analysis.
Patients ‘fast tracked’ = 87 (22.7%).
297 patients (77.34%) were extubated on PICU, of which 28 patients (9.43%) under-
went ‘early extubation’. Median length of time ventilated for remaining patients = 2 days
(IQR 0.5 – 6).
Twenty-four patients failed extubation (6.25%), of which 5 patients had been fast tracked.
Median length of time ventilated prior to extubation failure = 4 days (IQR 2.15–6.75).
Reasons for failure: airway 10 patients (41.7%); respiratory failure 9 patients (37.5%); cardiac
failure 3 patient (12.5%); accidental extubation 1 (4.2%); bleeding 1 (4.2%).
CONCLUSION. 3 in 10 cardiac surgical cases are being extubated at the end of the operation
or immediately on PICU admission. Data analysis suggests near optimum use of fast track
extubation following cardiac surgery, implying appropriate assessment by Anaesthetic/PICU
team. The low extubation failure rate in this group provides evidence to support redirecting
postoperative care to high-dependency areas. Avoiding lengthy stays on PICU would reduce
patient and parental stress. In addition, this may have the potential to reduce in-patient stay
and enable higher throughput in cardiac department and reduce waiting lists. Continued audit
would further support this conclusion.
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PRO- AND ANTI-INFLAMMATORY RESPONSE IN ICU PATIENTS REQUIRING
PARENTERAL NUTRITION: COMPARISON OF A FISH OIL CONTAINING NEW
LIPID EMULSION (SMOFLIPID) WITH AN OLIVE AND SOYBEAN BASED
LIPID EMULSION
S. N. Piper, I. Schade, R. B. Beschmann, A. Schellhaaß, J. Boldt, K. D. Ro ¨hm*
Deparment of Anaesthesiology and Intensive Care Medicine, Klinikum Ludwigshafen,
Ludwigshafen, Germany
INTRODUCTION. Lipid emulsions are an essential part of parenteral nutrition (PN), both as
a part of energy supply, and as a source of essential fatty acids. It has been shown that the
fatty acid composition of cell membranes is inﬂuenced by the fatty acid proﬁle of dietary
lipids, and may therefore be responsible for modulation of immune response (1). The aim of
this study was to assess the effects of a new lipid emulsion based on soybean oil, medium-
chain triglycerides (MCT), olive and ﬁsh oil (SMOFlipid ) compared with a lipid emulsion
based on olive and soybean oil (ClinOleic ) on the inﬂammatory response in postoperative
intensive care unit (ICU) patients.
METHODS. A prospective randomised study. After approval of the ethical committee, 44
postoperative surgical patients with an indication for PN were included in this study. Non-
protein calories were given as 60% glucose and 40% lipids. The total energy intake per day
was 25 kcal/kg body weights. Sedation regimen was standardised, propofol (lipid emulsion as
a carrier) was avoided. Patients were thus allocated to one of two nutritional regimens: Group
A( n= 22) received SMOFlipid  20% (SMOF group), group B (n = 22) a lipid emulsion
based on olive and soybean oil (ClinOleic  20%, control group). PN including lipids were
given for 5 postoperative days. Interleucin-6- (IL-6), tumor tecrosis factor-alpha- (TNF-a),
leukotriene B5 (LTB5), and soluble E-selectin-levels (sE-selectin) were measured before the
start of infusion (d0), at day 2 (d2) and day 5 (d5) after the start of administration. The
signiﬁcance level was deﬁned at p\0.05.
RESULTS. There were no signiﬁcant differences between the two groups in the pro-
inﬂammatory response at d0 and d2, but at d5 signiﬁcantly lower IL-6- (SMOF group (A):
73 ± 58 vs. control group (B): 123 ± 107 pg/ml),TNF-a- (A: 15 ± 8 vs. B: 23 ± 13 pg/ml),
and sE-selectin-concentrations (A: 22 ± 14 vs. B: 33 ± 21 ng/ml) were observed in the
SMOF group, compared to the control group. The anti-inﬂammatory response objectiﬁed by
measuring LTB5 showed signiﬁcant higher LTB5-levels at d2 (A: 618 ± 525 vs. B:
340 ± 218 pg/ml) and d5 (A: 782 ± 591 vs. B: 371 ± 248 pg/ml) in the SMOF group.
CONCLUSION. The administration of SMOFlipid  within a parenteral nutrition regimen
led at the ﬁnal study day (d5) of the nutrition regimen to a signiﬁcantly reduced pro-
inﬂammatory response and at d2 and d5 a signiﬁcantly increased anti-inﬂammatory response
compared with a lipid emulsion based on olive and soybean oil.
REFERENCE(S). 1. Grimm H et al. Eur J Nutr 2006; 45: 55–60.
GRANT ACKNOWLEDGEMENT. The study was granted in parts by Fresenius-Kabi,
Germany.
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FAT EMBOLISM SYNDROME AS RARE COMPLICATION OF
DERMOLIPECTOMY
S. Nissar*
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Qatar
INTRODUCTION. Fat embolism syndrome (FES) is a multi-organ dysfunction (MODS)
frequently a triad of lung, brain and skin dysfunction due to fat emboli. FES commonly occurs
in trauma patients with long bone fractures, after intramedullary nailing of long bones,
however occasionally cases in patients with pancreatitis, burns and on parental nutrition and
very rarely after liposuction or dermolipectomy are reported. With increasing popularity of
cosmetic surgeries, the number of patient undergoing body sculpture surgery is increased and
up to 8% of the deaths are blamed to FES. FES can easily be confused with MODS due to
other etiologies, hence it is essential that critical care physicians are aware of this entity.
METHODS. Case report - A 46-years-old female suffering from hypertension, diabetes
mellitus and pendulous abdomen, underwent dermolipectomy and abdominoplasty. On the
2nd postoperative day, she complained of shortness of breath and drowsiness.
RESULTS. Her O2 saturation dropped to 69% and required intubation. Pulmonary embolism
(PE) was suspected. Chest X-ray and spiral CT chest showed no evidence of PE, but bilateral
basal lung collapse and consolidation. She was tachycardic (120 to 130/min), febrile (39.5 C),
oliguric for 8 h and showed signs of ARDS. By day 5, her chest improved, but she was
stuporous and remained in this state for almost 18 days. MRI showed periventricular scattered
white matter hyperintense lesions on T2 weighted images (Fig.). Septic work-up was negative
and FES was suspected. By day 23, her neurological status started to improve; she was
weaned off the ventilator and could be discharged from ICU. She made a complete neuro-
logical recovery and was discharged from the hospital on day 80.
CONCLUSION. FES post-dermolipectomy is a rare but life-threatening condition. The lack
of speciﬁc diagnostic test might complicate and delay the diagnosis.
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REDUCING RISK WITH THORACIC EPIDURAL ANALGESIA IN CRITICAL
CARE
F. J. Cox*
1, A. Smith
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2, J. G. Farrimond
2
1Pain Management Service,
2Anaesthesia & Critical Care, Royal Brompton and Hareﬁeld
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INTRODUCTION. Thoracic Epidural Analgesia (TEA) can be safe and effective for pro-
viding perioperative analgesia but is not without risk. Inadvertent intravenous administration
of bupivacaine may induce changes to cardiac rhythm and contractility
(1). We have pro-
spectively evaluated the safety of commercially prepared levobupivacaine (a potentially less
cardiotoxic local anaesthetic) since its introduction in June 2003.
METHODS. A multidisciplinary medication safety initiative (MSI) grouped was formed to
review current practice in the critical care environment including; reported TEA-related
adverse events, the variety of opioid and local anaesthetic presentations, clinical storage,
prescribing practices, initiation of the infusion, infusion devices and staff education.
RESULTS. Only two distinct presentations of infusates are identiﬁed on the pre-printed
prescription and available in our institution. Drug dilution errors (2001 n = 2, 2002 n = 1)
have not been reported since the introduction of levobupivacaine. The adverse incident rate
for epidural analgesia has fallen from 7 reports in 2001 (43% amber rating indicating sig-
niﬁcant patient impact using NPSA criteria
(2)), 6 reports in 2006 to 3 reports in 2007 (no
patients experiencing any signiﬁcant impact). Storage was revised with the sole opioid in-
fusate relocated to a dedicated cupboard. A competency based programme for all clinical staff
was initiated with the need for annual updates identiﬁed. All medication-related adverse
events are disseminated quarterly to all staff.
CONCLUSION. Identifying and managing risks related to TEA can reduce the incidence and
severity of adverse events. A multi-disciplinary approach can improve documentation, storage
and administration.
REFERENCE(S). 1. National Patient Safety Agency (2007) Safer practice with epidural
injections and infusions. London, NPSA
2. National Patient Safety Agency (2004) Seven Steps to Patient Safety. London, NPSA.
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NATRIURETIC PEPTIDES AND C REACTIVE PROTEIN AS EARLY MARKERS
OF CARDIAC OVERLOAD AND INFLAMATION AFTER PULMONARY
RESECTION
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INTRODUCTION. Despite being well studied molecules, little is known about the utilities
of brain natriuretic peptides(BNP) and C- Reactive Protein (CRP) as biological markers of
right cardiac overload and inﬂammation in thoracic surgery. The aim of this study is to ﬁnd
out the patterns and activity of such these molecules after large pulmonary resection
(lobectomy or pneumonectomy).
METHODS. Prospective and observational study including 32 consecutive patients. We
measured sequentially changes in plasma Pro-BNP levels using quimioluminiscence technics
(HELECSYS 2010, Hitachi. Japan) and CRP levels, before and just after pulmonary resection
and also 6,24,48 and 72 h after surgery.
Statistical analysis: Friedman test. Statistically signiﬁcant p\0.05.
RESULTS. Patients 32. Lobectomy:19. Pneumonectomy:13 (Right:5; Left:8).
Age: 65,4 ± 9,8; Male: 30 (93,8%); APACHE II: 7,1 ± 3; Smoke:27 (84,3%); COPD:7
(21,8%); Hypertension:8 (25%); FEV1: 2277,1 ± 609,5 ml;VC: 3356,6 ± 3340 ml;
77,4 ± 18,5; Time of surgery: 186,21 ± 42,7 minutes; time of anesthesia: 231,1 ± 48,6
minutes, epidural analgesia: 12 (37,5%); paravertebral analgesia: 18 (56,3%); PaO2/FiO2
postoperatory: 313,2 ± 92,6 mmHg; PaCO2 postoperatory: 42,5 ± 6,4; MAP postoperatory:
90,5 ± 16,2 mmHg;hemoglobyne: 12,04 ± 1,7 g/ml.
PRO BNP pre:140,7 ± 141,4; T0:148,2 ± 174,7; T6:181,6 ± 156,1; T24:404 ± 395,1;
T48:574,3 ± 685,3; T72:829,5 ± 1057,1 p\0,001.
CRP Pre:51,7 ± 72,6; T0:31,2 ± 44,6; T6:44,7 ± 37,4; T24: 120,9 ± 39,7; T48:
182,1 ± 65,5; T72:151,3 ± 59 p\0,001
CONCLUSION. We observed a remarkable elevation of both, proBNP and CRP since 24 h
after surgery. Plasma proBNP concentrations showed the highest increase at 72 h, possibly
owing to increased right ventricular wall stress as a result of an increment of pulmonary
vascular resistance. An inﬂammatory level peak (CRP) was found 48 h after surgery. Largest
studies are necessary to analyse correlation between right ventricular function and inﬂam-
mation with proBNP and CRP levels in such patients. It may be a potential predictor for both,
prognostic and postoperatory complications.
GRANT ACKNOWLEDGEMENT. In ˜igo Martı ´nez, Olga Campesino and Rafael Citores.
Intensive Care Unit. Hospital Clı ´nico. Valladolid. Spain.
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NONINVASIVE VENTILATION FOR ACUTE RESPIRATORY FAILURE AFTER
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INTRODUCTION. A single prospective randomised study (1)found that, in selected patients
with acute respiratory failure (ARF) following lung resection, Noninvasive Ventilation (NIV)
decreases the need for endotracheal mechanical ventilation (ETMV) and improves clinical
outcome.
METHODS. We prospectively evaluated NIV use for ARF after lung resection during a 4-
year period in the setting of a medical and a surgical ICU of a university hospital. We
documented demographics, initial clinical characteristics and clinical outcomes. NIV failure
was deﬁned as the need for tracheal intubation.
RESULTS. Among 690 patients at risk of severe complications following lung resection,113
(16.3%) experienced ARF, which was initially supported by NIV in 89 (78.7%), including 59
with hypoxemic ARF (66.3%) and 30 with hypercapnic ARF (33.7%). The overall success
rate of NIV was 85.3% (76/89). In-ICU mortality was 6.7% (6/89). The mortality rate fol-
lowing NIV failure was 46.1%. Predictive factors of NIV failure in univariate analysis were
age (p = 0.046), previous cardiac comorbidities (p = 0.0075), postoperative pneumonia
(p = 0.0016), admission in the surgical ICU (p = 0.034), no initial response to NIV
(p\0.0001) and occurrence of non infectious complications (p = 0.037). Only two inde-
pendent factors were signiﬁcantly associated with NIV failure in multivariate analysis:
cardiac comorbidities (odds ratio, 0.066; 95% conﬁdence interval, 0.008–0.557; p = 0.015)
and no initial response to NIV (odds ratio, 0.008; 95% conﬁdence interval, 0.001–0.092;
p\0.0001).
CONCLUSION. this prospective survey conﬁrms the feasibility and efﬁcacy of NIV in ARF
following lung resection.
REFERENCE(S). 1. Auriant I, Jallot A, Herve ´ P et al. Noninvasive ventilation reduces
mortality in acute respiratory failure following lung resection. Am J Respir Crit Care Med
2001; 164:1231–1235.
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CORRELATION BETWEEN HAEMODYNAMIC AND MICROCIRCULATION
PARAMETERS OBTAINED WITH NEAR INFRARED SPECTROSCOPY IN CAR-
DIAC SURGERY PATIENTS
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INTRODUCTION. The purpose of this study was to compare microcirculation parameters,
as assessed by the non-invasive method of Near Infrared Spectroscopy (NIRS), with hae-
modynamic indices, evaluated by right catheterization. The peripheral microcirculation of
cardiac surgery patients is post-operatively altered as a result of the extracorporeal circulation,
the anaesthesia and the hypothermia they undergo during surgery. A non-invasive monitoring
technique of the peripheral microcirculation would be very useful in aiding post-operative
monitoring and in helping ensure adequate tissue perfusion in these patients.
METHODS. We studied 10 cardiac surgery patients (8 males, 2 females, 59 ± 17 years)
during the immediate postoperative period. All patients had undergone extracorporeal cir-
culation and were treated with inotropic and/or vasopressor agents (7 norepinephrine, 6
dobutamine, 2 adrenaline, 3 levosimendan). A Swan-Ganz catheter was used to assess the
haemodynamic parameters. Tissue oxygen saturation (StO2%) of the thenar and masseter
muscles was obtained with the help of In Spectra Model 325 Near-Infrared Spectrometer
(NIRS). The brachial artery occlusion technique was utilized to better assess the endothelial
function, with the calculation of the oxygen consumption rate, the reperfusion rate and the
vascular reactivity.
RESULTS. The haemodynamic parameters of our patients were: MAP 73 ± 15 mmHg,
CVP 8 ± 4 mmHg, PCWP 12 ± 5 mmHg, MPAP 26 ± 6 mmHg, CI 2.6 ± 0.7 L/min/m2,
SVR 1161 ± 317 dyne x s/cm5, PVR 279 ± 146 dyne x s/cm5, HR 104 ± 11 bpm, Hb
10.7 ± 1.7 g/dl, lactate 3.5 ± 2.4 mg/dl. We found a signiﬁcant correlation between cardiac
index and reperfusion rate (r = 0.39, P = 0.016), as well as with vascular reactivity (r =-
0.39, P = 0.027). CI also correlated signiﬁcantly with masseter StO2 values (r = 0.64,
P = 0.001). We also found a signiﬁcant correlation between masseter StO2 values and SvO2
(r = 0.53, P = 0.011), as well as with ScvO2 (r = 0.52, P = 0.014).
CONCLUSION. By utilizing the occlusion technique with NIRS technology we found a
correlation of NIRS derived parameters and haemodynamic indices. As adequacy of tissue
oxygenation and not simple maintenance of ‘‘ideal pressures’’ is the physiologic role of
haemodynamic monitoring, the potential introduction of a non-invasive method to post-
operative cardiac surgery monitoring could help ensure the optimization of patient
management.
1024
AN INCREASE OF HIGH MOBILITY GROUP BOX-1 LEVEL DURING CARDIAC
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K. M. A. Haque*
1, F. Kunimoto
2, Y. Kadoi
3, F. Kurosawa
2, H. Hinohara
2, M. Okawa
1,
K. Oshima
1, S. Saito
3
1Anesthesia and Intensive Care Medicine, Gunma University Graduate School Of Medicine,
2Intensive Care Unit, Gunma University Hospital,
3Anesthesia, Gunma University Graduate
School Of Medicine, Maebashi, Japan
INTRODUCTION. High mobility group box 1 (HMGB 1) is a well known proinﬂammatory
cytokine that initially described as DNA binding protein responsible for transcriptional events
and gene expression. Further investigation focused HMGB 1 as a late appearing inﬂammatory
mediator that persist for longer duration after initiation of inﬂammatory response. Previous
studies have shown that cardiac surgery with cardiopulmonary bypass (CPB) triggers release
of proinﬂammatory cytokines and provokes inﬂammatory response. The present study was
designed to investigate the changes in serum HMGB-1 levels in cardiac surgery using car-
diopulmonary bypass (CPB).
METHODS. Eighteen cardiac valvular disease patients were included in our study; AVR8,
MVR6, MVR + CABG1, MVP3. Study protocol was approved by research committee of our
university. HMGB-1 levels were measured before surgery (immediately after tracheal intu-
bation,T1), 1 hr. after start of CPB(T2), 1 hr. after removal of CPB(T3), 1 hr. after ICU
admission (T4), ICU day-2(T5), ICU day-3(T6). Simultaneously, hemodynamic variables,
required doses of catecholamines, serum lactate concentrations and other laboratory data were
recorded. Repeated measure ANOVA was used to analyze the changes in Tl-T6 values and
values at T2-T6 were compared with T1 value (Dunnet’s test).
RESULTS. Serum HMGB-1 at T1 was 5.99 ± 2.4. It signiﬁcantly increased at T2 (16.76 ±
9.16, P\0.01) and gradually decreased at T3(9.71 ± 6.11), T4(6.51 ± 2.86), T5(4.98 ±
1.57) and at T6(5.54 ± 1.97) while IL-6, white blood cell count (WBC), C-reactive pro-
tein(CRP) elevated postoperatively. Patients’ postoperative course was uneventful and all
patients discharged from ICU within 3 days.
CONCLUSION. 1. Serum HMGB-1 level increased transiently during cardiac surgery using
cardiopulmonary bypass.
2. Patients’ postoperative course was uneventful in spite of high HMGB-1 level during
cardiac surgery.
3. This is the ﬁrst report showing an increase in serum HMGB-1 level during cardiac surgery.
4. High HMGB-1 level might be due to the combination of an increased HMGB-1 release
from ischemic organs and a decreased HMGB-1 elimination during CPB.
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CRITICAL CARE OUTCOME FOLLOWING RUPTURE OESOPHAGUS
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INTRODUCTION. Rupture oesophagus is a thoracic surgical emergency with signiﬁcant
morbidity and mortality [1]. We present our experience in managing these patients in a
tertiary care cardiothoracic critical care unit.
METHODS. We conducted a retrospective clinical review of patients who were admitted to
the Cardio thoracic intensive care unit following rupture oesophagus over a period of last ﬁve
years (2002–2007).
RESULTS. We had 24 admissions following isolated rupture oesophagus to our critical care
unit. Out of which 71% were males, 29% females. The median age was 64 years (range 22–
82). The aetiology was spontaneous (Boerhaave’s syndrome) in 87.5% and iatrogenic in
12.5%. The diagnosis was established early (\24 hrs) in 71% and delayed ([24 hrs) in 29
%. 19 patients (83.3%) were admitted to ITU preoperatively and all 24 (100 %) were admitted
postoperatively.
In preoperative admission group, 63.0% had shock requiring ionotropes and 42.0 % required
ventilation. Primary surgical repair was done in 74.4 %, a 2-stage repair in 8% and conser-
vative management in 16.6%. Postoperatively, 71% were electively ventilated and nearly half
of them (47%) were extubated within ﬁrst 24 hrs. Mean ITU length of stay was 12 days (range
1- 45) and mean hospital stay was 35 days (range 11–86). Over all in hospital mortality was
16.6%.
In 75% of the non-survivors, there was a delay in diagnosis ([24 hrs) along with shock
needing ionotropes on initial admission and they also required preoperative mechanical
ventilation.
Positive bacteriology was obtained in more than 50 % of patients (Gram Negatives) from one
or more specimens and fungal organisms in 41.5%. All the non-survivors had yeasts from one
or more specimens.
CONCLUSION. Our review conﬁrms the early diagnosis and management is crucial for
successful outcome in patients with rupture oesophagus. However, shock on admission and
need for preoperative ventilation by them selves are not indicative of poor outcome.
Microbiological surveillance and aggressive management of bacterial and fungal infection are
crucial for improving outcomes. Our mortality ﬁgures are marginally lower than other centres
[1, 2], possibly because of higher volume and also early critical care interventions.
REFERENCE(S). 1. AD Muir, J White, JA McGuigan, KG McManus and NA Gra-
ham.Treatment and outcomes of oesophageal perforation in a tertiary referral centre. Eur J of
Cardiothorac Surg 2003;23:799–804.
2. E Teh, J Edwards, J Duffy and D.Beggs. Boerhaave’s syndrome: a review of management
and outcome. Interact Cardio Thorac Surg 2007;6:640–643.
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INTRODUCTION. With increasing afﬂuence and changing lifestyles chronic diseases are
becoming increasingly common in the Indian subcontinent. There is dearth of data regarding
the incidence of co morbidities and postoperative complications in patients undergoing single
sitting Bilateral Total Knee Replacement (BTKR) Surgery in the Indian scenario.So we
planned to study.
1. Incidence of co morbidities in patients undergoing BTKR.
2. To determine the relationship of age with postoperative complications.
METHODS. Retrospective study of 565 consecutive patients admitted to 6 Bedded Joint
Replacement ICU undergoing single sitting BTKR between May 2006 to Feb 2008. Patients
were divided into 2 groups: Age[70 and Age\70yrs. Patients were monitored for post-
operative complications including bleeding, transfusion of blood products, transfusion related
complications, postoperative myocardial ischemia, pulmonary embolism, length of ICU stay.
RESULTS. 1. Age[70 yrs comprised 37.3% (n = 210/565) of the total patients.
2. Cardiovascular disease was the most common co morbidity seen in 86.6% (n = 489) of
patients with 73.3% (n = 414) hypertensive, 6.66% (n = 39) coronary artery disease and
4.44% (n = 25) rheumatic heart disease and obesity was the second most common 35.5%
(n = 200). Other comorbid conditions were diabetes mellitus and bronchial asthma in 13.3%
(n = 75) each, hypothyroidism 10.6% (n = 61), depression 9.3% (n = 52), nephropathy
6.6% (n = 37), anaemia 4 % (n = 22) and dyslipidemias 2.6%(n = 14).
TABLE 1
Complications Age[70 Age\70 p value
Postoperative bleeding 895 795 \0.05
Blood transfusions 1.78 units 0.82 units \0.05
Tranfusion related complications 7% nil \0.05
Length of icu stay 68.5 h 46.5 h \0.05
Postoperative myocardial ischemia 14.2% nil \0.05
Postoperative pulmonary embolism 7.2% nil \0.05
CONCLUSION. 1. Patients undergoing single sitting BTKR have signiﬁcant co morbid
conditions demanding ICU care in the postoperative period.
2. Increasing age is associated with higher incidence of postoperative complications and
morbidity.
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WHAT IS THE ADEQUATE TIMING FOR EXTUBATION MAXILOFACIAL
SURGERY?
E. Curiel, M. M. A. Prieto*, J. Mora, M. M. D. Arias, M. Salguero, G. Quesada
Intensive Care Unit, Carlos Haya Hospital, Ma ´laga, Spain
INTRODUCTION. We usually consider delaying the extubation of maxillofacial surgery
more than other postoperative, because of the anatomy of face and neck, the inﬂammatory
response after surgery and the length of surgical procedure. Our objective is to detect com-
plications in a cohort of patients after maxillofacial surgery trying to relate with early or late
extubation.
METHODS. Observational, prospective study of a cohort of 104 patients after maxillofacial
surgery and admitted in our ICU between February 200 to March 2008. We analyzed
demographic and clinic variables, preoperative situation, surgical risk (measured with
American Anestesiology Scale risk), difﬁcult to intubation, length of surgery, complications
in ICU and time under mechanical ventilation and complications due to extubation moment.
We considered early extubation before than 6 h after admitted in ICU. Dates are shown as
mean and standard desviation or percentages and absolute number. We used SPSS package
for the statistical analysis.
RESULTS. We collected 104 patients (59,6% male). Mean age 52,6 ± 18,9 years, urgent
surgery 5,8%(6), Lengh of surgery 4,41 ± 1,5 h, difﬁcult expected intubation 26,1% (24) and
mehanical ventilation in ICU 8,64 ± 11,8 h. We registered complicatios in 13 patients
(12,5%), most frequents respiratory (5,8%), hemodynamic (2,9%) or combinations. One
patient died and 4 patients were reoperated. 38 patients were intubated six or more h and this
group had more rate of complications than the group extubated prior to 6 h. (p = 0,02) 3,78
IC95% (1,16–12,31). ASA risk and difﬁcult expectation to intubate were not associated with
more complication. Univariate analysis showed that cervical ganglionic drainage was asso-
ciated with more complications after extubation. (p = 0,012. 4,4 IC95% 1,2–13,1).
Multivariate analysis reported as predictors of more rate of complications: Extubation after
6 h in ICU(p = 0,049. 3,3 IC95% (1–11,2)) and tumoral surgery which needs cervical gan-
glionic drainage (p = 0,032. 3,6 IC95% (1,1–12,1)).
CONCLUSION. Premature tracheal extubation can be hazardous in this surgery due to
oedema and haemorrage and the proximity to the airway. We usually leave intubated more
time to patients who are difﬁcult to intubate after a surgical procedure. In spite of a not very
high rate of complications (12,5%), our study revealed that delayed extubation and cervical
ganglionic drainage are associated with more complications and rate of reintubation.
REFERENCE(S). 1. HALFPENNY W., MCGURK M. Analysis of tracheostomy-associated
morbidity after operations for head and neck cancer. British journal of oral & maxillofacial
surgery 2000;38(5): 509–512.
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INTRODUCTION. Purpose: Use of airway system ﬁlters (ASF) in anaesthesia and the
possibility for a prolongated operation time of the breathing circuit system (BCS) is con-
troversial with the consequence of still lacking recommendations. To clarify one part of this
dilemma we investigated the contamination risk of BCS, protected by an HME-F, for either 1,
2, 5 and 7d in a clinical setting.
METHODS. METHODS: In a prospective longitudinal clinical survey, the inner and outer
surface contamination of BCS were monitored and compared with the bioburden of the ASF
by the respiratory pathogenic patient ﬂora. Sample swabs were taken from trachea and the tip
of the tubus, both inner sides of the ASF, condensation water from the BCS, the outer surface
of the BCS and the anesthesia bag. The consequences for the costs of this prolonged use up to
7 d of the BCS were calculated.
RESULTS. RESULTS. Neither germs of the physiological ﬂora nor the colonizing pathogens
of the oropharynx of the operated patients were transmitted through the ﬁlters. No organisms
were cultivatet from the condensation water or in the ventilator. In opposite, all anesthesia
bags surfaces were highly contaminated.
CONCLUSION. CONCLUSION. The HME-F protects the BCS as well as the ventilator
from the respiratory ﬂora of the patient, allowing to use the BCS for more than one patient and
extend the change interval up to 7d, which proved to be cost effective. In order to minimize
cross infections, the external surface of the BCS as well as the anaesthesia bag must be
disinfected after each patient.
GRANT ACKNOWLEDGEMENT. Pall Medical Europe.
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POSTPNEUMONECTOMY SYNDROME; DESCRIPTION OF A CASE AND
REVIEW OF THE LITERATURE
M. van Dam*, J. Horn
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INTRODUCTION. Postpneumonectomy syndrome (PPS), is deﬁned as an airway obstruc-
tion due to heart and mediastinal shift and rotation, after pneumonectomy left or right.
METHODS. A 64-year-old male with 45 pack-years was evaluated for arthropathy. After a
positive Mantoux skin test chest x-ray revealed a right central tumor. Pulmonary function
studies showed FEV1 2,96L (91% predicted) and FEV1/VC 0,55. PET-CT showed a PET
positive lesion apical in the right inferior lobe and a positive lymph node. Bronchoscopy,
mediastinoscopy and EUS were tumor-negative. Right-sided pneumonectomy was performed
for squamous cell bronchuscarcinoma T1N0M0, stage IA. After surgery he developed ARDS,
followed by stump leakage for which revision was performed. Intercurrent airway infections
were treated with antibiotics. Despite this, the patient had major problems weaning from the
ventilator. CT scan showed compression atelectasis of the left inferior lobe, reason to consider
the possibility of PPS. Despite absence of mediastinal shift, surgery was performed 4 months
later to implant expandable prosthesis in the pleural cavity. In spite of this intervention,
weaning from the ventilator was hampered by muscle weakness and swallowing difﬁculties
leading to recurrent aspiration.
RESULTS. PPS is a rare complication of pneumonectomy. Jansen et al. reported one case in
a series of 640 pneumonectomies (incidence 0,2%) and just over 20 cases are reported in
literature. Clinical symptoms are progressive dyspnoe, cough, inspiratory stridor, recurrent
pneumonia and bronchiectasis. In reported cases the symptoms developed 5 months to
35 years after pneumonectomy. In all described patients a shift of the heart and mediastinum
towards the side of the pneumectomy, causing bronchial obstruction, was found. As PPS can
lead to respiratory insufﬁciency and death this diagnosis should be considered in every
postpneumonectomy patient presenting with corresponding symptoms. Conﬁrmation of the
clinical diagnosis PPS is accomplished with CT-scan and bronchoscopy, showing a shift of
heart and mediastinum towards the pneumectomy-side with hyperinﬂation of the contralateral
lung, stretching of the distal trachea and left main bronchus and lobair bronchus. The stret-
ched airways can be compressed by pulmonary arteries, aorta and spine leading to trachea-
broncho-malacia. Current surgical treatment consists of mediastinum repositioning and
implantation of expandable prostheses with an additional role for airway stenting.
CONCLUSION. PPS, although rare, may have contributed to the weaning problems in this
patient and should be considered after pneumonectomy.
REFERENCE(S). 1. Jansen JP et al. Postpneumonectomy syndrome in adulthood. Surgical
correction using an expandable prosthesis. Chest 1992;101:1167–1170.
2. Grillo HC et al. Postpneumonectomy syndrome: Diagnosis, management and results. Ann
Thorac Surg 1992;54:638–651.
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INTRODUCTION. Cortisol levels are of prognostic value in patients with community-
acquired pneumonia (CAP). However, the predictive value of total cortisol (TC) and of the
frequency and impact of adrenal insufﬁciency (AI) in severe CAP remains to be thoroughly
evaluated.
METHODS. The main objective was to investigate the predictive value of baseline and post-
ACTH (250mcg) TC levels at ICU admission in patients with severe CAP in a prospective
cohort study of patients with severe CAP admitted to the ICU. TC at baseline and after ACTH
test, C-reactive protein, D-dimer, clinical variables, SOFA, APACHE II and the CURB-65
score were measured. The major outcome measures were hospital mortality and disease
severity.
RESULTS. Seventy-two patients with age 71 (52.5–83.7), APACHE II 14 (11–17), PaO2/
FiO2 267 (240–312) were evaluated. Twenty-three patients (31.9%) had septic shock at
presentation, SOFA at admission was 4 (3–6) points and 20 (27.8%) patients required invasive
mechanical ventilation. Hospital lenght of stay was 10 (7–18.5) days and 12 (16.7%) patients
died during hospital stay. Corticosteroids were administered in 33 (45%) patients for a mean
period of 3 (3–5) days and the mean dose was 60 mg of methylprednisolone. Total cortisol
levels were 18.1 (14.4–26.7) mcg/dL and delta cortisol after 250mcg ACTH was 19 (12.8–
27)mcg/dL. Baseline TC, increased with increasing severity of CAP according to the CURB-
65, APACHE II and SOFA (P\0.05). Using the criteria of Annane et al (2002) AI was
diagnosed in 29 (40.8%) patients. TC levels in non-survivors were signiﬁcantly higher than in
survivors. Signiﬁcant correlations were observed (in linear regression) amongTC and D-dimer
and TC and APACHE II (r2 = 0.20 and 0.24, p\0.0001 respectively). There was also
correlation of TC and SOFA at day 1 (r = 0.48, p = 0.01). In univariate analysis, TC, CURB-
65 and APACHE II, but not the presence of AI, were predictors of death. The discriminative
ability of TC [Area under ROC curve = 0.77(95%CI, 0.65–0.90)] for in-hospital mortality
was better than those of usually employed severity predictors as APACHE II, CURB-65, D-
dimer or C-reactive protein. In ROC curve analysis, the best cutoff for TC was 25.7mcg/dL.
CONCLUSION. Baseline TC levels are better predictors of severity and outcome in severe
CAP than routinely measured laboratory parameters or scores as APACHE II, SOFA and
CURB-65. In patients with severe CAP requiring ICU admission, the presence of AI does not
have a signiﬁcant impact on survival.
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ATTITUDES AND PERCEPTIONS IMPEDING INFLUENZA VACCINE UPTAKE
AMONG HEALTH CARE WORKERS AT A SINGLE CENTRE POST SARS
J. Tan, E. Ng*, J. Foong, R. Sim, K. Lee, T. Chong, T. Chua, A. S. L. Wong, T. Koh
Cardiology, National Heart Centre, Singapore, Singapore, Singapore
INTRODUCTION. Health Care Workers (HCWs) are at risk of occupational exposures to
inﬂuenza and infected HCWs may become potential vectors in the nosocomial transmission of
inﬂuenza(1). Inﬂuenza vaccinnation is effective in preventing inﬂuenza infection for hospital-
based HCWs(2). Since 2004, and after SARS, the hospital campus has initiated a inﬂuenza
vaccination program, at no cost, to all HCWs. Despite the availability of this program,the take
up rate is a low 58%.
We aim to explore the perceptions and decision making factors towards vaccination amongst
HCWs at our centre.
METHODS. The study was approved by Singapore General Hospital ethics committee. All
employees except doctors were asked to participate in the survey. Employees were asked for
signed consent before the survey was administered. Statistical analysis was performed with
JMP 7.
RESULTS. 436 completed questionnaires out of a total of 668 employees were gathered.
59% of the cohort were nurses, 41% were outpatient staff. 89.2% of respondents were female
and the median age group was between 21 to 30 years old. 75% of this cohort did participate
in the last vaccination program with 78% agreeing that HCWs should be vaccinated but only
30% feel it is ethically wrong for HCWs not to do so. The strongest reason for vaccination
was for protection against a possible ﬂu pandemic (73%) followed by the wish to protect our
patients (15%) and the main reasons for opting out was due to forgetfulness or inconvenience
(37%), fear of needles or side effects (21%) and the notion that it was ineffective (20%). Only
one respondent was unaware that it was available in campus and free of charge. 53% of
respondents developed side effects post vaccination, the most common was Flu-like symp-
toms (21.8%); post vaccination 8.3% surveyed required medical leave. Surprising, 36% of
staff would be willing to pay to receive vaccination and the majority would not comply if told
to do so by superiors. 76% believe vaccination to be effective and prevents deaths in high risk
individuals; however 22.2% believed ﬂu vaccination to have serious adverse effects. 95% was
aware of Ministry of Health’s recommendation for vaccination. Interestingly, 90% was either
neutral or pro legislation to mandate vaccination amongst HCWs, the majority believing that
the program would be more effective if there was 100% take up rate. For the time being, most
felt that vaccination campaigns are effective.
CONCLUSION. If the reasons for refusing vaccination can be addressed, the vaccination
program can be more effective with higher take up rates.
REFERENCE(S). 1. Mossad SB.Inﬂuenza update 2007–2008: vaccine advances, pandemic
preparation.Cleve Clin J Med. 2007 Dec;74(12):889–94.
2. Braun MM, Izurieta HS, Ball R. Effectiveness of inﬂuenza vaccination.N Engl J Med. 2007
Dec 27;357(26):2730.
1032
REMIFENTANIL WITHDRAWAL AND SUBSEQUENT INTENSIVE CARE UNIT-
ACQUIRED INFECTIONS
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INTRODUCTION. A recent animal study suggested that morphine withdrawal lowers host
defense to enteric bacteria resulting in higher rates of infection [1]. We hypothesized that
remifentanil withdrawal would be associated with higher rates of intensive care unit (ICU)-
acquired infections.
METHODS. Prospective observational cohort study performed in a 30-bed ICU during a 12-
month period. All patients requiring intubation, mechanical ventilation, and sedation for[3d
were eligible. Patients who died before sedation withdrawal were excluded. Sedation was
based on a written protocol including remifentanil with or without midazolam. The bedside
nurse adjusted sedative infusion according to physician’s prescription. Ramsay score was
used to evaluate consciousness. Incidence rate of ICU-acquired infections was compared
between the period of 96 h preceding remifentanil withdrawal and that of 96 h following
remifentanil withdrawal. McNemar’s test and Wilcoxon test were used to compare categorical
and continuous variables, respectively.
RESULTS. 266 consecutive patients were included (mean ± sd or %): age 57 ± 17, male
gender 66%, SAPS II 50 ± 18, duration of mechanical ventilation 23 ± 22d, length of ICU
stay 30 ± 28d, ICU-mortality 30%. Rate of patients with ICU-acquired infection was sig-
niﬁcantly higher during the 96 h following remifentanil withdrawal than the 96 h preceding
remifentanil withdrawal (23 vs. 8%, p\0.001), as well as rate of patients with ventilator-
associated pneumonia (10 vs. 3%, p = 0.004) and ICU-acquired bacteremia (6 vs. 1.5%,
p = 0.012). Incidence rate of ICU-acquired infection was signiﬁcantly higher during the 96 h
following remifentanil withdrawal than the 96 h preceding remifentanil withdrawal (94 vs.
29/1000 ICU-days, p\0.001), including incidence rates of ventilator-associated pneumonia
(32 vs. 8/1000 mechanical ventilation-days, p\0.001) and ICU-acquired bacteremia (18 vs.
6.5/1000 ICU-days, p\0.001). In addition, incidence rate of ICU-acquired infection was
signiﬁcantly higher during the 96 h following remifentanil withdrawal than all ICU stay (94
vs. 40/1000 ICU-days, p\0.001).
CONCLUSION. Remifentanil withdrawal is associated with higher rates of ICU-acquired
infections, including ventilator-associated pneumonia and ICU-acquired bacteremia.
REFERENCE(S). 1. Feng P et al. Infect Immun 2006; 74:5221–6.
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NEBULIZED ANTITHROMBIN ATTENUATES BACTERIAL OUTGROWTH IN
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INTRODUCTION. Pulmonary coagulopathy is a hallmark of pneumonia and is important
for its pathogenesis. Natural inhibitors of coagulation, such as activated protein C (APC) and
antithrombin (AT), may exert lung–protective effects via anticoagulant and anti–inﬂamma-
tory pathways. Systemic administration of anticoagulants increases the risk of bleeding; local
treatment may allow for higher treatment dosages and increased local efﬁcacy while reducing
the risk of bleeding.
METHODS. We investigated effects of local administration through nebulization of APC
and AT in male Sprague–Dawley rats with Streptococcus pneumoniae (SP)– or Pseudomonas
aeruginosa (PA)–pneumonia. Rats were intratracheally challenged with either S. pneumoniae
or P. aeruginosa, and randomized to local treatment with normal saline, recombinant human
APC (5 mg/kg) 30 minutes before induction of pneumonia and was repeated every six h.
Human plasma–derived AT (500 IU/kg) was repeated after 24 h because of its longer
pharmaceutical half life. Non–infected rats served as controls. Rats were sacriﬁced at 16 h
(PA-pneumonia) or 40 h (SP pneumonia) after the bacterial challenge, for bronchoalveolar
lavage. Data are presented as means (SD). Statistical analysis by one-way analysis of variance
and Kruskal-Wallis test combined with Dunnett’s or Dunn’s method where appropriate.
RESULTS. Both SP– and PA–pneumonia resulted in pulmonary thrombin generation, as
reﬂected by a rise in thrombin–antithrombin complex (TATc)–levels (9.13 ± 0.75 [SP] and
5.83 ± 0.76 [PA] vs. 0.45 ± 0.21 [control], P\0.01 and P\0.01, respectively). While
nebulized APC or AT had no systemic effects, they attenuated the local rise in TATc–levels
(SP–pneumonia: 3.60 ± 0.62 [APC] and 4.57 ± 0.56 [AT) vs. 9.13 ± 0.75 [saline], P\0.01
and P\0.01, respectively; PA–pneumonia: 1.36 ± 0.41 [APC] and 3.64 ± 0.88 [AT) vs.
5.83 ± 0.76 [saline], P\0.01 and P\0.01, respectively). Bacterial outgrowth of SP was
attenuated in after AT treatment (P\.05) but not after APC treatment.
CONCLUSION. Local treatment with APC or AT impairs pulmonary activation of coagu-
lation in pneumonia; nebulized AT attenuates outgrowth of SP.
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CHARACTHERISTICS OF HIV-INFECTED PATIENTS ADMITTED IN A SPE-
CIALIZED ICU IN BRAZIL
A. M. Japiassu*, I. C. Tavares, H. B. Bernal, R. Valls, L. D. Facchinetti, E. P. Nunes,
F. A. Bozza
Intensive Care, Instituto De Pesquisa Clı ´nica Evandro Chagas, Rio De Janeiro, Brazil
INTRODUCTION. HAART led to a great decline in lethality of HIV infected patients. ICU
admission rates of this population are however increasing in many areas. It is important to
elucidate their characteristics and prognosis. We evaluated the reasons for admission and
prognosis factors of HIV infected patients on an infectious diseases ICU of a middle income
country.
METHODS. We conducted an observational study of all HIV infected patients admitted on
our ICU between 07/01/2006 and 12/31/2007, collecting data regarding age, gender, reason
for admission, time since AIDS deﬁning condition and CD4 count, besides length of ICU stay,
opportunistic infection at admission and sepsis during ICU stay. Clinical severity was eval-
uated by expanded SAPS II and SOFA scores on the ﬁrst 24 and 72 h of admission.
Multivariate analysis examined organ dysfunctions independently related with length of stay
and lethality.
RESULTS. Ninety-one HIV-infected patients were included with a lethality rate of 37%
(predicted mortality of 44% by SAPS II). Age mean was 41.5 years with a predominance of
male gender (74%). CD4 count was lower than 100/mm3 in 71% of patients. Respiratory
(31%) and neurological (22%) diseases, besides sepsis (23%), were the most frequent reasons
for admission. Many admissions were motivated by non-infectious causes (27%), mainly
metabolic and cardiovascular. Higher SAPS II and SOFA scores were highly associated with
death (p\0.0001). These scores had good performance in predicting death, as analyzed by
area under ROC curves: SAPS II exp 0.78 (0.68–0.88); 1st day SOFA 0.80 (0.71–0.89); 3rd
day SOFA 0.83 (0.73–0.93). Sepsis, but not infection or last recorded CD4 count, was
statistically related with lethality. Combined renal and hematological dysfunctions was
independently associated with lethality and respiratory or cardiovascular dysfunctions were
associated with prolonged length of stay.
CONCLUSION. One quarter of ICU admissions were motivated by non-infectious causes.
SOFA and expanded SAPS II were useful tools for prognosis evaluation in this population.
Sepsis and combined renal and hematological dysfunctions were associated with higher
lethality and respiratory or cardiovascular dysfunctions were associated with a prolonged ICU
stay.
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ELEVATED EXTRAVASCULAR LUNG WATER INDEX AS A SIGN OF SEPTIC
PROGRESSION IN BURNED PATIENTS
Z. Bognar, V. Foldi, B. Rezmann, L. Bogar, C. Csontos*
Department of Anaesthesia and Intensive Care, University of Pecs, Pecs, Hungary
INTRODUCTION. Sepsis and the developing multiple organ failure (MOF) are the major
cause of mortality in burned patients. It needs early diagnosis and speciﬁc treatment. The
early detection of sepsis is difﬁcult due to systemic inﬂammatory response syndrome (SIRS),
which can develop without detectable infection [1]. It has been proven that inhalation injury
and ﬂuid resuscitation do not inﬂuence extravascular lung water index (EVLWI) [2]. Data in
the literature suggest that elevated EVLWI may be a sign of the developing bacterial sepsis in
burned patients [3]. The aim of our retrospective study was to analyse EVLWI regarding
presence of infection, sepsis and mortality. The correlation between serum procalcitonin
(PCT) level and EVLWI has also been studied.
METHODS. Daily data from 38 patients admitted with burn injury (Total Body Surface
Area[15%) were analysed (laboratory parameters and thermodilution monitoring). The day
when microbiological samples were taken due to suspected developing bacterial infection was
determined as day 0, the onset point of infection and /or sepsis. Data collected three days
before and after onset of sepsis were studied. Patients were divided into survivors and non-
survivors according to the outcome. Laboratory parameters were sorted into two groups using
EVLWI, with a cut-off point of 8 ml kg-1. Correlations between variables were analyzed with
the Spearman test and variables were compared with repeated measure ANOVA.
RESULTS. EVLWI signiﬁcantly correlated with PCT (r = 0,556; p\0.001), Baltimore
Sepsis Scale (BSS) (r = 0,275; p\0.01), Intrathoracic Blood Volume Index (ITBVI)
(r = 0.334; p\0.001) and Positive End Expiratory Pressure (PEEP) (r = 0.211; p\0.05).
Cardiac Index (CI), ITBVI, PEEP, PCT and BSS were signiﬁcantly higher in the high-
EVLWI group (p\0,05). EVLWI showed a marked elevation on day -1 in both groups
(p\0.05) compared to day -3. Elevated PCT level was ﬁrst detected (p\0.05) on day 0 in
both groups. PCT started to normalise both in the survivor and non-survivor groups after
administration of antibiotics (i.e. after day 0) but its level still remained elevated on day +3 in
non-survivors. In contrast to PCT, EVLWI remained in higher range or further increased
among non-survivors on day +3 (p\0.01) but no signiﬁcant difference could be found in the
survivors on day +3 compared to the value measured on day -3.
CONCLUSION. Our data suggest that EVLWI may be an early warning sign of developing
bacterial infection and its continuously increased level may predict poor prognosis in burned
patients.
REFERENCE(S). 1. Greenhalgh D. G. et al. J of Burn Care & Research 2007;28:776–790. 2.
Csontos C. et al. Acta Anaesth Scand in press.
3. Tranbaugh RF et al. J Trauma 1983;23:597–604.
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INTRODUCTION. The morbidity and mortality of HIV-infected patients admitted to the
ICU has improved signiﬁcantly. Many ascribe this improvement to the increased use of highly
active retroviral therapy (HAART) (1,2) whereas others have found it has no inﬂuence on
outcome (3). The aim of this study was to describe the demographics and outcomes for HIV
infected patients admitted to a London Teaching Hospital Intensive Care Unit.
METHODS. The clinical information system of our ICU was interrogated to identify all
HIV-infected patients treated between 2002–6. Standard demographic data, reason for ICU
admission, severity of illness scores, use of HAART, ICU and hospital length of stay (LOS)
and mortality were recorded.
RESULTS. 106 (61male:45female) HIV-infected patients had 113 patient episodes. ICU
mortality was 22.1% and hospital mortality 25.9%, with median ICU and hospital LoS of 5 and
16 days respectively. Mortality for known HIV patients was 28% and that of newly diagnosed
patients 16% (Table 1). Admissions for HIV related illnesses were associated with a higher
mortality than those for non-HIV related illnesses (29% vs. 10%, P\0.05). Admission diag-
noses were mainly HIV related with associated mortalities as shown in Table 2.
TABLE 1
N (%) HIV rel
adm N (%)
Mean
APACHE
2 (sd)
Mean
SOFA
(sd)
ICU Mort
N (%)
Hosp Mort
N (%)
Known HIV 87 (82) 57 (66) 22 (7.3) 7.1 (3.3) 20 (23) 24 (28)
+ive HAART 57 (54) 37 (64) 22 (7.2) 6.8 (3.6) 13 (23) 16 (28)
-ive HAART 30 (28) 20 (71) 21.2 (7.6) 7.2 (2.8) 7 (23) 8 (27)
New HIV Diag 19 (18) 19 (100) 19.9 (5.5) 6.6 (4.4) 3 (16) 3 (16)
TABLE 2 PRESENTATION
N (%) New HIV
Diagnosis
(N)
HAART
(N)
No HAART
(N)
ICU Mort
N (%)
Hosp
Mort
N (%)
Respiratory 31 (27) 12 13 6 9 (29) 10 (32)
Sepsis 22 (19) 1 18 3 5 (23) 7 (32)
Neurological 21 (19) 4 9 8 5 (24) 5 (29)
Toxicology 14 (12) 0 8 6 2 (14) 2 (14)
Other 25 (22) 2 17 6 2 (8) 2 (8)
CONCLUSION. In line with recent studies (1,2,3) mortality rates in our cohort of HIV-
infected patients are similar to those of the general ICU population. Unlike recent reports (4),
the most common presentations are HIV related. New HIV diagnosis also has a better out-
come in our cohort, as do those patients admitted for non-HIV related illness.
REFERENCE(S). 1. AJRCCM.2002;66(3):262–7.
2. AIDS.2003;17(1):73–80.
3. Thorax.2007;62(11):964–8.
4. Chest.2004;125(5):1800–4.
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VENTRICULOSTOMY-RELATED INFECTION (VRI) AFTER SUBARACHNOI ¨D
HEMORRHAGE (SAH) : DIAGNOSTIC CRITERIA AND RISK FACTORS
I. Ouanounou*, E. Gayat, R. Pirracchio, J. Mateo, D. Payen
Lariboisiere Hospital, Surgical Intensive Care, Paris, France
INTRODUCTION. Interpretation of pleı ¨ocytosis in the context of SAH is often difﬁcult
because of the presence of blood in the CSF. The aim of the study was to evaluate classical
diagnostic criteria of meningitis for patients needing an external ventriculostomy drain (EVD)
after SAH.
METHODS. Inclusion criteria : All consecutive patients admitted to our ICU for SAH and
needing an EVD between 2005 and 2007. Collection of all CSF values available. CSF
samples were obtained if there was a clinical suspicion of VRI (fever[38 C and (or) altered
consciousness). Proved VRI (PVRI) was deﬁned when there was a positive culture of CSF,
and suspected VRI (SVRI) when culture was negative but treatment was prescribed[5 days
by the attending physician. Sensibility, speciﬁcity, positive and negative predictive values
were obtained for the following variables and their association : CSF WBC[100/mm3 and
PMN[50%, CSF WBC/RBC[1/500, hypoglycorachia deﬁned as glycorachia (G).
RESULTS. Among169SAH,54neededanEVD(32%).TheirWFNSscore was4 ± 1,Fischer
4 ± 1, GCS 9 ± 4. Among the 54 patients, 223 CSF were analysed, 7 PVRI (13%) and 8 SVRI
(15%) were identiﬁed. Staphylococcus wasfound in71% and a gramnegative bacteriain29% of
PVRI. Diagnostic criteria of VRI for the 223 CSF are summarized in Table 1. The univariate
analysis identiﬁed an EVD[20 days (47% vs. 21%), a co-infection (67% vs. 37%) and the
number of CSF withdrawn during ICU stay (10 ± 5v s .6± 5) as signiﬁcant factors associated
with VRI (p\0,05 for PVRI + SVRI vs. non VRI respectively), whereas physiological scores,
surgery and number of EVD placed were not. By multivariate analysis, among the 3 signiﬁcant
variables tested, none was independently associated with VRI.
TABLE 1 DIAGNOSTIC CRITERIA OF PVRI (AND OF PVRI+SVRI)
Se PVRI
(PVRI+SVRI)
Spe PVRI
(PVRI+SVRI)
PPV PVRI
(PVRI+SVRI)
NPV PVRI
(PVRI+SVRI)
WBC[100/mm3
+PNN[50%
100% (100%) 66% (66%) 9% (17%) 100% (100%)
WBC[100/mm3
+PNN[50%
+WBC/RBC[1/500
100% (100%) 73% (73%) 11% (21%) 100% (100%)
WBC[100/mm3
+PNN[50%
+WBC/RBC[1/500
+HYPOG
67% (64%) 95% (95%) 31% (50%) 99% (97%)
CONCLUSION. Usual criteria for meningitis diagnosis had very low PPV for VRI diagnosis
in SHA patients, although their absence could eliminate the diagnosis in 99% cases. Hypo-
glycorachia was absent in 33% of PVRI. In addition, given the low size of the study, none of
the classical risk factors for VRI was found in our population.
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TIME TO POSITIVITY AS A PREDICTOR FOR LENGTH OF STAY IN INTENSIVE
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INTRODUCTION. Inadequate antibiotic therapy predicts poor outcome from sepsis, but
there is no simple test of adequacy. We suggest that a time-to-positivity assay (Tpos) might
act as a surrogate for antimicrobial activity and predict outcome from sepsis in ICU.
1 We
conducted a prospective trial to test this hypothesis.
METHODS. In this phase II exploratory study 47 sequential ICU patients with onset of sepsis
who had not had antibiotics for[3 days were recruited. Sepsis was deﬁned as evidence of
infection plus C 3 criteria for SIRS. Sera taken at 24 h post empiric antibiotics were inoc-
ulated into culture bottles containing standardised bacteria, incubated in an automated system
and time to positivity noted. The primary clinical endpoint was days in ICU. We also looked
at 28 day survival.
RESULTS. 48.9% were female with an average age of 59.7yrs. Cultures that are negative at
5d incubation indicate adequate antimicrobial therapy; cultures that become positive in\5d
indicate inadequate therapy. The median SOFA scores on day 1 in the negative group was 9
and in the positive group 10(p[0.05).There was no statistical association between Tpos1 and
28 day survival(p[0.05): consequently, the area under the ROC curve was 55.9%
(SE = 9.4%) and sensitivity 50%, speciﬁcity 65% for a cutoff of 9 h.Figure 1 shows the
length of stay in ICU was signiﬁcantly predicted by time for Tpos1 (p\0.05).The group
where it remained negative at 5 days (ie indicating adequate antimicrobial therapy) were
more likely to have a shorter stay in ICU (median 7.8d vs. 14.4d).
CONCLUSION. These data show that patients whose Tpos1 remains negative are more
likely to leave ICU early. The data also show that if Tpos1 has not become positive after 9 h
the patient may do worse. At this point a change in therapy could be considered.
REFERENCE(S). 1. Jerwood S, Hudson S, Hankins M et al. Time to Positivity as a Novel
Predictor of Outcome in ICU Patients with Sepsis Crit Care 2007;11(S)P54.
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LIPOPOLYSACCHARIDE INDUCES ALTERATIONS IN LUNG EPITHELIAL
CELLS INDIRECTLY THROUGH MACROPHAGES
V. Puntorieri, E. L. Martin*, L. Del Sorbo, V. M. Ranieri
Anesthesia and Intensive Care, University of Turin, Turin, Italy
INTRODUCTION. In vivo, lipopolysaccharide (LPS) induces lung injury, causing inﬂam-
mation, alveolar-capillary leak and epithelial cell death. In contrast to this observation, several
in vitro studies have shown pulmonary epithelial cells to be hyporesponsive to LPS stimu-
lation. A possible explanation is that in vivo alveolar macrophages act as a ﬁrst line of defense
to infections, thereby regulating the epithelial response to LPS; however the mechanisms and
effects of interaction remain unclear. Therefore, the aim of this study is to further understand
and characterize the pulmonary epithelial response to LPS through macrophages. It is
hypothesized that the effects of LPS on lung epithelial cells occurs indirectly through the
mediators released by activated macrophages.
METHODS. THP1 differentiated macrophages were stimulated with LPS or vehicle and the
resulting conditioned media (CM) was subsequently used to stimulate pulmonary epithelial
A549 cells. Additionally, polymyxin B (PMX-B) was added to LPS CM prior to A549 cell
stimulation to bind and sequester residual LPS. Epithelial cells were also stimulated with LPS
alone. After 24 hrs, the epithelial production of IL1b, VEGF, and TNFa (ELISA) and the
surface expression of ICAM-1 (IF) were determined.
RESULTS. LPS (10ug/ml or 100ug/ml) and control CM had no direct effects on A549 cells
compared to the vehicle. Incubation with LPS stimulated macrophage CM resulted in
increased production of IL1b (27.45 ± 0.94 pg/ml) and VEGF (1085 ± 121 pg/ml) versus
control CM (0 and 584 ± 36 pg/ml respectively). TNFa, which is not produced by A549
cells, in the LPS CM was reduced by 75% following incubation with A549 cells, suggesting
internalization of this molecule by pulmonary epithelial cells. Additionally, there was an up-
regulation of ICAM-1 surface expression (representative ﬁgure below) by LPS CM versus
controls. All observed effects were unaltered by the presence of PMX-B.
CONCLUSION. Inﬂammatory mediator production and adhesion molecule expression of
A549 cells can be induced by LPS indirectly through macrophages. Furthermore, LPS
sequestration did not alter this response, implying LPS does not enhance the effects of the
macrophage mediators. By understanding these cellular mechanisms involved in LPS-induced
pulmonary injury novel therapeutic strategies to prevent acute lung injury can be developed.
1040
CLINICAL CLUES IN MANAGEMENT OF ACUTE ENCEPHALITIS IN INTEN-
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INTRODUCTION. Encepahlitis occur infrequently and often is difﬁcult to conﬁrm the
etiologic agent. The potential for death and neurologic damage makes them important to study
all characteristics clinical and biological characteristics registered from the patients.
METHODS. A retrospective study was performed for all persons hospitalized between 2004
– 2006 in Clinic of Infectious Diseases (Iasi) with acute encephalitis. Clinical characteristics,
laboratory ﬁndings and therapeutic possibilities were obtained.
RESULTS. 106 patients were found. Prodrome or frequent concurrent symptoms at onset
consisted of: fever (64,7%), altered level of consciousness (63%), headache (34,5%), gastro-
intestinal symptoms (31,8%), seizures (24,8%). The clinical proﬁles founded were: signs of
meningeal irritation (36,2%), trouble of conciousness (44,8%), extrapyramidal syndrom
(15,5%), paresis of cranial nervs (15,5%), cerrebelar syndrom (13,8%). The frequent
abnormal neuroimaging was diffuse cerebral edema (19%). CSF WBC counts median, protein
and glucose level median were normal. Identiﬁed infectious etiologies were Coxackie virus
and measles causing subacute sclerosing panencephalitis. Agreed therapeutical possibilities
were: Ampicillin, Acyclovir, measures to control elevated intracranial pressure, dexametha-
sone and isoprinosine. Conclusions—Diversity of clinical and etiologic characteristics of
encephalitis contributes to the difﬁculty in the diagnosis, management and treatment of this
severe syndrome. From 106 cases we found etiologic agent in two cases.
CONCLUSION. Encephalitis remains a signiﬁcant health problem with tremendous
importance especially in children.The diagnosis of acute and atypical neurological disorders
must include also the point of view from infectious diseases practitioner.
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RENAL FAILURE AND ICU-ACQUIRED INFECTION
P. Wiesen*, N. Layios, M. Nys, P. Damas
General Intensive Care, University Hospital Centre - University of Liege, Lie `ge, Belgium
INTRODUCTION. The widespread use of SOFA score to describe the severity of organ
dysfunction or failure in ICU-patients prompted us to use it to prospectively investigate the
relationship between renal failure (RF) and ICU-acquired infection (IAI).
METHODS. Assessment of daily SOFA score in 2422 patients hospitalized in a 26-bed
general ICU of a university hospital during 4 years (2004–2007). RF was deﬁned by a renal
SOFA score of 3 or 4. Each episode of infection was recorded and sepsis severity was deﬁned
according to the ACCP-SCCM consensus conference guidelines.
RESULTS. Among 1557 patients without infection on admission (IOA), (62.9% were male,
median age was 68 (54–77), SAPS II score 36.3 ± 13.4; 20.9% came for medical reasons,
42.1% from scheduled surgery, 21.5 % from unscheduled surgery and 15.5% were trauma
patients), the median ICU length of stay (LOS) was 6 days (4–12) and hospital mortality was
18.4%. Among these, 215 (13.8%) had a RF either on admission (n = 122) or occurring
before any IAI (n = 93). 79 (36.7%) developed an IAI and 28 a septic shock (13%). Among
the 1342 patients without RF, 352 (26.2%) developed an IAI infection and 76 (5.7%) a septic
shock. There were 37 new episodes of RF possibly related to the IAI. Therefore the proportion
of RF related to IAI was only 14.7% (37/352).
The same proportion was observed for the 865 patients with IOA (63.9% were male, median
age was 65 (53–75), SAPS II score 43.1 ± 14.8; 48.0% were medical patients, 14.9% had
scheduled surgery, 30.3% had unscheduled surgery and 6.8% were trauma patients) with an
ICU LOS of 10 days (5–18) and a hospital mortality of 33.5%. Among the 247 patients with
RF occurring before any IAI either on admission (n = 160) or soon after (n = 87), there were
97 patients (39.3%) who developed an IAI with 45 septic shock (18.2%). Among the 618
patients without early RF, 164 (26.5%) developed an IAI with 49 septic shock (5.7%) There
were 35 new episodes of RF possibly related to IAI leading to a proportion of 12.4% (35/282).
Whether the patient has IOA or not, RF occurrence increases the incidence of IAI and septic
shock in the ICU in a statistically signiﬁcant manner (p\0.05).
CONCLUSION. 1) RF related to IAI represent a minority of cases (72/534 = 13.5%). 2) RF
appears to be a risk factor for infection and for the development of septic shock.
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INTRODUCTION. Renal failure in severely ill patients is one of the mean markers of
gravity. Objective: To assess the characteristics and infection rate (IR) of ICU patients
requiring extra renal depuration (DER).
METHODS. Prospective study performed through out 3 months per year during 2 consec-
utive years (2006 and 2007) using the methodology and database of the ENVIN-HELICS
study. IR are shown per 100 patients and per 1000 days of ICU’ stay. The following
parameters were surveyed: Ventilator associated pneumonia (VAP), urine infection related to
urinary catheter (UC), primary and catheter related bacteremia (PB +CB) and any other kind
of bacteremia.
RESULTS. 947 (3,9%) out of 24137 patients required DER. Mean age: 62,2 years. APACHE
II score: 24,3 (8,4). Immune system alterations. 26,2%. Extrinsic risk factors: mechanical
ventilation (MV) 75,7%, central venous catheter (CVC): 96,2%. UC: 90,88%. Total parenteral
nutrition (TPN): 64,7%. Emergency surgery: 28,6%. Antibiotics prescribed before admission:
52,1%, and into the ICU: 84,5%.
Device related IR, mean ICU stay and mortality are shown in table. In addition to the 532
infections controlled by the ENVIN study, another 359 were reported related to other focus
(94 infections x 100 patients). Infections caused sepsis in 36,2%, severe sepsis in 18,7% and
septic shock in 25%. The micro organisms involved were: GP 28,8%, BGN 51,9%, fungi
18,5% and others 0,8%. Multirresistent infections: colonization-infection by MRSA was
reported (was present) in 4,7%, by Acinetobacter in 8,5%, by P aeruginosa in 5,2% and by
BLEE in 3,3% of the patients.
TABLE 1
ICU-Acq
Inf % pat
ID
0/00 VAP
%p t
UTI
% pat
PB+CRB
%pat
LOS
days
Mortality
%
ALL 14,2 19,6 6,1 14,1 3,8 7,5 10
ERD 56,1 32,3 23,1 24,2 14,2 17,3 46,5
CONCLUSION. Patients with DER are less than 4% of the total admissions in the ICU.
Nonetheless they consume many resources due to the long stay and mortality. Their IR is
higher than the overall IR in the ICU and this could be explained by the associated extrinsic
and intrinsic risk factors.
GRANT ACKNOWLEDGEMENT. Aventis.
21st ESICM Annual Congress – Lisbon, Portugal – 21–24 September 2008 S2651043
THE EFFECT OF DANAPAROID SODIUM COMBINED WITH ANTITHROMBIN
FOR THE PATIENTS WITH SYSTEMIC INFLAMMATORY RESPONSE SYN-
DROME (SIRS) ASSOCIATED COAGULOPATHY (SAC)
K. Ikeda*, T. Ikeda, H. Taniuchi, T. Ueno, S. Suda
Critical Care And Subacute Medicine, Hachiouji Medical Center Of Tokyo Medical Uni-
versity, Tokyo, Japan
INTRODUCTION. Introduction: Danaparoid sodium (DA) is a low molecular weight he-
parinoid with a mean molecular weight of 6000 daltons. It consists of mainly of heparin
sulfate, and high–afﬁnity fraction of heparin sulfate inhibits factor Xa by catalyzing its
binding to antithrombin (AT).
In animal experiment,DA was proved to have both anticoagulant and anti-inﬂammatory
activities.
The aim of this study was to investigate the potential beneﬁts of combination therapy using
DA with AT compared with the use of AT alone for the patients with SAC.
METHODS. METHODS: The subjects were 22 patients with SAC in our ICU. The patients
were divided into two groups, including the AT group: intravenous (iv) administration of
1500 units of AT alone and the AT + DA group: iv administration of the same dose of AT and
2500 units of DA for three days. We measured WBC, CRP, the platelet counts, the values of
AT, ﬁbrinogen, FDP, % PT before, 1 and 3 days after the administration of these medicines.
Furthermore we examined the changes in scores of APACHE II, SOFA, SIRS, DIC in this
study. All data are expressed as mean ± SD.
RESULTS. APACHE II and SIRS scores were decreased signiﬁcantly in the both groups.
SOFA and DIC scores before administration of medicine were signiﬁcantly high compared
with the AT group and signiﬁcantly decreased at 3 days after the administration in the
AT + DA group. The platelet counts decreased signiﬁcantly in the AT + DA group. The
ATIII values increased signiﬁcantly in the both groups. The FDP values before the admin-
istration were signiﬁcant high in the AT + DA group compared with the AT group and
decreased markedly in the AT + DA group. We did not observe signiﬁcant change of
ﬁbrinogen in the both groups. We observed signiﬁcant increase of % PT only in the AT group.
CONCLUSION. The combination therapy of using danaparoid with antithrombin could
reduce SOFA and DIC scores. This therapy may have the potential beneﬁt to improve
coagulation abnormalities for the patients with SAC reducing FDP.
GRANT ACKNOWLEDGEMENT. Japanese society of intensive care medicine.
Poster Sessions
Practices at the end of life: 1044–1052
1044
PATIENT OR FAMILY CONTROLLED PALLIATIVE SEDATION IN TERMINAL
CANCER
D. Aretha*, E. S. Panteli, P. Kiekkas, M. Karanikolas
Anesthesiology and Critical Care Medicine, University Hospital of Patras, Patras, Greece
INTRODUCTION. Terminal cancer patients (pts) experience distressing symptoms (1).
Patient/Family-Controlled Sedation(PFCS) with midazolam has not been described before.
METHODS. A prospective protocol was established and a singe sedative was used. Inclusion
criteriawereseverepain(VAS[7),age[18,writtenptorfamilyconsent,continuouspresence
of a competent adult at bedside and limited life expectancy, based on a PPI[7(2)(table1).
Midazolam was administered IV in a Pt Control Analgesia mode. The dose was adjusted to pt
comfort and the pump was activated as-needed by the pt or a ﬁrst degree relative. Sedation was
rated as: 1) awake 2) arousable to voice 3) arousable to light pain or 4) unarousable. Family
satisfaction was rated as: 1) good, 2) fair, 3) poor, or 4) unacceptable.
RESULTS. PFCS was applied in 7 pts in a 3-years period. Respiratory distress, when present,
improved. Death occurred 1–6 days after PFCS started; Median sedation score was in the
range 1–3 based on three measurements/day (Table 2). Pt demographics, family satisfaction
and daily midazolam use are summarized in Table 1.
TABLE 1 PATIENT CHARACTERISTICS, MIDAZOLAM DOSE AND FAMILY
SATISFACTION
Case/
Age/
Sex
Main
Tumor
Main
Symptom
PPI Satisfaction
G=good,
F=fair
Mean
Midazolam
dose
(mg/day)
Analgesic
Regimen
1/ 38,M Gastric Pa, dys, ag 9 G 17 Fe 100 + Mo 80
2/ 24,M Kidney Pa, dys, ag 10 G 34 Fe 75 + Mo 100
3/ 64,F Colon Pa, ag 9 G 12 Fe 75 + Mo 40
4/ 55,M Pancreas Pa, dys 9 F 20 Fe 150 + Mo 60
5/ 73,F Pancreas Pa, ag 10 G 15 Fe 50 + Mo 30
6/ 40,M Gastric Pa, ag 8 G 40 Fe 150 + Mo 40
7/ 64,F Lung Pa, ag 8 G 25 Epidural
Fe=Fentanyl (TTS, mcg/h), Mo=Morphine (IV, mg/day), dys=dyspnea, pa=pain,
ag=agitation
TABLE 2 MEDIAN SEDATION SCORE
Case Day 1 Day 2 Day 3 Day 4 Day 5 Day6
1 3 3 2 death
2 3 1 death
3 3 death
4 3 3 3 death
5 3 3 2 death
6 1 2 2 3 3 death
7 222323
CONCLUSION. Patient/Family-Controlled Sedation with Midazolam is very effective in
providing comfort in terminal cancer pts, by allowing titration of sedation to individual pt
need.
REFERENCE(S). 1. Kohara H,J.Pall.Med. 2005, 2.Morita T Sup.Care Cancer 1999.
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DOES NON INVASIVE VENTILATION IMPROVE QUALITY OF END-OF-LIFE
CARE IN PATIENTS WITH HEART FAILURE?
S. Georgiou, E. Zampeli, A. Spyropoulou*, H. Kavvouras, D. Karlis, I. Nikitas, K. Alige-
orgas, E. Spyratou, M. Guillaume-Vassilakis
Intensive Care Unit, Tripoli General Hospital, Tripoli, Greece
INTRODUCTION. End stage heart failure (NYHA class IV) is associated with frequent and
prolonged admissions in the hospital. It has been shown that non invasive ventilatory support
(continuous positive airway pressure-CPAP and bi-level airway pressure-BiPAP) improves
clinical parameters and alleviates breathlessness in these patients. The aim of our study was to
assess the role of non invasive ventilation (NIV) in end-of-life care of critically ill patients
with end stage heart failure.
METHODS. The study was carried out in the Cardiology Department of a District General
Hospital in cooperation with the Intensive Care Unit. Patients with acute respiratory failure in
the context of refractory heart failure (functional capacity IV) were enrolled. None was
suitable for heart transplantation due to malignancy, multiple organ failure, diabetes or
age[75 years. Standard medical treatment was initially offered to all of them (oxygen,
diuretics, digoxin, angiotensin converting enzyme inhibitors, b-blockers, levosimendan,
inotropic agents and morphine). NIV was implemented additionally to conventional treatment
in order to relieve patients’ distress. Dyspnea intensity was assessed independently by two
physicians on a 3 hourly basis. The assessment was based on a scale, ranging from 0 to 2
(0 = no effect, 1 = medium improvement, 2 = maximum improvement).
RESULTS. 24 patients were included. The mean age was 69 years and 16 were males. In
relevance to dyspnea the score was 1 for 14 patients (58.33%) and 2 for 2 patients (8.33%).
No response was noted in 8 cases (33.33%). 20/24 patients died within 24–36 h since
application of NIV. In 4 cases signiﬁcant improvement was documented and ICU supervision
was no longer necessary.
CONCLUSION. The majority of critically ill patients with end stage heart failure in our
study manifested symptomatic response to NIV. The indication for applying NIV was not
therapeutic. Our objective was to palliate patients’ agony and provide better end-of-life care.
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CARE UNTIL THE END OF LIFE: REVIEW OF SEDATION AND ANALGESIA IN
PATIENTS 24 HOURS BEFORE DEATH
M. Lugarinho*, P. P. Galhardo, R. Beranger, P. C. P. Souza
Intensive Care Unit, Hospital de Clı ´nicas Mario Lioni, Rio de Janeiro, Brazil
INTRODUCTION. Among the recommendations for end-of-life care, one of the most
important methods of comfort is analgesia and sedation. In a hostile and painful environment
as intensive care units, the concern with the reduction of the suffering must be present from
the admission of the patient and during through the entire hospitalization. In this work we
analyze the prescribed analgesics and sedatives in patients who progressed to death.
METHODS. We retrospectively analyzed the prescriptions of patients who died in the year
2007 with more than 24 h of hospitalization, in a general ICU with 23 beds. We collected
patients informations about age, length of stay and the presence of regular analgesics and
sedatives prescription within 24 h preceding the death.
RESULTS. There were 1043 admissions and 139 patient deaths. Twenty-ﬁve patients were
excluded because died before the ﬁrst 24 h. The mean age was 65.34 years (SD 18.23), with
an average length of hospitalization of 13.49 days (SD 12.5). In the select group, 63 patients
(55.26%) were in regular use of analgesics within 24 h preceding death and 67 patients were
receiving sedatives (58.77%). Seventy-two patients (63.16%) used or analgesia or sedation,
and 48 patients (42.11%) received both. A research previously conducted about end of life
care with the physicians group (n = 21), none was favorable of the suspension of sedatives or
analgesics. In the group of nurses (n = 39) 12.82% agree with the suspension of analgesia
(n = 5) and 17.97% of sedation (n = 7).
CONCLUSION. An approach with quality must ensure routine sedation and analgesia of all
hospitalized patients, regardless of their prognosis. The speech of maintaining such care, even
when death is inevitable, needs to be checked daily since the start of hospitalization. Our goal
is that all of our patients receive comfort, and not just a piece, as shown in this study.
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CAUSES OF DEATH AND INCIDENCE OF WITHDRAWAL OF LIFE-SUSTAINING
TREATMENT IN A DUTCH ICU
M. D. Nieuwenhoff*, J. Bakker, E. J. O. Kompanje
Intensive Care, Erasmus Medical Center, Rotterdam, Netherlands
INTRODUCTION. Withholding and withdrawal of life sustaining treatment is common in
the intensive care unit (ICU), but little is known about the type of patients in which treatment
is withdrawn. The objective of this study was to evaluate the causes of death, and the
incidence of withdrawal of treatment in patients who died in the ICU.
METHODS. A retrospective observational, single centre study in the mixed ICU of a uni-
versity hospital. All patients admitted to the ICU between November 1, 2006, and October 31,
2007 were included. Age, sex, length of stay, APACHE II score and diagnosis, and SOFA-
score were collected for all subjects. Additional data on cause of death and withdrawal of
treatment were collected for patients who died in the ICU. Data were extracted from our
patient data management system, electronic patient dossier, and handwritten medical charts.
RESULTS. Of the 1,353 patients admitted to the ICU, 218 patients (16.1%) died. Severe and
irreversible central nervous system failure was the most frequent cause of death (41.5%),
followed by multiple organ failure, accounting for 38.7% of the deaths. Life sustaining
treatment was withdrawn in 83.7% of the cases. Almost all patients who died of central
nervous system failure, died after withdrawal of therapy.
CONCLUSION. Central nervous system failure is the leading cause of death, closely fol-
lowed by multiple organ failure. In 83.7% of patients who died in the ICU, life-sustaining
treatment is withdrawn.
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MODE OF CARE STRATEGY AT END-OF-LIFE: A 12-MONTH ANALYSIS OF
DATA FROM A CENTRAL LONDON INTENSIVE CARE UNIT
P. A. Hopkins*
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1Intensive Care,
2Palliative Care, Kings College Hospital, London, United Kingdom
INTRODUCTION. There is little published data in the UK examining the detailed epide-
miology of end-of-life management in the critical care setting. Speciﬁcally, the distribution of
treatment strategy at time of death has not been reported. In this study we examined end-of-
life care strategies in 267 patients, who died on the general ICU at a single London teaching
hospital between March 1st, 2007 and February 29th, 2008.
METHODS. The study was conducted in the ICU of a large central London teaching hospital
(30 critical care beds), accepting general medical, surgical and neurosurgical patients with an
established, nurse-led, end-of-life care plan. A prospective deﬁnition of ﬁve modes of death
was made: ‘Dead-on-arrival’; ‘Death on full support’; ‘treatment limitation’; ‘treatment
withdrawal’; or ‘admission for end-of-life care only’. Analysis of patient notes and deﬁnition
of treatment strategy at death was performed within a month of death to determine the
predominant treatment strategy at death. Records were further examined to categorize the
primary basis for treatment withdrawal or limitation if this had occurred. Categorization was
performed by case record review by an independent ICU physician and checked and agreed
with the primary ICU consultant (responsible for the patient at time of death) and nursing/
paramedical team at a monthly multidisciplinary meeting.
RESULTS. 5 patients were dead on arrival (4 ﬁxed-dilated pupils[1 hour). 14 patients were
admitted for the sole purpose of providing end-of-life care in an intensive care environment.
In 16 additional patients, the consensus of the reviewing clinicians was that (in retrospect)
ICU admission had been unequivocally inappropriate, although this latter group were not
excluded from the analysis. Treatment withdrawal occurred in 98 patients; treatment limi-
tation occurred in 115 patients and treatment failure (with death on escalating or maximal
support) occurred in 35 patients. The primary reason for treatment limitation or withdrawal
was underlying diagnosis in 126 (59.2%); pathophysiological futility in 70 (32.9%); patient
request in 11 (5.2%) and subjective (age or quality of life prior to acute illness) in 6 (2.8%).
No advanced directives were available for any unconscious patient.
CONCLUSION. Most patients who died in the ICU had treatment limitation or withdrawal.
The commonest justiﬁcation for treatment limitation/withdrawal was futility related to the
underlying diagnosis rather than from extremes of pathophysiology or subjective criteria such
as age. Interestingly, 14 cases were admitted with the sole purpose of providing end-of-life
care.
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COMMUNICATION WITH RELATIVES OR VISITORS OF ICU PATIENTS -
REALISTIC GOALS
S. Saxena*, T. Ali, I. Lambert, R. Baba
Intensive Care, Mayday University Hospital NHS Trust, Croydon, United Kingdom
INTRODUCTION. Effective communication with the relatives or visitors of critically ill
patients is essential for clinical, ethical and legal reasons, and provides relatives with an
insight into the patients’ diagnosis, current condition, management plan and likely outcome.
This allows family to feel part of the management and reduces fears and anxieties which arise
due to misunderstandings.
METHODS. We conducted a prospective audit over 6 months at our ICU department. Next
of kins of 76 patients admitted were questioned using a pre-prepared questionnaire based on
‘‘Proposed standard or target for best practice’’ with regards to ‘‘Communication with rela-
tives or visitors of ICU patients’’ as described by the Royal College of Anaesthetists audit
recipe book.
RESULTS. 1. 40% of relatives were acknowledged by the ICU nurses within 2 minutes.
2. 36% were given information within 15 minutes of arrival and 24% within 15–30 minutes.
3. 50% were interviewed by the ICU doctor in less than 30 minutes and 20% had no interview
at all.
4. On 32% of days there were formal interviews with doctors; 24% of whom were consultants.
5. 98% of the time the interviews were documented in patient notes and the consistency
between medical and nursing notes were 46%. Nurses documentation towards the end of their
shift and incomplete information were the main reasons for the inconsistency. Essential
information were however consistent.
CONCLUSION. Inspite of the observed results being signiﬁcantly less than the 100% targets
set by the Royal College, a similar survey in our ICU department (in 2006) showed that 92%
of relatives were satisﬁed with the overall level of communication. Following the results of
our audit we conducted a telephone survey of 70 ICU departments across UK, questioning a
senior member of the nursing staff. The results showed only 10% were aware of the national
guidelines; 26% acknowledged relatives within 2 minutes of their arrival into the ICU; 10%
see them within 15 minutes of arrival of the patient; 24% have a daily formal interview with a
doctor; 6% said relatives are seen by a consultant daily; and 100% said all communication is
documented in case notes.
If proposed guidelines were strictly adhered to the satisfaction of relatives would likely be
signiﬁcantly higher than our survey results however the reality is that ICU departments are
frequently unpredictable and busy. Common reasons for failure to reach these targets are,
insufﬁcient medical or nursing staff available to talk to relatives, preoccupation of staff with
emergencies and family being unable to travel to the hospital. We contend that the proposed
standards are unrealistic given the busy and unpredictable nature of the intensive care
environment. We suggest that overall satisfaction is ultimately the best measure to evaluate
communication between health care staff and relatives of critically ill patients.
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WITHDRAWING AND WITHHOLDING LIFE SUSTAINING TREATMENTS:
DECISION MAKING AND APPLICATION: A TWO-YEARS STUDY
M. Lefevre, A. Renault, G. Prat, S. Jaffuel, J. Tonnelier, E. L’Her, J. Boles*
Intensive Care, CHU Brest, Brest, France
INTRODUCTION. Decisions of withdrawing and withholding of life sustaining treatments
are made during a weekly meeting so called ‘‘ethical meeting’’, during which a report is
systematically written. Since april 2005, french law has deﬁned conditions under which such
type of decision can be made. We analyzed how our decision-making process matched the
law, and what were the modalities of application of such decisions.
METHODS. This retrospective study was performed within our 15-beds intensive care unit.
We analysed the patient ﬁles and ethical meeting reports from 2005 and 2006: 52 items were
collected, including the number and qualiﬁcation of participants to the meeting, whether an
external practitioner had given advice, the implication of the family, the modalities of
application.
RESULTS. 1137 patients were admitted in the study period: 280 died (23.8%) and 94
withdrawing or withholding life sustaining treatments (WWLST) were decided (8% of
admissions). Patient with WWLST tended to be elderly (61 mean age vs. 55.5) and more
severe (SAPS 56.9 vs. 46)as compared with overall patients. The average delay between
admission and ethical meeting was 12.9 days; the idea of WWLST appeared in the ﬁle in
37.2% of cases, on average 2 days before the decision. Patients will were expressed in 26.6%
of cases, by the patient himself in 56% of cases. Relatives were known in 97% of cases, 76%
of which had given their opinion. On average, 5.5 people were present in ethical meetings.
External practitioners have been contacted 42 times = 44.7% of cases . 87.2% of families
accepted the decision, one family refused, others did not give their opinion. 42 withdrawing
decisions: a sedation protocol has been used for 54.7% of patients; 29 terminal extubations
have been performed (= 69% of cases). Death occurred on average 2.2 days later. 56 with-
holding decisions: death occurred on average 7.1 days later. 74 of the 94 patients died (78.7%
of WWLST, 26.4% of all dead patients) and 20 survived (21.2% of WWLST). The family was
present during death in 52.7% of cases.
CONCLUSION. A WWLST decision is made on average once a week, more often in older
patients, and those whose SAPS is 25% higher than the average. These weekly ethical
meetings implying all persons in charge of the patient are important events in the life of the
unit. Reaching a consensus may delay the moment of the decision. The fact that more than
one for ﬁve of these patients leaves the unit alive proves that nothing is done to accelerate
their death. Advice from an external practitioner often remains difﬁcult to obtain, but this is
improving with time.
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A COMPARATIVE PROFILE OF FAMILY MEMBER NEEDS OF ICU PATIENTS
BASED ON THE SEVERITY OF ILLNESS
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INTRODUCTION. We have earlier elucidated the immediate needs of family members of
patients admitted to the Intensive care units (ICU). We sought to conduct a comparative
analysis of the needs among family members of patients on the basis of the severity of the
illness.
METHODS. We conducted a multi-center prospective questionnaire based study. All patients
admitted to the ICU of the three Fortis Hospitals (tertiary care multi-specialty hospitals) in the
North India (Noida, Vasant Kunj & Faridabad) for at least 72 h were included. The nearest
relative of each patient were administered an Indian customized version of the modiﬁed
Molter’s questionnaire, also known as the Critical Care family Needs Inventory. The total
number of domains (namely Information, Comfort, Support, Assurance, and Proximity), the
total number of questions (n = 45) as well as the choice of responses (1: ‘not important’ to 4:
‘very important’) were as in the original questionnaire. The responses were converted into a
binomial variable by merging 1&2 as one category and 3&4 as another category. The fre-
quency of each response was then compared between the groups formed on the basis of
APACHE II score (with a cut-off of 10) and need of mechanical ventilation.
RESULTS. A total of 268 patients were included (Noida: n = 104, 38.8%; VK: n = 84,
31.3%; Faridabad: n = 80, 29.9%). Overall Information was the most frequent felt need
followed by Comfort, Proximity, Assurance and Support. However, relative of patients with
higher APACHE II score were more likely to have Assurance needs (‘A14’: 94.5% vs. 81.3%,
OR, 95% CI: 4.1, 1.6–10.2, P\0.001; A28: 75.2% vs. 62.2%, OR, 95% CI: 1.8, 1.1–3.2,
P = 0.033) and Information needs (I39: 91.7% vs. 81.4%, OR, 95% CI: 2.5, 1.1–5.6,
P = 0.02; I4: 73.6% vs. 60.9%, OR, 95% CI: 1.79, 1.04–3.06, P = 0.035). Further, relative of
patients who were being mechanically ventilated also had higher Assurance needs (A25:
60.9% vs.40.5%, OR, 95% CI: 1.17, 1.03–1.33, P = 0.014).
CONCLUSION. Family members of ICU patients with higher severity of critical illnesses, as
indicated by APACHE II score and need of mechanical ventilation, are more likely to have
needs related to Assurance and Information.
GRANT ACKNOWLEDGEMENT. This work was supported by an investigator initiated
research grant from Pﬁzer, India.
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SUPPORT OF THE FAMILY IN THE INTENSIVE CARE UNIT: A NATIONAL
SURVEY
D. Trainor*, C. Gowers, C. McAllister
The Department of Intensive Care, Craigavon Area Hospital, Craigavon, United Kingdom
INTRODUCTION. It could be argued that the structure of an intensive care unit (ICU) is
designed to suit the functions of the medical and allied professions. Within such a framework,
it is important that we also recognise the needs of the patient’s family. Guidelines for support
of the family in the patient-centred intensive care unit have recently been published. [1]
METHODS. Part A: We circulated a post-discharge questionnaire to the next of kin of
patients discharged from our ICU during the month of October 2007. Part B: A telephone
survey was also conducted in order to ascertain arrangements for family support across all of
the ICUs in Northern Ireland.
RESULTS. Part A: Out of 29 discharges 27 responses were obtained. 96% of respondents felt
that the visiting arrangements suited them. Despite a time limited visiting policy, 67% of
respondents were able to visit out of h. 96% of respondents felt the waiting area met their
needs. 93% felt that their questions were listened to and answered all of the time. 85% felt that
they had the opportunity to participate in decision making. Part B: All 9 ICUs in Northern
Ireland were contacted. A 100% response rate was obtained. 4 units did not have a designated
family waiting room. 7 units did not have a designated family discussion room. 1 unit allowed
24 h unrestricted visitation. 8 units had a restricted visiting h policy ranging from 4 to 8 h. 5
units placed an age restriction on visitation (age 16).
CONCLUSION. Restricted visiting policies are in place in ICUs across Northern Ireland.
Despite a restricted visiting policy in our ICU 67% of respondents were able to visit out of h.
This indicates a degree of ﬂexibility with regard to visitation on a case by case basis. A
number of ICUs across Northern Ireland have neither a designated waiting area for families
nor a designated discussion room. This contravenes nationally accepted guidelines for min-
imum standards for intensive care units.[2] A majority of units in Northern Ireland use age 16
as the threshold age for visitation to the ICU. Attitudes of both healthcare staff and relatives to
age restriction on visitation to the ICU should be assessed.
REFERENCE(S). 1. Davidson et al. Clinical practice guidelines for support of the family in
the patient-centred intensive care unit: American College of Critical Care Medicine Task
Force 2004–2005. Critical Care Medicine 2007, 35 (2): 605–622.
2. http://www.ics.ac.uk/icmprof/downloads/ICSstandards4302.pdf.
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